Citrus Sinensis ID: 037068
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 967 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.282 | 0.292 | 0.761 | 1e-127 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.283 | 0.333 | 0.648 | 1e-101 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.263 | 0.197 | 0.453 | 2e-64 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.259 | 0.390 | 0.474 | 9e-63 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.274 | 0.384 | 0.449 | 3e-62 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.264 | 0.341 | 0.452 | 1e-61 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.269 | 0.284 | 0.411 | 2e-58 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.267 | 0.511 | 0.450 | 1e-55 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.265 | 0.158 | 0.441 | 1e-55 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.260 | 0.152 | 0.364 | 3e-55 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 458 bits (1178), Expect = e-127, Method: Compositional matrix adjust.
Identities = 208/273 (76%), Positives = 238/273 (87%)
Query: 682 GEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAE 741
+V E EI W DL I ERIG+GSYGEVY ADWHGTEVAVKKFLDQDFSG +L++F+ E
Sbjct: 657 ADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVR 716
Query: 742 IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK 801
IM RLRHPNVV F+GAVTR P+ SI+TEFLPRGSLYR+LHRP +DERRR++MALDVA
Sbjct: 717 IMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAM 776
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
GMN LHTS PTIVHRDLK+PNLLVD NW VKV DFGLSR+KH+T+LSSKSTAGTPEWMAP
Sbjct: 777 GMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAP 836
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
EVLRNEP+NEKCDVYSFGVILWELATL +PW+G+NPMQVVGAVGFQNRRLEIP ++DP V
Sbjct: 837 EVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVV 896
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954
+II +CWQT+P+LRPSFAQL L+ L RL++
Sbjct: 897 GRIILECWQTDPNLRPSFAQLTEVLKPLNRLVL 929
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 371 bits (953), Expect = e-101, Method: Compositional matrix adjust.
Identities = 179/276 (64%), Positives = 214/276 (77%), Gaps = 2/276 (0%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
+I W DL I E+IG GS+G V+RA+WHG++VAVK ++QDF + +++F E IM RLR
Sbjct: 545 DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 604
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR--PNHQLDERRRMRMALDVAKGMNY 805
HPN+VLFMGAVT+ P+ SI+TE+L RGSLYRLLH+ QLDERRR+ MA DVAKGMNY
Sbjct: 605 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 664
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
LH +P IVHRDLKSPNLLVDK + VKVCDFGLSR+K T+LSSKS AGTPEWMAPEVLR
Sbjct: 665 LHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 724
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
+EP+NEK DVYSFGVILWELATL PW LNP QVV AVGF+ +RLEIP +++P VA II
Sbjct: 725 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 784
Query: 926 RDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTN 961
CW EP RPSFA +M LR L + V N ++
Sbjct: 785 EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 820
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (633), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 117/258 (45%), Positives = 169/258 (65%), Gaps = 3/258 (1%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
EWE+ ++ IG RIG G YG+V+R W GTEVAVK + + + +S + E +++ +
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCK 902
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
LRHPN+VLFMGA T I+TE+L RGSL +L + ++D R+++ D A+GM Y
Sbjct: 903 LRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTY 962
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
LH+ +P I+HRDLK+ NLLVD +W VKV DFGL+ +K HT+ +K+ GT W+APEVL
Sbjct: 963 LHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPEVLA 1020
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
E EK DVYS+ ++LWEL T +P+ G N MQVV ++ + RL +P P A ++
Sbjct: 1021 EEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERLPMPAWCPPKYAALM 1079
Query: 926 RDCWQTEPHLRPSFAQLM 943
CW+T+P RPSF +++
Sbjct: 1080 NRCWETDPTHRPSFPEIL 1097
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (618), Expect = 9e-63, Method: Compositional matrix adjust.
Identities = 120/253 (47%), Positives = 160/253 (63%), Gaps = 2/253 (0%)
Query: 694 LQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
++IG RIG G+YGEVY W G++VAVKK + + + L +F E +M LRHPNV+
Sbjct: 374 IKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNVIQ 433
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
F+G+ P I TE++PRGSLY +LH QL ++M +D AKG+ YLH S P I
Sbjct: 434 FLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLHNSTPVI 493
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKC 873
+HRDLKS NLLVD+NW VKV DFGLS I+ ++ + GTP W +PEVLR++ EK
Sbjct: 494 LHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYTEKA 551
Query: 874 DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933
DVYSFG+ILWE AT P+ G+ P QV+ AVG + R +P + P Q++ DC P
Sbjct: 552 DVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLIDCLNENP 611
Query: 934 HLRPSFAQLMSRL 946
RP+ Q + RL
Sbjct: 612 SHRPTMEQCLERL 624
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 124/276 (44%), Positives = 167/276 (60%), Gaps = 11/276 (3%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
+ ++IG RIG G++GEVY W G++VAVKK + + + L +F E +M LRHPNV
Sbjct: 389 QQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNV 448
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ F+G+ SP I TE++PRGSLY +LH ++ RM +D AKG+ YLH S P
Sbjct: 449 IQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLHGSTP 508
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
I+HRDLKS NLLVD+NW VKV DFGLS I+ ++ + GTP W +PEVLR++ E
Sbjct: 509 VILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYTE 566
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQT 931
K DVYSFG+ILWE AT P+ G+ P QV+ AVG + R P P Q+++DC
Sbjct: 567 KADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKDCLNE 626
Query: 932 EPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSELP 967
P RP+ Q CL+ L S T F ++P
Sbjct: 627 NPSQRPTMEQ------CLEIL---ESIETKGFDDIP 653
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (608), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 118/261 (45%), Positives = 163/261 (62%), Gaps = 5/261 (1%)
Query: 693 DLQIGERIGIGSYGEVYRADWHGTEVAVKK--FLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
++ + RIG GS EV+ W G VA+KK L++D D L++ EA IM +LRHPN
Sbjct: 490 EIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNED-DEDFLNELAQEATIMSQLRHPN 548
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+ F+G P I+ E++P GSLYR+LH P+ LD R MALD+AKGMNYLH
Sbjct: 549 ICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGMNYLHCCD 608
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKST-AGTPEWMAPEVLRNEP 868
P ++HRDLKS NLLVD+++ VK+ DFGLS R K H + T GTP W APEVLRN+P
Sbjct: 609 PIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTAPEVLRNDP 668
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928
EK DV+SF ++LWE+ T P++G+ Q+V +VG R +P + ++I +C
Sbjct: 669 YTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPFTRLITEC 728
Query: 929 WQTEPHLRPSFAQLMSRLRCL 949
W +P RPSF +++ RL +
Sbjct: 729 WSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (582), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 109/265 (41%), Positives = 175/265 (66%), Gaps = 4/265 (1%)
Query: 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKF-LDQDFSGDSLSQFKCEAEI 742
++ EI + +L+I ++G G++G VY+ W G+ VA+K+ +++D + L +F+ E I
Sbjct: 652 FSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTI 711
Query: 743 MLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
+ RLRHPN+VL M A T P+ +TE+LP GSLY LH +++ + ++A+ +A+G
Sbjct: 712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQG 771
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPE 862
MNYLH S ++HRD+KS NLL+D++ VK+CDFGLS++K + +KS G+P WM+PE
Sbjct: 772 MNYLHLS--GVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSI-GSPIWMSPE 828
Query: 863 VLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
+L E EK DVY+FG+ILWEL T +P+ GL+ +Q+ AV ++ R IP+ ++
Sbjct: 829 LLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLS 888
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRLR 947
+I+ CW +P RPSF ++++ L
Sbjct: 889 HLIQACWHQDPLKRPSFTEILNLLN 913
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (557), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 118/262 (45%), Positives = 162/262 (61%), Gaps = 3/262 (1%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
EI E++ E IG GS+G+VY+ VAVK Q+F +LS F+ E +M ++
Sbjct: 18 EIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNFDAATLSAFRKEVHLMSKIY 77
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
HPN+ LFMGA T I+TE +P+G+L LLH QL RMRMA D A G+N+LH
Sbjct: 78 HPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQLPLYLRMRMARDAALGINWLH 137
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH-HTYLSSKSTA-GTPEWMAPEVLR 865
S+P VHRD+KS NLLVD+N VK+CDFGLS +K H L +S+A GTP +MAPEV+
Sbjct: 138 ESNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLYMAPEVMM 197
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVV-GAVGFQNRRLEIPDDIDPAVAQI 924
+ NE DVYSFG++LWE+ T P+ ++ AV ++ R IP+D ++ ++
Sbjct: 198 FKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDCLDSLRRL 257
Query: 925 IRDCWQTEPHLRPSFAQLMSRL 946
I CW EP RPSF +++S L
Sbjct: 258 IEKCWDKEPISRPSFKEIISAL 279
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 218 bits (556), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 120/272 (44%), Positives = 166/272 (61%), Gaps = 15/272 (5%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
+WEI + +L+IGE +G G YGEVY++ W GTEVAVK + S D F E +IM
Sbjct: 778 DWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEVKIMTS 837
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL-HRPNHQLDERRRMRMALDVAKGMN 804
LRHPNVVLFM A T+SP+ I+ EF+ GSLY LL + ++ +++MA +KGM+
Sbjct: 838 LRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIKMAYQASKGMH 897
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST----AGTPEWMA 860
+LH+S IVHRDLKS NLL+D W VKV DFGL+++K L K T GT W+A
Sbjct: 898 FLHSSG--IVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSE--LDKKKTNDNIIGTIHWIA 953
Query: 861 PEVLRNEPANEK--CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
PE+L + + DVYSFG+ILWEL T P+KG+ P + +V R I D+
Sbjct: 954 PEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIRDGMRPPISDEAV 1013
Query: 919 PA----VAQIIRDCWQTEPHLRPSFAQLMSRL 946
A +I+ CW ++ +RP+F ++M+RL
Sbjct: 1014 TAHSIEYIDLIKQCWHSDTIIRPTFLEIMTRL 1045
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 93/255 (36%), Positives = 164/255 (64%), Gaps = 3/255 (1%)
Query: 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+ W I ++++++GE+IG+GSYG VYR W +VA+KKF+ Q + L + E +
Sbjct: 1389 LCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFL 1448
Query: 744 LRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
+L HPN++ +GA + P+ I+TE++ +G+L + +L+ +++++ +++AKG+
Sbjct: 1449 KKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGI 1508
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEV 863
+YLH+ P I+HRD+K N+L+D+NW VK+ DFG +RIK + ++ GTP W APE+
Sbjct: 1509 SYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR--CGTPCWTAPEI 1566
Query: 864 LRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923
+RN+ +EK DV+SFG+++WE+ T P+ G N M++ + ++ R +IP D A+
Sbjct: 1567 IRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFAK 1625
Query: 924 IIRDCWQTEPHLRPS 938
++R CW + RP+
Sbjct: 1626 LMRKCWHAKSTKRPT 1640
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 967 | ||||||
| 359475950 | 929 | PREDICTED: serine/threonine-protein kina | 0.946 | 0.984 | 0.652 | 0.0 | |
| 296081663 | 876 | unnamed protein product [Vitis vinifera] | 0.891 | 0.984 | 0.634 | 0.0 | |
| 255550798 | 968 | map3k delta-1 protein kinase, putative [ | 0.980 | 0.979 | 0.628 | 0.0 | |
| 449447333 | 969 | PREDICTED: uncharacterized protein LOC10 | 0.979 | 0.977 | 0.620 | 0.0 | |
| 356564057 | 933 | PREDICTED: uncharacterized protein LOC10 | 0.942 | 0.976 | 0.580 | 0.0 | |
| 356554074 | 924 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.982 | 0.583 | 0.0 | |
| 357437463 | 925 | MAP kinase kinase kinase [Medicago trunc | 0.934 | 0.977 | 0.539 | 0.0 | |
| 449486753 | 712 | PREDICTED: uncharacterized LOC101214554 | 0.709 | 0.963 | 0.529 | 1e-175 | |
| 224142886 | 839 | predicted protein [Populus trichocarpa] | 0.381 | 0.439 | 0.749 | 1e-163 | |
| 224088840 | 889 | predicted protein [Populus trichocarpa] | 0.327 | 0.356 | 0.817 | 1e-156 |
| >gi|359475950|ref|XP_002279319.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1210 bits (3131), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 634/972 (65%), Positives = 742/972 (76%), Gaps = 57/972 (5%)
Query: 1 MSKVKHLLRKLHIGGGLNEHQRLPDARPVINPSPSPSPSPSPNATPSSSSPSSGTLGRIG 60
MS++KHLLRKLHIGG LNEHQR+P+ RPVINPSPSP+ S ++ S + G++G
Sbjct: 1 MSRMKHLLRKLHIGGSLNEHQRIPETRPVINPSPSPNQSSP--VAAAAPSSALGSVGGGD 58
Query: 61 AVESAASDRRDGDSGVDFNLLEEEFQVQLALAISASDPDAREKVESAQIDAAKRMSLGCR 120
AV+ AA D +D + VDF+ LEEEFQVQLALAISASDPDAR+ E+AQI AKR+SLGC
Sbjct: 59 AVDRAAVDSQD--AAVDFSFLEEEFQVQLALAISASDPDARDDRETAQIKVAKRISLGC- 115
Query: 121 SASVTETDALVEFLSLRYWSYSAVNYDEKIVDGFYDVYGITSNSVSQGKMPLLVDLQAIS 180
S S T+T+ LVE LSLRYW+Y+AVNYDEK++DGFYDVYGIT+NSV QGKMPLLVDLQAIS
Sbjct: 116 SPSTTDTETLVELLSLRYWNYNAVNYDEKVMDGFYDVYGITANSVVQGKMPLLVDLQAIS 175
Query: 181 LSDNLDYEVIVVNRLVDPNLKELEKRAYNVSVECRYSDLGPILSGLIQKIADLVVERMGG 240
+ DN+DYEVI+V+R++DP+L+ELE +AY++S+E + SD IL GL+QKIAD+VVERMGG
Sbjct: 176 VLDNVDYEVILVDRMIDPDLRELEDKAYSLSMEYQVSDQLTILDGLVQKIADMVVERMGG 235
Query: 241 PVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKVLADRINLPCMLVK 300
PVG+A+E+ RWT+R +LR+SLNT ILPLG LD+GLSRHRALLFKVLADRINLPC+LVK
Sbjct: 236 PVGDADEMLKRWTIRSYELRSSLNTIILPLGRLDIGLSRHRALLFKVLADRINLPCLLVK 295
Query: 301 GSYYTGTDDGAVNLIKLDNGSEYIIDLMGAPGTLIPAEVPSCLLQNAGLDVREFPDHTET 360
GSYYTGTDDGA+NLIK+DNGSEYIIDLMGAPG LIPAEVPS QN GLDVR D E
Sbjct: 296 GSYYTGTDDGAINLIKIDNGSEYIIDLMGAPGALIPAEVPSSHHQNFGLDVRSCTDVIEA 355
Query: 361 SVISHMELDDGTETPTISRPMPDRIPEVGSTGSEEASFVGKITNKDESELADKNQTEKFE 420
+ S + + GT P D + + GS+ SEEA F+G + D+ +K +TE+FE
Sbjct: 356 ARESLLVPEKGTGF----SPNLDVVSKPGSSKSEEAPFIGIRSKGDDRSPVEKFETERFE 411
Query: 421 KDFGQLSPALSNPCEGTSGTSRKPSSAQKKKVKSVSKYVISAAKDPEFARKLHAVLLQSG 480
+FG L P+L CEG+SGT K S AQK KVK VSKYVISAAK+PEFA+KLHAVLL+SG
Sbjct: 412 NEFGNLLPSLRKLCEGSSGTCGKASPAQKMKVKDVSKYVISAAKNPEFAQKLHAVLLESG 471
Query: 481 ASPPPDLFLDINSQDLGEWKMLEQVHLADGKNVDNDVQCLSNRFLSNHEQSHASSVGVES 540
ASPPPDLF DINS+ E K+LEQ+H+A GK VD+ V FL N EQ S
Sbjct: 472 ASPPPDLFSDINSRGQVEQKVLEQIHMAKGKQVDHGVWYSPGEFLLNSEQPLMPS----- 526
Query: 541 SNYLNYESRKRQPAEWFAEQHKKLEPNVINCDLSLSSDTAGERFVLVGNELKLNNATSVN 600
++E NV N D SL SDT E F+L+G A +
Sbjct: 527 ---------------------HQVETNVTNSDFSLPSDTTSEGFILIG-------AGANG 558
Query: 601 TVPVNPPGVVAGASCEKEIPGSPLPAAAEFCQRQPENALVSVKQPVYTD-LG-------- 651
+ N GV ++I S LP+A E CQRQPENALVS P + D +G
Sbjct: 559 MIRTNATGVTM-----EQIHESFLPSAGETCQRQPENALVSDGGPCFQDNIGRILSNIGT 613
Query: 652 -KESAADLMPMINSGLLMTCNGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYR 710
KESA LM N L + N S+ INPML EVAEWEI WEDLQIGERIGIGSYGEVYR
Sbjct: 614 EKESALGLMETANGALHIPSNAHSEQINPMLAEVAEWEIPWEDLQIGERIGIGSYGEVYR 673
Query: 711 ADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770
ADW+GTEVAVKKFL QDFSGD+L QF+ E EIMLRLRHPNVVLFMGAVTR P+ SILTEF
Sbjct: 674 ADWNGTEVAVKKFLAQDFSGDALVQFRYEVEIMLRLRHPNVVLFMGAVTRPPNLSILTEF 733
Query: 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830
LPRGSLYRLLHR N QLDE+RR+RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV
Sbjct: 734 LPRGSLYRLLHRSNIQLDEKRRLRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 793
Query: 831 VKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSV 890
VKVCDFGLSR+KHHT+LSSKSTAGTPEWMAPEVLRNEP+NEKCDVYSFGVILWELATL +
Sbjct: 794 VKVCDFGLSRLKHHTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRI 853
Query: 891 PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950
PW G+NPMQVVGAVGFQ+RRLEIP+++DP VAQII DCW+ EP RPSF+QLMSRL+ LQ
Sbjct: 854 PWSGMNPMQVVGAVGFQDRRLEIPEEVDPMVAQIINDCWEVEPRKRPSFSQLMSRLKHLQ 913
Query: 951 RLLVDRSNSTNQ 962
L+ +R++S+ Q
Sbjct: 914 HLVFERASSSRQ 925
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081663|emb|CBI20668.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1171 bits (3029), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 617/972 (63%), Positives = 716/972 (73%), Gaps = 110/972 (11%)
Query: 1 MSKVKHLLRKLHIGGGLNEHQRLPDARPVINPSPSPSPSPSPNATPSSSSPSSGTLGRIG 60
MS++KHLLRKLHIGG LNEHQR+P+ RPVINPSPSP+ S ++ S + G++G
Sbjct: 1 MSRMKHLLRKLHIGGSLNEHQRIPETRPVINPSPSPNQSSP--VAAAAPSSALGSVGGGD 58
Query: 61 AVESAASDRRDGDSGVDFNLLEEEFQVQLALAISASDPDAREKVESAQIDAAKRMSLGCR 120
AV+ AA D +D + VDF+ LEEEFQVQLALAISASDPDAR+ E+AQI AKR+SLGC
Sbjct: 59 AVDRAAVDSQD--AAVDFSFLEEEFQVQLALAISASDPDARDDRETAQIKVAKRISLGC- 115
Query: 121 SASVTETDALVEFLSLRYWSYSAVNYDEKIVDGFYDVYGITSNSVSQGKMPLLVDLQAIS 180
S S T+T+ LVE LSLRYW+Y+AVNYDEK++DGFYDVYGIT+NSV QGKMPLLVDLQAIS
Sbjct: 116 SPSTTDTETLVELLSLRYWNYNAVNYDEKVMDGFYDVYGITANSVVQGKMPLLVDLQAIS 175
Query: 181 LSDNLDYEVIVVNRLVDPNLKELEKRAYNVSVECRYSDLGPILSGLIQKIADLVVERMGG 240
+ DN+DYEVI+V+R++DP+L+ELE +AY++S+E + SD IL GL+QKIAD+VVERMGG
Sbjct: 176 VLDNVDYEVILVDRMIDPDLRELEDKAYSLSMEYQVSDQLTILDGLVQKIADMVVERMGG 235
Query: 241 PVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKVLADRINLPCMLVK 300
PVG+A+E+ RWT+R +LR+SLNT ILPLG LD+GLSRHRALLFKVLADRINLPC+LVK
Sbjct: 236 PVGDADEMLKRWTIRSYELRSSLNTIILPLGRLDIGLSRHRALLFKVLADRINLPCLLVK 295
Query: 301 GSYYTGTDDGAVNLIKLDNGSEYIIDLMGAPGTLIPAEVPSCLLQNAGLDVREFPDHTET 360
GSYYTGTDDGA+NLIK+DNGSEYIIDLMGAPG LIPAEVPS QN GLD
Sbjct: 296 GSYYTGTDDGAINLIKIDNGSEYIIDLMGAPGALIPAEVPSSHHQNFGLD---------- 345
Query: 361 SVISHMELDDGTETPTISRPMPDRIPEVGSTGSEEASFVGKITNKDESELADKNQTEKFE 420
SEEA F+G + D+ +K +TE+FE
Sbjct: 346 --------------------------------SEEAPFIGIRSKGDDRSPVEKFETERFE 373
Query: 421 KDFGQLSPALSNPCEGTSGTSRKPSSAQKKKVKSVSKYVISAAKDPEFARKLHAVLLQSG 480
+FG L P+L CEG+SGT K S AQK KVK VSKYVISAAK+PEFA+KLHAVLL+SG
Sbjct: 374 NEFGNLLPSLRKLCEGSSGTCGKASPAQKMKVKDVSKYVISAAKNPEFAQKLHAVLLESG 433
Query: 481 ASPPPDLFLDINSQDLGEWKMLEQVHLADGKNVDNDVQCLSNRFLSNHEQSHASSVGVES 540
ASPPPDLF DINS+ E K+LEQ+H+A GK VD+ V FL N EQ S
Sbjct: 434 ASPPPDLFSDINSRGQVEQKVLEQIHMAKGKQVDHGVWYSPGEFLLNSEQPLMPS----- 488
Query: 541 SNYLNYESRKRQPAEWFAEQHKKLEPNVINCDLSLSSDTAGERFVLVGNELKLNNATSVN 600
++E NV N D SL SDT E F+L+G A +
Sbjct: 489 ---------------------HQVETNVTNSDFSLPSDTTSEGFILIG-------AGANG 520
Query: 601 TVPVNPPGVVAGASCEKEIPGSPLPAAAEFCQRQPENALVSVKQPVYTD-LG-------- 651
+ N A E CQRQPENALVS P + D +G
Sbjct: 521 MIRTN--------------------ATGETCQRQPENALVSDGGPCFQDNIGRILSNIGT 560
Query: 652 -KESAADLMPMINSGLLMTCNGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYR 710
KESA LM N L + N S+ INPML EVAEWEI WEDLQIGERIGIGSYGEVYR
Sbjct: 561 EKESALGLMETANGALHIPSNAHSEQINPMLAEVAEWEIPWEDLQIGERIGIGSYGEVYR 620
Query: 711 ADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770
ADW+GTEVAVKKFL QDFSGD+L QF+ E EIMLRLRHPNVVLFMGAVTR P+ SILTEF
Sbjct: 621 ADWNGTEVAVKKFLAQDFSGDALVQFRYEVEIMLRLRHPNVVLFMGAVTRPPNLSILTEF 680
Query: 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830
LPRGSLYRLLHR N QLDE+RR+RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV
Sbjct: 681 LPRGSLYRLLHRSNIQLDEKRRLRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 740
Query: 831 VKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSV 890
VKVCDFGLSR+KHHT+LSSKSTAGTPEWMAPEVLRNEP+NEKCDVYSFGVILWELATL +
Sbjct: 741 VKVCDFGLSRLKHHTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRI 800
Query: 891 PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950
PW G+NPMQVVGAVGFQ+RRLEIP+++DP VAQII DCW+ EP RPSF+QLMSRL+ LQ
Sbjct: 801 PWSGMNPMQVVGAVGFQDRRLEIPEEVDPMVAQIINDCWEVEPRKRPSFSQLMSRLKHLQ 860
Query: 951 RLLVDRSNSTNQ 962
L+ +R++S+ Q
Sbjct: 861 HLVFERASSSRQ 872
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550798|ref|XP_002516447.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223544267|gb|EEF45788.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1164 bits (3012), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 614/977 (62%), Positives = 738/977 (75%), Gaps = 29/977 (2%)
Query: 1 MSKVKHLLRKLHIGGGLNEHQRLPDA-------RPVINPSPSPSPSPSPNATPSSSSPSS 53
MSK+KHLLRKLHIGGG+N+HQRL + RPV+NPS + S S + + SSSS
Sbjct: 1 MSKMKHLLRKLHIGGGINDHQRLAETTAATTATRPVVNPSAAASSSIAAVESSSSSSSPP 60
Query: 54 GTLGRIGAVESAASDRRDGDSGVDFNLLEEEFQVQLALAISASDPDAREKVESAQIDAAK 113
AV +S G DF+LLEEEFQVQLALAIS SDPD R ESAQIDAAK
Sbjct: 61 L------AVVDGSSISSSGGGAADFSLLEEEFQVQLALAISVSDPDMRTDPESAQIDAAK 114
Query: 114 RMSLGCRSASVTETDALVEFLSLRYWSYSAVNYDEKIVDGFYDVYGITSNSVSQGKMPLL 173
R+SLGC +SV+ +DA+ + LSLRYWSY+ VNY++K++DGFYDVY I+SNSV QGKMPLL
Sbjct: 115 RISLGCPVSSVSVSDAVNQSLSLRYWSYNVVNYNDKVMDGFYDVYCISSNSVIQGKMPLL 174
Query: 174 VDLQAISLSDNLDYEVIVVNRLVDPNLKELEKRAYNVSVECRYSDLGPILSGLIQKIADL 233
VDLQAIS+ DN+DYEV++VNR +DP L+ELE++AY +S+E R SD P L+GLIQK+ADL
Sbjct: 175 VDLQAISILDNVDYEVVLVNRFMDPELRELERKAYIMSLEQRVSDGLP-LNGLIQKLADL 233
Query: 234 VVERMGGPVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKVLADRIN 293
VV+RMGGPVG+A+EI RWT R +LRN+LN+ ++PLG LDVGLSRHRALLFKVLADRIN
Sbjct: 234 VVDRMGGPVGDADEISTRWTKRSYELRNALNSIVIPLGRLDVGLSRHRALLFKVLADRIN 293
Query: 294 LPCMLVKGSYYTGTDDGAVNLIKLDNGSEYIIDLMGAPGTLIPAEVPSCLLQNAGLDVRE 353
LPCMLVKGSYYTGTDDGAVNLI++DN SEYIIDLMGAPGTLIPAE+PS L N G D R
Sbjct: 294 LPCMLVKGSYYTGTDDGAVNLIRIDNESEYIIDLMGAPGTLIPAELPSSHLLNTGFDARG 353
Query: 354 FPDHTETSVISHMELDDGTETPTISRPMPDRIPEVGSTGSEEASFVGKITNKDESELADK 413
F D TET+ S + L + + +S P +R+ +G++ +EE F+G TN+ + L +K
Sbjct: 354 FADLTETAKRSSLLLGEESRDIAVS-PHLNRVYHLGASRTEEDLFLGIKTNEAHTSLVEK 412
Query: 414 NQTEKFEKDFGQLSPALSNPCEGTSGTSRKPSSAQKKKVKSVSKYVISAAKDPEFARKLH 473
NQ E FE++F + P+ P + GT R PS A+ KVK+VSKYVISAAKDPEFA+KLH
Sbjct: 413 NQIETFEQEFAKFFPSSHKPHHNSLGTGR-PSLAENIKVKNVSKYVISAAKDPEFAQKLH 471
Query: 474 AVLLQSGASPPPDLFLDINSQDLGEWKMLEQVHLADGKNVDNDVQCLSNRFLSNHEQSHA 533
AVLL+SGASPPPDLF D N Q +GE K LEQ++L +G N + C + L+ H QSH
Sbjct: 472 AVLLESGASPPPDLFSDTNQQVMGEGKALEQIYLKNGVNPGDGRYCHLGKSLARHMQSHE 531
Query: 534 SSVGVESSNYLNYESRKRQPAEWFAEQHKKLEPNVINCDLSLSSDTAGERFVLVGNELKL 593
S ++ N + + A+ A+Q +++E + LSSD + + +LV N +K
Sbjct: 532 SLTTEDALNNGRCNAEQGWTADRTAKQQREMEVEFLKSKAFLSSDASSDGPLLVENRIKQ 591
Query: 594 N---NATSVNTVPVNPPGVVAGASCEKEIPGSPLPAAAEFCQRQPENAL----------V 640
A +T+ +P +V +I LP+A + CQ Q E+AL
Sbjct: 592 ELQIGAIGADTIHNDPLVMVGRPMHGNQIHEPSLPSAVDSCQLQSEDALDCDDDNRCFQE 651
Query: 641 SVKQPVYTDLGKESAADLMPMINSGLLMTCNGQSDSINPMLGEVAEWEILWEDLQIGERI 700
+ + + GKESA L+ NS L ++CNG S+ I+PMLGEVAEWEI WEDLQIGERI
Sbjct: 652 KLGRNFNMETGKESAMKLIGTSNSALHISCNGYSEKIHPMLGEVAEWEIPWEDLQIGERI 711
Query: 701 GIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760
GIGSYGEVY ADW+GTEVAVKKFLDQD SGD+L QFKCEAEIMLRLRHPNVVLFMGAVTR
Sbjct: 712 GIGSYGEVYHADWNGTEVAVKKFLDQDLSGDALVQFKCEAEIMLRLRHPNVVLFMGAVTR 771
Query: 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKS 820
PH SILTEFLPRGSLYRLLHRPN Q+DE+RRMRMALDVAKGMNYLHTSHP IVHRDLKS
Sbjct: 772 PPHLSILTEFLPRGSLYRLLHRPNPQIDEKRRMRMALDVAKGMNYLHTSHPPIVHRDLKS 831
Query: 821 PNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGV 880
PNLLVDKNWVVKVCDFGLSR+KHHT+LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFG+
Sbjct: 832 PNLLVDKNWVVKVCDFGLSRLKHHTFLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGM 891
Query: 881 ILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFA 940
ILWELAT +PWKGLNPMQVVGAVGFQN+RLEIP+D+DPA+A+II DCWQ EP LRPSF+
Sbjct: 892 ILWELATCQIPWKGLNPMQVVGAVGFQNKRLEIPEDVDPAIAEIINDCWQREPDLRPSFS 951
Query: 941 QLMSRLRCLQRLLVDRS 957
QL+S+LR +QRL V+RS
Sbjct: 952 QLISQLRHIQRLRVERS 968
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449447333|ref|XP_004141423.1| PREDICTED: uncharacterized protein LOC101214554 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1108 bits (2865), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 612/987 (62%), Positives = 732/987 (74%), Gaps = 40/987 (4%)
Query: 1 MSKVKHLLRKLHIGGGLNEHQRLPDARPVINPSPSPSPSPSPNATPSS----------SS 50
MSK+KHLLRKLHIGGGLNEHQRL DARPV PS SPSP PSPN+ PS S
Sbjct: 1 MSKMKHLLRKLHIGGGLNEHQRLSDARPVTRPSSSPSPGPSPNSNPSGSSSSGSSSSLSM 60
Query: 51 PSSGTLGRIGAVESAASDRRDGDSG---VDFNLLEEEFQVQLALAISASDPDAREKVESA 107
SS T+GR+ AVES GD G VDFN LEEEFQVQLA+AISASDPD+R+ ESA
Sbjct: 61 ASSTTMGRLEAVESVVDPAASGDVGGGCVDFNALEEEFQVQLAMAISASDPDSRQDTESA 120
Query: 108 QIDAAKRMSLGCRSASVTETDALVEFLSLRYWSYSAVNYDEKIVDGFYDVYGITSNSVSQ 167
QIDAAKRMSLGC S SV+ + AL EFLSL+YWSY+ VNYDEK++DGFYD+YGIT++S ++
Sbjct: 121 QIDAAKRMSLGC-SPSVSGSKALAEFLSLQYWSYNVVNYDEKVMDGFYDLYGITASSSTR 179
Query: 168 GKMPLLVDLQAISLSDNLDYEVIVVNRLVDPNLKELEKRAYNVSVECRYSDLGPILSGLI 227
GKMPLLVDL+ I ++ ++DYEVI+VNRL+DP L++LE++AYN+ +ECR S+ G ILSGL+
Sbjct: 180 GKMPLLVDLKEICVTSDIDYEVILVNRLLDPELQQLERQAYNIFMECRVSEYGFILSGLV 239
Query: 228 QKIADLVVERMGGPVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKV 287
QKIAD+VV RMGGPVG+AEE+ RWT R ++R+SLNT ILPLG LD+GL+RHRALLFKV
Sbjct: 240 QKIADMVVARMGGPVGDAEEMLRRWTRRSYEMRSSLNTIILPLGRLDIGLARHRALLFKV 299
Query: 288 LADRINLPCMLVKGSYYTGTDDGAVNLIKLDNGSEYIIDLMGAPGTLIPAEVPSCLLQNA 347
LADRINLPC+LVKGSYYTGTDDGAVN+IK+DNGSEYIIDLMGAPGTLIP+E PS N
Sbjct: 300 LADRINLPCILVKGSYYTGTDDGAVNMIKIDNGSEYIIDLMGAPGTLIPSEAPSGQFSNY 359
Query: 348 GLDVREFPDHTETSVISHMELDDGTETPTISRPMPDRIPEVGSTGSEEASFVGKITNKDE 407
G D R D E + + ++G E +IS D + +V + S+EAS + + ++
Sbjct: 360 GFD-RRPADVIEVPEDTPILQNEGAEAVSISSTQ-DEVADVCNLISKEASDLDAQSKENI 417
Query: 408 SELADKNQTEKFEKDFGQLSPALSNPCEGTSGTSRKPSSAQKKKVKSVSKYVISAAKDPE 467
++ Q+ DF +L + S+ CEG+ G + +SAQKKKVK VSKYVISAAK+PE
Sbjct: 418 RNFIEEIQSGSSGYDFAKLLESESSACEGSLGAFAQSASAQKKKVKKVSKYVISAAKNPE 477
Query: 468 FARKLHAVLLQSGASPPPDLFLDINSQDLGEWKMLEQVHLADGKNVDNDVQCLSNRFLSN 527
FA+KLHAVLL+SGASPP DLF DI SQD GE K Q++ +GK +D +Q S L++
Sbjct: 478 FAQKLHAVLLESGASPPADLFSDIESQDNGESKETFQMYPINGKGIDVGLQSHS-YILAS 536
Query: 528 HEQSHASSVGVESSNYLNYESRKRQPAEWFAEQHKKLEPNVINCDLSLSSDTAGERFVLV 587
H QS A+S E N + +E++++ P+ +E+ + N N + E FV V
Sbjct: 537 HGQSSATSTEAEYLNNVVHENKQKVPSGGLSEE-QMANTNANNHSIFWPHSMKNEGFVFV 595
Query: 588 GNELKLNNATSVNTVPVNPPGVVAGASCEKEIPGSPLPAAAEFCQRQPENALVSVKQPVY 647
N + V VN + +E L + ++ +ALVS ++ +
Sbjct: 596 DV-----NGEAGKLVDVN-------GTFHREHMDDVLLTSDTDSHKKLGSALVSEERRLL 643
Query: 648 TDL--GKESAADLMPMINSGLLMT-------CNGQSDSINPMLGEVAEWEILWEDLQIGE 698
D G DL LL T + +++INP+LGEVAEWEI WEDL IGE
Sbjct: 644 QDKSGGTLQCFDLCEKPLENLLQTDDSKLHASDEHNETINPILGEVAEWEIPWEDLHIGE 703
Query: 699 RIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV 758
RIGIGSYGEVYRADW+GTEVAVKKFLDQDFSG +L Q KCE EIMLRLRHPNVVLFMGAV
Sbjct: 704 RIGIGSYGEVYRADWNGTEVAVKKFLDQDFSGAALVQLKCEVEIMLRLRHPNVVLFMGAV 763
Query: 759 TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDL 818
TR PHFSILTEFLPRGSLYRLLHRPN QLDERRR++MALDVAKGMNYLHTSHPTIVHRDL
Sbjct: 764 TRPPHFSILTEFLPRGSLYRLLHRPNSQLDERRRLKMALDVAKGMNYLHTSHPTIVHRDL 823
Query: 819 KSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSF 878
KSPNLLVDKNWVVKVCDFGLSR+K +T+LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSF
Sbjct: 824 KSPNLLVDKNWVVKVCDFGLSRVKQNTFLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSF 883
Query: 879 GVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPS 938
GVILWEL T +PWKGLNPMQVVGAVGFQNRRLEIP D+DPAVAQII DCWQT+ LRPS
Sbjct: 884 GVILWELTTCRIPWKGLNPMQVVGAVGFQNRRLEIPQDVDPAVAQIICDCWQTDSQLRPS 943
Query: 939 FAQLMSRLRCLQRLLVDRSNSTNQFSE 965
F+QL++RLR LQR LV +++S NQ SE
Sbjct: 944 FSQLITRLRRLQR-LVQKTDSGNQISE 969
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564057|ref|XP_003550273.1| PREDICTED: uncharacterized protein LOC100779137 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1050 bits (2715), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/983 (58%), Positives = 698/983 (71%), Gaps = 72/983 (7%)
Query: 1 MSKVKHLLRKLHIGGGL------NEHQRLPDARPVINPSPSPSPSPSPNATPSSSSPSSG 54
M K+KHLLRKLHIGGG H L PSPS S PSP S SP S
Sbjct: 1 MPKMKHLLRKLHIGGGAATINPSTNHNALSSHAHNHTPSPSTSTLPSPTVV-SDRSPVS- 58
Query: 55 TLGRIGAVESAASDRRDGDSGVDFNLL-EEEFQVQLALAISASDPDAREKVESAQIDAAK 113
VE+ + DFNLL EEEFQ+QLALAISASD D R+ ESAQIDAAK
Sbjct: 59 -------VEAQ-------NEVADFNLLQEEEFQMQLALAISASDSDRRDTAESAQIDAAK 104
Query: 114 RMSLGCRSASVTETDALVEFLSLRYWSYSAVNYDEKIVDGFYDVYGITSNSVSQGKMPLL 173
++SLG SAS+T+T ALV+F SLRYW+Y+ + YDEK++DGFYDVYG+TSN V +GKMPLL
Sbjct: 105 QISLG-YSASLTDTHALVQFQSLRYWNYNVIGYDEKVMDGFYDVYGVTSNLVERGKMPLL 163
Query: 174 VDLQAISLSDNLDYEVIVVNRLVDPNLKELEKRAYNVSVECRYSDLGPILSGLIQKIADL 233
+DLQ S+ ++D EVI+VN +VD L LE++A ++ EC S+LG +LSGL+QK+AD
Sbjct: 164 LDLQTASVFGDVDCEVILVNHVVDLELNHLERKACSLVEECCVSELGLVLSGLLQKLADA 223
Query: 234 VVERMGGPVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKVLADRIN 293
VV RMGGPV NAE++ RW +R +LR+S+ T +LPLGCLDVGLSRHRALLFKVLADRIN
Sbjct: 224 VVNRMGGPVVNAEKLTKRWAMRSRELRDSMQTIVLPLGCLDVGLSRHRALLFKVLADRIN 283
Query: 294 LPCMLVKGSYYTGTDDGAVNLIKLDNGSEYIIDLMGAPGTLIPAEVPSCLLQNAGLDVRE 353
+PC LVKGSYYTGTDDGAVNLIK D+GSEYIID+MGAPGTLIPAEVPS L N VR
Sbjct: 284 VPCKLVKGSYYTGTDDGAVNLIKADDGSEYIIDMMGAPGTLIPAEVPSSQLGNNSFAVRG 343
Query: 354 FPDHTETSVISHMELDDGTETPTISRPMPDRIPEVGSTGSEEASFVGKITNKDESELADK 413
+ +H +DDGT + RI + +EE +G T DE +
Sbjct: 344 CSEVVVLPNKTHSMVDDGTGVLGVFSDR-GRISTMERVQTEELLVMGSQTKPDEKNIFKV 402
Query: 414 NQTEKFEKDFGQLSPALSNPCEGTSGTSRKPSSAQKKKVKSVSKYVISAAKDPEFARKLH 473
N+T +FE + E +S T +PS A+ +VK+VSKYV+SAAKDPEFA+KLH
Sbjct: 403 NETRRFEH---------TESYECSSHT--EPSPAENMRVKNVSKYVLSAAKDPEFAQKLH 451
Query: 474 AVLLQSGASPPPDLFLDINSQDLGEWKMLEQVHLADGKNVDNDVQCLSNRFLSNHEQSHA 533
VL++SGA PPPDLF DIN QD G K+ E N+ VQ +NR L ++E+S
Sbjct: 452 NVLVESGALPPPDLFSDINPQDRGVDKVNE--------NIVGSVQADTNRLLLSYEKSLI 503
Query: 534 SSVGVESSNYLNYESRKRQPAEWFAEQHKKLEPNVINCDLSLSSDTAGERFVLVGN---E 590
S GV S++ +++ QPA+W AEQ K+L NV + + +T FV V + +
Sbjct: 504 PSYGVGSAS----DAKLCQPADWLAEQQKELHTNVEFYNFAQGGNTRNG-FVNVSDRDYD 558
Query: 591 LKLNNATSVNTVPVNPPGVVAGASCEKEIPGSPLPAAAE----------FCQRQPENALV 640
++ +NA SV ++ + C+++ P S LP AA FC+ +
Sbjct: 559 IEQSNAMSVVLASIHSHKI-----CKEKRPESSLPKAALSCKMHNGADCFCEDDENGSRN 613
Query: 641 SVKQPVY-TDLGKESAADLMPMINSGLLMTC-NGQSDSINPMLGEVAEWEILWEDLQIGE 698
+V+ ++LG++SA + M G+ C +G++ +NP+LGE +EWEI WEDL IGE
Sbjct: 614 NVEASFNNSELGRDSAVQINEM---GVNGDCYDGRNKEVNPVLGESSEWEIQWEDLDIGE 670
Query: 699 RIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV 758
RIGIGSYGEVYRAD +GTEVAVKKFLDQDFSGD+L+QFK E EIMLRLRHPNVVLFMGA+
Sbjct: 671 RIGIGSYGEVYRADCNGTEVAVKKFLDQDFSGDALAQFKSEVEIMLRLRHPNVVLFMGAI 730
Query: 759 TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDL 818
TRSPHFSILTEFLPRGSLYRLLHRPN +LDE++R+RMALDVAKGMNYLHTSHP IVHRDL
Sbjct: 731 TRSPHFSILTEFLPRGSLYRLLHRPNLRLDEKKRLRMALDVAKGMNYLHTSHPPIVHRDL 790
Query: 819 KSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSF 878
KSPNLLVD++W VKVCDFGLSR+KHHTYLSSKS AGTPEWMAPEVLRNEPANEKCDVYSF
Sbjct: 791 KSPNLLVDRHWAVKVCDFGLSRMKHHTYLSSKSCAGTPEWMAPEVLRNEPANEKCDVYSF 850
Query: 879 GVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPS 938
GVILWEL T +PW+GLNPMQVVGAVGFQN+RLEIP+D++P VAQIIRDCWQTEPHLRPS
Sbjct: 851 GVILWELTTTRIPWQGLNPMQVVGAVGFQNKRLEIPEDVNPVVAQIIRDCWQTEPHLRPS 910
Query: 939 FAQLMSRLRCLQRLLVDRSNSTN 961
F+QLMSRL LQ L+V ++ +T+
Sbjct: 911 FSQLMSRLYRLQNLIVPKTGATH 933
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554074|ref|XP_003545374.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1042 bits (2695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 570/977 (58%), Positives = 698/977 (71%), Gaps = 69/977 (7%)
Query: 1 MSKVKHLLRKLHIGGGLNEHQRLPDARPVINPSPSPSP--SPSPNATPSSSSPSSGTLGR 58
M K+KHLLRKLHIGGG INPSP+ + S + N TP PS+ TL
Sbjct: 1 MPKMKHLLRKLHIGGG----------AATINPSPNHNALSSHAHNHTPP---PSTSTLPS 47
Query: 59 IGAVESAASDRRDGDSGV-DFNLL-EEEFQVQLALAISASDPDAREKVESAQIDAAKRMS 116
V + + + V DFNLL EEEFQ+QLALAISASD D R+ ESAQIDAAK++S
Sbjct: 48 PSVVSDRSPVVVEAQNEVADFNLLQEEEFQMQLALAISASDSDRRDTAESAQIDAAKQIS 107
Query: 117 LGCRSASVTETDALVEFLSLRYWSYSAVNYDEKIVDGFYDVYGITSNSVSQGKMPLLVDL 176
LG SAS+T+T ALV+F SLRYW+Y+ + YDEK++DGFYDVYG+TSN V +GKMPLLVDL
Sbjct: 108 LG-YSASLTDTHALVQFQSLRYWNYNVIGYDEKVMDGFYDVYGVTSNLVERGKMPLLVDL 166
Query: 177 QAISLSDNLDYEVIVVNRLVDPNLKELEKRAYNVSVECRYSDLGPILSGLIQKIADLVVE 236
Q S+S ++D EVI+VN +VD L LE++A ++ EC S+LG +LSGL+QK+AD+VV
Sbjct: 167 QTASVSGDVDCEVILVNHVVDLELNHLERKACSLVEECCVSELGLVLSGLLQKLADVVVN 226
Query: 237 RMGGPVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKVLADRINLPC 296
RMGGPV NAE++ W +R +LR+S+ T +LPLGCLDVGLSRHRALLFKVLADRIN+PC
Sbjct: 227 RMGGPVVNAEKLTKMWAMRGRELRDSMQTIVLPLGCLDVGLSRHRALLFKVLADRINIPC 286
Query: 297 MLVKGSYYTGTDDGAVNLIKLDNGSEYIIDLMGAPGTLIPAEVPSCLLQNAGLDVREFPD 356
MLVKGSYYTGTDDGAVNLIK D+GSEYIID+MGAPGTLIPAEVPS L N VR +
Sbjct: 287 MLVKGSYYTGTDDGAVNLIKADDGSEYIIDMMGAPGTLIPAEVPSSQLGNNSFAVRGCSE 346
Query: 357 HTETSVISHMELDDGTETPTISRPMPDRIPEVGSTGSEEASFVGKITNKDESELADKNQT 416
+H +DDGT + RI + +EE +G T DE+ L N+T
Sbjct: 347 IVGLPSKTHSMVDDGTGVLGVFSDC-SRISTMERVQTEELLIMGSQTKPDENNLVKVNET 405
Query: 417 EKFEKDFGQLSPALSNPCEGTSGTSRKPSSAQKKKVKSVSKYVISAAKDPEFARKLHAVL 476
+FE + E +S T +PS A+ +VK+VSKYV+SAAKDPEFA+KLH VL
Sbjct: 406 RRFEH---------TEAYECSSHT--EPSPAENMRVKNVSKYVLSAAKDPEFAQKLHNVL 454
Query: 477 LQSGASPPPDLFLDINSQDLGEWKMLEQVHLADGKNVDNDVQCLSNRFLSNHEQSHASSV 536
++SGA PPPDLF DIN QD G K+ E N+ + VQ N + +H
Sbjct: 455 VESGALPPPDLFSDINPQDRGVDKVNE--------NIVDSVQA-DNSLIPSH-------- 497
Query: 537 GVESSNYLNYESRKRQPAEWFAEQHKKLEPNVINCDLSLSSDTAGERFVLVGNELKLNNA 596
GV S++ +++ Q A+W AEQ K+L NV + S S+T R V + N+
Sbjct: 498 GVGSAS----DTKLCQSADWLAEQQKELHRNVEFYNFSQGSNT---RNGFVNVYDRDNDI 550
Query: 597 TSVNTVPVNPPGVVAGASCEKEIPGSPLPAAAE----------FCQRQPENALVSVKQPV 646
NT+ V + + C+++ P S LP AA FC+ + +V+ +
Sbjct: 551 EQSNTINVVLASIHSHKICKEKRPESSLPKAALSCKMHNGVDCFCEDEENGFRNNVEASL 610
Query: 647 Y-TDLGKESAADLMPMINSGLLMTC-NGQSDSINPMLGEVAEWEILWEDLQIGERIGIGS 704
++L K+SA + M G+ C +G++ +NP+LGE +EWEI WEDL IGERIGIGS
Sbjct: 611 NNSELRKDSAILINEM---GVNGDCYDGRNKEVNPVLGESSEWEIQWEDLDIGERIGIGS 667
Query: 705 YGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764
YGEVYRAD +GTEVAVKKFLDQDFSGD+L+QFK E EIM+RLRHPNVVLFMGA+TRSPHF
Sbjct: 668 YGEVYRADCNGTEVAVKKFLDQDFSGDALAQFKSEVEIMIRLRHPNVVLFMGAITRSPHF 727
Query: 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLL 824
SILTEFLPRGSLYRLLHRPN +LDE++R+RMALDVAKGMNYLHTSHP IVHRDLKSPNLL
Sbjct: 728 SILTEFLPRGSLYRLLHRPNLRLDEKKRLRMALDVAKGMNYLHTSHPPIVHRDLKSPNLL 787
Query: 825 VDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWE 884
VD++WVVKVCDFGLSR+KHHTYLSSKS AGTPEWMAPEVLRNEPANEKCDVYSFGVILWE
Sbjct: 788 VDRHWVVKVCDFGLSRMKHHTYLSSKSCAGTPEWMAPEVLRNEPANEKCDVYSFGVILWE 847
Query: 885 LATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
L T +PW+GLNPMQVVGAVGFQN+RLEIP+D++P VAQIIRDCWQTEPHLRPSF+QLMS
Sbjct: 848 LTTTRIPWQGLNPMQVVGAVGFQNKRLEIPEDVNPVVAQIIRDCWQTEPHLRPSFSQLMS 907
Query: 945 RLRCLQRLLVDRSNSTN 961
RL LQ L+V +++ST+
Sbjct: 908 RLYRLQHLIVPKTSSTH 924
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357437463|ref|XP_003589007.1| MAP kinase kinase kinase [Medicago truncatula] gi|355478055|gb|AES59258.1| MAP kinase kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 959 bits (2479), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/982 (53%), Positives = 658/982 (67%), Gaps = 78/982 (7%)
Query: 1 MSKVKHLLRKLHIGGGLNEHQRLPDARPVINPSPSPSPSPSPNATPSSSSPSSGTLGRIG 60
M K+K LLRKLHIGGG P + + + + + + + A P S S S T
Sbjct: 1 MPKMKQLLRKLHIGGGA------PTSPINNHNTIANANANANVALPLSHSDSLTTTPSPS 54
Query: 61 AVESAASD-----RRDGDSGVDFNLL-EEEFQVQLALAISASDPDAREKVESAQIDAAKR 114
S + R DG DFNLL EEEFQVQLALAISASD D ++ ESAQIDAAK+
Sbjct: 55 PSPSPSPTVVQNPRNDGAGVNDFNLLQEEEFQVQLALAISASDSDPKDVDESAQIDAAKQ 114
Query: 115 MSLGCRSASVTETDALVEFLSLRYWSYSAVNYDEKIVDGFYDVYGITSNSVSQGKMPLLV 174
+SLG SAS+T+T ALV+F SLRYW+Y+ + YDEK++DGFYDVYGI ++ + +GKMPLLV
Sbjct: 115 ISLG-YSASLTDTPALVQFQSLRYWNYNVIAYDEKVMDGFYDVYGIDASLIERGKMPLLV 173
Query: 175 DLQAISLSDNLDYEVIVVNRLVDPNLKELEKRAYNVSVECRYSDLGPILSGLIQKIADLV 234
DL+ + S N+DYEVI VNR+VD L +LE++A + EC ++LG LSGLIQK+AD+V
Sbjct: 174 DLKTVPTSRNVDYEVISVNRVVDVELSQLEEKARALFEECSVTELGLFLSGLIQKLADVV 233
Query: 235 VERMGGPVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKVLADRINL 294
V RMGGPVG+A+ I +W +R +LR+SL T +LPLGCLDVGLSRHRALLFKVLADRIN+
Sbjct: 234 VNRMGGPVGSADNIMTKWAMRSRELRDSLRTVVLPLGCLDVGLSRHRALLFKVLADRINI 293
Query: 295 PCMLVKGSYYTGTDDGAVNLIKLDNGSEYIIDLMGAPGTLIPAEVPSCLLQNAGLDVREF 354
PCMLVKGSYYTGTDDGAVNLIK D+GSEYIID+MGAPGTLIPAEVPS +QN G R+F
Sbjct: 294 PCMLVKGSYYTGTDDGAVNLIKADDGSEYIIDMMGAPGTLIPAEVPSSQIQNYGFAGRDF 353
Query: 355 PDHTETSVISHMELDDGTETPTISRPMPDRIPEVGSTGSEEASFVGKITNKDESELADKN 414
+ + L D T+ + VG ++E +G T DE A N
Sbjct: 354 AEIAGQHNNLYPMLGDETDVLGVLSDC-----TVGRVQTKELIKIGSQTKPDEINHAKVN 408
Query: 415 QTEKFEKDFGQLSPALSNPCEGTSGTSRKPSS--AQKKKVKSVSKYVISAAKDPEFARKL 472
+ +F+ G+S P S A+ VK+VS+YV+SAAK+PEFA KL
Sbjct: 409 EAGRFKH-------------TDAYGSSSHPESSHAENMHVKNVSQYVLSAAKNPEFASKL 455
Query: 473 HAVLLQSGASPPPDLFLDINSQDLGEWKMLEQVHLADGKNVDNDVQCLSNRFLSNHEQSH 532
H +LL+SGASPP DLF D+NS+ G + VQ NR L ++++S
Sbjct: 456 HTILLESGASPPSDLFSDMNSRHGGL----------------DTVQADQNRLLLSYDKSL 499
Query: 533 ASSVGVESSNYLNYESRKRQPAEWFAEQHKKLEPNVINCDLSLSSDTAGERFVLVGNELK 592
GV S+ + + AEQ K+L + I SL S F V K
Sbjct: 500 LLPQGVGSAG-------NTRLCQAVAEQQKELHTDAIEFYDSLQSSCTRNAFATVSG--K 550
Query: 593 LNNATSVNTVPVNPPGVVAGASCEKEIPGSPLPAAAEFCQRQ-------------PENAL 639
++ N + V+ + +C+++ P S LP C+R P N
Sbjct: 551 DSDIEQSNPLIVDFACLNTHKTCKEKCPESSLPKTVLSCKRHNGVECFCDDDESGPRNEA 610
Query: 640 VSVKQPVYTDLGKESAADLMPMINSGLLMTCNGQSDSINPMLGEVAEWEILWEDLQIGER 699
+ + +LG +S + + ++ + ++ ++P+LGE +WEI WEDL +GER
Sbjct: 611 GASSNNI--ELGNDSVIQINETVIGDCVLYDDDKTKKVHPILGEDTQWEIQWEDLVVGER 668
Query: 700 IGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT 759
IGIGSYGEVYRAD +GTEVAVKKFLDQD SGD+L QFK E EIMLRLRHPNVVLFMGA+T
Sbjct: 669 IGIGSYGEVYRADCNGTEVAVKKFLDQDVSGDALDQFKSEIEIMLRLRHPNVVLFMGAIT 728
Query: 760 RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK 819
R PHFSILTEFLP R+LHRPN LDE+RR+RMALDVAKGMNYLHTSHP +VHRDLK
Sbjct: 729 RPPHFSILTEFLP-----RILHRPNLVLDEKRRLRMALDVAKGMNYLHTSHPPVVHRDLK 783
Query: 820 SPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFG 879
+PNLLVD+NWVVKVCDFGLSR+KHHTYLSSKS AGTPEWMAPEVLRNEPANEKCDVYSFG
Sbjct: 784 TPNLLVDRNWVVKVCDFGLSRMKHHTYLSSKSCAGTPEWMAPEVLRNEPANEKCDVYSFG 843
Query: 880 VILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSF 939
VILWEL T +PW G+NPMQVVGAVGFQN+RLEIP+++DP VAQIIRDCWQTEPHLRPSF
Sbjct: 844 VILWELTTTKIPWHGMNPMQVVGAVGFQNKRLEIPEEMDPGVAQIIRDCWQTEPHLRPSF 903
Query: 940 AQLMSRLRCLQRLLVDRSNSTN 961
+QLMSRL L++L+ ++ ST+
Sbjct: 904 SQLMSRLYRLRQLVARKTGSTH 925
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449486753|ref|XP_004157391.1| PREDICTED: uncharacterized LOC101214554 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 621 bits (1601), Expect = e-175, Method: Compositional matrix adjust.
Identities = 384/725 (52%), Positives = 488/725 (67%), Gaps = 39/725 (5%)
Query: 1 MSKVKHLLRKLHIGGGLNEHQRLPDARPVINPSPSPSPSPSPNATPSS----------SS 50
MSK+KHLLRKLHIGGGLNEHQRL DARPV PS SPSP PSPN+ PS S
Sbjct: 1 MSKMKHLLRKLHIGGGLNEHQRLSDARPVTRPSSSPSPGPSPNSNPSGSSSSGSSSSLSM 60
Query: 51 PSSGTLGRIGAVESAASDRRDGDSG---VDFNLLEEEFQVQLALAISASDPDAREKVESA 107
SS T+GR+ AVES GD G VDFN LEEEFQVQLA+AISASDPD+R+ ESA
Sbjct: 61 ASSTTMGRLEAVESVVDPAASGDVGGGCVDFNALEEEFQVQLAMAISASDPDSRQDTESA 120
Query: 108 QIDAAKRMSLGCRSASVTETDALVEFLSLRYWSYSAVNYDEKIVDGFYDVYGITSNSVSQ 167
QIDAAKRMSLGC S SV+ + AL EFLSL+YWSY+ VNYDEK++DGFYD+YGIT++S ++
Sbjct: 121 QIDAAKRMSLGC-SPSVSGSKALAEFLSLQYWSYNVVNYDEKVMDGFYDLYGITASSSTR 179
Query: 168 GKMPLLVDLQAISLSDNLDYEVIVVNRLVDPNLKELEKRAYNVSVECRYSDLGPILSGLI 227
GKMPLLVDL+ I ++ ++DYEVI+VNRL+DP L++LE++AYN+ +ECR S+ G ILSGL+
Sbjct: 180 GKMPLLVDLKEICVTSDIDYEVILVNRLLDPELQQLERQAYNIFMECRVSEYGFILSGLV 239
Query: 228 QKIADLVVERMGGPVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKV 287
QKIAD+VV RMGGPVG+AEE+ RWT R ++R+SLNT ILPLG LD+GL+RHRALLFKV
Sbjct: 240 QKIADMVVARMGGPVGDAEEMLRRWTRRSYEMRSSLNTIILPLGRLDIGLARHRALLFKV 299
Query: 288 LADRINLPCMLVKGSYYTGTDDGAVNLIKLDNGSEYIIDLMGAPGTLIPAEVPSCLLQNA 347
LADRINLPC+LVKGSYYTGTDDGAVN+IK+DNGSEYIIDLMGAPGTLIP+E PS N
Sbjct: 300 LADRINLPCILVKGSYYTGTDDGAVNMIKIDNGSEYIIDLMGAPGTLIPSEAPSGQFSNY 359
Query: 348 GLDVREFPDHTETSVISHMELDDGTETPTISRPMPDRIPEVGSTGSEEASFVGKITNKDE 407
G D R D E + + ++G E +IS D + +V + S+EAS + + ++
Sbjct: 360 GFD-RRPADVIEVPEDTPILQNEGAEAVSISSTQ-DEVADVCNLISKEASDLDAQSKENI 417
Query: 408 SELADKNQTEKFEKDFGQLSPALSNPCEGTSGTSRKPSSAQKKKVKSVSKYVISAAKDPE 467
++ Q+ DF +L + S+ CEG+ G + +SAQKKKVK VSKYVISAAK+PE
Sbjct: 418 RNFIEEIQSGSSGYDFAKLLESESSACEGSLGAFAQSASAQKKKVKKVSKYVISAAKNPE 477
Query: 468 FARKLHAVLLQSGASPPPDLFLDINSQDLGEWKMLEQVHLADGKNVDNDVQCLSNRFLSN 527
FA+KLHAVLL+SGASPP DLF DI SQD GE K Q++ +GK +D +Q S L++
Sbjct: 478 FAQKLHAVLLESGASPPADLFSDIESQDNGESKETFQMYPINGKGIDVGLQSHS-YILAS 536
Query: 528 HEQSHASSVGVESSNYLNYESRKRQPAEWFAEQHKKLEPNVINCDLSLSSDTAGERFVLV 587
H QS A+S E N + +E++++ + +E+ + N N + E FV V
Sbjct: 537 HGQSSATSTEAEYLNNVVHENKQKVSSGGLSEE-QMANTNANNHSIFWPHSMKNEGFVFV 595
Query: 588 GNELKLNNATSVNTVPVNPPGVVAGASCEKEIPGSPLPAAAEFCQRQPENALVSVKQPVY 647
N + V VN + +E L + ++ +ALVS ++ +
Sbjct: 596 D-----VNGEAGKLVDVN-------GTFHREHMDDVLLTSDTDSHKKLGSALVSEERRLL 643
Query: 648 TDL--GKESAADLMPMINSGLLMT-------CNGQSDSINPMLGEVAEWEILWEDLQIGE 698
D G DL LL T + +++INP+LGEVAEWEI WEDL IGE
Sbjct: 644 QDKSGGTLQCFDLCEKPLENLLQTDDSKLHASDEHNETINPILGEVAEWEIPWEDLHIGE 703
Query: 699 RIGIG 703
RIGIG
Sbjct: 704 RIGIG 708
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142886|ref|XP_002324765.1| predicted protein [Populus trichocarpa] gi|222866199|gb|EEF03330.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1501), Expect = e-163, Method: Compositional matrix adjust.
Identities = 278/371 (74%), Positives = 309/371 (83%), Gaps = 2/371 (0%)
Query: 595 NATSVNTVPVNPPGVVAGASCEKEIPGSPLPAAAEFCQRQPENALVSVKQPVYTDLGKES 654
+ + ++ V ++ G+ A E + S L + E CQ QPE+AL + + GKES
Sbjct: 471 DTSGIDMVSIHASGIAGSAMHENPLHDSFLFSGLEPCQLQPEHAL-KTGRLFNMETGKES 529
Query: 655 AADLMPMINSGLLMTCNGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWH 714
LM NSGL T NG S+ INPMLGEVAEWEI WEDL+IGERIGIGSYGEVY DW+
Sbjct: 530 DFKLMETANSGL-HTSNGYSERINPMLGEVAEWEIPWEDLEIGERIGIGSYGEVYHGDWN 588
Query: 715 GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774
GTEVAVKKFL+Q FSGD L QFKCEAEIMLRLRHPNVVLFMGAVTR PH SILTEFLPRG
Sbjct: 589 GTEVAVKKFLNQGFSGDVLVQFKCEAEIMLRLRHPNVVLFMGAVTRPPHLSILTEFLPRG 648
Query: 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVC 834
SLYRLLHRPN Q+DE+RRM+MALDVAKGMNYLHTSHPTIVHRDLKSPNLLV+KNW+VKVC
Sbjct: 649 SLYRLLHRPNSQIDEKRRMQMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVNKNWLVKVC 708
Query: 835 DFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG 894
DFGLSRIKHHT+LSSKSTAGTPEWMAPEVLRNEPANEKCD+YSFGVILWELAT +PWKG
Sbjct: 709 DFGLSRIKHHTFLSSKSTAGTPEWMAPEVLRNEPANEKCDIYSFGVILWELATCQIPWKG 768
Query: 895 LNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954
LNPMQVVGAVGFQNR LEIP IDPA+AQIIRDCWQ EP+LRPSFAQL++RLRC Q LLV
Sbjct: 769 LNPMQVVGAVGFQNRHLEIPGYIDPAIAQIIRDCWQLEPNLRPSFAQLITRLRCAQHLLV 828
Query: 955 DRSNSTNQFSE 965
+ N TNQ ++
Sbjct: 829 ETPNHTNQTAD 839
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224088840|ref|XP_002308563.1| predicted protein [Populus trichocarpa] gi|222854539|gb|EEE92086.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1442), Expect = e-156, Method: Compositional matrix adjust.
Identities = 260/318 (81%), Positives = 285/318 (89%), Gaps = 1/318 (0%)
Query: 649 DLGKESAADLMPMINSGLLMTCNGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEV 708
D GKESA L+ NSG ++C G S+ INPMLGEVAEWEI WEDL+IGERIGIGSYGEV
Sbjct: 572 DAGKESALKLIETANSGQHISCCGHSERINPMLGEVAEWEIPWEDLEIGERIGIGSYGEV 631
Query: 709 YRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768
Y DW+GTEVAVKKFLDQD SGD+L QFKCEAEIMLRLRHPNVVLFMGAVTR PH SILT
Sbjct: 632 YHGDWNGTEVAVKKFLDQDLSGDALVQFKCEAEIMLRLRHPNVVLFMGAVTRPPHLSILT 691
Query: 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN 828
EFLPRGSLYRLLHRP+ Q+DE+RRMRMA+DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN
Sbjct: 692 EFLPRGSLYRLLHRPHSQVDEKRRMRMAIDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN 751
Query: 829 WVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL 888
W VKVCDFGLSRIKHHT+LSSKSTAGTPEWMAPEVLRNEPANEKCD+YSFGVILWELAT
Sbjct: 752 WNVKVCDFGLSRIKHHTFLSSKSTAGTPEWMAPEVLRNEPANEKCDIYSFGVILWELATC 811
Query: 889 SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR-LR 947
+PWKGLNPMQVVGAVGFQNR LEI +DIDPA+AQIIRDCWQ EP+LRP+FA+L+SR L
Sbjct: 812 QIPWKGLNPMQVVGAVGFQNRHLEITEDIDPAIAQIIRDCWQLEPNLRPTFAELISRLLH 871
Query: 948 CLQRLLVDRSNSTNQFSE 965
+Q LLV+ +N NQ ++
Sbjct: 872 HVQHLLVETTNYRNQTAD 889
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 967 | ||||||
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.343 | 0.377 | 0.791 | 3.2e-274 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.281 | 0.291 | 0.764 | 7.1e-180 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.278 | 0.261 | 0.754 | 6.3e-179 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.288 | 0.281 | 0.720 | 5.1e-177 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.285 | 0.336 | 0.643 | 2.4e-130 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.292 | 0.366 | 0.597 | 2.3e-93 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.324 | 0.410 | 0.549 | 4.3e-92 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.304 | 0.399 | 0.555 | 4.1e-88 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.269 | 0.388 | 0.602 | 1.2e-83 | |
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.269 | 0.322 | 0.488 | 1.9e-83 |
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1376 (489.4 bits), Expect = 3.2e-274, Sum P(2) = 3.2e-274
Identities = 266/336 (79%), Positives = 293/336 (87%)
Query: 628 AEFCQRQPENALVSVKQPVYTD-LGKESAADLMPMINS-GLLMTCNGQSDSINPMLGEVA 685
AE Q+ E L S+K+ D GK S+++ M + + G C+ INP+LGE A
Sbjct: 542 AESYQQSVEVDL-SMKRNFDLDNTGKASSSENMEVGTADGESAVCDSHDQGINPLLGEAA 600
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
+WEI+WEDLQIGERIGIGSYGEVYRA+W+GTEVAVKKFLDQDFSGD+L+QFK E EIMLR
Sbjct: 601 KWEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEIMLR 660
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
LRHPNVVLFMGAVTR P+FSILTEFLPRGSLYRLLHRPNHQLDE+RRMRMALDVAKGMNY
Sbjct: 661 LRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKGMNY 720
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
LHTSHPT+VHRDLKSPNLLVDKNWVVKVCDFGLSR+KHHTYLSSKSTAGTPEWMAPEVLR
Sbjct: 721 LHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPEVLR 780
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
NEPANEKCDVYSFGVILWELAT VPWKGLNPMQVVGAVGFQNRRLEIPDDID VAQII
Sbjct: 781 NEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVAQII 840
Query: 926 RDCWQTEPHLRPSFAQLMSRLRCLQRLLV-DRSNST 960
R+CWQTEPHLRPSF QLM L+ LQ L + +R+N++
Sbjct: 841 RECWQTEPHLRPSFTQLMQSLKRLQGLNISNRANTS 876
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1126 (401.4 bits), Expect = 7.1e-180, Sum P(2) = 7.1e-180
Identities = 208/272 (76%), Positives = 238/272 (87%)
Query: 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEI 742
+V E EI W DL I ERIG+GSYGEVY ADWHGTEVAVKKFLDQDFSG +L++F+ E I
Sbjct: 658 DVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRI 717
Query: 743 MLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
M RLRHPNVV F+GAVTR P+ SI+TEFLPRGSLYR+LHRP +DERRR++MALDVA G
Sbjct: 718 MRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMG 777
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPE 862
MN LHTS PTIVHRDLK+PNLLVD NW VKV DFGLSR+KH+T+LSSKSTAGTPEWMAPE
Sbjct: 778 MNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPE 837
Query: 863 VLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
VLRNEP+NEKCDVYSFGVILWELATL +PW+G+NPMQVVGAVGFQNRRLEIP ++DP V
Sbjct: 838 VLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVG 897
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954
+II +CWQT+P+LRPSFAQL L+ L RL++
Sbjct: 898 RIILECWQTDPNLRPSFAQLTEVLKPLNRLVL 929
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1131 (403.2 bits), Expect = 6.3e-179, Sum P(2) = 6.3e-179
Identities = 203/269 (75%), Positives = 240/269 (89%)
Query: 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEI 742
+V++ EILWE++ +GERIG+GSYGEVYR DWHGTEVAVKKFLDQD +G++L +F+ E I
Sbjct: 737 DVSDCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRI 796
Query: 743 MLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
M +LRHPN+VLFMGAVTR P+ SI+TEFLPRGSLYRL+HRPN+QLDERRR+RMALD A+G
Sbjct: 797 MKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAARG 856
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPE 862
MNYLH+ +P IVHRDLKSPNLLVDKNWVVKVCDFGLSR+KH TYLSSKSTAGT EWMAPE
Sbjct: 857 MNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPE 916
Query: 863 VLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
VLRNEPA+EKCDVYS+GVILWEL TL PW +NPMQVVGAVGFQ+RRL+IPD +DPA+A
Sbjct: 917 VLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIA 976
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
+I CWQT+ LRPSFA++M+ L+ LQ+
Sbjct: 977 DLISKCWQTDSKLRPSFAEIMASLKRLQK 1005
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1118 (398.6 bits), Expect = 5.1e-177, Sum P(2) = 5.1e-177
Identities = 201/279 (72%), Positives = 240/279 (86%)
Query: 673 QSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDS 732
+S + + +VAE EILWE++ + ERIG+GSYGEVYR DWHGT VAVKKF+DQD +G++
Sbjct: 694 ESSKSDAAIDDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEA 753
Query: 733 LSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRR 792
L +F+ E +M RLRHPN+VLFMGAVTR P+ SI+TEFLPRGSLYRL+HRPN+QLDER+R
Sbjct: 754 LEEFRSEVRMMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKR 813
Query: 793 MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST 852
+RMALD A+GMNYLH+ +P IVHRDLKSPNLLVDKNWVVKVCDFGLSR+K TYLSSKST
Sbjct: 814 LRMALDAARGMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKST 873
Query: 853 AGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE 912
AGT EWMAPEVLRNEPA+EKCDVYS+GVILWEL TL PW +NPMQVVGAVGFQ+RRL+
Sbjct: 874 AGTAEWMAPEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLD 933
Query: 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
IP+ +DP +A IIR CWQT+P LRPSF ++M L+ LQ+
Sbjct: 934 IPEFVDPGIADIIRKCWQTDPRLRPSFGEIMDSLKQLQK 972
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 927 (331.4 bits), Expect = 2.4e-130, Sum P(3) = 2.4e-130
Identities = 179/278 (64%), Positives = 215/278 (77%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
+ +I W DL I E+IG GS+G V+RA+WHG++VAVK ++QDF + +++F E IM R
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN--HQLDERRRMRMALDVAKGM 803
LRHPN+VLFMGAVT+ P+ SI+TE+L RGSLYRLLH+ QLDERRR+ MA DVAKGM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEV 863
NYLH +P IVHRDLKSPNLLVDK + VKVCDFGLSR+K T+LSSKS AGTPEWMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 864 LRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923
LR+EP+NEK DVYSFGVILWELATL PW LNP QVV AVGF+ +RLEIP +++P VA
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 782
Query: 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTN 961
II CW EP RPSFA +M LR L + V N ++
Sbjct: 783 IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 820
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 904 (323.3 bits), Expect = 2.3e-93, Sum P(2) = 2.3e-93
Identities = 171/286 (59%), Positives = 212/286 (74%)
Query: 669 TCNGQSDSINPML---GEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLD 725
+C S S+ + E E+EILW+DL IGE++G GS G VY W G++VAVK F
Sbjct: 466 SCGSTSSSVMNKVDTDSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSK 525
Query: 726 QDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNH 785
Q++S + + FK E +M RLRHPNV+LFMGAVT I++EFLPRGSL+RLL +
Sbjct: 526 QEYSAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTS 585
Query: 786 QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845
+LD RRR+ MALD+A+GMNYLH P I+HRDLKS NLLVDKNW VKV DFGLSRIKH T
Sbjct: 586 KLDWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHET 645
Query: 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG 905
YL+SKS GTP+WMAPEVLRNE A+EK D+YSFGV+LWELAT +PW+ LN MQV+GAVG
Sbjct: 646 YLTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVG 705
Query: 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
F ++RLEIP DIDP ++ CW ++ LRP+F +LM +LR LQR
Sbjct: 706 FMDQRLEIPKDIDPRWISLMESCWHSDTKLRPTFQELMDKLRDLQR 751
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 895 (320.1 bits), Expect = 4.3e-92, Sum P(2) = 4.3e-92
Identities = 177/322 (54%), Positives = 225/322 (69%)
Query: 637 NALVSVK-QPVYTDLGKESAADLMPMIN---SGLLMTCNGQSDSI-NP--MLGEVAEWEI 689
N+ SVK + + ++ K + + M +N + +C S S+ N M + ++EI
Sbjct: 423 NSYNSVKSESLASESNKPANNENMGSVNVNSASSASSCGSTSSSVMNKVDMDSDCLDYEI 482
Query: 690 LWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
LWEDL IGE+IG GS G VY W G++VAVK F Q++S + ++ FK E +M RLRHP
Sbjct: 483 LWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKRLRHP 542
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
NV+LFMGAV I+TEFLPRGSL+RLL R +LD RRR+ MA D+A+GMNYLH
Sbjct: 543 NVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMNYLHHC 602
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
P I+HRDLKS NLLVD+NW VKV DFGLSRIKH TYL++ GTP+WMAPEVLRNE A
Sbjct: 603 SPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNGR-GTPQWMAPEVLRNEAA 661
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929
+EK DVYSFGV+LWEL T +PW+ LN MQV+GAVGF N+RLE+P D+DP ++ CW
Sbjct: 662 DEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQWIALMESCW 721
Query: 930 QTEPHLRPSFAQLMSRLRCLQR 951
+EP RPSF +LM +LR LQR
Sbjct: 722 HSEPQCRPSFQELMDKLRELQR 743
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
Identities = 166/299 (55%), Positives = 226/299 (75%)
Query: 655 AADLMPM--INSGLLMTCNGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRAD 712
+ D +P+ +NSG + Q + N ++ + + EI WEDLQ+GE +G GS+ V+R
Sbjct: 430 SVDPLPILGVNSGRQQSPVNQRN--NRLVTD-SSCEIRWEDLQLGEEVGRGSFAAVHRGV 486
Query: 713 WHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLP 772
W+G++VA+K + D D++ +L++ K E IM +LRHPNV+LFMGAV +I+ E++P
Sbjct: 487 WNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKLRHPNVLLFMGAVCTEEKSAIIMEYMP 546
Query: 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVK 832
RGSL+++LH N LD++RR+RMALDVA+GMNYLH +P IVHRDLKS NLLVDKNW VK
Sbjct: 547 RGSLFKILHNTNQPLDKKRRLRMALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVK 606
Query: 833 VCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPW 892
V DFGLS+ K+ T+LS+KS GTP+WMAPEVLR+EP+NEKCDV+SFGVILWEL T VPW
Sbjct: 607 VGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPW 666
Query: 893 KGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
LN +QVVG VGF +RRL++P+ ++P +A II+DCWQT+P RPSF +L+S++ L R
Sbjct: 667 DRLNSIQVVGVVGFMDRRLDLPEGLNPRIASIIQDCWQTDPAKRPSFEELISQMMSLFR 725
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
Identities = 159/264 (60%), Positives = 193/264 (73%)
Query: 669 TCNGQSDSINPML---GEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLD 725
+C S S+ + + E EILW+DL IGE+IG GS G VY W G++VAVK F
Sbjct: 406 SCGSTSRSVMDKVDIDSDPLEHEILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSK 465
Query: 726 QDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNH 785
Q++S + F+ E +M RLRHPNV+LFMGAVT I++EF+PRGSL+RLL R
Sbjct: 466 QEYSESVIKSFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMS 525
Query: 786 QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845
+LD RRR+ MALD+A+GMNYLH P I+HRDLKS NLLVD+NW VKV DFGLSRIKH T
Sbjct: 526 KLDWRRRINMALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQT 585
Query: 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG 905
YL+SKS GTP+WMAPEVLRNE A+EK D+YSFGV+LWELAT +PW+ LN MQV+GAVG
Sbjct: 586 YLTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVG 645
Query: 906 FQNRRLEIPDDIDPAVAQIIRDCW 929
F N+RLEIP D DP +I CW
Sbjct: 646 FMNQRLEIPKDTDPDWISLIESCW 669
|
|
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 702 (252.2 bits), Expect = 1.9e-83, Sum P(2) = 1.9e-83
Identities = 132/270 (48%), Positives = 188/270 (69%)
Query: 679 PMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKC 738
P+L EW I + +L +G R+GIG +GEV+R W+GT+VA+K FL+QD + +++ F
Sbjct: 539 PLL-PYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCN 597
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ--LDERRRMRMA 796
E I+ RLRHPNV+LF+GA T+ P S++TE++ GSLY LLH + L RR+++M
Sbjct: 598 EISILSRLRHPNVILFLGACTKPPRLSLITEYMEMGSLYYLLHLSGQKKRLSWRRKLKML 657
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856
D+ +G+ +H IVHRD+KS N L+ W VK+CDFGLSRI T + +AGTP
Sbjct: 658 RDICRGLMCIHRMG--IVHRDIKSANCLLSNKWTVKICDFGLSRIMTGTTMRDTVSAGTP 715
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDD 916
EWMAPE++RNEP +EKCD++S GVI+WEL TL+ PW+G+ P +VV A+ ++ RLEIP+
Sbjct: 716 EWMAPELIRNEPFSEKCDIFSLGVIMWELCTLTRPWEGVPPERVVYAIAYEGARLEIPEG 775
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
P + ++I DCW TEP RPS +++SRL
Sbjct: 776 --P-LGKLIADCW-TEPEQRPSCNEILSRL 801
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 4.6.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XVIII000160 | hypothetical protein (839 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 967 | |||
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 3e-90 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-78 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-72 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-70 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-68 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-56 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-56 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-51 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-51 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-49 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-48 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-46 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-46 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-45 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-45 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-45 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-44 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-44 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-43 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-43 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-43 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-42 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-42 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-41 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-41 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-41 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-41 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-40 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-40 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-39 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-39 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-39 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-39 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-38 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-38 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-38 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-38 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-38 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-37 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-37 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-37 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-36 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-36 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-36 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-36 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-35 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-35 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-35 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-35 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-35 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-34 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-34 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-34 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-34 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-34 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-34 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-33 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-33 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-33 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-33 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-33 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-32 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-32 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-31 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-31 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-31 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-31 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-31 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-31 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-31 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-30 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-30 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-30 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-30 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-30 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-30 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-29 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-29 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-28 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-27 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-26 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-26 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-25 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-25 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-25 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-25 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-25 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-25 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-24 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-23 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-23 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-23 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-22 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-21 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-21 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-21 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-21 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-18 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-18 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.003 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 285 bits (732), Expect = 3e-90
Identities = 107/211 (50%), Positives = 140/211 (66%), Gaps = 10/211 (4%)
Query: 128 DALVEFLSLRYWSYSAVNYDEKIVDGFYDVYGI--TSNSVSQGKMPLLVDLQAISLSDNL 185
+ E LS RYW Y ++YD+KI DGFYD+YG+ S+ G++P L DLQA+ +
Sbjct: 1 RSSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVP-PGDS 59
Query: 186 DYEVIVVNRLVDPNLKELEKRAYNVSVECRYSDLGPILSGLIQKIADLVVERMGGPVGNA 245
+EV++V+R DP LKELE+ A C S G + L+QK+A LV + MGGPV +A
Sbjct: 60 SFEVVLVDRRTDPKLKELEQLAR-----CLVSGCGTNTAALVQKLAGLVSDHMGGPVKDA 114
Query: 246 EEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKVLADRINLPCMLVKGSYYT 305
E + RW +L+ N+ ++PLG L +GL RHRALLFKVLAD I LPC LVKG Y
Sbjct: 115 ESMLARWKECSNELKE--NSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYC 172
Query: 306 GTDDGAVNLIKLDNGSEYIIDLMGAPGTLIP 336
G+DD A NL+K D+G EY++DLMGAPGTLIP
Sbjct: 173 GSDDDASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 255 bits (655), Expect = 2e-78
Identities = 98/262 (37%), Positives = 152/262 (58%), Gaps = 13/262 (4%)
Query: 694 LQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
L++G+++G G++GEVY+ G T+VAVK L + S + +F EA IM +L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
HPN+V +G T+ I+TE++P G L L + +L + ++MAL +AKGM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTP-EWMAPEVLR 865
+ + VHRDL + N LV +N VVK+ DFGLSR I Y + P +WMAPE L+
Sbjct: 120 SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 866 NEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924
+ K DV+SFGV+LWE+ TL P+ G++ +V+ + RL P++ + ++
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 925 IRDCWQTEPHLRPSFAQLMSRL 946
+ CW +P RP+F++L+ L
Sbjct: 237 MLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 4e-72
Identities = 94/261 (36%), Positives = 139/261 (53%), Gaps = 12/261 (4%)
Query: 694 LQIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
L +G+++G G++GEVY+ EVAVK L +D S + +F EA IM +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
HPNVV +G T I+ E++ G L L + +L + AL +A+GM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRN 866
S +HRDL + N LV +N VVK+ DFGLSR + Y + WMAPE L+
Sbjct: 120 -SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 867 EPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
K DV+SFGV+LWE+ TL P+ G++ +V+ + RL P + P + ++
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYDLM 236
Query: 926 RDCWQTEPHLRPSFAQLMSRL 946
CW +P RP+F++L+ L
Sbjct: 237 LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 7e-70
Identities = 95/262 (36%), Positives = 142/262 (54%), Gaps = 13/262 (4%)
Query: 694 LQIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
L +G+++G G++GEVY+ EVAVK L +D S + +F EA IM +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDVAKGMNYL 806
HPN+V +G T I+ E++P G L L + + L + AL +A+GM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLR 865
S +HRDL + N LV +N VVK+ DFGLSR + Y K WMAPE L+
Sbjct: 120 E-SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 866 NEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924
K DV+SFGV+LWE+ TL P+ G++ +V+ + + RL P + P + ++
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYKL 236
Query: 925 IRDCWQTEPHLRPSFAQLMSRL 946
+ CW +P RP+F++L+ L
Sbjct: 237 MLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 228 bits (585), Expect = 1e-68
Identities = 95/267 (35%), Positives = 143/267 (53%), Gaps = 22/267 (8%)
Query: 698 ERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+++G G++GEVY+ G TEVAVK L +D S + F EA +M +L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPNHQ------LDERRRMRMALDVAKGMN 804
+G T ++ E++ G L L RP L + + A+ +AKGM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE---WMAP 861
YL + VHRDL + N LV ++ VVK+ DFGLSR + + G WMAP
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 862 EVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
E L++ K DV+SFGV+LWE+ TL + P+ GL+ +V+ + + RL P+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDE 235
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMSRLR 947
+ +++ CWQ +P RP+F++L+ RL
Sbjct: 236 LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 225 bits (577), Expect = 1e-67
Identities = 77/257 (29%), Positives = 123/257 (47%), Gaps = 17/257 (6%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+I E++G GS+G+VY A T VA+K + + + E +I+ +L+HPN+V
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
++ E+ G L+ LL + +L E + + YLH+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK 872
IVHRDLK N+L+D++ VK+ DFGL+R + GTPE+MAPEVL + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLGKGYGKA 176
Query: 873 CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD------DIDPAVAQIIR 926
D++S GVIL+EL T P+ G + + + F+ P DI P +IR
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLEL----FKKIGKPKPPFPPPEWDISPEAKDLIR 232
Query: 927 DCWQTEPHLRPSFAQLM 943
+P R + + +
Sbjct: 233 KLLVKDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 2e-64
Identities = 86/260 (33%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 694 LQIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
++ ++G GS+G VY+A GT VAVK + + E I+ RL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
V + A H ++ E+ G L+ L R L E ++AL + +G+ YLH S+
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLH-SNG 118
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR-NEPAN 870
I+HRDLK N+L+D+N VVK+ DFGL++ + S + GTP +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 871 EKCDVYSFGVILWELATLSVPWKG---LNPMQVVGAVGFQNRRLEIP----DDIDPAVAQ 923
K DV+S GVIL+EL T P+ G L+ +Q++ + LE
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL--GPPLEFDEPKWSSGSEEAKD 235
Query: 924 IIRDCWQTEPHLRPSFAQLM 943
+I+ C +P RP+ +++
Sbjct: 236 LIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 210 bits (538), Expect = 1e-62
Identities = 83/251 (33%), Positives = 122/251 (48%), Gaps = 40/251 (15%)
Query: 700 IGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGA 757
+G G +G VY A G +VA+K ++ S L + E EI+ +L HPN+V G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 758 VTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRD 817
H ++ E+ GSL LL +L E +R+ L + +G+ YLH S+ I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-SNG-IIHRD 117
Query: 818 LKSPNLLVDK-NWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP-ANEKCDV 875
LK N+L+D N VK+ DFGLS++ K+ GTP +MAPEVL + +EK D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 876 YSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHL 935
+S GVIL+EL P + +IR Q +P
Sbjct: 178 WSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204
Query: 936 RPSFAQLMSRL 946
RPS +++ L
Sbjct: 205 RPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 2e-56
Identities = 90/260 (34%), Positives = 132/260 (50%), Gaps = 16/260 (6%)
Query: 693 DLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+ GE +G GS+G VY A G +AVK S + L + E I+ L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 751 VVLFMGA-VTRSP-HFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKGMNY 805
+V + G+ +I E++ GSL LL + +L E R+ R L +G+ Y
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQIL---EGLAY 116
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH--HTYLSSKSTAGTPEWMAPEV 863
LH++ IVHRD+K N+LVD + VVK+ DFG ++ T + S GTP WMAPEV
Sbjct: 117 LHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 864 LRNEPANEKCDVYSFGVILWELATLSVPWKGL-NPMQVVGAVGFQNRRLEIPDDIDPAVA 922
+R E D++S G + E+AT PW L NPM + +G EIP+ +
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234
Query: 923 QIIRDCWQTEPHLRPSFAQL 942
+R C + +P RP+ +L
Sbjct: 235 DFLRKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 6e-56
Identities = 97/263 (36%), Positives = 147/263 (55%), Gaps = 13/263 (4%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL 746
W I ++L++G IG G +G+V D+ G +VAVK D + F EA +M L
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDD---STAAQAFLAEASVMTTL 57
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMNY 805
RHPN+V +G V + I+TE++ +GSL L R + +++ ALDV +GM Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPEVL 864
L + VHRDL + N+LV ++ V KV DFGL++ S K P +W APE L
Sbjct: 118 LEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWTAPEAL 171
Query: 865 RNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923
R + + K DV+SFG++LWE+ + VP+ + VV V + R+E P+ P V +
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYK 230
Query: 924 IIRDCWQTEPHLRPSFAQLMSRL 946
+++DCW+ +P RP+F QL +L
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-51
Identities = 79/254 (31%), Positives = 137/254 (53%), Gaps = 6/254 (2%)
Query: 693 DLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+ Q+G+ IG G++G VY+ + G VA+K+ + ++L E +++ L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V ++G++ S I+ E+ GSL +++ + E V +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHEQ- 118
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPAN 870
++HRD+K+ N+L K+ VVK+ DFG++ + S GTP WMAPEV+ A+
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 871 EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQ 930
D++S G + EL T + P+ LNPM + + Q+ +P+ I P + + C+Q
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236
Query: 931 TEPHLRPSFAQLMS 944
+P+LRP+ QL+
Sbjct: 237 KDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 2e-51
Identities = 96/261 (36%), Positives = 144/261 (55%), Gaps = 11/261 (4%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIML 744
WE+ D+ + ++G G YGEVY W + VAVK + + +F EA +M
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDVAKGM 803
++HPN+V +G TR P F I+TEF+ G+L L N Q ++ + MA ++ M
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPE 862
YL + +HRDL + N LV +N +VKV DFGLSR + TY + +W APE
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 863 VLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
L + K DV++FGV+LWE+AT + P+ G++ QV + + R+E P+ P V
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKV 234
Query: 922 AQIIRDCWQTEPHLRPSFAQL 942
+++R CWQ P RPSFA++
Sbjct: 235 YELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-49
Identities = 87/279 (31%), Positives = 142/279 (50%), Gaps = 23/279 (8%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCE 739
WE+ E + + +G GS+G VY G T VA+K + + + +F E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNE 59
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL--YRLLHRPNHQ-------LDER 790
A +M +VV +G V+ ++ E + +G L Y RP + +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 791 RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSS 849
+ ++MA ++A GM YL VHRDL + N +V ++ VK+ DFG++R I Y
Sbjct: 120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 850 KSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQ 907
P WMAPE L++ K DV+SFGV+LWE+ATL P++GL+ +V+ V
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236
Query: 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
L++P++ + +++R CWQ P +RP+F +++S L
Sbjct: 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-48
Identities = 88/264 (33%), Positives = 140/264 (53%), Gaps = 10/264 (3%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI E L++ ++G G +GEV+ W+G T+VAVK S ++ Q EA+IM +
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKK 57
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMN 804
LRH +V + I+TE++ +GSL L +L + + MA +A+GM
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPEV 863
YL + + +HRDL + N+LV +N V K+ DFGL+R+ +++ A P +W APE
Sbjct: 118 YLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA 175
Query: 864 LRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
K DV+SFG++L E+ T VP+ G+ +V+ V + R+ P + +
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELY 234
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRL 946
++ CW +P RP+F L S L
Sbjct: 235 DLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 4e-47
Identities = 86/261 (32%), Positives = 122/261 (46%), Gaps = 18/261 (6%)
Query: 698 ERIGIGSYGEVYRADWHGT-----EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+++G GS+G V R +W + VAVK L D D + F EA IM L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKGMNYLHTS 809
G V P ++TE P GSL L + L A+ +A GM YL +
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGTPEWMAPEVLRN 866
+HRDL + N+L+ + VK+ DFGL R Y+ + W APE LR
Sbjct: 117 R--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 867 EPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
+ DV+ FGV LWE+ T PW GL+ Q++ + + RLE P+ + ++
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234
Query: 926 RDCWQTEPHLRPSFAQLMSRL 946
CW P RP+FA L L
Sbjct: 235 LQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 86/261 (32%), Positives = 132/261 (50%), Gaps = 20/261 (7%)
Query: 693 DLQIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+I E+IG G +GEVY+A H G EVA+K + + E +I+ + +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKA-RHKRTGKEVAIKV-IKLESKEKKEKIIN-EIQILKKCKHP 57
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
N+V + G+ + I+ EF GSL LL N L E + + ++ KG+ YLH++
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
I+HRD+K+ N+L+ + VK+ DFGLS T + + GTP WMAPEV+ +P
Sbjct: 118 G--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMVGTPYWMAPEVINGKPY 174
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQV------VGAVGFQNRRLEIPDDIDPAVAQ 923
+ K D++S G+ ELA P+ L PM+ G G +N P+
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-----PEKWSDEFKD 229
Query: 924 IIRDCWQTEPHLRPSFAQLMS 944
++ C Q P RP+ QL+
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 7e-46
Identities = 70/257 (27%), Positives = 130/257 (50%), Gaps = 20/257 (7%)
Query: 700 IGIGSYGEVYRA----DWHGTEVAVKK----FLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
IG GS+G+VY D G +K+ + + D+L+ E +I+ +L HPN+
Sbjct: 8 IGKGSFGKVYLVRRKSD--GKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALDVAKGMNYLHT 808
+ + + I+ E+ G L + + + + E + + + + + YLH+
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
I+HRD+K N+ + N +VK+ DFG+S++ T +K+ GTP +++PE+ +N+P
Sbjct: 122 RK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928
N K D++S G +L+EL TL P++G N +++ + IP + ++
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSL 238
Query: 929 WQTEPHLRPSFAQLMSR 945
Q +P RPS AQ++
Sbjct: 239 LQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 8e-46
Identities = 90/264 (34%), Positives = 133/264 (50%), Gaps = 10/264 (3%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WE E+ + ++G G +GEV+ W VA+K L D F+ E + + R
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIK-ILKSD-DLLKQQDFQKEVQALKR 58
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDVAKGMN 804
LRH +++ + I+TE + +GSL L P Q L + MA VA+GM
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEV 863
YL + +HRDL + N+LV ++ V KV DFGL+R IK YLSS +W APE
Sbjct: 119 YLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS-DKKIPYKWTAPEA 175
Query: 864 LRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
+ + K DV+SFG++L+E+ T VP+ G+N +V + R+ P +
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIY 234
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRL 946
+I+ +CW EP RPSF L L
Sbjct: 235 KIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 83/253 (32%), Positives = 134/253 (52%), Gaps = 8/253 (3%)
Query: 698 ERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
E+IG G++G+VY+ TEVAVK +F EAEI+ + HPN+V +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ I+ E +P GSL L + ++L ++ ++M+LD A GM YL + + +HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHR 117
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHT-YLSSKSTAGTP-EWMAPEVLRNEPANEKCD 874
DL + N LV +N V+K+ DFG+SR + Y S P +W APE L + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 875 VYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933
V+S+G++LWE +L P+ G++ Q + R+ P + +++ CW +P
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDP 236
Query: 934 HLRPSFAQLMSRL 946
RPSF+++ + L
Sbjct: 237 ENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 87/273 (31%), Positives = 131/273 (47%), Gaps = 30/273 (10%)
Query: 700 IGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
+G G +G+V + G +VAVK L+ S F+ E EI+ L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 754 FMGAVTRSPHFSIL---TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+ G V P L E+LP GSL L R Q++ +R + + + KGM+YL +
Sbjct: 71 YKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTP-EWMAPEVLRNE 867
+HRDL + N+LV+ +VK+ DFGL+++ + Y K +P W APE LR
Sbjct: 130 --YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 868 PANEKCDVYSFGVILWELATLSVPWKG--LNPMQVVGAVGFQ------------NRRLEI 913
+ DV+SFGV L+EL T P + ++++G Q RL
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247
Query: 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
P V +++ CW+ EP RPSFA L+ +
Sbjct: 248 PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 88/259 (33%), Positives = 137/259 (52%), Gaps = 13/259 (5%)
Query: 693 DLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
+L + +G G +G V+ W G +VA+K + S D F EA++M++L HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
V G T+ I+TE++ G L L +L + M DV + M YL ++
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-- 119
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNEPAN 870
+HRDL + N LV ++ VVKV DFGL+R + Y SS+ T +W PEV +
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 871 EKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAV--GFQNRRLEIPDDIDPAVAQIIRD 927
K DV+SFGV++WE+ + +P++ + +VV +V G+ RL P V I+
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---RLYRPKLAPTEVYTIMYS 236
Query: 928 CWQTEPHLRPSFAQLMSRL 946
CW +P RP+F +L+S+L
Sbjct: 237 CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 91/268 (33%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 693 DLQIGERIGIGSYGEVYRADWHGT-----EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
+ I + IG G +GEV R +VA+K S F EA IM +
Sbjct: 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFD 63
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
HPN++ G VT+S I+TE++ GSL + L + + + + M +A GM YL
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL- 122
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP------EWMAP 861
S VHRDL + N+LV+ N V KV DFGLSR S++T T W AP
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE----DSEATYTTKGGKIPIRWTAP 177
Query: 862 EVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAV--GFQNRRLEIPDDID 918
E + DV+SFG+++WE+ + P+ ++ V+ AV G+ RL P D
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDCP 234
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
A+ Q++ DCWQ + + RP+F+Q++S L
Sbjct: 235 SALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 89/264 (33%), Positives = 131/264 (49%), Gaps = 10/264 (3%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI +Q+ ++G G +GEV+ W+ T VAVK F EA+IM +
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKK 57
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMN 804
LRHP ++ T I+TE + GSL L L + + MA VA GM
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEV 863
YL + +HRDL + N+LV +N + KV DFGL+R IK Y + + +W APE
Sbjct: 118 YLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEA 175
Query: 864 LRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
+ K DV+SFG++L E+ T +P+ G+ +V+ V Q R+ P +
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELY 234
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRL 946
I+ DCW+ +P RP+F L +L
Sbjct: 235 DIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 88/258 (34%), Positives = 131/258 (50%), Gaps = 16/258 (6%)
Query: 695 QIGERIGIGSYGEVYRA--DWHGTEVAVK--KFLDQDFSG-DSLSQFKCEAEIMLRLRHP 749
+ GE +G GS+G VY G AVK D +G +++ Q + E ++ +L+HP
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRM--RMALDVAKGMNYLH 807
N+V ++G + I E +P GSL +LL + + R+ R L G+ YLH
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLH 119
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS-SKSTAGTPEWMAPEVLRN 866
+ VHRD+K N+LVD N VVK+ DFG++ K S +KS G+P WMAPEV+
Sbjct: 120 DRN--TVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 867 E-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
+ D++S G + E+AT PW L + V +G IPD + I
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235
Query: 926 RDCWQTEPHLRPSFAQLM 943
C Q +P LRP+ A+L+
Sbjct: 236 LKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 5e-43
Identities = 92/266 (34%), Positives = 144/266 (54%), Gaps = 17/266 (6%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQ-FKCEAEIMLR 745
W + ++L++ + IG G +G+V D+ G +VAVK D+ +Q F EA +M +
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQ 55
Query: 746 LRHPNVVLFMGA-VTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGM 803
LRH N+V +G V I+TE++ +GSL L R L ++ +LDV + M
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPE 862
YL + VHRDL + N+LV ++ V KV DFGL++ S++ T P +W APE
Sbjct: 116 EYLEAN--NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPE 169
Query: 863 VLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
LR + + K DV+SFG++LWE+ + VP+ + VV V + +++ PD P V
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVV 228
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRLR 947
+++ CW + RPSF QL +L
Sbjct: 229 YDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 87/256 (33%), Positives = 128/256 (50%), Gaps = 9/256 (3%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+DL + +G G +G V W G +VA+K + S D +F EA++M++L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEK 60
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V G T+ I+TE++ G L L + + + M DV +GM YL +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
+HRDL + N LVD VKV DFGLSR + Y SS + W PEVL
Sbjct: 121 --FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 870 NEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928
+ K DV++FGV++WE+ +L +P++ N + V V Q RL P V I+ C
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSC 237
Query: 929 WQTEPHLRPSFAQLMS 944
W + RP+F QL+S
Sbjct: 238 WHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 93/287 (32%), Positives = 151/287 (52%), Gaps = 30/287 (10%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTE-------VAVKKFLDQDFSGDSLSQFKC 738
EWE+ + L +G+ +G G++G+V +A+ G + VAVK L D + LS
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM-LKDDATEKDLSDLVS 64
Query: 739 EAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRP------------ 783
E E+M + +H N++ +G T+ ++ E+ G+L L RP
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 784 -NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842
L ++ + A VA+GM +L + +HRDL + N+LV ++ V+K+ DFGL+R
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASK--KCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 843 HHTYLSSKSTAG-TP-EWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQ 899
HH K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 241
Query: 900 VVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+ + + R+E P + + ++RDCW P RP+F QL+ L
Sbjct: 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 88/263 (33%), Positives = 146/263 (55%), Gaps = 15/263 (5%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQ-FKCEAEIMLR 745
W + + L +GE IG G +G V + ++ G +VAVK + D +Q F E +M +
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVK-----NIKCDVTAQAFLEETAVMTK 55
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMN 804
L H N+V +G + + + I+ E + +G+L L R + + ++ +LDVA+GM
Sbjct: 56 LHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
YL + +VHRDL + N+LV ++ V KV DFGL+R+ +SK +W APE L
Sbjct: 115 YLESK--KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEAL 169
Query: 865 RNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923
+++ + K DV+S+GV+LWE+ + P+ ++ +V V + R+E P+ V
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYV 228
Query: 924 IIRDCWQTEPHLRPSFAQLMSRL 946
++ CW+TEP RPSF +L +L
Sbjct: 229 LMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 3e-41
Identities = 95/264 (35%), Positives = 143/264 (54%), Gaps = 11/264 (4%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI E LQ+ +++G G +GEV+ W+G T+VAVK S +S F EA+IM +
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKK 57
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMN 804
LRH +V V+ P + I+TE++ +GSL L L + MA VA GM
Sbjct: 58 LRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPEV 863
Y+ + +HRDL+S N+LV V K+ DFGL+R+ +++ A P +W APE
Sbjct: 117 YIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 864 LRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
K DV+SFG++L EL T VP+ G+N +V+ V + R+ P D ++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH 233
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRL 946
+++ CW+ +P RP+F L S L
Sbjct: 234 ELMLQCWKKDPEERPTFEYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 74/256 (28%), Positives = 124/256 (48%), Gaps = 9/256 (3%)
Query: 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
E I E++G GSYG VY+A G VA+K + L + E I+ + P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSP 58
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+V + G+ ++ I+ E+ GS+ ++ N L E + KG+ YLH++
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
+HRD+K+ N+L+++ K+ DFG+S T + GTP WMAPEV++
Sbjct: 119 K--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-RRLEIPDDIDPAVAQIIRDC 928
N K D++S G+ E+A P+ ++PM+ + + + L P+ P ++ C
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236
Query: 929 WQTEPHLRPSFAQLMS 944
+P RPS QL+
Sbjct: 237 LVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 84/261 (32%), Positives = 130/261 (49%), Gaps = 12/261 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
ED ++ +RIG G+YG+VY+A D G VA+K + GD + E ++ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHP 60
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
N+V + G+ R I+ E+ GSL + L E + + + KG+ YLH +
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL---RN 866
+HRD+K N+L+ ++ VK+ DFG+S T KS GTP WMAPEV R
Sbjct: 121 G--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 867 EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVV---GAVGFQNRRLEIPDDIDPAVAQ 923
+ KCD+++ G+ ELA L P L+PM+ + F +L+ + P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238
Query: 924 IIRDCWQTEPHLRPSFAQLMS 944
I+ C +P RP+ +L+
Sbjct: 239 FIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 85/262 (32%), Positives = 137/262 (52%), Gaps = 18/262 (6%)
Query: 695 QIGERIGIGSYGEVYRA---DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
Q G +IG G++G+VY A D G +AVK+ QD ++ + E +++ L+HPN+
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
V + G I E+ G+L LL LDE L + +G+ YLH+
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHG- 119
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYL---SSKSTAGTPEWMAPEVLRNE 867
IVHRD+K N+ +D N V+K+ DFG + ++K++T +S AGTP +MAPEV+
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 868 PANEK---CDVYSFGVILWELATLSVPWKGL-NPMQVVGAVGFQNRRLEIPD--DIDPAV 921
D++S G ++ E+AT PW L N Q++ VG ++ IPD + P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSPEG 237
Query: 922 AQIIRDCWQTEPHLRPSFAQLM 943
+ C +++P RP+ ++L+
Sbjct: 238 KDFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 90/288 (31%), Positives = 145/288 (50%), Gaps = 31/288 (10%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRAD-------WHGTEVAVKKFLDQDFSGDSLSQFKCEA 740
EI ++ E +G G++G+VY+ + T VA+K L ++ +F+ EA
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQEA 59
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPN-------------H 785
E+M L+HPN+V +G T+ +L E+L G L+ L + P+
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 786 QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHH 844
LD + +A+ +A GM YL + H VHRDL + N LV + VK+ DFGLSR I
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 845 TYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVG 902
Y +S + P WM PE + + D++SFGV+LWE+ + + P+ G + +V+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237
Query: 903 AVGFQNRR-LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949
+ ++R+ L P+D V ++ +CW P RP F + +RLR
Sbjct: 238 MI--RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 84/267 (31%), Positives = 134/267 (50%), Gaps = 12/267 (4%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTE-----VAVKKFLDQDFSGDSLSQFKCEAE 741
+EI ED+ +G IG G +G+VY+ + E VAVK S +F EA
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAY 59
Query: 742 IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK 801
IM + HP++V +G +T +P + I+ E P G L L + LD + + ++
Sbjct: 60 IMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMA 860
+ YL + VHRD+ + N+LV VK+ DFGLSR ++ +Y + +WMA
Sbjct: 119 ALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 861 PEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919
PE + DV+ FGV +WE+ L V P++G+ V+G + RL +P + P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 235
Query: 920 AVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+ ++ CW +P RP F +L ++L
Sbjct: 236 TLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 8e-40
Identities = 85/279 (30%), Positives = 136/279 (48%), Gaps = 27/279 (9%)
Query: 692 EDLQIGERIGIGSYGEVYRAD-WHG------TEVAVKKFLDQDFSGDSLSQFKCEAEIML 744
+ + + +G G++G+V+ + +H VAVK L + S D+ F+ EAE++
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFEREAELLT 63
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR-------------PNHQLDERR 791
+H N+V F G T ++ E++ G L + L P +L +
Sbjct: 64 NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 792 RMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT-YLSSK 850
+++A+ +A GM YL + H VHRDL + N LV + VVK+ DFG+SR + T Y
Sbjct: 124 LLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181
Query: 851 STAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQN 908
P WM PE + + DV+SFGV+LWE+ T PW GL+ +V+ + Q
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-QG 240
Query: 909 RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
R L+ P V I+ CW+ +P R + + RL+
Sbjct: 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 92/264 (34%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 694 LQIGERIGIGSYGEVYR-----ADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH 748
++I E IG G +GEV R VA+K L ++ F EA IM + H
Sbjct: 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
PN++ G VT+S I+TEF+ G+L L + + Q + + M +A GM YL
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-- 122
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH-----TYLSSKSTAGTPEWMAPEV 863
S VHRDL + N+LV+ N V KV DFGLSR TY SS W APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 864 LRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
+ DV+S+G+++WE+ + P+ ++ V+ A+ Q+ RL P D A+
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALH 241
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRL 946
Q++ DCWQ + + RP F Q++S L
Sbjct: 242 QLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 84/264 (31%), Positives = 148/264 (56%), Gaps = 11/264 (4%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WE+ E L++ +++G G +GEV+ ++G T+VA+K S ++ F EA +M +
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQ 57
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMN 804
L+HP +V VT+ P + I+TE++ GSL L P +L + + MA +A+GM
Sbjct: 58 LQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPEV 863
++ + +HRDL++ N+LV + K+ DFGL+R+ +++ A P +W APE
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 864 LRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
+ K DV+SFG++L E+ T +P+ G+ +V+ + + R+ PD+ +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRL 946
+++R CW+ +P RP+F L S L
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 93/292 (31%), Positives = 146/292 (50%), Gaps = 29/292 (9%)
Query: 691 WEDLQIGERIGIGSYGEVYRA----DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL 746
W D++ + IG G++G+V +A D + A+K+ + S D F E E++ +L
Sbjct: 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKL 64
Query: 747 -RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL---------------HRPNHQLDER 790
HPN++ +GA + + E+ P G+L L + L +
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 791 RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850
+ + A DVA+GM+YL S +HRDL + N+LV +N+V K+ DFGLSR Y+
Sbjct: 125 QLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKT 181
Query: 851 STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNR 909
WMA E L DV+S+GV+LWE+ +L P+ G+ ++ + Q
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 240
Query: 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTN 961
RLE P + D V ++R CW+ +P+ RPSFAQ+ L L R+L +R N
Sbjct: 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI---LVSLNRMLEERKTYVN 289
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 6e-39
Identities = 86/260 (33%), Positives = 136/260 (52%), Gaps = 13/260 (5%)
Query: 692 EDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+L + + IG G +G V+ W +VA+K + S + F EA++M++L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V G T ++ EF+ G L L + + + M LDV +GM YL +S
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS- 119
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK-HHTYLSSKSTAGTPEWMAPEVLRNEPA 869
++HRDL + N LV +N VVKV DFG++R Y SS T +W +PEV
Sbjct: 120 -NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 870 NEKCDVYSFGVILWEL-ATLSVPWKGLNPMQVVGAV--GFQNRRLEIPDDIDPAVAQIIR 926
+ K DV+SFGV++WE+ + P++ + +VV + GF RL P +V ++++
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---RLYKPRLASQSVYELMQ 235
Query: 927 DCWQTEPHLRPSFAQLMSRL 946
CW+ P RPSF+ L+ +L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 76/259 (29%), Positives = 125/259 (48%), Gaps = 15/259 (5%)
Query: 695 QIGERIGIGSYGEVY---RADWHGTEVAVKKF----LDQDFSGDSLSQFKCEAEIMLRLR 747
+ G+ +G G++G VY D G E+AVK+ + + ++ +CE +++ L+
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKE-VNALECEIQLLKNLQ 62
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
H +V + G + SI E++P GS+ L + L E + + +G+ YLH
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLH 121
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIK--HHTYLSSKSTAGTPEWMAPEVL 864
++ IVHRD+K N+L D VK+ DFG S R++ + KS GTP WM+PEV+
Sbjct: 122 SNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 865 RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924
E K DV+S G + E+ T PW M + + Q ++P + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
Query: 925 IRDCWQTEPHLRPSFAQLM 943
+R + RPS +L+
Sbjct: 240 LRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 76/258 (29%), Positives = 129/258 (50%), Gaps = 24/258 (9%)
Query: 698 ERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
E+IG G+ GEVY+A T EVA+KK + E IM +HPN+V +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ ++ E++ GSL ++ + +++E + + +V +G+ YLH+ + ++H
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIH 139
Query: 816 RDLKSPNLLVDKNWVVKVCDFG----LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
RD+KS N+L+ K+ VK+ DFG L++ K S GTP WMAPEV++ +
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEK----SKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA-VAQIIRD--- 927
K D++S G++ E+A P+ P++ + F IP +P + +D
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKGIPPLKNPEKWSPEFKDFLN 251
Query: 928 -CWQTEPHLRPSFAQLMS 944
C +P RPS +L+
Sbjct: 252 KCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 82/263 (31%), Positives = 128/263 (48%), Gaps = 23/263 (8%)
Query: 698 ERIGIGSYGEVYRADW---HGTEVAVK-KFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
+ +G G++G V + + G EV V K L Q+ +F EA +M +L HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLL----HRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+G V + ++ E P G L + L P L E +A VA GM YL +
Sbjct: 61 LIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-----LAHQVAMGMAYLESK 114
Query: 810 HPTIVHRDLKSPN-LLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTP-EWMAPEVLR 865
H VHRDL + N LLV+++ K+ DFG+SR Y + + P +W APE +
Sbjct: 115 H--FVHRDLAARNVLLVNRHQA-KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 866 NEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924
+ K DV+S+GV LWE + + P+ + +V+ + RL P++ + I
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSI 230
Query: 925 IRDCWQTEPHLRPSFAQLMSRLR 947
+ CW+ P RP+F++L S R
Sbjct: 231 MLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 5e-38
Identities = 99/306 (32%), Positives = 156/306 (50%), Gaps = 35/306 (11%)
Query: 681 LGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHG---------TEVAVKKFLDQDFSGD 731
L E WE+ + L +G+ +G G +G+V A+ G T+VAVK L D +
Sbjct: 7 LPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK-MLKSDATEK 65
Query: 732 SLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSL-------------- 776
LS E E+M + +H N++ +GA T+ ++ E+ +G+L
Sbjct: 66 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 125
Query: 777 -YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835
Y P QL + + A VA+GM YL + +HRDL + N+LV ++ V+K+ D
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIAD 183
Query: 836 FGLSRIKHHTYLSSKSTAG--TPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPW 892
FGL+R HH K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
Query: 893 KGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952
G+ P++ + + + R++ P + + ++RDCW P RP+F QL+ L R+
Sbjct: 244 PGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRI 299
Query: 953 LVDRSN 958
L SN
Sbjct: 300 LALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 90/264 (34%), Positives = 142/264 (53%), Gaps = 11/264 (4%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI E L++ ++G G +GEV+ W+GT VA+K S ++ Q EA++M +
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKK 57
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMN 804
LRH +V V+ P + I+TE++ +GSL L L + + MA +A GM
Sbjct: 58 LRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPEV 863
Y+ + VHRDL++ N+LV +N V KV DFGL+R+ +++ A P +W APE
Sbjct: 117 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 864 LRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
K DV+SFG++L EL T VP+ G+ +V+ V + R+ P + ++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 233
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRL 946
++ CW+ EP RP+F L + L
Sbjct: 234 DLMCQCWRKEPEERPTFEYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 9e-38
Identities = 91/281 (32%), Positives = 138/281 (49%), Gaps = 26/281 (9%)
Query: 691 WEDLQIGERIGIGSYGEVYRA----DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL 746
WED++ + IG G++G+V RA D A+K L + S + F E E++ +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDFAGELEVLCKL 59
Query: 747 -RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL---------------HRPNHQLDER 790
HPN++ +GA + I E+ P G+L L H L +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 791 RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850
+ ++ A DVA GM YL S +HRDL + N+LV +N K+ DFGLSR Y+
Sbjct: 120 QLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKKT 176
Query: 851 STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNR 909
WMA E L K DV+SFGV+LWE+ +L P+ G+ ++ + Q
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235
Query: 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950
R+E P + D V +++R CW+ P+ RP FAQ+ +L +
Sbjct: 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 82/257 (31%), Positives = 132/257 (51%), Gaps = 9/257 (3%)
Query: 693 DLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
+L + +G G +G V+ W +VA+K + S + F EA++M++L HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKL 61
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
V G T+ I+TEF+ G L L + +L + + M DV +GM YL +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN-- 119
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNEPAN 870
+ +HRDL + N LV VVKV DFG++R + Y SS +W PEV +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 871 EKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929
K DV+SFGV++WE+ T +P++ + +VV + + RL P V +++ CW
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSCW 238
Query: 930 QTEPHLRPSFAQLMSRL 946
+P RP+FA+L+ +
Sbjct: 239 HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 93/278 (33%), Positives = 136/278 (48%), Gaps = 23/278 (8%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVK-KFLDQDFSGDSLSQFKCEAE 741
E+ + + + +G G++GEVY + G E+ V K L + S S F EA
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 742 IMLRLRHPNVVLFMG-AVTRSPHFSILTEFLPRGSLYRLLH----RPNH--QLDERRRMR 794
IM + H N+V +G + R P F IL E + G L L RP L + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 795 MALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD---KNWVVKVCDFGLSR-IKHHTYLSSK 850
A DVAKG YL +H +HRD+ + N L+ V K+ DFG++R I +Y
Sbjct: 121 CARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 851 STAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQN 908
A P +WM PE + K DV+SFGV+LWE+ +L +P+ G +V+ V
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGG 237
Query: 909 RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
RL+ P V +I+ DCWQ P RP+FA ++ R+
Sbjct: 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-37
Identities = 83/252 (32%), Positives = 132/252 (52%), Gaps = 7/252 (2%)
Query: 698 ERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
E +G G++GEV++ T VAVK +D + +F EA I+ + HPN+V +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
T+ I+ E +P G L + +L ++ ++ ALD A GM YL + + +HR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHR 117
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDV 875
DL + N LV +N V+K+ DFG+SR + SS P +W APE L + + DV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 876 YSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPH 934
+S+G++LWE +L V P+ G+ Q V + R+ P V ++++ CW +P
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236
Query: 935 LRPSFAQLMSRL 946
RP F++L L
Sbjct: 237 NRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 88/264 (33%), Positives = 144/264 (54%), Gaps = 11/264 (4%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI E L++ ++G G +GEV+ W+GT +VA+K ++ Q EA+IM +
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ---EAQIMKK 57
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDVAKGMN 804
LRH +V V+ P + I+TEF+ +GSL L + + L + + MA +A GM
Sbjct: 58 LRHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPEV 863
Y+ + +HRDL++ N+LV N V K+ DFGL+R+ +++ A P +W APE
Sbjct: 117 YIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 864 LRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
K DV+SFG++L EL T VP+ G+ +V+ V + R+ P ++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRL 946
++++ CW+ +P RP+F + S L
Sbjct: 234 ELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 79/263 (30%), Positives = 125/263 (47%), Gaps = 25/263 (9%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
E + E IG GS+GEVY+A T VA+K +D + + D + + E + + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+ + G+ + I+ E+ GS LL +P +LDE + +V G+ YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPG-KLDETYIAFILREVLLGLEYLHEE 117
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
+HRD+K+ N+L+ + VK+ DFG+S T + GTP WMAPEV++
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP---------DDIDPA 920
+EK D++S G+ ELA P L+PM+V+ IP +
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLEGNKFSKP 226
Query: 921 VAQIIRDCWQTEPHLRPSFAQLM 943
+ C +P RPS +L+
Sbjct: 227 FKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 89/256 (34%), Positives = 135/256 (52%), Gaps = 13/256 (5%)
Query: 698 ERIGIGSYGEVY----RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
ERIG G++GEV+ RAD T VAVK + D ++F EA I+ + HPN+V
Sbjct: 1 ERIGRGNFGEVFSGRLRAD--NTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
+G T+ I+ E + G L +L + ++M + A GM YL + H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--C 115
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH-TYLSSKSTAGTP-EWMAPEVLRNEPANE 871
+HRDL + N LV + V+K+ DFG+SR + Y S+ P +W APE L +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 872 KCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQ 930
+ DV+SFG++LWE +L +VP+ L+ Q A+ Q RL P+ AV +++ CW+
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE 234
Query: 931 TEPHLRPSFAQLMSRL 946
+P RPSF+ + L
Sbjct: 235 YDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 89/261 (34%), Positives = 136/261 (52%), Gaps = 11/261 (4%)
Query: 694 LQIGERIGIGSYGEVY--RADWHGT-EVAVK-KFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
++I + IG G +GEV R G E+ V K L ++ F EA IM + HP
Sbjct: 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
N++ G VT+S I+TE++ GSL L + + Q + + M +A GM YL S
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL--S 123
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP---EWMAPEVLRN 866
VHRDL + N+LV+ N V KV DFGLSR+ ++ +T G W APE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 867 EPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
DV+S+G+++WE+ + P+ ++ V+ A+ + RL P D A+ Q++
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLM 242
Query: 926 RDCWQTEPHLRPSFAQLMSRL 946
DCWQ + + RP F Q++S L
Sbjct: 243 LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 85/260 (32%), Positives = 133/260 (51%), Gaps = 19/260 (7%)
Query: 700 IGIGSYGEVYRADWHGTE-----VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
IG G +G VY ++ AVK L++ + + QF E IM HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 755 MGAVTR---SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+G SP ++ ++ G L + H + + L VAKGM YL +
Sbjct: 62 LGICLPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL--ASK 117
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLS--SKSTAGTP-EWMAPEVLRNE 867
VHRDL + N ++D+++ VKV DFGL+R I Y S + + A P +WMA E L+ +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 868 PANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926
K DV+SFGV+LWEL T P+ ++ + + Q RRL P+ + +++
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLYEVML 236
Query: 927 DCWQTEPHLRPSFAQLMSRL 946
CW +P +RP+F++L+SR+
Sbjct: 237 SCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 83/282 (29%), Positives = 135/282 (47%), Gaps = 29/282 (10%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCE 739
WE +L G+ +G G++G+V A +G +VAVK L E
Sbjct: 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSE 88
Query: 740 AEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMAL 797
+IM L H N+V +GA T ++TE+ G L L R L + +
Sbjct: 89 LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTP 856
VAKGM +L + + +HRDL + N+L+ +VK+CDFGL+R I + + K A P
Sbjct: 149 QVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 857 -EWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGL-------NPMQVVGAVGFQ 907
+WMAPE + N + DV+S+G++LWE+ +L P+ G+ ++ G+
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGY- 261
Query: 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949
R+ P+ + I++ CW +P RP+F Q++ +
Sbjct: 262 --RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 77/274 (28%), Positives = 134/274 (48%), Gaps = 18/274 (6%)
Query: 694 LQIGERIGIGSYGEVYRADWH------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
L+ + +G G++G VY+ W VA+K + + S + + EA +M +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVD 67
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
HP+VV +G + S ++T+ +P G L + + + + + +AKGM+YL
Sbjct: 68 HPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG-TP-EWMAPEVLR 865
+VHRDL + N+LV VK+ DFGL+++ + G P +WMA E +
Sbjct: 127 EKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 866 NEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924
+ K DV+S+GV +WEL T + P++G+ +++ + + RL P V +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMV 243
Query: 925 IRDCWQTEPHLRPSFAQLMSRL----RCLQRLLV 954
+ CW + RP+F +L++ R QR LV
Sbjct: 244 LVKCWMIDAESRPTFKELINEFSKMARDPQRYLV 277
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 88/280 (31%), Positives = 150/280 (53%), Gaps = 23/280 (8%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCE 739
WE+ E + + +G GS+G VY G T VA+K +++ S +F E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNE 59
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH--RPNHQLDE-------R 790
A +M +VV +G V++ ++ E + RG L L RP + + +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 791 RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850
+ ++MA ++A GM YL+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 120 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 851 STAG--TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQ 907
G WM+PE L++ DV+SFGV+LWE+ATL+ P++G++ QV+ V +
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-ME 236
Query: 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
L+ PD+ + +++R CWQ P +RPSF +++S ++
Sbjct: 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 19/263 (7%)
Query: 697 GERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDS-------LSQFKCEAEIMLRLR 747
G IG GS+G VY G +AVK+ S S L E ++ L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
H N+V ++G+ + H +I E++P GS+ LL+ +E + KG+NYLH
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH 123
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK------STAGTPEWMAP 861
I+HRD+K N+LVD +K+ DFG+S+ LS+K S G+ WMAP
Sbjct: 124 NR--GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
EV++ K D++S G ++ E+ T P+ +Q + +G +N EIP +I
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSEA 240
Query: 922 AQIIRDCWQTEPHLRPSFAQLMS 944
+ ++ + + RP+ A+L+
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 86/291 (29%), Positives = 148/291 (50%), Gaps = 32/291 (10%)
Query: 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHGTE---------VAVKKFLDQDFSGDSLSQ 735
+WE + L +G+ +G G +G+V RA+ +G + VAVK L + + L+
Sbjct: 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLAD 63
Query: 736 FKCEAEIM-LRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR------------ 782
E E+M L +H N++ +G T+ ++ E+ +G+L L
Sbjct: 64 LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123
Query: 783 ---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839
P QL + + A VA+GM YL + +HRDL + N+LV ++ V+K+ DFGL+
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 840 RIKHHTYLSSKSTAG--TPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLN 896
R H K++ G +WMAPE L + + DV+SFG+++WE+ TL P+ G+
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI- 240
Query: 897 PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
P++ + + + R++ P + + ++R+CW P RP+F QL+ L
Sbjct: 241 PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 97/309 (31%), Positives = 158/309 (51%), Gaps = 37/309 (11%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTE---------VAVKKFLDQDFSGDSLSQF 736
+WE+ L +G+ +G G +G+V A+ G + VAVK L D + LS
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK-MLKDDATDKDLSDL 64
Query: 737 KCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR------------- 782
E E+M + +H N++ +GA T+ +L E+ +G+L L
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 783 --PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840
P QL + + A VA+GM YL + +HRDL + N+LV ++ V+K+ DFGL+R
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQ--KCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 841 IKHHTYLSSKSTAG--TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNP 897
H+ K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-P 241
Query: 898 MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRS 957
++ + + + R++ P + + I+R+CW P RP+F QL+ L R+L
Sbjct: 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED---LDRVLT--V 296
Query: 958 NSTNQFSEL 966
ST+++ +L
Sbjct: 297 TSTDEYLDL 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-34
Identities = 84/269 (31%), Positives = 145/269 (53%), Gaps = 21/269 (7%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI E L++ +++G G +GEV+ A ++ T+VAVK S + F EA +M
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 57
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRM------ALDV 799
L+H +V VT+ P + I+TEF+ +GSL L + DE + + + +
Sbjct: 58 LQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFL-----KSDEGSKQPLPKLIDFSAQI 111
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EW 858
A+GM ++ + +HRDL++ N+LV + V K+ DFGL+R+ +++ A P +W
Sbjct: 112 AEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDI 917
APE + K DV+SFG++L E+ T +P+ G++ +V+ A+ + R+ P++
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENC 228
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+ I+ CW+ P RP+F + S L
Sbjct: 229 PEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 85/257 (33%), Positives = 129/257 (50%), Gaps = 15/257 (5%)
Query: 700 IGIGSYGEVYRADWH---GTEVAVK-KFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
IG G +GEV+R EVAV K L ++ F EA IM + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
G VT+ I+TE++ G+L + L + + + + M +A GM YL S VH
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL--SDMNYVH 130
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP---EWMAPEVLRNEPANEK 872
RDL + N+LV+ N KV DFGLSR+ + +T+G W APE +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190
Query: 873 CDVYSFGVILWELATL-SVPWKGLNPMQVVGAV--GFQNRRLEIPDDIDPAVAQIIRDCW 929
DV+SFG+++WE+ + P+ ++ +V+ A+ GF RL P D AV Q++ CW
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDCPSAVYQLMLQCW 247
Query: 930 QTEPHLRPSFAQLMSRL 946
Q + RP F +++ L
Sbjct: 248 QQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 88/280 (31%), Positives = 134/280 (47%), Gaps = 29/280 (10%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIML 744
D+ + +G G++G+V+ A+ H VAVK ++ S + F+ EAE++
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLT 62
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPNHQLDERRRM--------- 793
L+H ++V F G T ++ E++ G L R L H P+ ++
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 794 ---RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--YLS 848
+A +A GM YL + H VHRDL + N LV + VVK+ DFG+SR + T Y
Sbjct: 123 QMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQ 907
T WM PE + + D++SFGV+LWE+ T PW L+ + + + Q
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239
Query: 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
R LE P P V I++ CWQ EP R + SRL+
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 86/268 (32%), Positives = 135/268 (50%), Gaps = 26/268 (9%)
Query: 700 IGIGSYGEVYRA----DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLF 754
IG G++G+V +A D + A+K + + S D F E E++ +L HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLL---------------HRPNHQLDERRRMRMALDV 799
+GA + + E+ P G+L L + L ++ + A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWM 859
A+GM+YL S +HRDL + N+LV +N+V K+ DFGLSR Y+ WM
Sbjct: 122 ARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWM 178
Query: 860 APEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
A E L DV+S+GV+LWE+ +L P+ G+ ++ + Q RLE P + D
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCD 237
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
V ++R CW+ +P+ RPSFAQ++ L
Sbjct: 238 DEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-34
Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 21/266 (7%)
Query: 697 GERIGIGSYGEVYRA--DWHGTEVAVKKF--------LDQDFSGDSLSQFKCEAEIMLRL 746
GE IG G+YG VY A G +AVK+ D + + E E + L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806
H N+V ++G T + SI E++P GS+ L + +E+ V +G+ YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYL 124
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA--GTPEWMAPEVL 864
H+ I+HRDLK+ NLLVD + + K+ DFG+S+ Y + ++ + G+ WMAPEV+
Sbjct: 125 HSK--GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 865 RNEPA--NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
+ + K D++S G ++ E+ PW + + +G + IP D+ ++
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 923 QI----IRDCWQTEPHLRPSFAQLMS 944
+ + C+ P RP+ +L+
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 79/269 (29%), Positives = 144/269 (53%), Gaps = 20/269 (7%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI E +++ +++G G +GEV+ ++ T+VAVK S + F EA +M
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 57
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRM------ALDV 799
L+H +V VT+ I+TE++ +GSL L + DE ++ + + +
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL-----KSDEGGKVLLPKLIDFSAQI 112
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EW 858
A+GM Y+ + +HRDL++ N+LV ++ + K+ DFGL+R+ +++ A P +W
Sbjct: 113 AEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917
APE + K DV+SFG++L+E+ T +P+ G++ V+ A+ + R+ ++
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENC 229
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+ I++ CW+ + RP+F L S L
Sbjct: 230 PDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 9e-34
Identities = 90/294 (30%), Positives = 150/294 (51%), Gaps = 32/294 (10%)
Query: 681 LGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTE---------VAVKKFLDQDFSGD 731
L E WE + L +G+ +G G +G+V A+ G + VAVK L D +
Sbjct: 4 LPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEK 62
Query: 732 SLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSL-------------- 776
LS E E+M + +H N++ +GA T+ ++ E+ +G+L
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122
Query: 777 -YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835
Y + P+ Q+ + + VA+GM YL + +HRDL + N+LV +N V+K+ D
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIAD 180
Query: 836 FGLSRIKHHTYLSSKSTAG--TPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPW 892
FGL+R ++ K+T G +WMAPE L + + DV+SFGV++WE+ TL P+
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
Query: 893 KGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
G+ P++ + + + R++ P + + ++RDCW P RP+F QL+ L
Sbjct: 241 PGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 84/275 (30%), Positives = 138/275 (50%), Gaps = 29/275 (10%)
Query: 698 ERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
E +G ++G++Y+ H VA+K D + + +F+ EA +M L HPN+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNI 69
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYR-LLHRPNH---------------QLDERRRMRM 795
V +G VT+ +L E+L +G L+ L+ R H LD + +
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAG 854
A+ +A GM YL +SH VH+DL + N+L+ + VK+ D GLSR I Y + +
Sbjct: 130 AIQIAAGMEYL-SSH-FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 855 TP-EWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLE 912
P WM PE + + D++SFGV+LWE+ + + P+ G + +V+ V + + L
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-KRQLLP 246
Query: 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
+D P + ++ +CWQ P RP F + +RLR
Sbjct: 247 CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 24/266 (9%)
Query: 700 IGIGSYGEVYRADWHGTE-------VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+G G +GEV+ A G E V VK + S+F+ E ++ +L H NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVV 71
Query: 753 LFMGAV-TRSPHFSILTEFLPRGSLYRLLHRPNHQLDER---------RRMRMALDVAKG 802
+G PH+ IL E+ G L + L R DE+ +++ + +A G
Sbjct: 72 RLLGLCREAEPHYMIL-EYTDLGDLKQFL-RATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT-YLSSKSTAGTPEWMAP 861
M++L + VHRDL + N LV VKV LS+ +++ Y ++ W+AP
Sbjct: 130 MDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
E ++ + + K DV+SFGV++WE+ T P+ GL+ +V+ + L +P+
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMSRL 946
+ +++ CW P RPSF++L+S L
Sbjct: 248 LYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 75/266 (28%), Positives = 131/266 (49%), Gaps = 27/266 (10%)
Query: 697 GERIGIGSYGEVYRAD--WHGTEVAVKKFLDQDFSG----DSLSQFKCEAEIMLRLRHPN 750
G+++G G++ Y+A GT +AVK+ + + + + E +M RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
++ +GA HF++ E++ GS+ LL + E + + +G++YLH +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 811 PTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIKHHTYLSSKSTA---------GTPEWMA 860
I+HRD+K NLL+D +++ DFG + + L++K T GT +MA
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFG-AAAR----LAAKGTGAGEFQGQLLGTIAFMA 176
Query: 861 PEVLRNEPANEKCDVYSFGVILWELATLSVPW---KGLNPMQVVGAVGFQNRRLEIPDDI 917
PEVLR E CDV+S G ++ E+AT PW K N + ++ + IP+ +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLM 943
P + + C + +P RP +L+
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 79/272 (29%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 692 EDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSL--SQFKCEAEIMLRLR 747
DL+ + +G GS G VY+ G A+KK GD Q E + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCE 57
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
P VV GA + SI+ E++ GSL LL + + E +A + KG++YLH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK-IPEPVLAYIARQILKGLDYLH 116
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI------KHHTYLSSKSTAGTPEWMAP 861
T I+HRD+K NLL++ VK+ DFG+S++ + +T++ GT +M+P
Sbjct: 117 TKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMSP 169
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI-------- 913
E ++ E + D++S G+ L E A G P G F I
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECAL------GKFPFLPPGQPSFFELMQAICDGPPPSL 223
Query: 914 -PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
++ P I C Q +P RPS A+L+
Sbjct: 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 85/279 (30%), Positives = 136/279 (48%), Gaps = 47/279 (16%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEV-AVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI IGE +G G++G+VY+A T + A K + + S + L F E +I+
Sbjct: 7 WEI------IGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSE 58
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
+HPN+V A IL EF G+L ++ L E + + + + +N+
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS------RIKHHTYLSSKSTAGTPEWM 859
LH+ ++HRDLK+ N+L+ + VK+ DFG+S K T++ GTP WM
Sbjct: 119 LHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWM 170
Query: 860 APEVL-----RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP 914
APEV+ ++ P + K D++S G+ L ELA + P LNPM+V+ L+I
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKIL 221
Query: 915 DDIDPAVAQ----------IIRDCWQTEPHLRPSFAQLM 943
P + Q ++ C +P RP+ A+L+
Sbjct: 222 KSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 92/284 (32%), Positives = 133/284 (46%), Gaps = 40/284 (14%)
Query: 700 IGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
IG G++G V++A G T VAVK L ++ S D + F+ EA +M HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHR---------------------PNHQLDERR 791
+G +L E++ G L L L
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 792 RMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--YLSS 849
++ +A VA GM YL VHRDL + N LV +N VVK+ DFGLSR + Y +S
Sbjct: 132 QLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 850 KSTAGTPEWMAPE-VLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQ 907
++ A WM PE + N E DV+++GV+LWE+ + + P+ G+ +V+ V
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248
Query: 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
N L PD+ + ++R CW P RPSFA + R LQR
Sbjct: 249 N-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASIN---RILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 89/280 (31%), Positives = 139/280 (49%), Gaps = 36/280 (12%)
Query: 700 IGIGSYGEVYR------ADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
+G G++G V D G VAVKK Q + + L F+ E EI+ L+H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 754 FMGAVTRSP---HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+ G V S + ++ E+LP GSL L + +LD R+ + A + KGM YL +
Sbjct: 70 YKG-VCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTPE-WMAPEVLRNE 867
VHRDL + N+LV+ VK+ DFGL+++ + Y + +P W APE L
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 868 PANEKCDVYSFGVILWELATLSVPWKGLNP----MQVVGA-------------VGFQNRR 910
+ DV+SFGV+L+EL T S K +P M+++G + N R
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSD--KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244
Query: 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950
L P + I+++CW +P RPSF++L ++ ++
Sbjct: 245 LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 81/271 (29%), Positives = 130/271 (47%), Gaps = 28/271 (10%)
Query: 690 LWEDLQIGERIGIGSYGEVYRA-DWHGTEVAVKKFL----DQDFSGDSLSQFKCEAEIML 744
W GE +G G+YG VY G +AVK+ + + + + E +++
Sbjct: 1 EW---TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR--PNHQLDERRRMRMALDVAKG 802
L+H N+V ++G SI EF+P GS+ +L+R P + + + LD G
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---G 114
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR--------IKHHTYLSSKSTAG 854
+ YLH + +VHRD+K N+++ N ++K+ DFG +R H L KS G
Sbjct: 115 VAYLHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHG 170
Query: 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--E 912
TP WMAPEV+ K D++S G ++E+AT P ++ + + +G +R L
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPR 229
Query: 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+PD A + C + H RPS QL+
Sbjct: 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 74/262 (28%), Positives = 134/262 (51%), Gaps = 22/262 (8%)
Query: 693 DLQIGERIGIGSYGEVYR----ADWHGTEVAVKKF----LDQDFSGDSLSQFKCEAEIML 744
D ++ +++G GSYG VY+ +D A+K+ + Q D+++ E I+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSD--NQFYALKEVDLGSMSQKEREDAVN----EIRILA 54
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALDVAK 801
+ HPN++ + A I+ E+ P G L + + + + + E+ R+ + + +
Sbjct: 55 SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
G+ LH I+HRDLKS N+L+ N +VK+ D G+S++ K+ GTP +MAP
Sbjct: 115 GLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAP 170
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
EV + P + K D++S G +L+E+AT + P++ MQ + + + IP +
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPPIPPIYSQDL 229
Query: 922 AQIIRDCWQTEPHLRPSFAQLM 943
IR Q +P LRP+ +++
Sbjct: 230 QNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 88/273 (32%), Positives = 130/273 (47%), Gaps = 34/273 (12%)
Query: 700 IGIGSYGEVYRA-----DWHGTE---VAVKKF----LDQDFSGDSLSQFKCEAEIMLRLR 747
+G G++GEVY G+ VAVK DQ+ +F EA +M
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-----EFLKEAHLMSNFN 57
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ------LDERRRMRMALDVAK 801
HPN+V +G + I+ E + G L L + L + + + LDVAK
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLV-----DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGT 855
G YL H +HRDL + N LV D + VVK+ DFGL+R I Y +
Sbjct: 118 GCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 856 P-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEI 913
P WMAPE L + + DV+SFGV++WE+ TL P+ LN +V+ V RL+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQK 234
Query: 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
P++ + Q++ +CW +P RP+F ++ L
Sbjct: 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 73/268 (27%), Positives = 131/268 (48%), Gaps = 25/268 (9%)
Query: 693 DLQIGERIGIGSYGEVY----RADWHGTEVAVKKFLDQDFSGDSLSQFKC-----EAEIM 743
D ++ E IG GS+G V ++D G + K + ++++ + E I+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSD--GKILVWK-----EIDYGNMTEKEKQQLVSEVNIL 53
Query: 744 LRLRHPNVVLFMG-AVTRSPH-FSILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALD 798
L+HPN+V + + RS I+ E+ G L +L+ + ++E R+
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 799 VAKGMNYLHT---SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855
+ + H T++HRDLK N+ +D N VK+ DFGL++I H +K+ GT
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173
Query: 856 PEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD 915
P +M+PE L + +EK D++S G +++EL LS P+ N +Q+ + + + IP
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPY 232
Query: 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+ ++I+ +P RPS +L+
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 3e-32
Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 695 QIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHP-NVV 752
+I ++G GS+GEVY A VA+K + S + +F E +I+ L HP N+V
Sbjct: 3 RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRP--NHQLDERRRMRMALDVAKGMNYLHTSH 810
++ E++ GSL LL + L E + + + + YLH+
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 811 PTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIKHHTYLSSKSTA------GTPEWMAPEV 863
I+HRD+K N+L+D++ VVK+ DFGL+++ +S A GTP +MAPEV
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 864 LR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--------- 911
L A+ D++S G+ L+EL T P++G L
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 912 --EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945
P+ I A + +++ +P R S + +S
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 66/257 (25%), Positives = 125/257 (48%), Gaps = 12/257 (4%)
Query: 693 DLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSG-DSLSQFKC--EAEIMLRLR 747
D +I +IG GS+G V++ A+K+ D S + + + EA ++ +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQI---DLSKMNRREREEAIDEARVLAKLD 57
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDVAKGMNYL 806
++ + + +I+ E+ G L++LL + L E + R + + G+ +L
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN 866
H+ I+HRD+KS NL +D VK+ D G++++ + + GTP +++PE+ +
Sbjct: 118 HSK--KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175
Query: 867 EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926
+P NEK DV++ GV+L+E T P+ N ++ + + + +AQ+I
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLID 234
Query: 927 DCWQTEPHLRPSFAQLM 943
C + RP QL+
Sbjct: 235 QCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 85/297 (28%), Positives = 146/297 (49%), Gaps = 40/297 (13%)
Query: 693 DLQIGERIGIGSYGEVYRA---DWHG----TEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
+L +G+ +G G +G+V +A G T VAVK L ++ S L E ++ +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLKQ 59
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL---------------HRPNHQLD-- 788
+ HP+V+ GA ++ ++ E+ GSL L +R + LD
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 789 ERRRMRM------ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-- 840
+ R + M A +++GM YL + +VHRDL + N+LV + +K+ DFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQ 899
+ +Y+ +WMA E L + + DV+SFGV+LWE+ TL P+ G+ P +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 900 VVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDR 956
+ + R+E P++ + ++ CW+ EP RP+FA + L++++V
Sbjct: 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE---LEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 87/280 (31%), Positives = 143/280 (51%), Gaps = 23/280 (8%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCE 739
WE+ E + + +G GS+G VY + T VAVK +++ S +F E
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNE 59
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH--RPNHQLDERR------ 791
A +M +VV +G V++ ++ E + G L L RP + + R
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 792 -RMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850
++MA ++A GM YL+ VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 120 EMIQMAAEIADGMAYLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 851 STAG--TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQ 907
G WMAPE L++ D++SFGV+LWE+ +L+ P++GL+ QV+ V
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MD 236
Query: 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
L+ PD+ V ++R CWQ P +RP+F ++++ L+
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 84/276 (30%), Positives = 128/276 (46%), Gaps = 24/276 (8%)
Query: 694 LQIGERIGIGSYGEVYRA-----DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH 748
+G +G G +G V A D +VAVK FS + +F EA M H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 749 PNVVLFMGAVTRS------PHFSILTEFLPRGSLY------RLLHRPNHQLDERRRMRMA 796
PNV+ +G RS P ++ F+ G L+ R+ P L + +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP-FTLPLQTLVRFM 119
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGT 855
+D+A GM YL S +HRDL + N ++++N V V DFGLS+ I Y +
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 856 P-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEI 913
P +W+A E L + DV++FGV +WE+ T P+ G+ ++ + + RL+
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQ 236
Query: 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949
P D V +++ CW EP RPSF L +L +
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 87/273 (31%), Positives = 134/273 (49%), Gaps = 30/273 (10%)
Query: 700 IGIGSYGEV--YRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
+G G +G+V Y D G VAVK L ++ + S +K E I+ L H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 754 FMGAVTRSPHFSIL--TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ G + + E++P GSL L P H+L+ + + A + +GM YLH+ H
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHSQH- 127
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTPE-WMAPEVLRNEP 868
+HRDL + N+L+D + +VK+ DFGL++ + H Y + +P W A E L+
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 869 ANEKCDVYSFGVILWELAT-----LSVPWKGL-------NPMQVVGAVGFQNR--RLEIP 914
+ DV+SFGV L+EL T S P K M VV + R RL P
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP 246
Query: 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
+ V ++++CW+TE RP+F L+ L+
Sbjct: 247 KNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 79/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 694 LQIGERIGIGSYGEVYRA-----DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH 748
L++G+ +G G +G V D +VAVK + + +F EA M H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 749 PNVVLFMG------AVTRSPHFSILTEFLPRGSLY------RLLHRPNHQLDERRRMRMA 796
PNV+ +G ++ + P ++ F+ G L+ RL P L + ++
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTLLKFM 119
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGT 855
+D+A GM YL S+ +HRDL + N ++ ++ V V DFGLS+ I Y A
Sbjct: 120 VDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 856 P-EWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEI 913
P +W+A E L + K DV++FGV +WE+AT P+ G+ ++ + RL+
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQ 236
Query: 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
P+D + ++ CW+ +P RP+F +L L
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 83/281 (29%), Positives = 137/281 (48%), Gaps = 27/281 (9%)
Query: 693 DLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
++ + +G G++G+V+ A+ + VAVK +D S ++ F EAE++
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAELLTN 63
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH------------RPNHQLDERRRM 793
L+H ++V F G ++ E++ G L + L +L + + +
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 794 RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--YLSSKS 851
+A +A GM YL + H VHRDL + N LV +N +VK+ DFG+SR + T Y
Sbjct: 124 HIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 852 TAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRR 910
T WM PE + + DV+S GV+LWE+ T PW L+ +V+ + Q R
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGRV 240
Query: 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
L+ P V ++ CWQ EPH+R + ++ S L+ L +
Sbjct: 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 62/255 (24%), Positives = 125/255 (49%), Gaps = 14/255 (5%)
Query: 700 IGIGSYGE--VYRADWHGTEVAVKKF----LDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
+G G++GE +YR + V K+ L + D+L+ E I+ L+HPN++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN----EIVILSLLQHPNIIA 63
Query: 754 FMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ I E+ G+LY +++ + +E + + ++Y+H +
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA--G 121
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK 872
I+HRD+K+ N+ + K ++K+ DFG+S+I Y +++ GTP +M+PE+ + N K
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFK 181
Query: 873 CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTE 932
D+++ G +L+EL TL + NP+ +V + Q + + ++ Q +
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHSLLQQD 240
Query: 933 PHLRPSFAQLMSRLR 947
P RP+ +++ +
Sbjct: 241 PEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 76/270 (28%), Positives = 134/270 (49%), Gaps = 11/270 (4%)
Query: 698 ERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
ERIG GS+GEVY+ D EV K +D + + D + + E ++ + P + + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ + I+ E+L GS LL +P L+E + ++ KG++YLH+ +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-KPG-PLEETYIATILREILKGLDYLHSERK--IHR 125
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVY 876
D+K+ N+L+ + VK+ DFG++ T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 877 SFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
S G+ ELA P L+PM+V+ + +N + + + C +P R
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLNKDPRFR 244
Query: 937 PSFAQLMSRLRCLQRLLVDRSNSTNQFSEL 966
P+ +L+ + + + T+ +EL
Sbjct: 245 PTAKELLK-----HKFITRYTKKTSFLTEL 269
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 87/284 (30%), Positives = 133/284 (46%), Gaps = 30/284 (10%)
Query: 693 DLQIGERIGIGSYGEVYRADWHGTE-------VAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
D+ + +G G++G+V+ A+ + VAVK D + + F+ EAE++
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREAELLTN 63
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRP-------------NHQLDER 790
L+H ++V F G ++ E++ G L + L H P +L
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 791 RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--YLS 848
+ + +A +A GM YL + H VHRDL + N LV N +VK+ DFG+SR + T Y
Sbjct: 124 QMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQ 907
T WM PE + + DV+SFGVILWE+ T PW L+ +V+ + Q
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-Q 240
Query: 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
R LE P V I+ CWQ EP R + ++ L L +
Sbjct: 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 84/264 (31%), Positives = 132/264 (50%), Gaps = 18/264 (6%)
Query: 692 EDLQIGERIGIGSYGEVY---RADWHGTEVAVKKF-LDQDFSGDS--LSQFKCEAEIMLR 745
+ ++G+ +G G++GEVY AD G E+AVK+ D D S ++ +CE +++
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60
Query: 746 LRHPNVVLFMGAVTRSPH---FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
LRH +V + G + R P SI E++P GS+ L + L E R + +G
Sbjct: 61 LRHDRIVQYYGCL-RDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQG 118
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS---KSTAGTPEWM 859
++YLH++ IVHRD+K N+L D VK+ DFG S+ +S KS GTP WM
Sbjct: 119 VSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 860 APEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919
+PEV+ E K DV+S + E+ T PW M + + Q + +PD +
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236
Query: 920 AVAQIIRDCWQTEPHLRPSFAQLM 943
A ++ + E RP+ L+
Sbjct: 237 ACRDFLKQIF-VEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 71/252 (28%), Positives = 128/252 (50%), Gaps = 11/252 (4%)
Query: 700 IGIGSYGEV----YRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+G GSYGEV +R D G + +KK ++ S + EA+++ +L+HPN+V +
Sbjct: 8 VGKGSYGEVSLVRHRTD--GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 756 GAVT-RSPHFSILTEFLPRGSLYRLLHRPNHQL-DERRRMRMALDVAKGMNYLHTSHPTI 813
+ I+ F G LY L +L E + + + +A + YLH H I
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--I 123
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKC 873
+HRDLK+ N+ + + ++KV D G++R+ + + + GTP +M+PE+ N+P N K
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183
Query: 874 DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933
DV++ G ++E+ATL + + +V + + + +P D P + ++I P
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLSKRP 242
Query: 934 HLRPSFAQLMSR 945
RPS ++ +
Sbjct: 243 EKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 68/284 (23%), Positives = 124/284 (43%), Gaps = 37/284 (13%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWH-GTEVAVK----KFLDQDFSGDSLSQFKCEAEIMLR 745
+D + G+ IG GS+ V A + E A+K + L ++ + K E E++ R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE---KKVKYVKIEKEVLTR 57
Query: 746 L-RHPNVV-LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
L HP ++ L+ + +L E+ P G L + + + LDE+ A ++ +
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVL-EYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLAL 115
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS-------------- 849
YLH+ I+HRDLK N+L+DK+ +K+ DFG +++
Sbjct: 116 EYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 850 ------KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGA 903
S GT E+++PE+L +PA + D+++ G I++++ T P++G N
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
+ P + P +I +P R + L+
Sbjct: 234 I--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 82/266 (30%), Positives = 136/266 (51%), Gaps = 18/266 (6%)
Query: 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+D ++ E IG+G+ VY A + +VA+K+ +D + S+ + + E + M + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR--PNHQLDERRRMRMALDVAKGMNYLH 807
NVV + + ++ +L GSL ++ P LDE + +V KG+ YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI----KHHTYLSSKSTAGTPEWMAPEV 863
S+ I HRD+K+ N+L+ ++ VK+ DFG+S T K+ GTP WMAPEV
Sbjct: 120 -SNGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 864 LRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP--- 919
+ + K D++SFG+ ELAT + P+ PM+V+ + QN + D
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-MLTLQNDPPSLETGADYKKY 236
Query: 920 --AVAQIIRDCWQTEPHLRPSFAQLM 943
+ ++I C Q +P RP+ +L+
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 87/287 (30%), Positives = 134/287 (46%), Gaps = 23/287 (8%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEV-AVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI IGE +G G++G+VY+A T A K ++ S + L + E EI+
Sbjct: 14 WEI------IGE-LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILAT 65
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
HP +V +GA I+ EF P G++ ++ + L E + + + + + Y
Sbjct: 66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEV-- 863
LH+ I+HRDLK+ N+L+ + +K+ DFG+S T S GTP WMAPEV
Sbjct: 126 LHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 864 ---LRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-RRLEIPDDIDP 919
+++ P + K D++S G+ L E+A + P LNPM+V+ + L P
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243
Query: 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSEL 966
++ P RPS AQL L+ V S EL
Sbjct: 244 EFRDFLKTALDKHPETRPSAAQL------LEHPFVSSVTSNRPLREL 284
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 73/261 (27%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 692 EDLQIGERIGIGSYGEVYRAD--WHGTEVAVKKFLDQDFSGDSLSQFKCEAEIML--RLR 747
+ +I ++IG G + VY+A G VA+KK + D+ ++ C EI L +L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLD 60
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALDVAKGMN 804
HPNV+ ++ + + +I+ E G L R++ Q + ER + + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA-----GTPEWM 859
++H+ I+HRD+K N+ + VVK+ D GL R + SSK+TA GTP +M
Sbjct: 121 HMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYM 173
Query: 860 APEVLRNEPANEKCDVYSFGVILWELATLSVPWKG--LNPMQVVGAVGFQNRRLEIPDDI 917
+PE + N K D++S G +L+E+A L P+ G +N + + + +P D
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADH 232
Query: 918 DPA-VAQIIRDCWQTEPHLRP 937
+ ++ C +P RP
Sbjct: 233 YSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 88/269 (32%), Positives = 137/269 (50%), Gaps = 28/269 (10%)
Query: 700 IGIGSYGEVY------RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
+G G +G+V D G +VAVK L + G+ ++ K E EI+ L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 754 FMGAVTRSPHFSI--LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ G T I + EFLP GSL L R ++++ +++++ A+ + KGM+YL +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ- 129
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IK-HHTYLSSKSTAGTPE-WMAPEVLRNEP 868
VHRDL + N+LV+ VK+ DFGL++ I+ Y + K +P W APE L
Sbjct: 130 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 869 ANEKCDVYSFGVILWELAT--------LSVPWKGLNP----MQVVGAVGF--QNRRLEIP 914
DV+SFGV L+EL T +++ K + P M V V + +RL P
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP 248
Query: 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+ V Q++R CW+ +P R +F L+
Sbjct: 249 PNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 76/270 (28%), Positives = 134/270 (49%), Gaps = 11/270 (4%)
Query: 698 ERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
ERIG GS+GEV++ D +V K +D + + D + + E ++ + P V + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ + I+ E+L GS LL DE + M ++ KG++YLH+ +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKK--IHR 125
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVY 876
D+K+ N+L+ + VK+ DFG++ T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 877 SFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
S G+ ELA P ++PM+V+ + +N + + + I C +P R
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACLNKDPSFR 244
Query: 937 PSFAQLMSRLRCLQRLLVDRSNSTNQFSEL 966
P+ +L+ + +V + T+ +EL
Sbjct: 245 PTAKELLK-----HKFIVKNAKKTSYLTEL 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 1e-29
Identities = 77/270 (28%), Positives = 138/270 (51%), Gaps = 11/270 (4%)
Query: 698 ERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
E+IG GS+GEV++ D +V K +D + + D + + E ++ + P V + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ + I+ E+L GS LL P LDE + + ++ KG++YLH+ +HR
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL-EPG-PLDETQIATILREILKGLDYLHSEKK--IHR 125
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVY 876
D+K+ N+L+ ++ VK+ DFG++ T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 185
Query: 877 SFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
S G+ ELA P L+PM+V+ + +N + + + + + C EP R
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPSFR 244
Query: 937 PSFAQLMSRLRCLQRLLVDRSNSTNQFSEL 966
P+ +L+ + +V + T+ +EL
Sbjct: 245 PTAKELLK-----HKFIVRFAKKTSYLTEL 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 86/293 (29%), Positives = 133/293 (45%), Gaps = 53/293 (18%)
Query: 694 LQIGERIGIGSYGEVYRADWHGTE------------------VAVKKFLDQDFSGDSLSQ 735
L E++G G +GEV+ + G + VAVK L D S ++
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDASDNARED 65
Query: 736 FKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRR--- 792
F E +I+ RL PN+ +G T P ++ E++ G L + L + H +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK--HVAETSGLACN 123
Query: 793 ---------MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IK 842
+ MA +A GM YL VHRDL + N LV KN+ +K+ DFG+SR +
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 843 HHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATLS--VPWKGLNPMQ 899
Y + A P WMA E + K DV++FGV LWE+ TL P++ L Q
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
Query: 900 VVGAVG--FQNRRLEI--------PDDIDPAVAQIIRDCWQTEPHLRPSFAQL 942
V+ G F++ +I P DI +++ +CW+ + RP+F ++
Sbjct: 242 VIENAGHFFRDDGRQIYLPRPPNCPKDI----YELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 77/258 (29%), Positives = 134/258 (51%), Gaps = 18/258 (6%)
Query: 700 IGIGSYGEVY---RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
+G G++G V+ R V +K+ + + D + E +++ L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQ-KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
I+ E+ P G+L + R N LDE + + + ++++HT I+H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILH 124
Query: 816 RDLKSPNLLVDKN-WVVKVCDFGLSRIKHHTYLSSKSTA----GTPEWMAPEVLRNEPAN 870
RDLK+ N+L+DK+ VVK+ DFG+S+I LSSKS A GTP +++PE+ +P N
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 871 EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQ 930
+K D+++ G +L+ELA+L ++ N +V + I D P + Q+I
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKI-MSGTFAPISDRYSPDLRQLILSMLN 238
Query: 931 TEPHLRPSFAQLMSRLRC 948
+P RP +Q+M++ C
Sbjct: 239 LDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 22/234 (9%)
Query: 700 IGIGSYGEVYRADWHGTE--VAVKKFLDQDFSG-DSLSQFKCEAEIMLRLRHPNVVLFMG 756
I G+YG V+ A T A+K D + + Q E +I+ + + P VV
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ + ++ E+LP G L LL LDE ++ + YLH S+ I+HR
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH-SN-GIIHR 117
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTA-----GTPEWMAPEVLRNEP 868
DLK N+L+D N +K+ DFGLS+ ++ L+ GTP+++APEV+ +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN---RRLEIPDDIDP 919
++ D +S G IL+E P+ G P ++ FQN ++E P+D++
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILNGKIEWPEDVEV 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 31/286 (10%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRADWHGTE-------VAVKKFLDQDFSGDSLSQFKCEA 740
EI ++ E +G +G+VY+ GT VA+K D+ G +FK EA
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL-----HRPNHQLDERRRMRM 795
+ RL+HPN+V +G VT+ S++ + L+ L H D+ + ++
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 796 ALD----------VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHH 844
L+ +A GM +L + H +VH+DL + N+LV VK+ D GL R +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 845 TYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVG 902
Y + P WM+PE + + D++S+GV+LWE+ + + P+ G + V+
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237
Query: 903 AVGFQNRR-LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
+ +NR+ L PDD V ++ +CW P RP F + SRLR
Sbjct: 238 MI--RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 69/252 (27%), Positives = 127/252 (50%), Gaps = 11/252 (4%)
Query: 698 ERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH---PNVVL 753
E IG G+YG VYR T V K ++ D D +S + E ++ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
+ G+ + P I+ E+ GS+ R L + + E+ + +V + Y+H +
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAG-PIAEKYISVIIREVLVALKYIH--KVGV 122
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEK 872
+HRD+K+ N+LV VK+CDFG++ + + + GTP WMAPEV+ + K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182
Query: 873 CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDD-IDPAVAQIIRDCWQT 931
D++S G+ ++E+AT + P+ ++ + + + +++ + D+ + + + C
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLREFVAACLDE 241
Query: 932 EPHLRPSFAQLM 943
EP R S +L+
Sbjct: 242 EPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 75/265 (28%), Positives = 124/265 (46%), Gaps = 23/265 (8%)
Query: 692 EDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDS--LSQFKCEAEIMLRLR 747
+DL+ +G G+ G V + G +AVK + Q E +I+ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR---LEINEAIQKQILRELDILHKCN 57
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
P +V F GA + SI E++ GSL ++L ++ ER ++A+ V KG+ YLH
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS---SKSTAGTPEWMAPEVL 864
H I+HRD+K N+LV+ +K+CDFG+S L +K+ GT +MAPE +
Sbjct: 118 EKH-KIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 865 RNEPANEKCDVYSFGVILWELATLSVPWKG-----LNPMQVVGAVGFQNRRLEIPDDI-D 918
+ + K D++S G+ L ELAT P+ +++ + +P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFS 230
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLM 943
P + C +P RPS+ +L+
Sbjct: 231 PDFQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 11/262 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
D ++ +R+G G+YG+VY+A + H E+A K + + GD S + E ++ +H N
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCN 67
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V + G+ I E+ GSL + H L E + + + +G+ YLH+
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKG 126
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL---RNE 867
+HRD+K N+L+ N VK+ DFG++ T KS GTP WMAPEV +N
Sbjct: 127 K--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 868 PANEKCDVYSFGVILWELATLSVPWKGLNPMQ---VVGAVGFQNRRLEIPDDIDPAVAQI 924
N+ CD+++ G+ ELA L P L+PM+ ++ FQ +L+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244
Query: 925 IRDCWQTEPHLRPSFAQLMSRL 946
++ P RP+ +L++ L
Sbjct: 245 VKISLTKNPKKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 65/244 (26%), Positives = 111/244 (45%), Gaps = 16/244 (6%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV- 752
+G GS+G+V T V KK + + E I+ R+ HP +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI---IKRKEVEHTLTERNILSRINHPFIVK 57
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
L T ++ E+ P G L+ L + + E R A ++ + YLH+
Sbjct: 58 LHYAFQTEE-KLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLG-- 113
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK 872
I++RDLK N+L+D + +K+ DFGL++ + + GTPE++APEVL + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 873 CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTE 932
D +S GV+L+E+ T P+ + ++ + L P+ + P +I Q +
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQKD 231
Query: 933 PHLR 936
P R
Sbjct: 232 PTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 91/287 (31%), Positives = 138/287 (48%), Gaps = 36/287 (12%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEV-AVKKFLDQDFSGDSLSQFKCEAEIMLR 745
WEI IGE +G G++G+VY+A T V A K +D S + L + E +I+
Sbjct: 7 WEI------IGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILAS 58
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
HPN+V + A + IL EF G++ ++ L E + + + +NY
Sbjct: 59 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL- 864
LH + I+HRDLK+ N+L + +K+ DFG+S T S GTP WMAPEV+
Sbjct: 119 LHEN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 865 ----RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
++ P + K DV+S G+ L E+A + P LNPM+V+ L+I P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSEPPT 227
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSELP 967
+AQ R W F + +CL++ VD +T Q + P
Sbjct: 228 LAQPSR--WS------SEFKDFLK--KCLEK-NVDARWTTTQLLQHP 263
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 81/259 (31%), Positives = 129/259 (49%), Gaps = 11/259 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
ED ++ +RIG G+YG+VY+A T E+A K + + G+ + + E +M +H N
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKHSN 67
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V + G+ R I EF GSL + H L E + ++ + +G+ YLH+
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKG 126
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL---RNE 867
+HRD+K N+L+ N VK+ DFG+S T KS GTP WMAPEV R
Sbjct: 127 K--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 868 PANEKCDVYSFGVILWELATLSVPWKGLNPMQ---VVGAVGFQNRRLEIPDDIDPAVAQI 924
N+ CD+++ G+ ELA L P L+PM+ ++ FQ +L+ +
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF 244
Query: 925 IRDCWQTEPHLRPSFAQLM 943
++ P RP+ +L+
Sbjct: 245 VKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 80/262 (30%), Positives = 122/262 (46%), Gaps = 22/262 (8%)
Query: 698 ERI-GIGSYGEVYRA-----DWHGTEVAVKKFLDQDFSGDSLSQFKC---EAEIMLRLRH 748
ERI G G +GE+ R VA+ G S Q + EA + + H
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA----GCSDKQRRGFLAEALTLGQFDH 65
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
N+V G +TR I+TE++ G+L L + QL + M M +A GM YL
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL-- 123
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFG-LSRIKHHTYLSSKSTAGTPEWMAPEVLRNE 867
S VH+ L + +LV+ + V K+ F L K ++ S W APE ++
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 868 PANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAV--GFQNRRLEIPDDIDPAVAQI 924
+ DV+SFG+++WE+ + P+ ++ V+ AV GF RL P + + Q+
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF---RLPAPRNCPNLLHQL 240
Query: 925 IRDCWQTEPHLRPSFAQLMSRL 946
+ DCWQ E RP F+Q+ S L
Sbjct: 241 MLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 81/263 (30%), Positives = 127/263 (48%), Gaps = 22/263 (8%)
Query: 695 QIGERIGIGSYGEVY---RADWHGTEVAVKKFL---DQDFSGDSLSQFKCEAEIMLRLRH 748
++G+ +G G++G VY AD G E+AVK+ + + ++ +CE +++ L H
Sbjct: 5 RLGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 749 PNVVLFMGAVTRSPH--FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806
+V + G + SI E +P GS+ L + L E + + +G++YL
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYL 122
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS---KSTAGTPEWMAPEV 863
H++ IVHRD+K N+L D VK+ DFG S+ LS KS GTP WM+PEV
Sbjct: 123 HSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 864 LRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923
+ E K D++S G + E+ T PW M + + Q +P P V+
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP----PHVSD 236
Query: 924 IIRDCWQ---TEPHLRPSFAQLM 943
RD + E LRPS +L+
Sbjct: 237 HCRDFLKRIFVEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 90/297 (30%), Positives = 139/297 (46%), Gaps = 53/297 (17%)
Query: 694 LQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGD---------------------S 732
L E++G G +GEV+ + G E KF+D+DFS D +
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGME----KFMDKDFSLDVSGNQPVLVAVKMLREDANKNA 62
Query: 733 LSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPNHQLDER 790
+ F E +IM RL+ PN++ + S ++TE++ G L + L H P ++
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 791 RR--------MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-I 841
+ MA +A GM YL S VHRDL + N LV KN+ +K+ DFG+SR +
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 842 KHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL--SVPWKGLNPM 898
Y + A P WM+ E + DV++FGV LWE+ TL P+ L+
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
Query: 899 QVVGAVG-F---QNRRLEIPDDIDPA-----VAQIIRDCWQTEPHLRPSFAQLMSRL 946
QV+ G F Q R++ +P PA + +++ CW+ RPSF ++ + L
Sbjct: 241 QVIENTGEFFRDQGRQVYLP---KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 82/267 (30%), Positives = 129/267 (48%), Gaps = 16/267 (5%)
Query: 700 IGIGSYGEVYRADW--HGTEVAVK---KFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
+G G++G VY+ W G V + K L++ + +F EA IM + HP++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
+G V SP ++T+ +P G L +H + + + + +AKGM YL +V
Sbjct: 75 LG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LV 131
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP--EWMAPEVLRNEPANEK 872
HRDL + N+LV VK+ DFGL+R+ + G +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 873 CDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQT 931
DV+S+GV +WEL T P+ G+ P + + + + RL P V ++ CW
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250
Query: 932 EPHLRPSFAQL---MSRL-RCLQRLLV 954
+ RP F +L SR+ R QR LV
Sbjct: 251 DADSRPKFKELAAEFSRMARDPQRYLV 277
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 698 ERIGIGSYGEVYRADWH---GTEVAVKKF-LDQD---FSGDSLSQFKCEAEIMLRLRHPN 750
E++G G+YG VY+A G VA+KK LD + +L E ++ L+HPN
Sbjct: 5 EKLGEGTYGVVYKA-RDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELKHPN 59
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V + + ++ E+ L + L + L + + +G+ Y H+
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE----WM-APEVLR 865
I+HRDLK N+L++++ V+K+ DFGL+R T E W APE+L
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEILL 171
Query: 866 NEPA-NEKCDVYSFGVILWELAT 887
+ D++S G I E+ T
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 17/246 (6%)
Query: 700 IGIGSYGEVY--RADWHGTEVAVKKFL-DQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
+G+G +G V + A+K E EI+ HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ +L E+ G L+ +L + R +A V YLH I++R
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHNRG--IIYR 117
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA----GTPEWMAPEVLRNEPANEK 872
DLK NLL+D N VK+ DFG ++ L S GTPE++APE++ N+ +
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 873 CDVYSFGVILWELATLSVPWKG--LNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQ 930
D +S G++L+EL T P+ +PM++ + N +LE P+ ID A +I+ +
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232
Query: 931 TEPHLR 936
P R
Sbjct: 233 RNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 69/252 (27%), Positives = 129/252 (51%), Gaps = 7/252 (2%)
Query: 698 ERIGIGSYGEVY--RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
++IG GS+G++Y +A +K+ K E ++ +++HPN+V F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQL-DERRRMRMALDVAKGMNYLHTSHPTIV 814
+ + I+ E+ G L + ++R L E + + + ++ G+ ++H I+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR--KIL 123
Query: 815 HRDLKSPNLLVDKN-WVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKC 873
HRD+KS N+ + KN V K+ DFG++R + + + + GTP +++PE+ +N P N K
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT 183
Query: 874 DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933
D++S G +L+EL TL P++G N Q+V + Q I + + +I ++ P
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFSRDLRSLISQLFKVSP 242
Query: 934 HLRPSFAQLMSR 945
RPS ++ R
Sbjct: 243 RDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 86/268 (32%), Positives = 134/268 (50%), Gaps = 18/268 (6%)
Query: 688 EILWEDLQIGERI--GIGSYGEVYRADWHGTEV--AVKKFLDQDFSGDSLSQFKCEAEIM 743
E +E + GER+ G G+YG VY A T+V A+K+ ++D Q E EI
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHE-EIA 57
Query: 744 L--RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQL--DERRRMRMALDV 799
L L+H N+V ++G+ + + F I E +P GSL LL L +E+ + +
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSRIKHHTYLSSKSTAGTPEW 858
+G+ YLH + IVHRD+K N+LV+ + VVK+ DFG S+ +++ GT ++
Sbjct: 118 LEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQY 175
Query: 859 MAPEVLRNEPA--NEKCDVYSFGVILWELATLSVPWKGL-NPMQVVGAVGFQNRRLEIPD 915
MAPEV+ P D++S G + E+AT P+ L P + VG EIP+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE 235
Query: 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+ I C++ +P R S L+
Sbjct: 236 SLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 47/266 (17%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVKKF-------LDQDFSGDSLSQFKCEAEI 742
+D + + +G GS+G V G+ A+K L Q + E I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ------VEHVLNEKRI 54
Query: 743 MLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK- 801
+ +RHP +V G+ + ++ E++P G L+ L R+ R VA+
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---------RKSGRFPEPVARF 105
Query: 802 -------GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTA 853
+ YLH+ IV+RDLK NLL+D + +K+ DFG + R+K TY +
Sbjct: 106 YAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLC 159
Query: 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRR 910
GTPE++APE++ ++ + D ++ G++++E+ P+ NP+Q+ ++ +
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-----YEKILEGK 214
Query: 911 LEIPDDIDPAVAQIIRDCWQTEPHLR 936
+ P P +IR+ Q + R
Sbjct: 215 VRFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 82/272 (30%), Positives = 127/272 (46%), Gaps = 23/272 (8%)
Query: 694 LQIGERIGIGSYGEVYRADWHGTE----VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
L +G+ +G G +G V + + VAVK + + F EA M HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 750 NVVLFMGAVTRS------PHFSILTEFLPRGSLY------RLLHRPNHQLDERRRMRMAL 797
NV+ +G ++ P ++ F+ G L+ RL P + L + ++
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY-LPTQMLVKFMT 119
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTP 856
D+A GM YL S + +HRDL + N ++++N V V DFGLS+ I + Y A P
Sbjct: 120 DIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 857 -EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIP 914
+W+A E L + K DV+SFGV +WE+AT P+ G+ ++ + Q RL+ P
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQP 236
Query: 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
D + ++ CW P RPSF L L
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 74/270 (27%), Positives = 123/270 (45%), Gaps = 37/270 (13%)
Query: 703 GSYGEVYRADWHGT------EVAVKKFLDQDFSGDSLSQFKC---EAEIMLRLRHPNVVL 753
G++G ++ EV VK D S Q E+ ++ L H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 754 FMGAVTRSPHFS-ILTEFLPRGSLYRLLHRP------NHQ-LDERRRMRMALDVAKGMNY 805
+ +L ++ G+L L + N Q L ++ + MA+ +A GM+Y
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE-----WMA 860
LH ++H+D+ + N ++D+ VK+ D LSR + G E WMA
Sbjct: 133 LHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNENRPVKWMA 187
Query: 861 PEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAV--GFQNRRLEIPDDI 917
E L N+ + DV+SFGV+LWEL TL P+ ++P ++ + G+ RL P +
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---RLAQPINC 244
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
+ ++ CW +P RPSF+QL+ L
Sbjct: 245 PDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 76/259 (29%), Positives = 122/259 (47%), Gaps = 16/259 (6%)
Query: 697 GERIGIGSYGEV---YRADWHGTEVAVKKFL---DQDFSGDSLSQFKCEAEIMLRLRHPN 750
G+ +G G++G V Y D G E+A K+ + + +S +CE +++ L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 751 VVLFMGAVTRSPH--FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
+V + G + +I E++P GS+ L + L E + + +GM+YLH+
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS---KSTAGTPEWMAPEVLR 865
+ IVHRD+K N+L D VK+ DFG S+ +S +S GTP WM+PEV+
Sbjct: 125 N--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
E K DV+S G + E+ T PW M + + Q ++P I +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 926 RDCWQTEPHLRPSFAQLMS 944
C E RPS +L+
Sbjct: 243 G-CIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 72/256 (28%), Positives = 123/256 (48%), Gaps = 13/256 (5%)
Query: 700 IGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLS-QFKCEAEIMLRLRHPNVVLFM 755
+G G++G V + + + K L D + +L + EA +M +L +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
G + + + ++ E G L + L + N + E+ + V+ GM YL ++ VH
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETN--FVH 118
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTP-EWMAPEVLRNEPANEK 872
RDL + N+L+ K+ DFGLS+ Y +K+ P +W APE + + K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 873 CDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQT 931
DV+SFGV++WE + P+KG+ +V + R+E P P + +++ CW
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWTY 237
Query: 932 EPHLRPSFAQLMSRLR 947
RP FA + RLR
Sbjct: 238 GVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-25
Identities = 55/159 (34%), Positives = 88/159 (55%), Gaps = 15/159 (9%)
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR--IKHHTYLSSKSTA 853
+ VA+GM +L + +HRDL + N+L+ +N VVK+CDFGL+R K Y+
Sbjct: 179 SFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNR--- 909
+WMAPE + ++ + DV+SFGV+LWE+ +L + P+ G+ + F R
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRRLKE 291
Query: 910 --RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
R+ P+ P + I+ DCW P RP+F++L+ L
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 83/293 (28%), Positives = 138/293 (47%), Gaps = 40/293 (13%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE----------------VAVKKFLDQDFSGDSLSQ 735
+ L++ E++G G +GEV+ + G VAVK L D + + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKM-LRADVTKTARND 63
Query: 736 FKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ--------- 786
F E +IM RL++PN++ +G ++TE++ G L + L + +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 787 --LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKH 843
+ + MA+ +A GM YL + + VHRDL + N LV ++ +K+ DFG+SR +
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 844 HTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL--SVPWKGLNPMQV 900
Y + A P WMA E + DV++FGV LWE+ TL P+ L+ QV
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241
Query: 901 VGAVG--FQNRRLEIPDDIDP----AVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
+ G F+N+ +I P V +++ CW + RP+F ++ LR
Sbjct: 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-25
Identities = 74/260 (28%), Positives = 124/260 (47%), Gaps = 12/260 (4%)
Query: 700 IGIGSYGEVYRADW--HGTEVAVK---KFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
+G G++G VY+ W G +V + K L + S + + EA +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
+G S ++T+ +P G L + + + + + +AKGMNYL +V
Sbjct: 75 LGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LV 131
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG-TP-EWMAPEVLRNEPANEK 872
HRDL + N+LV VK+ DFGL+++ + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 873 CDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQT 931
DV+S+GV +WEL T S P+ G+ P + ++ + RL P V I+ CW
Sbjct: 192 SDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 932 EPHLRPSFAQLMSRLRCLQR 951
+ RP F +L+ + R
Sbjct: 251 DADSRPKFRELIIEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 82/301 (27%), Positives = 134/301 (44%), Gaps = 53/301 (17%)
Query: 694 LQIGERIGIGSYGEVYRAD------------------WHGTEVAVKKFLDQDFSGDSLSQ 735
L E++G G +GEV+ + VAVK L D + ++ +
Sbjct: 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK-ILRPDANKNARND 65
Query: 736 FKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRR--- 792
F E +I+ RL+ PN++ +G ++TE++ G L + L +H LD++
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLDDKEENGN 123
Query: 793 -----------------MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835
+ +AL +A GM YL + + VHRDL + N LV +N +K+ D
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIAD 181
Query: 836 FGLSR-IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL--SVP 891
FG+SR + Y + A P WMA E + DV++FGV LWE+ L P
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 892 WKGLNPMQVVGAVG--FQNRRLEIPDDIDPAVAQ----IIRDCWQTEPHLRPSFAQLMSR 945
+ L QV+ G F+++ ++ P Q ++ CW + RPSF+ + +
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301
Query: 946 L 946
L
Sbjct: 302 L 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-25
Identities = 70/256 (27%), Positives = 128/256 (50%), Gaps = 13/256 (5%)
Query: 700 IGIGSYG----EVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+G G++G VY+ +VA+K +++ + EAEIM +L +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMR-EAEIMHQLDNPYIVRMI 61
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
G V + ++ E G L + L ++ + + V+ GM YL + VH
Sbjct: 62 G-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVH 118
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTP-EWMAPEVLRNEPANEK 872
RDL + N+L+ K+ DFGLS+ +Y ++S P +W APE + + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 873 CDVYSFGVILWE-LATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQT 931
DV+S+G+ +WE + P+K + +V+ + Q +RL+ P + P + +++DCW
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIY 237
Query: 932 EPHLRPSFAQLMSRLR 947
+ RP+FA++ R+R
Sbjct: 238 KWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPN 750
++ E IG G+YG+VY+A H G VA+K D D + K E I+ + HPN
Sbjct: 9 ELVEVIGEGTYGKVYKAR-HKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPN 64
Query: 751 VVLFMGAVTRSPHFS------ILTEFLPRGSLYRL---LHRPNHQLDERRRMRMALDVAK 801
+ F GA + ++ E GS+ L L + +L E + + +
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
G+ YLH + ++HRD+K N+L+ KN VK+ DFG+S T + GTP WMAP
Sbjct: 125 GLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 862 EVLRNEPANE-----KCDVYSFGVILWELATLSVPWKGLNPM 898
EV+ + + + DV+S G+ ELA P ++PM
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 698 ERIGIGSYGEVYRA--DWHGTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
+IG G+YG VY+A G VA+KK L + G + + E +++ L HPN++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKL 63
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
+ ++ EF+ LY+L+ L E + +G+ + H SH I+
Sbjct: 64 LDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SH-GIL 120
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE----WM-APEVLRNEPA 869
HRDLK NLL++ V+K+ DFGL+R S T W APE+L +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 870 -NEKCDVYSFGVILWELATLSVPWKGLN 896
+ D++S G I EL + + G +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 35/273 (12%)
Query: 698 ERIGIGSYGEVYRADWHGT--------EVAV------KKFLDQDFS-GDSLSQFKCEAEI 742
E +G G++G VY+ E+ V K ++D S GD +S+ I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI---I 62
Query: 743 MLRLRHPNVVLFMGAVTRSPHFSILTEFL---PRGSLYRLLHRPNHQLDERRRMRMALDV 799
+LRHPN+V + + I+ + + P G + L + E R + + +
Sbjct: 63 KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH-HTYLSSKSTAGTPEW 858
+ YLH IVHRDL N+++ ++ V + DFGL++ K + L+S GT +
Sbjct: 123 VLALRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV--VGTILY 179
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN----PMQVVGAVGFQNRRLEIP 914
PE+++NEP EK DV++FG IL+++ TL P+ N ++V AV +P
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-----YEPLP 234
Query: 915 DDI-DPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+ + V +I C + RP Q+ + +
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 59/155 (38%), Positives = 89/155 (57%), Gaps = 7/155 (4%)
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR--IKHHTYLSSKSTA 853
+ VAKGM +L + +HRDL + N+L+ +N VVK+CDFGL+R K Y+ K A
Sbjct: 185 SFQVAKGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGDA 241
Query: 854 GTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRL 911
P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + + R+
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
PD P + Q + DCW EP RP+F++L+ L
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 76/260 (29%), Positives = 127/260 (48%), Gaps = 24/260 (9%)
Query: 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIML--RLRH 748
+ +I ++IG G + EVYRA G VA+KK D D+ ++ C EI L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNH 61
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALDVAKGMNY 805
PNV+ + + +I+ E G L R++ Q + E+ + + + + +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA-----GTPEWMA 860
+H+ ++HRD+K N+ + VVK+ D GL R + SSK+TA GTP +M+
Sbjct: 122 MHSRR--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMS 174
Query: 861 PEVLRNEPANEKCDVYSFGVILWELATLSVPWKG--LNPMQVVGAVGFQNRRLEIPDD-I 917
PE + N K D++S G +L+E+A L P+ G +N + + Q +P D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPLPSDHY 233
Query: 918 DPAVAQIIRDCWQTEPHLRP 937
+ Q++ C +P RP
Sbjct: 234 SEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 69/256 (26%), Positives = 130/256 (50%), Gaps = 12/256 (4%)
Query: 696 IGERIGIGSYGEVY-----RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+ +R+G GS+G VY +A +K+ + + + Q EA+++ +L HP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSL---YRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
+V F + F I+TE+ L L L E + + + G++Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNE 867
I+HRDLK+ N+ + N ++K+ DFG+SR+ + + + GTP +M+PE L+++
Sbjct: 124 QRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 868 PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927
+ K D++S G IL+E+ L+ ++G N + VV + + +P+ + I++
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQLNSIMQS 239
Query: 928 CWQTEPHLRPSFAQLM 943
+P LRPS A+++
Sbjct: 240 MLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 79/261 (30%), Positives = 123/261 (47%), Gaps = 19/261 (7%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+D+Q E +G G+ G VY+A +H + K + D + + Q E EI+ + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKA-YHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
++ F GA SI TEF+ GSL P H L R+A+ V KG+ YL +
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWSL 114
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
I+HRD+K N+LV+ VK+CDFG+S ++ +K+ GT +MAPE + E
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQY 170
Query: 870 NEKCDVYSFGVILWELATLSVPWK-------GLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
DV+S G+ ELA P+ L P+Q++ + ++ +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230
Query: 923 QIIRDCWQTEPHLRPSFAQLM 943
I C + +P RP+ LM
Sbjct: 231 HFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 74/277 (26%), Positives = 116/277 (41%), Gaps = 45/277 (16%)
Query: 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH- 748
DL+ IG G+ G+VY+ + G +AVK+ + + + +++L H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVL-KSHD 72
Query: 749 -PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
P +V G I E L L +LL R + E +M + + K ++YL
Sbjct: 73 CPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RI---KHHTYLSSKSTAGTPEWMAPEV 863
H ++HRD+K N+L+D + VK+CDFG+S R+ K T +AG +MAPE
Sbjct: 132 EKH-GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-----RSAGCAAYMAPER 185
Query: 864 LRNEPANEK----CDVYSFGVILWELATLSVPWKG-------------LNPMQVVGAVGF 906
+ N K DV+S G+ L ELAT P+K P + GF
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF 245
Query: 907 QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
P + C + RP + +L+
Sbjct: 246 S-----------PDFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 73/260 (28%), Positives = 122/260 (46%), Gaps = 12/260 (4%)
Query: 700 IGIGSYGEVYRADW--HGTEVAVK---KFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
+G G++G VY+ W G V + K L ++ S + + EA +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
+G S ++T+ +P G L + ++ + + + +AKGM+YL +V
Sbjct: 75 LGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LV 131
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG-TP-EWMAPEVLRNEPANEK 872
HRDL + N+LV VK+ DFGL+R+ + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 873 CDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQT 931
DV+S+GV +WEL T P+ G+ P + + + + RL P V I+ CW
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 932 EPHLRPSFAQLMSRLRCLQR 951
+ RP F +L+ + R
Sbjct: 251 DSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 73/273 (26%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 693 DLQIGERIGIGSYGEVYRADW----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIML---R 745
+L+ + +G G +G V++ W ++ V QD SG F+ + ML
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ--TFQEITDHMLAMGS 65
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
L H +V +G + ++T+ P GSL + + LD +R + + +AKGM Y
Sbjct: 66 LDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI-----KHHTYLSSKSTAGTP-EWM 859
L +VHR+L + N+L+ + +V++ DFG++ + K + Y S TP +WM
Sbjct: 125 LEEH--RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY----SEHKTPIKWM 178
Query: 860 APEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDID 918
A E + + DV+S+GV +WE+ + P+ G+ P +V + + RL P
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICT 237
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
V ++ CW + ++RP+F +L + + R
Sbjct: 238 IDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 55/251 (21%), Positives = 127/251 (50%), Gaps = 6/251 (2%)
Query: 698 ERIGIGSYGE--VYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
++IG GS+G+ + ++ G + +K+ S + + E ++ ++HPN+V +
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQL-DERRRMRMALDVAKGMNYLHTSHPTIV 814
+ + + I+ ++ G LY+ ++ L E + + + + + ++H I+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR--KIL 123
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCD 874
HRD+KS N+ + K+ +K+ DFG++R+ + T +++ GTP +++PE+ N P N K D
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSD 183
Query: 875 VYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPH 934
+++ G +L+E+ TL ++ N +V + + + + ++ ++ P
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNMKNLVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRNPR 242
Query: 935 LRPSFAQLMSR 945
RPS ++ +
Sbjct: 243 DRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 54/154 (35%), Positives = 88/154 (57%), Gaps = 5/154 (3%)
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR--IKHHTYLSSKSTA 853
+ VA+GM +L + +HRDL + N+L+ +N VVK+CDFGL+R K Y+ S
Sbjct: 180 SFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLE 912
+WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
P++ P + +I+ CWQ +P RP+F+ L+ L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 75/269 (27%), Positives = 125/269 (46%), Gaps = 37/269 (13%)
Query: 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTE--VAVKKFLDQDF----SGDSLSQF 736
+ + W++ D ++GE +G GS+G V A GT A+K ++ ++Q
Sbjct: 11 DTSSWKL--SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ- 67
Query: 737 KCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMA 796
E I++ L HP +V M + L EF+ G L+ L R+ R
Sbjct: 68 --EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---------RKAGRFP 116
Query: 797 LDVAK--------GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYL 847
DVAK YLH+ I++RDLK NLL+D VKV DFG + ++ T+
Sbjct: 117 NDVAKFYHAELVLAFEYLHSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF- 173
Query: 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ 907
+ GTPE++APEV++++ + D ++ GV+L+E P+ P ++ +
Sbjct: 174 ---TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--L 228
Query: 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
RL+ P+ D +++ QT+ R
Sbjct: 229 AGRLKFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 75/264 (28%), Positives = 128/264 (48%), Gaps = 32/264 (12%)
Query: 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSG-DSLSQFKCEAEIML--RLR 747
+ QI ++IG G + EVYRA VA+KK Q F D+ ++ C EI L +L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKV--QIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALDVAKGMN 804
HPNV+ ++ + +I+ E G L +++ Q + ER + + + +
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA-----GTPEWM 859
++H+ ++HRD+K N+ + VVK+ D GL R + SSK+TA GTP +M
Sbjct: 121 HMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYM 173
Query: 860 APEVLRNEPANEKCDVYSFGVILWELATLSVPWKG--LNPMQVVGAVGFQNRRLEIPDDI 917
+PE + N K D++S G +L+E+A L P+ G +N + + + + P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQCDYPPLP 229
Query: 918 DPAVAQIIRD----CWQTEPHLRP 937
++ +R+ C +P RP
Sbjct: 230 TEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 80/271 (29%), Positives = 128/271 (47%), Gaps = 31/271 (11%)
Query: 692 EDLQIGERIGIGSYGEVY--RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH- 748
+DL++ E +G G+YG V R GT +AVK+ S + + + +I +R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDC 59
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRG--SLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806
P V F GA+ R I E + Y+ ++ + E ++A+ + K + YL
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL--SSKST--AGTPEWMAPE 862
H S +++HRD+K N+L+++N VK+CDFG+S YL S T AG +MAPE
Sbjct: 120 H-SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKTIDAGCKPYMAPE 173
Query: 863 VLRNEPANE------KCDVYSFGVILWELATLSVP---WKGLNPMQVVGAVGFQNRRLEI 913
R P K DV+S G+ + ELAT P WK P Q + V + ++
Sbjct: 174 --RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK--TPFQQLKQV-VEEPSPQL 228
Query: 914 PDD-IDPAVAQIIRDCWQTEPHLRPSFAQLM 943
P + P + C + RP++ +L+
Sbjct: 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 88/290 (30%), Positives = 126/290 (43%), Gaps = 32/290 (11%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRA-DWHGTE-VAVKKFLDQDFSGDSLSQFKC-----EA 740
E L+ DL+ IG GS+G VY A D E VA+KK +SG S K E
Sbjct: 14 EKLFTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQ-SNEKWQDIIKEV 66
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
+ +LRHPN + + G R ++ E+ GS +L L E +
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGAL 125
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMA 860
+G+ YLH SH I HRD+K+ N+L+ + VK+ DFG + + + S GTP WMA
Sbjct: 126 QGLAYLH-SHERI-HRDIKAGNILLTEPGTVKLADFGSASLVS----PANSFVGTPYWMA 179
Query: 861 PEV---LRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI-PDD 916
PEV + + K DV+S G+ ELA P +N M + + QN + +D
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSSND 238
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSEL 966
+ C Q P RPS + L+ V R +L
Sbjct: 239 WSDYFRNFVDSCLQKIPQDRPSSEE------LLKHRFVLRERPPTVIIDL 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 73/272 (26%), Positives = 123/272 (45%), Gaps = 28/272 (10%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH 748
EDL+ IG G++G V + H GT +AVK+ + + + ++++R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKM-LHKPSGTIMAVKR-IRSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 749 -PNVVLFMGAVTRSPHFSILTEFLPRG--SLYRLLH-RPNHQLDERRRMRMALDVAKGMN 804
P +V F GA+ R I E + Y+ ++ + E ++A+ K +N
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL--SSKST--AGTPEWMA 860
YL I+HRD+K N+L+D+N +K+CDFG+S L S T AG +MA
Sbjct: 122 YLKEEL-KIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMA 175
Query: 861 PEVL---RNEPANEKCDVYSFGVILWELATLSVPWKGLNPM--QVVGAVGFQNRRLEIPD 915
PE + + + + DV+S G+ L+E+AT P+ N + Q+ V L
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS-NS 234
Query: 916 D---IDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ P+ I C + RP + +L+
Sbjct: 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 14/213 (6%)
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQL-DERRRMRMAL 797
EA ++ +++HPN+V F + H I+ E+ G L + + +L E ++ +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE 857
+ G+ ++H ++HRD+KS N+ + +N VK+ DFG +R+ + + GTP
Sbjct: 108 QMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY 165
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATLSVP-----WKGLNPMQVVGAVGFQNRRLE 912
++ PE+ N P N K D++S G IL+EL TL P WK L G+
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK------P 219
Query: 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945
+P + +I+ ++ P RPS ++SR
Sbjct: 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 698 ERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
R+G G+ G V + + + K + D + D Q E EI + P +V + G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 757 AVT--RSPHFSILTEFLPRGSL---YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
A S I E+ GSL Y+ + + ++ E+ ++A V KG++YLH+
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK- 125
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST-AGTPEWMAPEVLRNEPAN 870
I+HRD+K N+L+ + VK+CDFG+S S T GT +MAPE ++ +P +
Sbjct: 126 -IIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSFYMAPERIQGKPYS 181
Query: 871 EKCDVYSFGVILWELATLSVP 891
DV+S G+ L E+A P
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 9e-22
Identities = 82/278 (29%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIML 744
WEI+ E IG G+YG+VY+ G+ AVK D D + + E I+
Sbjct: 24 WEII-------ETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQ 73
Query: 745 RL-RHPNVVLFMGAVTRSPHFS-----ILTEFLPRGSLYRL---LHRPNHQLDERRRMRM 795
L HPNVV F G ++ ++ E GS+ L L +LDE +
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855
G+ +LH + I+HRD+K N+L+ VK+ DFG+S T L ++ GT
Sbjct: 134 LYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
Query: 856 PEWMAPEVLRNEPA-----NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR 910
P WMAPEV+ E + +CDV+S G+ EL P ++P++ + F+ R
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL----FKIPR 247
Query: 911 LEIPDDIDP-----AVAQIIRDCWQTEPHLRPSFAQLM 943
P + P + I C + RPS L+
Sbjct: 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-21
Identities = 84/294 (28%), Positives = 118/294 (40%), Gaps = 35/294 (11%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+L+ RIG G+ G VY+ T + K + + Q E EI+ + HPN
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPN 133
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
VV + +L EF+ GSL H DE+ +A + G+ YLH H
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRH 188
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR---NE 867
IVHRD+K NLL++ VK+ DFG+SRI T S+ GT +M+PE + N
Sbjct: 189 --IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 868 PANEKC--DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ------------NRRLEI 913
A + D++S GV + E P+ VG Q ++ E
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPF----------GVGRQGDWASLMCAICMSQPPEA 296
Query: 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSELP 967
P I C Q EP R S QL+ L+ N LP
Sbjct: 297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLP 350
|
Length = 353 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 19/235 (8%)
Query: 700 IGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRH-PNVVLFM 755
I G++G VY A G A+K D + + ++ K E IM+ P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ + ++ E+L G L+ L E + +V G+ LH I+H
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQR--GIIH 120
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RD+K NLL+D+ +K+ DFGLSR L +K GTP+++APE + ++ D
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKMSDW 176
Query: 876 YSFGVILWELATLSVPWKGLNPMQVVGAVGFQN---RRLEIPDDIDPAVAQIIRD 927
+S G +++E P+ P V F N RR+ P+++ + D
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAV-----FDNILSRRINWPEEVKEFCSPEAVD 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-21
Identities = 58/161 (36%), Positives = 91/161 (56%), Gaps = 12/161 (7%)
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR--IKHHTYLSSKSTAGTP 856
VA GM +L + + VHRDL + N+L+ + +VK+CDFGL+R ++ Y+S ST
Sbjct: 248 VANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPM--QVVGAVGFQNRRLEI 913
+WMAPE + N DV+SFG++LWE+ TL P+ L PM Q A+ + R+
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL-PMNEQFYNAIK-RGYRMAK 363
Query: 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954
P + +I++ CW+ + +RP F+QL + + LL
Sbjct: 364 PAHASDEIYEIMQKCWEEKFEIRPDFSQL---VHLVGDLLT 401
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-21
Identities = 52/154 (33%), Positives = 91/154 (59%), Gaps = 5/154 (3%)
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS--KSTAG 854
+ V ++++H+ H ++HRD+KS N+L+ N +VK+ DFG S++ T ++ G
Sbjct: 150 IQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP 914
TP ++APE+ R +P ++K D++S GV+L+EL TL P+ G N M+ V R +P
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLP 266
Query: 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948
I P + +I+ ++P RPS ++L++ C
Sbjct: 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC 300
|
Length = 496 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-21
Identities = 52/163 (31%), Positives = 91/163 (55%), Gaps = 5/163 (3%)
Query: 787 LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHT 845
LD + + VAKGM++L + + +HRDL + N+L+ + K+CDFGL+R I++ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268
Query: 846 YLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGA 903
K A P +WMAPE + N + DV+S+G++LWE+ +L S P+ G+
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+ + R+ P+ + I++ CW +P RP+F Q++ +
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 71/262 (27%), Positives = 127/262 (48%), Gaps = 15/262 (5%)
Query: 698 ERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
E+IG G+ G VY A G EVA+K+ Q L E +M +HPN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYL 82
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ ++ E+L GSL ++ +DE + + + + + +LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIH 138
Query: 816 RDLKSPNLLVDKNWVVKVCDFGL-SRIKHHTYLSSKST-AGTPEWMAPEVLRNEPANEKC 873
RD+KS N+L+ + VK+ DFG ++I S +ST GTP WMAPEV+ + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 874 DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQIIRDCWQTE 932
D++S G++ E+ P+ NP++ + + L+ P+ + + C + +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256
Query: 933 PHLRPSFAQLMSR--LRCLQRL 952
R S +L+ L+ + L
Sbjct: 257 VEKRGSAKELLQHPFLKIAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 5e-21
Identities = 71/211 (33%), Positives = 103/211 (48%), Gaps = 37/211 (17%)
Query: 695 QIGERIGIGSYGEVYRADWHGTE--VAVKKF-LDQDFSGDSLSQFKCEA--EIML--RLR 747
QIGE G+YG+VY+A T VA+KK ++ + G F A EI L +LR
Sbjct: 6 QIGE----GTYGQVYKARNKKTGELVALKKIRMENEKEG-----FPITAIREIKLLQKLR 56
Query: 748 HPNVVLFMGAVTRSPHFSI--LTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKG 802
HPN+V VT SI + E++ L LL P + E + M+ L +G
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLL---EG 112
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE----W 858
+ YLH++ I+HRD+K N+L++ + V+K+ DFGL+R Y S T W
Sbjct: 113 LQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVITLW 166
Query: 859 M-APEVLRNEPA-NEKCDVYSFGVILWELAT 887
PE+L + D++S G IL EL
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNV 751
++ +++G G++G VY A G VA+KK + +S + + E + + +L HPN+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNI 60
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLL-HRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
V + + E++ G+LY+L+ R E + + +G+ ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IK----HHTYLSSKSTAGTPEWM-APEV- 863
HRDLK NLLV VVK+ DFGL+R I+ + Y+S++ W APE+
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-------WYRAPEIL 170
Query: 864 LRNEPANEKCDVYSFGVILWELATL 888
LR+ + D+++ G I+ EL TL
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 56/242 (23%), Positives = 111/242 (45%), Gaps = 20/242 (8%)
Query: 708 VYRADWHGTEVAVKKFLDQDFSGDS---LSQFKCEAEIMLRLRHPNVV----LFMGAVTR 760
+Y+ ++ EV ++ F + F + + E + + R+ N++ + V
Sbjct: 36 IYKGIFNNKEVIIRTF--KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKS 820
P S++ E+ RG L +L L + ++ MA+D KG+ L+ +++L S
Sbjct: 94 LPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK-PYKNLTS 151
Query: 821 PNLLVDKNWVVKVCDFGLSRIKHHTYLSSKS--TAGTPEWMAPEVLRN--EPANEKCDVY 876
+ LV +N+ +K+ GL +I LSS + + ++L + K D+Y
Sbjct: 152 VSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIY 206
Query: 877 SFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
S GV+LWE+ T +P++ L ++ + +N L++P D + I+ C + R
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKR 266
Query: 937 PS 938
P+
Sbjct: 267 PN 268
|
Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-21
Identities = 58/152 (38%), Positives = 88/152 (57%), Gaps = 15/152 (9%)
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHT-YLSSKSTAGTP 856
VA+GM +L + + VHRDL + N+L+ + +VK+CDFGL+R I H + Y+S ST
Sbjct: 246 VARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNR-----R 910
+WMAPE + + DV+S+G++LWE+ +L P+ G+ +V + F N+ R
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM----IVDST-FYNKIKSGYR 358
Query: 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQL 942
+ PD V I+ CW +EP RPSF L
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 71/210 (33%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 684 VAEWEILWEDLQIGERIGIGSYGEVYRA-DWHGTE-VAVKKF-LDQDFSGDSLSQFKCEA 740
V E+E L RIG G+YG VYRA D E VA+KK +D + G +S + E
Sbjct: 6 VTEFEKL-------NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EI 57
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG----SLYRLLHRPNHQLDERRRMRMA 796
++L LRHPN+V V SI FL L LL E + +
Sbjct: 58 TLLLNLRHPNIVELKEVVVGKHLDSI---FLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856
L + +G+ YLH + I+HRDLK NLL+ +K+ DFGL+R T
Sbjct: 115 LQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL 172
Query: 857 EWMAPEVLRN-EPANEKCDVYSFGVILWEL 885
+ APE+L D+++ G IL EL
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+I RIG G++G V++A T VA+KK + G +Q E + + +HP VV
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKGMNYLHTS 809
+ F ++ E++P L +L L E + MRM L KG+ Y+H +
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN 118
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE----W-MAPEVL 864
I+HRDLK NLL+ + V+K+ DFGL+R+ + + + + W APE+L
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQVATRWYRAPELL 172
Query: 865 RNEPA-NEKCDVYSFGVILWEL 885
+ D+++ G I EL
Sbjct: 173 YGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 20/268 (7%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE-VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
EDL+ +G G+ G V + T V KK + Q E +IM R P
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V F GA + + EF+ GSL R+ + + ++A+ V +G+ YL+ H
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS--KSTAGTPEWMAPEVLRNEP 868
I+HRD+K N+LV+ +K+CDFG+S ++S + GT +M+PE ++
Sbjct: 124 -RIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGK 178
Query: 869 ANEKCDVYSFGVILWELATLSVPW--------KGLNPMQVVGAVG--FQNRRLEIPDDID 918
K DV+S G+ + ELA P+ +PM ++ + Q +P
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238
Query: 919 PAVAQIIRD-CWQTEPHLRPSFAQLMSR 945
P + D C +P RP+ QL +
Sbjct: 239 PEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 698 ERIGIGSYGEVYRADWHGTE--VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+G G+YG V + T VA+KKF + + D E +++ +LRH N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
A R ++ E++ R +L LL L + + + Y H SH I+H
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH-SH-NIIH 123
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA------GTPEWMAPEVLRNEPA 869
RD+K N+LV ++ V+K+CDFG +R L ++ + T + APE+L +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 870 NEK-CDVYSFGVILWELAT 887
K DV++ G I+ EL
Sbjct: 179 YGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-20
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 9/230 (3%)
Query: 693 DLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRHP 749
D QI ++G G YG+V+ A T E+ K + + F + + E +I+ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+V + A + + E++P G LL+ ++ R MA ++ + ++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA-EMFEAVDALH-- 118
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
+HRDLK N L+D + +K+ DFGLS+ + S G+P++MAPEVLR +
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919
+ D +S G +L+E P+ G P + + + L+ P DP
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP 225
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 73/269 (27%), Positives = 127/269 (47%), Gaps = 26/269 (9%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTEV--AVKKF-LDQDFSGDSLSQFKCEAEIMLRLRH 748
+++++ + +G G+YG VY+ T V A+K+ L+ D S +Q E +I+ +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES--KFNQIIMELDILHKAVS 58
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPNHQLDERRRMRMALDVAKGMNYL 806
P +V F GA + E++ GSL +L + E R+ V KG+ +L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN 866
H I+HRD+K N+LV+ N VK+CDFG+S + +K+ G +MAPE +++
Sbjct: 119 KEEH-NIIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 867 EPANE------KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL------EIP 914
N+ + DV+S G+ + E+A P+ P + + Q + +P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDGDPPTLP 231
Query: 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+ C P+ RP++AQL+
Sbjct: 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 7e-20
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 700 IGIGSYGEVYRADWHGT-EVAVKKFLDQDF--SGDSLSQFKCEAEIML---RLRHPNVVL 753
+G G +G+V A++ T E+ K L + + D + CE I RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
H + E+ G L +H E R + A V G+ YLH + I
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--I 122
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST-AGTPEWMAPEVLRNEPANEK 872
V+RDLK NLL+D VK+ DFGL + + + ST GTPE++APEVL
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA 181
Query: 873 CDVYSFGVILWELATLSVPWKG 894
D + GV+++E+ P+ G
Sbjct: 182 VDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 7e-20
Identities = 66/249 (26%), Positives = 118/249 (47%), Gaps = 9/249 (3%)
Query: 698 ERIGIGSYGEVYRAD--WHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
E+IG G+ G V+ A G EVA+K+ Q L E +M L++PN+V F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFL 82
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ ++ E+L GSL ++ +DE + + + + + +LH + ++H
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RD+KS N+L+ + VK+ DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 876 YSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQIIRDCWQTEPH 934
+S G++ E+ P+ NP++ + + L+ P+ + P + C + +
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258
Query: 935 LRPSFAQLM 943
R S +L+
Sbjct: 259 KRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 9e-20
Identities = 68/301 (22%), Positives = 115/301 (38%), Gaps = 75/301 (24%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTEVAV------KKF--LDQDFSGDSLSQFKCEAEIM 743
+D ++ + IG G++GEV+ V +K + ++ + + E +I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLV-RDKDTGQVYAMKVLRKSDMIKRNQI----AHVRAERDIL 55
Query: 744 LRLRHPNVV-LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERR------RMRMA 796
P +V L+ + H ++ E++P G L LL R E + +A
Sbjct: 56 ADADSPWIVKLYY-SFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLA 113
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS----------------- 839
LD + + +HRD+K N+L+D + +K+ DFGL
Sbjct: 114 LDSVHKLGF--------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 840 -------RIKHHTYLS-----SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT 887
+ + ST GTP+++APEVLR P +CD +S GVIL+E+
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 888 LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
P+ + + L P D P + P L+ RL
Sbjct: 226 GFPPFYSDTLQETYNKIINWKESLRFPPD----------------PPVSPEAIDLICRLL 269
Query: 948 C 948
C
Sbjct: 270 C 270
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 691 WEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR- 747
WE I E IG G+YG+V++ +G++ AVK LD D + + E I+ L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDE--EIEAEYNILKALSD 73
Query: 748 HPNVVLFMGA-----VTRSPHFSILTEFLPRGSLYRLLH---RPNHQLDERRRMRMALDV 799
HPNVV F G V ++ E GS+ L+ + +++E + +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWM 859
G+ +LH + +HRD+K N+L+ VK+ DFG+S T L ++ GTP WM
Sbjct: 134 LMGLQHLHVN--KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191
Query: 860 APEVLRNEPA-----NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP 914
APEV+ E + +CDV+S G+ EL P L+PM+ + +IP
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIP 242
Query: 915 DDIDPAVAQ----------IIRDCWQTEPHLRPSFAQLM 943
+ P + Q IR C + RP+ + L+
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 60/241 (24%), Positives = 117/241 (48%), Gaps = 17/241 (7%)
Query: 692 EDLQIGERIGIGSYGEVY--RADWHGTEVAVKKFLDQDFSGDSLSQ---FKCEAEIMLRL 746
+DL+ + +G G++G V+ R A+K + L Q E ++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI--RLKQEQHVHNEKRVLKEV 58
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806
HP ++ +L E++P G L+ L R + + + A ++ + YL
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYL 117
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLR 865
H+ IV+RDLK N+L+DK +K+ DFG ++ ++ T+ + GTPE++APEV++
Sbjct: 118 HSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYLAPEVIQ 171
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
++ N+ D ++ G++++E+ P+ NP + + +LE P +D +I
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRHLDLYAKDLI 229
Query: 926 R 926
+
Sbjct: 230 K 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 71/254 (27%), Positives = 117/254 (46%), Gaps = 21/254 (8%)
Query: 699 RIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQ------FKCEAEIMLRLRHPN 750
+IG GS G V A D G +VAVKK D Q F E IM +HPN
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKM-------DLRKQQRRELLFN-EVVIMRDYQHPN 77
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V + ++ EFL G+L ++ ++E + + L V K +++LH
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQ- 134
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPAN 870
++HRD+KS ++L+ + VK+ DFG KS GTP WMAPEV+ P
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYG 193
Query: 871 EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV-GFQNRRLEIPDDIDPAVAQIIRDCW 929
+ D++S G+++ E+ P+ P+Q + + +L+ + P + +
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253
Query: 930 QTEPHLRPSFAQLM 943
+P R + A+L+
Sbjct: 254 VRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 58/165 (35%), Positives = 90/165 (54%), Gaps = 23/165 (13%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRH 748
D +I ++G G++GEVY+A G VA+KK L + G ++ + E +I+ +L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKH 66
Query: 749 PNVV-LFMGAVTRSPHFSILTEFLPRGSLYR-----------LLHRPNHQLDERRRMRMA 796
PNVV L AV R RGS+Y LL P+ +L E +
Sbjct: 67 PNVVPLIDMAVERPDKSKRK-----RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841
L + +G+NYLH +H I+HRD+K+ N+L+D ++K+ DFGL+R
Sbjct: 122 LQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 28/264 (10%)
Query: 698 ERIGIGSYGEVYRADWH-GTEVA--VKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
+ IG G +G+V + H G A V K L + D F E + L HPNV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQL-----DERRRMRMALDVAKGMNYLHTS 809
+G S + ++ EF P G L L R N + + RMA +VA G+ +LH +
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGL--SRIKHHTYLSSKSTAGTPEWMAPEVLRNE 867
+H DL N + + VK+ D+GL + Y++ A W+APE++
Sbjct: 120 D--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 868 PAN-------EKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPD-DID 918
+ +K +++S GV +WEL T + P+ L+ QV+ V + + +++P +D
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQLD 236
Query: 919 PAVA----QIIRDCWQTEPHLRPS 938
+ ++++ CW +P RP+
Sbjct: 237 LKYSDRWYEVMQFCW-LDPETRPT 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 53/285 (18%)
Query: 700 IGIGSYGEVY--RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEI-MLR-LRHPNVVLFM 755
+G GSYG V + G VA+KKFL+ + D + + EI ML+ LRH N+V +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESE--DDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
R ++ EF+ L L PN LDE R + + +G+ + H SH I+H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH-SH-NIIH 123
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK-CD 874
RD+K N+LV ++ VVK+CDFG +R T + APE+L + + D
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183
Query: 875 VYSFGVILWELAT-----------------------LSVPWKGL---NPMQVVGAVGFQN 908
+++ G ++ E+ T L + + NP+ F
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL-------FAG 236
Query: 909 RRLEIPDDIDPA----------VAQIIRDCWQTEPHLRPSFAQLM 943
RL +I+P V + + C + +P RPS +QL+
Sbjct: 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKKF---LDQDFSGDSLSQFKCEAEIML----- 744
+ IG G+YG VY+A D + G VA+KK L ++ G LS + EI L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPLSTLR---EIALLKQLE 56
Query: 745 RLRHPNVVLFMG-----AVTRSPHFSILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALD 798
HPN+V + R +++ E + + L L + P L +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEW 858
+ +G+++LH SH IVHRDLK N+LV + VK+ DFGL+RI +++ + ++ W
Sbjct: 116 LLRGVDFLH-SH-RIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVTLW 171
Query: 859 M-APEVLRNEPANEKCDVYSFGVILWELATL 888
APEVL D++S G I EL
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRR 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 23/273 (8%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRA-DWHGTEV-AVKKFLDQDFSGDSLSQ----FKCEAE 741
E L+ DL+ IG GS+G VY A D +EV A+KK +SG ++ E
Sbjct: 14 EKLFSDLR---EIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVR 67
Query: 742 IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK 801
+ +LRHPN + + G R ++ E+ GS LL L E + +
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
G+ YLH+ + ++HRD+K+ N+L+ + +VK+ DFG + I + GTP WMAP
Sbjct: 127 GLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAP 180
Query: 862 EVLRNEPANE---KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
EV+ + K DV+S G+ ELA P +N M + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
+ C Q P RP+ L+ R + R
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLLKH-RFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 62/242 (25%), Positives = 118/242 (48%), Gaps = 11/242 (4%)
Query: 700 IGIGSYGEVYRADWHGT-EVAVKKFLDQD--FSGDSLSQFKCEAEIM-LRLRHPNVV-LF 754
+G GS+G+V A+ GT E+ K L +D D + E ++ L +HP + L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
T+ F ++ E++ G L + R + + DE R A ++ G+ +LH I+
Sbjct: 63 SCFQTKDRLFFVM-EYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHER--GII 118
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCD 874
+RDLK N+L+D +K+ DFG+ + +++ + GTP+++APE+L +P D
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178
Query: 875 VYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPH 934
++ GV+L+E+ P++G + ++ ++ + P + I++ P
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDEDELFQSI--LEDEVRYPRWLSKEAKSILKSFLTKNPE 236
Query: 935 LR 936
R
Sbjct: 237 KR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 3e-18
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 39/211 (18%)
Query: 700 IGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKC---EAEIMLRLRHPNVV-L 753
IG G+YG V A D G +VA+KK + D L K E +++ LRH N++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 754 FMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
+ R P I+TE + L++++ P D+ + + + +G+ YLH
Sbjct: 65 L--DILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFL-YQILRGLKYLH 120
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWM-------- 859
+++ ++HRDLK N+LV+ N +K+CDFGL+R ++
Sbjct: 121 SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE-------DEKGFLTEYVVTRW 171
Query: 860 --APEVLRNEPA-NEKCDVYSFGVILWELAT 887
APE+L + + D++S G I EL T
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 60/173 (34%), Positives = 98/173 (56%), Gaps = 14/173 (8%)
Query: 787 LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHT 845
LD +R + VA+GM++L + +HRD+ + N+L+ V K+CDFGL+R I + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 846 YLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGL---NPMQV 900
K A P +WMAPE + + + DV+S+G++LWE+ +L P+ G+ +
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
Query: 901 VGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953
+ G+Q R PD P + I++ CW EP RP+F+Q+ S+L +QR L
Sbjct: 327 MVKRGYQMSR---PDFAPPEIYSIMKMCWNLEPTERPTFSQI-SQL--IQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 80/272 (29%), Positives = 124/272 (45%), Gaps = 22/272 (8%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRA-DWHGTEV-AVKKFLDQDFSGDSLSQ----FKCEAE 741
E L+ DL+ IG GS+G VY A D EV A+KK +SG ++ E +
Sbjct: 24 EKLFTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDIIKEVK 77
Query: 742 IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK 801
+ R++HPN + + G R ++ E+ GS LL L E + +
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
G+ YLH SH ++HRD+K+ N+L+ + VK+ DFG + I + S GTP WMAP
Sbjct: 137 GLAYLH-SH-NMIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANSFVGTPYWMAP 190
Query: 862 EVLRNEPANE---KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
EV+ + K DV+S G+ ELA P +N M + + ++
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 250
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950
+ C Q P RP+ +L+ + L+
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 64/249 (25%), Positives = 118/249 (47%), Gaps = 9/249 (3%)
Query: 698 ERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
E+IG G+ G VY A G EVA+K+ Q L E +M ++PN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 82
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ ++ E+L GSL ++ +DE + + + + +++LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLHSNQ--VIH 138
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RD+KS N+L+ + VK+ DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 876 YSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQIIRDCWQTEPH 934
+S G++ E+ P+ NP++ + + L+ P+ + + C + +
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVD 258
Query: 935 LRPSFAQLM 943
R S +L+
Sbjct: 259 RRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 77/262 (29%), Positives = 123/262 (46%), Gaps = 20/262 (7%)
Query: 692 EDLQIG-ERIGIGSYGEVYRA-DWHGTE-VAVKKFLDQDFSGDSLSQ----FKCEAEIML 744
E++ +G IG GS+G VY A + H E VAVKK +SG ++ E + +
Sbjct: 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQ 76
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMN 804
+L+HPN + + G + ++ E+ GS LL L E + +G+
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
YLH SH ++HRD+K+ N+L+ + VK+ DFG + + S GTP WMAPEV+
Sbjct: 136 YLH-SH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVI 189
Query: 865 RNEPANE---KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
+ K DV+S G+ ELA P +N M + + + ++ +
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249
Query: 922 AQIIRDCWQTEPHLRPSFAQLM 943
+ C Q P RP+ A+L+
Sbjct: 250 RGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 5e-18
Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 36/273 (13%)
Query: 694 LQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNV 751
++ E +G G+YG+VY+ T ++A K +D +GD + K E ++ + H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNI 65
Query: 752 VLFMGA-VTRSP-----HFSILTEFLPRGSLYRLL-HRPNHQLDERRRMRMALDVAKGMN 804
+ GA + ++P ++ EF GS+ L+ + + L E + ++ +G++
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
+LH ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 126 HLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 865 ---RNEPA--NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919
N A + K D++S G+ E+A + P ++PM+ + IP + P
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAP 234
Query: 920 AVA---------QIIRDCWQTEPHLRPSFAQLM 943
+ I C RP+ QLM
Sbjct: 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 27/273 (9%)
Query: 692 EDLQIGERIGIGSYGEVY--RADWHGTEVAVKKFL-DQDFSGDSLSQFKCEAEIMLRLRH 748
+D + +G G +GEV R G A+K + +++S F+ E +I+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
P + A + ++ E+ P G L LL+R Q DE ++ ++ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFG----LSRIKHHTYLSSKSTAGTPEWMAPEVL 864
VHRD+K N+L+D+ +K+ DFG L+ K ++SK GTP+++APEVL
Sbjct: 121 M--GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM---VNSKLPVGTPDYIAPEVL 175
Query: 865 RNEPANEK------CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
+ K CD +S GVI +E+ P+ + + R L+ P+ D
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE--D 233
Query: 919 PAVAQIIRDCWQ---TEPHLRPSFAQLMSRLRC 948
P V+ D Q R + L C
Sbjct: 234 PKVSSDFLDLIQSLLCGQKERLGY----EGLCC 262
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 9e-18
Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 14/220 (6%)
Query: 700 IGIGSYGEVYRADWHGT-EVAVKKFLDQD--FSGDSLSQFKCEAEIM-LRLRHPNVVLFM 755
+G GS+G+V+ A+ GT + K L +D D + E ++ L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
+ + E+L G L + H + H+ D R A ++ G+ +LH+ IV
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK--GIV 118
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCD 874
+RDLK N+L+D + +K+ DFG+ + + + GTP+++APE+L + N D
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVD 178
Query: 875 VYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP 914
+SFGV+L+E+ P+ G + ++ FQ+ R++ P
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 6/157 (3%)
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL-YRLLHRPNHQLDERRRMRMAL 797
E I+ L HP +V + + ++ + L G L Y L + +E+ + +
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS-EEQVKFWIC- 107
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE 857
++ + YLH+ I+HRD+K N+L+D+ V + DF ++ L++ ST+GTP
Sbjct: 108 EIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-STSGTPG 164
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG 894
+MAPEVL + + D +S GV +E P++G
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 700 IGIGSYGEVYRADWHGT-EVAVKKFLDQD--FSGDSLSQFKCEAEIM-LRLRHPNVV-LF 754
+G GS+G+V A+ GT E K L +D D + E ++ L HP + LF
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
T+ H + E+L G L + H + + + DE R A ++ G+ +LH I
Sbjct: 63 CTFQTKE-HLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--I 117
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA--GTPEWMAPEVLRNEPANE 871
++RDLK N+L+DK+ +K+ DFG+ K + K++ GTP+++APE+L+ + NE
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 872 KCDVYSFGVILWELATLSVPWKG 894
D +SFGV+L+E+ P+ G
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 64/244 (26%), Positives = 114/244 (46%), Gaps = 15/244 (6%)
Query: 700 IGIGSYGEVYRA------DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV 752
IG GS+G+V A ++ +V KK + + E ++L+ L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI---LKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ + + +++ G L+ L R L+ R R A +VA + YLH+ +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN-- 116
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK 872
I++RDLK N+L+D V + DFGL + ++ + GTPE++APEVLR EP +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 873 CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTE 932
D + G +L+E+ P+ + Q+ ++ L++P A ++ +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYD--NILHKPLQLPGGKTVAACDLLVGLLHKD 234
Query: 933 PHLR 936
R
Sbjct: 235 QRRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 10/206 (4%)
Query: 699 RIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKC-EAEIMLRLRHPNVVLFM 755
+IG GS G V A + H G +VAVKK D + E IM H NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ ++ EFL G+L ++ + +++E + + L V + ++YLH ++H
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQ--GVIH 141
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RD+KS ++L+ + +K+ DFG KS GTP WMAPEV+ P + D+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 876 YSFGVILWELATLSVPWKGLNPMQVV 901
+S G+++ E+ P+ P+Q +
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAM 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 61/222 (27%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 694 LQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNV 751
++ E +G G+YG+VY+ T ++A K +D + D + K E ++ + H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNI 75
Query: 752 VLFMGA-VTRSP-----HFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMN 804
+ GA + +SP ++ EF GS+ L+ + L E + ++ +G+
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
+LH ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 136 HLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 865 RNEPANE-----KCDVYSFGVILWELATLSVPWKGLNPMQVV 901
+ + + D++S G+ E+A + P ++PM+ +
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 63/249 (25%), Positives = 116/249 (46%), Gaps = 9/249 (3%)
Query: 698 ERIGIGSYGEVYRAD--WHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
E+IG G+ G VY A G EVA+++ Q L E +M ++PN+V ++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 83
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ ++ E+L GSL ++ +DE + + + + + +LH++ ++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ--VIH 139
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RD+KS N+L+ + VK+ DFG + GTP WMAPEV+ + K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 876 YSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQIIRDCWQTEPH 934
+S G++ E+ P+ NP++ + + L+ P+ + + C +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 935 LRPSFAQLM 943
R S +L+
Sbjct: 260 KRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-17
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 30/224 (13%)
Query: 691 WEDLQIGERIGIGSYGEVYRADWHGTE---VAVKKF----------LDQDFSGDSLSQFK 737
+ED +G GS+G V A + + VA+K+F +D FS
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-------- 80
Query: 738 CEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
E +I+ + HP V G+ + ++ EF+ G + L R N + A
Sbjct: 81 -ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAA 138
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI-KHHTYLSSKSTAGTP 856
+ YL + + IV+RDLK NLL+DK+ +K+ DFG +++ TY + GTP
Sbjct: 139 QIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TLCGTP 192
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV 900
E++APE+L N + D ++ G+ ++E+ P+ P+ +
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 46/226 (20%)
Query: 700 IGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIML--RLRHPNVV- 752
IG G+YG VY+A G E A+KKF +SQ C EI L L+H NVV
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELKHENVVS 66
Query: 753 ---LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRM---RMA-------LDV 799
+F+ +S +L ++ + + L +R M L+
Sbjct: 67 LVEVFLEHADKS--VYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN- 119
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSRIKH---HTYLSSKST 852
G++YLH++ ++HRDLK N+LV + VVK+ D GL+R+ +
Sbjct: 120 --GVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 853 AGTPEWMAPEVL---RN-EPANEKCDVYSFGVILWELATLSVPWKG 894
T + APE+L R+ A D+++ G I EL TL +KG
Sbjct: 176 VVTIWYRAPELLLGARHYTKA---IDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 79/266 (29%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 692 EDLQIGERIGIGSYGEVY--RADWHGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRH 748
ED + + I G+YG VY R A+KK Q+ + + Q E +I+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
P VV + H ++ E++ G LL + RM A V + YLH
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLHN 119
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI---------------KHHTYLSSKSTA 853
IVHRDLK NLL+ +K+ DFGLS+I K K
Sbjct: 120 Y--GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI 913
GTPE++APEV+ + + D ++ G+IL+E VP+ G P ++ G V + +E
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISDDIEW 235
Query: 914 P--DDIDPAVAQ-IIRDCWQTEPHLR 936
P D+ PA AQ +I + P R
Sbjct: 236 PEGDEALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-17
Identities = 50/158 (31%), Positives = 88/158 (55%), Gaps = 3/158 (1%)
Query: 737 KCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMA 796
K E +I+ + HP +V A ++ +FL G L+ L + +E + +A
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856
++A +++LH+ I++RDLK N+L+D+ +K+ DFGLS+ + S GT
Sbjct: 106 -ELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG 894
E+MAPEV+ + D +SFGV+++E+ T S+P++G
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 24/209 (11%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRH 748
++ + RI G+YG VYRA T VA+KK ++++ G ++ + E I+L+L+H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 749 PNVV----LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMN 804
PN+V + +G + ++ E++ L L+ + + L + G+
Sbjct: 64 PNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-----IKHHTYLSSKSTAGTPEWM 859
+LH I+HRDLK+ NLL++ ++K+CDFGL+R +K +T L T +
Sbjct: 121 HLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-----TLWYR 173
Query: 860 APEVLRNEPA-NEKCDVYSFGVILWELAT 887
APE+L + D++S G I EL T
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 700 IGIGSYGEV--YRADWHGTEVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+G G++G+V R G A+K L ++ + D ++ E+ ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ + E++ G L+ L R ++R R A ++ ++YLH+ IV+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--KIVY 118
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RDLK NL++DK+ +K+ DFGL + + K+ GTPE++APEVL + D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 876 YSFGVILWELATLSVPW 892
+ GV+++E+ +P+
Sbjct: 179 WGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 698 ERIGIGSYGEVY--RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEI-MLR-LRHPNVVL 753
+IG GSYG V+ R G VA+KKF++ + D + + EI ML+ L+HPN+V
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
+ R ++ E+ L L P + E ++ + +N+ H H I
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH-KHNCI 122
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEK 872
HRD+K N+L+ K +K+CDFG +RI T + APE+L +
Sbjct: 123 -HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPP 181
Query: 873 CDVYSFGVILWELATLSVPWKG 894
DV++ G + EL T W G
Sbjct: 182 VDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 16/195 (8%)
Query: 700 IGIGSYGEVYRADWHGTE--VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGA 757
+G G+YG V + T+ VA+KKF D + + + E +++ L+ N+V A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 758 VTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRD 817
R ++ E++ + L L PN E+ R + + K +++ H + IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKND--IVHRD 125
Query: 818 LKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMA------PEVLRNEPANE 871
+K NLL+ N V+K+CDFG +R LS S A E++A PE+L P +
Sbjct: 126 IKPENLLISHNDVLKLCDFGFAR-----NLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 872 KCDVYSFGVILWELA 886
D++S G IL EL+
Sbjct: 181 AVDMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 33/270 (12%)
Query: 698 ERIGIGSYGEVYRADW----------HGTEVAV-KKFLDQDFSGDSLSQFKCEAEIMLRL 746
E +G G++ +Y+ G EV+V K L D DSL+ F+ A +M +L
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-DSLAFFET-ASLMSQL 58
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806
H ++V G R + ++ E++ G L LHR + + ++ +A +A ++YL
Sbjct: 59 SHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWV-------VKVCDFGLSRIKHHTYLSSKSTAGTPEWM 859
+VH ++ N+LV + + +K+ D G+ T LS + W+
Sbjct: 118 EDK--KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERVERIPWI 171
Query: 860 APEVLRNEPAN--EKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDD 916
APE +RN A+ D +SFG L E+ + P L+ + F + +P
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQDQHRLPMP 228
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+A +I CW +P RPSF ++ L
Sbjct: 229 DCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 26/267 (9%)
Query: 698 ERIGIGSYGEVY----RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
+ IG G +G+V + + +V VK+ L S +F EA+ L+H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKE-LRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHR----PNHQLDERRRMRMALDVAKGMNYLHTS 809
+G T + ++ EF P G L L D RMA ++A G+ +LH +
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--YLSSKSTAGTPEWMAPEVLRNE 867
+ +H DL N L+ + VK+ D+GLS K+ Y++ W+APE++
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 868 PAN-------EKCDVYSFGVILWELATL-SVPWKGLNPMQVVG-AVGFQNRRLEIPDDID 918
N ++ +V+S GV +WEL L S P++ L+ QV+ V Q +L P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237
Query: 919 PAVA---QIIRDCWQTEPHLRPSFAQL 942
P ++++ CW +P RPS ++
Sbjct: 238 PLSDRWYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 43/208 (20%)
Query: 700 IGIGSYGEVYRADWHGTEV--AVKKFLDQDFSGDSLSQFKCEAEIMLR-------LRHPN 750
IG GS+G+V A AVK ++ + K + IM ++HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 751 VVLFMGAVTRSPHFSILT--------EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
+V H+S T +++ G L+ L R + R R A ++A
Sbjct: 58 LV--------GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASA 108
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR--IKHHTYLSSKSTA---GTPE 857
+ YLH+ + I++RDLK N+L+D V + DFGL + I+H SK+T+ GTPE
Sbjct: 109 LGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-----SKTTSTFCGTPE 161
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWEL 885
++APEVLR +P + D + G +L+E+
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 71/249 (28%), Positives = 117/249 (46%), Gaps = 21/249 (8%)
Query: 699 RIGIGSYGEV--YRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
+IG GS G V R G +VAVK +D F E IM +H NVV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYK 85
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ +L EFL G+L ++ + +L+E + + V + + YLH+ ++HR
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQ--GVIHR 141
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVY 876
D+KS ++L+ + VK+ DFG KS GTP WMAPEV+ P + D++
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 877 SFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
S G+++ E+ P+ +P+Q + +RL D P +++ + P LR
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAM-------KRLR--DSPPPK----LKNAHKISPVLR 248
Query: 937 PSFAQLMSR 945
++++R
Sbjct: 249 DFLERMLTR 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 63/218 (28%), Positives = 110/218 (50%), Gaps = 42/218 (19%)
Query: 699 RIGIGSYGEVYRADWHGTE--VAVKKFL-DQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+IG G++GEV++A T+ VA+KK L + + G ++ + E +I+ L+H NVV +
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 77
Query: 756 GAVTRSP---------HFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKGM 803
+ R+ F ++ EF L LL N + ++ M+M L+ G+
Sbjct: 78 -EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN---GL 132
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG--------T 855
Y+H + I+HRD+K+ N+L+ K+ ++K+ DFGL+R + SK++ T
Sbjct: 133 YYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNRYTNRVVT 186
Query: 856 PEWMAPEVLRNE----PANEKCDVYSFGVILWELATLS 889
+ PE+L E P D++ G I+ E+ T S
Sbjct: 187 LWYRPPELLLGERDYGPP---IDMWGAGCIMAEMWTRS 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 69/216 (31%), Positives = 116/216 (53%), Gaps = 27/216 (12%)
Query: 680 MLGEVAEWEILWEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLS-QF 736
+ G V E + DLQ +G+G++G V A G VA+KK + + FS L+ +
Sbjct: 1 IFGTVFEITNRYVDLQ---PVGMGAFGLVCSARDQLTGQNVAIKKIM-KPFSTPVLAKRT 56
Query: 737 KCEAEIMLRLRHPNVVLFMGAVTRSPHFSI--LTEFLPRGSLYRLLH-RPNHQLDERRRM 793
E +++ LRH N++ + + SP I +TE L L+RLL RP L+++
Sbjct: 57 YRELKLLKHLRHENIIS-LSDIFISPLEDIYFVTELLGT-DLHRLLTSRP---LEKQFIQ 111
Query: 794 RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT---YLSSK 850
+ +G+ Y+H++ +VHRDLK N+L+++N +K+CDFGL+RI+ Y+S
Sbjct: 112 YFLYQILRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS-- 167
Query: 851 STAGTPEWMAPEV-LRNEPANEKCDVYSFGVILWEL 885
T + APE+ L + + + D++S G I E+
Sbjct: 168 ----TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-16
Identities = 62/245 (25%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFS----GDSLSQFKC 738
++ + ++ ED + + IG G++GEV ++ L F DS + F
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS-AFFWE 92
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALD 798
E +IM P VV A + ++ E++P G L L+ N+ + E+ +
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAE 150
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA-GTPE 857
V ++ +H+ ++HRD+K N+L+DK+ +K+ DFG T + TA GTP+
Sbjct: 151 VVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208
Query: 858 WMAPEVLRNEPAN----EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI 913
+++PEVL+++ + +CD +S GV L+E+ P+ + + + L
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF 268
Query: 914 PDDID 918
P+D++
Sbjct: 269 PEDVE 273
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 6/196 (3%)
Query: 700 IGIGSYGEV--YRADWHGTEVAVKKFLDQ-DFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
+G G++G+V R G A+K + + D ++ E+ ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
A + E+ G L+ L R +ER R A ++ + YLH+ +V+R
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD--VVYR 119
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVY 876
D+K NL++DK+ +K+ DFGL + + K+ GTPE++APEVL + D +
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 877 SFGVILWELATLSVPW 892
GV+++E+ +P+
Sbjct: 180 GLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 71/271 (26%), Positives = 122/271 (45%), Gaps = 29/271 (10%)
Query: 700 IGIGSYGEVYRADWHGTEV--AVKKFLDQD-FSGDSLSQFKCEAEIMLR-LRHPNVVLFM 755
IG GS+G+V A E AVK + E ++L+ ++HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ + + +++ G L+ L R L+ R R A ++A + YLH+ + IV+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN--IVY 119
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RDLK N+L+D + + DFGL + ++ + GTPE++APEVL +P + D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 876 YSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHL 935
+ G +L+E+ GL P + E+ D+ I+ Q +P++
Sbjct: 180 WCLGAVLYEMLY------GLPPF-------YSRNTAEMYDN-------ILNKPLQLKPNI 219
Query: 936 RPSFAQLMSRLRCLQRLLVDRSNSTNQFSEL 966
S L+ L LQ+ R + + F E+
Sbjct: 220 TNSARHLLEGL--LQKDRTKRLGAKDDFMEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 65/204 (31%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 698 ERIGIGSYGEVYRA--DWHGTEVAVKKF-LDQDFSGDSLSQFKCEAEIML--RLRHPNVV 752
E+IG G+YG VY+A G VA+KK L+ + G + + EI L L HPN+V
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIV 61
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ V ++ EFL + P LD + +G+ Y H SH
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH-SH-R 119
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGTPE----WM-APEVL 864
++HRDLK NLL+D+ +K+ DFGL+R + TY T E W APE+L
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--------THEVVTLWYRAPEIL 171
Query: 865 RNEPA-NEKCDVYSFGVILWELAT 887
+ D++S G I E+
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 37/209 (17%)
Query: 697 GERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKC--------EAEIMLRL 746
G+++G G+Y VY+A G VA+KK + K E +++ L
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA-----KDGINFTALREIKLLQEL 59
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQL---DERRRMRMALDVAKGM 803
+HPN++ + + +++ EF+ L +++ + L D + M M L +G+
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGL 115
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK----STAGTPEWM 859
YLH++ I+HRDLK NLL+ + V+K+ DFGL+R + S T +
Sbjct: 116 EYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARS----FGSPNRKMTHQVVTRWYR 169
Query: 860 APEVLRNEPANE---KCDVYSFGVILWEL 885
APE+L A D++S G I EL
Sbjct: 170 APELLFG--ARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-15
Identities = 60/243 (24%), Positives = 114/243 (46%), Gaps = 28/243 (11%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKC-----------EA 740
ED ++ + IG G++GEV ++ K + ++ LS+F+ E
Sbjct: 43 EDYEVVKVIGRGAFGEV--------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
+IM P VV A + ++ E++P G L L+ N+ + E+ +V
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVV 152
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWM 859
++ +H+ +HRD+K N+L+DK+ +K+ DFG ++ + + GTP+++
Sbjct: 153 LALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 860 APEVLRNEPAN----EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD 915
+PEVL+++ + +CD +S GV L+E+ P+ + + + L PD
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270
Query: 916 DID 918
D D
Sbjct: 271 DND 273
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 698 ERIGIGSYGEVYRADWHGTE--VAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
E+IG G+YG VY+ T VA+KK L+ + G + + E ++ L+HPN+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCL 64
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL-DVAKGMNYLHTSHPTI 813
+ + ++ EFL L P Q + ++ L + +G+ + H+ +
Sbjct: 65 QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--V 122
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSR-----IKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
+HRDLK NLL+D V+K+ DFGL+R ++ +T+ T + APEVL P
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-----EVVTLWYRAPEVLLGSP 177
Query: 869 A-NEKCDVYSFGVILWELAT 887
+ D++S G I E+AT
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 58/240 (24%), Positives = 110/240 (45%), Gaps = 7/240 (2%)
Query: 700 IGIGSYGEVYRADWHGT-EVAVKKFLDQDF--SGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
+G G++G+V T K L ++ + D ++ E ++ RHP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ + E+ G L+ L R ++R R A ++ ++YLH S +V+R
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLH-SEKNVVYR 120
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVY 876
DLK NL++DK+ +K+ DFGL + + K+ GTPE++APEVL + D +
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 877 SFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
GV+++E+ +P+ + ++ + + R P + P ++ + +P R
Sbjct: 181 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-15
Identities = 66/242 (27%), Positives = 107/242 (44%), Gaps = 57/242 (23%)
Query: 695 QIGERIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSL--SQFKCEAEIMLRLRH 748
I IG G GEVY A + VA+KK + +D S + L +F EA+I L H
Sbjct: 5 DIIRLIGKGGMGEVYLA--YDPVCSRRVALKK-IREDLSENPLLKKRFLREAKIAADLIH 61
Query: 749 PNVVLFMGAVTRSPHFSILTE---------FLPRGSLYRLLHRPNHQ------LDERRR- 792
P +V P +SI ++ ++ +L LL + L E+
Sbjct: 62 PGIV---------PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV 112
Query: 793 ---MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK------- 842
+ + + + Y+H+ ++HRDLK N+L+ V + D+G + K
Sbjct: 113 GAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 843 -----------HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVP 891
+ + GTP++MAPE L PA+E D+Y+ GVIL+++ TLS P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
Query: 892 WK 893
++
Sbjct: 231 YR 232
|
Length = 932 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 699 RIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKC-EAEIMLRLRHPNVVLFM 755
+IG GS G V A G VAVKK D + E IM +H NVV
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ ++ EFL G+L ++ + +++E + + L V K ++ LH ++H
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQ--GVIH 139
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RD+KS ++L+ + VK+ DFG KS GTP WMAPE++ P + D+
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 876 YSFGVILWELATLSVPWKGLNPMQVV 901
+S G+++ E+ P+ P++ +
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAM 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 52/199 (26%), Positives = 102/199 (51%), Gaps = 7/199 (3%)
Query: 700 IGIGSYGEVYRADWHGT-EVAVKKFLDQD--FSGDSLSQFKCEAEIM-LRLRHPNVVLFM 755
+G GS+G+V A+ GT E+ K L +D D + E ++ L + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ E++ G L + + + E + A ++A G+ +LH+ I++
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSK--GIIY 124
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RDLK N+++D +K+ DFG+ + +++K+ GTP+++APE++ +P + D
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 876 YSFGVILWELATLSVPWKG 894
++FGV+L+E+ P++G
Sbjct: 185 WAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 67/293 (22%), Positives = 120/293 (40%), Gaps = 48/293 (16%)
Query: 696 IGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
IG+ + + T VAVKK S + L + E +L+HPN++ ++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL---DVAKGMNYLHTSHPT 812
+ +++ + GS LL H + + +A DV ++Y+H+
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLK--THFPEGLPELAIAFILKDVLNALDYIHSKG-- 121
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDF--GLSRIKH-----HTYLSSKSTAGTPEWMAPEVLR 865
+HR +K+ ++L+ + V + +S IKH + KS+ W++PEVL+
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 866 N--EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVV---------------------G 902
+ NEK D+YS G+ ELA VP+K + Q++
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241
Query: 903 AVGFQNRRLEIPDDID-----------PAVAQIIRDCWQTEPHLRPSFAQLMS 944
++ E P++ D Q + C Q +P RPS +QL++
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 692 EDLQIGERIGIGSYGEVYRAD--WHGTEVAVKK---FLDQDFSGDSLSQFKCEAEIMLRL 746
Q IG G+YG V A G +VA+KK F Q F +L + K I+ R
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 747 RHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
+H N++ + + R P F I+ E + LY+L+ L +
Sbjct: 61 KHENIIGIL-DIIRPPSFESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQIL 116
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWM- 859
+G+ Y+H+++ ++HRDLK NLL++ N +K+CDFGL+RI T E++
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARI---ADPEHDHTGFLTEYVA 171
Query: 860 -----APEVLRNEPANEKC-DVYSFGVILWEL 885
APE++ N K D++S G IL E+
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 13/193 (6%)
Query: 700 IGIGSYGEVYRAD------WHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV 752
IG GS+G+V A + +V KK + + E ++L+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV---LNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ + + +F+ G L+ L R + R R A ++A + YLH+ +
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSIN-- 116
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK 872
IV+RDLK N+L+D V + DFGL + ++ + GTPE++APEV+R +P +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 873 CDVYSFGVILWEL 885
D + G +L+E+
Sbjct: 177 VDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 4/149 (2%)
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALD 798
E +++ P +V F GA SI E + GSL ++L + ++ E ++++
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISIA 107
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEW 858
V +G+ YL H I+HRD+K N+LV+ +K+CDFG+S + + S GT +
Sbjct: 108 VLRGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSY 164
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELAT 887
M+PE L+ + D++S G+ L E+A
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 39/225 (17%)
Query: 695 QIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFK----C--------EA 740
Q G +G G+YG+V +A G VA+KK + S D + C E
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 741 EIMLRLRHPNVVLFMGAV---TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
+IM ++H N+ MG V +++ + + L +++ R +L E + + L
Sbjct: 72 KIMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDR-KIRLTESQVKCILL 126
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-----IKHHTYLSSKST 852
+ G+N LH + +HRDL N+ ++ + K+ DFGL+R T ++
Sbjct: 127 QILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 853 AG----TPE----WM-APEVLRN-EPANEKCDVYSFGVILWELAT 887
T + W APE+L E + D++S G I EL T
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 61/262 (23%), Positives = 118/262 (45%), Gaps = 40/262 (15%)
Query: 679 PMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKC 738
++ + + ED + + IG G++GEV ++ K Q ++ LS+F+
Sbjct: 30 KAAEKITKLRMKAEDFDVIKVIGRGAFGEV--------QLVRHKSSKQVYAMKLLSKFEM 81
Query: 739 -----------EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQL 787
E +IM +V A + ++ E++P G L L+ N+ +
Sbjct: 82 IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDI 139
Query: 788 DER------RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-R 840
E+ + +ALD M + +HRD+K N+L+DK+ +K+ DFG +
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPAN----EKCDVYSFGVILWELATLSVPWKGLN 896
+ + + + GTP++++PEVL+++ + +CD +S GV L+E+ P+ +
Sbjct: 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 897 PMQVVGAVGFQNRRLEIPDDID 918
+ + L PDDI+
Sbjct: 252 LVGTYSKIMDHKNSLTFPDDIE 273
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-14
Identities = 74/313 (23%), Positives = 121/313 (38%), Gaps = 81/313 (25%)
Query: 692 EDLQIGERIGIGSYGEV---YRADWHGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLR 747
ED + IG G++GEV + D G A+K L + F D L+ K E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMA-----LDVAKG 802
P VV + + + ++ EFLP G L +L + + ++ R MA ++
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY---------------- 846
+ + +HRD+K N+L+D+ +K+ DFGLS H +
Sbjct: 120 LGF--------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 847 ----------------LSSK---------------STAGTPEWMAPEVLRNEPANEKCDV 875
+SSK ST GTP+++APE+ + ++CD
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231
Query: 876 YSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHL 935
+S G I++E P+ N + + L PDDI HL
Sbjct: 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI----------------HL 275
Query: 936 RPSFAQLMSRLRC 948
L+ RL
Sbjct: 276 SVEAEDLIRRLIT 288
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-14
Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 5/201 (2%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE-VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+D + +G G+ G V++ + + +K + + +Q E +++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V F GA SI E + GSL ++L + ++ E+ ++++ V KG+ YL H
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPAN 870
I+HRD+K N+LV+ +K+CDFG+S + + S GT +M+PE L+ +
Sbjct: 124 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYS 180
Query: 871 EKCDVYSFGVILWELATLSVP 891
+ D++S G+ L E+A P
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 8e-14
Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 41/230 (17%)
Query: 693 DLQIGERIGIGSYGEVYRADW------HGTEVAVKKFLD--QDFSGDSLSQFKCEAEIML 744
D++ IG G++G V W G VA+KK + Q+ S + E +++
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLC 54
Query: 745 RLRHPNVVLFMGA--VTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRMRMA 796
+H NV + A + + PH ++TE + + L++++ P + ++
Sbjct: 55 FFKHDNV---LSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKV-FL 109
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI------KHHTYLSSK 850
+ +G+ YLH++ I+HRD+K NLLV+ N V+K+CDFGL+R+ KH T
Sbjct: 110 YQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT----- 162
Query: 851 STAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQ 899
T + APE+L D++S G I EL + ++ +P+Q
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-14
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 700 IGIGSYGEVYRADWHGT-EVAVKKFLDQD--FSGDSLSQFKCEAEIM-LRLRHPNVVLFM 755
+G GS+G+V A+ G E K L +D D + E ++ L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
H + EFL G L + H + + D R A ++ G+ +LH+ I+
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK--GII 118
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA--GTPEWMAPEVLRNEPANEK 872
+RDLK N+++D++ +K+ DFG+ K + + ++++ GTP+++APE+L+
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176
Query: 873 CDVYSFGVILWELATLSVPWKG 894
D +SFGV+L+E+ P+ G
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 57/278 (20%)
Query: 700 IGIGSYGEV--YRADWHGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
IG G++GEV + G A+KK + + ++ + E +I+ +P VV
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMR-----MALDVAKGMNYLHTSHP 811
+ + ++ E+LP G + LL + + +E R +A+D + Y
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY------ 122
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLS------------RIKHH-----------TYLS 848
+HRD+K NLL+D +K+ DFGL RI H +S
Sbjct: 123 --IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 849 SK---------------STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWK 893
SK ST GTP+++APEV N++CD +S GVI++E+ P+
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 894 GLNPMQVVGAVGFQNRRLEIPDDI---DPAVAQIIRDC 928
NP + + L+ PD++ A I R C
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC 278
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 7/201 (3%)
Query: 700 IGIGSYGEVYRADWHGT-EVAVKKFLDQD--FSGDSLSQFKCEAEIM-LRLRHPNVVLFM 755
+G GS+G+V A+ GT EV K L +D D + E I+ L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ E++ G L + R + + DE R A +V + +LH +++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRH--GVIY 119
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RDLK N+L+D K+ DFG+ + +++ + GTP+++APE+L+ D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 876 YSFGVILWELATLSVPWKGLN 896
++ GV+++E+ P++ N
Sbjct: 180 WALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 5/201 (2%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE-VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+D + +G G+ G V + + + +K + + +Q E +++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V F GA SI E + GSL ++L + ++ E ++++ V +G+ YL H
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPAN 870
I+HRD+K N+LV+ +K+CDFG+S + + S GT +M+PE L+ +
Sbjct: 124 -QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYS 180
Query: 871 EKCDVYSFGVILWELATLSVP 891
+ D++S G+ L ELA P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 3/154 (1%)
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALD 798
E+ ++ RHP + + + E+ G L+ L R ++R R A +
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-E 103
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEW 858
+ + YLH+ +V+RDLK NL++DK+ +K+ DFGL + + K+ GTPE+
Sbjct: 104 IVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATLSVPW 892
+APEVL + D + GV+++E+ +P+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 37/240 (15%)
Query: 688 EILWE---DLQIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKC---E 739
+ +WE Q +G G+YG+V A T +VA+KK L + F S K E
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKK-LSRPF--QSAIHAKRTYRE 64
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRM 793
++ + H NV+ + T + ++T + L ++ +L +
Sbjct: 65 LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKC--QKLSDDHIQ 121
Query: 794 RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853
+ + +G+ Y+H++ I+HRDLK N+ V+++ +K+ DFGL+R HT + T
Sbjct: 122 FLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLAR---HT--DDEMTG 174
Query: 854 --GTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNP-------MQVVGA 903
T + APE++ N N+ D++S G I+ EL T + G + M +VG
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 8/198 (4%)
Query: 698 ERIGIGSYGEVYRADWHGTE--VAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
E+IG G+YG V++A T VA+K+ LD D G S + E ++ L+H N+V
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRL 64
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
+ +++ E+ + L + N +D + KG+ + H+ + ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VL 121
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEKC 873
HRDLK NLL++KN +K+ DFGL+R + T + P+VL +
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 181
Query: 874 DVYSFGVILWELATLSVP 891
D++S G I ELA P
Sbjct: 182 DMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 41/233 (17%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
+G G G V+ GT V KK + + + + + E EI+ L HP +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR---NKVKRVLTEQEILATLDHPFLPT 65
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ + ++ ++ P G L+RLL R P L E A +V + YLH
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL--G 123
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLS-------------------RIKHHTYLS----- 848
IV+RDLK N+L+ ++ + + DF LS R ++ S
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 849 -----SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN 896
S S GT E++APEV+ + D ++ G++L+E+ + P+KG N
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 31/99 (31%), Positives = 62/99 (62%), Gaps = 2/99 (2%)
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855
A ++A G+ +LH+ I++RDLK N+++D +K+ DFG+ + ++++ GT
Sbjct: 107 AAEIAIGLFFLHSK--GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT 164
Query: 856 PEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG 894
P+++APE++ +P + D ++FGV+L+E+ P+ G
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 69/220 (31%), Positives = 104/220 (47%), Gaps = 47/220 (21%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
QIGE G+YG+VY+A D G VA+KK LD + G ++ + E +I+ +L H N+
Sbjct: 14 QIGE----GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNI 68
Query: 752 VLFMGAVTRSPHFSILTEFLPR-GSLYRLLHRPNHQL--------------DERRRMRMA 796
V VT +F G+ Y + +H L + M+
Sbjct: 69 VNLKEIVTDK---QDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856
L+ G+NY H + +HRD+K N+L++ +K+ DFGL+R+ Y S +S T
Sbjct: 126 LE---GLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL----YNSEESRPYTN 176
Query: 857 E-----WMAPEVLRNE----PANEKCDVYSFGVILWELAT 887
+ + PE+L E PA DV+S G IL EL T
Sbjct: 177 KVITLWYRPPELLLGEERYGPA---IDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 44/282 (15%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRH 748
ED + + IG G++GEV T V K L + + + + E +I++
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
VV + + ++ EFLP G + LL + + +E + +A + ++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH- 118
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGL------------------------------ 838
+HRD+K NLL+D VK+ DFGL
Sbjct: 119 -QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 839 SRIKHHTYLSSK-----STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWK 893
S+ K T+ ++ ST GTP+++APEV N+ CD +S GVI++E+ P+
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 894 GLNPMQVVGAVGFQNRRLEIPDDI---DPAVAQIIRDCWQTE 932
P + V L P ++ + A I+R C + E
Sbjct: 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWE 279
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 699 RIGIGSYGEVYRAD--WHGTEVAVKKFLDQDFSGDSLSQFKCEAEI--MLRLR-HPNVVL 753
+IG G++ EV +A G A+K + + F SL Q EI + RL HPN++
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKC-MKKHF--KSLEQVNNLREIQALRRLSPHPNILR 62
Query: 754 FMGAVTRSPHFSILTEF-LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ + + F L +LY L+ L E+R + K ++++H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--RNG 120
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT-----YLSSKSTAGTPEWM-APE-VLR 865
I HRD+K N+L+ + ++K+ DFG R + Y+S++ W APE +L
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-------WYRAPECLLT 172
Query: 866 NEPANEKCDVYSFGVILWELATL 888
+ K D+++ G + +E+ +L
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSL 195
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 49/199 (24%), Positives = 102/199 (51%), Gaps = 7/199 (3%)
Query: 700 IGIGSYGEVYRADWHGT-EVAVKKFLDQD--FSGDSLSQFKCEAEIM-LRLRHPNVVLFM 755
+G GS+G+V A+ GT E+ K L +D D + E ++ L+ + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ E++ G L + + + E + + A +++ G+ +LH I++
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRR--GIIY 124
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDV 875
RDLK N+++D +K+ DFG+ + +++++ GTP+++APE++ +P + D
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 876 YSFGVILWELATLSVPWKG 894
+++GV+L+E+ P+ G
Sbjct: 185 WAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 739 EAEIMLRLRHPNVV-----LFMGAVT--RSPHFSILTEFLPRGSLYRLLHRPNHQLDERR 791
EA ++ + HP+V+ L GA+T PH+ LY L + + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY--------SSDLYTYLTKRSRPLPIDQ 158
Query: 792 RMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR--IKHHTYLSS 849
+ + + +G+ YLH I+HRD+K+ N+ ++ V + D G ++ + +L
Sbjct: 159 ALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG- 215
Query: 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWEL 885
AGT E APEVL + N K D++S G++L+E+
Sbjct: 216 --LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-12
Identities = 42/134 (31%), Positives = 75/134 (55%), Gaps = 5/134 (3%)
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS---SKSTAGTPEWMAPEVLRNEPA 869
++HRDLKS N+ + ++K+ DFG S+ ++ +S + S GTP ++APE+ +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929
++K D++S GVIL+EL TL P+KG + +++ V + P + + ++
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLL 307
Query: 930 QTEPHLRPSFAQLM 943
P LRP+ QL+
Sbjct: 308 SKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 66/254 (25%), Positives = 107/254 (42%), Gaps = 31/254 (12%)
Query: 700 IGIGSYGEVY--RADWHGTEVAVKKFLDQDF----SGDSLSQFKCEAEIMLRLRHPNVVL 753
+G G +GEV + G A KK LD+ G+ ++ E +I+ ++ +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALN--EKKILEKVSSRFIVS 57
Query: 754 FMGAVTRSPHFSILTEFLPRGSL-YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
A ++ + G L Y + + E R + A + G+ +LH
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR-- 115
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
IV+RDLK N+L+D + V++ D GL+ +K K AGTP +MAPEVL+ E +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 872 KCDVYSFGVILWELATLSVPWKG---------LNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
D ++ G L+E+ P++ L + AV E PD P
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV-------EYPDKFSPEAK 226
Query: 923 QIIRDCWQTEPHLR 936
+ Q +P R
Sbjct: 227 DLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 77/229 (33%)
Query: 695 QIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQ--FKCEAEIML--RLR- 747
+I +++G G+YG V++A VA+KK D F + +Q F+ EIM L
Sbjct: 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFR---EIMFLQELGD 65
Query: 748 HPNVV-------------LFMG---------AVTRSPHFSILTEFLPRGSLYRLLHRPNH 785
HPN+V +++ AV R+ +IL + R +Y+LL
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA---NILEDVHKRYIMYQLL----- 117
Query: 786 QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845
K + Y+H+ + ++HRDLK N+L++ + VK+ DFGL+R +
Sbjct: 118 ---------------KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----S 156
Query: 846 YLSSKSTAGTP--------EWM-APEVLRNEPANEKCDVYSFGVILWEL 885
+ P W APE+L Y+ GV +W +
Sbjct: 157 LSELEENPENPVLTDYVATRWYRAPEILL------GSTRYTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 20/251 (7%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVV 752
IG GSY +V TE V K+ ++ D + + + E + + HP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLV 59
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ E++ G L + R +E R A +++ +NYLH
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHER--G 116
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK 872
I++RDLK N+L+D +K+ D+G+ + ++ + GTP ++APE+LR E
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 873 CDVYSFGVILWELATLSVPWKGL----NPMQVVGAVGFQ---NRRLEIPDDIDPAVAQII 925
D ++ GV+++E+ P+ + NP Q FQ +++ IP + A ++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236
Query: 926 RDCWQTEPHLR 936
+ +P R
Sbjct: 237 KSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 37/220 (16%)
Query: 737 KCEAEIMLRLRH-PNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMR 794
+ E +++ +R P +V A ++ +++ G L+ L R + E R
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 795 MALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI-----KHHTYLSS 849
+ +A +++LH I++RD+K N+L+D V + DFGLS+ + Y
Sbjct: 112 AEIVLA--LDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--- 164
Query: 850 KSTAGTPEWMAPEVLRNEPA--NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ 907
S GT E+MAPEV+R ++ D +S GV+ +EL T G +P V G Q
Sbjct: 165 -SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT------GASPFTVDGE---Q 214
Query: 908 NRRLEI-----------PDDIDPAVAQIIRDCWQTEPHLR 936
N + EI P + I+ + +P R
Sbjct: 215 NSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 687 WEI--LWEDLQIGERIGIGSYGEV-YRADWH-GTEVAVKKFLDQDFSGDSLSQFKC-EAE 741
WE+ + DL+ ++G G+YG V D G +VA+KK L + F + ++ E
Sbjct: 11 WEVPDRYRDLK---QVGSGAYGTVCSALDRRTGAKVAIKK-LYRPFQSELFAKRAYRELR 66
Query: 742 IMLRLRHPNVVLFMGAVTRSPHFSILTEF---LP-RGS-LYRLLHRPNHQLDERRRMRMA 796
++ ++H NV+ + T +F +P G+ L +L+ + +L E R +
Sbjct: 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLV 124
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856
+ KG+ Y+H + I+HRDLK NL V+++ +K+ DFGL+R T T
Sbjct: 125 YQMLKGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTR 179
Query: 857 EWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKG 894
+ APEV+ N + D++S G I+ E+ T +KG
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 69/282 (24%), Positives = 119/282 (42%), Gaps = 44/282 (15%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRH 748
+D + + IG G++GEV T A+K D + ++ + E +I++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
VV + + ++ EFLP G + LL + + +E + +A + ++ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH- 118
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGL------------------------------ 838
+HRD+K NLL+D VK+ DFGL
Sbjct: 119 -QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 839 SRIKHHTYLSSK-----STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWK 893
S+ K T+ ++ ST GTP+++APEV N+ CD +S GVI++E+ P+
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 894 GLNPMQVVGAVGFQNRRLEIPDDI---DPAVAQIIRDCWQTE 932
P + V L P ++ + A I+R C +E
Sbjct: 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSE 279
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 700 IGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQ--FKCEAEIMLRLRHPNVVLFM 755
+G G+YG V A G +VA+KK L + F + ++ ++ E ++ ++H NV+ +
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKK-LSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80
Query: 756 GAVTRSPHFSILTEF---LP--RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
T + +F +P + L +++ H L E + + + G+ Y+H++
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSA- 136
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN-EPA 869
I+HRDLK NL V+++ +K+ DFGL+R H T + APEV+ N
Sbjct: 137 -GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILNWMHY 192
Query: 870 NEKCDVYSFGVILWELATLSVPWKG 894
N+ D++S G I+ E+ T +KG
Sbjct: 193 NQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 3/160 (1%)
Query: 737 KCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMA 796
K E I+ ++HP +V + A ++ E+L G L+ L R +++ ++
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856
+++ + +LH I++RDLK N+L+D VK+ DFGL + H + + GT
Sbjct: 108 -EISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI 164
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN 896
E+MAPE+L + D +S G +++++ T + P+ N
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 698 ERIGIGSYGEVYR--ADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
E++G GSY VY+ + +G VA+K Q+ G + + EA ++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLH 69
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ +++ E++ + P E ++ + + +G++Y+H + I+H
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQRY--ILH 126
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIK---HHTYLSSKSTAGTPEWMAPEVLRNEPANEK 872
RDLK NLL+ +K+ DFGL+R K HTY + T + P+VL
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTY---SNEVVTLWYRPPDVLLGSTEYST 183
Query: 873 C-DVYSFGVILWELATLSVPWKGLNPMQ 899
C D++ G I E+ + G+ +Q
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 2/110 (1%)
Query: 784 NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843
N E R + G+ +LH I++RDLK N+L+D + V++ D GL+
Sbjct: 91 NPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELK 148
Query: 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWK 893
+K AGTP +MAPE+L+ E + D ++ GV L+E+ P++
Sbjct: 149 DGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 62/207 (29%), Positives = 90/207 (43%), Gaps = 44/207 (21%)
Query: 698 ERIGIGSYGEVYRA--DWHGTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
E+IG G+YG VY+A G VA+KK LD + G + + E ++ L HPN+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKL 64
Query: 755 MGAVTRSPHFSILTEFL------------PRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
+ + ++ EFL G L+ QL +G
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL------------LQG 112
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGTPEWM 859
+ + H SH ++HRDLK NLL++ +K+ DFGL+R + TY T W
Sbjct: 113 LAFCH-SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL----WY 166
Query: 860 -APEVLRNEPANEKCDVYSFGVILWEL 885
APE+L C YS V +W L
Sbjct: 167 RAPEILLG------CKYYSTAVDIWSL 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 9e-12
Identities = 57/246 (23%), Positives = 97/246 (39%), Gaps = 49/246 (19%)
Query: 700 IGIGSYGEVYRADWHGTEV--AVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
IGIG++GEV T A+K D + + K E +I+ + VV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ + + +++P G + LL R ++ R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKM--GFIHR 125
Query: 817 DLKSPNLLVDKNWVVKVCDFGLS------------------------------------- 839
D+K N+L+D++ +K+ DFGL
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185
Query: 840 ------RIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWK 893
R + H + S GTP ++APEVL + CD +S GVIL+E+ P+
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
Query: 894 GLNPMQ 899
P +
Sbjct: 246 ADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 700 IGIGSYGEVYRA---DWHGTEVAVKKFLDQ-DFSGDSLSQFKCEAEIMLRLR---HPNVV 752
IG G+YG+V++A G VA+K+ Q G LS + E ++ L HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 753 LFMGAVT-----RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
T R +++ E + + L P + M + +G+++LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNE 867
SH +VHRDLK N+LV + +K+ DFGL+RI + S T + APEVL
Sbjct: 128 -SH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVVTLWYRAPEVLLQS 184
Query: 868 PANEKCDVYSFGVILWEL 885
D++S G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 38/121 (31%), Positives = 70/121 (57%), Gaps = 4/121 (3%)
Query: 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV 825
++T+++ G L+ L + ++R + +A ++ + +LH IV+RDLK N+L+
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD--IVYRDLKPENILL 129
Query: 826 DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK-CDVYSFGVILWE 884
D + +CDFGLS+ ++ + GT E++APEVL +E K D +S GV+++E
Sbjct: 130 DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 885 L 885
+
Sbjct: 190 M 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 11/133 (8%)
Query: 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPN 822
H I+ +++ G L+ LL + +L E ++ + + +N LH H I+H D+K N
Sbjct: 84 HVLIM-DYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLH-KH-NIIHNDIKLEN 139
Query: 823 LLVD-KNWVVKVCDFGLSRIKHHTYLSSKSTA-GTPEWMAPEVLRNEPANEKCDVYSFGV 880
+L D + +CD+GL +I + S GT ++ +PE ++ + D ++ GV
Sbjct: 140 VLYDRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGV 194
Query: 881 ILWELATLSVPWK 893
+ +EL T P+K
Sbjct: 195 LTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 700 IGIGSYGEV--YRADWHGTEVAVKKFLDQDF----SGDSLSQFKCEAEIMLRLRHPNVVL 753
+G G +GEV + G A KK LD+ SG+ ++ E EI+ ++ P +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALL--EKEILEKVNSPFIVN 57
Query: 754 FMGAVTRSPHFSILTEFLPRGSL-YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
A H ++ + G L Y + + L+ R + + + G+ +LH+
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM--D 115
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
IV+RD+K N+L+D ++ D GL+ +K ++ + AGT +MAPE+L+ EP +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--AGTNGYMAPEILKEEPYSY 173
Query: 872 KCDVYSFGVILWELATLSVPWK 893
D ++ G ++E+ P+K
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 72/257 (28%), Positives = 115/257 (44%), Gaps = 32/257 (12%)
Query: 715 GTEVAVKKFLDQDFSGDS--LSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI-LTEFL 771
G EVA+K L D + ++F+ E + RL HPN+V + + P + E++
Sbjct: 3 GHEVAIK-LLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV- 830
P +L +L + L R+ L V + H IVHRDLK N++V + V
Sbjct: 62 PGRTLREVL-AADGALPAGETGRLMLQVLDALACAHNQ--GIVHRDLKPQNIMVSQTGVR 118
Query: 831 --VKVCDFGLSRIKHHTYLSSKSTA-------GTPEWMAPEVLRNEPANEKCDVYSFGVI 881
KV DFG+ + + +T GTP + APE LR EP D+Y++G+I
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 882 LWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDD--IDPAVA-----QIIRDCWQTEPH 934
E T +G + +++ ++L P D + P +A Q++R +P
Sbjct: 179 FLECLTGQRVVQGASVAEIL------YQQLS-PVDVSLPPWIAGHPLGQVLRKALNKDPR 231
Query: 935 LRPSFA-QLMSRLRCLQ 950
R + A L R R L+
Sbjct: 232 QRAASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 695 QIGERIGIGSYGEV----YRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR--- 747
++ + +G G+YG V VA+KK + FS L++ + E+ L LR
Sbjct: 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKK-ITNVFSKKILAK-RALRELKL-LRHFR 59
Query: 748 -HPNVV-LF-MGAVTRSPHFSI-LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
H N+ L+ M V + L E L L++++ R L + + G+
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGL 118
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR------IKHHTYLSSKSTAGTPE 857
Y+H+++ ++HRDLK NLLV+ + +K+CDFGL+R ++ +++ T
Sbjct: 119 KYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA--TRW 174
Query: 858 WMAPEV-LRNEPANEKCDVYSFGVILWEL 885
+ APE+ L + + DV+S G IL EL
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 700 IGIGSYGEVYRA------DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIM-LRLRHPNVV 752
+G GS+G+V A + +V K + QD D + E I+ L HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD---DDVECTMTEKRILSLARNHPFLT 59
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ EF+ G L + H + + + DE R A ++ + +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDK-- 115
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
I++RDLK N+L+D K+ DFG+ + ++ + GTP+++APE+L+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 872 KCDVYSFGVILWELATLSVPWKGLN 896
D ++ GV+L+E+ P++ N
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 31/210 (14%)
Query: 698 ERIGIGSYGEVYRAD-WHGTEVA--VKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
+ IG G +G+V ++ + T VA V K L + S ++F + + L+HPN++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLL-----HRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+G + + ++ E+ G L L HR N QL +RM A ++A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMHKH 118
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGL--SRIKHHTYLSSKSTAGTP-EWMAPEVL-- 864
+ +H DL N + + VKV D+G+ SR K Y+ ++ P W+APE++
Sbjct: 119 N--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPELVGE 175
Query: 865 ---------RNEPANEKCDVYSFGVILWEL 885
+ +P+N V++ GV LWEL
Sbjct: 176 FHGGLITAEQTKPSN----VWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 63/197 (31%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 700 IGIGSYGEVYRA-DWH-GTEVAVKKFLDQ-DFSGDSLSQFKCEAEIMLRLR---HPNVVL 753
IG+G+YG VY+A D H G VA+K Q + G LS + E ++ RL HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIVR 66
Query: 754 FMGAVT-----RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
M R +++ E + + L P L + +G+++LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
+ IVHRDLK N+LV VK+ DFGL+RI + ++ T + APEVL
Sbjct: 127 N--CIVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRAPEVLLQST 183
Query: 869 ANEKCDVYSFGVILWEL 885
D++S G I E+
Sbjct: 184 YATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 63/268 (23%), Positives = 120/268 (44%), Gaps = 30/268 (11%)
Query: 698 ERIGIGSYGEVYRA---------DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH 748
E +G G++ ++++ + H TEV + K LD+ S S F+ A +M +L H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEV-LLKVLDKSHRNYSESFFEA-ASMMSQLSH 58
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
++VL G ++ E++ GSL L + + ++ ++ +A +A +++L
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 809 SHPTIVHRDLKSPNLLVDKNW--------VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMA 860
+ H ++ + N+L+ + +K+ D G+S T L + W+
Sbjct: 119 K--GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVP 172
Query: 861 PEVLRN-EPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
PE + N + + D +SFG LWE+ + P L+ + + F R ++P
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLPAPKW 229
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+A +I C EP RPSF ++ L
Sbjct: 230 TELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 700 IGIGSYGEVYRADWH--GTEVAVKK----FLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
IG G+ G V A G VA+KK F + + + + +M + H N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIG 79
Query: 754 FMGAVTRSPHFSILTEF--------LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
+ T P S L EF L +L +++ LD R + + G+ +
Sbjct: 80 LLNVFT--PQKS-LEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKH 133
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
LH++ I+HRDLK N++V + +K+ DFGL+R +++ + T + APEV+
Sbjct: 134 LHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVIL 190
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKG 894
E D++S G I+ E+ +V + G
Sbjct: 191 GMGYKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQ-DFSGDSLSQFKCEAEIMLRLRHPNV 751
+I E IG GSYG V A D H G +VA+KK D + D+ + E +++ LRHP++
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDI 61
Query: 752 V---LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
V M +R I F S + + N L + + + Y+HT
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWM--------- 859
++ + HRDLK N+L + + +K+CDFGL+R+ + T W
Sbjct: 122 AN--VFHRDLKPKNILANADCKLKICDFGLARV------AFNDTPTAIFWTDYVATRWYR 173
Query: 860 APEVL-----RNEPANEKCDVYSFGVILWELAT 887
APE+ + PA D++S G I E+ T
Sbjct: 174 APELCGSFFSKYTPA---IDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 55/247 (22%), Positives = 112/247 (45%), Gaps = 14/247 (5%)
Query: 692 EDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLD--QDFSGDSLSQFKCEAEIMLRLRH 748
ED +I + IG G++GEV + +V K L+ + + F+ E ++++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
+ A + ++ ++ G L LL + +L E ++ ++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWMAPEVLRNE 867
H VHRD+K N+L+D N +++ DFG ++ + S GTP++++PE+L+
Sbjct: 121 LH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 868 PANE-----KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP---DDIDP 919
+ +CD +S GV ++E+ P+ + ++ G + R + P D+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238
Query: 920 AVAQIIR 926
+IR
Sbjct: 239 DAKDLIR 245
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 698 ERIGIGSYGEVYRA-DWHGTE-VAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
E+IG G+YG VY+A D E +A+KK L+Q+ G + + E ++ ++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRL 66
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
V ++ E+L + P+ + R + +G+ Y H SH ++
Sbjct: 67 QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH-SH-RVL 124
Query: 815 HRDLKSPNLLVDK-NWVVKVCDFGLSR---IKHHTYLSSKSTAGTPEWM-APEVLR-NEP 868
HRDLK NLL+D+ +K+ DFGL+R I T+ T W APE+L +
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL----WYRAPEILLGSRH 180
Query: 869 ANEKCDVYSFGVILWELAT 887
+ D++S G I E+
Sbjct: 181 YSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 700 IGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVVLFMG 756
IG G+ G V A G VAVKK L + F + ++ ++L+ + H N++ +
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKK-LSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 87
Query: 757 AVTRSPHFSILTEF--------LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
T P S L EF L +L +++H +LD R + + G+ +LH+
Sbjct: 88 VFT--PQKS-LEEFQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHS 141
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
+ I+HRDLK N++V + +K+ DFGL+R ++ + T + APEV+
Sbjct: 142 A--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMG 198
Query: 869 ANEKCDVYSFGVILWELATLSVPWKG 894
E D++S G I+ EL SV ++G
Sbjct: 199 YKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 13/236 (5%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE-VAVKKFLD--QDFSGDSLSQFKCEAEIMLRLRH 748
+D +I + IG G++GEV TE + K L+ + + F+ E +++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
+ A + ++ ++ G L LL + +L E ++ ++ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFG--LSRIKHHTYLSSKSTAGTPEWMAPEVLRN 866
H VHRD+K N+L+D N +++ DFG L + T SS + GTP++++PE+L+
Sbjct: 121 LH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQA 177
Query: 867 E-----PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917
+CD +S GV ++E+ P+ + ++ G + R + P I
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 47/191 (24%), Positives = 91/191 (47%), Gaps = 6/191 (3%)
Query: 700 IGIGSYGEVYRADWHGTE-VAVKKFLDQDF--SGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
IG GS+G+V + T+ + K + + S ++ E ++ ++ P +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ ++ F+ G L+ L R + D R ++ + LH + +++R
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFN--VIYR 117
Query: 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVY 876
DLK N+L+D + +CDFGL ++ + + GTPE++APE+L + D +
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 877 SFGVILWELAT 887
+ GV+L+E+ T
Sbjct: 178 TLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 45/214 (21%)
Query: 698 ERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKC---EAEIMLRLRHPNVV 752
E IG G+YG V A G +VA+KK + D + K E +I+ +H N++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPH---AFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRL-----------LHRPNH--QLDERRRMRMAL-D 798
+I P G+ ++ LH H Q +R L
Sbjct: 68 ------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR------IKHHTYLSSKST 852
+ +G+ Y+H+++ ++HRDLK NLLV+++ +++ DFG++R +H +++
Sbjct: 116 LLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 853 AGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWEL 885
T + APE+L + P D++S G I E+
Sbjct: 174 --TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 69/255 (27%), Positives = 114/255 (44%), Gaps = 33/255 (12%)
Query: 700 IGIGSYGEVY---RADWHGTEVAVKKFLDQDF----SGDSLSQFKCEAEIMLRLRH---- 748
IG G +GEVY +AD G A+K LD+ G++L+ IML L
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMK-CLDKKRIKMKQGETLA---LNERIMLSLVSTGDC 56
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRM-ALDVAKGMNYLH 807
P +V A S + + + G L+ H H + MR A ++ G+ ++H
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL----SRIKHHTYLSSKSTAGTPEWMAPEV 863
+V+RDLK N+L+D++ V++ D GL S+ K H ++ GT +MAPEV
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEV 166
Query: 864 LRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGA-VGFQNRRLEIPDDIDPAV 921
L+ A + D +S G +L++L P++ +E+PD P +
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226
Query: 922 AQIIRDCWQTEPHLR 936
++ Q + + R
Sbjct: 227 RSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 43/176 (24%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV 825
++ E++ G L + R +E R A ++ +N+LH I++RDLK N+L+
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER--GIIYRDLKLDNVLL 129
Query: 826 DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWEL 885
D + +K+ D+G+ + ++ + GTP ++APE+LR E D ++ GV+++E+
Sbjct: 130 DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 886 ATLSVPWKGL--NPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
P+ + NP FQ + + IP + + +++ +P R
Sbjct: 190 MAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKC---EAE 741
WE+ E Q +G G+YG V A G VAVKK L + F S+ K E
Sbjct: 13 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQ--SIIHAKRTYRELR 68
Query: 742 IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALD--- 798
++ ++H NV+ + T + EF +Y + H L+ + + D
Sbjct: 69 LLKHMKHENVIGLLDVFTPARSLE---EF---NDVYLVTHLMGADLNNIVKCQKLTDDHV 122
Query: 799 ------VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST 852
+ +G+ Y+H++ I+HRDLK NL V+++ +K+ DFGL+R HT
Sbjct: 123 QFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 177
Query: 853 AGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELAT 887
T + APE++ N N+ D++S G I+ EL T
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 65/268 (24%), Positives = 123/268 (45%), Gaps = 39/268 (14%)
Query: 693 DLQIGERIGIGSYGEVY---RADWHGT------EVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+ ++ + +G G+YG+V+ + H T +V K L Q ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ--KAKTVEHTRTERNVL 58
Query: 744 LRLRH-PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
+R P +V A ++ +++ G ++ L++ ++ ++ R ++
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILA 117
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-----IKHHTYLSSKSTAGTPE 857
+ +LH IV+RD+K N+L+D V + DFGLS+ K TY S GT E
Sbjct: 118 LEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY----SFCGTIE 171
Query: 858 WMAPEVLRNEPANEKC-DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRL-- 911
+MAPE++R + + K D +S G++++EL T G +P + G Q +RR+
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLT------GASPFTLEGERNTQSEVSRRILK 225
Query: 912 ---EIPDDIDPAVAQIIRDCWQTEPHLR 936
P I P ++ + +P R
Sbjct: 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 715 GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774
G V V++ + + + ++ + E + HPN+V + ++T F+ G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 775 SLYRLLHRPNHQLDERRRMRMA---LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVV 831
S L+ H +D + +A V K ++Y+H H VHR +K+ ++L+ +
Sbjct: 85 SAKDLI--CTHFMDGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDG-- 138
Query: 832 KVCDFGL----SRIKHHTYLS-----SKSTAGTPEWMAPEVLRN--EPANEKCDVYSFGV 880
KV GL S I H L K + W++PEVL+ + + K D+YS G+
Sbjct: 139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198
Query: 881 ILWELATLSVPWKGLNPMQV 900
ELA VP+K + Q+
Sbjct: 199 TACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 700 IGIGSYGEVY---RADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
IG G +GEVY +AD G A+K + IML L F+
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 757 AVTRSPH----FSILTEFLPRGSLYRLLHRPNHQLDERRRMRM-ALDVAKGMNYLHTSHP 811
+T + H + + + G L+ H H + + MR A ++ G+ ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRFYATEIILGLEHMHNRF- 117
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGL----SRIKHHTYLSSKSTAGTPEWMAPEVLRNE 867
+V+RDLK N+L+D++ V++ D GL S+ K H ++ GT +MAPEVL+
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQKG 170
Query: 868 PA-NEKCDVYSFGVILWELATLSVPWK 893
A + D +S G +L++L P++
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 9e-10
Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 27/161 (16%)
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR--GSLYRLLHRPNHQLDERRR---- 792
EA I+ + HP+++ G T + LPR LY L +R
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYN---KFTCLILPRYKTDLY-------CYLAAKRNIAIC 182
Query: 793 --MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS----RIKHHTY 846
+ + V + + YLH + I+HRD+K+ N+ ++ V + DFG + I + Y
Sbjct: 183 DILAIERSVLRAIQYLHEN--RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT 887
AGT APE+L +P D++S G++L+E+AT
Sbjct: 241 YG---WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 700 IGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV----- 752
+G GS G V+ A VAVKK + D S+ E +I+ RL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 753 LFMGAVTRSPHFSILTEF--------LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMN 804
L + LTE L +L + L E + +G+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLK 128
Query: 805 YLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRI-----KHHTYLSSKSTAGTPEW 858
Y+H+++ ++HRDLK N+ ++ ++ V+K+ DFGL+RI H YLS T +
Sbjct: 129 YIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--TKWY 184
Query: 859 MAPEVLRNEPAN--EKCDVYSFGVILWELAT 887
+P +L + P N + D+++ G I E+ T
Sbjct: 185 RSPRLLLS-PNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 700 IGIGSYGEVYRADWHGTEVA-----VKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVL 753
IG GSY +V + T +KK L D + + + E + HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVND--DEDIDWVQTEKHVFETASNHPFLVG 60
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
+ EF+ G L + R +E R A +++ +N+LH I
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHER--GI 117
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKC 873
++RDLK N+L+D +K+ D+G+ + ++ + GTP ++APE+LR E
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 874 DVYSFGVILWELATLSVPWKGLNPMQVVGA 903
D ++ GV+++E+ G +P +VG
Sbjct: 178 DWWALGVLMFEMMA------GRSPFDIVGM 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 698 ERIGIGSYGEVYRAD--WHGTEVAVKK-FLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
E+IG G+YG+VY+A G VA+KK L+ D G + + E ++ L ++
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVR 65
Query: 755 MGAVTRS------PHFSILTEFLPRG------SLYRLLHRPNHQLDERRRMRMALDVAKG 802
+ V P ++ E+L S R RP L + + KG
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP---LPAKTIKSFMYQLLKG 122
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSR-----IKHHTYLSSKSTAGTP 856
+ + H H ++HRDLK NLLVDK ++K+ D GL R +K +T+ T
Sbjct: 123 VAHCH-KH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-----EIVTL 175
Query: 857 EWMAPEVLRNEPA-NEKCDVYSFGVILWELAT 887
+ APEVL + D++S G I E++
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 700 IGIGSYGEVYRADWHGT--EVAVKKFLDQ-DFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
IG G+YG V A T +VA+KK + D D+ + E +++ L H NV+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIA-IK 70
Query: 757 AVTRSPH---FS---ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+ PH F+ I+ E L L++++ R + L + + +G+ Y+H+++
Sbjct: 71 DIMPPPHREAFNDVYIVYE-LMDTDLHQII-RSSQTLSDDHCQYFLYQLLRGLKYIHSAN 128
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN-EPA 869
++HRDLK NLL++ N +K+CDFGL+R T + APE+L N
Sbjct: 129 --VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEY 186
Query: 870 NEKCDVYSFGVILWEL 885
DV+S G I EL
Sbjct: 187 TTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 46/193 (23%), Positives = 94/193 (48%), Gaps = 7/193 (3%)
Query: 698 ERIGIGSYGEVYRADWHGTE--VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+++G G+Y VY+ T+ VA+K+ + G + + E ++ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ +++ E+L + L + L + ++ + +G+NY H ++H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--KVLH 127
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEKCD 874
RDLK NLL+++ +K+ DFGL+R K + + T + P++L + + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 875 VYSFGVILWELAT 887
++ G I +E++T
Sbjct: 188 MWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 25/239 (10%)
Query: 720 VKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRL 779
V K LD +L+ F+ A +M ++ H ++ G R ++ EF+ G L
Sbjct: 48 VLKVLDPSHRDIALAFFET-ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 780 LHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV-------VK 832
L + ++ ++ +A +A ++YL +VH ++ + N+L+ + + +K
Sbjct: 107 LRKEKGRVPVAWKITVAQQLASALSYLEDK--NLVHGNVCAKNILLARLGLAEGTSPFIK 164
Query: 833 VCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN----EPANEKCDVYSFGVILWELA-T 887
+ D G+S T LS + W+APE + A +K +SFG L E+
Sbjct: 165 LSDPGVS----FTALSREERVERIPWIAPECVPGGNSLSTAADK---WSFGTTLLEICFD 217
Query: 888 LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
VP K P + F ++ +P+ +A +I C EP RPSF ++ L
Sbjct: 218 GEVPLKERTPSE---KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 700 IGIGSYGEV----YRADWHGTEVAVKKFLDQDFS---GDSLSQFKCEAEIMLRLRHPNVV 752
+G G +GEV RA G A KK + G+S++ E +I+ ++ VV
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMAL--NEKQILEKVNSRFVV 63
Query: 753 LFMGAVTRSPHFSILTEFLPRGSL-YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
A ++ + G L + + H +E R + A ++ G+ LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER- 122
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
IV+RDLK N+L+D + +++ D GL+ + + K GT +MAPEV++NE
Sbjct: 123 -IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 872 KCDVYSFGVILWELATLSVPWK 893
D ++ G +L+E+ P++
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 50/193 (25%), Positives = 93/193 (48%), Gaps = 7/193 (3%)
Query: 698 ERIGIGSYGEVYRADWHGTE--VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+++G G+Y V++ TE VA+K+ + G + + E ++ L+H N+V
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ +++ E+L L + N ++ M + +G++Y H I+H
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM-FQLLRGLSYCH--KRKILH 126
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEKCD 874
RDLK NLL+++ +K+ DFGL+R K + + T + P+VL + D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 875 VYSFGVILWELAT 887
++ G IL+E+AT
Sbjct: 187 MWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 3/111 (2%)
Query: 784 NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843
N +E R + A ++ G+ LH + V+RDLK N+L+D +++ D GL+ +K
Sbjct: 96 NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKI 152
Query: 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG 894
S + GT +MAPEVL N+ D + G +++E+ P++G
Sbjct: 153 PEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 700 IGIGSYGEV----YRADWHGTEVAVKKFLDQDFS---GDSLSQFKCEAEIMLRLRHPNVV 752
+G G +GEV RA G A KK + G++++ E +I+ ++ VV
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMAL--NEKQILEKVNSRFVV 63
Query: 753 LFMGAVTRSPHFSILTEFLPRGSL-YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
A ++ + G L + + + N DE R + A ++ G+ LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER- 122
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWMAPEVLRNEPAN 870
IV+RDLK N+L+D +++ D GL+ I + + GT +MAPEV++NE
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGRVGTVGYMAPEVVKNERYT 179
Query: 871 EKCDVYSFGVILWELATLSVPWKG 894
D + G +++E+ P++
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 65/289 (22%)
Query: 715 GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774
GT V V+ ++ + + L + E + RHPN++ T +++ F+ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 775 SLYRLL--HRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVK 832
S LL + P + E + +G+NYLH + +HR++K+ ++L+ + +V
Sbjct: 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN--GYIHRNIKASHILISGDGLVS 141
Query: 833 VCDFGLSRI--------KHHTY--LSSKSTAGTPEWMAPEVLRNEPA--NEKCDVYSFGV 880
+ GLS + K ST+ P W++PE+LR + N K D+YS G+
Sbjct: 142 LS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 881 ILWELATLSVPW-------------KGL--------------NPMQ-------------V 900
ELAT VP+ KG + M+ V
Sbjct: 199 TACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESV 258
Query: 901 VGAVGFQ---NRRLEIPDD--IDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
V A Q + RL P PA ++ C Q +P RPS + L+S
Sbjct: 259 VAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 698 ERIGIGSYGEVYR--ADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
E++G GSY VY+ + +G VA+K + G + + EA ++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLH 69
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ + + E++ ++ P R+ M + +G+ Y+H H I+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYIHGQH--ILH 126
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEKCD 874
RDLK NLL+ +K+ DFGL+R K + S T + P+VL + D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 875 VYSFGVILWEL 885
++ G I E+
Sbjct: 187 IWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 62/265 (23%), Positives = 107/265 (40%), Gaps = 53/265 (20%)
Query: 700 IGIGSYGEVYRADWHGTEV--AVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756
+GIG++GEV A T+ A+K +D + ++ K E +I+ + VV
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
+ + + +++P G + LL R ++ R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKM--GFIHR 125
Query: 817 DLKSPNLLVDKNWVVKVCDFGL-------------------------------------- 838
D+K N+L+D++ +K+ DFGL
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 839 -SRIK--------HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS 889
R+K H + S GTP ++APEVL + CD +S GVIL+E+
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
Query: 890 VPWKGLNPMQVVGAVGFQNRRLEIP 914
P+ P++ V L IP
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 47/193 (24%), Positives = 92/193 (47%), Gaps = 7/193 (3%)
Query: 698 ERIGIGSYGEVYRADWHGTE--VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
E++G G+Y V++ TE VA+K+ + G + + E ++ L+H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
V +++ E+L + L + + + + + +G+ Y H ++H
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--KVLH 127
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEKCD 874
RDLK NLL+++ +K+ DFGL+R K + + T + P+VL + + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 875 VYSFGVILWELAT 887
++ G I +E+A+
Sbjct: 188 MWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 67/278 (24%), Positives = 127/278 (45%), Gaps = 36/278 (12%)
Query: 700 IGIGSYGEVY---RADWHGT------EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH-P 749
+G G+YG+V+ + H + +V K + Q + + E +++ +R P
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ--KAKTTEHTRTERQVLEHIRQSP 65
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+V A ++ +++ G L+ L + + E+ + ++ + +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS-SKSTAGTPEWMAPEVLR-NE 867
I++RD+K N+L+D N V + DFGLS+ H + + S GT E+MAP+++R +
Sbjct: 125 --GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182
Query: 868 PANEKC-DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRL-----EIPDDID 918
++K D +S GV+++EL T G +P V G Q +RR+ P ++
Sbjct: 183 GGHDKAVDWWSMGVLMYELLT------GASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236
Query: 919 PAVAQIIRDCWQTEPHLR----PSFAQLMSRLRCLQRL 952
II+ +P R PS A + + Q++
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 698 ERIGIGSYGEVY--RADWHGTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
E++G G+Y VY R G VA+K+ LD + G + + E +M L+H N+V
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIR-EISLMKELKHENIVRL 63
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ--LDERRRMRMALDVAKGMNYLHTSHPT 812
+ ++ E++ L + + + LD + KG+ + H +
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGTPEWM-APEVLR-NE 867
++HRDLK NLL++K +K+ DFGL+R I +T+ + T W AP+VL +
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL----WYRAPDVLLGSR 176
Query: 868 PANEKCDVYSFGVILWELAT 887
+ D++S G I+ E+ T
Sbjct: 177 TYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 36/270 (13%)
Query: 698 ERIGIGSYGEVY----------RADWHGTEVAVK---KFLDQDFSGDSLSQFKCEAEIML 744
E +G G+ ++Y D + E +K K LD SL+ F+ A +M
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFET-ASMMR 59
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMN 804
++ H ++VL G R ++ EF+ G L +HR + L + ++A +A ++
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWV-------VKVCDFGLSRIKHHTYLSSKSTAGTPE 857
YL +VH ++ + N+L+ + + +K+ D G+ T LS +
Sbjct: 120 YLEDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TVLSRQECVERIP 173
Query: 858 WMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQ---VVGAVGFQNRRLEI 913
W+APE + + + D +SFG LWE+ + G P++ + F + +
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLKDKTLAEKERFYEGQCML 228
Query: 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+A ++ C +P+ RP F +M
Sbjct: 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 65/279 (23%), Positives = 110/279 (39%), Gaps = 57/279 (20%)
Query: 700 IGIGSYGEV---YRADWHGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+GIG++GEV + D H A+K +D + + ++ K E +I+ + VV
Sbjct: 9 LGIGAFGEVCLACKVDTHAL-YAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ + + +++P G + LL R + R +A ++ + +H +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKM--GFIH 124
Query: 816 RDLKSPNLLVDKNWVVKVCDFGL----------------SRI------------------ 841
RD+K N+L+D + +K+ DFGL S I
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 842 -------------KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL 888
K H + S GTP ++APEVL + + CD +S GVIL+E+
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 889 SVPWKGLNPMQVVGAVGFQNRRLEIPDDI--DPAVAQII 925
P+ P + V L IP + P +I
Sbjct: 245 QPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKC-EAEIMLRLRHPNV 751
++G IG GS+G VY A T +VA+KK L QD Q+K E IM L H N+
Sbjct: 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QD------PQYKNRELLIMKNLNHINI 121
Query: 752 VLF--------MGAVTRSPHFSILTEFLPRGSLYRLLH--RPNHQLDERRRMRMALDVAK 801
+ ++ +++ EF+P+ + H R NH L + + +
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFG-----LSRIKHHTYLSSKSTAGT 855
+ Y+H+ I HRDLK NLL+D N +K+CDFG L+ + +Y+ S+
Sbjct: 182 ALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF---- 235
Query: 856 PEWMAPEV-LRNEPANEKCDVYSFGVILWEL 885
+ APE+ L D++S G I+ E+
Sbjct: 236 --YRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 3/109 (2%)
Query: 786 QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845
+LD R + + G+ +LH++ I+HRDLK N++V + +K+ DFGL+R +
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG 894
++ + T + APEV+ E D++S G I+ E+ V + G
Sbjct: 180 FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 32/109 (29%), Positives = 58/109 (53%), Gaps = 3/109 (2%)
Query: 786 QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845
+LD R + + G+ +LH++ I+HRDLK N++V + +K+ DFGL+R +
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG 894
++ + T + APEV+ E D++S G I+ E+ + + G
Sbjct: 173 FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 39/144 (27%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 793 MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKS 851
M +A+D + Y VHRD+K N+L+DKN +++ DFG R+ + S
Sbjct: 111 MVLAIDSVHQLGY--------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV 162
Query: 852 TAGTPEWMAPEVLRNEPANE--------KCDVYSFGVILWELATLSVPWKGLNPMQVVGA 903
GTP++++PE+L+ A E +CD +S GV ++E+ P+ + ++ G
Sbjct: 163 AVGTPDYISPEILQ---AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219
Query: 904 VGFQNRRLEIPDDIDPAVAQIIRD 927
+ + P D V++ +D
Sbjct: 220 IMNHKEHFQFPPD-VTDVSEEAKD 242
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 15/197 (7%)
Query: 698 ERIGIGSYGEVYRADWHGTE--VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+++G GSY VY+ T VA+K+ + G + + EA ++ L+H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVH 815
+ +++ E+L L + + L + +G+ Y H ++H
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLH 126
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKH---HTYLSSKSTAGTPEWM-APEVLRNEPANE 871
RDLK NLL+ + +K+ DFGL+R K TY + T W P+VL
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL----WYRPPDVLLGSTEYS 182
Query: 872 KC-DVYSFGVILWELAT 887
D++ G I +E+AT
Sbjct: 183 TSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 784 NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843
N DE+R + A ++ G+ L IV+RDLK N+L+D +++ D GL+ ++
Sbjct: 96 NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLA-VQI 152
Query: 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWK 893
+ + GT +MAPEV+ NE D + G +++E+ P++
Sbjct: 153 PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 4e-07
Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 32/248 (12%)
Query: 680 MLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTE--VAVKKFLDQDFSGDSLSQFK 737
M G+ + E + ++ ++IG G +GEV+ T+ K + SQ
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 738 CEAEIMLRLRHPNVVLFMGAVTRSPH--FSILTEFLPRGSLYRLLHRPNH---QLDERRR 792
E +M L+H N+V ++ + IL EF G L R + + +++E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 793 MRMALDVAKGMNYLHT-----SHPTIVHRDLKSPNLLVDKNW-----------------V 830
+ + + + Y H + ++HRDLK N+ + +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 831 VKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA--NEKCDVYSFGVILWELATL 888
K+ DFGLS+ ++ S GTP + +PE+L +E ++K D+++ G I++EL +
Sbjct: 181 AKIGDFGLSKNIGIESMA-HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 889 SVPWKGLN 896
P+ N
Sbjct: 240 KTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 6/154 (3%)
Query: 692 EDLQIGERIGIGSYGEVY--RADWHGTEVAVKKFLDQDFSGDSL-SQFKCEAEIMLRLRH 748
E+ I + I G++G+VY R + AVK D ++ Q + E + + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
P +V ++ + + ++ E+L G + LLH + DE ++ +VA ++YLH
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH- 121
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842
H I+HRDLK N+L+ +K+ DFGLS++
Sbjct: 122 RH-GIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSG--DSLSQFKCEAEI 742
WE+ E Q +G G+YG V A +VAVKK L + F + ++ E +
Sbjct: 11 WEVP-ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKK-LSRPFQSLIHARRTYR-ELRL 67
Query: 743 MLRLRHPNVVLFMGAVTRSPHFSILTEF-----LPRGSLYRLLHRPNHQLDERRRMRMAL 797
+ ++H NV+ + T + E L L ++ +L + +
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIY 125
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE 857
+ +G+ Y+H++ I+HRDLK N+ V+++ +++ DFGL+R T
Sbjct: 126 QLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATRW 180
Query: 858 WMAPEVLRN-EPANEKCDVYSFGVILWEL 885
+ APE++ N N+ D++S G I+ EL
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVVLFM 755
G ++G G+YG VY+A + K++ + G +S C +LR L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDE-KEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 756 GAVTRSPHFSILTEF-LPRGSLYRLL--HRPNH------QLDERRRMRMALDVAKGMNYL 806
+ F L+ ++ HR + QL + + G++YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 807 HTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWM- 859
H + ++HRDLK N+LV + VK+ D G +R+ + L+ W
Sbjct: 125 HANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 860 APEVLRNEPANEKC-DVYSFGVILWELAT 887
APE+L K D+++ G I EL T
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-06
Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLP--RGSLYRLLHRPNHQLDERRRMRMA 796
EA ++ RL HP V+ + + LP R LY L L + +A
Sbjct: 210 EARLLRRLSHPAVLALLDV---RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST---- 852
+ ++Y+H I+HRD+K+ N+LV+ + + DFG + S ST
Sbjct: 267 RQLLSAIDYIHGE--GIIHRDIKTENVLVNGPEDICLGDFGAACFAR----GSWSTPFHY 320
Query: 853 --AGTPEWMAPEVLRNEPANEKCDVYSFGVILWELA 886
AGT + APEVL +P D++S G++++E A
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV--- 752
G ++G G+YG VY+A + + + + G +S C +LR L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 753 -LFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPNH------QLDERRRMRMALDVAKGM 803
+F+ R +L ++ L+ ++ HR + QL + + G+
Sbjct: 65 KVFLSHADRK--VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 804 NYLHTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPE 857
+YLH + ++HRDLK N+LV + VK+ D G +R+ + L+
Sbjct: 122 HYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 858 WM-APEVLRNEPANEKC-DVYSFGVILWELAT 887
W APE+L K D+++ G I EL T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 41/130 (31%), Positives = 59/130 (45%), Gaps = 15/130 (11%)
Query: 677 INPM-LGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDF 728
++PM L + WE+ ++L +G +G G++G V A HG +VAVK L
Sbjct: 21 VDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVK-MLKSTA 79
Query: 729 SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ- 786
E +IM L H N+V +GA T+ I+TE+ G L LHR H
Sbjct: 80 RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139
Query: 787 ----LDERRR 792
LD+ R
Sbjct: 140 LQYYLDKNRD 149
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-05
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 743 MLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
M +L+HPN+V +G ++ E++ +L +L L RR ++A+ +AK
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKA 792
Query: 803 MNYLHTS-HPTIVHRDLKSPNLLVDKNWVVKVCDF--GLSRIKHHTYLSSKSTAGTPEWM 859
+ +LH P +V +L +++D + GL ++SS ++
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA-------YV 845
Query: 860 APEVLRNEPANEKCDVYSFGVILWELAT 887
APE + EK D+Y FG+IL EL T
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLT 873
|
Length = 968 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYL-SSKSTAGTPEWMAPE 862
YLH I+HRD+K+ N+ +D+ + DFG + ++ H +GT E +PE
Sbjct: 200 YLHGR--GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE 257
Query: 863 VLRNEPANEKCDVYSFGVILWELATLSVPWKG 894
+L +P K D++S G++L+E++ +V G
Sbjct: 258 LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 28/100 (28%), Positives = 41/100 (41%), Gaps = 12/100 (12%)
Query: 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI 913
P +MAPEV++ + EK D+YS G+ L+E +P+ + + LEI
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL---------SAILEI 116
Query: 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953
+ PA R + R SF M C RL
Sbjct: 117 LLNGMPADDPRDRSNLEGVSAAR-SFEDFMR--LCASRLP 153
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 41/173 (23%), Positives = 67/173 (38%), Gaps = 27/173 (15%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKC 738
+WE ++LQ G+ +G G++G+V A G VAV K L D
Sbjct: 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAV-KMLKASAHTDEREALMS 90
Query: 739 EAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
E +I+ L +H N+V +GA T ++TE+ G L L +
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK-------------- 136
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850
A+ + P I N+ ++K ++ D G S TY+ +
Sbjct: 137 --AETFLNFVMALPEISETSSDYKNITLEKKYIRS--DSGFSSQGSDTYVEMR 185
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 41/139 (29%), Positives = 63/139 (45%), Gaps = 13/139 (9%)
Query: 677 INPM-LGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDF 728
++PM L + WE + L +G +G G++G+V +G +VAVK
Sbjct: 21 VDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR 80
Query: 729 SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH--RPNH 785
S + E +IM L H N+V +GA T+S I+TE+ G L LH R N
Sbjct: 81 SSEK-QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139
Query: 786 QLDERRRMRMALDVAKGMN 804
+ + LD+ G+N
Sbjct: 140 LSRHPEKPKKDLDIF-GIN 157
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 36/158 (22%), Positives = 65/158 (41%), Gaps = 24/158 (15%)
Query: 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSL------SQFKCEAEIMLRLRHPN 750
+ I G+ E+Y D+ G + +K + + + L + + EA IM R R
Sbjct: 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG 60
Query: 751 V---VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
V ++ F I+ E++ L L++ + E R + V K LH
Sbjct: 61 VNVPAVYFVDPEN---FIIVMEYIEGEPLKDLINSNGMEELELSR-EIGRLVGK----LH 112
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVC--DFGLSRIKH 843
++ I+H DL + N+++ K+ DFGL+
Sbjct: 113 SAG--IIHGDLTTSNMILSGG---KIYLIDFGLAEFSK 145
|
Length = 211 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 19/86 (22%), Positives = 26/86 (30%), Gaps = 1/86 (1%)
Query: 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816
L R L +L +R +A + L +VH
Sbjct: 111 EALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHG 170
Query: 817 DLKSPNLLVDKNWVVKVC-DFGLSRI 841
DL NLLVD V DF + +
Sbjct: 171 DLHPGNLLVDPGGRVTGVIDFEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 967 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.14 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.0 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 98.39 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 98.26 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.25 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 98.2 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.17 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.08 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.75 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.68 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.47 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.44 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.31 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.3 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.25 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.22 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.11 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.1 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.87 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.8 | |
| PF04473 | 153 | DUF553: Transglutaminase-like domain; InterPro: IP | 96.76 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.69 | |
| COG1305 | 319 | Transglutaminase-like enzymes, putative cysteine p | 96.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.44 | |
| PLN02236 | 344 | choline kinase | 96.31 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.27 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.01 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.61 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.54 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.37 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.01 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.0 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.49 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.2 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.15 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.04 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.01 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.74 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-63 Score=517.76 Aligned_cols=199 Identities=56% Similarity=0.952 Sum_probs=188.3
Q ss_pred hHHHHHHHhhhccccccCCcccCceeeeecccc---cccCCCCCCchhhhccccCCCCCcceEEEEeccCChhHHHHHHH
Q 037068 130 LVEFLSLRYWSYSAVNYDEKIVDGFYDVYGITS---NSVSQGKMPLLVDLQAISLSDNLDYEVIVVNRLVDPNLKELEKR 206 (967)
Q Consensus 130 ~~~~~s~~~w~~~~lsy~~~i~dGFYdi~~~~~---~~~~~~~iP~le~L~~~~~~~~~~~EvIlVDr~~D~~L~~l~~~ 206 (967)
++|++|+|||++|+|+|+||||||||||+|++. ..+++++||+|+||++++ .+++++|||||||++|++|++|+++
T Consensus 2 ~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~-~~~~~~EvIlVDr~~D~~L~~L~~~ 80 (204)
T PF14381_consen 2 SAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVP-PDDSSREVILVDRRRDPSLKELEQR 80 (204)
T ss_pred cHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCC-CCCCCeeEEEEccccCHHHHHHHHH
Confidence 689999999999999999999999999999974 246899999999999999 6788899999999999999999999
Q ss_pred HHhhhhccccccCCCcHHHHHHHHHHHHHHhcCCCCCCchhhhhhHHHHHHHHHHhhcCceeeeeecccccchhhHHHHH
Q 037068 207 AYNVSVECRYSDLGPILSGLIQKIADLVVERMGGPVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFK 286 (967)
Q Consensus 207 a~~~~~~~~~~~~~~~~~~~~~~la~lv~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~~~v~plg~l~~g~~~~~a~lfk 286 (967)
|++++..|.. +..+++++||++|+++|||++.+.+.....|+.++.+||+ +++|+|||+|++|+|||||||||
T Consensus 81 a~~~~~~~~~-----~~~~~v~~LA~lVa~~MGG~~~~~~~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFK 153 (204)
T PF14381_consen 81 AHELSKGLST-----NTKELVQKLAKLVADRMGGPVSDAEDMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFK 153 (204)
T ss_pred HHHHHhcccc-----CHHHHHHHHHHHHHHHhCCCCCcchhhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHH
Confidence 9999766652 3579999999999999999999999999999998888888 99999999999999999999999
Q ss_pred HHhhhcCCceeEeeccccccC-CCCceEEEEcCCCceeeeeccCCCCcccc
Q 037068 287 VLADRINLPCMLVKGSYYTGT-DDGAVNLIKLDNGSEYIIDLMGAPGTLIP 336 (967)
Q Consensus 287 ~~~d~~~~~~~lv~G~~y~~~-~~~a~~~v~~~~~~~~~~dlm~~pg~l~~ 336 (967)
+|||++||||+||||+|||++ ++++||+|++.+++|||||||++||+|+|
T Consensus 154 vLAD~iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 154 VLADRIGLPCRLVRGCYYCGWDDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred HHHHhcCCCceEEeeccCCccCCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 999999999999999999999 99999999999999999999999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=426.64 Aligned_cols=271 Identities=47% Similarity=0.817 Sum_probs=247.4
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecCCCe-EEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWHGTE-VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~-VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
...|.+...++.+.+.||.|+||+||+|.+.|+. ||||++.....+....+.|.+|+.+|++++|||||+|+|++.+..
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3456666677788888999999999999999999 999999887766666889999999999999999999999999987
Q ss_pred -ceEEEEeecCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-eEEEEecccc
Q 037068 763 -HFSILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-VVKVCDFGLS 839 (967)
Q Consensus 763 -~l~LVmEy~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-~VKLsDFGLA 839 (967)
.++|||||+++|+|.+++.. .+..+++..++.|+.||++||+|||++++ ||||||||+||||+.++ ++||+|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccc
Confidence 79999999999999999987 47889999999999999999999999943 99999999999999998 9999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLR--NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~--g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
+.............||+.|||||++. ...|+.|+||||||++||||+||+.||....+.++...+...+.++.+|..+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 98776544455578999999999999 5689999999999999999999999999999988888888889999999999
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
++.+..+|..||+.||..||++.+|+..|..+......
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999999999876654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=403.45 Aligned_cols=255 Identities=30% Similarity=0.469 Sum_probs=228.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc-eE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH-FS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~-l~ 765 (967)
+...+++..+.||+|..|+||+++++ ++.+|+|++ .-..+.....++.+|+++++..+||+||++|+.|..++. +.
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 44467788899999999999999885 778999998 344567778899999999999999999999999999984 99
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
|+||||++|+|..++... +.++|....+|+.+|++||.|||+.. +||||||||+||||+..|.|||||||.+....++
T Consensus 155 I~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~-~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEER-KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred eehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhcc-CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999999999864 67999999999999999999999743 7999999999999999999999999999988776
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChhHHHhhhhccccccCCCCC-CcH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL-----NPMQVVGAVGFQNRRLEIPDD-IDP 919 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~-----~~~ei~~~i~~~~~~~~ip~~-ls~ 919 (967)
...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||... +..+....|. .+..+.+|.. +++
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEFSP 309 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccCCH
Confidence 467899999999999999999999999999999999999999999874 5556666665 4566777876 999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
++..|+..||++||.+||++.|+++|-.-.
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 999999999999999999999999996544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=411.07 Aligned_cols=252 Identities=28% Similarity=0.450 Sum_probs=233.0
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.+|..++.||+|||..+|++++ +|..||+|++.+... +....+.+.+||+|.++|+|||||+|+++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999976 688999999987543 4456678999999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|+|..++|.+++++ .+.++|..++.++.||+.||.|||++ +|||||||..|+||+++.+|||+|||||.........
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~--~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSL--GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhc--CceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999999999984 67899999999999999999999999 6999999999999999999999999999988776667
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
..+.+|||-|.|||++.....+..+||||+||+||-|++|++||+..+..+....|. .....+|..++.+..+||+++
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHHHH
Confidence 888999999999999999999999999999999999999999999999888888875 345677889999999999999
Q ss_pred hhcCCCCCcCHHHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L~~ 948 (967)
|+.||.+|||+.+||.|-.-
T Consensus 253 L~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred hcCCcccCCCHHHHhcCHhh
Confidence 99999999999999998544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=392.42 Aligned_cols=251 Identities=24% Similarity=0.433 Sum_probs=227.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|++.+.||+|+||+||.++. +++.+|+|++.+.... ....+....|..||.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 47899999999999999999965 5788999999876543 34677899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
+||+.||.|..+|.+ ++.+++..+..++.+|+.||.|||++ |||||||||+|||||.+|+++|+|||+++.......
T Consensus 104 ld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~--gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSK--GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhC--CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999999999986 66799999999999999999999999 799999999999999999999999999997666666
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.+.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+..++.+.+. ..+....|..++.+.++++++
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~-~~k~~~~p~~ls~~ardll~~ 259 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL-KGKLPLPPGYLSEEARDLLKK 259 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh-cCcCCCCCccCCHHHHHHHHH
Confidence 6788999999999999999999999999999999999999999999999998888875 334455667799999999999
Q ss_pred hhhcCCCCCc----CHHHHHHH
Q 037068 928 CWQTEPHLRP----SFAQLMSR 945 (967)
Q Consensus 928 CLq~dPe~RP----S~~ELLe~ 945 (967)
+|+.+|++|. .+.+|..|
T Consensus 260 LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 260 LLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HhccCHHHhcCCCCChHHhhcC
Confidence 9999999995 56666655
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=407.68 Aligned_cols=262 Identities=35% Similarity=0.645 Sum_probs=237.0
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecCCC-eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~-~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
...|++..+.+++.+.||+|.||.||.|.+++. .||+|.+.....+ .+.|.+|+++|++|+|+|||++++++..++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 346777888889999999999999999999877 8999998765333 356779999999999999999999999988
Q ss_pred ceEEEEeecCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.++||||||..|+|.++|.. .+..+.....+.++.|||.||+||+++ .+|||||.++||||++++.+||+||||||.
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~--~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK--NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC--CccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999999999987 566789999999999999999999999 499999999999999999999999999997
Q ss_pred cccCcc-CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 842 KHHTYL-SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 842 ~~~~~~-~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
..+... ......-+..|.|||.+..+.++.|||||||||+||||+| |+.||.+....+++..+. .+.+++-|..||+
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPD 431 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCH
Confidence 655544 3444455779999999999999999999999999999999 899999999999998885 8899999999999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
++.++|..||+.+|++||||+.+...|..+..
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 99999999999999999999999999988754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=390.94 Aligned_cols=251 Identities=26% Similarity=0.496 Sum_probs=225.6
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.+|.+.++||.|+|++||+|++ ++..||||.+.+........+.+..|+.+|+.++|||||.+++++...+.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 6888999999999999999976 57899999998887788888999999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC------CeEEEEecccccccc
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN------WVVKVCDFGLSRIKH 843 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~------g~VKLsDFGLAr~~~ 843 (967)
||+||+|.+++.+ .+.+++..+..++.||+.||++||++ +||||||||.||||+.. -.+||+|||+||...
T Consensus 90 yC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~--~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHEN--NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999999987 44799999999999999999999999 59999999999999764 579999999999887
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc-CCCCCCcHHHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL-EIPDDIDPAVA 922 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~-~ip~~ls~eL~ 922 (967)
... ...+.+|+|.|||||+++.++|+.|+|+||+|+++|++++|+.||...+..+....+....... .++..+++.+.
T Consensus 167 ~~~-~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 167 PGS-MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred chh-HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence 553 4667899999999999999999999999999999999999999999999999888776544433 34556788888
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+++...++.+|.+|-++.+-+.+-
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhh
Confidence 999999999999998887766553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=384.56 Aligned_cols=254 Identities=27% Similarity=0.492 Sum_probs=224.4
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEee-eeeccCc-eEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG-AVTRSPH-FSI 766 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig-~~~~~~~-l~L 766 (967)
..+|++.++||.|+||+||++++ +|..+|.|.+.....+......+..|+.+|++|+|||||++++ .|.++.. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35788889999999999999976 6889999999876677777888999999999999999999999 4444444 999
Q ss_pred EEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--eEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 767 LTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPT--IVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~G--IVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
|||||.+|+|..+++. .+..++++.+|+++.|++.||..+|.+-+. |+||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999863 456799999999999999999999984334 99999999999999999999999999999
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC-CCCcHH
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP-DDIDPA 920 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip-~~ls~e 920 (967)
+........+.+|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.+.+-.+....|. ++.-.++| ...|.+
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-QGDYPPLPDEHYSTD 256 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-cCCCCCCcHHHhhhH
Confidence 9887777888999999999999999999999999999999999999999999998888877775 44445577 678999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+..+|..|+..||+.||+.-.++..
T Consensus 257 l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred HHHHHHHHccCCcccCCCcchHHHH
Confidence 9999999999999999985444433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=390.74 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=217.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChh-----hHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGD-----SLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~-----~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
..+.|.+.+.||+|+||.|-+|.. +++.||||++.+...... ....+.+|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 457889999999999999999954 689999999987654331 2234679999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC---CeEEEEecccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN---WVVKVCDFGLS 839 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~---g~VKLsDFGLA 839 (967)
..||||||+.||+|.+.+-. ++.+.+..-..++.|++.|+.|||++ ||+||||||+|||++.+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~--GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQ--GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHc--CcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999876 56688888899999999999999999 89999999999999765 89999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChhH-HHhhhhcccccc--CC
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRNEP---ANEKCDVYSFGVILWELATLSVPWKGLNPMQ-VVGAVGFQNRRL--EI 913 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g~~---~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e-i~~~i~~~~~~~--~i 913 (967)
+..... ....+.+|||.|.|||++.+.. +..++|+||+||+||-+++|.+||....... ..+++......+ ..
T Consensus 327 K~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 327 KVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 987743 4577899999999999997764 3347899999999999999999998776555 566665333322 33
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 914 p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
...++++..+||.+||..||++|||+.|+|+|-+
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 4678999999999999999999999999999854
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=372.48 Aligned_cols=262 Identities=31% Similarity=0.575 Sum_probs=217.0
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeee
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAV 758 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~ 758 (967)
|.+..++|++.++||+|+||.||+|.+ .++.||||++... ........+.+|+.+++++ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 667788999999999999999999963 2457999987643 2334456789999999999 899999999988
Q ss_pred ecc-CceEEEEeecCCCchhhhhcCCC-----------------------------------------------------
Q 037068 759 TRS-PHFSILTEFLPRGSLYRLLHRPN----------------------------------------------------- 784 (967)
Q Consensus 759 ~~~-~~l~LVmEy~~gGsL~~lL~~~~----------------------------------------------------- 784 (967)
... ..+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 45899999999999999886421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC--ccCCCCCCC
Q 037068 785 --------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--YLSSKSTAG 854 (967)
Q Consensus 785 --------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~--~~~~~~~~G 854 (967)
..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... ........+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC--CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 2477888999999999999999998 7999999999999999999999999999864322 112233456
Q ss_pred CCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 855 T~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
++.|+|||++.+..++.++|||||||++|||++ |..||......+........+.....|..+++.+.+++.+||+.||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 788999999999999999999999999999997 9999987654433333223444556678899999999999999999
Q ss_pred CCCcCHHHHHHHHHHHHH
Q 037068 934 HLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 934 e~RPS~~ELLe~L~~L~~ 951 (967)
++|||+.+|++.|+.+..
T Consensus 319 ~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 319 KERPTFSALVEILGDLLQ 336 (338)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=391.59 Aligned_cols=256 Identities=38% Similarity=0.692 Sum_probs=232.0
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
..|++.++....++-||.|+.|.||+|+.++..||||++... -..+|+-|++|+|+||+.|.|+|.....+
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 458888888888888999999999999999999999986432 23478889999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
|||||||..|.|...|+. +..++......|..+|+.||+|||.+ +|||||||.-||||+.+..|||+|||-++...+
T Consensus 188 CIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~h--KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLH--KIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHh--hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 999999999999999987 56788999999999999999999999 699999999999999999999999999987665
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
. .....++||..|||||+|++++.+.|+||||||||||||+||..||...+...++--+......+++|..+++-+.-|
T Consensus 265 ~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 265 K-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred h-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHH
Confidence 5 345679999999999999999999999999999999999999999999988777666666677889999999999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
|++||+-.|.+||+|.+|+.||......+
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 99999999999999999999998765443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=380.63 Aligned_cols=256 Identities=28% Similarity=0.457 Sum_probs=226.2
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC---hhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccC
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS---GDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSP 762 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s---~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~ 762 (967)
...+.|.+++.||+|+||+|++|.+ ++..||+|++.+.... ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457999999999999999999966 5889999966553221 234567788999999998 999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-CeEEEEecccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRI 841 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-g~VKLsDFGLAr~ 841 (967)
.+++||||+.+|+|.+++.+ .+.+.+..+..++.||+.|++|+|++ ||+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~--gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR--GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999988 78899999999999999999999999 89999999999999999 9999999999987
Q ss_pred cccCccCCCCCCCCCCccChhccccCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCC-c
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEP-AN-EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDI-D 918 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~-~s-~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~l-s 918 (967)
...........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...+...+ ......+|..+ +
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S 248 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLS 248 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCC
Confidence 743334567889999999999999977 75 7899999999999999999999998877776664 45677888888 9
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+++..|+++||..+|.+|+++.+|+.|=+--
T Consensus 249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~ 279 (370)
T KOG0583|consen 249 PEARSLIEKMLVPDPSTRITLLEILEHPWFQ 279 (370)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence 9999999999999999999999999664433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.33 Aligned_cols=257 Identities=33% Similarity=0.555 Sum_probs=219.9
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC--ceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP--HFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~--~l~LV 767 (967)
.+|..++.||+|+||.||++... |...|||.+.... ....+.+.+|+.+|++|+|||||+++|...... .++|.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45777899999999999999774 6899999876542 222677999999999999999999999854444 69999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-CCeEEEEeccccccccc--
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSRIKHH-- 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-~g~VKLsDFGLAr~~~~-- 844 (967)
|||+.+|+|.+++.+.+..+++..+..+..||+.||.|||++ |||||||||+||||+. ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~--g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK--GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999987655899999999999999999999988 8999999999999999 79999999999987653
Q ss_pred -CccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCC-CChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 -TYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKG-LNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 -~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~-~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
.........||+.|||||++.++ ....++|||||||++.||+||+.||.. .........+......+.+|..++++.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 22234467899999999999953 344699999999999999999999998 555555555655555668999999999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
++||++|+..+|++|||+.++|+|.......
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999998765433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=365.07 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=213.6
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+.|+...++|+|+||+||++++ +|+.||||+|.....+....+-..+||++|++|+|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4677788999999999999976 58899999998876666666778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
||+..-|.++ ......++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+||........-
T Consensus 82 ~~dhTvL~eL-e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDHTVLHEL-ERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecchHHHHHH-HhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9988655554 444567999999999999999999999995 9999999999999999999999999999877554445
Q ss_pred CCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh-------------------cccc
Q 037068 850 KSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG-------------------FQNR 909 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~-------------------~~~~ 909 (967)
...+.|.+|.|||++.| .+|...+|||++||++.||++|.+-|.+...-+.+..|. +.+.
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 56788999999999988 679999999999999999999999999876654433332 1122
Q ss_pred ccCCCC----------CCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 RLEIPD----------DIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 ~~~ip~----------~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+++.|+ .++..+.+|+.+||+.||.+|++-+|++.|
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 222221 356678999999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=384.70 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=226.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~ 765 (967)
-..+|.+++.||+|+|++|++|+. +++.||||++.++-. .+..++-+..|-.+|.+| +||+|++|+..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 447899999999999999999966 588999999866533 234456688899999999 8999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+|+||+++|+|.++|++ .+.|++..++.++.||+.||+|||++ |||||||||+|||||.++++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~--GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSN--GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhc--CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999987 46799999999999999999999999 8999999999999999999999999999875432
Q ss_pred ccC-----------C--CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC
Q 037068 846 YLS-----------S--KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE 912 (967)
Q Consensus 846 ~~~-----------~--~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ 912 (967)
... . ..++||-.|.+||++.+...++.+|||+|||+||.|+.|.+||.+.+...+.+.|. .....
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l~y~ 305 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--ALDYE 305 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--Hhccc
Confidence 221 1 45889999999999999999999999999999999999999999999888877774 45678
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+|+.+++...+||.++|..||.+|+|.++|.+|.
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 8999999999999999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=385.97 Aligned_cols=249 Identities=29% Similarity=0.511 Sum_probs=229.7
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|.+.+.||+|+||+||||+. +.+.||+|.+.+....+..+..+.+|++|++.|+|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5788899999999999999966 46679999998888788888999999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.| +|+.++.+ .+.++|..+..++.|++.||.|||++ +|+|||+||.|||+..++++|+||||+|+.+.......
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~--rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSN--RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhc--CcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9977 99999987 66799999999999999999999999 79999999999999999999999999999887766667
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
....|||.|||||+..+.+|+..+|+|||||++||+++|++||-.....+.+..|. ......|...+..+.+|+...|
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHHHh
Confidence 77889999999999999999999999999999999999999999888877777764 3455667799999999999999
Q ss_pred hcCCCCCcCHHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~L 946 (967)
++||.+|.++.+++.|-
T Consensus 236 ~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHP 252 (808)
T ss_pred hcChhhcccHHHHhcCh
Confidence 99999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=398.92 Aligned_cols=262 Identities=32% Similarity=0.592 Sum_probs=231.2
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeee
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV 758 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~ 758 (967)
..++...+.+..+.||+|.||+||+|+.. ...||||.+++.. +.+...+|.+|++++..|+|||||+|+|+|
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 34566778889999999999999999653 3469999986653 445678999999999999999999999999
Q ss_pred eccCceEEEEeecCCCchhhhhcCC---------C----CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE
Q 037068 759 TRSPHFSILTEFLPRGSLYRLLHRP---------N----HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV 825 (967)
Q Consensus 759 ~~~~~l~LVmEy~~gGsL~~lL~~~---------~----~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL 825 (967)
..++-+++|+|||..|||.+||... + .+++..+.+.|+.||+.||+||-++ .+|||||.++|+||
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~--~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH--HFVHRDLATRNCLV 636 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--cccccchhhhhcee
Confidence 9999999999999999999999642 1 2388999999999999999999999 49999999999999
Q ss_pred cCCCeEEEEeccccccccc-CccCCC-CCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHh
Q 037068 826 DKNWVVKVCDFGLSRIKHH-TYLSSK-STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVG 902 (967)
Q Consensus 826 d~~g~VKLsDFGLAr~~~~-~~~~~~-~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~ 902 (967)
.++..|||+||||+|.... .++... ...-..+||+||.|.-++++++||||||||+|||+++ |+.||.+...+++++
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 9999999999999986433 333333 4566789999999999999999999999999999999 899999999999999
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 903 AVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 903 ~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
.+. .+..++-|+.+|.++++||..||+.+|++||+|.||-..|.....
T Consensus 717 ~i~-~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 717 CIR-AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHH-cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 886 455589999999999999999999999999999999999987754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=356.49 Aligned_cols=249 Identities=22% Similarity=0.374 Sum_probs=216.6
Q ss_pred EEeecCCceEEEEeecCCCeEEEEEeecCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeeeec----cCceEEEEeecC
Q 037068 698 ERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSG-DSLSQFKCEAEIMLRLRHPNVVLFMGAVTR----SPHFSILTEFLP 772 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~-~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~----~~~l~LVmEy~~ 772 (967)
..||+|++|.||+|.++++.||||++....... ...+.+.+|+.++++++||||+++++++.+ ...+++||||+.
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 569999999999999999999999986543322 235678899999999999999999999876 346899999999
Q ss_pred CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCC
Q 037068 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST 852 (967)
Q Consensus 773 gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~ 852 (967)
+|+|.+++.+ ...+++...+.++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++..... ....
T Consensus 106 ~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~ 180 (283)
T PHA02988 106 RGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYT-NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKN 180 (283)
T ss_pred CCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcC-CCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccc
Confidence 9999999976 456899999999999999999999853 6889999999999999999999999999865432 2235
Q ss_pred CCCCCccChhcccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 037068 853 AGTPEWMAPEVLRN--EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQ 930 (967)
Q Consensus 853 ~GT~~YmAPE~l~g--~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq 930 (967)
.++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+.....++.+|..+++++.++|.+||+
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 68899999999976 6799999999999999999999999999887777766655556667777899999999999999
Q ss_pred cCCCCCcCHHHHHHHHHHHHH
Q 037068 931 TEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 931 ~dPe~RPS~~ELLe~L~~L~~ 951 (967)
.||++|||+.++++.|+.+..
T Consensus 261 ~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 261 HDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCcccCcCHHHHHHHHHHHHh
Confidence 999999999999999998853
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=382.27 Aligned_cols=251 Identities=26% Similarity=0.462 Sum_probs=227.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
....|...++||+|+.|.||.++. +++.||||++...... ..+-+.+|+.+|+.++|+|||++++.|...+.+++|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 346788889999999999999966 5778999998765433 345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
||||+||+|.+.+.. ..++|.++..|.+++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 349 MEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~--gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHAR--GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhc--ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999999874 4599999999999999999999998 899999999999999999999999999998887776
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-cccCCCCCCcHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-RRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-~~~~ip~~ls~eL~dLI~ 926 (967)
.....+|||+|||||+.....|++|.||||||++++||+-|++||-..++-+.+..+...+ ..+..|+.+++++++|+.
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 7788899999999999999999999999999999999999999999988888877776443 356678899999999999
Q ss_pred HhhhcCCCCCcCHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L 946 (967)
+||+.|+++|+++.|||+|-
T Consensus 505 ~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred HHhhcchhcCCCHHHHhcCh
Confidence 99999999999999999983
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=382.78 Aligned_cols=250 Identities=28% Similarity=0.478 Sum_probs=228.3
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecC-CCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQ-DFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~-~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
+-|++++.||.|+-|.|-.|++ +|+.+|||++.+. .........+.+||-||+.+.||||+++|++|+...++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578899999999999999987 7999999999876 455666778999999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+++|.|++++.. ++.+++..+.+++.||+.|+.|+|.. +|+||||||+|+|||..++|||+|||+|...... ..
T Consensus 92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~--~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAF--NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhh--cceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 99999999999976 66799999999999999999999999 5999999999999999999999999999866544 34
Q ss_pred CCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
..+.+|.|.|.+||++.|.+| +.++||||.||+||.|+||+.||++.+...++..+ +...+++|.++++++.+||++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHHH
Confidence 677899999999999999998 47899999999999999999999988888877766 566788999999999999999
Q ss_pred hhhcCCCCCcCHHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L~ 947 (967)
||..||.+|.|++||++|..
T Consensus 246 ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HhccCccccccHHHHhhCch
Confidence 99999999999999999964
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=376.34 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=215.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccC-ceE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSP-HFS 765 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~-~l~ 765 (967)
.-++|.+.++||.|+||.||+|+. ++..||||+++++-.+.+.. .-.+|++-|++|+ |||||+|.+++.+.. .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 347999999999999999999965 68889999998776554433 3457999999998 999999999999887 899
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+|||||+. +|+++++.++..|++..+..|+.||++||+|+|.+ |+.||||||+||||.....|||+|||+||.....
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~--GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH--GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc--CcccccCChhheEecccceeEecccccccccccC
Confidence 99999976 89999999999999999999999999999999999 8999999999999999999999999999976554
Q ss_pred ccCCCCCCCCCCccChhcc-ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc------------------
Q 037068 846 YLSSKSTAGTPEWMAPEVL-RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF------------------ 906 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l-~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~------------------ 906 (967)
.. -...+.|.+|+|||++ +...|+.+.|+|++||+++|+++-++-|.+.+..+.+..+..
T Consensus 164 pP-YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 PP-YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CC-cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 32 3457889999999986 566799999999999999999999999999877654444331
Q ss_pred -cccccC---------CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 907 -QNRRLE---------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 907 -~~~~~~---------ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.+.+++ +-...++++.+||.+||.+||.+|||+.|.++|-
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 011111 1124778999999999999999999999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=356.15 Aligned_cols=247 Identities=23% Similarity=0.411 Sum_probs=216.5
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||+|.++ ++.||+|++..... .......+.+|+.++++++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999774 78899999865432 2234566889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 99999999999876 45689999999999999999999998 7999999999999999999999999999765432
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....+|..+++.+.++|.+|
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHHHH
Confidence 234568999999999999999999999999999999999999999888777666553 234567788899999999999
Q ss_pred hhcCCCCCcC-----HHHHHHHH
Q 037068 929 WQTEPHLRPS-----FAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RPS-----~~ELLe~L 946 (967)
|+.||.+||+ +.++++|-
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCc
Confidence 9999999995 99999985
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=362.08 Aligned_cols=243 Identities=23% Similarity=0.429 Sum_probs=212.2
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
+.||+|+||.||+++. .++.||||++..... .......+.+|+.++++++||||+++++++...+.++|||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999975 578899999875422 2344567788999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCC
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG 854 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~G 854 (967)
+|..++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSC--DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 99998875 45789999999999999999999998 7999999999999999999999999999754333333445679
Q ss_pred CCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 037068 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPH 934 (967)
Q Consensus 855 T~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe 934 (967)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..+++++.++|.+||+.||+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999887776665553 234567888999999999999999999
Q ss_pred CCc-----CHHHHHHH
Q 037068 935 LRP-----SFAQLMSR 945 (967)
Q Consensus 935 ~RP-----S~~ELLe~ 945 (967)
+|| ++.++++|
T Consensus 236 ~R~~~~~~~~~~ll~h 251 (323)
T cd05571 236 QRLGGGPEDAKEIMEH 251 (323)
T ss_pred HcCCCCCCCHHHHHcC
Confidence 999 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=343.74 Aligned_cols=256 Identities=28% Similarity=0.469 Sum_probs=218.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
..++|++.+.||+|+||.||+|.+ .+..||+|.+... .+......+.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC-CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 346899999999999999999964 2457999987643 3334456788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+|+|.+++......+++..++.++.||+.||.|||++ |++||||||+|||++.++.+|++|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~--~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM--GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999987566789999999999999999999998 799999999999999999999999998765432
Q ss_pred Cc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 TY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
.. .......++..|+|||.+.+..++.++|||||||++||+++ |..||......+....+. .....+.|..++..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNLLH 238 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 21 11223345678999999999999999999999999999775 999999888777666554 3445567788999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+++.+||+.+|.+||++.+|++.|.++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=372.31 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=217.1
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--CceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l~LV 767 (967)
+.|+..++||+|+||.||+|++ +|+.||+|++......+.......+||.||++|+||||++|.+..... +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 5677789999999999999977 588899999998877777888899999999999999999999988775 689999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
+|||++ +|..++....-.|++.++..|+.||+.||+|+|.+ ||+|||||.+|||||++|.+||+|||||+++.....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~--gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR--GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc--CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 999987 89999998888999999999999999999999998 799999999999999999999999999997765432
Q ss_pred -CCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--------cccccCCC---
Q 037068 848 -SSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF--------QNRRLEIP--- 914 (967)
Q Consensus 848 -~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~--------~~~~~~ip--- 914 (967)
.....+.|.+|.|||++.|. .|+..+|+||.||||.||++|++.|.+.+..+.+..|-. .+....+|
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 24456789999999999886 599999999999999999999999999887665544421 01111111
Q ss_pred ----------------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 915 ----------------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 915 ----------------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..+++...+|+..+|..||.+|.|+.+.|++
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 2467788999999999999999999998865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=378.74 Aligned_cols=264 Identities=39% Similarity=0.676 Sum_probs=231.3
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
..+|++..+++.+...||+|.||+||+|++.| .||||++.......+..+.|++|+.++++-+|.||+-|.|++...+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 36799999999999999999999999999988 69999998888888899999999999999999999999999998876
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.||+.+|+|-+|+.+++.....|+....+.|+.||++||.|||.+ +|||||||..|||+.++++|||+|||++....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK--~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK--NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh--hhhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999999998888899999999999999999999999 59999999999999999999999999997543
Q ss_pred cCcc--CCCCCCCCCCccChhcccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc---ccCCCC
Q 037068 844 HTYL--SSKSTAGTPEWMAPEVLRN---EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR---RLEIPD 915 (967)
Q Consensus 844 ~~~~--~~~~~~GT~~YmAPE~l~g---~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~---~~~ip~ 915 (967)
-... ......|...|||||+++. .+|++.+||||||+|+|||+||..||...+.++++..+..... ...+-.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 3211 1223447778999999964 4789999999999999999999999997666666655543211 223345
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
.++.++++|+..||.+++++||.+.+||..|..+..
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 788899999999999999999999999999988876
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=377.27 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=227.5
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCc
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~ 763 (967)
.+..++|.+.+.||+|+||+|+++.. ++..+|||++++... ..+.++..+.|.+|+... +||+++.++.+|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34558999999999999999999977 467899999987753 567789999999999888 59999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+|+||||+.||++..+.+ ...+++..+..|+..|+.||+|||++ ||||||||.+|||||..|++||+||||++...
T Consensus 444 l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~--~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHEN--GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhc--CceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999999555544 46799999999999999999999999 79999999999999999999999999999766
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
.....+.+++|||.|||||++.+..|+..+|+|+|||+||||+.|..||.+.+.+++.+.|. .....+|..++.+..+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~ea~~ 597 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKEAIA 597 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHHHHH
Confidence 55557889999999999999999999999999999999999999999999999999999885 5567788899999999
Q ss_pred HHHHhhhcCCCCCcC-----HHHHHHH
Q 037068 924 IIRDCWQTEPHLRPS-----FAQLMSR 945 (967)
Q Consensus 924 LI~~CLq~dPe~RPS-----~~ELLe~ 945 (967)
+|+++|.++|++|.- +.+|.+|
T Consensus 598 il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHHhccCcccccCCCCCCchhhhhC
Confidence 999999999999973 5677766
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.89 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=217.7
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|.+.+.||+|+||.||+|++ .++.||||++..... .......+.+|+.++++++||||+++++++..++.+++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 47899999999999999999977 478899999865432 223456788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.....
T Consensus 97 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999999999876 45689999999999999999999998 7999999999999999999999999999865433
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..++..+.+||.+
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHHHH
Confidence 234578999999999999999999999999999999999999999888776665553 33566778899999999999
Q ss_pred hhhcCCCCCcC-----HHHHHHHH
Q 037068 928 CWQTEPHLRPS-----FAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RPS-----~~ELLe~L 946 (967)
||+.||.+|++ +.+++.|-
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCC
Confidence 99999999986 79999884
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=366.34 Aligned_cols=271 Identities=32% Similarity=0.509 Sum_probs=217.5
Q ss_pred cccchhhhhhccCCeeEeEEeecCCceEEEEeecCC-CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeee
Q 037068 680 MLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV 758 (967)
Q Consensus 680 ~l~~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g-~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~ 758 (967)
......++...+++|.-.+.||+|+||.||+|...+ +.||||++....... ..+|.+|+.++.+++|||+|+|+|||
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 345677888899999999999999999999998765 899999875433221 45699999999999999999999999
Q ss_pred eccC-ceEEEEeecCCCchhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhcC-CCeEEeccCCCcEEEcCCCeEEEEe
Q 037068 759 TRSP-HFSILTEFLPRGSLYRLLHRPNH-QLDERRRMRMALDVAKGMNYLHTSH-PTIVHRDLKSPNLLVDKNWVVKVCD 835 (967)
Q Consensus 759 ~~~~-~l~LVmEy~~gGsL~~lL~~~~~-~Lse~~i~~I~~QIa~aL~YLHs~n-~GIVHRDLKPsNILLd~~g~VKLsD 835 (967)
.+.+ +.+||+|||.+|+|.++|..... .++|..+++|+.++|+||+|||+.. +.||||||||+|||||++++.||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999987665 8999999999999999999999853 3699999999999999999999999
Q ss_pred cccccccccCccCCCCC-CCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH---HHhh---hhccc
Q 037068 836 FGLSRIKHHTYLSSKST-AGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ---VVGA---VGFQN 908 (967)
Q Consensus 836 FGLAr~~~~~~~~~~~~-~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e---i~~~---i~~~~ 908 (967)
||+|+............ .||.+|++||++..+..+.|+|||||||+|+||+||+.|.....+.. .... .....
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997554311112222 89999999999999999999999999999999999998877543111 1111 10011
Q ss_pred c-----ccCCC-CCCc-----HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 909 R-----RLEIP-DDID-----PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 909 ~-----~~~ip-~~ls-----~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
. ...+. ...+ ..+..+..+|++.+|+.||+|.|+++.|+.+...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 1 11222 2222 2356777899999999999999999988665433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=348.09 Aligned_cols=238 Identities=24% Similarity=0.462 Sum_probs=218.7
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|++.+.||.|+||+|.+++. .+..+|+|++.+... .-..++...+|..+|+.+.||+++++++.|.+...++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 46788899999999999999976 578899999876543 445677899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||.+||.|+.++++ .+.+++..+..++.||+.||+|||+. +|++|||||+|||||.+|++||+|||+|+.....
T Consensus 123 meyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~--~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSL--DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhc--CeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 999999999999987 56799999999999999999999999 6999999999999999999999999999877654
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
+-+.+|||.|+|||++....|+..+|.|+|||++|||+.|.+||...++.++.+.|. .....+|..+++++++|++.
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~--~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL--EGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH--hCcccCCcccCHHHHHHHHH
Confidence 456899999999999999999999999999999999999999999999998888874 55678899999999999999
Q ss_pred hhhcCCCCC
Q 037068 928 CWQTEPHLR 936 (967)
Q Consensus 928 CLq~dPe~R 936 (967)
+|+.|-.+|
T Consensus 275 LL~vD~t~R 283 (355)
T KOG0616|consen 275 LLQVDLTKR 283 (355)
T ss_pred HHhhhhHhh
Confidence 999999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.39 Aligned_cols=254 Identities=25% Similarity=0.431 Sum_probs=221.9
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.+-.++|++++.||+|+||.||+|+. +|..+|+|++.+... ....++.+..|..+|....++.||+|+..|++...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34558999999999999999999965 688999999987654 456678899999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
||||||++||++..+|.+ ...|++.++..++.+++.|++.||+. |+|||||||+|+|||..|++||+||||+.-...
T Consensus 217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~--gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQL--GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHc--CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999999976 56799999999999999999999999 799999999999999999999999999853110
Q ss_pred -----------------------CccC------------------------CCCCCCCCCccChhccccCCCCchhHHHH
Q 037068 845 -----------------------TYLS------------------------SKSTAGTPEWMAPEVLRNEPANEKCDVYS 877 (967)
Q Consensus 845 -----------------------~~~~------------------------~~~~~GT~~YmAPE~l~g~~~s~ksDVWS 877 (967)
.... ....+|||.|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 01245999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCc---CHHHHHHH
Q 037068 878 FGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD--DIDPAVAQIIRDCWQTEPHLRP---SFAQLMSR 945 (967)
Q Consensus 878 LGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CLq~dPe~RP---S~~ELLe~ 945 (967)
||||||||+.|.+||...++.+....|......+..|. .++++.++||.+||. ||++|. .++||.+|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999999999999988875555566664 578999999999999 999996 57777776
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=346.80 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=209.8
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
|++.+.||+|+||.||++.. +++.||+|++...... ......+.+|+.++++++|+||+++++++.+.+.+++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 77889999999999999976 5889999988654322 22334578899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 771 LPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
+.+|+|..++... ...+++..++.++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE--RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-ee
Confidence 9999998887543 34689999999999999999999998 79999999999999999999999999998654322 23
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh--ccccccCCCCCCcHHHHHHHHH
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG--FQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~--~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .......++..+++++.+|+++
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 34578999999999999999999999999999999999999998765432221111 1233445677899999999999
Q ss_pred hhhcCCCCCcC-----HHHHHHH
Q 037068 928 CWQTEPHLRPS-----FAQLMSR 945 (967)
Q Consensus 928 CLq~dPe~RPS-----~~ELLe~ 945 (967)
||+.||++||+ ++++++|
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999997 8999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.31 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=217.4
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.+|...++||+|.||.||+|++ +|+.||||++...+..........+||+.|+.++|+||+.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999977 58899999998877666666778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
||+. +|...++.....++..++..|+.++++||+|||++ .|+||||||.|+||+.+|.+||+|||+|+.+.......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~--~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK--WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh--hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 9965 89999999888999999999999999999999999 69999999999999999999999999999988766555
Q ss_pred CCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--------ccc-----------
Q 037068 850 KSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF--------QNR----------- 909 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~--------~~~----------- 909 (967)
...+.|.+|.|||++.|. .|+..+|+||.||++.||+.|.+-|.+.+.-+.+..+-. ++.
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 556889999999999876 499999999999999999999988888765544433220 000
Q ss_pred -ccCCC------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 -RLEIP------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 -~~~ip------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..+.| ...+.++.+|+.++|.+||.+|+++.|.++|=
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 00101 13467789999999999999999999999873
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=357.10 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=214.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||+|++ .++.||||++..... .......+.+|+.+++.++||||+++++++...+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999977 478899999875432 2234567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+++++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHEL--GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 99999999999975 45689999999999999999999998 799999999999999999999999999976544 2
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC------CCCcHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP------DDIDPAVA 922 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip------~~ls~eL~ 922 (967)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........| ..+++++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 345679999999999999999999999999999999999999999888777655544222222222 25689999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++|.+||..+|.+||++.++++|-
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCc
Confidence 999999999999999999999883
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=374.88 Aligned_cols=269 Identities=30% Similarity=0.599 Sum_probs=240.6
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC--C---Ce-EEEEEeecC-CCChhhHHHHHHHHHHHHHcCCCceeEEeee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH--G---TE-VAVKKFLDQ-DFSGDSLSQFKCEAEIMLRLRHPNVVLFMGA 757 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~--g---~~-VAVKkl~~~-~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~ 757 (967)
..|++.+++..+.++||+|+||.||+|+.+ + .. ||||..... ........++.+|.++|++++|||||+|||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 579999999999999999999999999663 1 13 899987653 3567788899999999999999999999999
Q ss_pred eeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 758 VTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 758 ~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
+....-++||||+|+||+|.++|.+....++..+...++.+.+.||+|||++ .+|||||.++|+|++.++.+||+|||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k--~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK--NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC--CCcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999999998777799999999999999999999999 59999999999999999999999999
Q ss_pred cccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCC
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDD 916 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ 916 (967)
+++.................|+|||.+....|+.++|||||||++||+++ |..||.+....++...+...+.+.+.|..
T Consensus 308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~ 387 (474)
T KOG0194|consen 308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK 387 (474)
T ss_pred cccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence 99865422221212346779999999999999999999999999999999 78899999999999888778899999999
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
.+.++..++.+||..+|++||+|.++.+.|..+......
T Consensus 388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 388 TPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999999999766553
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=359.67 Aligned_cols=251 Identities=26% Similarity=0.465 Sum_probs=216.8
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSG-DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~-~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|.+.+.||+|+||.||+|++. ++.||||++....... .....+..|+.+++.++|+||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999774 8899999987543222 44567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-- 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-- 846 (967)
||+.+++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999998764 6799999999999999999999997 79999999999999999999999999998654432
Q ss_pred ---------------------------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH
Q 037068 847 ---------------------------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ 899 (967)
Q Consensus 847 ---------------------------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e 899 (967)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12334569999999999999999999999999999999999999999888776
Q ss_pred HHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCcC-HHHHHHHH
Q 037068 900 VVGAVGFQNRRLEIPD--DIDPAVAQIIRDCWQTEPHLRPS-FAQLMSRL 946 (967)
Q Consensus 900 i~~~i~~~~~~~~ip~--~ls~eL~dLI~~CLq~dPe~RPS-~~ELLe~L 946 (967)
....+........+|. .+++++.++|.+||. +|.+||+ +.++++|.
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 6665544223333443 469999999999997 9999999 99999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=344.99 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=207.6
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||+++++ ++.||||++..........+.+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999774 6789999987654444556678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-cC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-LS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-~~ 848 (967)
|+.++.+..+... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKN--DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9998877655443 45689999999999999999999998 79999999999999999999999999998654322 12
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc--------------c---ccc
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ--------------N---RRL 911 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~--------------~---~~~ 911 (967)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+... . ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23456899999999999989999999999999999999999999876654332221100 0 000
Q ss_pred C-------------CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 E-------------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 ~-------------ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. ....++.++.+||.+||+.||++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 112368889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.35 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=220.9
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
..|....++|++.+.||.|.-++||+|++ ++..||||++.-.+++.. ++.+.+|+..|+.++||||++++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 34556668999999999999999999987 578899999977766555 789999999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.+++||.||.+|++.++++.. ...++|..+..|++++++||.|||++ |.||||||+.||||+.+|.|||+|||.+..
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~--G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN--GHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc--CceecccccccEEEcCCCcEEEcCceeeee
Confidence 999999999999999999763 34699999999999999999999999 899999999999999999999999998764
Q ss_pred cccCccC---C-CCCCCCCCccChhcccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc----
Q 037068 842 KHHTYLS---S-KSTAGTPEWMAPEVLRN--EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL---- 911 (967)
Q Consensus 842 ~~~~~~~---~-~~~~GT~~YmAPE~l~g--~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~---- 911 (967)
+.+.... . ..+.||+.|||||++.. .-|+.|+||||||++.+||.+|..||..+.+.+++-... ++..+
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t 254 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLT 254 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCccc
Confidence 4332221 1 55689999999999643 359999999999999999999999999999998765433 22221
Q ss_pred -CCC----CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 912 -EIP----DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 912 -~ip----~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.++ +.++..++.++..||++||.+|||++++++|=
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 111 24677899999999999999999999999983
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.99 Aligned_cols=244 Identities=23% Similarity=0.423 Sum_probs=211.2
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
+.||+|+||.||+++. .++.||+|++..... .......+.+|+.+++.++||||+++++++...+.++|||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999976 578999999875422 2334566788999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCC
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG 854 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~G 854 (967)
+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 99988865 45689999999999999999999998 7999999999999999999999999998754333333345679
Q ss_pred CCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 037068 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPH 934 (967)
Q Consensus 855 T~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe 934 (967)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..+++++.++|.+||+.||+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999887776665553 234567788999999999999999999
Q ss_pred CCc-----CHHHHHHHH
Q 037068 935 LRP-----SFAQLMSRL 946 (967)
Q Consensus 935 ~RP-----S~~ELLe~L 946 (967)
+|+ ++.++++|-
T Consensus 236 ~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 236 QRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HhCCCCCCCHHHHHcCC
Confidence 998 899999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=394.15 Aligned_cols=260 Identities=34% Similarity=0.583 Sum_probs=229.7
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC---CC----eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH---GT----EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~---g~----~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
+.....++.+.||+|.||.||+|... +. .||||.+.+. .+.+....|.+|..+|++++|||||+++|++.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 34577888999999999999999763 32 4899987543 4677888999999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEe
Q 037068 762 PHFSILTEFLPRGSLYRLLHRP------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsD 835 (967)
...+|++|||.+|+|..+|++. ...++..+.+.++.||++|++||+++ ++|||||.++|+||+....|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~--~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK--HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC--CCcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999999876 56799999999999999999999999 599999999999999999999999
Q ss_pred cccccc-cccCccCCCCC-CCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccC
Q 037068 836 FGLSRI-KHHTYLSSKST-AGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLE 912 (967)
Q Consensus 836 FGLAr~-~~~~~~~~~~~-~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ 912 (967)
|||||. +...++..... .....|||||.+..+.++.|+|||||||+|||++| |..||...++.++...+...+ +++
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence 999994 34444433333 45679999999999999999999999999999999 899999999998887665444 999
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
.|..|+..++++|.+||+.+|++||+|..|++.+..+.+-
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 9999999999999999999999999999999988777543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=345.99 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=208.0
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.++||.|+||.||+|.. +++.||+|++.... .......+.+|+.++++++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 36899999999999999999966 57889999886443 2223456778999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+ +|.+++......+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR--KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99975 89888876566689999999999999999999998 7999999999999999999999999999765444333
Q ss_pred CCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-----------------cc
Q 037068 849 SKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-----------------RR 910 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-----------------~~ 910 (967)
.....+++.|+|||++.+ ..++.++|||||||++|+|+||+.||...+..+....+.... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 445678999999999876 568999999999999999999999998877655443321100 00
Q ss_pred c-----------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 911 L-----------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 911 ~-----------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. .....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0112467899999999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=353.73 Aligned_cols=241 Identities=23% Similarity=0.397 Sum_probs=209.7
Q ss_pred eecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 700 IGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 700 LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
||+|+||.||++++ +++.||+|++.... ........+..|+.++++++||||+++++++...+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999976 47789999986532 2334556788899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCC
Q 037068 777 YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856 (967)
Q Consensus 777 ~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~ 856 (967)
.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............||+
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKF--NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 999875 45689999999999999999999998 799999999999999999999999999986443333344567999
Q ss_pred CccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 037068 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936 (967)
Q Consensus 857 ~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~R 936 (967)
.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++++.++|.+||+.||.+|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 9999999999999999999999999999999999999887776665543 34556778899999999999999999999
Q ss_pred c---CHHHHHHH
Q 037068 937 P---SFAQLMSR 945 (967)
Q Consensus 937 P---S~~ELLe~ 945 (967)
| ++.+++.|
T Consensus 236 ~~~~~~~e~l~h 247 (312)
T cd05585 236 LGYNGAQEIKNH 247 (312)
T ss_pred CCCCCHHHHHcC
Confidence 7 47888877
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=342.13 Aligned_cols=254 Identities=32% Similarity=0.596 Sum_probs=217.1
Q ss_pred cCCeeEeEEeecCCceEEEEeecCC-------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~g-------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
.++|++.+.||+|+||.||+|...+ ..|++|.+... ........+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 3578899999999999999997532 45899987543 234455678999999999999999999999999889
Q ss_pred eEEEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC
Q 037068 764 FSILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN 828 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~ 828 (967)
.+++|||+.+++|.+++.... ..+++..++.++.||+.||.|||++ |++||||||+||+++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~--~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH--HFVHRDLAARNCLVGEG 160 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccccceEEEcCC
Confidence 999999999999999986421 4578899999999999999999998 79999999999999999
Q ss_pred CeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhh
Q 037068 829 WVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVG 905 (967)
Q Consensus 829 g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~ 905 (967)
+.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999997543321 12334456889999999998899999999999999999998 999999888877766654
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
.......|..+++++.+|+.+||+.+|.+||++.+|+++|+.
T Consensus 241 -~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 -SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 334455678899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=350.49 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=213.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|++.+.||+|+||.||++++. +..+|+|.+... ........+.+|++++++++||||+++++++..++.+++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4579999999999999999999774 678999987543 2344556799999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred eecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999999876 346899999999999999999999864 6999999999999999999999999999765432
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc---------------------
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF--------------------- 906 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~--------------------- 906 (967)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 23445799999999999999999999999999999999999999987665443322110
Q ss_pred ------------------------cccccCCC-CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 907 ------------------------QNRRLEIP-DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 907 ------------------------~~~~~~ip-~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
.......+ ..+++++.+||.+||+.||++|||+.+|++|..-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00011111 2467899999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.15 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=209.5
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC------------------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH------------------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~------------------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI 751 (967)
..++|.+.++||+|+||.||++.+. +..||+|.+... ........+.+|+.++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCe
Confidence 3478999999999999999999642 236999987643 234455678999999999999999
Q ss_pred eEEeeeeeccCceEEEEeecCCCchhhhhcCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCe
Q 037068 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN------------------HQLDERRRMRMALDVAKGMNYLHTSHPTI 813 (967)
Q Consensus 752 VkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~------------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GI 813 (967)
+++++++...+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ ||
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i 159 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--NF 159 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--Cc
Confidence 999999999999999999999999999885421 2467788999999999999999998 79
Q ss_pred EEeccCCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh--CC
Q 037068 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT--LS 889 (967)
Q Consensus 814 VHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT--Gk 889 (967)
+||||||+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999997653321 12233456789999999999999999999999999999987 56
Q ss_pred CCCCCCChhHHHhhhhc------cccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 890 VPWKGLNPMQVVGAVGF------QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 890 ~PF~~~~~~ei~~~i~~------~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.||......+....+.. .......+..++..+.++|.+||+.+|++|||+.+|.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 78988776655443321 11122345678899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=355.38 Aligned_cols=244 Identities=23% Similarity=0.419 Sum_probs=211.6
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
+.||+|+||.||+++. .++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 578999999875432 2344567888999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCC
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG 854 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~G 854 (967)
+|..++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 99988865 45689999999999999999999998 7999999999999999999999999998754333223345679
Q ss_pred CCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 037068 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPH 934 (967)
Q Consensus 855 T~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe 934 (967)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....+|..+++++.++|.+||+.||+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 999999999999999999999999999999999999998887766655543 334567888999999999999999999
Q ss_pred CCc-----CHHHHHHHH
Q 037068 935 LRP-----SFAQLMSRL 946 (967)
Q Consensus 935 ~RP-----S~~ELLe~L 946 (967)
+|+ ++.++++|-
T Consensus 236 ~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 236 KRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HcCCCCCCCHHHHhcCC
Confidence 997 899999883
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=341.37 Aligned_cols=248 Identities=35% Similarity=0.665 Sum_probs=210.1
Q ss_pred eEeEEeecCCceEEEEeecC------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 695 QIGERIGIGSYGEVYRADWH------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~~------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.+.+.||.|.||.||+|.+. +..|+||.+.. .......+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999776 56799999844 234455788999999999999999999999999888899999
Q ss_pred eecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc--C
Q 037068 769 EFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH--T 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~--~ 845 (967)
||+.+|+|.+++... ...+++..++.|+.||+.||.|||++ +++|+||+++|||++.++.+||+|||+++.... .
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN--NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT--TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccc
Confidence 999999999999875 56799999999999999999999998 699999999999999999999999999986622 1
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
............|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+ ....+...+..++..+.++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHH
Confidence 122333456779999999999999999999999999999999 78999999888877776 4566677788899999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L 946 (967)
|.+||..+|++||++.+|++.|
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.74 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=211.3
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHH---HcCCCceeEEeeeeeccCceEEE
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIML---RLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk---~L~HpNIVkLig~~~~~~~l~LV 767 (967)
|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+.+|++++. .++||||+++++++...+.+++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999976 478899999875432 2234456777776654 56799999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+++|..++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~--~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN--KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999988764 4699999999999999999999998 799999999999999999999999999875443333
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.. .....|..+++.+.++|.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPRFLSREAISIMRR 234 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHH
Confidence 34556799999999999999999999999999999999999999998887776665532 3445678899999999999
Q ss_pred hhhcCCCCCc-----CHHHHHHHH
Q 037068 928 CWQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RP-----S~~ELLe~L 946 (967)
||+.||.+|| ++.++++|-
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHHhhCC
Confidence 9999999999 688888874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=358.32 Aligned_cols=252 Identities=23% Similarity=0.422 Sum_probs=218.5
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC---CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~---g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
.....++|++.+.||+|+||.||+|.++ +..||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3445678999999999999999999753 25799998865432 2334567889999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSL--NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999999876 45689999999999999999999998 7999999999999999999999999999765
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+. .....+|..+++.+.
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~ 256 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNNCK 256 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHH
Confidence 432 234679999999999999989999999999999999999999999887766665553 234456788999999
Q ss_pred HHHHHhhhcCCCCCc-----CHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 923 dLI~~CLq~dPe~RP-----S~~ELLe~L 946 (967)
++|++||+.+|++|+ +++++++|-
T Consensus 257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred HHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 999999999999995 899999883
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=343.38 Aligned_cols=269 Identities=32% Similarity=0.575 Sum_probs=226.2
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeE
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVL 753 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVk 753 (967)
...|++..++|.+.+.||+|+||.||++++. ...+|+|.+... ........+..|+.+++++ +|+||++
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 3467777899999999999999999999652 246999987643 2334456788899999999 7999999
Q ss_pred EeeeeeccCceEEEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEecc
Q 037068 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDL 818 (967)
Q Consensus 754 Lig~~~~~~~l~LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDL 818 (967)
+++++...+..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++ |++||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--gi~H~dl 166 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK--KCIHRDL 166 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--Ccccccc
Confidence 9999999999999999999999999986532 3488899999999999999999988 7999999
Q ss_pred CCCcEEEcCCCeEEEEecccccccccCccC--CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 037068 819 KSPNLLVDKNWVVKVCDFGLSRIKHHTYLS--SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGL 895 (967)
Q Consensus 819 KPsNILLd~~g~VKLsDFGLAr~~~~~~~~--~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~ 895 (967)
||+||+++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999999999765432211 122234568999999999999999999999999999998 88999887
Q ss_pred ChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcC
Q 037068 896 NPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDR 956 (967)
Q Consensus 896 ~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~ 956 (967)
...+....+. .......+..++.++.+++.+||+.+|++||++.++++.|+.+.+...++
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~~ 306 (307)
T cd05098 247 PVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSNQ 306 (307)
T ss_pred CHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhcC
Confidence 7766655543 34455677889999999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.25 Aligned_cols=262 Identities=28% Similarity=0.498 Sum_probs=216.5
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMG 756 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig 756 (967)
.+|.+..++|++.+.||+|+||.||+|++ .+..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 46777778999999999999999999853 24579999875432 233456788999999999 8999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCC----------------------------------------------------
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPN---------------------------------------------------- 784 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~---------------------------------------------------- 784 (967)
++...+..++||||+++|+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999998885421
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 785 ----------------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 785 ----------------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCchhhEEEECCCcEEEecCccceec
Confidence 2478888999999999999999998 7999999999999999999999999999865
Q ss_pred ccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 843 HHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 843 ~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....................|...+.
T Consensus 265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (375)
T cd05104 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS 344 (375)
T ss_pred cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCH
Confidence 43221 1222345678999999999999999999999999999998 88999876544333332223444555677889
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
++.++|.+||+.||++||++.+|++.|++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=355.10 Aligned_cols=245 Identities=23% Similarity=0.426 Sum_probs=211.2
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
+.||+|+||.||++++ +++.||+|++..... .......+..|+++++.++||||+++++++...+.++|||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 578999999875432 2334567788999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCC
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG 854 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~G 854 (967)
+|..++.. ...+++..++.++.||+.||.|||+.. ||+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 99988865 456899999999999999999999732 7999999999999999999999999998754333333345679
Q ss_pred CCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 037068 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPH 934 (967)
Q Consensus 855 T~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe 934 (967)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..+++++.++|.+||+.||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 999999999999999999999999999999999999999887766665553 335567788999999999999999999
Q ss_pred CCc-----CHHHHHHHH
Q 037068 935 LRP-----SFAQLMSRL 946 (967)
Q Consensus 935 ~RP-----S~~ELLe~L 946 (967)
+|+ ++.++++|-
T Consensus 237 ~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 237 QRLGGGPDDAKEIMQHK 253 (325)
T ss_pred HhCCCCCCCHHHHhcCC
Confidence 996 899999883
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.03 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=216.9
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC------------hhhHHHHHHHHHHHHHcCCCceeE
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS------------GDSLSQFKCEAEIMLRLRHPNVVL 753 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s------------~~~~~~~~~Ei~ILk~L~HpNIVk 753 (967)
....++|++.+.||.|.||+|-+|++ .++.||||++.+.... ...++.+.+||.||++++|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34558999999999999999999977 5889999999764321 123468999999999999999999
Q ss_pred Eeeeeec--cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeE
Q 037068 754 FMGAVTR--SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVV 831 (967)
Q Consensus 754 Lig~~~~--~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~V 831 (967)
|+++..+ .+.+|||+|||..|.+...-.. +..+++.++++|+.+++.||+|||.+ |||||||||+|+||+.+|+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Q--giiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQ--GIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhc--CeeccccchhheEEcCCCcE
Confidence 9999865 4579999999999877655332 22399999999999999999999999 79999999999999999999
Q ss_pred EEEecccccccccC-----ccCCCCCCCCCCccChhccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHh
Q 037068 832 KVCDFGLSRIKHHT-----YLSSKSTAGTPEWMAPEVLRNEP----ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVG 902 (967)
Q Consensus 832 KLsDFGLAr~~~~~-----~~~~~~~~GT~~YmAPE~l~g~~----~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~ 902 (967)
||+|||.+...... .......+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+....+...
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999755222 11233478999999999987743 3568899999999999999999999988888888
Q ss_pred hhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 903 AVGFQNRRLEIPD--DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 903 ~i~~~~~~~~ip~--~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
.|. +..+.+|. .+.+++++||.++|.+||++|.++.+|..|.+..+.
T Consensus 330 KIv--n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIV--NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHh--cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 875 34445554 589999999999999999999999999999876543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=359.91 Aligned_cols=263 Identities=29% Similarity=0.520 Sum_probs=218.0
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMG 756 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig 756 (967)
..|.+..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.+ +|+||+++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 456677789999999999999999998642 2479999886543 334456788999999999 8999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCC-----------------------------------------------------
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRP----------------------------------------------------- 783 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------------------------------------------- 783 (967)
++...+..++||||+.+|+|.+++...
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 999999999999999999999887531
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 784 ----------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 784 ----------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
...+++..+++++.||+.||.|||++ ||+||||||+|||+++++++||+|||+++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK--NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 12478888999999999999999998 799999999999999999999999999976433211
Q ss_pred --CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 848 --SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 848 --~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
......++..|||||++.+..++.++|||||||++|||++ |+.||.....................|..+++++.++
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence 1122335678999999999999999999999999999997 9999987665443333333444555667789999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
+.+||+.+|++|||+.++++.|+++.
T Consensus 348 i~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=352.89 Aligned_cols=244 Identities=25% Similarity=0.422 Sum_probs=210.7
Q ss_pred EEeecCCceEEEEeec-----CCCeEEEEEeecCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 698 ERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDF--SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 698 k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~--s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+.||+|+||.||+++. .++.||||++..... .......+..|+.+++.++||||+++++++..++.+++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999864 467899999865322 123345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.+++|..++.. ...+.+..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 999999999875 45688999999999999999999998 799999999999999999999999999875443333344
Q ss_pred CCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 037068 851 STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQ 930 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq 930 (967)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..+++++.++|.+||+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHcc
Confidence 5679999999999999889999999999999999999999999888766665553 23456788899999999999999
Q ss_pred cCCCCCc-----CHHHHHHHH
Q 037068 931 TEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 931 ~dPe~RP-----S~~ELLe~L 946 (967)
.+|++|| ++.++++|-
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcCC
Confidence 9999999 899998874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=356.73 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=212.9
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||+||++++ +++.||||++..... .......+.+|+.+++.++|+||+++++++.+...++|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999976 478999999875432 2334566888999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL- 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~- 847 (967)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999999876 45699999999999999999999998 799999999999999999999999999875322110
Q ss_pred -------------------------------------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCC
Q 037068 848 -------------------------------------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSV 890 (967)
Q Consensus 848 -------------------------------------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~ 890 (967)
......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999999999999999999999999999999
Q ss_pred CCCCCChhHHHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCcC---HHHHHHHH
Q 037068 891 PWKGLNPMQVVGAVGFQNRRLEIPD--DIDPAVAQIIRDCWQTEPHLRPS---FAQLMSRL 946 (967)
Q Consensus 891 PF~~~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CLq~dPe~RPS---~~ELLe~L 946 (967)
||...+..+....+........+|. .+++++.++|.+||. +|.+|++ +.++++|-
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9998887766655543333344443 578999999999996 9999997 99999974
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=333.87 Aligned_cols=255 Identities=34% Similarity=0.557 Sum_probs=218.7
Q ss_pred cCCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
.++|++.+.||+|+||+||+|.+. ...||||++... ........+.+|+.++++++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 468999999999999999999763 346899987543 34445567889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc-
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH- 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~- 844 (967)
+||||+.+++|.+++......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~--~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM--NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999977666799999999999999999999998 799999999999999999999999999987642
Q ss_pred -CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 -TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 -~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .....+.+..+++.+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 238 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSALY 238 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 1112223345678999999999999999999999999999998 999998877766665553 3344556678899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+++.+||+.+|++||++.+|+++|..+
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.86 Aligned_cols=248 Identities=21% Similarity=0.389 Sum_probs=212.5
Q ss_pred CeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCC-CceeEEeeeeeccCceEEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRH-PNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~H-pNIVkLig~~~~~~~l~LVm 768 (967)
+|++.+.||+|+||.||+|++. ++.||||++..... .......+..|+.++..++| ++|+++++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999764 56899999865422 23445678889999999966 56888999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+++|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999998865 45689999999999999999999998 7999999999999999999999999998754333333
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+....+. .....+|..+++++.+++.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999888777666653 334567788999999999999
Q ss_pred hhcCCCCCcCH-----HHHHHH
Q 037068 929 WQTEPHLRPSF-----AQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS~-----~ELLe~ 945 (967)
|+.+|.+|++. .++++|
T Consensus 236 l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred hhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999976 777776
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=365.28 Aligned_cols=249 Identities=30% Similarity=0.495 Sum_probs=223.0
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
..|...++||+|.||.||+|.+ +++.||+|++... .....++.+.+|+.++.+++++||.++|+.|..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4566678999999999999977 5788999998654 345567889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
||.||++.++++. +..+++..+..++++++.||.|||.+ +.+|||||+.|||+...|.+||+|||++..........
T Consensus 92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~--~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSE--KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhc--ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999999975 44558999999999999999999999 69999999999999999999999999998887776667
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
.+++|||.|||||++.+..|+.|+||||||++.+||.+|.+||....++.++..|- ....+.+...+++.+++|+..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHHh
Confidence 88999999999999998899999999999999999999999999999987766654 33344444578999999999999
Q ss_pred hcCCCCCcCHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSR 945 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~ 945 (967)
.+||+.||++.++|+|
T Consensus 248 ~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKH 263 (467)
T ss_pred hcCcccCcCHHHHhhh
Confidence 9999999999999987
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.25 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=203.8
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||.||+|+. +++.||||++..... ......+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 37899999999999999999977 578899999865432 223345678999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+. ++|.+++......+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9996 578777776566789999999999999999999998 7999999999999999999999999999765433333
Q ss_pred CCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhcc--c----------------
Q 037068 849 SKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQ--N---------------- 908 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~--~---------------- 908 (967)
.....+|+.|+|||++.+. .++.++|||||||++|||++|..||.+.... .....+... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 4456789999999998764 5889999999999999999999999875432 111111000 0
Q ss_pred ---cccCCCC---------CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 909 ---RRLEIPD---------DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 909 ---~~~~ip~---------~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.....+. ..++.+.+|+.+||+.||++|||+.++++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 0000011 2356789999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=333.31 Aligned_cols=257 Identities=29% Similarity=0.564 Sum_probs=218.8
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
|.+..++|++.++||+|+||.||+|... +..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 4566789999999999999999999764 5679999865422 23567889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++|||+.+++|.+++... ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999998653 45688999999999999999999998 799999999999999999999999999986654
Q ss_pred Ccc-CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 TYL-SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~~-~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
... ......++..|+|||.+.+..++.++|||||||++|+|+| |+.||...........+. .....+.+..++.++.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELY 234 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 321 1223345678999999999889999999999999999998 999998877766665553 2334445567899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+++.+||+.+|++||++.++++.|+++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=329.77 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=219.1
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|.+.+.||+|+||.||++.. .++.|++|.+............+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478899999999999999976 578899999876555556677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 771 LPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
+.+++|.+++... ...+++..++.++.||+.||.|||+. |++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~--~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK--KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999998763 46789999999999999999999988 79999999999999999999999999998665544334
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+. ......++..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHc
Confidence 45568899999999999999999999999999999999999999887666555443 33444566678999999999999
Q ss_pred hcCCCCCcCHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSR 945 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~ 945 (967)
+.+|++||++.+++++
T Consensus 238 ~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 238 TKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=331.20 Aligned_cols=249 Identities=33% Similarity=0.584 Sum_probs=213.5
Q ss_pred CCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
++|++.+.||+|+||.||+++++ +..+|+|.+..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 57889999999999999999875 45799998754322 245688899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-cCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-LSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-~~~ 849 (967)
+++|+|.+++......+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN--SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC--CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999999876556789999999999999999999988 79999999999999999999999999997653322 122
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+. .......|...+.++.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 23345678999999998889999999999999999999 899999888777666654 3334555677889999999999
Q ss_pred hhcCCCCCcCHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L 946 (967)
|+.+|++||++.++++.|
T Consensus 238 ~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 238 WHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ccCCcccCcCHHHHHHhh
Confidence 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=353.92 Aligned_cols=251 Identities=26% Similarity=0.391 Sum_probs=210.1
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||+||+++. +++.||||++.+... .......+..|+.++.+++|+||+++++.+.+...++|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999976 478899999865432 2334567888999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL- 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~- 847 (967)
||+++|+|.+++.+ ...+++..+..++.||+.||+|||++ ||+||||||+||||+.++++||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~--givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQL--GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999999876 45799999999999999999999998 799999999999999999999999999875432100
Q ss_pred ----------------------------------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 037068 848 ----------------------------------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWK 893 (967)
Q Consensus 848 ----------------------------------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~ 893 (967)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0123579999999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhhccccccCCCC--CCcHHHHHHHHHhhh--cCCCCCcCHHHHHHH
Q 037068 894 GLNPMQVVGAVGFQNRRLEIPD--DIDPAVAQIIRDCWQ--TEPHLRPSFAQLMSR 945 (967)
Q Consensus 894 ~~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CLq--~dPe~RPS~~ELLe~ 945 (967)
..+..+....+........+|. .+++++.++|.+++. .++..||++.||++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 8887776666543333344443 478999999998654 233456899999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=332.10 Aligned_cols=257 Identities=36% Similarity=0.656 Sum_probs=220.2
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
|++...+|.+.+.||+|+||.||+|.+ .++.|++|++... ......+.+|+.+++.++|+||+++++++..++.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 455667899999999999999999976 4778999987543 23356788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+++|||+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||++++++.+||+|||+++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999999999998653 34689999999999999999999988 79999999999999999999999999998654
Q ss_pred cCccC-CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 844 HTYLS-SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 844 ~~~~~-~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+. .......+..++.++
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKV 234 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence 43221 222334678999999999999999999999999999998 999998887766655543 344566778899999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+++.+||+.+|++||++.++++.|+.+
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=363.77 Aligned_cols=252 Identities=25% Similarity=0.464 Sum_probs=231.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc-eEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH-FSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~-l~LVm 768 (967)
++|..++.||+|+||.++.+++ .++.+++|++.....+........+|+.++++++|||||.+.+.|..++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 6788999999999999998866 47789999998777666666688999999999999999999999999888 99999
Q ss_pred eecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 769 EFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
+||+||+|.+.+.+.+ ..++++.++.|+.||+.|+.|||++ .|+|||||+.|||++.++.|||+|||+|+.......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~--~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN--RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh--hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999999999987655 6799999999999999999999977 699999999999999999999999999998877665
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
...+..|||.||+||++.+.+|+.|+|||||||++|||++-+++|...+....+..+. ...-.++|...+.+++.+|+.
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~~~~~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-RGLYSPLPSMYSSELRSLVKS 240 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-hccCCCCCccccHHHHHHHHH
Confidence 5778899999999999999999999999999999999999999999999988888775 444678899999999999999
Q ss_pred hhhcCCCCCcCHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L 946 (967)
||..+|+.||++.++|.+.
T Consensus 241 ~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRRP 259 (426)
T ss_pred HhhcCCccCCCHHHHhhCh
Confidence 9999999999999999984
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=353.20 Aligned_cols=243 Identities=26% Similarity=0.435 Sum_probs=210.4
Q ss_pred EEeecCCceEEEEeec-----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecC
Q 037068 698 ERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 698 k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~ 772 (967)
+.||+|+||.||+++. .++.||+|++............+..|+.++++++||||+++++++..++.+++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998854 47889999987644333344567889999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCC
Q 037068 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST 852 (967)
Q Consensus 773 gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~ 852 (967)
+|+|..++.+ ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++............
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 9999999865 45689999999999999999999998 79999999999999999999999999998654443334456
Q ss_pred CCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcC
Q 037068 853 AGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTE 932 (967)
Q Consensus 853 ~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~d 932 (967)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++.+.++|++||+.|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 79999999999999889999999999999999999999999888776665553 2345677889999999999999999
Q ss_pred CCCCcC-----HHHHHHH
Q 037068 933 PHLRPS-----FAQLMSR 945 (967)
Q Consensus 933 Pe~RPS-----~~ELLe~ 945 (967)
|++||+ +.+++.|
T Consensus 237 P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 237 PANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HhHcCCCCCCCHHHHhCC
Confidence 999999 5667665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.39 Aligned_cols=248 Identities=21% Similarity=0.401 Sum_probs=212.4
Q ss_pred CeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVm 768 (967)
+|.+.+.||+|+||.||+|++. ++.||||++.+... .......+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999764 67899999875432 223345567788888877 5899999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+++|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999999988865 45689999999999999999999998 7999999999999999999999999999754433333
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.......+. .....+|..+++++.+++.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999988877766654 234567788999999999999
Q ss_pred hhcCCCCCcCH-----HHHHHH
Q 037068 929 WQTEPHLRPSF-----AQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS~-----~ELLe~ 945 (967)
|+.+|.+|++. .++++|
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred cccCHHhcCCCCCCCHHHHhcC
Confidence 99999999974 677765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=358.18 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=210.9
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|.+.+.||+|+||.||++.. .++.||||++.+.. ........+.+|++++++++||||+++++++.+...++|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999966 57889999986542 23344567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL- 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~- 847 (967)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~--givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKL--GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999999875 45689999999999999999999998 799999999999999999999999999963211000
Q ss_pred ----------------------------------------------CCCCCCCCCCccChhccccCCCCchhHHHHHHHH
Q 037068 848 ----------------------------------------------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVI 881 (967)
Q Consensus 848 ----------------------------------------------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvl 881 (967)
......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCC---cCHHHHHHHH
Q 037068 882 LWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD--DIDPAVAQIIRDCWQTEPHLR---PSFAQLMSRL 946 (967)
Q Consensus 882 L~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CLq~dPe~R---PS~~ELLe~L 946 (967)
+|||++|..||...+..+....+........+|. .++.++.+||.+||. +|.+| +++.+++.|-
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 9999999999998877666555543233344444 578999999999997 67765 5999999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=336.52 Aligned_cols=257 Identities=32% Similarity=0.576 Sum_probs=214.9
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT 759 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~ 759 (967)
|.+..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4566789999999999999999998653 3569999875432 2334556889999999999999999999999
Q ss_pred ccCceEEEEeecCCCchhhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 760 RSPHFSILTEFLPRGSLYRLLHRPN---------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 760 ~~~~l~LVmEy~~gGsL~~lL~~~~---------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
.....++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCcchheEEEcCCCC
Confidence 9999999999999999999986422 2357788999999999999999998 7999999999999999999
Q ss_pred EEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcc
Q 037068 831 VKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQ 907 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~ 907 (967)
+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-E 236 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999875433221 1122345778999999999999999999999999999999 789998887766665543 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
......+..++..+.+++.+||+.+|++|||+.+++++|+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 3344567788999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=331.37 Aligned_cols=257 Identities=24% Similarity=0.445 Sum_probs=214.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||+|+. .++.||||++.... ........+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 6899999999999999999976 57899999876433 23444567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 769 EFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
||+.+++|..++.. ....+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988753 234588999999999999999999998 7999999999999999999999999999866543
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHhhhhccccccCCCCCCcHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP--MQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~--~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
........+++.|+|||.+.+..++.++|+||||+++|||++|+.||..... ......+.........+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 3333345688999999999988899999999999999999999999965432 23333332222222223467889999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
+|.+||+.+|.+||++.++++.|+.++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=356.30 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=209.6
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.|++.+.||+|+||+||+|++ +++.||||++..... .......+.+|+.++++++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 688999999999999999976 577899999876433 33456678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc---
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--- 846 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~--- 846 (967)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+. ||+||||||+||||+.++++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~--givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKM--GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999875 45689999999999999999999998 79999999999999999999999999975321000
Q ss_pred --------------------------------------------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHH
Q 037068 847 --------------------------------------------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVIL 882 (967)
Q Consensus 847 --------------------------------------------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL 882 (967)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001235699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHhhhhccccccCCCC--CCcHHHHHHHHHhh--hcCCCCCcCHHHHHHHH
Q 037068 883 WELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD--DIDPAVAQIIRDCW--QTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 883 ~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CL--q~dPe~RPS~~ELLe~L 946 (967)
|||+||+.||...+..+....+........+|. .+++++.++|.+|+ ..++..|+++.+++.|-
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 999999999998877655544432233334443 58999999999854 55666699999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=345.31 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=201.1
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc-----CceE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-----PHFS 765 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~-----~~l~ 765 (967)
+|++.+.||+|+||.||+|.+ ++..||||++............+.+|+.++++++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999976 578999999864433334455788999999999999999999987543 2489
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+. ++|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 688888865 44689999999999999999999998 7999999999999999999999999999754322
Q ss_pred c---cCCCCCCCCCCccChhcccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--------------
Q 037068 846 Y---LSSKSTAGTPEWMAPEVLRN--EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-------------- 906 (967)
Q Consensus 846 ~---~~~~~~~GT~~YmAPE~l~g--~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-------------- 906 (967)
. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 11234578999999999876 6789999999999999999999999987654322211100
Q ss_pred ------------cccccC---CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 907 ------------QNRRLE---IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 907 ------------~~~~~~---ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
...... ....+++.+.++|.+||+.+|++|||+.++++|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 000000 0124678899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.60 Aligned_cols=243 Identities=23% Similarity=0.393 Sum_probs=209.3
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||.||+|++ +++.||||++.+... .......+..|+.+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999976 477899999865422 234456677888888877 699999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~--~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 999988865 45689999999999999999999998 799999999999999999999999999875433333344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++++.++|++||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999988777766653 33455677899999999999999999
Q ss_pred CCCcCH------HHHHHH
Q 037068 934 HLRPSF------AQLMSR 945 (967)
Q Consensus 934 e~RPS~------~ELLe~ 945 (967)
++||++ .+++.|
T Consensus 236 ~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 236 TMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHCCCCCCCCCHHHHHcC
Confidence 999998 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.55 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=213.7
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|.+.+.||+|+||+||+++. .++.||+|++..... .......+..|+.+++.++|+||+++++++...+.++|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4789999999999999999976 578899999875432 2334567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL- 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~- 847 (967)
||+++|+|.+++.+....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM--GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999987657799999999999999999999998 799999999999999999999999999986543322
Q ss_pred CCCCCCCCCCccChhccc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC--CCCcH
Q 037068 848 SSKSTAGTPEWMAPEVLR------NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDP 919 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~------g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~ 919 (967)
......||+.|+|||++. +..++.++|||||||++|||++|+.||...........+........+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223456899999999986 4567899999999999999999999998877766655543322223333 35789
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
++.+||.+||+ +|.+||++.++++|
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 99999999998 99999999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.46 Aligned_cols=268 Identities=30% Similarity=0.580 Sum_probs=226.3
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec---------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEE
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW---------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLF 754 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~---------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkL 754 (967)
..|.+..++|.+.+.||+|+||.||++++ .+..||+|.+... ........+.+|+.+++.+ +|+||+++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhe
Confidence 34667788999999999999999999964 1346899987543 2334457789999999999 89999999
Q ss_pred eeeeeccCceEEEEeecCCCchhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccC
Q 037068 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRP---------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK 819 (967)
Q Consensus 755 ig~~~~~~~l~LVmEy~~gGsL~~lL~~~---------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLK 819 (967)
++++......++||||+.+++|.+++.+. ...+++..++.++.||+.||.|||++ ||+|||||
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--givH~dlk 164 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ--KCIHRDLA 164 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC--Ceeecccc
Confidence 99999999999999999999999998652 23478888999999999999999998 79999999
Q ss_pred CCcEEEcCCCeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 037068 820 SPNLLVDKNWVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLN 896 (967)
Q Consensus 820 PsNILLd~~g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~ 896 (967)
|+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986543221 1223345678999999999889999999999999999998 789998888
Q ss_pred hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcC
Q 037068 897 PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDR 956 (967)
Q Consensus 897 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~ 956 (967)
..+....+. .......+..++..+.+++.+||+.+|.+||++.++++.|.++.....++
T Consensus 245 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~~ 303 (304)
T cd05101 245 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE 303 (304)
T ss_pred HHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhcC
Confidence 777766654 34455567788999999999999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=332.92 Aligned_cols=256 Identities=32% Similarity=0.566 Sum_probs=220.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
....+|++.++||.|+||.||+|.+. ++.+++|.+.... ......+..|+.+++.++|+||+++++++......++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 34467899999999999999999764 6779999875432 22355788899999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 768 TEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
|||+++++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ--NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999998763 45689999999999999999999988 79999999999999999999999999998665443
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
.......++..|++||.+.+..++.++||||||+++|+|++ |+.||......+....+. ...+...+..+++.+.++|
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHH
Confidence 33334456778999999998899999999999999999998 899998887776666554 4445566778999999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+||+.+|.+|||+.+|++.|+.+
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 238 LECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.47 Aligned_cols=257 Identities=33% Similarity=0.575 Sum_probs=218.9
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
|++..++|++.+.||+|+||.||+|.+ .++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 456678999999999999999999976 45679999875432 23466888999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+||||+.+++|.+++.... ..+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999999987543 5689999999999999999999998 799999999999999999999999999986653
Q ss_pred CccC-CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 TYLS-SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~~~-~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
.... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||...........+. .......+..++..+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELY 234 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 2211 122223457999999999999999999999999999999 999999888776665553 3344556677899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+++.+||+.+|.+||++.+|++.|+.+
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.78 Aligned_cols=244 Identities=21% Similarity=0.364 Sum_probs=210.2
Q ss_pred EEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||.||+|++. ++.||||++..... .......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999764 67899999865422 234455677889998876 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
++|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRH--GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 999988865 45689999999999999999999998 799999999999999999999999999976443333344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. ......|..+++++.++|.+||+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhccCH
Confidence 9999999999999999999999999999999999999999988777766654 23345667789999999999999999
Q ss_pred CCCc-------CHHHHHHHH
Q 037068 934 HLRP-------SFAQLMSRL 946 (967)
Q Consensus 934 e~RP-------S~~ELLe~L 946 (967)
++|| ++.++++|-
T Consensus 236 ~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 236 NKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HHcCCCCCCCCCHHHHhcCC
Confidence 9999 889999884
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.56 Aligned_cols=251 Identities=30% Similarity=0.398 Sum_probs=206.6
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.++||+|+||.||++++ .++.||||++.... .......+.+|+++++.++|+||+++++++...+.+++||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 46777889999999999999976 47899999985432 3344567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+++|.... ...+..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++........
T Consensus 152 e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR--HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999999986542 356788889999999999999998 7999999999999999999999999999876544333
Q ss_pred CCCCCCCCCccChhcccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHH---HhhhhccccccCCCCCCcHH
Q 037068 849 SKSTAGTPEWMAPEVLRN-----EPANEKCDVYSFGVILWELATLSVPWKGLNPMQV---VGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g-----~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei---~~~i~~~~~~~~ip~~ls~e 920 (967)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||........ ...+ ........+..++.+
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQPPEAPATASRE 303 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccCCCCCCCccCHH
Confidence 445679999999999853 2345689999999999999999999974332221 1111 123344566788999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
+.+||.+||+.||++|||+.|+++|-.-..
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 999999999999999999999999865443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=337.57 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=202.2
Q ss_pred CCeeEeEEeecCCceEEEEeec---CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc---CCCceeEEeeeee-----c
Q 037068 692 EDLQIGERIGIGSYGEVYRADW---HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL---RHPNVVLFMGAVT-----R 760 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~---~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L---~HpNIVkLig~~~-----~ 760 (967)
++|++.+.||+|+||+||+|++ .++.||+|++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4789999999999999999976 356799998865543333444566788877766 6999999999875 2
Q ss_pred cCceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
...+++||||+. ++|..++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999996 5888887653 35589999999999999999999998 7999999999999999999999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc----------
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR---------- 909 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~---------- 909 (967)
+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+....+.....
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 865433 223456789999999999998999999999999999999999999998776554433321000
Q ss_pred ------cc---------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 ------RL---------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 ------~~---------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+ .+...+++.+.+++.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0113467889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=347.68 Aligned_cols=243 Identities=25% Similarity=0.443 Sum_probs=206.5
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999976 467899999865422 223345556677777654 899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKK--GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 999998875 45689999999999999999999998 799999999999999999999999999986543333345567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+. .....+|..++.++.++|.+||+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999988877766653 33456677899999999999999999
Q ss_pred CCCcCHH-HHHHH
Q 037068 934 HLRPSFA-QLMSR 945 (967)
Q Consensus 934 e~RPS~~-ELLe~ 945 (967)
.+||++. ++++|
T Consensus 236 ~~R~~~~~~l~~h 248 (316)
T cd05592 236 TKRLGVDGDIRQH 248 (316)
T ss_pred HHcCCChHHHHcC
Confidence 9999865 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.42 Aligned_cols=257 Identities=28% Similarity=0.507 Sum_probs=216.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCC----eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGT----EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~----~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
..+|++.+.||+|+||.||+|.+ .+. .||+|++... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 36799999999999999999975 233 4899987532 2344566788999999999999999999998764 57
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++++||+.+|+|.+++......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc--CeeccccchhheEecCCCcEEEccccccccccC
Confidence 899999999999999987666789999999999999999999998 799999999999999999999999999986543
Q ss_pred Ccc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 TYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 ~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
... ......++..|++||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHH
Confidence 322 1222334678999999999999999999999999999998 999999877666544332 444556667789999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
.+++.+||+.+|.+||++.+++.+|..+.+.
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 9999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=356.10 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=217.8
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
..+....++|++.+.||+|+||.||+++. +++.||+|++..... .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34455668999999999999999999976 477899999865322 223345678899999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
..+++||||+.+|+|..++.. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999999999874 3588999999999999999999998 799999999999999999999999999976
Q ss_pred cccCcc-CCCCCCCCCCccChhccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCC-
Q 037068 842 KHHTYL-SSKSTAGTPEWMAPEVLRNE----PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD- 915 (967)
Q Consensus 842 ~~~~~~-~~~~~~GT~~YmAPE~l~g~----~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~- 915 (967)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+........+|.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 543321 23456799999999998754 478899999999999999999999998887666666543333444554
Q ss_pred -CCcHHHHHHHHHhhhcCCCC--CcCHHHHHHHH
Q 037068 916 -DIDPAVAQIIRDCWQTEPHL--RPSFAQLMSRL 946 (967)
Q Consensus 916 -~ls~eL~dLI~~CLq~dPe~--RPS~~ELLe~L 946 (967)
.++.++.++|.+||+.+|.+ |+++.++++|-
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 57999999999999999988 99999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=349.90 Aligned_cols=263 Identities=30% Similarity=0.558 Sum_probs=216.5
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeee
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGA 757 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~ 757 (967)
.|++..++|++.+.||+|+||.||+|... ++.||+|++.... .......+..|+.+++++ +|+||++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 36777889999999999999999999542 3679999875432 333456788899999999 89999999998
Q ss_pred eec-cCceEEEEeecCCCchhhhhcCCC----------------------------------------------------
Q 037068 758 VTR-SPHFSILTEFLPRGSLYRLLHRPN---------------------------------------------------- 784 (967)
Q Consensus 758 ~~~-~~~l~LVmEy~~gGsL~~lL~~~~---------------------------------------------------- 784 (967)
+.. +..++++|||+.+++|.+++....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 765 456889999999999998875321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCC
Q 037068 785 --------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAG 854 (967)
Q Consensus 785 --------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~G 854 (967)
..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...... .......+
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 2578899999999999999999998 79999999999999999999999999998653221 12223456
Q ss_pred CCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 855 T~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
+..|+|||++.+..++.++|||||||++|||++ |..||......+..............|...++++.+++.+||+.+|
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCCh
Confidence 778999999999999999999999999999998 9999987654443322222344555677789999999999999999
Q ss_pred CCCcCHHHHHHHHHHHHH
Q 037068 934 HLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 934 e~RPS~~ELLe~L~~L~~ 951 (967)
++||++.+++++|..+..
T Consensus 318 ~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 318 EDRPTFSELVEILGDLLQ 335 (337)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.95 Aligned_cols=252 Identities=37% Similarity=0.669 Sum_probs=219.2
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.+..++|++.+.||.|+||.||++...++.||+|++..... ...++.+|+.++++++|+||+++++++......++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 34457899999999999999999999999999999864422 467789999999999999999999999988899999
Q ss_pred EeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 768 TEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~--~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999987643 3689999999999999999999998 79999999999999999999999999998663322
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||...........+. .......+..+++.+.++|
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHH
Confidence 12345668999999998889999999999999999997 999998887766655543 3334566778899999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
.+||..+|++||++.++++.|+.
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.85 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=210.1
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
+..++|++.++||+|+||.||++.+. +..+|+|.+... ........+.+|++++++++|+||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 34589999999999999999999774 677888876543 334455678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999999876 446899999999999999999999854 6999999999999999999999999999755332
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh---------------------
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG--------------------- 905 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~--------------------- 905 (967)
......||..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2234578999999999999899999999999999999999999998655433322110
Q ss_pred ----------------------ccccccCCC-CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 906 ----------------------FQNRRLEIP-DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 906 ----------------------~~~~~~~ip-~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.......++ ..++.++.+||.+||+.||++|||+.|+++|-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000011111 135788999999999999999999999998843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=357.36 Aligned_cols=265 Identities=32% Similarity=0.520 Sum_probs=220.9
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEE
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLF 754 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkL 754 (967)
....|++..++|+++++||+|+||.||+|.+. +..||||++... ......+.+.+|+.+++++. ||||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l 106 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNL 106 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 34678888899999999999999999999752 236999988543 23344567899999999996 9999999
Q ss_pred eeeeeccCceEEEEeecCCCchhhhhcCC---------------------------------------------------
Q 037068 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRP--------------------------------------------------- 783 (967)
Q Consensus 755 ig~~~~~~~l~LVmEy~~gGsL~~lL~~~--------------------------------------------------- 783 (967)
++++...+.++|||||+++|+|.+++.+.
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 99999999999999999999999887532
Q ss_pred --------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccC
Q 037068 784 --------------------------------------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK 819 (967)
Q Consensus 784 --------------------------------------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLK 819 (967)
...+++..++.++.||+.||.|||+. +|+|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivH~dik 264 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK--NCVHRDLA 264 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCC
Confidence 12477888899999999999999998 79999999
Q ss_pred CCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 037068 820 SPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLN 896 (967)
Q Consensus 820 PsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~ 896 (967)
|+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999999999998653321 12233457788999999999999999999999999999997 999998765
Q ss_pred hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 897 PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 897 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
.................+..++.++.+++.+||+.+|++||++.+|.+.|..+.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 443333322344455667788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.26 Aligned_cols=257 Identities=32% Similarity=0.566 Sum_probs=219.4
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT 759 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~ 759 (967)
|++..++|++.+.||+|+||.||++..+ +..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 4566789999999999999999998653 2579999875432 3334567889999999999999999999999
Q ss_pred ccCceEEEEeecCCCchhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 760 RSPHFSILTEFLPRGSLYRLLHRP---------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 760 ~~~~l~LVmEy~~gGsL~~lL~~~---------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
.....++||||+.+++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK--KFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccChheEEEcCCCC
Confidence 999999999999999999998642 12468889999999999999999988 7999999999999999999
Q ss_pred EEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcc
Q 037068 831 VKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQ 907 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~ 907 (967)
+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+. .
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-c
Confidence 99999999976543321 2233456789999999998889999999999999999998 999999888777766665 4
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
......|..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 4556678888999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=355.92 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=209.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.+|++.+.||+|+||.||+++. +++.||||++.+... .......+.+|+.+++.++|+||+++++.+.+++.++|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999976 478899999864322 2233566889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC---
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--- 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~--- 845 (967)
||+++|+|.+++.+ ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999876 45689999999999999999999998 7999999999999999999999999997532100
Q ss_pred ----------------------------------------ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHH
Q 037068 846 ----------------------------------------YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWEL 885 (967)
Q Consensus 846 ----------------------------------------~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~EL 885 (967)
........||+.|||||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0011234699999999999999999999999999999999
Q ss_pred HhCCCCCCCCChhHHHhhhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCc---CHHHHHHH
Q 037068 886 ATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQIIRDCWQTEPHLRP---SFAQLMSR 945 (967)
Q Consensus 886 lTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI~~CLq~dPe~RP---S~~ELLe~ 945 (967)
++|+.||...+..+....+........+| ..+++++.++|.+|+ .+|.+|+ ++.++++|
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999888766555443222233333 368999999999976 5999999 99999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=364.97 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=219.4
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC---
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP--- 762 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~--- 762 (967)
+...++|.+.+.||+|+||+||++++ +++.||||++.....+......+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457999999999999999999966 5889999998776666666778899999999999999999988765422
Q ss_pred -----ceEEEEeecCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEE
Q 037068 763 -----HFSILTEFLPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVC 834 (967)
Q Consensus 763 -----~l~LVmEy~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLs 834 (967)
.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~--~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK--HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999988642 35689999999999999999999998 79999999999999999999999
Q ss_pred ecccccccccC--ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC
Q 037068 835 DFGLSRIKHHT--YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE 912 (967)
Q Consensus 835 DFGLAr~~~~~--~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ 912 (967)
|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. ......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~-~~~~~~ 264 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL-AGRYDP 264 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCC
Confidence 99999865432 122345679999999999999999999999999999999999999999888766665543 333445
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+|..+++++.+++.+||+.+|.+||++.+++.+
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 778899999999999999999999999999987
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.33 Aligned_cols=253 Identities=28% Similarity=0.519 Sum_probs=214.1
Q ss_pred eeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc-----
Q 037068 694 LQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH----- 763 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~----- 763 (967)
|++.+.||+|+||.||+|... +..||+|++............+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999653 3579999987655555556789999999999999999999998866543
Q ss_pred -eEEEEeecCCCchhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 764 -FSILTEFLPRGSLYRLLHRP-----NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 764 -l~LVmEy~~gGsL~~lL~~~-----~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
.+++|||+.+++|..++... ...+++..++.++.|++.||.|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR--NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC--CeeccccchheEEECCCCeEEECCcc
Confidence 79999999999999887432 24689999999999999999999998 79999999999999999999999999
Q ss_pred cccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCC
Q 037068 838 LSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 838 LAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip 914 (967)
+++....... ......++..|++||.+.+..++.++|||||||++|||++ |..||......+....+. .......|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 9986543221 1222345678999999998999999999999999999999 899998887776665553 34556677
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
..++.++.+++.+||+.||++||++.+++++|.++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.49 Aligned_cols=252 Identities=30% Similarity=0.534 Sum_probs=216.4
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS---GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s---~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
+.|.+.+.||+|+||.||++.. .++.+++|.+...... ......+.+|+.++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788999999999999999965 5789999988654322 2234678899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
|+||+++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||+|+||+++.++.+||+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999999998875 34688999999999999999999998 79999999999999999999999999997554321
Q ss_pred cCC---CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 847 LSS---KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 847 ~~~---~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...+................+|..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23557889999999999999999999999999999999999998876665555544444556678889999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+|.+||..+|.+|||+.+++++.
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.72 Aligned_cols=246 Identities=28% Similarity=0.515 Sum_probs=209.7
Q ss_pred EeecCCceEEEEeec----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 699 RIGIGSYGEVYRADW----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 699 ~LGeG~FG~VYka~~----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
+||+|+||.||+|.+ ++..+|+|++..........+.+..|+.+++.++|+||+++++++. ....++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999854 4678999987655444556678999999999999999999999875 45678999999999
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc---CCCC
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL---SSKS 851 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~---~~~~ 851 (967)
+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||.||+++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEET--NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999865 34689999999999999999999998 799999999999999999999999999976543321 1122
Q ss_pred CCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 037068 852 TAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQ 930 (967)
Q Consensus 852 ~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq 930 (967)
..++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. .+.....|..+++++.++|.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhc
Confidence 334678999999988889999999999999999998 999999887776666654 344567788899999999999999
Q ss_pred cCCCCCcCHHHHHHHHHHH
Q 037068 931 TEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 931 ~dPe~RPS~~ELLe~L~~L 949 (967)
.||++||++.+|.+.|.++
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 237 YGVDERPGFAVVELRLRNY 255 (257)
T ss_pred cCchhCcCHHHHHHHHhcc
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.56 Aligned_cols=261 Identities=32% Similarity=0.627 Sum_probs=221.9
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeee
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGA 757 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~ 757 (967)
+|++..++|++.+.||+|+||.||++... ...+|+|.+... ........+.+|+.+++++ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 56677789999999999999999999753 246899987643 2334456788999999999 89999999999
Q ss_pred eeccCceEEEEeecCCCchhhhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCc
Q 037068 758 VTRSPHFSILTEFLPRGSLYRLLHR---------------PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPN 822 (967)
Q Consensus 758 ~~~~~~l~LVmEy~~gGsL~~lL~~---------------~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsN 822 (967)
+..++.++++|||+.+++|..++.. ....+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK--KCIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC--Cccccccceee
Confidence 9999999999999999999999853 234689999999999999999999988 79999999999
Q ss_pred EEEcCCCeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhH
Q 037068 823 LLVDKNWVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQ 899 (967)
Q Consensus 823 ILLd~~g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~e 899 (967)
||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999986544321 1222335678999999999999999999999999999997 999999888777
Q ss_pred HHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 900 VVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 900 i~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
....+. .......+..++..+.+|+.+||..+|++|||+.++++.|..+.
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 666554 34455667788999999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.89 Aligned_cols=249 Identities=34% Similarity=0.593 Sum_probs=213.6
Q ss_pred CCeeEeEEeecCCceEEEEeecCCC-eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 692 EDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~g~-~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
++|.+.+.||+|+||.||++++.+. .+|||.+..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 5789999999999999999987554 599998754332 245688999999999999999999999988889999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-cCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-LSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-~~~ 849 (967)
+.+++|.+++......+++..++.++.||+.||.|||+. |++|+||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999999876555789999999999999999999988 79999999999999999999999999987654322 112
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
....++..|++||.+.+..++.++|||||||++|+|++ |..||...........+. .......+...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHH
Confidence 23345678999999998889999999999999999998 999999887766655553 3444555667889999999999
Q ss_pred hhcCCCCCcCHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L 946 (967)
|+.+|.+||++.+|++.|
T Consensus 238 l~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 238 WHEKAEERPTFQQLLSSI 255 (256)
T ss_pred cCCCcccCCCHHHHHHhh
Confidence 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.93 Aligned_cols=253 Identities=34% Similarity=0.644 Sum_probs=215.7
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee-ccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT-RSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~-~~~~l~ 765 (967)
|.+...+|++.+.||+|+||.||++...+..+++|.+... .....+.+|+.++++++|+||+++++++. ..+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 3445578999999999999999999999999999987432 23456889999999999999999999764 456789
Q ss_pred EEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++|||+++++|.+++.+.. ..+++..++.++.||+.||.|||++ ||+||||||+||++++++.+||+|||+++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999999999987643 3488999999999999999999988 799999999999999999999999999875443
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
.. ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+. .......+..+++.+.+
T Consensus 155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYD 230 (256)
T ss_pred cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHH
Confidence 22 22345668999999999899999999999999999997 999999887766665553 33345566788999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
++.+||+.+|++|||+.++++.|+.+
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.58 Aligned_cols=255 Identities=32% Similarity=0.613 Sum_probs=217.7
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
|++..++|++.++||+|+||.||+|.. .++.||+|.+..... ....+.+|+.++++++|+||+++++++. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 567778999999999999999999976 467899998764432 3457888999999999999999999874 45689
Q ss_pred EEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++|||+.+++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK--NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999988653 45689999999999999999999988 799999999999999999999999999976552
Q ss_pred C-ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 T-YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~-~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
. ........++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+. .....+.+..++.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 2 222233456778999999999989999999999999999999 999999887766665553 3344566778899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+++.+||..+|++||+++++++.|+.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHHHhhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=333.17 Aligned_cols=253 Identities=32% Similarity=0.555 Sum_probs=215.6
Q ss_pred cCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
.++|.+.+.||+|+||.||+|... +..||||++.... .......+.+|++++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 467888999999999999999652 3679999875432 33345788999999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 764 FSILTEFLPRGSLYRLLHRP-------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~-------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||++ |++||||||+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeeccccccceEEEcCCCe
Confidence 99999999999999998643 23478899999999999999999998 7999999999999999999
Q ss_pred EEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcc
Q 037068 831 VKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQ 907 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~ 907 (967)
+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-Q 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-c
Confidence 9999999997543221 11233446788999999999999999999999999999998 999998888777666654 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+.....+..++..+.+++++||+.||++||++.|+++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 4444556778999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=346.24 Aligned_cols=249 Identities=21% Similarity=0.369 Sum_probs=207.8
Q ss_pred CeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCC--ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 693 DLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDF--SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~--s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
+|++.+.||+|+||.||+++. .++.||+|++.+... .....+.+..|+.+++.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999864 477899999865322 223345678899999999 599999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999875 45689999999999999999999998 799999999999999999999999999976433
Q ss_pred C-ccCCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHhhhhccccccCCCCCCc
Q 037068 845 T-YLSSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNP----MQVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 845 ~-~~~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~----~ei~~~i~~~~~~~~ip~~ls 918 (967)
. ........||+.|+|||++.+.. ++.++|||||||++|||+||+.||..... ......+ ......++..++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 2 22233467999999999998754 78899999999999999999999975332 1222222 233456777899
Q ss_pred HHHHHHHHHhhhcCCCCCc-----CHHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RP-----S~~ELLe~L 946 (967)
+.+.++|.+||+.||++|| +++++++|-
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 9999999999999999999 888999873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.09 Aligned_cols=254 Identities=30% Similarity=0.574 Sum_probs=214.6
Q ss_pred cCCeeEeEEeecCCceEEEEeec------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|++.+.||+|+||.||+|.. .+..+++|.+... ........+.+|+.++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 36789999999999999999964 3467999987643 2344556788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC
Q 037068 765 SILTEFLPRGSLYRLLHRP----------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN 828 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~----------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~ 828 (967)
++||||+.+++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i~H~dlkp~nili~~~ 160 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH--FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc--CeehhccccceEEEcCC
Confidence 9999999999999988532 23478899999999999999999998 79999999999999999
Q ss_pred CeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhh
Q 037068 829 WVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVG 905 (967)
Q Consensus 829 g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~ 905 (967)
+.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999997653321 12233446778999999998889999999999999999998 999998877665555443
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
....+..+..+++++.+++.+||+.+|.+||++.+|+++|+.
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 -KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 334456678899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.17 Aligned_cols=253 Identities=30% Similarity=0.522 Sum_probs=210.1
Q ss_pred eeEeEEeecCCceEEEEeecCC--C--eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------Cc
Q 037068 694 LQIGERIGIGSYGEVYRADWHG--T--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------PH 763 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~g--~--~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------~~ 763 (967)
|.+.+.||+|+||.||+|.+.. . .+|+|.+..........+.+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999997642 2 589998765544555677889999999999999999999976432 24
Q ss_pred eEEEEeecCCCchhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 764 FSILTEFLPRGSLYRLLHR-----PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~-----~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
.+++|||+.+|+|..++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK--SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhheEEcCCCCEEECCCCc
Confidence 7899999999999988632 224588999999999999999999998 799999999999999999999999999
Q ss_pred ccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCC
Q 037068 839 SRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPD 915 (967)
Q Consensus 839 Ar~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~ 915 (967)
++....... ......+++.|++||.+.+..++.++|||||||++|||++ |+.||......+....+. .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 986543321 1223346778999999999999999999999999999999 899998877766665554 334445667
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.++..+.++|.+||+.+|++|||+.+|+++|+.+
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=354.45 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=209.0
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+|.+.++||+|+||.||+|+. .++.||+|++..... .......+.+|+.++++++|+||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 688999999999999999976 577899999865432 23445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC----
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT---- 845 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~---- 845 (967)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~--~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999875 35689999999999999999999998 7999999999999999999999999997532100
Q ss_pred -------------------------------------------ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHH
Q 037068 846 -------------------------------------------YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVIL 882 (967)
Q Consensus 846 -------------------------------------------~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL 882 (967)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001234689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHhhhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCcC---HHHHHHH
Q 037068 883 WELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQIIRDCWQTEPHLRPS---FAQLMSR 945 (967)
Q Consensus 883 ~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI~~CLq~dPe~RPS---~~ELLe~ 945 (967)
|||++|+.||...++.+....+........+| ..+++++.++|.+|+ .+|++|++ +.++++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999888766555544333333344 468999999999976 59999987 9999887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=345.63 Aligned_cols=243 Identities=23% Similarity=0.415 Sum_probs=209.7
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||+||++.+ +++.||||++.+... .......+..|+.+++.+ +||||+++++++...+.+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999977 467899999875422 233456677899999888 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
++|..++.+ ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHER--GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 999988875 45699999999999999999999998 799999999999999999999999999975433333344557
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..++.++.++|.+||+.||
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCCH
Confidence 8999999999999999999999999999999999999999888776665553 33456677899999999999999999
Q ss_pred CCCcCH-----HHHHHH
Q 037068 934 HLRPSF-----AQLMSR 945 (967)
Q Consensus 934 e~RPS~-----~ELLe~ 945 (967)
.+||++ .+++++
T Consensus 236 ~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 236 EKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHcCCCCCCCHHHHhcC
Confidence 999999 888887
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.25 Aligned_cols=257 Identities=32% Similarity=0.556 Sum_probs=217.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
.+.+|.+.+.||+|+||.||++.. .+..+|+|.+... .......+.+|+.++++++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 457899999999999999999964 2345888877543 2344567899999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
.+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++ |++||||||+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~--~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ--HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccCcceEEEccCCc
Confidence 9999999999999999986422 3489999999999999999999988 7999999999999999999
Q ss_pred EEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcc
Q 037068 831 VKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQ 907 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~ 907 (967)
+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-~ 237 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-Q 237 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 9999999997553321 11223445778999999999999999999999999999998 899998887776666554 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
+.....+..++.++.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 238 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 33445667789999999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=337.60 Aligned_cols=266 Identities=30% Similarity=0.578 Sum_probs=223.7
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEe
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFM 755 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLi 755 (967)
.|.+..++|.+.+.||+|+||.||+++.. ...+|+|.+... ........+.+|+.+++++ +|+||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 46667789999999999999999999642 346889987543 2344566788999999999 699999999
Q ss_pred eeeeccCceEEEEeecCCCchhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCC
Q 037068 756 GAVTRSPHFSILTEFLPRGSLYRLLHRP---------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKS 820 (967)
Q Consensus 756 g~~~~~~~l~LVmEy~~gGsL~~lL~~~---------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKP 820 (967)
+++...+.++++|||+.+|+|.+++... ...+++..+..++.||+.||.|||++ ||+||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--gi~H~dlkp 162 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR--RCIHRDLAA 162 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC--Ceeeccccc
Confidence 9999888999999999999999998642 23588899999999999999999988 799999999
Q ss_pred CcEEEcCCCeEEEEecccccccccCccC--CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 037068 821 PNLLVDKNWVVKVCDFGLSRIKHHTYLS--SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNP 897 (967)
Q Consensus 821 sNILLd~~g~VKLsDFGLAr~~~~~~~~--~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~ 897 (967)
+|||++.++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865432211 122234568999999999999999999999999999999 8999998887
Q ss_pred hHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 898 MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 898 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
.+....+. .......+..++.++.+++.+||+.+|++||++.++++.|..+.....+
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 243 EELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 77666554 3344566778899999999999999999999999999999999776544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=349.29 Aligned_cols=251 Identities=27% Similarity=0.480 Sum_probs=223.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
...+|++.+.||+|+||+|-+|.. .|+.||||.+.+... +++.+-.+.+||+||..|+||||+.+|++|+..+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346899999999999999999965 589999999877654 45667789999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||..+|.|++++.+ .+.+++..+..++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+.+..
T Consensus 131 vMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHkn--rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKN--RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhc--cceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999987 56799999999999999999999998 79999999999999999999999999998776653
Q ss_pred cCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
...+++|+|-|.+||+++|.+| .+.+|.|||||+||-|+.|..||++.+...++.+|.....+. | .-+....-||
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P-~~PSdA~gLI 283 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--P-ETPSDASGLI 283 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--C-CCCchHHHHH
Confidence 3678999999999999999998 467999999999999999999999999998888886433322 2 2345677899
Q ss_pred HHhhhcCCCCCcCHHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+.||..||++|.|+.+|..|-+
T Consensus 284 RwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHHHhcCcccchhHHHHhhhhe
Confidence 9999999999999999999853
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=345.32 Aligned_cols=243 Identities=23% Similarity=0.405 Sum_probs=206.2
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||.||+|++ ++..||+|++..... .......+..|..++..+ +|+||+++++++...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999976 477899999865421 123345667788888765 899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSK--GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 999998865 45689999999999999999999998 799999999999999999999999999875432222344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..++.++.++|.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888777666553 23455677889999999999999999
Q ss_pred CCCcCH-HHHHHH
Q 037068 934 HLRPSF-AQLMSR 945 (967)
Q Consensus 934 e~RPS~-~ELLe~ 945 (967)
++||++ .++++|
T Consensus 236 ~~R~~~~~~~~~h 248 (316)
T cd05620 236 TRRLGVVGNIRGH 248 (316)
T ss_pred HHcCCChHHHHcC
Confidence 999997 467655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.91 Aligned_cols=246 Identities=35% Similarity=0.628 Sum_probs=216.1
Q ss_pred EEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecC
Q 037068 698 ERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~ 772 (967)
+.||+|+||.||++... +..|++|.+....... ....+.+|+.+++.++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46999999999999774 6789999886543332 56788999999999999999999999999999999999999
Q ss_pred CCchhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 773 RGSLYRLLHRP--------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 773 gGsL~~lL~~~--------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+++|.+++... ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC--CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999875 47799999999999999999999998 799999999999999999999999999986654
Q ss_pred Cc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 TY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 ~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCChHH
Confidence 32 23445667889999999998899999999999999999999 699999988777766665 345667788889999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.+++.+||+.+|.+|||+.+++++|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.10 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=204.5
Q ss_pred eecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 700 IGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 700 LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
||+|+||+||++.+ +++.||+|++...... ......+..|+.+++.++|+||+++++++.....+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999976 5788999998654322 22345678899999999999999999999999999999999999999
Q ss_pred hhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 777 YRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 777 ~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
..++.. .+..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 887743 345689999999999999999999998 799999999999999999999999999976554433344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh--ccccccCCCCCCcHHHHHHHHHhhhc
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG--FQNRRLEIPDDIDPAVAQIIRDCWQT 931 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~--~~~~~~~ip~~ls~eL~dLI~~CLq~ 931 (967)
||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+. .......++..+++.+.+++.+||+.
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999998654321111111 11223456677899999999999999
Q ss_pred CCCCCc-----CHHHHHHHH
Q 037068 932 EPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 932 dPe~RP-----S~~ELLe~L 946 (967)
||++|| +++++++|-
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred CHHHhcCCCCCCHHHHhcCh
Confidence 999999 788999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=346.49 Aligned_cols=243 Identities=25% Similarity=0.422 Sum_probs=204.8
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHH-HHHHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAE-IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~-ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||+||+|++ +++.||||++...... ......+..|.. +++.++||||+++++.+...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999977 5788999998654321 222344555555 45778999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.. +..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 999998875 45789999999999999999999998 799999999999999999999999999975433333344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....++..+++.+.++|.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999999999999999999999999888777666553 23445667789999999999999999
Q ss_pred CCCcCH----HHHHHH
Q 037068 934 HLRPSF----AQLMSR 945 (967)
Q Consensus 934 e~RPS~----~ELLe~ 945 (967)
.+||++ .++++|
T Consensus 236 ~~R~~~~~~~~~il~~ 251 (323)
T cd05575 236 TKRLGAKDDFLEIKNH 251 (323)
T ss_pred HhCCCCCCCHHHHHcC
Confidence 999987 466665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.62 Aligned_cols=249 Identities=26% Similarity=0.455 Sum_probs=215.7
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||+|+||.||++++ .++.+++|.+.... .....+.+.+|+.+++.++|+||+++++.+...+.++++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999976 47889999875433 234456788899999999999999999999999999999999
Q ss_pred cCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 771 LPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
+++++|..++.. ....+++..++.++.||+.||.|||++ ||+|+||||+||+++.++.++|+|||+++.........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK--RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 999999988764 345689999999999999999999998 79999999999999999999999999998665443334
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+.++|.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHH
Confidence 45678999999999999899999999999999999999999999877666555543 33344567788999999999999
Q ss_pred hcCCCCCcCHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSR 945 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~ 945 (967)
+.+|++||++.+++..
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.89 Aligned_cols=248 Identities=20% Similarity=0.383 Sum_probs=211.5
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LVm 768 (967)
+|.+.+.||+|+||.||+|+. +++.||+|++..... .......+..|+.+++.+. |++|+++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999976 478899999865422 2334566778899998885 577888999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+++|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~--~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRR--GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 99999999998865 45699999999999999999999998 7999999999999999999999999999754433333
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..++.++.+++.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999988777766654 234567788999999999999
Q ss_pred hhcCCCCCcC-----HHHHHHH
Q 037068 929 WQTEPHLRPS-----FAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS-----~~ELLe~ 945 (967)
|+.+|.+|++ ..++++|
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred cccCHhhCCCCCCCCHHHHhcC
Confidence 9999999997 3566665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=324.32 Aligned_cols=256 Identities=24% Similarity=0.476 Sum_probs=216.1
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||+|.. .++.|++|.+..... .......+.+|++++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6899999999999999999977 488999998864332 3334677899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 769 EFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
||+++++|..++.. .+..+++..++.++.||+.||.|||+. ||+||||+|+||+++.++.++|+|||+++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC--CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999998853 245589999999999999999999998 7999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHhhhhccccccCCCC-CCcHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP--MQVVGAVGFQNRRLEIPD-DIDPAVA 922 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~--~ei~~~i~~~~~~~~ip~-~ls~eL~ 922 (967)
........+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... .+....+. .....+.|. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHHH
Confidence 3333445688999999999998899999999999999999999999965432 22333322 222333444 6888999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
++|.+||..+|.+||++.+|++.|+.++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.02 Aligned_cols=246 Identities=33% Similarity=0.582 Sum_probs=208.5
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCc
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGS 775 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGs 775 (967)
+.||+|+||.||+|++ .++.+|+|.+... ........+.+|++++++++|+||+++++++......++||||+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999976 5788999986543 344556778999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC--CCCC
Q 037068 776 LYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS--KSTA 853 (967)
Q Consensus 776 L~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~--~~~~ 853 (967)
|.+++......+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK--HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999976566789999999999999999999988 79999999999999999999999999987544321111 1112
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTE 932 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~d 932 (967)
.+..|+|||.+.+..++.++|||||||++|||++ |..||...........+. .......+..++..+.+++.+||+.+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCCC
Confidence 3457999999999999999999999999999998 899998777665544443 33445667788999999999999999
Q ss_pred CCCCcCHHHHHHHHH
Q 037068 933 PHLRPSFAQLMSRLR 947 (967)
Q Consensus 933 Pe~RPS~~ELLe~L~ 947 (967)
|++|||+.++++.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=346.29 Aligned_cols=243 Identities=22% Similarity=0.400 Sum_probs=204.9
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||.||++++ .++.||||++...... ......+..|+.+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999976 4778999998764322 33456688899999998 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHER--GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 999988865 45799999999999999999999998 799999999999999999999999999875333223344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------hHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP---------MQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~---------~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+ ......+|..++.++.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASSV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHHH
Confidence 99999999999999999999999999999999999999963221 1112222 234556788899999999
Q ss_pred HHHhhhcCCCCCcC------HHHHHHH
Q 037068 925 IRDCWQTEPHLRPS------FAQLMSR 945 (967)
Q Consensus 925 I~~CLq~dPe~RPS------~~ELLe~ 945 (967)
|++||+.||.+|++ +.++++|
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999987 7888887
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.07 Aligned_cols=249 Identities=34% Similarity=0.597 Sum_probs=212.9
Q ss_pred CCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
.+|++.+.||+|+||.||++++. +..+|+|++..... ....+.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 46888999999999999999775 45799998754332 234677899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-CC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL-SS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~-~~ 849 (967)
+++++|.+++......+++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||+++...+... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN--GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999876556789999999999999999999998 799999999999999999999999999976543221 12
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. .......+..++.++.+++.+|
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHH
Confidence 22234568999999999999999999999999999999 899998877766665553 3445566778899999999999
Q ss_pred hhcCCCCCcCHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L 946 (967)
|..+|++|||+.++++.|
T Consensus 238 l~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred hcCChhhCcCHHHHHHHh
Confidence 999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=343.81 Aligned_cols=243 Identities=24% Similarity=0.412 Sum_probs=206.1
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||+||+|++ .++.||||++..... ..........|..+++.+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999976 467899999865421 123345566788888764 899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSK--GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 999999875 45689999999999999999999998 799999999999999999999999999975433333344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+... ...+|..++.++.++|.+||+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCH
Confidence 999999999999999999999999999999999999999988877776665432 345667789999999999999999
Q ss_pred CCCcCHH-HHHHH
Q 037068 934 HLRPSFA-QLMSR 945 (967)
Q Consensus 934 e~RPS~~-ELLe~ 945 (967)
++||++. ++++|
T Consensus 236 ~~R~~~~~~l~~h 248 (316)
T cd05619 236 ERRLGVKGDIRQH 248 (316)
T ss_pred hhcCCChHHHHcC
Confidence 9999996 77665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=359.35 Aligned_cols=249 Identities=21% Similarity=0.362 Sum_probs=212.9
Q ss_pred CCeeEeEEeecCCceEEEEeec--C-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--H-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
..|.+.+.||+|+||.||+|.. . +..|++|++... .......+.+|+.+++.++||||+++++++..++.++|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4599999999999999999965 2 556888865432 2334456788999999999999999999999999999999
Q ss_pred eecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 769 EFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
||+.+|+|.+++.+ ....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999988754 244689999999999999999999998 7999999999999999999999999999865433
Q ss_pred cc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 846 YL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 846 ~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. +...++|..+++++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCccCCHHHHH
Confidence 21 23456699999999999999999999999999999999999999998877766665542 3334566788999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+|.+||+.+|++||++.+++.+
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhC
Confidence 9999999999999999999865
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=331.65 Aligned_cols=254 Identities=30% Similarity=0.555 Sum_probs=214.3
Q ss_pred CeeEeEEeecCCceEEEEeecCC-------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 693 DLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~g-------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+|++.+.||+|+||.||+|.... ..+++|.+... ........+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47888999999999999996532 45788876543 23344567889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCc
Q 037068 766 ILTEFLPRGSLYRLLHRP-----------------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPN 822 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~-----------------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsN 822 (967)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM--KLVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC--Ceehhhhhhhe
Confidence 999999999999987531 13478899999999999999999988 79999999999
Q ss_pred EEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhH
Q 037068 823 LLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQ 899 (967)
Q Consensus 823 ILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~e 899 (967)
||+++++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997543221 11223345678999999998889999999999999999998 999999888777
Q ss_pred HHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 900 VVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 900 i~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
....+. .......+..++.++.+++.+||+.+|++||++.++++.|+++.
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 666554 33455567789999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=333.34 Aligned_cols=258 Identities=33% Similarity=0.595 Sum_probs=215.1
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CC--eEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~--~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~ 765 (967)
+++|++.+.||+|+||.||+|... +. .+++|.+... ........+.+|+.+++++ +||||+++++++...+.++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 478999999999999999999653 32 4688876532 2334456788999999999 7999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 766 ILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
++|||+++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK--QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCcCCcceEEECCCCe
Confidence 9999999999999986421 3488999999999999999999998 7999999999999999999
Q ss_pred EEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcccc
Q 037068 831 VKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNR 909 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~ 909 (967)
+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. ...
T Consensus 158 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235 (297)
T ss_pred EEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCC
Confidence 9999999986432211 1122233567999999999999999999999999999997 999999888777665553 334
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 910 ~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
....+..++..+.+++.+||+.+|.+||++.++++.|..+.+..
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 55667789999999999999999999999999999998886544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=328.54 Aligned_cols=257 Identities=27% Similarity=0.502 Sum_probs=215.7
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCC----eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGT----EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~----~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|++.+.||+|+||+||+|++ ++. .||+|++... ........+.+|+.+++.++|+||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 46899999999999999999975 333 4899987543 234445678899999999999999999998875 457
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+++|||+++|+|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 899999999999999987666799999999999999999999998 799999999999999999999999999986543
Q ss_pred Ccc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 TYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 ~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
... ......+++.|++||.+.+..++.++|||||||++|||++ |..||...........+. .....+.+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCHHH
Confidence 221 1222345678999999999999999999999999999998 899998877665554443 334455667789999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
.+++.+||+.||++||++.++++.|..+.+.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 9999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.08 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=216.2
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
.......++|++.+.||+|+||.||++++ .++.+|+|++.+... .......+.+|+.+++.++||||+++++++..+
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34455668999999999999999999977 467899999865322 223345678899999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
..+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~--~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999999864 3589999999999999999999998 799999999999999999999999999986
Q ss_pred cccCcc-CCCCCCCCCCccChhccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCC-
Q 037068 842 KHHTYL-SSKSTAGTPEWMAPEVLRNEP----ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD- 915 (967)
Q Consensus 842 ~~~~~~-~~~~~~GT~~YmAPE~l~g~~----~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~- 915 (967)
...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+........+|.
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 543322 234567999999999997643 78899999999999999999999998887666666554444455554
Q ss_pred -CCcHHHHHHHHHhhhcCCCC--CcCHHHHHHHH
Q 037068 916 -DIDPAVAQIIRDCWQTEPHL--RPSFAQLMSRL 946 (967)
Q Consensus 916 -~ls~eL~dLI~~CLq~dPe~--RPS~~ELLe~L 946 (967)
.++..+.+++..||+.++.+ |+++.++++|-
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 56999999999999866554 89999999994
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.28 Aligned_cols=255 Identities=35% Similarity=0.604 Sum_probs=215.8
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
|++..++|++.++||+|+||.||++... +..+|+|.+...... ...+.+|+.++++++|+||+++++++. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 4566789999999999999999999764 567999987654332 356889999999999999999999875 45689
Q ss_pred EEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+||++++++.+||+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM--NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999998653 34589999999999999999999998 799999999999999999999999999976543
Q ss_pred Ccc-CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 TYL-SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~~-~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .....+.+...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH 233 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 321 1223345678999999998899999999999999999999 899998887776666554 3345566778899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+++.+||..+|.+|||+.++.+.|+.
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=358.44 Aligned_cols=264 Identities=30% Similarity=0.564 Sum_probs=234.5
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeecC----CC--eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEee
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWH----GT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~----g~--~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig 756 (967)
...++++..+...+.++||+|.||.||+|.++ |. -||||.-+ .+...+..+.|..|..+|+++.||||++++|
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK-~d~t~d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCK-TDCTPDDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhc-cCCChhhHHHHHHHHHHHHhCCCcchhheee
Confidence 34567888888899999999999999999663 33 37888644 3445566788999999999999999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEec
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDF 836 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDF 836 (967)
++.+. ..+||||.++-|.|..++..++..++......+..||+.||.|||+. .+|||||..+|||+.....|||+||
T Consensus 459 v~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk--rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 459 VCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK--RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred eeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh--chhhhhhhhhheeecCcceeeeccc
Confidence 99876 48999999999999999999889999999999999999999999999 5999999999999999999999999
Q ss_pred cccccccc-CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCC
Q 037068 837 GLSRIKHH-TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 837 GLAr~~~~-~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip 914 (967)
|++|...+ .++.......+..|||||.++-.+++.++|||.|||+|||++. |..||.+..+.+++..+. ++.+++.|
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P 614 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCP 614 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCC
Confidence 99998654 4444555566789999999999999999999999999999987 899999998888776664 78899999
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
++||+.|+.|+.+||.++|.+||++.+|...|..+..
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999988865
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=322.61 Aligned_cols=251 Identities=23% Similarity=0.406 Sum_probs=219.1
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||+|+||.||.++. .+..+++|++.....+......+.+|+.++++++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999998887765 578899999876655666677889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 771 LPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
+++++|.+++... ...+++..+..++.|++.+|.|||+. |++|+||+|+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA--GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999998764 45689999999999999999999988 79999999999999999999999999998664443334
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
....+++.|+|||.+.+..++.++||||||+++|||++|..||...+..+....+.. ......+..++.++.+++.+||
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSLL 237 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHc
Confidence 456789999999999988899999999999999999999999998877766655542 3333455678999999999999
Q ss_pred hcCCCCCcCHHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~L 946 (967)
+.+|.+||++.++++++
T Consensus 238 ~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 238 QQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCcccCCCHHHHhhCc
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=330.92 Aligned_cols=257 Identities=32% Similarity=0.533 Sum_probs=217.3
Q ss_pred cCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
..+|.+.+.||+|+||.||+++.. +..+++|.+... .......+.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 467999999999999999999642 345888876432 23344678899999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC
Q 037068 764 FSILTEFLPRGSLYRLLHRP---------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN 828 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~---------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~ 828 (967)
.++||||+.+++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ--HFVHRDLATRNCLVGAN 159 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccCcceEEEccC
Confidence 99999999999999998642 23488999999999999999999988 79999999999999999
Q ss_pred CeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhh
Q 037068 829 WVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVG 905 (967)
Q Consensus 829 g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~ 905 (967)
+.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999997544322 11233456789999999999999999999999999999999 999998887776665543
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
.......+..++..+.+++.+||+.+|++||++.++++.|..+...
T Consensus 240 -~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 -QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 3344455667899999999999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.09 Aligned_cols=254 Identities=32% Similarity=0.535 Sum_probs=212.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeecCC-------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~g-------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
.+++|++.+.||+|+||.||+|.+.+ ..|++|.+... ........+.+|+.++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45789999999999999999997743 56888876433 23344566888999999999999999999999888
Q ss_pred ceEEEEeecCCCchhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---eEEE
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---VVKV 833 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---~VKL 833 (967)
..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+||+++.++ .+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999986532 2589999999999999999999998 799999999999998654 6999
Q ss_pred EecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccc
Q 037068 834 CDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRR 910 (967)
Q Consensus 834 sDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~ 910 (967)
+|||+++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...........+. ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCc
Confidence 99999986533211 1112234568999999999999999999999999999997 999999887766655543 3344
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 911 ~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
...|..++..+.+++.+||+.+|++||++.+++++|.
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 5667788999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=321.59 Aligned_cols=250 Identities=27% Similarity=0.480 Sum_probs=214.3
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-cCceEEEEe
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-SPHFSILTE 769 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-~~~l~LVmE 769 (967)
.|++.+.||.|+||.||++.. .++.+++|++............+.+|++++++++|+||+++++.+.. +..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999976 46789999987655455556678899999999999999999998764 446899999
Q ss_pred ecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 770 FLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|+++++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~--~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999988753 44689999999999999999999998 7999999999999999999999999999866544333
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+. .......+..+++++.+++.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHH
Confidence 445668999999999999999999999999999999999999998877665544432 2333456677899999999999
Q ss_pred hhcCCCCCcCHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~ 945 (967)
|+.+|++||++.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 238 LSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hccCcccCCCHHHHhcC
Confidence 99999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.36 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=212.3
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--cCceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--SPHFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--~~~l~LV 767 (967)
++|+..++|++|+||.||+|+++ +..||+|+++........--.-.+||.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56778899999999999999874 6789999997665443333456789999999999999999998764 3469999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
||||++ +|..++..-...+....+..++.|+++|++|||.+ .|+||||||+|+|+++.|.+||+|||+||.+.....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~--wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN--WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc--eeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 999987 89999988778899999999999999999999998 799999999999999999999999999999888766
Q ss_pred CCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc----------ccc-------
Q 037068 848 SSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF----------QNR------- 909 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~----------~~~------- 909 (967)
.....+.|.+|.|||++.+. .|++..|+||+||++.||+++++-|.+......++.|-. .+.
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 66677889999999999876 499999999999999999999999998776554443320 000
Q ss_pred cc------------CCCCC-CcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 RL------------EIPDD-IDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 ~~------------~ip~~-ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.. .++.. +++.-.+|+..+|.+||.+|.|+.+.|+|=
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 00 11111 567889999999999999999999999873
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=326.64 Aligned_cols=255 Identities=33% Similarity=0.560 Sum_probs=216.3
Q ss_pred cCCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
.++|++.+.||+|+||.||+|.+. +..+|+|.+... ........+.+|+.++++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 367899999999999999999752 236899887543 33445678899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+++++|.+++......+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999987666789999999999999999999998 7999999999999999999999999999865432
Q ss_pred ccC---CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 846 YLS---SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 846 ~~~---~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
... .....++..|++||.+.+..++.++|+||||+++||+++ |..||......+....+. .....+.+..+++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAAL 238 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCCCCCCHHH
Confidence 211 112223568999999999899999999999999999886 999998887766655554 334455566789999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+++.+||+.+|.+||++.++++.|..+
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.84 Aligned_cols=243 Identities=22% Similarity=0.406 Sum_probs=204.3
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||.||+++. .++.||+|++.+... .......+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999976 467899999876532 233456678899998877 899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 999988765 45699999999999999999999998 799999999999999999999999999975433333344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------hHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP---------MQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~---------~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+ ......+|..++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAASV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHHHH
Confidence 99999999999999999999999999999999999999963211 1112222 234566788899999999
Q ss_pred HHHhhhcCCCCCcC------HHHHHHH
Q 037068 925 IRDCWQTEPHLRPS------FAQLMSR 945 (967)
Q Consensus 925 I~~CLq~dPe~RPS------~~ELLe~ 945 (967)
|.+||+.||++||+ +.++++|
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999998 5788877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.20 Aligned_cols=257 Identities=25% Similarity=0.466 Sum_probs=214.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||.|+||.||++.+ .++.++||.+..... .......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999975 588999998765432 3344567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 769 EFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
||+++++|.+++.. ....+++..++.++.||+.||.|||++ |++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998763 245689999999999999999999998 7999999999999999999999999998766543
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh--HHHhhhhccccccCCCCCCcHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM--QVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~--ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+.........+..+++.+.+
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 33334456899999999999988999999999999999999999999765432 2222222111122223468899999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
++.+||..+|++|||+.+|++.+++++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=329.15 Aligned_cols=255 Identities=26% Similarity=0.509 Sum_probs=213.1
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCC----eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGT----EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~----~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
++|++.+.||+|+||.||+|.+ .+. .+++|++... .......++..|+.+++++.||||+++++++. ....+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 5788899999999999999976 344 3677765322 22334567888888999999999999999875 44578
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+++||+.+|+|.+++......+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999987667799999999999999999999998 7999999999999999999999999999865332
Q ss_pred c--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 846 Y--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 846 ~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
. .......++..|++||.+.+..++.++|||||||++|||++ |..||.+.........+. .+.....+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCCCCHHHH
Confidence 1 11233456778999999999899999999999999999998 999998887766554443 4445556667888999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
+++.+||..+|.+|||+.++++.|..+.+
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=334.01 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=210.3
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.|++.+.||+|+||.||++.. +++.||||++....... .....+.+|+.+++.++|+||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478899999999999999976 47899999986543322 223457789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 770 FLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|+.+|+|..++... ...+++..+..++.||+.||.|||+. +|+||||||+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE--RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 99999999887543 34689999999999999999999998 79999999999999999999999999997654322 2
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh--ccccccCCCCCCcHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG--FQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~--~~~~~~~ip~~ls~eL~dLI~ 926 (967)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...........+. .......++..+++.+.+||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 234578999999999999999999999999999999999999998765533222221 122344566778999999999
Q ss_pred HhhhcCCCCCc-----CHHHHHHH
Q 037068 927 DCWQTEPHLRP-----SFAQLMSR 945 (967)
Q Consensus 927 ~CLq~dPe~RP-----S~~ELLe~ 945 (967)
+||+.||.+|| ++.++++|
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 89999888
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.41 Aligned_cols=250 Identities=30% Similarity=0.479 Sum_probs=208.0
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||+|+. .++.||+|++.... ......+.+|+.++++++|+||+++++.+...+.+++|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 6799999999999999999976 57789999886432 2334567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 87 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSK--GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 9999999998865 45689999999999999999999988 79999999999999999999999999998664433333
Q ss_pred CCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc---CCCCCCcHHHHH
Q 037068 850 KSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL---EIPDDIDPAVAQ 923 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~---~ip~~ls~eL~d 923 (967)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||....+......+....... ..+..++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 4567889999999984 3457889999999999999999999997665544332222111111 122357889999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+|++||+.+|++||++.+++++|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=345.07 Aligned_cols=239 Identities=25% Similarity=0.404 Sum_probs=200.2
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHH-HHHHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAE-IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~-ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||+||++++ .++.||+|++...... ......+..|.. +++.++|+||+++++++...+.+++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999976 4678999998654221 122234444444 46778999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
++|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~--giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 999999875 45688899999999999999999998 799999999999999999999999999975433333344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....++..+++.+.++|.+||+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999888777665553 23345566889999999999999999
Q ss_pred CCCcCHHH
Q 037068 934 HLRPSFAQ 941 (967)
Q Consensus 934 e~RPS~~E 941 (967)
.+|+++.+
T Consensus 236 ~~R~~~~~ 243 (325)
T cd05602 236 TKRLGAKD 243 (325)
T ss_pred HHCCCCCC
Confidence 99998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=325.32 Aligned_cols=246 Identities=26% Similarity=0.504 Sum_probs=207.7
Q ss_pred EeecCCceEEEEeecC----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 699 RIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
.||+|+||.||+|.+. +..||+|++... ......+.+.+|+.++++++|+||+++++++. ....++||||+.++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999998652 446899987543 23444567899999999999999999999875 45789999999999
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC---CCC
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS---SKS 851 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~---~~~ 851 (967)
+|.+++......+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++........ ...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK--NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc--CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999876566799999999999999999999998 7999999999999999999999999999754332211 112
Q ss_pred CCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 037068 852 TAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQ 930 (967)
Q Consensus 852 ~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq 930 (967)
..++..|+|||.+.+..++.++|||||||++|||++ |..||...........+. .+.....|..+++++.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcC
Confidence 233578999999998889999999999999999996 999999887766655543 445566778889999999999999
Q ss_pred cCCCCCcCHHHHHHHHHHH
Q 037068 931 TEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 931 ~dPe~RPS~~ELLe~L~~L 949 (967)
.+|++||++.+|++.|+.+
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CChhhCcCHHHHHHHHhhh
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.65 Aligned_cols=254 Identities=29% Similarity=0.517 Sum_probs=214.1
Q ss_pred cCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
..+|.+.+.||+|+||.||+|... ++.||+|++.... .......+..|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 346778899999999999999653 3679999876432 33345678899999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC
Q 037068 764 FSILTEFLPRGSLYRLLHRP---------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN 828 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~---------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~ 828 (967)
.++++||+.+++|..++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~--gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH--HVVHKDLATRNVLVFDK 160 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc--CccccccchhheEecCC
Confidence 99999999999999987421 23478889999999999999999988 79999999999999999
Q ss_pred CeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhh
Q 037068 829 WVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVG 905 (967)
Q Consensus 829 g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~ 905 (967)
+.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876533221 1233446789999999988889999999999999999998 889999888777666654
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
.......+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 -NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 334455678899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=330.55 Aligned_cols=260 Identities=31% Similarity=0.548 Sum_probs=216.3
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT 759 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~ 759 (967)
|++..++|++.++||+|+||.||+|..+ +..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 5677889999999999999999998542 3479999865432 2333456788999999999999999999999
Q ss_pred ccCceEEEEeecCCCchhhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 760 RSPHFSILTEFLPRGSLYRLLHRPN---------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 760 ~~~~l~LVmEy~~gGsL~~lL~~~~---------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
.....++||||+.+|+|.+++.... ..++...+..++.||+.||.|||++ +|+||||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK--KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcCCCCChheEEEcCCCc
Confidence 9889999999999999999986421 2346778899999999999999998 7999999999999999999
Q ss_pred EEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcc
Q 037068 831 VKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQ 907 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~ 907 (967)
+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. .
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-D 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999985433221 1122345678999999999999999999999999999998 788999888777665543 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
......+..+++.+.+++.+||+.+|++|||+.++++.|+...
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 3344566778899999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=335.90 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=207.4
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|.+.+.||+|+||.||+|++ .++.||+|.+..... ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 6899999999999999999976 477899998865432 2233457789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+ +|..++......+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 9975 78888776566789999999999999999999998 79999999999999999999999999997654433334
Q ss_pred CCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-----------------ccc
Q 037068 850 KSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-----------------RRL 911 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-----------------~~~ 911 (967)
....+|+.|+|||.+.+ ..++.++|||||||++|+|+||+.||...+..+....+.... ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 44568999999999865 458999999999999999999999998776544332221000 000
Q ss_pred -----------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 912 -----------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 912 -----------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.....+++++.++|.+||+.||.+|||+.|+++|-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 111347889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.38 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=211.1
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||+++. .++.||+|++..... .......+..|+.++..++|+||+++++.+.+.+.++|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999976 478899999865322 2344567888999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-- 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-- 846 (967)
||+++|+|.+++.+ ...+++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~--givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQL--GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999999875 45689999999999999999999998 79999999999999999999999999987432110
Q ss_pred ---------------------------------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 037068 847 ---------------------------------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWK 893 (967)
Q Consensus 847 ---------------------------------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~ 893 (967)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123569999999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCc---CHHHHHHH
Q 037068 894 GLNPMQVVGAVGFQNRRLEIPD--DIDPAVAQIIRDCWQTEPHLRP---SFAQLMSR 945 (967)
Q Consensus 894 ~~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CLq~dPe~RP---S~~ELLe~ 945 (967)
..++......+........+|. .+++++.++|.+++. +|.+|+ ++.++++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 8888776665543333344443 478999999999774 999998 47899988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=325.33 Aligned_cols=256 Identities=34% Similarity=0.592 Sum_probs=214.8
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
|.+..++|.+.++||+|+||.||+|++. ...||+|++..... ..+.+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 4456688999999999999999999774 35799998764332 23568889999999999999999998754 5689
Q ss_pred EEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+||||+.+++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC--CccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999999998753 34578999999999999999999998 799999999999999999999999999976543
Q ss_pred Ccc-CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 TYL-SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~~-~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
... ......++..|++||++.+..++.++|||||||++|||+| |..||......+....+. .......+..++..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 233 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 233 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHH
Confidence 322 1223446778999999998899999999999999999999 888998877766655543 2333445667899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+++.+||+.+|++||++.++++.|+.+
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=322.53 Aligned_cols=256 Identities=34% Similarity=0.609 Sum_probs=218.7
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
|++..++|.+.+.||+|+||.||++... ++.++||.+..... ..+.+.+|+.++++++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 4566789999999999999999999764 46799998764332 3467889999999999999999999999888999
Q ss_pred EEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++ +++|+||||+||+++.++.+||+|||+++....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~--~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR--NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999999987643 5689999999999999999999998 799999999999999999999999999876543
Q ss_pred C-ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 T-YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~-~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
. ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+. .......+...+.++.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELY 234 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 2 111223335678999999999889999999999999999998 999998887766666553 3345566677899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+++.+||+.+|++||++.++++.|+.
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHHHHhc
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=349.99 Aligned_cols=261 Identities=23% Similarity=0.377 Sum_probs=217.1
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeee
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT 759 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~ 759 (967)
.+.+.....++|++.+.||+|+||.||++++ .++.+|+|++..... .......+.+|+.+++.++||||+++++++.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3445666779999999999999999999977 477899999864322 2233456788999999999999999999999
Q ss_pred ccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 760 RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 760 ~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
.+..+++||||+.+|+|..++.. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++++||+|||++
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC--CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999999875 3589999999999999999999998 7999999999999999999999999999
Q ss_pred cccccCc-cCCCCCCCCCCccChhccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC
Q 037068 840 RIKHHTY-LSSKSTAGTPEWMAPEVLRNEP----ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 840 r~~~~~~-~~~~~~~GT~~YmAPE~l~g~~----~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip 914 (967)
+...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+........+|
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 269 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 8654322 1234567999999999997643 7889999999999999999999999888776666655433334444
Q ss_pred --CCCcHHHHHHHHHhhhcCCCC--CcCHHHHHHHHH
Q 037068 915 --DDIDPAVAQIIRDCWQTEPHL--RPSFAQLMSRLR 947 (967)
Q Consensus 915 --~~ls~eL~dLI~~CLq~dPe~--RPS~~ELLe~L~ 947 (967)
..++..+.++|.+||..++.+ |+++.++++|..
T Consensus 270 ~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 368999999999999844443 789999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.17 Aligned_cols=255 Identities=31% Similarity=0.487 Sum_probs=214.5
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
+-...+.|++.++||.|+||.||+|+. .+..+++|.+... +......+.+|+.+++.++|+||+++++.+..++.+
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 334457899999999999999999976 4678999987543 344567788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+++|..++.+....+++..++.++.||+.+|.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM--KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC--CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 999999999999988876566799999999999999999999998 799999999999999999999999999876544
Q ss_pred CccCCCCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCc
Q 037068 845 TYLSSKSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDID 918 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls 918 (967)
.........+++.|+|||++. ...++.++|||||||++|||++|..||...+.......+... ......+..++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence 333334556889999999985 345788999999999999999999999887765544443211 11233456788
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.++.++|.+||+.+|++||++.+++++
T Consensus 243 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 243 MEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 999999999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=350.71 Aligned_cols=264 Identities=32% Similarity=0.526 Sum_probs=221.2
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEe
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFM 755 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLi 755 (967)
...|++..++|.+.+.||+|+||.||+|++. +..||+|++.... .......+.+|+.++.++. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 3458888899999999999999999999753 3579999986542 2333457889999999997 99999999
Q ss_pred eeeeccCceEEEEeecCCCchhhhhcCCC---------------------------------------------------
Q 037068 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPN--------------------------------------------------- 784 (967)
Q Consensus 756 g~~~~~~~l~LVmEy~~gGsL~~lL~~~~--------------------------------------------------- 784 (967)
+++...+..++||||+.+|+|.+++....
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999999999999999999999885421
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEecc
Q 037068 785 ----------------------------------------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDL 818 (967)
Q Consensus 785 ----------------------------------------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDL 818 (967)
..+++..++.++.||+.||.|||+. +|+||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrdl 265 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK--NCVHRDL 265 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--CcCcccC
Confidence 1356778889999999999999987 7999999
Q ss_pred CCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 037068 819 KSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGL 895 (967)
Q Consensus 819 KPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~ 895 (967)
||+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999998643221 12233457889999999999899999999999999999998 89999876
Q ss_pred ChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 896 NPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 896 ~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
...+........+.++..|..++.++.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 346 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 346 PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 6555443333345556677889999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=333.72 Aligned_cols=261 Identities=29% Similarity=0.512 Sum_probs=218.1
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeee
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGA 757 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~ 757 (967)
+|+...++|.+.+.||+|+||.||++.+ .+..||+|++.... .....+.+.+|+.+++++ +|+||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4666778999999999999999999864 23468999875432 234456788999999999 79999999999
Q ss_pred eeccCceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEec
Q 037068 758 VTRSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDF 836 (967)
Q Consensus 758 ~~~~~~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDF 836 (967)
+...+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ +|+|+||||+|||++.++.+||+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999999987533 3489999999999999999999998 7999999999999999999999999
Q ss_pred ccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCC
Q 037068 837 GLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEI 913 (967)
Q Consensus 837 GLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~i 913 (967)
|+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....................
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 99975433211 1223346788999999999999999999999999999998 99999877655444333333444455
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 914 p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+...++++.+++.+||..+|++||++.++++.|.++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 667899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.83 Aligned_cols=251 Identities=33% Similarity=0.556 Sum_probs=214.1
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||.||+|.. .++.+++|.+.... ......+.+|+.++++++||||+++++.+.....++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 36899999999999999999976 46789999986543 235678899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+++|..++......+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET--GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 99999999999877557799999999999999999999998 7999999999999999999999999999765544333
Q ss_pred CCCCCCCCCccChhccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc---ccCCCCCCcHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNE---PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR---RLEIPDDIDPAVA 922 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~---~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~---~~~ip~~ls~eL~ 922 (967)
.....++..|++||.+.+. .++.++|||||||++|+|++|+.||......+....+..... ....+...+.++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 4456788899999999877 789999999999999999999999988776655444332211 1122345678899
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+++.+||..+|.+|||+.+++.|
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.80 Aligned_cols=243 Identities=26% Similarity=0.420 Sum_probs=203.5
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHH-HHHHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAE-IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~-ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||.||+|++ .++.||+|++.+... .......+..|+. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999976 477899999865432 1222344555554 57888999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
++|...+.. ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 999888865 45688999999999999999999988 799999999999999999999999999875433333344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....+|...+.++.++|.+||+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888766665553 33456777889999999999999999
Q ss_pred CCCcCH----HHHHHH
Q 037068 934 HLRPSF----AQLMSR 945 (967)
Q Consensus 934 e~RPS~----~ELLe~ 945 (967)
.+||+. .++++|
T Consensus 236 ~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 236 RRRLGAKADFLEIKNH 251 (321)
T ss_pred hhcCCCCCCHHHHhCC
Confidence 999865 466554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.91 Aligned_cols=255 Identities=31% Similarity=0.533 Sum_probs=215.7
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CC---eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GT---EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~---~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
.++|+..+.||+|+||.||+|... +. .+++|++... ........+..|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 467889999999999999999763 32 6888887543 33444667889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+.+++|..++......+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM--NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999977667789999999999999999999998 7999999999999999999999999999765432
Q ss_pred ccCC---CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 846 YLSS---KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 846 ~~~~---~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
.... .....++.|++||++.+..++.++|||||||++|||++ |..||...+..+....+. .....+.+..++.++
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~ 239 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCPSAV 239 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCCCHHH
Confidence 2111 11223457999999998889999999999999999997 999998877766666554 233445556789999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+++.+||+.+|++||++.++++.|+++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=341.58 Aligned_cols=262 Identities=32% Similarity=0.562 Sum_probs=214.6
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeee
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAV 758 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~ 758 (967)
|....++|++.+.||+|+||.||+|.+ .++.||||++.... .......+.+|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 666678999999999999999999963 35789999986432 233456788999999999 789999999987
Q ss_pred ec-cCceEEEEeecCCCchhhhhcCCC-----------------------------------------------------
Q 037068 759 TR-SPHFSILTEFLPRGSLYRLLHRPN----------------------------------------------------- 784 (967)
Q Consensus 759 ~~-~~~l~LVmEy~~gGsL~~lL~~~~----------------------------------------------------- 784 (967)
.. +..+++||||+.+|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 65 456889999999999999875421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--cCC
Q 037068 785 -------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSS 849 (967)
Q Consensus 785 -------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~ 849 (967)
..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 2367788899999999999999998 79999999999999999999999999997643221 112
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....................|..+++++.+++.+|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999999999999999999999999997 89999876544333332234445566777889999999999
Q ss_pred hhcCCCCCcCHHHHHHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
|+.+|++||++.+|+++|..+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=320.13 Aligned_cols=250 Identities=28% Similarity=0.496 Sum_probs=215.8
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--cCceEEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--SPHFSILT 768 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--~~~l~LVm 768 (967)
+|++.+.||.|+||.||++.+ .++.+++|.+..........+.+..|+.++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588899999999999999965 57789999887665556667788999999999999999999997754 45689999
Q ss_pred eecCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 769 EFLPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLH-----TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLH-----s~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
||+.+++|..++... ...+++..++.++.||+.||.||| +. +++|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~--~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN--TVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC--cceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998643 467899999999999999999999 65 79999999999999999999999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.............+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+. ......++..++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHH
Confidence 76554332345578999999999999889999999999999999999999999887666555543 33344567788999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+.+++.+||+.+|++||++.+|++|
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=337.16 Aligned_cols=265 Identities=32% Similarity=0.580 Sum_probs=223.5
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEE
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLF 754 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkL 754 (967)
.+|++...+|++.+.||+|+||.||++.+. ...||+|.+... ........+.+|+.+++++ +|+||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 568888889999999999999999999642 236899976532 3344567889999999999 79999999
Q ss_pred eeeeeccCceEEEEeecCCCchhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccC
Q 037068 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRP---------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK 819 (967)
Q Consensus 755 ig~~~~~~~l~LVmEy~~gGsL~~lL~~~---------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLK 819 (967)
++++...+..+++|||+.+|+|.+++... ...+++..++.++.||+.||.|||++ ||+|||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--givH~dlk 161 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ--KCIHRDLA 161 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--Ceeccccc
Confidence 99999999999999999999999998642 23478889999999999999999998 79999999
Q ss_pred CCcEEEcCCCeEEEEecccccccccCccC--CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 037068 820 SPNLLVDKNWVVKVCDFGLSRIKHHTYLS--SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLN 896 (967)
Q Consensus 820 PsNILLd~~g~VKLsDFGLAr~~~~~~~~--~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~ 896 (967)
|+|||++.++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||...+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999865432211 222334568999999999999999999999999999998 889999888
Q ss_pred hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 897 PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 897 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
..+....+. .......+..++.++.+++.+||+.+|++||++.+++++|..+....
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 242 VEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 777666554 33445567788999999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=340.60 Aligned_cols=253 Identities=21% Similarity=0.360 Sum_probs=209.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||+++. .++.||+|++.+.. ........+.+|+.+++.++|+||+++++++..++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999976 47889999986432 22334566888999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL- 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~- 847 (967)
||+.+|+|.+++.+....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL--GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999999976566799999999999999999999998 799999999999999999999999999876543222
Q ss_pred CCCCCCCCCCccChhcccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC---CCCcH
Q 037068 848 SSKSTAGTPEWMAPEVLRN-----EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP---DDIDP 919 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g-----~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip---~~ls~ 919 (967)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+........++ ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2233569999999999863 457889999999999999999999998877666555543333233333 34799
Q ss_pred HHHHHHHHhhhcCCCC--CcCHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHL--RPSFAQLMSRL 946 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~--RPS~~ELLe~L 946 (967)
.+.++|++||..++++ |+++.++++|-
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 9999999988654433 78999999993
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.87 Aligned_cols=259 Identities=30% Similarity=0.536 Sum_probs=217.7
Q ss_pred hccCCeeEeEEeecCCceEEEEeecCC-----CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~g-----~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
+..++|.+.+.||+|+||.||+|.+.. ..|+||..... ......+.+.+|+.+++++.|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 345679999999999999999997532 35888876433 234456788999999999999999999998875 45
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.++||||+.+++|.+++......+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 7899999999999999977556789999999999999999999988 79999999999999999999999999997654
Q ss_pred cCcc-CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 844 HTYL-SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 844 ~~~~-~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. .......+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTL 237 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHH
Confidence 3321 1222334568999999988889999999999999999986 999998887766555543 344556778899999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
.++|.+||..+|.+|||+.++++.|..+...
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.77 Aligned_cols=255 Identities=33% Similarity=0.592 Sum_probs=213.6
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecCC-CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~g-~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
|++..++|.+.+.||+|+||.||++.+.+ ..+++|.+.... .....+.+|+.+++.++|+||+++++++.. +..+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 44556789999999999999999997754 478999865432 234567889999999999999999998754 5688
Q ss_pred EEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++|||+.+++|.+++... ...+++..+..++.||+.||.|||+. |++||||||+||++++++.+||+|||+++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM--NYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999999999998753 34588999999999999999999988 799999999999999999999999999976543
Q ss_pred Cc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 TY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
.. .......++..|++||.+.+..++.++||||||+++|||+| |..||......+....+. .......+..++..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHH
Confidence 32 12223346778999999998999999999999999999999 899998877766655543 3334456678899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+++.+||..+|++||+++++++.|+.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=333.75 Aligned_cols=257 Identities=33% Similarity=0.626 Sum_probs=213.3
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCe--EEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTE--VAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~--VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~ 765 (967)
+++|++.+.||+|+||.||+|.+ ++.. +++|.+... ........+.+|+.++.++ +|+||+++++++...+.++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 47899999999999999999975 3443 577765432 2344556788999999999 8999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 766 ILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC--CccccccchheEEecCCCc
Confidence 9999999999999986422 3578999999999999999999988 7999999999999999999
Q ss_pred EEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcccc
Q 037068 831 VKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNR 909 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~ 909 (967)
+||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...+..+....+. ...
T Consensus 163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 240 (303)
T ss_pred EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCC
Confidence 999999998643221 11222334678999999988889999999999999999998 999998877766655543 233
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 910 ~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
....+..+++++.+++.+||+.+|++||++.++++.|..+...
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 4455667889999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=341.96 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=203.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC-----
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP----- 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~----- 762 (967)
..++|++.+.||+|+||.||++.+ .+..||||++............+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 348999999999999999999966 5788999998655444455667889999999999999999999886543
Q ss_pred -ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 763 -HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 763 -~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.+++||||+.+ +|...+. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 47999999976 5655553 2478899999999999999999998 799999999999999999999999999975
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh----------------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG---------------- 905 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~---------------- 905 (967)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 173 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 44322 2344678999999999999999999999999999999999999998766432211110
Q ss_pred ------ccccc------------------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 906 ------FQNRR------------------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 906 ------~~~~~------------------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
..... .......++++.+||.+||+.||++|||+.|+++|-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000 0011234678999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.65 Aligned_cols=254 Identities=35% Similarity=0.590 Sum_probs=215.6
Q ss_pred CCeeEeEEeecCCceEEEEeecC--C---CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--G---TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g---~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
.+|++.+.||+|+||.||+|... + ..||||.+... ........+..|+.++++++||||+++++++..+...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 56889999999999999999763 2 35999987543 345556789999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+++|.+++......+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~--g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999987666789999999999999999999998 79999999999999999999999999987554321
Q ss_pred cC---CCCC--CCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 847 LS---SKST--AGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 847 ~~---~~~~--~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.. .... ..+..|++||.+.+..++.++|||||||++|||++ |..||...+.......+. .....+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHH
Confidence 11 1111 12457999999999999999999999999999886 999998887776666553 33445556778999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+.+++.+||+.+|.+||++.+|+..|..+
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.99 Aligned_cols=249 Identities=31% Similarity=0.525 Sum_probs=207.2
Q ss_pred eeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 694 LQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
|++.+.||+|+||+||+++.. ++.+|+|++...............|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 789999999999999999874 557999998776544444445566999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCC
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKS 851 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~ 851 (967)
.+++|.+++.. ...+++..++.++.||+.||.|||++ +|+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~--~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSK--GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHT--TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccc-cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc
Confidence 99999999973 46689999999999999999999998 7999999999999999999999999999764333334556
Q ss_pred CCCCCCccChhccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh---cccccc--CCCCCCcHHHHHHH
Q 037068 852 TAGTPEWMAPEVLR-NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG---FQNRRL--EIPDDIDPAVAQII 925 (967)
Q Consensus 852 ~~GT~~YmAPE~l~-g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~---~~~~~~--~ip~~ls~eL~dLI 925 (967)
..++..|+|||++. +..++.++||||||+++|+|++|..||...........+. ...... ......++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 77899999999998 8889999999999999999999999999873322222211 111111 11122348999999
Q ss_pred HHhhhcCCCCCcCHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||+.||++||++.+++++
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.59 Aligned_cols=246 Identities=29% Similarity=0.527 Sum_probs=208.5
Q ss_pred EEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecC
Q 037068 698 ERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~ 772 (967)
++||+|+||.||+|.+. +..+|+|.+...... .....+.+|+.+++.+.|+||+++++++. ....++||||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46999999999999652 257999987654433 45567889999999999999999999876 456899999999
Q ss_pred CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC---C
Q 037068 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS---S 849 (967)
Q Consensus 773 gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~---~ 849 (967)
+++|.+++... ..+++..++.++.|++.||.|||.. +++||||||+|||++.++.+||+|||+++........ .
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~--~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESK--HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhc--CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999999764 3789999999999999999999988 7999999999999999999999999999865433221 1
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+..++..+.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHH
Confidence 12223568999999999999999999999999999998 999999888776666554 3445567788999999999999
Q ss_pred hhcCCCCCcCHHHHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L~~L 949 (967)
|..+|++||++.++++.|..+
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.45 Aligned_cols=250 Identities=22% Similarity=0.442 Sum_probs=217.7
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||+|+||.||+++. .++.|++|.+............+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999866 578899999875544455567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 771 LPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
+.+++|.+++... ...+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR--KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9999999988653 34688999999999999999999998 79999999999999999999999999998665443333
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+. .+.....+..++.++.++|.+||
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHh
Confidence 44568889999999999999999999999999999999999998887766665553 33344567788999999999999
Q ss_pred hcCCCCCcCHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSR 945 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~ 945 (967)
+.+|.+||++.++++|
T Consensus 238 ~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 238 KRNPRDRPSVNSILEK 253 (256)
T ss_pred hCChhhCcCHHHHhhC
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=325.47 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=208.4
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeecc-----
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRS----- 761 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~----- 761 (967)
..+.|.+.+.||+|+||.||+|.. .++.||+|.+.... .....+..|+.+++++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 346788889999999999999976 47789999876432 3345678899999998 799999999998653
Q ss_pred -CceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 762 -PHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 762 -~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
..++++|||+.+++|..++... ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~--~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4589999999999999998763 35689999999999999999999998 7999999999999999999999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip 914 (967)
+.............|++.|+|||++. +..++.++|||||||++|||++|+.||...........+.........+
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 86544333344567899999999986 3457889999999999999999999998766555444333222233334
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..++.++.+||.+||+.+|.+|||+.++++|
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 5678999999999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.60 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=203.9
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||+|+||.||+|.. ++..||||++............+.+|+.++++++|+||+++++++..+..+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999976 478899999865444444456788899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 771 LPRGSLYRLLHRP--NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 771 ~~gGsL~~lL~~~--~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
+. ++|.+++... +..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 97 5788877542 35689999999999999999999998 7999999999999999999999999999765433323
Q ss_pred CCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc--------------------
Q 037068 849 SKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-------------------- 907 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-------------------- 907 (967)
.....+++.|+|||.+.+. .++.++|||||||++|+|+||+.||...........+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 3345678999999998764 4789999999999999999999999876543221111000
Q ss_pred -------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 -------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 -------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.........+++++.++|++||+.||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00001123578999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.64 Aligned_cols=243 Identities=24% Similarity=0.396 Sum_probs=203.8
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHH-HHHHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAE-IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~-ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||+||+++. .++.||+|++..... .......+..|.. +++.++||||+++++++...+.+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999976 578999999865422 2233445555655 46778999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~--givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 999988865 45789999999999999999999998 799999999999999999999999999975433333344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.. ....++...+..+.++|++||+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHHHHHHHHHhccCH
Confidence 99999999999999999999999999999999999999998887776665532 3344556789999999999999999
Q ss_pred CCCcCHH----HHHHH
Q 037068 934 HLRPSFA----QLMSR 945 (967)
Q Consensus 934 e~RPS~~----ELLe~ 945 (967)
.+||++. ++++|
T Consensus 236 ~~R~~~~~~~~~i~~h 251 (325)
T cd05604 236 QRRLGAKEDFLEIQEH 251 (325)
T ss_pred HhcCCCCCCHHHHhcC
Confidence 9999764 66655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.36 Aligned_cols=250 Identities=33% Similarity=0.599 Sum_probs=214.3
Q ss_pred cCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
..+|++.+.||+|+||.||++.+. ++.+|+|++..... ....+.+|++++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 357899999999999999999764 77899998754332 23568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-C
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL-S 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~-~ 848 (967)
|+.+++|.+++......+++..++.++.|++.+|.|||+. +++||||||+||+++.++.+||+|||+++....... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS--NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC--CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999876556789999999999999999999988 799999999999999999999999999875543221 1
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+. .......|...+..+.+++.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHH
Confidence 223345678999999998899999999999999999998 999999887777666654 233444566788999999999
Q ss_pred hhhcCCCCCcCHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L 946 (967)
||+.+|++||++.+++++|
T Consensus 237 ~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HcccChhhCCCHHHHHHhh
Confidence 9999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=344.55 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=205.7
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC-----ceE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP-----HFS 765 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~-----~l~ 765 (967)
+|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++|+||+++++++.... .++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999975 5889999998654333445567889999999999999999999998766 789
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+. ++|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 578777754 45689999999999999999999998 7999999999999999999999999999865432
Q ss_pred c-cCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-----------------
Q 037068 846 Y-LSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF----------------- 906 (967)
Q Consensus 846 ~-~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~----------------- 906 (967)
. .......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...++.+....+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 2 122345678999999999875 478999999999999999999999988776544333211
Q ss_pred ------cccc-------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 907 ------QNRR-------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 907 ------~~~~-------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.... ..+....++++.+||.+||+.||++|||+.++++|-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0000 0223456889999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.21 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=205.9
Q ss_pred CCe-eEeEEeecCCceEEEEeec------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--C
Q 037068 692 EDL-QIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--P 762 (967)
Q Consensus 692 e~y-~i~k~LGeG~FG~VYka~~------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~ 762 (967)
++| ++.+.||+|+||+||++.+ .+..||+|.+.... .......+.+|+.++++++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 455 8899999999999987642 46689999876442 334456788999999999999999999987653 3
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.++++|||+.+++|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 58899999999999999875 3599999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCcc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH--HH------------hhhh
Q 037068 843 HHTYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ--VV------------GAVG 905 (967)
Q Consensus 843 ~~~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e--i~------------~~i~ 905 (967)
..... ......++..|++||.+.+..++.++||||||+++|||+||..||....... .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 43221 1122345668999999998889999999999999999999999986543210 00 0001
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
......+.+..++.++.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 112233456678899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=339.88 Aligned_cols=244 Identities=22% Similarity=0.382 Sum_probs=204.3
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||+||+++. .++.||+|++..... .......+.+|+.++.++ +|+||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999976 467899999876432 234456688899999888 699999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHER--GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 999988865 45699999999999999999999998 799999999999999999999999999975433333344567
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN------PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~------~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...... ......+|..++..+.++|.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-HhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999999996432 111221111 234556788899999999999
Q ss_pred hhhcCCCCCcC------HHHHHHH
Q 037068 928 CWQTEPHLRPS------FAQLMSR 945 (967)
Q Consensus 928 CLq~dPe~RPS------~~ELLe~ 945 (967)
||+.||.+|++ +.++++|
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcC
Confidence 99999999997 5688777
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=328.49 Aligned_cols=254 Identities=31% Similarity=0.519 Sum_probs=211.3
Q ss_pred cCCeeEeEEeecCCceEEEEeecCC------------------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCcee
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWHG------------------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~g------------------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIV 752 (967)
.++|++.+.||+|+||.||++.... ..||+|++... ......+.+.+|++++++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4689999999999999999986532 45889987644 2334567889999999999999999
Q ss_pred EEeeeeeccCceEEEEeecCCCchhhhhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCc
Q 037068 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN----------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPN 822 (967)
Q Consensus 753 kLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~----------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsN 822 (967)
++++++..++..+++|||+.+++|..++.+.. ..+++..++.++.|++.||.|||++ ||+||||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~--~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL--NFVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--Cccccccchhc
Confidence 99999999999999999999999999986532 2689999999999999999999998 79999999999
Q ss_pred EEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChh
Q 037068 823 LLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT--LSVPWKGLNPM 898 (967)
Q Consensus 823 ILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT--Gk~PF~~~~~~ 898 (967)
|+++.++.++|+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999997543321 12233456789999999998889999999999999999998 67899877766
Q ss_pred HHHhhhhcc------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 899 QVVGAVGFQ------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 899 ei~~~i~~~------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+....+... ......+..++.++.+++.+||+.+|.+|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 655443311 1122334567899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.03 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=217.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-c
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-S 761 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-~ 761 (967)
+..++|++.+.||+|+||.||+|.+. +..|++|++.. .........+.+|+.++++++|+||+++++++.. +
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34578999999999999999999764 36788887653 3345556778999999999999999999998766 4
Q ss_pred CceEEEEeecCCCchhhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEE
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPN-------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVC 834 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~-------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLs 834 (967)
...++++||+.+++|..++.... ..+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR--GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccCHhhEEEcCCCcEEEC
Confidence 67899999999999999986532 4589999999999999999999988 79999999999999999999999
Q ss_pred ecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcccccc
Q 037068 835 DFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRL 911 (967)
Q Consensus 835 DFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~ 911 (967)
|||+++....... ......++..|+|||++.+..++.++|||||||++||+++ |+.||...++.+....+. ....+
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~ 238 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYRL 238 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCCC
Confidence 9999985432211 1223345678999999999999999999999999999999 999999887776655443 23344
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 912 ~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
..+..+++++.+++.+||..+|++|||+.++++.|..+.+.
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 45566889999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=340.29 Aligned_cols=253 Identities=20% Similarity=0.345 Sum_probs=211.1
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|.+.+.||+|+||.||+++. .++.||+|++.+.. ........+..|+.++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999976 46789999886432 12233455788999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL- 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~- 847 (967)
||+.+|+|..++.+....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~--~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL--HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999999999987566789999999999999999999998 799999999999999999999999999976543322
Q ss_pred CCCCCCCCCCccChhcccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCC---CCcH
Q 037068 848 SSKSTAGTPEWMAPEVLRN-----EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD---DIDP 919 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g-----~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~---~ls~ 919 (967)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+.....+.++|. .+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2233569999999999876 4678899999999999999999999998877666655543333444443 4689
Q ss_pred HHHHHHHHhhhcCCCC--CcCHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHL--RPSFAQLMSRL 946 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~--RPS~~ELLe~L 946 (967)
++.++|.+||...+++ |+++.++++|-
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 9999999999876554 46899999883
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.34 Aligned_cols=255 Identities=31% Similarity=0.585 Sum_probs=216.2
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
|++..++|++.++||+|+||.||++.. .+..+++|.+... ......+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 567789999999999999999999976 4567999876532 2345678889999999999999999999887 7789
Q ss_pred EEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++|||+.+++|.+++... ...+++..++.++.||+.||.|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC--CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999998653 45678899999999999999999987 799999999999999999999999999976543
Q ss_pred Cc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 TY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
.. .......++..|+|||++.+..++.++|+|||||++|+++| |+.||...+.......+. .....+.+...+.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHH
Confidence 22 12223345678999999998889999999999999999999 899999877766655543 3344456677899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+++.+||+.+|++||++.++++.|+.
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=339.25 Aligned_cols=252 Identities=21% Similarity=0.379 Sum_probs=210.4
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.++||+|+||.||+++.+ ++.+|+|++.+... .......+..|+.++..++|+||+++++++...+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999764 67799998854321 2233445788999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC-cc
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT-YL 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~-~~ 847 (967)
||+.+|+|.+++.+....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~--~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999999999987566799999999999999999999998 7999999999999999999999999998754322 22
Q ss_pred CCCCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC---CCCcH
Q 037068 848 SSKSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP---DDIDP 919 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip---~~ls~ 919 (967)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+..+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 233457999999999986 3468899999999999999999999999888777666654433333444 35799
Q ss_pred HHHHHHHHhhhcCCCC--CcCHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHL--RPSFAQLMSR 945 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~--RPS~~ELLe~ 945 (967)
++.+||++||..++.+ |+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999999665444 6899999999
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=366.13 Aligned_cols=259 Identities=24% Similarity=0.434 Sum_probs=215.9
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEee-eeec--
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMG-AVTR-- 760 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig-~~~~-- 760 (967)
+++-..+++|.+.|.+|||+.||.|+.. +..||+|++... ++..+..+++||.+|++|+ |+|||.+++ ....
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 4555678899999999999999999874 379999998654 6777889999999999995 999999999 3322
Q ss_pred -c---CceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEe
Q 037068 761 -S---PHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835 (967)
Q Consensus 761 -~---~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsD 835 (967)
. -+++|+||||.+|.|-++++++ ...|++..+++|+.|+++|+.+||...+.|||||||-+||||+.++++||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 1 2478999999999999998753 3459999999999999999999999988899999999999999999999999
Q ss_pred cccccccccCccCC---------CCCCCCCCccChhcc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhh
Q 037068 836 FGLSRIKHHTYLSS---------KSTAGTPEWMAPEVL---RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGA 903 (967)
Q Consensus 836 FGLAr~~~~~~~~~---------~~~~GT~~YmAPE~l---~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~ 903 (967)
||.|.......... .....|+.|++||++ .+...++|+|||+|||+||-|+....||+....-.++
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl-- 267 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL-- 267 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE--
Confidence 99987543322111 123379999999987 6778999999999999999999999999987433222
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 904 i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
-....++.....+..+.+||+.||+.||.+||++.|+++++.++..
T Consensus 268 --ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 268 --NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred --eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1223333335789999999999999999999999999999988863
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.29 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=211.1
Q ss_pred CeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
-|++.+.||+|+||.||++.+. +..+++|.+... .......+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3677899999999999999774 567788876432 334566788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.+++|..++.+....+++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++...........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999999998876566799999999999999999999998 799999999999999999999999999976544333344
Q ss_pred CCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHHHH
Q 037068 851 STAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dL 924 (967)
...+++.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+... ......|..++.++.++
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 567899999999984 445788999999999999999999999988766554444321 22334566788999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L 946 (967)
|.+||+.+|.+||++.+++++-
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCC
Confidence 9999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.86 Aligned_cols=253 Identities=34% Similarity=0.557 Sum_probs=213.5
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
.+.+|.+.++||+|+||.||++.. .+..+++|.+... .......+.+|+++++.+.|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 456889999999999999999853 2456888876542 3445667999999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN--------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN 828 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~--------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~ 828 (967)
..+++|||+.+++|.+++.... ..+++..++.++.||+.||.|||+. |++||||||+|||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL--HFVHRDLATRNCLVGQG 158 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC--CeecccccHhhEEEcCC
Confidence 9999999999999999986532 3478999999999999999999988 79999999999999999
Q ss_pred CeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhh
Q 037068 829 WVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVG 905 (967)
Q Consensus 829 g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~ 905 (967)
+.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 999999999987543221 11223345788999999999999999999999999999998 899998877666555543
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.+.....+..+++.+.+++.+||+.+|.+||++.+|++.|.
T Consensus 239 -~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 -QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 33445667788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.44 Aligned_cols=254 Identities=33% Similarity=0.534 Sum_probs=213.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
..++|++.+.||+|+||.||+|.. .+..||+|++... ........+.+|+.++++++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 357899999999999999999975 3567999987543 33445567889999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCC
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN---------------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSP 821 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~---------------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPs 821 (967)
..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~--~i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER--KFVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--CeecccccHh
Confidence 9999999999999999986321 2478889999999999999999988 7999999999
Q ss_pred cEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChh
Q 037068 822 NLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPM 898 (967)
Q Consensus 822 NILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ 898 (967)
||+++.++.+||+|||+++...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987543221 11223345678999999999999999999999999999998 88899888777
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 899 QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 899 ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+....+. .......+..++.++.+||.+||+.+|.+|||+.|+++.|+
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 7665553 33334556788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.08 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=206.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||++.+ .++.||+|++..........+.+.+|+.++++++|+||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4799999999999999999976 47889999886543333334567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|++++.|..++.. ...+++..++.++.||+.+|.|||++ |++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9999888887654 44689999999999999999999998 79999999999999999999999999998765443233
Q ss_pred CCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-------------------cc
Q 037068 850 KSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-------------------NR 909 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-------------------~~ 909 (967)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 44567889999999876 45789999999999999999999999877654433221100 00
Q ss_pred ccCC----------CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 RLEI----------PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 ~~~i----------p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..+. ...++..+.+|+.+||+.+|++||++.+++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 12467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.90 Aligned_cols=256 Identities=28% Similarity=0.534 Sum_probs=218.2
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CC----eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GT----EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~----~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
..+|++.+.||+|+||.||+|.+. +. .+|+|.+.... .......+.+|+.++++++|+||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 368899999999999999999652 32 58888765432 34455678899999999999999999999887 789
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+|+|.+++.+....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999987666799999999999999999999997 799999999999999999999999999986543
Q ss_pred CccC--CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 TYLS--SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 ~~~~--~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
.... .....++..|++||.+.+..++.++||||||+++||+++ |+.||......+....+. .......|..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHH
Confidence 2211 112224568999999988889999999999999999998 999999888777665554 444556677789999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
.+++.+||..+|.+||++.++++.|+.+.+
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.10 Aligned_cols=249 Identities=31% Similarity=0.535 Sum_probs=210.8
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh-------hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-------DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-------~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
+|.+.+.||+|+||.||+|.+ .++.+|+|.+....... ...+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999976 47889999876543221 234568899999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.+++|||+++++|..++.. ...+++..+..++.|++.||.|||++ |++||||+|+||+++.++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~--~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNR--GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhc--CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999976 35688999999999999999999998 79999999999999999999999999988654
Q ss_pred cCcc------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 844 HTYL------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 844 ~~~~------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
.... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+. ......++..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCccc
Confidence 2111 1123457889999999999889999999999999999999999998776554443332 23445677788
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+..+.++|.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 9999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.44 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=202.9
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||.|+||.||+|.+ +|+.+++|++............+.+|+.++++++|+||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588999999999999999976 578999999865443444445678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.+ +|..++......+++..++.++.||++||.|||++ ||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH--NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 974 78777765556799999999999999999999998 799999999999999999999999999986544333334
Q ss_pred CCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCC-CCChhHHHhhhhc------------------cccc
Q 037068 851 STAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWK-GLNPMQVVGAVGF------------------QNRR 910 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~-~~~~~ei~~~i~~------------------~~~~ 910 (967)
...+++.|+|||.+.+.. ++.++|||||||++|+|+||..||. ..+..+....+.. ....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987754 7899999999999999999988854 3333222211100 0000
Q ss_pred ---------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 911 ---------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 911 ---------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+....+++++.++|.+||+.||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 01123478899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.18 Aligned_cols=249 Identities=31% Similarity=0.543 Sum_probs=205.1
Q ss_pred EEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee-ccCceEEEEeec
Q 037068 698 ERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT-RSPHFSILTEFL 771 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~-~~~~l~LVmEy~ 771 (967)
+.||+|+||.||+|.+. ...+|+|++... ........+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999652 346899986432 23344677889999999999999999999765 455689999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc----c
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY----L 847 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~----~ 847 (967)
.+++|.+++......+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK--KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999976555678888899999999999999998 79999999999999999999999999997543321 1
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
......++..|+|||.+.+..++.++|||||||++|||++| .+||...+..+....+. .......+..+++.+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence 11233467789999999988999999999999999999995 66787776665554442 33445556778999999999
Q ss_pred HhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
+||+.+|++||++.++++.|+.+.
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.82 Aligned_cols=248 Identities=30% Similarity=0.527 Sum_probs=213.9
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||++... ++.+++|.+.... ....+.+|++++++++|+||+++++++.....+++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 68999999999999999999774 6889999875432 26789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+++|.+++......+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++..........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~--~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN--KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999999999976667799999999999999999999998 79999999999999999999999999998765544333
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-cccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~~C 928 (967)
....++..|++||++.+..++.++||||||+++|+|++|+.||....+......+.. .......+..++.++.++|.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 445688999999999999999999999999999999999999987766544333221 1222334556788999999999
Q ss_pred hhcCCCCCcCHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~ 945 (967)
|+.+|++|||+.+++++
T Consensus 237 l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 237 LVKDPEERPSAIQLLQH 253 (256)
T ss_pred HhcChhhCcCHHHHhcC
Confidence 99999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=326.92 Aligned_cols=252 Identities=31% Similarity=0.506 Sum_probs=215.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||.|+||.||++.. .+..+|+|.+... .....+.+..|+.++++++|+||+++++.+......++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 36789999999999999999976 4778999987543 3445567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+++++|..++......+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH--KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999999887667799999999999999999999998 7999999999999999999999999998765444333
Q ss_pred CCCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHH
Q 037068 849 SKSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVA 922 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~ 922 (967)
.....+++.|++||.+. +..++.++||||||+++|+|++|+.||...+..+....+... ......+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 44556899999999985 345678999999999999999999999988766554444321 123345667899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++|.+||+.+|.+||++.+++++-
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcCh
Confidence 999999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=325.84 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=227.7
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+..++|.+++.||+|-||.||.|+.+ +-.||+|++.+... ......++.+|++|-.+|+||||+++|++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 44589999999999999999999774 55799999876543 2334567899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
|++||...|+|...|.. +...+++...+.++.|++.||.|+|.. .||||||||+|+|++..+.+||+|||.+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k--~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC--CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999988874 456799999999999999999999998 59999999999999999999999999997554
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
.....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||......+....+. ..+..+|..++....++
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--KVDLKFPSTISGGAADL 252 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--HccccCCcccChhHHHH
Confidence 334667899999999999999999999999999999999999999999988777777763 45677889999999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
|.+||.++|.+|.+..|+++|-...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHH
Confidence 9999999999999999999997654
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.07 Aligned_cols=247 Identities=33% Similarity=0.621 Sum_probs=211.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
..++|++.+.||+|+||.||++...++.+|+|++... .....+.+|+.++++++|+||+++++++..+ ..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 3467999999999999999999989999999987532 2345688899999999999999999998765 4799999
Q ss_pred ecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 770 FLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|+.+++|.+++.... ..+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK--KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999987543 4589999999999999999999988 7999999999999999999999999998754332
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
......+..|+|||.+.+..++.++|+|||||++|||++ |+.||......+....+. .......+..++..+.+++++
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHH
Confidence 122334568999999998899999999999999999997 999999888776665553 334555667789999999999
Q ss_pred hhhcCCCCCcCHHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L~ 947 (967)
||+.+|++||++.++++.|+
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HcCCChhhCcCHHHHHHHHc
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.74 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=203.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------ 761 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------ 761 (967)
..++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 458999999999999999999966 478899999865544445566788999999999999999999988643
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
...++||||+.+ +|...+.. .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~--givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 347999999976 56666542 488999999999999999999998 799999999999999999999999999986
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc--------------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-------------- 907 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-------------- 907 (967)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 54432 234467899999999999999999999999999999999999999877644332211000
Q ss_pred --------cc------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 908 --------NR------------------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 908 --------~~------------------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.. ....+...+.++.+||.+||+.||++|||+.|+++|-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 00 0001123456789999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=314.83 Aligned_cols=246 Identities=32% Similarity=0.601 Sum_probs=209.0
Q ss_pred EEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 698 ERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 698 k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
+.||+|+||.||+|.. .++.+|+|++... ........+.+|+.++++++|+||+++++++......++||||+.+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999976 4677999986543 2334445688999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC-CCCCCC
Q 037068 777 YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS-KSTAGT 855 (967)
Q Consensus 777 ~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~-~~~~GT 855 (967)
.+++......+++..++.++.|++.+|.|||++ |++||||||+||+++.++.+||+|||+++......... ....++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESK--NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999876566789999999999999999999988 79999999999999999999999999997544332211 122346
Q ss_pred CCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 037068 856 PEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPH 934 (967)
Q Consensus 856 ~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe 934 (967)
..|+|||++.+..++.++||||||+++|++++ |..||...........+. .......+..++..+.+++.+||+.+|+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 68999999999999999999999999999998 999998887766655543 3445566778899999999999999999
Q ss_pred CCcCHHHHHHHHH
Q 037068 935 LRPSFAQLMSRLR 947 (967)
Q Consensus 935 ~RPS~~ELLe~L~ 947 (967)
+||++.++++.|.
T Consensus 237 ~Rp~~~~l~~~l~ 249 (250)
T cd05085 237 NRPKFSELQKELA 249 (250)
T ss_pred cCCCHHHHHHHhc
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.70 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=209.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeecCC----------------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWHG----------------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~g----------------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVk 753 (967)
..++|++.++||+|+||.||++...+ ..||+|++... ........+.+|++++++++|+||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 34689999999999999999986532 24899987543 34445567899999999999999999
Q ss_pred EeeeeeccCceEEEEeecCCCchhhhhcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCc
Q 037068 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPN-----------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPN 822 (967)
Q Consensus 754 Lig~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsN 822 (967)
+++++......++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ |++||||||+|
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i~H~dlkp~N 159 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL--NFVHRDLATRN 159 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc--CeeccccChhh
Confidence 9999999999999999999999999885422 2368889999999999999999998 79999999999
Q ss_pred EEEcCCCeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChh
Q 037068 823 LLVDKNWVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT--LSVPWKGLNPM 898 (967)
Q Consensus 823 ILLd~~g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT--Gk~PF~~~~~~ 898 (967)
|+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|+|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999975433211 1222345678999999998899999999999999999998 67899887766
Q ss_pred HHHhhhhc------cccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 899 QVVGAVGF------QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 899 ei~~~i~~------~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+....+.. .......+..+++.+.+++++||+.+|++||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 55443321 11122345568899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.18 Aligned_cols=249 Identities=27% Similarity=0.482 Sum_probs=215.5
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||+|+||.||++.. .++.+++|.+............+.+|+.+++.++|+||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999865 578899999876655556677899999999999999999999999989999999999
Q ss_pred cCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-CeEEEEecccccccccCccC
Q 037068 771 LPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 771 ~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-g~VKLsDFGLAr~~~~~~~~ 848 (967)
+++++|.+++... ...+++..++.++.|++.+|.|||++ ||+|+||||+||+++.+ +.+||+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK--LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-c
Confidence 9999999999764 34589999999999999999999998 79999999999999854 578999999998665432 2
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+. ......++..+++++.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcCHHHHHHHHHH
Confidence 234568899999999998889999999999999999999999998887766555443 2334456777899999999999
Q ss_pred hhcCCCCCcCHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~ 945 (967)
|+.+|.+|||+.+++++
T Consensus 237 l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 237 LNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ccCChhhCCCHHHHhhC
Confidence 99999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.87 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=198.7
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc---CCCceeEEeeeeec-----cC
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL---RHPNVVLFMGAVTR-----SP 762 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L---~HpNIVkLig~~~~-----~~ 762 (967)
+|++.+.||+|+||.||+|++ +++.||+|.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999976 478899998865433333334456677777665 79999999998764 34
Q ss_pred ceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.++++|||+.+ +|..++... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 58999999975 788887653 34589999999999999999999998 799999999999999999999999999986
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-c--------ccc-
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-N--------RRL- 911 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~--------~~~- 911 (967)
..... ......+|..|+|||++.+..++.++|||||||++|+|++|++||...........+... . ...
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 54332 233456899999999999989999999999999999999999999876654333222100 0 000
Q ss_pred ---------------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 ---------------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 ---------------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.....++..+.++|.+||+.||++|||+.+++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1113567889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.85 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=207.3
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|.+.+.||.|+||.||++.+ +++.||+|.+..... ......+.+|+.++++++|+||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 36899999999999999999976 478899998864432 223345778999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+. ++|..++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.........
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9997 589888876666789999999999999999999998 7999999999999999999999999999765433333
Q ss_pred CCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-----------------ccc
Q 037068 849 SKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-----------------NRR 910 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-----------------~~~ 910 (967)
.....+++.|+|||.+.+. .++.++|||||||++|||+||+.||...+..+....+... ...
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 3445678999999998764 4788999999999999999999999877654433221100 000
Q ss_pred cCC-----------CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 911 LEI-----------PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 911 ~~i-----------p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
... ...+++.+.+||.+||+.||.+|||+.++++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 135788999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.01 Aligned_cols=249 Identities=30% Similarity=0.490 Sum_probs=214.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||.|+||.||+|.+ .++.|++|.+.... .......+.+|+.+++.++|+||+++++++..+..+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4688889999999999999976 47789999876442 33445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+++|.+++... .+++..++.++.||+.||.|||++ +++|+||+|+||++++++.++|+|||+++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE--GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999998753 789999999999999999999998 79999999999999999999999999998766543334
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCC-CcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDD-IDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~-ls~eL~dLI~~C 928 (967)
....+++.|++||.+.+..++.++||||||+++|+|+||+.||...++......+. ......++.. +++++.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-hcCCCCCcccccCHHHHHHHHHH
Confidence 45678899999999999889999999999999999999999998877665554443 2233344444 889999999999
Q ss_pred hhcCCCCCcCHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L 946 (967)
|..+|++||++.+++++-
T Consensus 235 l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 235 LNKDPKERPSAKELLKHK 252 (274)
T ss_pred hhCChhhCcCHHHHhhCh
Confidence 999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=350.74 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=198.4
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------ 761 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------ 761 (967)
...+|.+.+.||+|+||.||+|.+ .++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 446899999999999999999976 57889999875432 2234699999999999999999876432
Q ss_pred --CceEEEEeecCCCchhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-CeEEEEe
Q 037068 762 --PHFSILTEFLPRGSLYRLLH---RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCD 835 (967)
Q Consensus 762 --~~l~LVmEy~~gGsL~~lL~---~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-g~VKLsD 835 (967)
..+++||||+.+ +|..++. .....+++..++.++.||+.||.|||++ ||+||||||+||||+.+ +.+||+|
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~--~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCcCHHHEEEcCCCCceeeec
Confidence 236799999975 6666553 2356799999999999999999999998 79999999999999865 4799999
Q ss_pred cccccccccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-------
Q 037068 836 FGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ------- 907 (967)
Q Consensus 836 FGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~------- 907 (967)
||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+....+...
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99998654332 23346789999999998764 6899999999999999999999999887654433222110
Q ss_pred --------------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 908 --------------------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 908 --------------------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.....+|...++++.+||.+||+++|.+|||+.|+++|-.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0011234557889999999999999999999999998843
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.10 Aligned_cols=246 Identities=34% Similarity=0.581 Sum_probs=210.6
Q ss_pred EEeecCCceEEEEeecC---CC--eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecC
Q 037068 698 ERIGIGSYGEVYRADWH---GT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~---g~--~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~ 772 (967)
+.||+|+||.||+|.+. ++ .||||.+...... .....+.+|+.++++++|+||+++++.+.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 36899999999999763 22 5899988665433 556789999999999999999999999888 88999999999
Q ss_pred CCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc---cC
Q 037068 773 RGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY---LS 848 (967)
Q Consensus 773 gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~---~~ 848 (967)
+++|.+++.+.. ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||+++...... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC--CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999987644 5689999999999999999999998 79999999999999999999999999998654321 11
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+.........+..++..+.+++.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 223457789999999999999999999999999999998 9999988877776665554445555667789999999999
Q ss_pred hhhcCCCCCcCHHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L~ 947 (967)
||+.+|++||++.++++.|.
T Consensus 237 ~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 237 CWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HCCCCcccCCCHHHHHHHhc
Confidence 99999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.92 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=208.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC------------------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH------------------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~------------------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI 751 (967)
..++|++.+.||+|+||.||++++. ...+|+|++... ........+.+|+.++++++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999998542 235888987543 234445678999999999999999
Q ss_pred eEEeeeeeccCceEEEEeecCCCchhhhhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCC
Q 037068 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN----------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSP 821 (967)
Q Consensus 752 VkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~----------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPs 821 (967)
+++++++...+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+. ||+||||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dlkp~ 159 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--NFVHRDLATR 159 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC--CeecccCChh
Confidence 999999999999999999999999999886522 2467889999999999999999998 7999999999
Q ss_pred cEEEcCCCeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCh
Q 037068 822 NLLVDKNWVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT--LSVPWKGLNP 897 (967)
Q Consensus 822 NILLd~~g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT--Gk~PF~~~~~ 897 (967)
|||++.++.+||+|||+++....... ......+++.|++||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999975433211 1122334678999999988889999999999999999998 7789987766
Q ss_pred hHHHhhhhc------cccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 898 MQVVGAVGF------QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 898 ~ei~~~i~~------~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.+....... .....+.+..+++.+.+++.+||+.||.+||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 554433211 11123445678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.21 Aligned_cols=249 Identities=31% Similarity=0.498 Sum_probs=207.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|.+.+.||+|+||.||+|.+ .++.||+|.+.... ......+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 5788889999999999999976 47889999876432 2334567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+++|.+++.. ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++..........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSK--GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 9999999999865 45689999999999999999999998 79999999999999999999999999987654433334
Q ss_pred CCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC-C--CCCCcHHHHH
Q 037068 850 KSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE-I--PDDIDPAVAQ 923 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~-i--p~~ls~eL~d 923 (967)
....|++.|+|||.+. ...++.++|||||||++|+|++|..||....+............... . ...++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 4567899999999984 45688999999999999999999999976655443332221211111 1 1246789999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+|.+||+.+|++||++.+|++|
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcC
Confidence 9999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=315.43 Aligned_cols=246 Identities=33% Similarity=0.597 Sum_probs=209.6
Q ss_pred EEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 698 ERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
++||+|+||.||++.+. ++.|++|++...... .....+.+|++++++++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36999999999999764 788999987654322 4556789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC--CCCCC
Q 037068 777 YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS--KSTAG 854 (967)
Q Consensus 777 ~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~--~~~~G 854 (967)
.+++......+++..++.++.|++.+|.|||++ +++||||||+||+++.++.+||+|||+++......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~--~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK--NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999976566789999999999999999999988 79999999999999999999999999997654221111 12234
Q ss_pred CCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 855 T~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
+..|+|||.+.+..++.++|||||||++|||+| |..||...........+. .......+..++.++.+++.+||+.+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999998899999999999999999999 889998877666555543 233455677889999999999999999
Q ss_pred CCCcCHHHHHHHHH
Q 037068 934 HLRPSFAQLMSRLR 947 (967)
Q Consensus 934 e~RPS~~ELLe~L~ 947 (967)
.+||++.++++.|+
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.44 Aligned_cols=240 Identities=22% Similarity=0.320 Sum_probs=195.3
Q ss_pred eecCCceEEEEeec--CCCeEEEEEeecCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 700 IGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 700 LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
||+|+||.||+++. .++.||+|++....... .....+..|++++++++||||+++++++..+..+++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999976 48899999986533222 2233456799999999999999999999999999999999999999
Q ss_pred hhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCC
Q 037068 777 YRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855 (967)
Q Consensus 777 ~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT 855 (967)
..++... ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM--DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 8887543 34588999999999999999999998 79999999999999999999999999987654332 22345689
Q ss_pred CCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh----HHHhhhhccccccCCCCCCcHHHHHHHHHhhhc
Q 037068 856 PEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM----QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQT 931 (967)
Q Consensus 856 ~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~----ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~ 931 (967)
..|+|||++.+..++.++|||||||++|||++|+.||...... +...... ..........+++++.++|.+||+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-ccccccccccCCHHHHHHHHHHhcc
Confidence 9999999999999999999999999999999999999765432 1211111 1111112246899999999999999
Q ss_pred CCCCCcCHHHHH
Q 037068 932 EPHLRPSFAQLM 943 (967)
Q Consensus 932 dPe~RPS~~ELL 943 (967)
||++||++.|++
T Consensus 237 ~P~~R~~~~~~~ 248 (277)
T cd05607 237 KPEDRLGSREKN 248 (277)
T ss_pred CHhhCCCCccch
Confidence 999999995554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=337.97 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=203.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------C
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------P 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------~ 762 (967)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++|+||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47999999999999999999976 478899999865444445566788999999999999999999987543 3
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+.+ +|...+.. .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999975 66666643 478899999999999999999998 7999999999999999999999999999865
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc-------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------------- 909 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------------- 909 (967)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 177 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 4432 23446789999999999999999999999999999999999999988765443332211000
Q ss_pred -------c--------------------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 -------R--------------------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 -------~--------------------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+ .......+.++.+||.+||+.||.+|||+.++++|-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0 001112356789999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=322.12 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=209.4
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeee--
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVT-- 759 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~-- 759 (967)
..+....++|++.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34455678999999999999999999966 57789999864321 2235678899999999 7999999999874
Q ss_pred ---ccCceEEEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEE
Q 037068 760 ---RSPHFSILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKV 833 (967)
Q Consensus 760 ---~~~~l~LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKL 833 (967)
.++.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN--KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC--CccccCCCHHhEEECCCCCEEE
Confidence 34568999999999999988752 345688999999999999999999998 7999999999999999999999
Q ss_pred EecccccccccCccCCCCCCCCCCccChhcccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-
Q 037068 834 CDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN-----EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ- 907 (967)
Q Consensus 834 sDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g-----~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~- 907 (967)
+|||+++.............|++.|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 999999866544333445578999999999853 44788999999999999999999999877654443322211
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
......+..++..+.++|.+||+.+|++|||+.++++++
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 112234556788999999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.47 Aligned_cols=247 Identities=34% Similarity=0.618 Sum_probs=205.1
Q ss_pred EeecCCceEEEEeecC--CC--eEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 699 RIGIGSYGEVYRADWH--GT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~--g~--~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
.||+|+||.||+|+.. +. .+++|.+... ........+.+|+.+++++ +||||+++++++...+.+++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 5899999999999763 33 4677776532 2334456788999999999 899999999999999999999999999
Q ss_pred CchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 774 GSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 774 GsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+|||++.++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~--~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccccceEEEcCCCeEEECCCCC
Confidence 99999986421 2478999999999999999999987 799999999999999999999999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
+....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...+.......+. .......+..+
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (270)
T cd05047 159 SRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236 (270)
T ss_pred ccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCcC
Confidence 86432211 1122234567999999998899999999999999999997 999998877766655543 23344566778
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
+.++.+++.+||..+|.+|||+.++++.|..+.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=340.23 Aligned_cols=242 Identities=24% Similarity=0.431 Sum_probs=202.1
Q ss_pred eecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc---CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 700 IGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL---RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 700 LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L---~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
||+|+||+||+|++ .++.||||++..... ..........|..++..+ +||||+++++++.....+++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999976 478999999865322 222334455677777665 699999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|..++.+ ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKY--DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 999988875 55689999999999999999999998 799999999999999999999999999976443333345567
Q ss_pred CCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC-CCCcHHHHHHHHHhhhc
Q 037068 854 GTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP-DDIDPAVAQIIRDCWQT 931 (967)
Q Consensus 854 GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip-~~ls~eL~dLI~~CLq~ 931 (967)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... ..+| ..+++++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--VRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCC
Confidence 99999999999765 47899999999999999999999999888777666654332 3334 35789999999999999
Q ss_pred CCCCCc----CHHHHHHHH
Q 037068 932 EPHLRP----SFAQLMSRL 946 (967)
Q Consensus 932 dPe~RP----S~~ELLe~L 946 (967)
||.+|| ++.++++|-
T Consensus 236 ~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 236 NPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred CHHHCCCCCCCHHHHhcCc
Confidence 999998 688888863
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=338.57 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=221.9
Q ss_pred hccCCeeEeEEeecCCceEEEEeecCC--CeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWHG--TEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~g--~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
.-.+.|++.++||.|.-|+||+++.++ ..+|+|++.+... ....+.++..|.+||+.+.||+++.||..|+.+...|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 344678888999999999999998865 7899999877644 3456778899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||.||+|..++++ +++.+++..+..++.+|+-||+|||.. |||+|||||+||||-++|+|.|+||-|+....-
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml--GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML--GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh--ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999999865 567899999999999999999999999 899999999999999999999999998642100
Q ss_pred ---------------------------------C-c----------------------cCCCCCCCCCCccChhccccCC
Q 037068 845 ---------------------------------T-Y----------------------LSSKSTAGTPEWMAPEVLRNEP 868 (967)
Q Consensus 845 ---------------------------------~-~----------------------~~~~~~~GT~~YmAPE~l~g~~ 868 (967)
. . .....++||-.|.|||++.|+-
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0122356999999999999999
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcC----HHHHHH
Q 037068 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPS----FAQLMS 944 (967)
Q Consensus 869 ~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS----~~ELLe 944 (967)
.+.++|+|+|||++|||+.|..||.+.+..+.+..+..+...++--..++..+++||+++|.+||.+|.. +.||-+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 9999999999999999999999999999999888886555555444578899999999999999999987 888888
Q ss_pred H
Q 037068 945 R 945 (967)
Q Consensus 945 ~ 945 (967)
|
T Consensus 392 H 392 (459)
T KOG0610|consen 392 H 392 (459)
T ss_pred C
Confidence 7
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=324.66 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=209.3
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.|+..+.||+|+||+||++.+ +++.+|+|.+....... .....+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367789999999999999976 47889999986543322 234457789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 770 FLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|+.+++|..++... ...+++..+..++.|++.||.|||+. ||+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE--NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-S 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-c
Confidence 99999999887643 34699999999999999999999988 79999999999999999999999999987543321 2
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--cccccCCCCCCcHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF--QNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~--~~~~~~ip~~ls~eL~dLI~ 926 (967)
.....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.. ......++..+++++.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 2345789999999999999999999999999999999999999987765433322221 22233456778999999999
Q ss_pred HhhhcCCCCCcC-----HHHHHHH
Q 037068 927 DCWQTEPHLRPS-----FAQLMSR 945 (967)
Q Consensus 927 ~CLq~dPe~RPS-----~~ELLe~ 945 (967)
.||+.+|++||+ +.+++.|
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcC
Confidence 999999999999 7888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=318.07 Aligned_cols=250 Identities=30% Similarity=0.514 Sum_probs=210.3
Q ss_pred CeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCC----hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFS----GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s----~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
+|++.+.||.|+||.||+|.. .++.+|+|.+...... ......+.+|+.++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999976 5778999987643221 23346688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC--
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT-- 845 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~-- 845 (967)
|||+.+++|.+++.+ ...+++..++.++.||+.||.|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999875 34688999999999999999999988 7999999999999999999999999998754211
Q ss_pred ----ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHH
Q 037068 846 ----YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPA 920 (967)
Q Consensus 846 ----~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~e 920 (967)
........++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... .....++..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11123356889999999999988999999999999999999999999876655433332222 2334567788999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+.++|++||+.+|.+||++.+++++
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=325.70 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=216.8
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
.+.....+|++.+.||.|+||.||++.+ .++.|++|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 3344456899999999999999999965 57899999886543 2235678889999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+++|+||+.+++|..++.. ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~--~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN--QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 9999999999999998864 3589999999999999999999998 79999999999999999999999999987654
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-cccccCCCCCCcHHHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRLEIPDDIDPAVA 922 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~~ip~~ls~eL~ 922 (967)
..........++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. .......+..+++.+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 433333445688999999999998899999999999999999999999988876554433322 2223445677899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++|.+||..+|.+||++.+++++=
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhCh
Confidence 999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=326.25 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=212.6
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
...+|++.+.||+|+||.||+|.+ .++.|++|.+..... .....+.+|+.+++.++|+||+++++.+..+...++|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 446899999999999999999975 578899998865432 2346688899999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+++|.+++.+ ..+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+++.......
T Consensus 96 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~--gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999999864 4588999999999999999999998 799999999999999999999999999876543332
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-cccccCCCCCCcHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~ 926 (967)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......... .......+..+++.+.++|.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 33445788999999999998899999999999999999999999987766443322221 12233445678899999999
Q ss_pred HhhhcCCCCCcCHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L 946 (967)
+||..+|++||++.+++++-
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred HHCcCCcccCcCHHHHhhCh
Confidence 99999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=314.91 Aligned_cols=249 Identities=33% Similarity=0.560 Sum_probs=214.0
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF---SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~---s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
+|+..+.||+|+||.||+|.. ++..|++|.+..... .......+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477789999999999999976 478899998865432 234567789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+. ||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999875 34688999999999999999999998 79999999999999999999999999987654433
Q ss_pred CCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
......+++.|++||.+.... ++.++|+||||+++|+|++|+.||...........+........++..+++.+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 234566889999999998776 8999999999999999999999998877555544444334455667788999999999
Q ss_pred HhhhcCCCCCcCHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~ 945 (967)
+||+.+|.+||++.+++.+
T Consensus 237 ~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 237 KCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHhhcCcccCcCHHHHhcC
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=327.67 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=209.7
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||++.+ ++..+|+|.+... .......++.+|++++++++||||+++++.+..++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 4789999999999999999976 4667888876533 344456678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.. +++||||||+|||++.++.+||+|||++....... .
T Consensus 80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~ 155 (308)
T cd06615 80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A 155 (308)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhC-CEEECCCChHHEEEecCCcEEEccCCCcccccccc--c
Confidence 9999999999876 356899999999999999999999843 79999999999999999999999999987654332 3
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc----------------------
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---------------------- 907 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~---------------------- 907 (967)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 4457899999999998888999999999999999999999999765544332222110
Q ss_pred -------------ccccCCC-CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 908 -------------NRRLEIP-DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 908 -------------~~~~~ip-~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
...+..| ..++.++.+++.+||..+|++||++.+++++..-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0011112 13678899999999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=360.95 Aligned_cols=264 Identities=34% Similarity=0.544 Sum_probs=236.7
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC--C---CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH--G---TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~--g---~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
.++......|.+.||.|.||.||+|+.+ + ..||||.++. ...+.....|..|..||-++.||||++|.|+....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 3556677889999999999999999763 3 4699998754 46677788899999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.-..||.|||++|+|+.||+++.++++..+...+++.|+.||+||-+. ++|||||.++||||+.+..+|++|||++|.
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm--~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM--NYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc--CchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999999999999999999999999999999999 699999999999999999999999999997
Q ss_pred cccCccCC---CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 842 KHHTYLSS---KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 842 ~~~~~~~~---~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
..+..... ..-.-..+|.|||.|...+++.++||||+|++|||.++ |..||....+.++++.+. ++.+++.|-.|
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDC 859 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDC 859 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCC
Confidence 75443222 22223569999999999999999999999999999877 899999999999998885 78899999999
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
|..|..||..||++|-.+||.|.||+.+|.++++...
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 9999999999999999999999999999999987653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.77 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=227.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
+.++|++.+.||+|.|+.||+..+ +|+.+|+|++....+.....+++.+|+.|.+.|+||||+++.+.+...+..|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 347888899999999999998854 688899998876666666778899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc---CCCeEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD---KNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd---~~g~VKLsDFGLAr~~~~ 844 (967)
+|+|.|++|..-|-.+ .-+++..+-.++.||+.+|.|.|.+ ||||||+||+|+|+. .+--+||+|||+|....
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n--~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN--GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc--CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 9999999998666543 4578899999999999999999999 799999999999994 45689999999998777
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC--CCCCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE--IPDDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~--ip~~ls~eL~ 922 (967)
.......++|||.|||||+++..+|+..+|||+-||+||-|+.|.+||.+.+...+.+.|.......+ ....++++.+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 55567889999999999999999999999999999999999999999999988888888875544443 3468999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
+|+++||..||.+|.|+.|.|+|-+...+
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999999999999999999988665543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=334.75 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=209.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-----cCc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-----SPH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-----~~~ 763 (967)
...|...+.||.|+||.|+.+.+ +|..||||++...-.+....++..+|+++++.++|+||+.+++.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 35677689999999999999966 58899999987554455667889999999999999999999999865 346
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+|+|+|+| +.+|..+++. +..+++..+..++.||++||.|+|+. +|+||||||.|+|++.++.+||+|||+||...
T Consensus 101 vYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSA--nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSA--NVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcc--cccccccchhheeeccCCCEEeccccceeecc
Confidence 99999999 5589999986 44599999999999999999999999 59999999999999999999999999999875
Q ss_pred cC--ccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh---------------
Q 037068 844 HT--YLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG--------------- 905 (967)
Q Consensus 844 ~~--~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~--------------- 905 (967)
.. .......+.|.+|.|||++.+ ..|+...||||+||++.||++|++-|.+.+.-..+..+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 32 122355778999999999754 569999999999999999999999998876543332221
Q ss_pred ---------ccccccCCC-----CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 906 ---------FQNRRLEIP-----DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 906 ---------~~~~~~~ip-----~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
......+.| ++.++...+|+.+||..||.+|+|++|.|+|-
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 011111111 36789999999999999999999999999983
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=317.42 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=208.9
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+..++.+.....||+|+||.||+|.+ .+..|++|.+.... ......+.+|+.+++.++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 44455666667899999999999975 46679999875432 334567899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-CCeEEEEeccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQL--DERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSRIK 842 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~L--se~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-~g~VKLsDFGLAr~~ 842 (967)
+|+||+.+++|..++......+ ++..+..++.||+.||.|||+. ||+||||||+||+++. ++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN--QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999987644445 8888999999999999999988 7999999999999976 679999999998765
Q ss_pred ccCccCCCCCCCCCCccChhccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChhHH-HhhhhccccccCCCCCCcH
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEP--ANEKCDVYSFGVILWELATLSVPWKGLNPMQV-VGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~--~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei-~~~i~~~~~~~~ip~~ls~ 919 (967)
...........+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||........ ............+|..+++
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 44333334456899999999987654 78899999999999999999999976543222 1122222344567778999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
++.+++.+||+.+|.+|||+.+++.|
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 99999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.65 Aligned_cols=250 Identities=30% Similarity=0.526 Sum_probs=209.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeeeec--cCce
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS---GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--SPHF 764 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s---~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--~~~l 764 (967)
.+|++.+.||+|+||.||+|.. .++.|++|++...... ......+.+|+.++++++|+||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999975 5788999987654322 2345678899999999999999999998875 3568
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+++|||+.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~--~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999875 34588999999999999999999988 799999999999999999999999999875432
Q ss_pred Cc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 TY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 ~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+........+|..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 11 112234588899999999998899999999999999999999999988776555544443444566677889999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+++ +||..+|++||++.+|++|
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcC
Confidence 9999 6888999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=324.07 Aligned_cols=252 Identities=26% Similarity=0.474 Sum_probs=211.7
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||++.+ .+..||+|.+... ........+.+|+.++++++|+||+++++.+...+.+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4688899999999999999977 4788999987643 344456788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 770 FLPRGSLYRLLHRP--NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 770 y~~gGsL~~lL~~~--~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|+++++|..++... ...+++..+..++.||+.||.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH-NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC-CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999999988753 246899999999999999999999753 7999999999999999999999999999765433
Q ss_pred CCCCCCCCCCccChhccccCC------CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh--ccccccCCCCCCcH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEP------ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG--FQNRRLEIPDDIDP 919 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~------~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~--~~~~~~~ip~~ls~ 919 (967)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...........+. .......++..+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence 223456888999999985543 4789999999999999999999997765544333221 12334556777999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
++.++|.+||+.+|++||++.+++.+-.
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 9999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=319.55 Aligned_cols=254 Identities=31% Similarity=0.541 Sum_probs=205.5
Q ss_pred CCeeEeEEeecCCceEEEEeec------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--cCc
Q 037068 692 EDLQIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--SPH 763 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--~~~ 763 (967)
.+|++.+.||+|+||.||++.. .+..||+|++... .......+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5789999999999999999863 4678999987543 33446678999999999999999999997654 346
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+++||||+++++|.+++......+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~--~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK--RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 8999999999999999976556789999999999999999999998 79999999999999999999999999998654
Q ss_pred cCcc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHH---------------Hhhhh
Q 037068 844 HTYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV---------------VGAVG 905 (967)
Q Consensus 844 ~~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei---------------~~~i~ 905 (967)
.... ......++..|+|||.+.+..++.++|||||||++|||++|..|+........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 11122344569999999998999999999999999999998776543321100 00011
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
........+..++.++.+++.+||..+|++|||+.+|++.|..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 12223445567889999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=324.39 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=208.3
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.|++.+.||+|+||.||++.+ +++.||||.+...... ......+.+|+.++++++|+||+++++.+...+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367889999999999999976 4778999988654332 2234557789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 770 FLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|+.+++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 99999999888542 34689999999999999999999988 79999999999999999999999999987554322 2
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH---HHhhhhccccccCCCCCCcHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ---VVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e---i~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... .......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 234578999999999999999999999999999999999999998654321 111111 1122345677899999999
Q ss_pred HHhhhcCCCCCcC-----HHHHHHHHH
Q 037068 926 RDCWQTEPHLRPS-----FAQLMSRLR 947 (967)
Q Consensus 926 ~~CLq~dPe~RPS-----~~ELLe~L~ 947 (967)
.+||+.||++||| +.++++|-.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChh
Confidence 9999999999999 899999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=342.69 Aligned_cols=247 Identities=21% Similarity=0.271 Sum_probs=198.5
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
+...+|++.+.||+|+||.||++.+ +++.||+|+.. ...+.+|+.++++++||||+++++++......++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 3457899999999999999999976 57889999642 2346789999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC-
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT- 845 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~- 845 (967)
|||++. ++|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 161 v~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~--~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHEN--RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999985 688888765 35689999999999999999999998 7999999999999999999999999999754322
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------hHHHhhhh-c-----------
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP-------MQVVGAVG-F----------- 906 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~-------~ei~~~i~-~----------- 906 (967)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+. .
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1223346799999999999999999999999999999999999987643211 00000000 0
Q ss_pred ------------cccccCCC---------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 907 ------------QNRRLEIP---------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 907 ------------~~~~~~ip---------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.......+ ..++.++.+||.+||+.||++|||+.|+|+|-.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 00000000 135678999999999999999999999998754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=341.95 Aligned_cols=253 Identities=29% Similarity=0.471 Sum_probs=224.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh-hhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-DSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~ 765 (967)
..+.|++.+.||.|.||.||+++. +|+.+|+|++.+..... .....+.+|+.+|+++. |||||.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 447899999999999999999976 47889999998765433 34678999999999997 999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC----CCeEEEEecccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK----NWVVKVCDFGLSRI 841 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~----~g~VKLsDFGLAr~ 841 (967)
+|||++.||.|.+.+... .+++..+..++.||+.+++|||+. ||+||||||+|+|+.. ++.+|++|||++..
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~--gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL--GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999998765 399999999999999999999998 8999999999999953 35899999999998
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCcH
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDIDP 919 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls~ 919 (967)
... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+.........+......+ +....++.
T Consensus 189 ~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 189 IKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 776 455778899999999999999999999999999999999999999999998877777665444333 33457899
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.+.++|+.+|..||.+|+|+.++|+|-+
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 9999999999999999999999999854
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=314.64 Aligned_cols=249 Identities=32% Similarity=0.563 Sum_probs=210.5
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||+|+||.||++.. .++.|++|.+............+..|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999965 578899999876654445678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC-
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS- 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~- 849 (967)
+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~--~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSH--GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999876 34588999999999999999999998 79999999999999999999999999988654432221
Q ss_pred ---CCCCCCCCccChhccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChhH-HHhhhhccccccCCCCC--CcHH
Q 037068 850 ---KSTAGTPEWMAPEVLRNEP---ANEKCDVYSFGVILWELATLSVPWKGLNPMQ-VVGAVGFQNRRLEIPDD--IDPA 920 (967)
Q Consensus 850 ---~~~~GT~~YmAPE~l~g~~---~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e-i~~~i~~~~~~~~ip~~--ls~e 920 (967)
....+++.|++||.+.+.. ++.++||||||+++|+|++|+.||....... ....+. ......+|.. +++.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPE 236 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccCHH
Confidence 1356788999999998776 8899999999999999999999998764332 222222 2334445544 4899
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+.++|.+||+.+|.+||++.+++.+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcC
Confidence 9999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.98 Aligned_cols=250 Identities=29% Similarity=0.516 Sum_probs=209.3
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--Cce
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF---SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHF 764 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~---s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l 764 (967)
++|.+.+.||+|+||.||++.+ +++.|+||.+..... .......+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999976 478899998754321 123456788999999999999999999988763 468
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+++|||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999998753 4588999999999999999999998 799999999999999999999999999975432
Q ss_pred Cc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 TY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 ~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||...........+.........|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 21 112334588899999999988899999999999999999999999987765555544443444555677788999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.++|++||. +|++||++.+|+++
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHhcC
Confidence 999999995 99999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=322.82 Aligned_cols=247 Identities=25% Similarity=0.458 Sum_probs=215.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||++.+ .++.+|+|++..... .......+.+|++++++++||||+++++++.....+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999976 478899999865432 2234567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+++|.+++... ..+++..+..++.||+.||.|||+. ||+|+||+|+||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~--~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL--DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999998763 5789999999999999999999998 7999999999999999999999999999865443
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....+++.|++||.+.+..++.++||||||+++|+|++|+.||...+.......+. .....+|..++..+.++|.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHH
Confidence 334568999999999988889999999999999999999999998877655555443 334567788899999999999
Q ss_pred hhcCCCCCc-----CHHHHHHHH
Q 037068 929 WQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RP-----S~~ELLe~L 946 (967)
|+.+|.+|+ ++.++++|-
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcCc
Confidence 999999999 888888774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=312.56 Aligned_cols=249 Identities=36% Similarity=0.669 Sum_probs=212.3
Q ss_pred eeEeEEeecCCceEEEEeecCC------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 694 LQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~g------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
+++.+.||.|+||.||++.+.. ..||+|++... ........+..|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999997753 77999987543 2333567889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 768 TEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~-Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
|||+.+++|.+++...... +++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~--~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC--CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999998764444 89999999999999999999998 79999999999999999999999999998655432
Q ss_pred cCC-CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 847 LSS-KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 847 ~~~-~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
... ....+++.|++||.+.+..++.++||||||+++|+|++ |..||...+.......+. .......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHH
Confidence 111 12347789999999988889999999999999999998 789998877776666554 334555667789999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L 946 (967)
+.+||..+|++|||+.++++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=320.48 Aligned_cols=245 Identities=31% Similarity=0.456 Sum_probs=203.9
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||++.+ .++.||+|.+... ........+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC-CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4678889999999999999975 5788999987643 233445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+++++|..+. .+++..+..++.||+.||.|||+. ||+|+||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~ 150 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA 150 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC--CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence 99999986552 368899999999999999999998 7999999999999999999999999999765433 23
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-------HHHhhhhccccccCC-CCCCcHHH
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-------QVVGAVGFQNRRLEI-PDDIDPAV 921 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-------ei~~~i~~~~~~~~i-p~~ls~eL 921 (967)
....+|..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+. ....... ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHHH
Confidence 3467899999999999999999999999999999999999999754321 1111111 1111222 23578899
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.+++.+||+.+|++||++.+++++..
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 99999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=321.14 Aligned_cols=253 Identities=31% Similarity=0.534 Sum_probs=207.0
Q ss_pred CeeEeEEeecCCceEEEEeec------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--Cce
Q 037068 693 DLQIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHF 764 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l 764 (967)
-|++.+.||+|+||.||++++ .+..||+|.+.... .......+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 468889999999999999863 46789999875432 344566799999999999999999999988775 568
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+++++|.+++.+....+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~--gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999876555689999999999999999999998 799999999999999999999999999986543
Q ss_pred Ccc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------------hhHHHhhhhc
Q 037068 845 TYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN---------------PMQVVGAVGF 906 (967)
Q Consensus 845 ~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~---------------~~ei~~~i~~ 906 (967)
... ......++..|+|||.+.+..++.++|||||||++|||+|+..|+.... .......+ .
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL-E 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-H
Confidence 221 1223456778999999998889999999999999999999876643211 01111111 1
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 907 QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 907 ~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.....+.+..++..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2334455677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=321.15 Aligned_cols=251 Identities=26% Similarity=0.425 Sum_probs=206.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeec------
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTR------ 760 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~------ 760 (967)
..+.|++.+.||.|+||.||+|.+ .++.+|+|.+... ......+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 447889999999999999999976 4678999987542 23445688899999998 79999999998853
Q ss_pred cCceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
...++++|||+.+|+|.+++... ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH--KVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 45689999999999999988753 34588999999999999999999998 7999999999999999999999999998
Q ss_pred cccccCccCCCCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip 914 (967)
+.............+++.|+|||.+. +..++.++|||||||++|||++|..||....+......+.........+
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 76543333344567899999999986 3467889999999999999999999998766544443332222222233
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..++.++.++|++||+.||.+||++.+|++|
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 4688999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=319.65 Aligned_cols=251 Identities=29% Similarity=0.494 Sum_probs=214.9
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+.|+..+.||.|+||.||+|.+ .+..||+|.+.... .......+.+|+.+++++.|+||+++++++..+...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4577788999999999999976 47789999876432 23456788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~--~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSE--KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999999864 4688999999999999999999998 79999999999999999999999999997655433333
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
....++..|+|||.+.+..++.++|+|||||++|||+||..||....+......+. ......++..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHc
Confidence 44568889999999998889999999999999999999999998877666554432 23344555678899999999999
Q ss_pred hcCCCCCcCHHHHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~L~~ 948 (967)
+.+|++||++.+++++-.-
T Consensus 238 ~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred ccCcccCcCHHHHHhChHh
Confidence 9999999999999998543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=317.58 Aligned_cols=253 Identities=29% Similarity=0.522 Sum_probs=213.4
Q ss_pred CCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
++|++.+.||.|+||.||+|+.+ .+.+++|.+.... .......+.+|++++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 67899999999999999999752 3568888764432 233467789999999999999999999999998899
Q ss_pred EEEEeecCCCchhhhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEec
Q 037068 765 SILTEFLPRGSLYRLLHRPN--------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDF 836 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~--------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDF 836 (967)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.++|+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc--CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999987533 1589999999999999999999988 7999999999999999999999999
Q ss_pred ccccccccC-ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCC
Q 037068 837 GLSRIKHHT-YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 837 GLAr~~~~~-~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip 914 (967)
|+++..... ........++..|++||.+.+..++.++||||||+++|+|++ |..||...........+.........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 998644322 222334456778999999988889999999999999999999 788998777666666554334344556
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 778999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=318.83 Aligned_cols=254 Identities=31% Similarity=0.544 Sum_probs=210.5
Q ss_pred CCeeEeEEeecCCceEEEEeecC------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--cCc
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--SPH 763 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--~~~ 763 (967)
++|++.+.||+|+||.||++.+. +..+|||++...... .....+.+|+.+++.+.|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 56788899999999999999753 568999988654322 356789999999999999999999999877 557
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.+++|||+++++|.+++......+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ--RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999987555799999999999999999999998 79999999999999999999999999998765
Q ss_pred cCcc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH---------------HHhhhh
Q 037068 844 HTYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ---------------VVGAVG 905 (967)
Q Consensus 844 ~~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e---------------i~~~i~ 905 (967)
.... ......++..|++||.+.+..++.++||||||+++|||++|..||....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL- 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH-
Confidence 3211 1222345667999999998899999999999999999999999986543211 11111
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
........+..++.++.+++.+||+.+|.+||++.+|++.|..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 12333445567889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=367.24 Aligned_cols=260 Identities=23% Similarity=0.367 Sum_probs=210.8
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR- 760 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~- 760 (967)
+...+...++|.+.++||+|+||+||++++ .+..+|+|++............+..|+.++++|+||||++++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 344566678999999999999999999977 46679999887665555667789999999999999999999998864
Q ss_pred -cCceEEEEeecCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCeEEeccCCCcEEEcC----
Q 037068 761 -SPHFSILTEFLPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSH-----PTIVHRDLKSPNLLVDK---- 827 (967)
Q Consensus 761 -~~~l~LVmEy~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n-----~GIVHRDLKPsNILLd~---- 827 (967)
...++|||||+.+++|..+|... ...+++..++.|+.||+.||.|||+.. .+||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 35689999999999999988642 356999999999999999999999852 25999999999999964
Q ss_pred -------------CCeEEEEecccccccccCccCCCCCCCCCCccChhcccc--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 037068 828 -------------NWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN--EPANEKCDVYSFGVILWELATLSVPW 892 (967)
Q Consensus 828 -------------~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g--~~~s~ksDVWSLGvlL~ELlTGk~PF 892 (967)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||+||..||
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 3459999999998654332 2344579999999999864 45889999999999999999999999
Q ss_pred CCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 893 KGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 893 ~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
...+..............++ ....+.++.+||..||+.+|.+||++.|+|.+
T Consensus 244 ~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 87654433222211222111 23578999999999999999999999999976
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=334.40 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=202.7
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------C
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------P 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------~ 762 (967)
.++|++.+.||.|+||.||++.+ .++.||||++............+.+|+.++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47899999999999999999965 577899999865433334456678899999999999999999987543 3
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
..+++++++ +++|..++.. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999987 7789888763 4699999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc--------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-------------- 907 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-------------- 907 (967)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 169 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 432 334578999999999977 56899999999999999999999999876544332222100
Q ss_pred -------ccccCC--------CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 908 -------NRRLEI--------PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 908 -------~~~~~i--------p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
...... ....++.+.+||.+||+.||.+|||+.++++|-.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 000001 12356778999999999999999999999998543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.48 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=212.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||++.. .++.||+|.+....... .....+..|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4789999999999999999976 47899999987654432 35567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-
Q 037068 769 EFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY- 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~- 846 (967)
||+.+++|.+++... ...+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC--CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999998753 45789999999999999999999998 79999999999999999999999999986432211
Q ss_pred ----------------------------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh
Q 037068 847 ----------------------------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM 898 (967)
Q Consensus 847 ----------------------------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ 898 (967)
.......||..|+|||++.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0112346888999999999999999999999999999999999999888776
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcC----HHHHHHH
Q 037068 899 QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPS----FAQLMSR 945 (967)
Q Consensus 899 ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS----~~ELLe~ 945 (967)
.....+............+++.+.++|.+||+.+|++||+ +.+++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 6554443222222222337999999999999999999999 8888886
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.84 Aligned_cols=257 Identities=28% Similarity=0.527 Sum_probs=213.6
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCC----eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGT----EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~----~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|+..+.||+|+||.||+|.+ .+. .+|+|.+... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 36788999999999999999975 343 4688876543 2333445688999999999999999999988654 47
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++++||+++|+|.+++......+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc--CeeccccccceeeecCCCceEEccccccccccC
Confidence 799999999999999887666789999999999999999999998 799999999999999999999999999986543
Q ss_pred Ccc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 TYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 ~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
... ......++..|++||.+.+..++.++|||||||++|||++ |..||.+....+....+. ....+..+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence 221 1223445778999999999999999999999999999997 899998876655544443 344455566788999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
.+++.+||..+|++||++.++++.|..+.+.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.93 Aligned_cols=250 Identities=30% Similarity=0.479 Sum_probs=210.6
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||.|+||+||+|.. .+..+++|++....... ....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999975 56789999876543333 56789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 770 FLPRGSLYRLLHRP--NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 770 y~~gGsL~~lL~~~--~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|+.+++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||++++++.+||+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~--~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999998753 24689999999999999999999988 799999999999999999999999999876544322
Q ss_pred C----CCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC-----CCC
Q 037068 848 S----SKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP-----DDI 917 (967)
Q Consensus 848 ~----~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip-----~~l 917 (967)
. .....++..|++||.+... .++.++|+|||||++|+|++|+.||......+........ ....++ ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKY 236 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccc
Confidence 1 2334688999999998877 7899999999999999999999999887765544433222 111111 357
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
++.+.+++.+||+.+|++||++.+|++|
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 8899999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.41 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=208.7
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||+|+||.||+|.+ .++.|++|++............+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999976 578999999876654445567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-cCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-LSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-~~~ 849 (967)
+ +++|.+++......+++..++.++.||+.+|.|||+. |++|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 9999999876667799999999999999999999998 79999999999999999999999999998654432 123
Q ss_pred CCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc-----------------cc
Q 037068 850 KSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-----------------RL 911 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~-----------------~~ 911 (967)
....++..|+|||.+.+.. ++.++||||||+++|||++|.+||...........+..... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 3456899999999987654 68999999999999999999888877665433322110000 00
Q ss_pred -----------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 912 -----------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 912 -----------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
......+..+.++|.+||+.+|++||++.+++.|-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 01134578999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=320.75 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=206.3
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||++.+ .++.||+|++..........+.+.+|+++++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4789999999999999999977 47889999876554443445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+++|..+... ...+++..++.++.||+.||.|||+. ||+|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9999999887764 34589999999999999999999998 79999999999999999999999999998655443333
Q ss_pred CCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-------------------cc
Q 037068 850 KSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-------------------NR 909 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-------------------~~ 909 (967)
....++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 445688999999998764 4788999999999999999999999765543221111100 00
Q ss_pred cc----------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 RL----------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 ~~----------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.. .....++..+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 1123568899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=324.39 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=212.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
...+|++.+.||+|+||.||++.. .++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++......++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 447899999999999999999975 588999999865432 2345678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~--~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 95 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred ecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999999864 4588999999999999999999998 799999999999999999999999999876544333
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-cccccCCCCCCcHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~ 926 (967)
......+++.|++||.+.+..++.++|+|||||++|+|++|+.||...++......+.. .......+..++..+.+++.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 33445688999999999998899999999999999999999999987665443322221 12223356678899999999
Q ss_pred HhhhcCCCCCcCHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L 946 (967)
+||+.+|++||++.+++++=
T Consensus 251 ~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred HHccCChhhCcCHHHHhcCc
Confidence 99999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.17 Aligned_cols=250 Identities=28% Similarity=0.517 Sum_probs=220.7
Q ss_pred CeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|.+.+.||.|+||.||++.+. +..+++|++............+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999774 78899999876655556677889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 771 LPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 771 ~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
+++++|..++... ...+++..++.++.||+.||.|||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC--CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999998764 36799999999999999999999998 799999999999999999999999999987655443
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+...... ......++..++..+.+++.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 3445678899999999999989999999999999999999999998887766665553 333556677889999999999
Q ss_pred hhhcCCCCCcCHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~ 945 (967)
||..+|.+||++.+++++
T Consensus 238 ~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 238 LLQKDPEERPSIAQILQS 255 (258)
T ss_pred HcCCChhhCcCHHHHhcC
Confidence 999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.91 Aligned_cols=250 Identities=28% Similarity=0.489 Sum_probs=211.9
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+.|+..+.||+|+||.||+|.+ .+..||+|.+.... .......+.+|+.++++++|+||+++++++..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3566778899999999999966 46789999875432 23345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+++|.+++.. ..+++..++.++.||+.||.|||++ +++|+||+|+||++++++.+||+|||++..........
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSE--RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC--CeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999999998864 4689999999999999999999988 79999999999999999999999999997655443333
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
....++..|+|||.+.+..++.++|||||||++|||++|+.||....+......+. ......++..++.++.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 44568899999999999999999999999999999999999998766555444332 22334455678899999999999
Q ss_pred hcCCCCCcCHHHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~L~ 947 (967)
+.+|.+||++.++++|-.
T Consensus 238 ~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 238 NKDPRFRPTAKELLKHKF 255 (277)
T ss_pred cCCcccCcCHHHHHHhHH
Confidence 999999999999999743
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.43 Aligned_cols=250 Identities=28% Similarity=0.502 Sum_probs=213.1
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|.+.+.||+|+||.||++.. .+..+|+|.+..........+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999976 478899999866544444556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-eEEEEecccccccccCccC
Q 037068 771 LPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-VVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 771 ~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-~VKLsDFGLAr~~~~~~~~ 848 (967)
+.+++|.+++... ...+++..+..++.||+.||.|||+. +++|+||||+||++++++ .+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR--KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999999988653 34589999999999999999999998 799999999999998775 5799999999766543323
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....|++.|+|||.+.+..++.++|+||||+++|||++|..||...+..+....+. .......+..++.++.++|.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHH
Confidence 334568899999999998889999999999999999999999998877665554433 2333445567889999999999
Q ss_pred hhcCCCCCcCHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~ 945 (967)
|+.+|++|||+.+++++
T Consensus 238 l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 238 FKVSPRDRPSITSILKR 254 (257)
T ss_pred hccChhhCcCHHHHhhC
Confidence 99999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.87 Aligned_cols=253 Identities=25% Similarity=0.446 Sum_probs=210.6
Q ss_pred CeeEeEEeecCCceEEEEeecC---CCeEEEEEeecCC--------CChhhHHHHHHHHHHHHH-cCCCceeEEeeeeec
Q 037068 693 DLQIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQD--------FSGDSLSQFKCEAEIMLR-LRHPNVVLFMGAVTR 760 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~---g~~VAVKkl~~~~--------~s~~~~~~~~~Ei~ILk~-L~HpNIVkLig~~~~ 760 (967)
.|++.+.||+|+||.||++.+. ++.+|+|.+.... ........+.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999764 4779999875432 123345667788988875 699999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
++..+++|||+.+++|.+++.. ....+++..++.++.|++.+|.|||+.. +++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC-ceeecCCCHHHEEECCCCcEEEeccc
Confidence 9999999999999999988742 3456899999999999999999999743 79999999999999999999999999
Q ss_pred cccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
++....... ......++..|++||.+.+..++.++||||||+++|+|++|+.||...+.......+............+
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 160 LAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred ceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 998655433 3345668899999999999889999999999999999999999998877665555543222222222367
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
++.+.++|.+||+.||++||++.|+.+++.
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.45 Aligned_cols=259 Identities=36% Similarity=0.664 Sum_probs=231.8
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
.+|+....++.+..+||-|.||.||.|.|+ .-.||||.++. +...+++|..|..+|+.++|||+|+|+|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 578888899999999999999999999886 45699998754 3456889999999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
-+|||+|||..|+|.++|++.+ ..++....+.++.||..||+||..+| +|||||.++|+||.++..||++||||+|+
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999998754 34677788899999999999999985 99999999999999999999999999998
Q ss_pred ccc-CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 842 KHH-TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 842 ~~~-~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
+.. ++.......-.+.|.|||-+.-..++.|+|||+|||+||||.| |--||.+.+..++...+. .+.++.-|+.|++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGCPP 493 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCCCH
Confidence 754 4444444456779999999999999999999999999999999 678999999988887764 7889999999999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+++||+.||+++|.+||+|.||-+.++.+
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 999999999999999999999999988654
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.33 Aligned_cols=256 Identities=30% Similarity=0.458 Sum_probs=209.7
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeecc
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRS 761 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~ 761 (967)
.++....++|.+.+.||+|+||.||++.. .++.+|+|.+.... .....+..|+.+++++ +|+||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34445568999999999999999999976 47789999875432 2345677899999999 899999999988653
Q ss_pred -----CceEEEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEE
Q 037068 762 -----PHFSILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKV 833 (967)
Q Consensus 762 -----~~l~LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKL 833 (967)
+.+++||||+++++|.+++.. ....+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN--RIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEEcCCCCEEE
Confidence 358999999999999998753 345689999999999999999999988 7999999999999999999999
Q ss_pred EecccccccccCccCCCCCCCCCCccChhccccCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-c
Q 037068 834 CDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP-----ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-Q 907 (967)
Q Consensus 834 sDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~-----~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~ 907 (967)
+|||+++.............++..|+|||.+.... ++.++|||||||++|||++|+.||...........+.. .
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 99999986554333334457889999999986543 67899999999999999999999988766544433321 1
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
......+...+..+.++|.+||+.+|++||++.++++|
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 12233455677899999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.33 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=207.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||+|.+ .++.|++|++............+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999976 47789999886554444556788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-C
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL-S 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~-~ 848 (967)
|+.++.+..+... ...+++..++.++.||+.||.|||++ +++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSH--NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9998777666544 45689999999999999999999998 799999999999999999999999999986554332 2
Q ss_pred CCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-------------------cc
Q 037068 849 SKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-------------------QN 908 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-------------------~~ 908 (967)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+.. ..
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345678899999999888 789999999999999999999999987654332221110 00
Q ss_pred cc-----------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 RR-----------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 ~~-----------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.. ...+..+++++.++|++||..+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 01233458899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.74 Aligned_cols=250 Identities=23% Similarity=0.400 Sum_probs=227.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.=|.+.+.||+|.|.+|.+|++ +|..||||++.+...+.-....+..|++.|+.+.|||||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 5688889999999999999977 79999999998888887777889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE-cCCCeEEEEecccccccccCccC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV-DKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL-d~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
.-++|+|+++|-+....+.+..+.+++.||+.|+.|+|+.+ +|||||||+||.+ .+-|.|||.|||++..+.... .
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-K 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcc-h
Confidence 99999999999988889999999999999999999999985 9999999999987 567999999999997665543 4
Q ss_pred CCCCCCCCCccChhccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPAN-EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s-~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
....+|...|-|||++.|..|+ +++|||||||+||.|++|+.||...+..+.+..|. .....+|..++.++++||..
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--DCKYtvPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--DCKYTVPSHVSKECRDLIQS 252 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh--cccccCchhhhHHHHHHHHH
Confidence 6678999999999999999886 57899999999999999999999998888776663 45677899999999999999
Q ss_pred hhhcCCCCCcCHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L 946 (967)
||..||++|.+.++|..+-
T Consensus 253 MLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred HHhcCchhhccHHHHhccc
Confidence 9999999999999998763
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=346.42 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=196.5
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC------CceeEEeeeee
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH------PNVVLFMGAVT 759 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H------pNIVkLig~~~ 759 (967)
....++|++.++||+|+||+||+|.+ .++.||||++.... .....+..|+.+++.++| .+|+++++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34568999999999999999999976 47789999985421 223445668888877754 45889999887
Q ss_pred cc-CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---------
Q 037068 760 RS-PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW--------- 829 (967)
Q Consensus 760 ~~-~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g--------- 829 (967)
.+ ..++||||++ +++|.+++.+ ...+++..+..|+.||+.||.|||++. |||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~-gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTEL-HLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEecCCccccccccc
Confidence 64 4688999987 6688888765 356999999999999999999999742 799999999999998665
Q ss_pred -------eEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHh
Q 037068 830 -------VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVG 902 (967)
Q Consensus 830 -------~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~ 902 (967)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+...
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred ccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 599999998864332 2345679999999999999999999999999999999999999998876544333
Q ss_pred hhhcccccc--------------------------CCC-------------C-CCcHHHHHHHHHhhhcCCCCCcCHHHH
Q 037068 903 AVGFQNRRL--------------------------EIP-------------D-DIDPAVAQIIRDCWQTEPHLRPSFAQL 942 (967)
Q Consensus 903 ~i~~~~~~~--------------------------~ip-------------~-~ls~eL~dLI~~CLq~dPe~RPS~~EL 942 (967)
.+......+ ..+ . ..++.+.+||.+||++||++|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 221100000 000 0 124567899999999999999999999
Q ss_pred HHHHHH
Q 037068 943 MSRLRC 948 (967)
Q Consensus 943 Le~L~~ 948 (967)
|+|-.-
T Consensus 436 L~Hp~~ 441 (467)
T PTZ00284 436 TTHPYV 441 (467)
T ss_pred hcCccc
Confidence 998543
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=316.92 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=212.7
Q ss_pred CeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+|++.+.||.|+||.||++.+. ++.|++|.+...... ....+.+.+|++++++++||||+++++.+.....+++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999774 789999998765432 2456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+++|..++... ..+++..+..++.||+.||.|||++ +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK--GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999998764 5789999999999999999999998 79999999999999999999999999987654432 23
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---hHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP---MQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~---~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
....++..|++||.+.+..++.++|+||||+++|+|++|..||..... ....... .......|..++..+.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHHH
Confidence 445688899999999988899999999999999999999999998763 3333222 22455677788999999999
Q ss_pred HhhhcCCCCCcCH--HHHHHH
Q 037068 927 DCWQTEPHLRPSF--AQLMSR 945 (967)
Q Consensus 927 ~CLq~dPe~RPS~--~ELLe~ 945 (967)
+||+.+|.+||++ .+++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHccCChhHcCCccHHHHhcC
Confidence 9999999999999 776653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.45 Aligned_cols=250 Identities=34% Similarity=0.581 Sum_probs=216.1
Q ss_pred CeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--CceEEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHFSILT 768 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l~LVm 768 (967)
+|++.+.||+|++|.||+|... ++.|++|++............+.+|+.++++++|+||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999774 88899999876554455678899999999999999999999999888 8899999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL- 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~- 847 (967)
||+.+++|.+++.... .+++..++.++.|++.+|.|||+. |++|+||+|+||+++.++.+||+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~--~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999987644 799999999999999999999997 799999999999999999999999999987655432
Q ss_pred -CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 848 -SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN-PMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 848 -~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~-~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
......++..|++||.+.+...+.++||||||+++|+|++|..||.... .......+........+|..++..+.++|
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1344568899999999998889999999999999999999999998876 22222233222345567788899999999
Q ss_pred HHhhhcCCCCCcCHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||+.+|.+||++.+++.|
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhCcCChhhCCCHHHHhhC
Confidence 99999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.16 Aligned_cols=255 Identities=27% Similarity=0.366 Sum_probs=210.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc-eeEEeeeeeccC------
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN-VVLFMGAVTRSP------ 762 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN-IVkLig~~~~~~------ 762 (967)
..|...++||+|+||+||+|+. +|+.||+|++.-....+..-....+|+.++++|+|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566678899999999999966 5889999999766443445566789999999999999 999999998876
Q ss_pred ceEEEEeecCCCchhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN---HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~---~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
.+++||||++. +|..++.... ..++...+..++.||+.||.|||++ ||+||||||.||||++.|.+||+|||+|
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~--~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH--GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCcceEEECCCCcEeeeccchH
Confidence 79999999965 8999987654 4688899999999999999999999 7999999999999999999999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc----------c-
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF----------Q- 907 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~----------~- 907 (967)
+...-........++|.+|.|||++.+. .|+...||||+||++.||++++.-|.+....+.+..+-. .
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 9766444445667899999999999887 699999999999999999999999998776554433320 0
Q ss_pred -----ccccCC-----C-------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH--HHHH
Q 037068 908 -----NRRLEI-----P-------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR--LRCL 949 (967)
Q Consensus 908 -----~~~~~i-----p-------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~--L~~L 949 (967)
.....+ + +..++...+++.+||+++|.+|.|+...++| +..+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 000011 1 1233578999999999999999999999998 4444
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.33 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=198.6
Q ss_pred EeEEeecC--CceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 696 IGERIGIG--SYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 696 i~k~LGeG--~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
+.++||+| +|++||++.. +++.||+|++............+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999966 5788999998655444455667888999999999999999999999999999999999
Q ss_pred CCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc---
Q 037068 772 PRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL--- 847 (967)
Q Consensus 772 ~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~--- 847 (967)
++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999998653 34589999999999999999999988 799999999999999999999999986543221110
Q ss_pred ----CCCCCCCCCCccChhcccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc------------
Q 037068 848 ----SSKSTAGTPEWMAPEVLRN--EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------------ 909 (967)
Q Consensus 848 ----~~~~~~GT~~YmAPE~l~g--~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------------ 909 (967)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0122346778999999976 4589999999999999999999999986543332211100000
Q ss_pred --------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 --------------------------------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 --------------------------------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..+....+++++.+||.+||+.||++|||+.++++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 0011123578899999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.19 Aligned_cols=249 Identities=30% Similarity=0.475 Sum_probs=214.4
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|++|.||++.. .++.|+||++...... .....+.+|+.++++++|+||+++++++.....+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4688999999999999999976 4788999988654322 456778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT-SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs-~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|+.+++|.+++... ..+++..++.++.||+.+|.|||+ . |++||||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC--CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999763 678999999999999999999999 7 7999999999999999999999999999866544333
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hhHHHhhhhccccccCCCCC-CcHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN---PMQVVGAVGFQNRRLEIPDD-IDPAVAQI 924 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~---~~ei~~~i~~~~~~~~ip~~-ls~eL~dL 924 (967)
.....++..|+|||.+.+..++.++|+||||+++|+|+||+.||.... ..+....+. ......++.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 334568889999999999999999999999999999999999998774 333343333 3333445555 89999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~ 945 (967)
|.+||..+|++||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.97 Aligned_cols=253 Identities=30% Similarity=0.533 Sum_probs=209.3
Q ss_pred eeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC------
Q 037068 694 LQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP------ 762 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~------ 762 (967)
|.+.+.||+|+||.||+|.. ++..||||.+..........+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56778999999999999964 3578999998765555566778899999999999999999999876432
Q ss_pred ceEEEEeecCCCchhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 763 HFSILTEFLPRGSLYRLLHRP-----NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~-----~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
..+++++|+.+|+|..++... ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK--NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeecccchhhEEEcCCCCEEECccc
Confidence 247889999999998876421 23578999999999999999999988 79999999999999999999999999
Q ss_pred cccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCC
Q 037068 838 LSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 838 LAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip 914 (967)
+++...... .......+++.|++||.+.+..++.++|||||||++|||++ |+.||...+.......+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 998653321 11223345678999999999989999999999999999999 899998877665554443 33344555
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.73 Aligned_cols=251 Identities=29% Similarity=0.480 Sum_probs=207.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccC----
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSP---- 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~---- 762 (967)
..++|++.+.||+|+||.||+|.. .++.+++|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 458999999999999999999977 46789999876432 2346788999999999 7999999999987644
Q ss_pred --ceEEEEeecCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 763 --HFSILTEFLPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 763 --~l~LVmEy~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
.+++||||+.+++|.+++... +..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN--KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999987642 46789999999999999999999998 79999999999999999999999999
Q ss_pred cccccccCccCCCCCCCCCCccChhcccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-cccc
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRN-----EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRL 911 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g-----~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~ 911 (967)
++..............++..|+|||.+.. ..++.++|||||||+||+|++|+.||...........+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 99765544333445668999999999854 34678899999999999999999999876655444433221 1122
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 ~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..+..++.++.++|.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2334578899999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.60 Aligned_cols=245 Identities=32% Similarity=0.552 Sum_probs=205.5
Q ss_pred EeecCCceEEEEeecCC--------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 699 RIGIGSYGEVYRADWHG--------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~g--------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
.||+|+||.||+|+... ..++||.+... ........+.+|+.+++.++||||+++++++......++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999997632 46888986543 2234456788999999999999999999999998999999999
Q ss_pred cCCCchhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-----eEEEEecccc
Q 037068 771 LPRGSLYRLLHRP------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-----VVKVCDFGLS 839 (967)
Q Consensus 771 ~~gGsL~~lL~~~------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-----~VKLsDFGLA 839 (967)
+++++|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++ .+||+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM--HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC--CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999998642 23478899999999999999999988 799999999999999877 8999999999
Q ss_pred cccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCC
Q 037068 840 RIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDD 916 (967)
Q Consensus 840 r~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ 916 (967)
+....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCccc
Confidence 75433211 1223345788999999999999999999999999999998 999998877666555443 3345566778
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
++..+.++|.+||..+|.+||++.++++.|.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 8999999999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=350.35 Aligned_cols=251 Identities=30% Similarity=0.490 Sum_probs=220.0
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+-|.|...||.|+||+||+|..+ +-..|.|++.. .++..++.+.-||.||..+.||+||+|++.|+.++.++|+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 34556688999999999999765 33456676543 246678889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
||.||-...++-.-+..+++..+..++.|++.||.|||+++ |||||||+.|||++-+|.|+|+|||.+.....+....
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999998887889999999999999999999999995 9999999999999999999999999987766666667
Q ss_pred CCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-cccccCCCCCCcHHHHH
Q 037068 850 KSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~~ip~~ls~eL~d 923 (967)
..+.|||+|||||+.. ..+|++++||||||++|+||..+.+|....+++.++-.+.. ....+-.|...+..+.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 7899999999999864 56899999999999999999999999999999988766643 22334457788999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L 946 (967)
|+.+||.+||..||++.+|++|-
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCc
Confidence 99999999999999999999884
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=315.62 Aligned_cols=249 Identities=30% Similarity=0.485 Sum_probs=210.5
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||.|+||.||++.++ ++.+++|.+.... .......+.+|+.++++++|+||+++++.+......++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36778889999999999999774 7889999876543 23456678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT-SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs-~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|+.+++|.+++......+++..++.++.||+.+|.|||+ . |++|+||||+||++++++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC--CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999999999998755779999999999999999999999 6 799999999999999999999999999876543321
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hhHHHhhhhccccccCCCCC-CcHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN-----PMQVVGAVGFQNRRLEIPDD-IDPAVA 922 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~-----~~ei~~~i~~~~~~~~ip~~-ls~eL~ 922 (967)
....++..|++||.+.+..++.++||||||+++|+|++|..||...+ ..+....+. .......+.. ++.++.
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHH
Confidence 12678899999999999999999999999999999999999997652 222222221 2233344444 889999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++|.+||..+|++|||+.+++.+-
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~~ 258 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEHP 258 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhCc
Confidence 999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.45 Aligned_cols=247 Identities=33% Similarity=0.571 Sum_probs=211.6
Q ss_pred CeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|.+.+.||.|++|.||++... +..+++|++..... .....+.+|+.++++++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4788899999999999999774 78899999865432 4567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+++++|.+++......+++..++.++.|++.+|.|||+. |++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--CEecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 999999999887556799999999999999999999997 799999999999999999999999999976654322 34
Q ss_pred CCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC--CCCcHHHHHHHHHh
Q 037068 851 STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQIIRDC 928 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI~~C 928 (967)
...++..|++||.+.+..++.++||||||+++|+|++|+.||...+.......... ......+ ..++..+.++|.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 56688999999999988899999999999999999999999988765554443332 2222222 33489999999999
Q ss_pred hhcCCCCCcCHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~ 945 (967)
|+.+|++|||+.++++|
T Consensus 235 l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 235 LQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=306.14 Aligned_cols=249 Identities=32% Similarity=0.591 Sum_probs=217.4
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||+|++|.||++.. .++.|++|.+............+.+|++++++++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588899999999999999966 467899999877655545677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.+++|.+++... ..+++..++.++.|++.+|.|||+. ||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ--GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999998764 5789999999999999999999988 799999999999999999999999999987665443344
Q ss_pred CCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 037068 851 STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQ 930 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq 930 (967)
...++..|++||.+.+..++.++|||+||+++|+|++|..||............. ......++..++..+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHh
Confidence 5678999999999988888999999999999999999999998776544443332 344556777889999999999999
Q ss_pred cCCCCCcCHHHHHHH
Q 037068 931 TEPHLRPSFAQLMSR 945 (967)
Q Consensus 931 ~dPe~RPS~~ELLe~ 945 (967)
.+|++||++.+++.+
T Consensus 237 ~~p~~R~~~~~~l~~ 251 (254)
T cd06627 237 KDPNLRPTAKQLLKH 251 (254)
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.94 Aligned_cols=250 Identities=31% Similarity=0.522 Sum_probs=206.2
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC--------hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS--------GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s--------~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
+|.+.+.||+|+||.||+|.. .++.+|+|.+...... ....+.+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578889999999999999965 5788999987532111 112456888999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+.+++|.+++... ..+++..+..++.||+.||.|||++ +++||||+|+||+++.++.+||+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK--GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC--CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999998764 5789999999999999999999998 7999999999999999999999999999765
Q ss_pred ccCcc--CCCCCCCCCCccChhccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC----
Q 037068 843 HHTYL--SSKSTAGTPEWMAPEVLRNEP--ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP---- 914 (967)
Q Consensus 843 ~~~~~--~~~~~~GT~~YmAPE~l~g~~--~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip---- 914 (967)
..... ......++..|++||.+.... ++.++|+||||+++|++++|..||......+....+........++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 43211 123345888999999987755 7899999999999999999999997665544333322222233333
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..++.++.++|.+||+.+|.+||++.++++|
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3568999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.33 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=206.7
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--CceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l~LV 767 (967)
++|++.+.||+|+||.||+|++. ++.+++|.+............+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999874 77899999875544444445677899999999999999999998877 789999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+ +|.+++......+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 999975 89888876556799999999999999999999988 799999999999999999999999999986655433
Q ss_pred CCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-------------------
Q 037068 848 SSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ------------------- 907 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~------------------- 907 (967)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 334456788999999987654 689999999999999999999999877655433322100
Q ss_pred ----------ccccCCCCC-CcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 ----------NRRLEIPDD-IDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 ----------~~~~~ip~~-ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.....++.. +++.+.++|.+||+.+|++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000112222 58889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.37 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=205.4
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS---GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s---~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
+|++.+.||+|+||.||+|.+ .++.|+||++...... ......+..|+.+++.++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588889999999999999976 4789999998765433 22345577899999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+ +++|..++......+++..++.++.||+.||.|||++ ||+|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN--WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 8899999976444799999999999999999999998 799999999999999999999999999987654433
Q ss_pred CCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc------------------
Q 037068 848 SSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN------------------ 908 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~------------------ 908 (967)
......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...........+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3344567889999999865 457899999999999999999988887766543322221000
Q ss_pred ---ccc-----CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 ---RRL-----EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 ---~~~-----~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
... ......+.++.++|.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 0113457889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=333.15 Aligned_cols=249 Identities=27% Similarity=0.471 Sum_probs=224.9
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+-|.+..+||+|+||.||++.+ .|.-+|||++... ..+.++..|+.||++++.+++|++||.|.....++||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3467789999999999999965 5889999997643 457789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
||..|++.++++-+++.+++..+..++..-+.||+|||.. +-||||||+.|||++.+|+.||+|||.|-.+.++....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~--~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL--KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH--HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999999999999899999999999999999999999987 47999999999999999999999999998888777777
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~C 928 (967)
.+..|||.|||||++..-.|+.++||||||++..||..|++||....++..+..+-.. ...+..|+..+.++.++++.|
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 7889999999999999999999999999999999999999999999988776555322 223456678899999999999
Q ss_pred hhcCCCCCcCHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L 946 (967)
|-++|++|-|+.++++|-
T Consensus 267 LiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHT 284 (502)
T ss_pred hcCCHHHHHHHHHHhhhh
Confidence 999999999999999984
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=320.45 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=211.7
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||+||++.+. ++.||+|++.... .......+.+|+++++.++|+||+++++.+...+.+++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 467889999999999999999764 7889999876432 3345677899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+++++|..++.. .+.+++..+..++.|++.+|.|||+.. +++||||||+||++++++.++|+|||++...... .
T Consensus 83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~-~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVH-RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--I 158 (284)
T ss_pred ecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhc-CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--c
Confidence 99999999998875 456899999999999999999999753 7999999999999999999999999998654332 1
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-----------HHHhhhhccccccCCCC-C
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-----------QVVGAVGFQNRRLEIPD-D 916 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-----------ei~~~i~~~~~~~~ip~-~ 916 (967)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+. ......++. .
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 237 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPSSD 237 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCchh
Confidence 23457899999999998888999999999999999999999999865542 1111111 112222333 3
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
++.++.+|+.+||+.||.+|||+.|++++..-+++
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 78899999999999999999999999998765543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.48 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=203.7
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||.|+||.||+|.+ +++.|+||++............+.+|++++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999976 578899998865443344456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 771 LPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
+. ++|..++.. ....+++..++.++.||+.||.|||+. +++||||+|+||+++.++.+||+|||+++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~--~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 96 578887754 345689999999999999999999988 79999999999999999999999999987654433333
Q ss_pred CCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-cc------------------
Q 037068 850 KSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NR------------------ 909 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~------------------ 909 (967)
....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||...+.......+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 4455788999999987654 688999999999999999999999776543322211100 00
Q ss_pred --------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 --------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 --------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
...+...+++++.++|.+||+.||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 001123578899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.24 Aligned_cols=252 Identities=28% Similarity=0.484 Sum_probs=200.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHH-HHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEI-MLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~I-Lk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||++.+ +++.||+|++....... ....+..|+.+ ++.++|+||+++++++..++..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999977 47899999886543332 23345556665 56679999999999999999999999
Q ss_pred eecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 769 EFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
||++ ++|..++.. .+..+++..++.++.||+.||.|||++. +++||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL-SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9997 577776643 3456899999999999999999999863 6999999999999999999999999999865433
Q ss_pred ccCCCCCCCCCCccChhcccc----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHhhhhccccccCCC-CCCcH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRN----EPANEKCDVYSFGVILWELATLSVPWKGLNP-MQVVGAVGFQNRRLEIP-DDIDP 919 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g----~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~-~ei~~~i~~~~~~~~ip-~~ls~ 919 (967)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... .+...... ......++ ..++.
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (283)
T cd06617 158 V-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFSP 235 (283)
T ss_pred c-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccCH
Confidence 2 1233568889999999865 4568899999999999999999999975332 22222221 22223333 35789
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
++.++|.+||..+|.+||++.+++++-.-
T Consensus 236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 264 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPNYPELLQHPFF 264 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 99999999999999999999999987443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.78 Aligned_cols=238 Identities=22% Similarity=0.406 Sum_probs=193.6
Q ss_pred EEeecCCceEEEEeecC--------------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 698 ERIGIGSYGEVYRADWH--------------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~--------------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
+.||+|+||.||+|+.. ...+++|.+... .......+..|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 36899999999999642 224788875432 22334567889999999999999999999999889
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe-------EEEEec
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV-------VKVCDF 836 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~-------VKLsDF 836 (967)
.++||||+++++|..++......+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +|++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC--CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999999876666799999999999999999999998 7999999999999986654 899999
Q ss_pred ccccccccCccCCCCCCCCCCccChhccc-cCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChhHHHhhhhccccccCCC
Q 037068 837 GLSRIKHHTYLSSKSTAGTPEWMAPEVLR-NEPANEKCDVYSFGVILWELA-TLSVPWKGLNPMQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 837 GLAr~~~~~~~~~~~~~GT~~YmAPE~l~-g~~~s~ksDVWSLGvlL~ELl-TGk~PF~~~~~~ei~~~i~~~~~~~~ip 914 (967)
|++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+..... .......
T Consensus 157 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~~ 229 (262)
T cd05077 157 GIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCMLV 229 (262)
T ss_pred CCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCccCC
Confidence 99865432 22345788999999987 466899999999999999998 588898876554433221 1122233
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
...++++.++|.+||+.||++||++.+|+++|
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 34567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.72 Aligned_cols=259 Identities=31% Similarity=0.500 Sum_probs=221.8
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecCC-CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~g-~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
++....+.+.++||+|.||.|.+.+..+ ..||||++...... .....|.+|+++|.+|+||||++++++|..++.+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 5567788999999999999999998776 88999998765433 335789999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc-
Q 037068 767 LTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH- 844 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~-Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~- 844 (967)
|+|||+.|+|.+++.....+ +......+|+.||+.||+||.+.| +|||||.++|||++.++++||+|||++|-...
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999999875433 355667789999999999999995 99999999999999999999999999995432
Q ss_pred -CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChhHHHhhhhcc------ccccCCCC
Q 037068 845 -TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT--LSVPWKGLNPMQVVGAVGFQ------NRRLEIPD 915 (967)
Q Consensus 845 -~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT--Gk~PF~~~~~~ei~~~i~~~------~~~~~ip~ 915 (967)
.+......+.+.+|||+|.+..+++++++|||+||++|||+++ ...||.....+++++....- ..-+..|.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 2333334556789999999999999999999999999999876 68999999888887765421 11334677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.++..+.++|.+||..+-++||+|+++..+|.+.
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 8999999999999999999999999999888654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.74 Aligned_cols=236 Identities=24% Similarity=0.433 Sum_probs=193.4
Q ss_pred EEeecCCceEEEEeecCCC------------eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 698 ERIGIGSYGEVYRADWHGT------------EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~g~------------~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+.||+|+||.||+|.+... .+++|.+.... .....+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3689999999999977432 36777654322 115678899999999999999999999887 7789
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-------eEEEEeccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-------VVKVCDFGL 838 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-------~VKLsDFGL 838 (967)
+||||+.+++|..++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK--KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC--CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999987555789999999999999999999998 799999999999999887 899999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCC
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNE--PANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPD 915 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~--~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~ 915 (967)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||............. . ....+.
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~--~~~~~~ 227 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-D--QHRLPM 227 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-c--CCCCCC
Confidence 976543 2234567789999999877 78999999999999999999 588887775443333222 1 122222
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.....+.++|.+||..+|.+|||+.++++.|
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2348999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.19 Aligned_cols=249 Identities=29% Similarity=0.512 Sum_probs=213.0
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+-|++.+.||.|+||.||+|.+ .+..||||.+.... .......+.+|+.++++++|+||+++++++..+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3467788999999999999965 47789999875432 23445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+++|..++.. ..+++..+..++.|++.+|.|||+. |++|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 83 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccC--CeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 9999999999864 4589999999999999999999998 79999999999999999999999999987654433333
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
....++..|++||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++.++.+++.+||
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 44568889999999998889999999999999999999999998877665555443 23344456678999999999999
Q ss_pred hcCCCCCcCHHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~L 946 (967)
+.+|.+||++.++++|-
T Consensus 238 ~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 238 NKEPSFRPTAKELLKHK 254 (277)
T ss_pred cCChhhCcCHHHHHhCH
Confidence 99999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=311.34 Aligned_cols=244 Identities=27% Similarity=0.471 Sum_probs=194.7
Q ss_pred EeecCCceEEEEeecC----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 699 RIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
+||+|+||.||+|... ...+++|.+... ........+.+|+.+++.++|+||+++++.+.....+++||||+.+|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 5899999999999642 345778875432 23344567888999999999999999999999999999999999999
Q ss_pred chhhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC--ccC
Q 037068 775 SLYRLLHRPN----HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--YLS 848 (967)
Q Consensus 775 sL~~lL~~~~----~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~--~~~ 848 (967)
+|.+++.... ...++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc--CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999986532 2346788899999999999999998 7999999999999999999999999998753322 112
Q ss_pred CCCCCCCCCccChhcccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcccc----ccCCCCC
Q 037068 849 SKSTAGTPEWMAPEVLRN-------EPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNR----RLEIPDD 916 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g-------~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~----~~~ip~~ 916 (967)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||......+.......... ...++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 233456778999999743 356889999999999999999 7889987766554443322211 2234456
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+++.+.+++..|| .+|++|||+.+|++.|
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 8899999999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.02 Aligned_cols=248 Identities=29% Similarity=0.518 Sum_probs=215.9
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.++||+|+||.||+++. .+..+++|++............+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999966 467899999876554555566788899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 771 LPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 771 ~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
+++++|..++.+. ...+++..++.++.|++.||.|||+. |++|+||+|.||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~--~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9999999988652 35689999999999999999999998 7999999999999999999999999999876554
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+. ......++..++.++.+++.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence 2334568899999999999999999999999999999999999999888766555543 333445566789999999999
Q ss_pred hhhcCCCCCcCHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~ 945 (967)
||+.+|++||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 236 MLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HcCCCcccCCCHHHHhcC
Confidence 999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=309.92 Aligned_cols=250 Identities=30% Similarity=0.531 Sum_probs=211.6
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC---CChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--Cce
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD---FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHF 764 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~---~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l 764 (967)
.+|.+.+.||+|+||.||++.+ ++..|++|.+.... ........+.+|+.++++++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999975 57889999875321 2234456789999999999999999999988764 458
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+++|||+++++|.+++.. ...+++..+..++.||+.||.|||++ |++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 899999999999998875 34588999999999999999999988 799999999999999999999999999986533
Q ss_pred Cc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 TY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 ~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+........+|..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 21 112235688999999999998899999999999999999999999988766655555544445566788899999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+++.+||+ +|..||++.+++.|
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhcC
Confidence 999999999 57999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.65 Aligned_cols=243 Identities=27% Similarity=0.428 Sum_probs=209.4
Q ss_pred eecCCceEEEEeecC--CCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 700 IGIGSYGEVYRADWH--GTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 700 LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
||.|+||.||++... ++.+++|++...... ......+.+|+.+++.++|+||+++++.+.++..++++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 889999998764432 23456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCC
Q 037068 777 YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856 (967)
Q Consensus 777 ~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~ 856 (967)
.+++.+ ...+++..+..++.||+.||.|||++ +++|+||+|+||+++.++.+||+|||+++...... ......+++
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~--~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNR--GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 999876 34589999999999999999999998 79999999999999999999999999998665432 233456889
Q ss_pred CccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 037068 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN--PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPH 934 (967)
Q Consensus 857 ~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~--~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe 934 (967)
.|++||.+.+..++.++|+||||+++|+|++|..||.... ..+....+.........|..+++++.++|.+||+.+|+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999999988889999999999999999999999998776 54554444333456667777899999999999999999
Q ss_pred CCcC-----HHHHHHHH
Q 037068 935 LRPS-----FAQLMSRL 946 (967)
Q Consensus 935 ~RPS-----~~ELLe~L 946 (967)
+||+ +.|+++|-
T Consensus 237 ~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 237 ERLGNLKGGIKDIKKHK 253 (262)
T ss_pred hCcCCcccCHHHHhcCh
Confidence 9999 88888763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.54 Aligned_cols=250 Identities=28% Similarity=0.531 Sum_probs=208.2
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC----hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS----GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s----~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
+|+..+.||+|+||.||++.. +++.+|+|++...... ......+.+|+.++++++|+||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999965 5788999988643321 1245678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-eEEEEecccccccccC
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-VVKVCDFGLSRIKHHT 845 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-~VKLsDFGLAr~~~~~ 845 (967)
||||+.+++|.+++.+ ...+++..++.++.||+.||.|||++ |++|+||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~--~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHEN--QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999875 45689999999999999999999998 799999999999998765 6999999998765432
Q ss_pred cc----CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHH---HhhhhccccccCCCCCCc
Q 037068 846 YL----SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV---VGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 846 ~~----~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei---~~~i~~~~~~~~ip~~ls 918 (967)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...+........++..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 12234678899999999988899999999999999999999999975543222 112212233455667789
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+++.+++.+||+.+|.+||++.++++|
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 999999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.98 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=214.1
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC--
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP-- 762 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~-- 762 (967)
.-+..++|.+.+.||+|||+.||.++. ++..||+|++.-.. .+..+...+|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 446678999999999999999999975 67889999986543 456788999999999999999999999876543
Q ss_pred ---ceEEEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEec
Q 037068 763 ---HFSILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDF 836 (967)
Q Consensus 763 ---~l~LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDF 836 (967)
..||+++|...|+|.+.+.. .+..+++.+++.|+.+|++||++||+..+.++||||||.|||+++.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 38999999999999988764 345699999999999999999999998666999999999999999999999999
Q ss_pred ccccccccCc---------cCCCCCCCCCCccChhcccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhh
Q 037068 837 GLSRIKHHTY---------LSSKSTAGTPEWMAPEVLRN---EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV 904 (967)
Q Consensus 837 GLAr~~~~~~---------~~~~~~~GT~~YmAPE~l~g---~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i 904 (967)
|.++...-.- ........|..|.|||++.- ...+.++|||||||+||+|+.|..||+.......--.+
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 9987432110 01122447889999999864 45688999999999999999999999864332111112
Q ss_pred hccccccCCCC--CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 905 GFQNRRLEIPD--DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 905 ~~~~~~~~ip~--~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
...+.+..+|. .+++.+.++|+.||+.||.+||++.+++.++..+.
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 22344455553 48999999999999999999999999999998764
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=317.99 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=208.0
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||.||++.. .++.|++|.+...... ......+.+|+.+++.++|+||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4789999999999999999976 4678999987654321 234567888999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-- 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-- 846 (967)
||+.+++|..++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999999999976 35689999999999999999999998 79999999999999999999999999986421110
Q ss_pred -------------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc-cC
Q 037068 847 -------------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR-LE 912 (967)
Q Consensus 847 -------------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~-~~ 912 (967)
.......++..|+|||.+.+..++.++|+|||||++|||++|..||.+....+........... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0111245788999999999888999999999999999999999999988777666554332211 22
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcC---HHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPS---FAQLMSR 945 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS---~~ELLe~ 945 (967)
.+..++.++.++|.+||+.+|++||+ +.+++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 22367899999999999999999998 5666666
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.75 Aligned_cols=248 Identities=28% Similarity=0.515 Sum_probs=208.5
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC---CCceeEEeeeeeccCceEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR---HPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~---HpNIVkLig~~~~~~~l~LV 767 (967)
.|++.+.||.|+||.||+|.+ .++.|++|.+... ........+.+|+.+++.++ |+||+++++++..+...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467788999999999999976 5788999987543 23445667889999999996 99999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+++|.+++.. ..+++..++.++.||+.||.|||+. ||+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999999865 3689999999999999999999998 799999999999999999999999999987654433
Q ss_pred CCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCC-CCcHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD-DIDPAVAQII 925 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~-~ls~eL~dLI 925 (967)
......|+..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+. ......++. ..+.++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-cCCCCCCCcccCCHHHHHHH
Confidence 34455789999999998754 46889999999999999999999998876655443332 112223333 3788999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L 946 (967)
.+||+.+|++||++.+++.+-
T Consensus 236 ~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 236 AACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred HHHcCCCcccCcCHHHHhhCh
Confidence 999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.07 Aligned_cols=246 Identities=28% Similarity=0.424 Sum_probs=195.2
Q ss_pred EEeecCCceEEEEeecC----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||.||+|... +..+++|++.... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 35899999999999653 3468999875443 233345788899999999999999999999988899999999999
Q ss_pred CchhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--c
Q 037068 774 GSLYRLLHRP----NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--L 847 (967)
Q Consensus 774 GsL~~lL~~~----~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~--~ 847 (967)
|+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++++||+|||+++...... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC--CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999998642 22456778889999999999999998 79999999999999999999999999997543322 1
Q ss_pred CCCCCCCCCCccChhccccC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhc-ccccc---CCCC
Q 037068 848 SSKSTAGTPEWMAPEVLRNE-------PANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGF-QNRRL---EIPD 915 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~-------~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~-~~~~~---~ip~ 915 (967)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+....... ..... .+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 22334578889999998643 35789999999999999996 9999987776554332211 11112 2223
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
..++.+.++|.+|| .+|++|||+.+|+..|.
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 56789999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=318.78 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=208.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
...+|.+.+.||+|+||.||+|.. .++.||+|++..... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 346789999999999999999976 578899998865432 23445678899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+. |+|.+++......+++..+..++.||+.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~--~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH--ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 999997 577777665456799999999999999999999998 7999999999999999999999999998754322
Q ss_pred cCCCCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
....+++.|+|||.+. ...++.++||||||+++|||+||+.||...+.......+.........+..++..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 3456788999999874 4568899999999999999999999998877665544443222222223457889999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+|.+||+.+|++||++.+++.+.
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcCh
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=313.83 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=202.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||+|.+ +++.|++|++............+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6799999999999999999976 47789999876544444445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-CCeEEEEecccccccccCcc
Q 037068 770 FLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 770 y~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-~g~VKLsDFGLAr~~~~~~~ 847 (967)
|+.+ +|..++... ...+++..++.++.||+.||+|||++ +++||||||+||+++. ++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 9964 777776542 33468899999999999999999998 7999999999999985 56899999999976543322
Q ss_pred CCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-c-----------------
Q 037068 848 SSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-N----------------- 908 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~----------------- 908 (967)
......+++.|+|||.+.+. .++.++|||||||++|+|+||+.||......+....+... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 23345678899999998764 5789999999999999999999999876654433222100 0
Q ss_pred -ccc--------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 -RRL--------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 -~~~--------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
... .....+++++.+++.+||+.+|++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0123568899999999999999999999999986
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=313.86 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=200.6
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||++.. .++.||||.+...... .....+.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 7899999999999999999976 4788999998654322 223456789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+ +|..++......+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR--RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9985 89998876566789999999999999999999998 79999999999999999999999999987544322222
Q ss_pred CCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHhhhhc-------------------cc
Q 037068 850 KSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLN-PMQVVGAVGF-------------------QN 908 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~-~~ei~~~i~~-------------------~~ 908 (967)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ..+....+.. ..
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 33456889999999876 458899999999999999999999997655 2221111100 00
Q ss_pred ccc---------CCCCCCc--HHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 RRL---------EIPDDID--PAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 ~~~---------~ip~~ls--~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
... .....++ ..+.+++.+||+.+|++|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0001234 788999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=332.49 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=200.3
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
+...+|.+.+.||+|+||.||++... +..|++|.+... ....+|+.++++++|+||+++++++......
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34578999999999999999998643 457888876432 2345799999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++|||++. ++|..++.. ...+++..++.|+.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 162 ~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~--givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGR--GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999986 578888743 56799999999999999999999998 799999999999999999999999999976543
Q ss_pred Ccc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH----HHhhhhc------------
Q 037068 845 TYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ----VVGAVGF------------ 906 (967)
Q Consensus 845 ~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e----i~~~i~~------------ 906 (967)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... +...+..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 321 2234679999999999999999999999999999999999999997654211 1100000
Q ss_pred ------------cccc--cCCC-----CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 907 ------------QNRR--LEIP-----DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 907 ------------~~~~--~~ip-----~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
...+ ..+| ..++.++.++|.+||+.+|++|||+.+++.|-.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 0000 1111 134678899999999999999999999999853
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=318.77 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=207.0
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--CceEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHFSI 766 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l~L 766 (967)
.++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.++++++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 47899999999999999999976 478999999865443333334566799999999999999999998754 46899
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+ +|..++......+++..++.++.||+.||.|||+. |++||||||+||+++.++.+||+|||+++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 9999975 78888776556799999999999999999999998 79999999999999999999999999998665433
Q ss_pred cCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-----------------
Q 037068 847 LSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN----------------- 908 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~----------------- 908 (967)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 23333456788999999876 457899999999999999999999998877765544332100
Q ss_pred cccCCC-----------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 909 RRLEIP-----------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 909 ~~~~ip-----------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
....++ ...++.+.++|.+||+.||++|||+.+++.|-.-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 000111 1257889999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=313.84 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=200.3
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCc-----
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPH----- 763 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~----- 763 (967)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+ +|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4789999999999999999976 478899998765433333445678899999999 56999999999877655
Q ss_pred eEEEEeecCCCchhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-CCeEEEEeccc
Q 037068 764 FSILTEFLPRGSLYRLLHRP----NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGL 838 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~----~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-~g~VKLsDFGL 838 (967)
.++||||+.+ +|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999986 788777542 24589999999999999999999998 7999999999999998 89999999999
Q ss_pred ccccccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-c--------
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-N-------- 908 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~-------- 908 (967)
++.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 9865433322333457889999998865 45789999999999999999999999876654332221100 0
Q ss_pred -------------ccc----CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 -------------RRL----EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 -------------~~~----~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
... ...+.+++++.++|.+||+.+|.+||++.+++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0013478899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=329.21 Aligned_cols=243 Identities=26% Similarity=0.418 Sum_probs=199.5
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC-----ceE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP-----HFS 765 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~-----~l~ 765 (967)
.|.-.+.+|.|+||.||+|.. ++..||||+...... .-.+|+++|+.+.|||||+++.+|.... .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 577889999999999999965 478899999865431 1235899999999999999999886422 356
Q ss_pred EEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-CeEEEEecccccc
Q 037068 766 ILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRI 841 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-g~VKLsDFGLAr~ 841 (967)
+|||||+. +|.+.++. .+..++...+..+..||++||.|||+. ||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~--~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH--GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc--CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 89999976 78888764 356788999999999999999999997 79999999999999965 9999999999998
Q ss_pred cccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--------------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-------------- 906 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-------------- 906 (967)
...... ......|..|+|||++.|. .|+.+.||||.||++.||+-|++-|.+.+....+..+..
T Consensus 176 L~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 176 LVKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 765443 4667788999999999886 499999999999999999999999998776544333220
Q ss_pred -ccccc-----------C-CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 907 -QNRRL-----------E-IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 907 -~~~~~-----------~-ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..... + +...+++++.+|+.++|+++|.+|.++.|++.|
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00000 1 234578999999999999999999999999988
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=319.01 Aligned_cols=242 Identities=22% Similarity=0.340 Sum_probs=186.3
Q ss_pred eEEeecCCceEEEEeec----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--cCceEEEEee
Q 037068 697 GERIGIGSYGEVYRADW----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--SPHFSILTEF 770 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--~~~l~LVmEy 770 (967)
+++||+|+||+||+|+. .++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 46899999999999975 356799998754322 2456789999999999999999998854 4568899999
Q ss_pred cCCCchhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE----cCCCeEEEEeccc
Q 037068 771 LPRGSLYRLLHRP--------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGL 838 (967)
Q Consensus 771 ~~gGsL~~lL~~~--------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL----d~~g~VKLsDFGL 838 (967)
+.+ +|..++... ...+++..+..++.||+.||.|||++ ||+||||||+|||+ +..+.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 865 787776421 23589999999999999999999998 79999999999999 4567999999999
Q ss_pred ccccccCcc---CCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChh---------HHHhhh-
Q 037068 839 SRIKHHTYL---SSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPM---------QVVGAV- 904 (967)
Q Consensus 839 Ar~~~~~~~---~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~---------ei~~~i- 904 (967)
++....... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||...... .....+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 986543321 23346789999999999774 5899999999999999999999999754321 000000
Q ss_pred hccc-------------------------cccC----------CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 905 GFQN-------------------------RRLE----------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 905 ~~~~-------------------------~~~~----------ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
...+ .... .....+.++.+||.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000 001235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.05 Aligned_cols=237 Identities=23% Similarity=0.399 Sum_probs=196.4
Q ss_pred EeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 699 RIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.||.|+||.||+|... ...+++|.+... .....+.+..|+.+++.+.||||+++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5899999999999653 224777775432 22344578889999999999999999999999889999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe--------EEEEecccccc
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV--------VKVCDFGLSRI 841 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~--------VKLsDFGLAr~ 841 (967)
|+.+|+|..++......+++..++.++.||+.||.|||++ ||+||||||+||+++.++. +|++|||++..
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK--GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999987666789999999999999999999998 7999999999999976654 79999999865
Q ss_pred cccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhC-CCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
... .....+++.|+|||.+.+. .++.++|||||||++|||++| ..||...+........ .....+|...+.
T Consensus 158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---EDRHQLPAPKWT 230 (258)
T ss_pred cCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---HccccCCCCCcH
Confidence 432 2234678899999999874 578999999999999999998 5777766655433322 234556777788
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++.++|.+||+.+|++|||+.+|++.|
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.32 Aligned_cols=237 Identities=23% Similarity=0.396 Sum_probs=194.2
Q ss_pred EeecCCceEEEEeecC--------------------------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCcee
Q 037068 699 RIGIGSYGEVYRADWH--------------------------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~--------------------------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIV 752 (967)
+||+|+||.||+|... ...|++|++... .......+.+|+.+++.++|+||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 6999999999998531 134788876432 223345678899999999999999
Q ss_pred EEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---
Q 037068 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW--- 829 (967)
Q Consensus 753 kLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g--- 829 (967)
++++++......++||||+++|+|..++......+++..+..++.||+.||+|||++ +|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK--NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC--CccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999999876667789999999999999999999988 799999999999997543
Q ss_pred ----eEEEEecccccccccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCChhHHHhh
Q 037068 830 ----VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELA-TLSVPWKGLNPMQVVGA 903 (967)
Q Consensus 830 ----~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELl-TGk~PF~~~~~~ei~~~ 903 (967)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+.+....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999988643221 22457788999999875 56899999999999999985 68999987766554332
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 904 i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.. .....|...++.+.++|.+||+.+|++|||+.+|++.|
T Consensus 234 ~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 234 YE---KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH---hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 22 22344555678899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.83 Aligned_cols=251 Identities=24% Similarity=0.430 Sum_probs=225.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
--++|...+.||+|.||+|.+++. +++.+|+|++++... ..+.+..-..|-++|+..+||++..+-..|+..+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 347888899999999999999866 588999999877643 44566777889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||.+||.|+.++.+ ...+++.....+...|+.||.|||++ +||+||||.+|+|+|.+|+|||+|||+++......
T Consensus 246 VMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~--~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSR--NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhC--CeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 9999999999999876 66799999999999999999999998 59999999999999999999999999998765555
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
.....++|||.|+|||++....|...+|+|.+||+||||++|+.||-..+...+...|.. ..+.+|..++++...|+.
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--EDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh--hhccCCccCCHHHHHHHH
Confidence 668889999999999999999999999999999999999999999999998888877753 467789999999999999
Q ss_pred HhhhcCCCCCc-----CHHHHHHH
Q 037068 927 DCWQTEPHLRP-----SFAQLMSR 945 (967)
Q Consensus 927 ~CLq~dPe~RP-----S~~ELLe~ 945 (967)
.+|.+||.+|. .+.||+.|
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhh
Confidence 99999999994 47777766
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.51 Aligned_cols=248 Identities=27% Similarity=0.414 Sum_probs=208.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+.|.....||+|+||.||++.. ++..||||++.... ....+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3444557799999999999965 57889999875432 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+++++|..++.. ..+++..++.++.||+.||.|||++ +|+||||||+||++++++.+||+|||++..........
T Consensus 100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQ--GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9999999998864 4589999999999999999999998 79999999999999999999999999987654433333
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~C 928 (967)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...+.......+... .........++..+.+++.+|
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 4456899999999999888999999999999999999999999887765554443211 112222345788999999999
Q ss_pred hhcCCCCCcCHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~ 945 (967)
|..+|.+|||+.+++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.13 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=199.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|.+.+.||+|+||.||+|.. +++.|++|.+..... ......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 37899999999999999999965 578999999865432 223345678999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+. ++|..++......+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ--HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9996 577666655455688889999999999999999998 7999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhc----------------cc--
Q 037068 849 SKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGF----------------QN-- 908 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~----------------~~-- 908 (967)
.....+++.|+|||.+.+. .++.++|||||||++|||++|..||...... +....+.. ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 3445678999999998764 4788999999999999999999999865532 11111000 00
Q ss_pred ---cccCCC-------C--CCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 ---RRLEIP-------D--DIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 ---~~~~ip-------~--~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.....+ . ..++.+.+++.+||+.||.+|||+.+++.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000 0 125688999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=328.68 Aligned_cols=244 Identities=20% Similarity=0.310 Sum_probs=194.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
...+|.+.+.||+|+||.||+|+.. ++.||+|+.... ....|+.++++++|+||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3457999999999999999999774 567999874321 234589999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+. ++|..++......+++..++.|+.||+.||.|||++ |||||||||+|||++.++.+||+|||+++......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ--RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99995 588888876667899999999999999999999998 79999999999999999999999999997543221
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChh----------HHHhhhhccc-cccCCC-
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPW-KGLNPM----------QVVGAVGFQN-RRLEIP- 914 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF-~~~~~~----------ei~~~i~~~~-~~~~ip- 914 (967)
......||+.|+|||++.+..++.++|||||||++|||+++..|+ ...... .+...+...+ ....++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 233466899999999999999999999999999999999865544 322110 0111010000 000000
Q ss_pred -----------------------------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 915 -----------------------------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 915 -----------------------------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..++.++.+||.+||+.||++|||+.|+|+|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1356677889999999999999999999987
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=313.64 Aligned_cols=254 Identities=29% Similarity=0.477 Sum_probs=215.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..+.|++.+.||+|+||.||++.+. +..+++|++..... ....+.+|+.+++.++|+||+++++.+......++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4567888899999999999999774 78899999865332 456788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
+||+.+++|.+++......+++..++.++.||+.||.|||+. ||+|+||+|+||+++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999987544799999999999999999999997 799999999999999999999999999875543332
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-cccCCCCCCcHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-RRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-~~~~ip~~ls~eL~dLI~ 926 (967)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||....+......+.... .....+..++..+.++|.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 3334557889999999998889999999999999999999999999877665444433221 122233448899999999
Q ss_pred HhhhcCCCCCcCHHHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+||+.+|.+||++.+++++..-
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred HHhccChhhCcCHHHHhhChHh
Confidence 9999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=316.45 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=211.0
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|.+.+.||+|+||.||++.. .++.|++|.+.... ....+.+.+|+.++++++||||+++++.+...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 47899999999999999999965 57889999875332 233466888999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+++++|.+++.+ ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~--gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC--CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999999875 3578999999999999999999998 7999999999999999999999999998765544333
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-cccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.....+++.|++||.+.+..++.++|+||||+++|++++|+.||...+.......+.. .......+..++..+.++|++
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 4445688999999999888899999999999999999999999987765443322211 112223345678899999999
Q ss_pred hhhcCCCCCcCHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L 946 (967)
||..+|++||++.+++.|-
T Consensus 252 ~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred HccCChhhCcCHHHHhcCH
Confidence 9999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.85 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=197.9
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeecc--CceEEEE
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRS--PHFSILT 768 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~--~~l~LVm 768 (967)
|++.++||+|+||.||++.. +++.||+|++........ .....+|+.+++++. |+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999976 578899998765432222 233457889999885 99999999999887 8899999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+ +|.+++......+++..++.++.||+.||+|||+. |++||||||+||+++. +.+||+|||+++.......
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN--GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99974 78777766556789999999999999999999998 7999999999999999 9999999999986544322
Q ss_pred CCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc----------------cccc
Q 037068 849 SKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ----------------NRRL 911 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~----------------~~~~ 911 (967)
.....++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+....+... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 233567899999997654 55788999999999999999999999887654433222100 0011
Q ss_pred CC-----------CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 EI-----------PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 ~i-----------p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+ ...++..+.++|.+||+.+|++||++.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 11 12567899999999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=338.53 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=197.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
....|.+.+.||+|+||.||++.+. ++.||||... ...+.+|++++++++|+||+++++++..++..++|
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3468999999999999999999774 6789999632 12356799999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
||++. ++|..++......+++..++.|+.||+.||.|||++ |||||||||+||||+.++.+||+|||+++.......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE--GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99995 688888876556799999999999999999999998 799999999999999999999999999986543221
Q ss_pred --CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hhHHHhhhhccccc-cCCC--
Q 037068 848 --SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN--------PMQVVGAVGFQNRR-LEIP-- 914 (967)
Q Consensus 848 --~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~--------~~ei~~~i~~~~~~-~~ip-- 914 (967)
......||+.|+|||++.+..++.++|||||||+||||++|..|+.... ..++...+...... ..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1234569999999999999999999999999999999999876543211 12222222110000 0000
Q ss_pred -----------------------------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 915 -----------------------------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 915 -----------------------------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..++..+.+||.+||+.||++|||+.|+|+|-
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 13466899999999999999999999999873
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=318.73 Aligned_cols=249 Identities=28% Similarity=0.413 Sum_probs=209.5
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
|.....||+|+||.||++.. .++.||+|.+.... ......+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 44455799999999999966 57899999885432 233466889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCC
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKS 851 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~ 851 (967)
++++|..++.. ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++............
T Consensus 101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 99999998764 4589999999999999999999998 7999999999999999999999999998765443333445
Q ss_pred CCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHHHHHHHhhh
Q 037068 852 TAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVAQIIRDCWQ 930 (967)
Q Consensus 852 ~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~CLq 930 (967)
..++..|+|||++.+..++.++|||||||++|||++|+.||......+....+... ......+..++..+.++|.+||+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 66899999999999988999999999999999999999999877765554443321 11223345678899999999999
Q ss_pred cCCCCCcCHHHHHHHHHH
Q 037068 931 TEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 931 ~dPe~RPS~~ELLe~L~~ 948 (967)
.+|++||++.+++++-.-
T Consensus 257 ~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 257 REPQERATAQELLDHPFL 274 (297)
T ss_pred CCcccCcCHHHHhhChhh
Confidence 999999999999997443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=353.91 Aligned_cols=258 Identities=26% Similarity=0.343 Sum_probs=209.4
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.++||+|+||.||+|.+ .++.||||++..... .......+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999976 478999999865422 2334567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 769 EFLPRGSLYRLLHRP----------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~----------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
||+++++|.+++... ...++...++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~--GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC--CccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999988531 12356677899999999999999998 799999999999999999999999999
Q ss_pred ccccccC------------------ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHH
Q 037068 839 SRIKHHT------------------YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV 900 (967)
Q Consensus 839 Ar~~~~~------------------~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei 900 (967)
++..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9765211 0011224699999999999999999999999999999999999999987655433
Q ss_pred Hhhhhcccc-ccCCCCCCcHHHHHHHHHhhhcCCCCCc-CHHHHHHHHHHHHH
Q 037068 901 VGAVGFQNR-RLEIPDDIDPAVAQIIRDCWQTEPHLRP-SFAQLMSRLRCLQR 951 (967)
Q Consensus 901 ~~~i~~~~~-~~~ip~~ls~eL~dLI~~CLq~dPe~RP-S~~ELLe~L~~L~~ 951 (967)
......... .......+++.+.+++.+||+.||++|| +++++++.|..+..
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 322111111 1111246789999999999999999996 67778888877754
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.34 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=200.6
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP------ 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~------ 762 (967)
.++|++.++||+|+||.||+|.. +++.||||++............+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 36899999999999999999976 5788999988654433333445678999999999999999999886543
Q ss_pred --ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 763 --HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 763 --~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
..++||||+.+ +|..++......+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN--KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 35999999965 78888776566799999999999999999999998 79999999999999999999999999997
Q ss_pred ccccCcc----CCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc------
Q 037068 841 IKHHTYL----SSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------ 909 (967)
Q Consensus 841 ~~~~~~~----~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------ 909 (967)
....... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...+.......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 6543221 112345788999999987654 78899999999999999999999987765443322211000
Q ss_pred -----------ccCCC-------------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 -----------RLEIP-------------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 -----------~~~ip-------------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
....+ ...+..+.++|.+||+.||.+|||+.++++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00011 1235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.21 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=208.3
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|...+.||+|++|.||++.. .++.+++|++.... ....+.+.+|+.+++.++|+||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567999999999999965 57789999875432 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.+++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||+|+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ--GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999876 4689999999999999999999998 799999999999999999999999998875543332334
Q ss_pred CCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-cccCCCCCCcHHHHHHHHHhh
Q 037068 851 STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-RRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-~~~~ip~~ls~eL~dLI~~CL 929 (967)
...|++.|+|||.+.+..++.++||||||+++|+|++|+.||...++......+.... .....+..++..+.++|.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 4568999999999999889999999999999999999999998877665555443221 122223447899999999999
Q ss_pred hcCCCCCcCHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSR 945 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~ 945 (967)
+.+|++||++.++++|
T Consensus 254 ~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 254 VRDPAQRATAAELLNH 269 (285)
T ss_pred ccChhhCcCHHHHccC
Confidence 9999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.94 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=203.1
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
|++.+.||.|++|.||+|.+ .++.|++|++............+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999976 5889999998765444444567888999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 772 PRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 772 ~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+ ++|..++.... ..+++..++.++.||+.||.|||++ +++||||+|+||+++.++.+||+|||+++..........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~--~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 58988886533 4689999999999999999999998 799999999999999999999999999976543322233
Q ss_pred CCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc----------------------
Q 037068 851 STAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---------------------- 907 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~---------------------- 907 (967)
...+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+...
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34568899999988764 4789999999999999999999999876653322211100
Q ss_pred -c----cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 -N----RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 -~----~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. ........++..+.++|.+||+.+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0001224577899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=332.27 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=219.9
Q ss_pred cccchhhhhhc------cCCeeEeEEeecCCceEEEEe--ecCCCeEEEEEeecCCCCh-hhHHHHHHHHHHHHHcCCCc
Q 037068 680 MLGEVAEWEIL------WEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSG-DSLSQFKCEAEIMLRLRHPN 750 (967)
Q Consensus 680 ~l~~l~~~ei~------~e~y~i~k~LGeG~FG~VYka--~~~g~~VAVKkl~~~~~s~-~~~~~~~~Ei~ILk~L~HpN 750 (967)
...++.+|+++ .+.|...+.||+||||.||-. +.+|+++|+|++.++.... ....-..+|..|+++++.++
T Consensus 167 yf~rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~F 246 (591)
T KOG0986|consen 167 YFTRFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPF 246 (591)
T ss_pred HHHHHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCc
Confidence 34455666543 367888999999999999965 5579999999986654433 22344678999999999999
Q ss_pred eeEEeeeeeccCceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC
Q 037068 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW 829 (967)
Q Consensus 751 IVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g 829 (967)
||.+-..|++.+.+|+||..|+||+|..+|.+.+ ..+++.+++.++.+|+.||++||+. +||+|||||+|||+|+.|
T Consensus 247 iVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~--~iVYRDLKPeNILLDd~G 324 (591)
T KOG0986|consen 247 IVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR--RIVYRDLKPENILLDDHG 324 (591)
T ss_pred EEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc--ceeeccCChhheeeccCC
Confidence 9999999999999999999999999999887743 5799999999999999999999998 699999999999999999
Q ss_pred eEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh--cc
Q 037068 830 VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG--FQ 907 (967)
Q Consensus 830 ~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~--~~ 907 (967)
+|+|+|+|+|..+..... ....+||.+|||||+++++.|+...|+|+|||+||||+.|+.||...........+. ..
T Consensus 325 hvRISDLGLAvei~~g~~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~ 403 (591)
T KOG0986|consen 325 HVRISDLGLAVEIPEGKP-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL 403 (591)
T ss_pred CeEeeccceEEecCCCCc-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh
Confidence 999999999987766543 445699999999999999999999999999999999999999998764332221211 13
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCc-----CHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRP-----SFAQLMSR 945 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RP-----S~~ELLe~ 945 (967)
....++++.+++++++|.+..|++||.+|. .++++.+|
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 445567889999999999999999999996 35566665
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.71 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=203.3
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|++.+.||.|++|.||+|++ .+..||||++..... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999977 478899998865432 23345677899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 771 LPRGSLYRLLHRPN--HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 771 ~~gGsL~~lL~~~~--~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
+.+ +|.+++.... ..+++..+..++.||+.||.|||+. |++||||||+||++++++.+||+|||+++........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN--RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 985 7888776533 5689999999999999999999988 7999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc----------------cccc
Q 037068 849 SKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ----------------NRRL 911 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~----------------~~~~ 911 (967)
.....++..|++||.+.+. .++.++|||+|||++|+|++|+.||...+..+....+... ....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3445678899999998664 4788999999999999999999999877655433322100 0000
Q ss_pred C-----------CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 E-----------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 ~-----------ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. +...+++.+.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 112457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=341.53 Aligned_cols=246 Identities=30% Similarity=0.456 Sum_probs=215.1
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
|.-.+.||.|+||.||.|++ +...||||++.... .+......+..|+..|++++|||+|.+-++|..+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 45567899999999999987 46679999987543 2344567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
|- |+-.+++.-.++++.+..+..|..+.+.||.|||++ +.||||||+.|||+++.|.|||+|||.|.+... ..
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~--~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----An 180 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----AN 180 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh--hHHhhhccccceEecCCCeeeeccccchhhcCc----hh
Confidence 95 478888877778899999999999999999999999 599999999999999999999999999976653 45
Q ss_pred CCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC-CCCcHHHHHHHH
Q 037068 851 STAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP-DDIDPAVAQIIR 926 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip-~~ls~eL~dLI~ 926 (967)
.++|||+|||||+|. .+.|+-|+||||||++.+||.-.++|+..++.+..+.-|. ++..+.++ ...+..+.+|+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-QNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-hcCCCCCCCchhHHHHHHHHH
Confidence 789999999999973 5789999999999999999999999999999988877775 44444444 457899999999
Q ss_pred HhhhcCCCCCcCHHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.||++-|.+|||.++++.|-.
T Consensus 260 ~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred HHHhhCcccCCcHHHHhhcch
Confidence 999999999999999998853
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.40 Aligned_cols=249 Identities=26% Similarity=0.486 Sum_probs=213.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LV 767 (967)
++|.+.+.||+|+||.||++.. .++.|++|++..... .......+.+|+.+++++. |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999976 578999998865432 2344567888999999998 99999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY- 846 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~- 846 (967)
|||+.+++|.+++.+. ..+++..++.++.||+.||.|||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~--~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999999763 4699999999999999999999998 79999999999999999999999999987654322
Q ss_pred -------------------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc
Q 037068 847 -------------------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ 907 (967)
Q Consensus 847 -------------------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~ 907 (967)
.......++..|++||.+.+..++.++||||||+++|++++|+.||...........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-- 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 11233457889999999998889999999999999999999999999887655544432
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCH----HHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSF----AQLMSR 945 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~----~ELLe~ 945 (967)
.....+|..+++.+.++|.+||+.+|.+||++ .++++|
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 33456777889999999999999999999999 888876
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.75 Aligned_cols=242 Identities=23% Similarity=0.344 Sum_probs=185.7
Q ss_pred eEEeecCCceEEEEeecC----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--cCceEEEEee
Q 037068 697 GERIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--SPHFSILTEF 770 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--~~~l~LVmEy 770 (967)
+.+||+|+||.||+|+.. +..||+|.+.... ....+.+|+.++++++||||+++++++.. +..+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999753 4679999875432 23457789999999999999999998854 4568999999
Q ss_pred cCCCchhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE----cCCCeEEEEeccc
Q 037068 771 LPRGSLYRLLHR--------PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGL 838 (967)
Q Consensus 771 ~~gGsL~~lL~~--------~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL----d~~g~VKLsDFGL 838 (967)
+.+ +|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 875 67666532 123588999999999999999999998 79999999999999 5667999999999
Q ss_pred ccccccCcc---CCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhH----------HHhhh
Q 037068 839 SRIKHHTYL---SSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQ----------VVGAV 904 (967)
Q Consensus 839 Ar~~~~~~~---~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e----------i~~~i 904 (967)
++....... ......+|+.|+|||++.+. .++.++|||||||++|||+||+.||....... .....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 986543321 22345689999999999764 58999999999999999999999997543210 00000
Q ss_pred hccc-----------------------ccc------------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 905 GFQN-----------------------RRL------------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 905 ~~~~-----------------------~~~------------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
...+ ... ......+..+.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 000 0011235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=341.53 Aligned_cols=254 Identities=33% Similarity=0.606 Sum_probs=223.9
Q ss_pred CCeeEeEEeecCCceEEEEeecC---CC--eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH---GT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~---g~--~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
++..+.++||+|.||.|++|.|+ |+ .||||.+....... ....|.+|+.+|.+|.|+|+++|||++.+ ..+.+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 55667789999999999999885 33 59999987665443 67889999999999999999999999988 56889
Q ss_pred EEeecCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 767 LTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
|||.+..|+|.+.|.+ ....|.......++.||+.||.||..+ ++|||||..+||||-....|||+||||.|.+...
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk--rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK--RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh--hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999999987 456688899999999999999999998 6999999999999999999999999999975432
Q ss_pred ---ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 846 ---YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 846 ---~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
+.........+.|+|||.++...++.++|||+|||++|||+| |+.||.+....++++.+. .+.+++-|+.|++++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDI 344 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHH
Confidence 222333445678999999999999999999999999999999 689999999999999998 888999999999999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
++++..||..+|.+||||..|.+.+-...
T Consensus 345 Y~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 99999999999999999999987665443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=341.19 Aligned_cols=244 Identities=31% Similarity=0.526 Sum_probs=216.5
Q ss_pred EEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCc
Q 037068 698 ERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGS 775 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGs 775 (967)
-.||+|+||+||-|++. ..++|||-+..++ .....-++.||.+.++|+|.|||+++|.+.+++.+-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 46999999999999885 4467889876543 3345568899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEEEecccccccccCccCCCCC
Q 037068 776 LYRLLHRPNHQL--DERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHHTYLSSKST 852 (967)
Q Consensus 776 L~~lL~~~~~~L--se~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKLsDFGLAr~~~~~~~~~~~~ 852 (967)
|..+++..=+++ .+.++..+.+||++||.|||++ .|||||||=+||||+ -.|.+||+|||-++........+.++
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen--~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN--KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc--ceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 999998866777 7899999999999999999999 599999999999996 67999999999999888777788899
Q ss_pred CCCCCccChhccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 853 AGTPEWMAPEVLRNEP--ANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 853 ~GT~~YmAPE~l~g~~--~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
.||..|||||++..++ |..++|||||||++.||.||++||...... .....+.+-...+++|+.++.+.+++|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 9999999999997664 888999999999999999999999876543 3344556667788999999999999999999
Q ss_pred hcCCCCCcCHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSR 945 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~ 945 (967)
..+|.+||++.++|.-
T Consensus 817 epd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcccCccHHHhccC
Confidence 9999999999999874
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.93 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=204.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC----
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP---- 762 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~---- 762 (967)
...++|++.+.||+|+||.||+|.. .++.||+|++............+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4457899999999999999999976 4788999998655433344456788999999999999999999887654
Q ss_pred ------ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEec
Q 037068 763 ------HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDF 836 (967)
Q Consensus 763 ------~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDF 836 (967)
.+++|+||+++ +|..++......+++..++.++.||+.||.|||+. ||+||||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK--NFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999986 67777665556799999999999999999999998 7999999999999999999999999
Q ss_pred ccccccccCcc-CCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc----
Q 037068 837 GLSRIKHHTYL-SSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR---- 910 (967)
Q Consensus 837 GLAr~~~~~~~-~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~---- 910 (967)
|++........ ......++..|++||.+.+. .++.++|||||||++|||++|+.||...+..+....+......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99986543321 12233567889999988654 5788999999999999999999999876654433222110000
Q ss_pred ------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 911 ------------------------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 911 ------------------------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
......++..+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01123468899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=338.24 Aligned_cols=246 Identities=27% Similarity=0.354 Sum_probs=205.5
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-C-----CceeEEeeeeeccCce
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-H-----PNVVLFMGAVTRSPHF 764 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-H-----pNIVkLig~~~~~~~l 764 (967)
+|.+.+.||+|+||.|.++.+ +++.||||+++.. .....+...|+.||+.|+ | -|||+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 899999999999999999966 5788999998653 345667788999999996 4 3899999999999999
Q ss_pred EEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC--CCeEEEEecccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK--NWVVKVCDFGLSRI 841 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~--~g~VKLsDFGLAr~ 841 (967)
|||+|.+ ..+|.+++++.+ ..++...++.|+.||+.||..||+. ||||+||||+||||.+ ...|||+|||.|+.
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l--~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL--GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999988 459999998754 5699999999999999999999998 7999999999999963 34899999999998
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh----------------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG---------------- 905 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~---------------- 905 (967)
..+... ....+..|+|||+|.|.+|+.+.|+||||||+.||++|.+.|.+.+..+.+..|.
T Consensus 341 ~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 341 ESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred cCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 776543 5678889999999999999999999999999999999999998877655443322
Q ss_pred ----ccc------------------------------cccCCC-C----------CCcHHHHHHHHHhhhcCCCCCcCHH
Q 037068 906 ----FQN------------------------------RRLEIP-D----------DIDPAVAQIIRDCWQTEPHLRPSFA 940 (967)
Q Consensus 906 ----~~~------------------------------~~~~ip-~----------~ls~eL~dLI~~CLq~dPe~RPS~~ 940 (967)
+.. .....| . .-...+.++|.+||.+||.+|+|..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 000 000122 0 1234578999999999999999999
Q ss_pred HHHHHHH
Q 037068 941 QLMSRLR 947 (967)
Q Consensus 941 ELLe~L~ 947 (967)
+.|+|-.
T Consensus 498 qal~Hpf 504 (586)
T KOG0667|consen 498 QALNHPF 504 (586)
T ss_pred HHhcCcc
Confidence 9999953
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=334.78 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=213.1
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
+.+....|++.++||.||.++||++... .+-||+|++.....+.+.+..+.+|+.+|.+| .|.+||+||+|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3456678999999999999999999774 46688888877777888899999999999999 599999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
||||||- ..+|..+|++....++...+..+..|++.++.++|++ ||||.||||.|+|+-+ |.+||+|||+|.....
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~--gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH--GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh--ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9999975 4599999998766666568899999999999999999 8999999999999965 5999999999986543
Q ss_pred --CccCCCCCCCCCCccChhccccCC-----------CCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhccccc
Q 037068 845 --TYLSSKSTAGTPEWMAPEVLRNEP-----------ANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRR 910 (967)
Q Consensus 845 --~~~~~~~~~GT~~YmAPE~l~g~~-----------~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~ 910 (967)
+.......+||+.||+||.+.... .+.++|||||||+||+|+.|+.||...... .-+..|...+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 333456688999999999985432 457899999999999999999999987633 233344334445
Q ss_pred cCCCCCCcH-HHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 911 LEIPDDIDP-AVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 911 ~~ip~~ls~-eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.++|..-+. ++.++|+.||+.||++||++.++|+|
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 566654333 39999999999999999999999987
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.28 Aligned_cols=241 Identities=28% Similarity=0.487 Sum_probs=204.4
Q ss_pred eecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 700 IGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 700 LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
||.|+||.||++.+. ++.+++|.+..... .......+.+|+.++++++|+||+++++.+......+++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999774 88999998865432 224466789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc--------C
Q 037068 777 YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL--------S 848 (967)
Q Consensus 777 ~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~--------~ 848 (967)
.+++.... .+++..++.++.||+.||.|||++ |++|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~--~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSN--GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc--CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99987633 789999999999999999999998 799999999999999999999999999875433211 2
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCC--cHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDI--DPAVAQIIR 926 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~l--s~eL~dLI~ 926 (967)
.....++..|++||.+.+..++.++||||||+++|+|++|..||......+....+.. .....+..+ +..+.+++.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHH
Confidence 2345578899999999988899999999999999999999999998887776665543 223344444 899999999
Q ss_pred HhhhcCCCCCcCH---HHHHHH
Q 037068 927 DCWQTEPHLRPSF---AQLMSR 945 (967)
Q Consensus 927 ~CLq~dPe~RPS~---~ELLe~ 945 (967)
+||+.+|.+|||+ .+++++
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhcC
Confidence 9999999999999 665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=320.63 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=202.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------ 761 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------ 761 (967)
..++|++.+.||+|+||.||++.+ +++.||||++............+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 348899999999999999999976 578999998865433444556778899999999999999999988643
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
...++||||+.+ +|...+.. .+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~--gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 357999999964 78887754 288999999999999999999998 799999999999999999999999999986
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc---------------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF--------------- 906 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~--------------- 906 (967)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 168 AGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 544322 3345688999999999999999999999999999999999999987654322211100
Q ss_pred -------ccccc-------------------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 907 -------QNRRL-------------------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 907 -------~~~~~-------------------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
..... ..+...++.+.++|.+||+.||++|||+.|+|+|-.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 00000 001234667899999999999999999999998843
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.79 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=202.3
Q ss_pred eecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 700 IGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 700 LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
||+|+||+||++.. +++.|++|.+...... ......+..|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999965 5789999998654322 22344567899999999999999999999999999999999999999
Q ss_pred hhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCC
Q 037068 777 YRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855 (967)
Q Consensus 777 ~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT 855 (967)
.+++.... ..+++..++.++.|++.||.|||+. |++||||+|+||++++++.+||+|||+++..... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 99887543 3689999999999999999999998 7999999999999999999999999998765432 223445678
Q ss_pred CCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh--ccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 856 PEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG--FQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 856 ~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~--~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
..|++||.+.+..++.++|||||||++|+|++|+.||...........+. ........+..+++.+.++|.+||+.+|
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 89999999998889999999999999999999999998765421111111 1223445667789999999999999999
Q ss_pred CCCc-----CHHHHHHHH
Q 037068 934 HLRP-----SFAQLMSRL 946 (967)
Q Consensus 934 e~RP-----S~~ELLe~L 946 (967)
.+|| ++.+++.|-
T Consensus 238 ~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 238 EKRLGCRGGSADEVREHP 255 (277)
T ss_pred hHccCCCcccHHHHHhCh
Confidence 9999 777788763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.18 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=206.5
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
|.+.+.||.|++|.||++.. .++.+++|.+............+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999976 4788999988665444345667888999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCC
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKS 851 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~ 851 (967)
.+ +|.+++......+++..++.++.||+.||.|||++ +|+|+||||+||+++.++.+||+|||.+............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC--CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 75 88888876556899999999999999999999998 7999999999999999999999999999766544322334
Q ss_pred CCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc--------------------
Q 037068 852 TAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR-------------------- 910 (967)
Q Consensus 852 ~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~-------------------- 910 (967)
..++..|++||.+.+. .++.++|+||||+++|+|+||+.||...+..+....+......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5678899999999877 7899999999999999999999999877654433222110000
Q ss_pred --------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 911 --------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 911 --------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
......++.++.++|.+||+.+|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 01123467899999999999999999999999876
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=313.69 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=210.3
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
+.|...+.||+|+||.||+++. .+..+|+|++..... .......+.+|+.++++++|+|++++++++......++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4577889999999999999976 577899998865432 2344567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+ +|.+++......+++..+..++.||+.||.|||++ ||+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 99975 78777765566799999999999999999999988 799999999999999999999999999865432
Q ss_pred CCCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
.....+++.|+|||.+. ...++.++|||||||++|||++|+.||...+.......+.........+..+++.+.+++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 23456888999999974 456889999999999999999999999887766555544333333333456788999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+||+.+|.+||++.++++++..+
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhh
Confidence 999999999999999999987554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.89 Aligned_cols=245 Identities=22% Similarity=0.396 Sum_probs=193.5
Q ss_pred EeecCCceEEEEeecC-C---CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 699 RIGIGSYGEVYRADWH-G---TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~-g---~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
.||+|+||.||+++.. + ..+++|.+... ........+.+|+.+++.++||||+++++.+......++||||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999642 2 23556655432 22344567899999999999999999999999999999999999999
Q ss_pred chhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC--ccCC
Q 037068 775 SLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--YLSS 849 (967)
Q Consensus 775 sL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~--~~~~ 849 (967)
+|.+++.+. ...+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC--CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999998753 23467778889999999999999998 7999999999999999999999999998643221 1122
Q ss_pred CCCCCCCCccChhcccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccc----cccCCCCCC
Q 037068 850 KSTAGTPEWMAPEVLRN-------EPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQN----RRLEIPDDI 917 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g-------~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~----~~~~ip~~l 917 (967)
....++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+.... .+..++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34567889999999853 235779999999999999997 577998777655444332111 223344567
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
++.+.+++..|| .+|++||++.+|++.|.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 899999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.92 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=220.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC------hhhHHHHHHHHHHHHHc-CCCceeEEeeeeec
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS------GDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTR 760 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s------~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~ 760 (967)
..+.|.-.+.||.|..++|-+... .++.+|+|++...... ....+.-.+|+.||+++ .||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 446777788999999999987744 6889999998653221 12245567899999998 79999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+..+++|+|.|+.|.|++++.. ...++++...+|+.|++.|++|||..+ ||||||||+|||++++.++||+|||+++
T Consensus 95 ~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceee
Confidence 9999999999999999999976 567999999999999999999999995 9999999999999999999999999999
Q ss_pred ccccCccCCCCCCCCCCccChhccccC------CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNE------PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~------~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip 914 (967)
...... .....+|||+|+|||.+... .|+..+|+|++||+||-|+.|.+||-.....-++..+.....++.-|
T Consensus 172 ~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 172 QLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred ccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 776543 46778999999999998543 46778999999999999999999999887777777776555555444
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 915 --DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 915 --~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
.+++...++||++||+.||.+|.|++|.|.|-..++
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 578999999999999999999999999999976654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.85 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=199.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LVm 768 (967)
++|...+.||+|+||.||++.+ .++.+|+|++...... .....+.+|+.++.++. |+||+++++++..++..+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4566678899999999999976 4788999987654322 44567888999999996 999999999999988999999
Q ss_pred eecCCCchhhhh---c-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 769 EFLPRGSLYRLL---H-RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 769 Ey~~gGsL~~lL---~-~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
||+.. +|..+. . .....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL-KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC-CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99864 554432 2 22456899999999999999999999753 799999999999999999999999999976543
Q ss_pred CccCCCCCCCCCCccChhccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhccccccC----CCCC
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNE---PANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRLE----IPDD 916 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~---~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~~~----ip~~ 916 (967)
... .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...... +....+. ...... .+..
T Consensus 161 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (288)
T cd06616 161 SIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEERE 238 (288)
T ss_pred CCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCCCc
Confidence 321 2334688999999999776 6899999999999999999999999866521 1111111 111111 2235
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++.++.+||.+||+.+|.+|||+.+|+++-
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 789999999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.53 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=206.6
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCc
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~ 763 (967)
|.+..++|++.+.||+|+||.||+|.+. ++.||||.+...... .....+..|+.++.++ .|+||+++++++.....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4455688999999999999999999875 888999998654322 3345566677777666 49999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
++++|||+. ++|..++......+++..+..++.||+.||.|||+.+ ||+||||+|+||++++++.+||+|||++....
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH-GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC-CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999999985 4777777655567899999999999999999999743 79999999999999999999999999997654
Q ss_pred cCccCCCCCCCCCCccChhccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHhhhhcc-ccccCCCCCC
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEP----ANEKCDVYSFGVILWELATLSVPWKGLNP-MQVVGAVGFQ-NRRLEIPDDI 917 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~----~s~ksDVWSLGvlL~ELlTGk~PF~~~~~-~ei~~~i~~~-~~~~~ip~~l 917 (967)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+....+... ....+....+
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06618 167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF 245 (296)
T ss_pred CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence 4322 22345788999999997654 78899999999999999999999976433 2222222211 1122222357
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+.++.+++.+||+.+|.+||++.+++.+..-
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 8999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.94 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=204.0
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--CceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l~LV 767 (967)
++|.+.+.||.|++|.||++.+ .++.+|+|.+.... .......+.+|++++++++|+||+++++++... +.+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4788999999999999999977 46789999876442 234567789999999999999999999988653 468999
Q ss_pred EeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR--KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887642 345689999999999999999999998 799999999999999999999999999875443
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hhHHHhhhhccccccCCC-----
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN-----PMQVVGAVGFQNRRLEIP----- 914 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~-----~~ei~~~i~~~~~~~~ip----- 914 (967)
.. .....++..|++||.+.+..++.++|||+|||++|+|++|..||.... ..+....+.. .....++
T Consensus 158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (287)
T cd06621 158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGN 234 (287)
T ss_pred cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCC
Confidence 22 223457889999999999999999999999999999999999998652 2222222221 1111111
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 915 -DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 915 -~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
...++.+.++|.+||..+|.+|||+.|++++-.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 234678999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=302.10 Aligned_cols=242 Identities=26% Similarity=0.390 Sum_probs=198.6
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHH-HHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIM-LRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~IL-k~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.||+|+||.||+|.. .++.||+|.+...... ......+..|..++ ...+|+||+++++++...+.+++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999976 5789999988654322 12223344555544 445899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
++|..++.. ...+++..+..++.||+.||.|||+. +++||||+|+||+++.++.+||+|||+++.... .....
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQR--GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 999999875 35689999999999999999999998 799999999999999999999999999875433 23456
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc--ccCCCCCCcHHHHHHHHHhhhc
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR--RLEIPDDIDPAVAQIIRDCWQT 931 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~--~~~ip~~ls~eL~dLI~~CLq~ 931 (967)
+++.|++||.+.+..++.++||||||+++|+|++|..||...+..+....+..... ....+..+++++.+++.+||+.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 88899999999988899999999999999999999999998887776655432221 2223446899999999999999
Q ss_pred CCCCCcCH---HHHHHHH
Q 037068 932 EPHLRPSF---AQLMSRL 946 (967)
Q Consensus 932 dPe~RPS~---~ELLe~L 946 (967)
+|++||++ .|+++|-
T Consensus 235 ~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 235 DPAKRLGANGYQEIKSHP 252 (260)
T ss_pred CHHHccCCCcHHHHHcCh
Confidence 99999955 6776663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.45 Aligned_cols=250 Identities=25% Similarity=0.389 Sum_probs=197.3
Q ss_pred CeeEeEEeecCCceEEEEeec----CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--CceE
Q 037068 693 DLQIGERIGIGSYGEVYRADW----HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHFS 765 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~----~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l~ 765 (967)
+|.+.++||+|+||.||+|.. .++.||+|.+..... .......+.+|+.++++++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 488899999999999999976 468899999876331 123345678899999999999999999999887 7899
Q ss_pred EEEeecCCCchhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC----CCeEEEEecc
Q 037068 766 ILTEFLPRGSLYRLLHR----PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK----NWVVKVCDFG 837 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~----~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~----~g~VKLsDFG 837 (967)
+||||+.+ +|..++.. ....+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999975 56665532 123689999999999999999999998 7999999999999999 9999999999
Q ss_pred cccccccCcc---CCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhH----------H---
Q 037068 838 LSRIKHHTYL---SSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQ----------V--- 900 (967)
Q Consensus 838 LAr~~~~~~~---~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e----------i--- 900 (967)
+++....... ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543322 23345678999999988764 57899999999999999999999998654322 0
Q ss_pred Hhhhh---------------c-----cccccCCC-----------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 901 VGAVG---------------F-----QNRRLEIP-----------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 901 ~~~i~---------------~-----~~~~~~ip-----------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
...+. + .......+ ...+.++.+++.+||+.||++|||+.++++|
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0 00001111 1566789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=318.02 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=205.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc-----Cc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-----PH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~-----~~ 763 (967)
.++|.+.+.||+|+||+||++.+ +++.||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 36899999999999999999976 578999998865433334456678899999999999999999987654 34
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.++||||+. ++|..++.. ...+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999996 688888865 45699999999999999999999998 79999999999999999999999999998654
Q ss_pred cCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc----------------
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF---------------- 906 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~---------------- 906 (967)
..........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 43222344567889999998865 4688999999999999999999999977653222111100
Q ss_pred --------cc--cc---cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH--HHHH
Q 037068 907 --------QN--RR---LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR--LRCL 949 (967)
Q Consensus 907 --------~~--~~---~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~--L~~L 949 (967)
.. .. ......+++++.++|++||+.+|++|||+.++++| +..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 00 01124578999999999999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=302.75 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=203.4
Q ss_pred eeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--CceEEEEe
Q 037068 694 LQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHFSILTE 769 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l~LVmE 769 (967)
|++.+.||.|+||.||+|... ++.+|+|++............+.+|+.+++.++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999764 68899999876543334456788899999999999999999999887 78999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-C
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL-S 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~-~ 848 (967)
|+.+ +|..++......+++..++.++.||+.||.|||+. |++|+||||+||++++++.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN--GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9975 89888876556799999999999999999999998 799999999999999999999999999986544321 1
Q ss_pred CCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc------------------
Q 037068 849 SKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------------------ 909 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------------------ 909 (967)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 233456889999998765 4578999999999999999999999988775544332211000
Q ss_pred ---cc--------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 ---RL--------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 ---~~--------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.. .+...+++.+.+++++||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 0011238899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.09 Aligned_cols=249 Identities=27% Similarity=0.493 Sum_probs=206.7
Q ss_pred CeeEeEEeecCCceEEEEeecC--CCeEEEEEeecC---CCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQ---DFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~---~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
+|.+.+.||+|+||.||++.+. +..+++|.+... .........+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999764 344555554432 22333344577799999999999999999999999999999
Q ss_pred EeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
|||+.+++|..++.. ....+++..++.++.|++.||.|||+. |++|+||||+||+++. +.+||+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR--RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc--CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988753 345789999999999999999999998 7999999999999975 5699999999987654
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
.........+++.|++||.+.+..++.++|+||||+++|+|++|..||...........+. .......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 4333445668899999999988889999999999999999999999998766555444432 334445567789999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~ 945 (967)
|.+||+.+|++||++.++++|
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=307.68 Aligned_cols=242 Identities=22% Similarity=0.351 Sum_probs=195.0
Q ss_pred EeecCCceEEEEeec--CCCeEEEEEeecCCCChhh-HHHHHHHHHHHH---HcCCCceeEEeeeeeccCceEEEEeecC
Q 037068 699 RIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDS-LSQFKCEAEIML---RLRHPNVVLFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 699 ~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~-~~~~~~Ei~ILk---~L~HpNIVkLig~~~~~~~l~LVmEy~~ 772 (967)
.||+|+||.||++.. +++.+|+|.+......... ...+.+|..+++ ..+|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999976 4788999988654332222 223344444433 3479999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCC
Q 037068 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST 852 (967)
Q Consensus 773 gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~ 852 (967)
+++|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~--~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCc
Confidence 9999988875 45699999999999999999999998 7999999999999999999999999998754432 22345
Q ss_pred CCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH--HHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 853 AGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQ--VVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 853 ~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e--i~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
.||+.|+|||.+.+ ..++.++|||||||++|+|++|..||....... ...... ......+|..+++++.++|.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHh
Confidence 68999999999864 568999999999999999999999997653321 111111 22344567789999999999999
Q ss_pred hcCCCCCc-----CHHHHHHHH
Q 037068 930 QTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 930 q~dPe~RP-----S~~ELLe~L 946 (967)
+.||.+|| +++++++|.
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhCc
Confidence 99999999 699999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=307.94 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=199.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc-------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------- 761 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------- 761 (967)
.++|++.++||+|+||.||+|.+ +++.++||++............+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47999999999999999999976 478899999865543333334567899999999999999999987543
Q ss_pred -CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 762 -PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 762 -~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
..+++||||+.+ +|...+......+++..+..++.||+.||.|||++ ||+||||||+||++++++.+||+|||+++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN--HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999975 67777665566799999999999999999999998 79999999999999999999999999997
Q ss_pred ccccCccC-----------CCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc
Q 037068 841 IKHHTYLS-----------SKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN 908 (967)
Q Consensus 841 ~~~~~~~~-----------~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~ 908 (967)
........ .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 64432211 1123467889999988654 58899999999999999999999998776654333221100
Q ss_pred c---------------------ccCCC-------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 R---------------------RLEIP-------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 ~---------------------~~~ip-------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. ....+ ..+++.+.++|.+||+.+|++|||+.+++.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 00001 2345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.85 Aligned_cols=241 Identities=22% Similarity=0.344 Sum_probs=196.3
Q ss_pred EeecCCceEEEEeec--CCCeEEEEEeecCCCChhh-HHHHHHHH---HHHHHcCCCceeEEeeeeeccCceEEEEeecC
Q 037068 699 RIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDS-LSQFKCEA---EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 699 ~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~-~~~~~~Ei---~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~ 772 (967)
.||+|+||.||++.. .++.||+|.+......... ...+..|. .+++...|+||+++++++...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999966 4789999998765433211 12233343 34445689999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCC
Q 037068 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST 852 (967)
Q Consensus 773 gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~ 852 (967)
+++|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 9999988865 45699999999999999999999998 7999999999999999999999999998755432 22345
Q ss_pred CCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCh---hHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 853 AGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNP---MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 853 ~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~---~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.|+..|+|||.+.++ .++.++||||+||++|+|++|+.||..... ....... ......+|..+++++.+++.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHHH
Confidence 789999999999754 589999999999999999999999987632 2222111 2334567778899999999999
Q ss_pred hhcCCCCCc-----CHHHHHHHH
Q 037068 929 WQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RP-----S~~ELLe~L 946 (967)
|..+|.+|| ++.+++++-
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhCc
Confidence 999999999 999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=311.07 Aligned_cols=252 Identities=24% Similarity=0.311 Sum_probs=203.3
Q ss_pred eeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 694 LQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.+++.+|.|+++.||++..+++.||||++............+..|+.+++.++|+||+++++++...+..+++|||+.+
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34566677778888888888899999999876545556678899999999999999999999999999999999999999
Q ss_pred CchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-----
Q 037068 774 GSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL----- 847 (967)
Q Consensus 774 GsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~----- 847 (967)
++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~--~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK--GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999998753 35689999999999999999999998 799999999999999999999999998865432111
Q ss_pred --CCCCCCCCCCccChhccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc---------------
Q 037068 848 --SSKSTAGTPEWMAPEVLRNE--PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN--------------- 908 (967)
Q Consensus 848 --~~~~~~GT~~YmAPE~l~g~--~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~--------------- 908 (967)
......++..|+|||++.+. .++.++|||||||++|||++|+.||................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 12234577889999998764 57889999999999999999999998765433221110000
Q ss_pred -----------------cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 909 -----------------RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 909 -----------------~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.....+..++.++.+++++||+.||++|||+.++++|-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000111234567899999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=363.49 Aligned_cols=253 Identities=29% Similarity=0.442 Sum_probs=220.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.-+|+-+.+||.|.||.||-+.. +|...|+|-+.-+.........+.+|+.++..|+|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34677788999999999999855 6778899987766655667788999999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-- 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-- 846 (967)
|||.+|+|.+++.. +.-.++.....+..|++.|+.|||++ |||||||||.||+++.+|.+|++|||.|+......
T Consensus 1314 EyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~--gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEH--GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhc--CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 99999999999875 45578888888999999999999999 89999999999999999999999999998765432
Q ss_pred --cCCCCCCCCCCccChhccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 847 --LSSKSTAGTPEWMAPEVLRNEP---ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 847 --~~~~~~~GT~~YmAPE~l~g~~---~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
.......||+.|||||+|.+.. ..-+.||||||||+.||+||+.||...+.+=.+-.....+..+++|+.++++-
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 2234577999999999997654 45679999999999999999999999887654444445778899999999999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.+||..||+.||++|+++.||++|=
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHhh
Confidence 9999999999999999999999873
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=296.74 Aligned_cols=241 Identities=26% Similarity=0.437 Sum_probs=209.1
Q ss_pred eecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 700 IGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 700 LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
||+|+||.||++.. .++.+++|.+...... ......+..|+.++++++|+||+++++.+..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999976 4788999988665432 23566889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCC
Q 037068 777 YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856 (967)
Q Consensus 777 ~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~ 856 (967)
.+++... ..+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~--~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSL--GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 9998763 4689999999999999999999997 799999999999999999999999999987654433344567888
Q ss_pred CccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 037068 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936 (967)
Q Consensus 857 ~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~R 936 (967)
.|++||.+.+...+.++|+|+||+++|+|++|..||...+..+....+.. ....+|..++..+.++|.+||..+|++|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 99999999988899999999999999999999999988876665555532 4567788889999999999999999999
Q ss_pred cCH---HHHHHH
Q 037068 937 PSF---AQLMSR 945 (967)
Q Consensus 937 PS~---~ELLe~ 945 (967)
|++ .++++|
T Consensus 236 ~~~~~~~~l~~~ 247 (250)
T cd05123 236 LGSGGAEEIKAH 247 (250)
T ss_pred CCcccHHHHHhC
Confidence 999 666654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.89 Aligned_cols=254 Identities=17% Similarity=0.195 Sum_probs=186.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeecCC-----CeEEEEEeecCCCChhh---------HHHHHHHHHHHHHcCCCceeEE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDS---------LSQFKCEAEIMLRLRHPNVVLF 754 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~g-----~~VAVKkl~~~~~s~~~---------~~~~~~Ei~ILk~L~HpNIVkL 754 (967)
+..++|++.+.||+|+||+||+|.+.+ ..+++|+.......... ......+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 445799999999999999999997643 34566643222111000 0111223334455689999999
Q ss_pred eeeeeccC----ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 755 MGAVTRSP----HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 755 ig~~~~~~----~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
++++.... ..+++++++.. ++.+++.. ....++..+..++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEH--GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCc
Confidence 98765443 24677887643 56666554 23467888999999999999999998 7999999999999999999
Q ss_pred EEEEecccccccccCc-------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHh
Q 037068 831 VKVCDFGLSRIKHHTY-------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP-MQVVG 902 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~-------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~-~ei~~ 902 (967)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999998653211 112234699999999999999999999999999999999999999987732 22211
Q ss_pred hhh-----ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 903 AVG-----FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 903 ~i~-----~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
... ........+..+++++.+++..||+.+|++||++.+|++.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 110 00011112346789999999999999999999999999876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=312.59 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=207.3
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC-----ceE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP-----HFS 765 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~-----~l~ 765 (967)
+|++.+.||.|+||.||+|+. .+..|+||++............+.+|+.+++.++|+||+++++++.... .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999976 4788999988654333445567889999999999999999999987765 789
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
++|||+. ++|..++... ..+++..++.++.||+.||.|||++ ||+||||||.|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~--gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 4888888763 4799999999999999999999998 7999999999999999999999999999876544
Q ss_pred c---cCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc-----------
Q 037068 846 Y---LSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR----------- 910 (967)
Q Consensus 846 ~---~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~----------- 910 (967)
. .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 123345678899999999888 7899999999999999999999999887765433332210000
Q ss_pred ------------------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 911 ------------------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 911 ------------------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
......+++.+.++|.+||+.+|.+||++.+++.|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 011234688999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=342.00 Aligned_cols=260 Identities=32% Similarity=0.617 Sum_probs=226.3
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEe
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFM 755 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLi 755 (967)
.|++..++..+.+.||+|.||.|++|... ...||||.++..... ...+.+..|+++|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 78999899999999999999999999542 346999988765444 6678899999999999 699999999
Q ss_pred eeeeccCceEEEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCC
Q 037068 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKS 820 (967)
Q Consensus 756 g~~~~~~~l~LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKP 820 (967)
+++...+.+++|+||+..|+|..+++... ..++....+.++.||+.||+||++. ++|||||..
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~--~~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV--PCVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC--Cccchhhhh
Confidence 99999999999999999999999998654 3488999999999999999999998 599999999
Q ss_pred CcEEEcCCCeEEEEeccccccccc-CccCCCCCC--CCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 037068 821 PNLLVDKNWVVKVCDFGLSRIKHH-TYLSSKSTA--GTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLN 896 (967)
Q Consensus 821 sNILLd~~g~VKLsDFGLAr~~~~-~~~~~~~~~--GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~ 896 (967)
+||||+++..+||+|||+|+.... ......... -...|||||.+....|+.++|||||||+||||+| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999999999995433 232222223 4557999999999999999999999999999999 789999866
Q ss_pred -hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 897 -PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 897 -~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
..++.. ....+.+++.|..++++++++|+.||+.+|++||++.++.+.+...
T Consensus 527 ~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 445544 4458889999999999999999999999999999999999999884
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=331.13 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=226.5
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
....|.+.+.||.|.|++|.++++ ++..||||.+.+...+......+.+|+++|+.|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346899999999999999999976 689999999988777777777799999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+|.+++++.+ .+.+.+..+..++.|+.+|++|||++ .|||||||++||||+.+-++||+|||++..+. ...
T Consensus 134 ~eya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k--~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSK--NIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGL 209 (596)
T ss_pred EEeccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhc--ceeccccchhhcccccccceeeeccccceeec-ccc
Confidence 999999999999987 44566699999999999999999999 59999999999999999999999999998877 344
Q ss_pred CCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
...+.+|++.|.|||++.+..| .+.+|+|++|+++|-|+.|..||++.+..+...... ...+.+|..++.++.++|+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl--~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL--RGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe--eeeecccceeechhHHHHH
Confidence 5778999999999999999886 578999999999999999999999887666554442 3456778889999999999
Q ss_pred HhhhcCCCCCcCHHHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
++|..+|.+|++.++++++-+.
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred HhhccCccccCCHHHhhhhccc
Confidence 9999999999999999998543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=335.81 Aligned_cols=247 Identities=31% Similarity=0.513 Sum_probs=207.8
Q ss_pred eEeEEeecCCceEEEEeec--CCCeEEEEE--eecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc--eEEEE
Q 037068 695 QIGERIGIGSYGEVYRADW--HGTEVAVKK--FLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH--FSILT 768 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~--~g~~VAVKk--l~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~--l~LVm 768 (967)
+...+||+|+|-+||+|.+ .|..||=-. +.+...+....+.+..|+.+|+.|+|+||++||+.|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4467899999999999976 455555221 22222345567899999999999999999999999987655 78999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEEEecccccccccCcc
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|.|..|+|..|+++ .+.++.+.+..|++||++||.|||+++|.|||||||-+||||+ ..|.|||+|+|||.......
T Consensus 123 EL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 99999999999987 4568899999999999999999999999999999999999997 55899999999999877654
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG-LNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~-~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
.....|||.|||||++. +.|+..+||||||++|+||+|+.+||.. .++.++...+....+...+.+.-++++++||.
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE 278 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence 33478999999999987 7799999999999999999999999975 56667776665333333444556899999999
Q ss_pred HhhhcCCCCCcCHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L 946 (967)
+||.. ...|+|+.|+|++-
T Consensus 279 kCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred HHhcC-chhccCHHHHhhCh
Confidence 99999 99999999999874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=314.82 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=204.3
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec----cCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR----SPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~----~~~l 764 (967)
.++|++.+.||+|+||.||++.. ++..||+|++............+.+|+.+++.++|+||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 37899999999999999999965 58899999987543333456678889999999999999999998753 3468
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+. ++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999995 589888865 34599999999999999999999998 799999999999999999999999999976543
Q ss_pred CccC----CCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-------------
Q 037068 845 TYLS----SKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF------------- 906 (967)
Q Consensus 845 ~~~~----~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~------------- 906 (967)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 2211 123468899999999866 4588999999999999999999999987654332211110
Q ss_pred -----------cccccC-----CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 907 -----------QNRRLE-----IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 907 -----------~~~~~~-----ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
...... .....++++.++|.+||+.+|++||++.+++.|-.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 000011 113468899999999999999999999999998544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.34 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=207.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
+.|...+.||+|+||.||+|.. .+..+++|.+..... .......+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4577788999999999999976 467899998864322 2334567888999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+. |+|.+++......+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9996 578777765556789999999999999999999988 7999999999999999999999999998754432
Q ss_pred CCCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.........+..++..+.++|
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 2356788999999975 356788999999999999999999999877665544433322222223446888999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+||+.+|++||++.+++++....
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcccc
Confidence 999999999999999999886544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.13 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=198.1
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc-----Cc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-----PH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~-----~~ 763 (967)
.++|++.++||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 47899999999999999999965 57889999875322 223445678899999999999999999876543 35
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.++|+||+.+ +|..++.. ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 8999999965 78877753 4689999999999999999999998 79999999999999999999999999997653
Q ss_pred cCcc---CCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh--------------
Q 037068 844 HTYL---SSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG-------------- 905 (967)
Q Consensus 844 ~~~~---~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~-------------- 905 (967)
.... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3211 1223568899999998755 468999999999999999999999997665432211110
Q ss_pred -c---------cccccC-----CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 906 -F---------QNRRLE-----IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 906 -~---------~~~~~~-----ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. ...... .....++++.++|.+||+.+|++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000000 112457889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.72 Aligned_cols=247 Identities=28% Similarity=0.431 Sum_probs=205.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
+.|...+.||+|+||+||+|+. .+..|++|++..... .......+.+|+.+++.++|+||+++++++.+....++||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 3466778899999999999976 578899999865433 2334467888999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+. ++|.+++......+++..++.++.||+.+|.|||++ |++|+||+|+||+++.++.+||+|||++.....
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~--gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 9996 577777766566799999999999999999999988 799999999999999999999999999864322
Q ss_pred CCCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
.....++..|+|||++. +..++.++|||||||++|+|++|..||...+.......+............++..+.+++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 23456889999999984 456888999999999999999999999887765555444322222222345678899999
Q ss_pred HHhhhcCCCCCcCHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||+.+|.+||++.+++.+
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 254 DYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.06 Aligned_cols=248 Identities=22% Similarity=0.390 Sum_probs=204.2
Q ss_pred CeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCC--ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 693 DLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDF--SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~--s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
+|++.+.||+|+||.||++.. ++..||+|.+..... .....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999865 578899999865322 122346678899999999 699999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. |++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999999875 45688999999999999999999998 799999999999999999999999999976543
Q ss_pred Cc-cCCCCCCCCCCccChhccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHhhhhccccccCCCCCC
Q 037068 845 TY-LSSKSTAGTPEWMAPEVLRNE--PANEKCDVYSFGVILWELATLSVPWKGLNP----MQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 845 ~~-~~~~~~~GT~~YmAPE~l~g~--~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~----~ei~~~i~~~~~~~~ip~~l 917 (967)
.. .......|+..|++||.+.+. .++.++||||||+++|+|++|..||..... ......+ .....++|..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccC
Confidence 22 122345688999999998753 467899999999999999999999974322 2222222 12334567788
Q ss_pred cHHHHHHHHHhhhcCCCCCc-----CHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRP-----SFAQLMSR 945 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RP-----S~~ELLe~ 945 (967)
++.+.+++.+||+.+|.+|| ++.+++++
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999999997 78888887
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.18 Aligned_cols=241 Identities=20% Similarity=0.374 Sum_probs=195.0
Q ss_pred cCCeeEeEEe--ecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceE
Q 037068 691 WEDLQIGERI--GIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 691 ~e~y~i~k~L--GeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~ 765 (967)
.++|.+.+.+ |.|+||.||++.. .+..+|+|.+........ |+.+...+ +|+||+++++.+...+.++
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 3566666665 9999999999965 477899998765432211 22222222 7999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-eEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-VVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-~VKLsDFGLAr~~~~ 844 (967)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+. |++||||||+||+++.++ .++|+|||+++....
T Consensus 86 iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKH--NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999999999999999764 4799999999999999999999998 799999999999999888 999999999876543
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHH--HhhhhccccccCCCCCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV--VGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei--~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
. ....++..|+|||++.+..++.++||||||+++|+|++|+.||........ .............+..+++.+.
T Consensus 163 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 163 P----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN 238 (267)
T ss_pred C----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence 2 234688999999999999999999999999999999999999985543221 1111112333455567899999
Q ss_pred HHHHHhhhcCCCCCcC-HHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPS-FAQLMSR 945 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS-~~ELLe~ 945 (967)
++|.+||+.+|.+||+ ++++++|
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcC
Confidence 9999999999999995 6999876
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=299.09 Aligned_cols=248 Identities=25% Similarity=0.318 Sum_probs=199.1
Q ss_pred eeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc---CCCceeEEeeeeeccCc-----
Q 037068 694 LQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL---RHPNVVLFMGAVTRSPH----- 763 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L---~HpNIVkLig~~~~~~~----- 763 (967)
|++.+.||+|+||.||+|+++ ++.+|+|++............+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999874 78899999865433333334566788877766 59999999999987766
Q ss_pred eEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
++++|||+.+ +|.+++.... ..+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~--~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999975 7888876532 3689999999999999999999998 7999999999999999999999999999765
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc-------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------------- 909 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------------- 909 (967)
..... .....++..|+|||.+.+..++.++|||||||++|+|++|..||......+....+.....
T Consensus 158 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 43322 2334578899999999999999999999999999999999999988765544332211000
Q ss_pred --------cc----CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 --------RL----EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 --------~~----~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.. .....+++.+.++|.+||+.||.+||++.+++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0011346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=332.85 Aligned_cols=255 Identities=16% Similarity=0.242 Sum_probs=189.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeecCC---CeEEEEE--------------eec-CCCChhhHHHHHHHHHHHHHcCCCc
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWHG---TEVAVKK--------------FLD-QDFSGDSLSQFKCEAEIMLRLRHPN 750 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~g---~~VAVKk--------------l~~-~~~s~~~~~~~~~Ei~ILk~L~HpN 750 (967)
...++|++.++||+|+||+||++..+. ..+++|. +.+ ..........+.+|+.++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345799999999999999999885421 1112110 111 0112233456889999999999999
Q ss_pred eeEEeeeeeccCceEEEEeecCCCchhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc
Q 037068 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRP----NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD 826 (967)
Q Consensus 751 IVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~----~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd 826 (967)
|+++++++...+..++|++++.+ +|..++... ........+..|+.||+.||.|||++ |||||||||+||||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~--gIiHrDLKP~NILl~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK--KLIHRDIKLENIFLN 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEC
Confidence 99999999999999999999854 666665432 12234667888999999999999998 799999999999999
Q ss_pred CCCeEEEEecccccccccCcc-CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCCh---hHHH
Q 037068 827 KNWVVKVCDFGLSRIKHHTYL-SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNP---MQVV 901 (967)
Q Consensus 827 ~~g~VKLsDFGLAr~~~~~~~-~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~-PF~~~~~---~ei~ 901 (967)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|.. ||..... .+..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999986654322 2334679999999999999999999999999999999999875 4543221 1111
Q ss_pred hhhhccc-ccc-----------------------CCC-----CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 902 GAVGFQN-RRL-----------------------EIP-----DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 902 ~~i~~~~-~~~-----------------------~ip-----~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..+.... ... .++ ..++.++.++|.+||+.||++|||+.|+|+|-
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 1111000 000 000 13566788899999999999999999999874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=305.41 Aligned_cols=242 Identities=27% Similarity=0.424 Sum_probs=204.5
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCc
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGS 775 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGs 775 (967)
.+||+|+||.||++.. ++..||||++... .......+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 5799999999999966 5788999987432 22345668899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCC
Q 037068 776 LYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855 (967)
Q Consensus 776 L~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT 855 (967)
|.+++.. ..+++..++.++.|++.+|.|||+. |++|+||||+||+++.++.++|+|||++..............++
T Consensus 104 L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~--givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 104 LTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 9998764 3588999999999999999999998 79999999999999999999999999987554333233445688
Q ss_pred CCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHHHHHHHhhhcCCC
Q 037068 856 PEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVAQIIRDCWQTEPH 934 (967)
Q Consensus 856 ~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~CLq~dPe 934 (967)
+.|++||.+.+..++.++|+||||+++|+|++|..||......+....+... .........+++.+.+++.+||+.+|.
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence 9999999998888999999999999999999999999887665554443211 112223456789999999999999999
Q ss_pred CCcCHHHHHHH
Q 037068 935 LRPSFAQLMSR 945 (967)
Q Consensus 935 ~RPS~~ELLe~ 945 (967)
+||++.++++|
T Consensus 260 ~R~~~~~ll~~ 270 (292)
T cd06657 260 QRATAAELLKH 270 (292)
T ss_pred cCcCHHHHhcC
Confidence 99999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=310.00 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=197.7
Q ss_pred EEeecC--CceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIG--SYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG--~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
..||.| +||+||++++ .++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999977 689999999876554555667899999999999999999999999999999999999999
Q ss_pred CchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC----
Q 037068 774 GSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS---- 848 (967)
Q Consensus 774 GsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~---- 848 (967)
++|..++.+. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN--GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999988753 34589999999999999999999988 7999999999999999999999999865432211100
Q ss_pred ---CCCCCCCCCccChhccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc----------------
Q 037068 849 ---SKSTAGTPEWMAPEVLRNE--PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---------------- 907 (967)
Q Consensus 849 ---~~~~~GT~~YmAPE~l~g~--~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~---------------- 907 (967)
.....++..|++||++.+. .++.++|||||||++|||++|+.||......+........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 1112345679999999764 4788999999999999999999999876544332211100
Q ss_pred -----------------------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 908 -----------------------------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 908 -----------------------------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
......+..+++.+.+||++||+.||++|||+.++++|-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0001112346778999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.51 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=204.9
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
|++.+.||+|+||.||+|+. .++.+++|++............+..|+.+++.++|+||+++++++...+.+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56778899999999999977 3788999998765433444567788999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCC
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKS 851 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~ 851 (967)
. ++|.+++.+....+++..++.++.|++.||.|||++ ||+||||+|+||++++++.+||+|||+++...........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 8 589999987546799999999999999999999998 7999999999999999999999999999865543333334
Q ss_pred CCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc------------------cccc-
Q 037068 852 TAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ------------------NRRL- 911 (967)
Q Consensus 852 ~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~------------------~~~~- 911 (967)
..++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+... ....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 4567889999998776 7899999999999999999999999876654333222100 0000
Q ss_pred --------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 --------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 --------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.....++..+.++|++||..+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0112347889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.95 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=201.6
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeecc--CceE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRS--PHFS 765 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~--~~l~ 765 (967)
.++|++.+.||+|+||.||+|.+ .++.+|+|++............+.+|+.+++++ +|+||+++++++... ..++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 47899999999999999999976 478899998865433334455677899999999 999999999988653 3689
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+. ++|..++... .+++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~--~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG--NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5898888753 688999999999999999999998 7999999999999999999999999999865432
Q ss_pred cc-----CCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-----------
Q 037068 846 YL-----SSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN----------- 908 (967)
Q Consensus 846 ~~-----~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~----------- 908 (967)
.. ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 2233568899999998765 457889999999999999999999998765443322211000
Q ss_pred --------------c----ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 --------------R----RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 --------------~----~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. .......++.++.++|.+||+.+|.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 001123378899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=310.28 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=202.6
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC-----
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP----- 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~----- 762 (967)
..++|++.+.||+|+||.||++.. ++..||||++............+.+|+.+++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 458899999999999999999965 5788999988554333344556889999999999999999999887643
Q ss_pred -ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 763 -HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 763 -~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.+++||||+ +++|..++.. ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~--gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999998 7789888764 4689999999999999999999998 799999999999999999999999999976
Q ss_pred cccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc------------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN------------ 908 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~------------ 908 (967)
.... .....+++.|++||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+....
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 168 TDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 5432 234567889999999876 458899999999999999999999998765433222111000
Q ss_pred -----------cc------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 909 -----------RR------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 909 -----------~~------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.. ..+...+++++.++|.+||+.||++|||+.+++.|-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00 012245788899999999999999999999999773
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.11 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=200.5
Q ss_pred CCee-EeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChh------------hHHHHHHHHHHHHHcCCCceeEEee
Q 037068 692 EDLQ-IGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGD------------SLSQFKCEAEIMLRLRHPNVVLFMG 756 (967)
Q Consensus 692 e~y~-i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~------------~~~~~~~Ei~ILk~L~HpNIVkLig 756 (967)
++|. +.+.||.|+||+||+|.+ .++.||||++........ ....+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 5665 457899999999999975 578899998865432210 0124678999999999999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEec
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDF 836 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDF 836 (967)
++..++..++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+. ||+|+||||+||+++.++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~--~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKW--YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 588888865 45689999999999999999999988 7999999999999999999999999
Q ss_pred ccccccccC--------------ccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 037068 837 GLSRIKHHT--------------YLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVV 901 (967)
Q Consensus 837 GLAr~~~~~--------------~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~ 901 (967)
|+++..... ........+++.|+|||.+.+. .++.++|||||||++|||++|..||...+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999765411 1112233468899999998764 4689999999999999999999999887765443
Q ss_pred hhhhcccc-------------------cc-------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 902 GAVGFQNR-------------------RL-------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 902 ~~i~~~~~-------------------~~-------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
..+..... .. .....++.++.++|.+||+.+|++||++.+++.|-.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 32211000 00 011345788999999999999999999999998753
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.41 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=202.5
Q ss_pred CeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCCC--hhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 693 DLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDFS--GDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~s--~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
+|++.+.||+|+||.||++.. .++.||||.+...... ......+.+|+.+++++ +|+||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999864 4578999988643221 22345678899999999 699999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+++|..++.. ...+++..+..++.|++.+|.|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~--~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQL--GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999998865 34689999999999999999999987 799999999999999999999999999876443
Q ss_pred Ccc-CCCCCCCCCCccChhccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHhhhhccccccCCCCCC
Q 037068 845 TYL-SSKSTAGTPEWMAPEVLRNEP--ANEKCDVYSFGVILWELATLSVPWKGLNP----MQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 845 ~~~-~~~~~~GT~~YmAPE~l~g~~--~s~ksDVWSLGvlL~ELlTGk~PF~~~~~----~ei~~~i~~~~~~~~ip~~l 917 (967)
... ......++..|++||.+.+.. .+.++||||||+++|||++|..||..... .+....+ .......|..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCccc
Confidence 221 223356889999999987765 78899999999999999999999964322 1222222 22344567778
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+..+.++|.+||+.+|++|||+.++.+.|
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 99999999999999999999966554443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.02 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=209.7
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCce
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l 764 (967)
....++++....||.|+.|.|++++. +|...|||.+.... +....+++...+.++.+.+ .|+||+.+|+|..+...
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 33445667778899999999999977 46889999987765 3445667777888877765 89999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+|.||.|.. -+..++++-.++++|..+-++...++.||.||.+++ ||+|||+||+|||+|+.|+|||||||++-.+.+
T Consensus 167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeec
Confidence 999998843 466677766778999999999999999999999988 999999999999999999999999999977665
Q ss_pred CccCCCCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHhhhhccccccCCC--CCCc
Q 037068 845 TYLSSKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNP-MQVVGAVGFQNRRLEIP--DDID 918 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~-~ei~~~i~~~~~~~~ip--~~ls 918 (967)
... ....+|-+.|||||.+. ...|+.++||||||++++||.||+.||.+-+. .+++..+. ....+.+| ..++
T Consensus 245 SkA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-n~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 245 SKA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-NEEPPLLPGHMGFS 322 (391)
T ss_pred ccc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-hcCCCCCCcccCcC
Confidence 532 44567899999999985 34689999999999999999999999998543 33333332 22223333 3589
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+.+.+|+..||++|+.+||...++|+|-
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 9999999999999999999999999984
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=309.64 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=201.3
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP------ 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~------ 762 (967)
.++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36899999999999999999975 5789999988654333334456788999999999999999999886542
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++|+||+.. +|..++. ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~--~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 46899999964 6766653 3588999999999999999999998 7999999999999999999999999998754
Q ss_pred ccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN------------- 908 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~------------- 908 (967)
... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+....
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 168 DAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 332 234567889999999876 468899999999999999999999998776543332211100
Q ss_pred --------cccC--------CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH--HHHHH
Q 037068 909 --------RRLE--------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR--LRCLQ 950 (967)
Q Consensus 909 --------~~~~--------ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~--L~~L~ 950 (967)
.... .....++.+.++|.+||+.||++||++.+++.| ++.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 012467889999999999999999999999988 66654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=306.08 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=201.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-cCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-SPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-~~~l~L 766 (967)
..++|++.+.||.|+||.||++.+ +++.||||++............+..|+.+++.++||||+++++++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 457899999999999999999965 57889999876543334455678889999999999999999998865 557899
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
+|||+ +++|..++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~--~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred Eeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 99998 5689888864 4578889999999999999999998 7999999999999999999999999998754322
Q ss_pred cCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-------------------
Q 037068 847 LSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF------------------- 906 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~------------------- 906 (967)
.....++..|++||.+.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 234567889999999866 5689999999999999999999999987664322111100
Q ss_pred -----cccccC-----CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 907 -----QNRRLE-----IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 907 -----~~~~~~-----ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
...... ....+++++.++|.+||+.+|++||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011 113567899999999999999999999999988
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=307.34 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=202.3
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc----
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS---- 761 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~---- 761 (967)
....++|.+.+.||+|+||.||++.+ +++.||+|++............+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 34568999999999999999999965 578899998865433333456788899999999999999999987543
Q ss_pred --CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 762 --PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 762 --~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
...+++++++ +++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3467888876 7799888764 3589999999999999999999998 7999999999999999999999999998
Q ss_pred cccccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc---------
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR--------- 909 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~--------- 909 (967)
+..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 168 RHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 754332 334568899999999876 4688899999999999999999999987665433222110000
Q ss_pred ------------ccCC--------CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 910 ------------RLEI--------PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 910 ------------~~~i--------p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.... ....++++.++|.+||+.+|.+||++.+++.|-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0001 1135788999999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=296.81 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=198.1
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEEEee
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LVmEy 770 (967)
|++.+.||+|+||.||+|.. .++.|+||++...... .......+|+..+++++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999977 4678999987654322 22234557899999998 99999999999999999999999
Q ss_pred cCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 771 LPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 771 ~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
+ +++|.+++.... ..+++..++.++.||+.+|.|||++ +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~--~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-Y 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-c
Confidence 9 778988886643 5689999999999999999999998 799999999999999999999999999976544321 2
Q ss_pred CCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-----------------cccc
Q 037068 850 KSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-----------------NRRL 911 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-----------------~~~~ 911 (967)
....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...........+... ....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 34567889999998854 45789999999999999999999999776544332211100 0000
Q ss_pred -----------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 -----------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 -----------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
......+..+.++|++||+.+|++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0011236789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.75 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=197.1
Q ss_pred CeeEeEEeecCCceEEEEeecC----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeec----cCc
Q 037068 693 DLQIGERIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTR----SPH 763 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~----~~~ 763 (967)
+|.+.+.||+|+||.||++... +..||+|++............+.+|+.+++++ +|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999774 56899998764322333456678899999999 59999999987543 245
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
++++++|+. ++|..++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSA--NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788889886 589888865 45689999999999999999999988 79999999999999999999999999997654
Q ss_pred cCcc----CCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc------------
Q 037068 844 HTYL----SSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF------------ 906 (967)
Q Consensus 844 ~~~~----~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~------------ 906 (967)
.... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 1233568999999998765 4689999999999999999999999987654332221110
Q ss_pred --------------ccccc---CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 907 --------------QNRRL---EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 907 --------------~~~~~---~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..... .....++..+.+++.+||+.+|++|||+.+++++=
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000 11124578999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=309.52 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=203.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc----
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH---- 763 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~---- 763 (967)
..++|++.+.||+|+||.||+|++ .+..||||++............+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 357899999999999999999977 46789999876543333445667889999999999999999998766544
Q ss_pred --eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 764 --FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 764 --l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~--gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999998 5699998874 4689999999999999999999998 799999999999999999999999999976
Q ss_pred cccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc-----------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR----------- 909 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~----------- 909 (967)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 168 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred cccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 5432 3345678899999998653 678999999999999999999999987765544332211000
Q ss_pred ---------------c---cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 ---------------R---LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 ---------------~---~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+ ......+++++.++|.+||+.+|++|||+.+|++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 01112458899999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=307.01 Aligned_cols=248 Identities=23% Similarity=0.339 Sum_probs=198.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc-------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------- 761 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------- 761 (967)
..+|.+.+.||.|+||.||+|.. +++.||+|++..... ...+.+.+|+.++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 47899999999999999999966 478899998865432 3456788899999999999999999876543
Q ss_pred -------CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEE
Q 037068 762 -------PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKV 833 (967)
Q Consensus 762 -------~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKL 833 (967)
...++||||+. ++|..++.. ..+++..++.++.||+.||.|||+. ||+||||||+||+++ .++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 588888764 4689999999999999999999998 799999999999997 5668999
Q ss_pred EecccccccccCcc---CCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc--
Q 037068 834 CDFGLSRIKHHTYL---SSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-- 907 (967)
Q Consensus 834 sDFGLAr~~~~~~~---~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-- 907 (967)
+|||+++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999976533211 1123457889999998754 55788999999999999999999999876654433222100
Q ss_pred ---------------------cccc-----CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 ---------------------NRRL-----EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 ---------------------~~~~-----~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.... .....++.++.++|.+||+.||++|||+.+++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 1123578899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=328.43 Aligned_cols=147 Identities=29% Similarity=0.461 Sum_probs=132.3
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|.+.++||+|+||.||+|.+. ++.||||++..... .......+..|+.+++.++|+||+++++++.....++||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 378999999999999999999875 88999999865432 334457788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
|||+.+++|..++.. ...+++..++.|+.||+.||.|||.+ +||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~--gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRH--GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999875 34688999999999999999999998 79999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.84 Aligned_cols=243 Identities=23% Similarity=0.412 Sum_probs=216.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeecCCC--eEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~g~--~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~ 765 (967)
...+|.+...||+|+||+|.++..+|+ .+|||++++... ..+.++--+.|-++|... +-|+++++..+|++-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 346888999999999999999977654 699999876532 334455566788888766 5788999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||++||+|..++.+ -+.+.+..+..++.+|+-||-+||++ |||+||||.+||+++.+|+|||+|||+++.....
T Consensus 427 FVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~k--gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcC--CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999999999887 45688999999999999999999998 8999999999999999999999999999876666
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
...+.+++|||.|+|||++.-.+|+..+|+|++||+||||+.|++||++.+..++...|. .....+|+.+|.+..++.
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--EHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HccCcCcccccHHHHHHH
Confidence 667889999999999999999999999999999999999999999999999999988885 345678899999999999
Q ss_pred HHhhhcCCCCCc
Q 037068 926 RDCWQTEPHLRP 937 (967)
Q Consensus 926 ~~CLq~dPe~RP 937 (967)
...|.+.|.+|.
T Consensus 582 kg~ltK~P~kRL 593 (683)
T KOG0696|consen 582 KGLLTKHPGKRL 593 (683)
T ss_pred HHHhhcCCcccc
Confidence 999999999995
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=341.68 Aligned_cols=267 Identities=24% Similarity=0.381 Sum_probs=229.4
Q ss_pred CcccchhhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEe
Q 037068 679 PMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFM 755 (967)
Q Consensus 679 p~l~~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLi 755 (967)
|....+.+.....++|.+.+.||+|+||.|..++. +++-||+|++.+... .......|..|..+|..-+.+=|+.+.
T Consensus 62 p~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh 141 (1317)
T KOG0612|consen 62 PIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH 141 (1317)
T ss_pred HHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence 34445666777889999999999999999999977 467799999865332 244567789999999998999999999
Q ss_pred eeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEe
Q 037068 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835 (967)
Q Consensus 756 g~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsD 835 (967)
..|.++.++|+|||||+||+|..++.+.. .+++.++..|+..|+-||.-||+. |+|||||||+|||||..|+|||+|
T Consensus 142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m--gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM--GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred HHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc--cceeccCCcceeEecccCcEeecc
Confidence 99999999999999999999999999866 899999999999999999999999 899999999999999999999999
Q ss_pred cccccccc-cCccCCCCCCCCCCccChhccc----c-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc
Q 037068 836 FGLSRIKH-HTYLSSKSTAGTPEWMAPEVLR----N-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR 909 (967)
Q Consensus 836 FGLAr~~~-~~~~~~~~~~GT~~YmAPE~l~----g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~ 909 (967)
||.+-.+. +........+|||.|.+||+++ + +.|+.-+|+||+||++|||+.|..||-.....+....|.....
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE 298 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence 99886665 4444456788999999999984 3 5689999999999999999999999998887777777765555
Q ss_pred ccCCC--CCCcHHHHHHHHHhhhcCCCCCcC---HHHHHHHHHHH
Q 037068 910 RLEIP--DDIDPAVAQIIRDCWQTEPHLRPS---FAQLMSRLRCL 949 (967)
Q Consensus 910 ~~~ip--~~ls~eL~dLI~~CLq~dPe~RPS---~~ELLe~L~~L 949 (967)
.+.+| ..+|++.++||.+.+. +|+.|.. ++++..|....
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~ 342 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE 342 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence 66777 4689999999998775 5788887 99999987544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=324.10 Aligned_cols=255 Identities=29% Similarity=0.528 Sum_probs=224.9
Q ss_pred CeeEeEEeecCCceEEEEeec--C----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--H----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
..+..++||+|+||+||+|.+ + ..+||||++... ...+...++..|+-+|.++.|||+++|++++.... +-|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 345567899999999999966 2 346999987654 34455678999999999999999999999998765 889
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
|++||+.|.|.++++..+..+-.+..+.|..||++||.|||++ ++|||||.++||||....++||.|||+++......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q--rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ--RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc--chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999998888899999999999999999999998 79999999999999999999999999999765432
Q ss_pred --cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 847 --LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 847 --~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
.........+.|||-|.+....|+.++|||||||++||++| |..||.+....++.+.+. .+.++..|+.++.+++.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTIDVYM 931 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHHHHH
Confidence 33444456789999999999999999999999999999999 899999999888887775 56679999999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
+|.+||..|+..||+|+++...+.+..+.
T Consensus 932 ~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 99999999999999999999999887543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=314.94 Aligned_cols=245 Identities=29% Similarity=0.423 Sum_probs=214.1
Q ss_pred eEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 697 GERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
.+.||.|.||+||-|++ +|+.||||++.+..+......++.+|+.||++++||.||.|...|++.+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46799999999998865 6999999999988888888899999999999999999999999999999999999999887
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC---CeEEEEecccccccccCccCCCC
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN---WVVKVCDFGLSRIKHHTYLSSKS 851 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~---g~VKLsDFGLAr~~~~~~~~~~~ 851 (967)
-|.-++...++.+++.....++.||+.||+|||-+ +|+|+||||+|||+... .++||||||+||...... ..+.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k--nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK--NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc--ceeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhh
Confidence 78888888788999999999999999999999998 59999999999999643 589999999999887654 3567
Q ss_pred CCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc--cccCCCCCCcHHHHHHHHHhh
Q 037068 852 TAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN--RRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 852 ~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~--~~~~ip~~ls~eL~dLI~~CL 929 (967)
.+|||.|+|||++++..|+..-|+||+||++|.-++|..||.... ++.++|.-.. .......+++++..+||..+|
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 889999999999999999999999999999999999999997543 2333332111 122334679999999999999
Q ss_pred hcCCCCCcCHHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~L 946 (967)
+..-++|.+..+-+.|.
T Consensus 804 qVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSHP 820 (888)
T ss_pred HHHHHHhcchHhhccch
Confidence 99999999999888774
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=321.93 Aligned_cols=265 Identities=27% Similarity=0.410 Sum_probs=214.7
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC------ceE
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP------HFS 765 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~------~l~ 765 (967)
|...+.||+|+||.||++++ +|+.||||.+.... .....+...+|+++|++|+|+|||+++++-++.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 44567899999999999975 58999999987654 4456778899999999999999999999865543 578
Q ss_pred EEEeecCCCchhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc----CCCeEEEEecccc
Q 037068 766 ILTEFLPRGSLYRLLHRPN--HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD----KNWVVKVCDFGLS 839 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~--~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd----~~g~VKLsDFGLA 839 (967)
+|||||.+|+|...+.++. .+|++..++.++.++..||.|||++ |||||||||.||++- ..-..||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn--~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN--GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc--CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998753 6799999999999999999999988 799999999999994 2336899999999
Q ss_pred cccccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH-----HHhhhh--------
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQ-----VVGAVG-------- 905 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e-----i~~~i~-------- 905 (967)
+-.++.. ...+..||+.|.+||++.. ..|+..+|.|||||++|+++||..||....... +...+.
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 9877665 4667899999999999985 778999999999999999999999997654331 111111
Q ss_pred ----------ccccccCCCCCCcHH----HHHHHHHhhhcCCCCCc--CHHHHHHHHHHHHHHhhcCCCCCCC
Q 037068 906 ----------FQNRRLEIPDDIDPA----VAQIIRDCWQTEPHLRP--SFAQLMSRLRCLQRLLVDRSNSTNQ 962 (967)
Q Consensus 906 ----------~~~~~~~ip~~ls~e----L~dLI~~CLq~dPe~RP--S~~ELLe~L~~L~~l~~~~~~~~~~ 962 (967)
.....+++|..+++. +..++..+|..+|++|. .+.+....+..|.++-+.+-++.++
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhiFs~~~ 323 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHIFSMVQ 323 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEEEeecc
Confidence 011223344455543 45678889999999999 8999999999998877766555444
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=283.77 Aligned_cols=224 Identities=20% Similarity=0.251 Sum_probs=185.4
Q ss_pred CCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCchhhhh
Q 037068 703 GSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL 780 (967)
Q Consensus 703 G~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL~~lL 780 (967)
|.||.||++++ +++.||+|++.... ....|...+....||||+++++++......++||||+.+|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999977 57889999986532 2234555556668999999999999999999999999999999988
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccC
Q 037068 781 HRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMA 860 (967)
Q Consensus 781 ~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmA 860 (967)
.+ ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SK-FLNIPEECVKRWAAEMVVALDALHRE--GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HH-hcCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 65 34589999999999999999999998 7999999999999999999999999988655432 223456778999
Q ss_pred hhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCH-
Q 037068 861 PEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSF- 939 (967)
Q Consensus 861 PE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~- 939 (967)
||.+.+..++.++||||+|+++|||++|+.||...... . .......+|..+++.+.++|.+||+.||.+||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 99998888999999999999999999999887643211 1 1122345677889999999999999999999986
Q ss_pred ----HHHHHH
Q 037068 940 ----AQLMSR 945 (967)
Q Consensus 940 ----~ELLe~ 945 (967)
+++++|
T Consensus 225 ~~~~~~~~~h 234 (237)
T cd05576 225 VAGVEDIKSH 234 (237)
T ss_pred ccchHHHHcC
Confidence 666554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-33 Score=312.68 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=229.1
Q ss_pred cCCeeEeEEeecCCceEEEEeecCCCe--EEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWHGTE--VAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~g~~--VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++++...||-||||.|-+++.+++. +|+|++++.. .+....+.+..|.+||...+.|+||++|..|.+....|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 356777788999999999999876655 7888876653 3456677899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
||-|-||.|..++++ .+.+++..+..++..++.|++|||++ |||+|||||+|++++.+|-+||.|||+|+.......
T Consensus 499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k--~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRK--GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhc--CceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999999999987 55799999999999999999999999 699999999999999999999999999998876643
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
+-+++|||.|.|||++.+.-.+..+|+|+||+++|||++|.+||.+.+++...+.|...-..+.+|..++....+||++
T Consensus 576 -TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 576 -TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK 654 (732)
T ss_pred -eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence 5679999999999999999999999999999999999999999999999999998877677788999999999999999
Q ss_pred hhhcCCCCCcC-----HHHHHHHHHH
Q 037068 928 CWQTEPHLRPS-----FAQLMSRLRC 948 (967)
Q Consensus 928 CLq~dPe~RPS-----~~ELLe~L~~ 948 (967)
+...+|.+|.- +.+|-+|-+.
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhh
Confidence 99999999974 7788887643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=329.96 Aligned_cols=245 Identities=29% Similarity=0.472 Sum_probs=193.4
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeee----------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV---------- 758 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~---------- 758 (967)
..+|+....||+||||.||+++. +|+.||||++.-.. +......+.+|+.++++|+|||||+++..|
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 35677788999999999999976 69999999998765 667778899999999999999999998430
Q ss_pred --------------------------------------------------e------------------c----------
Q 037068 759 --------------------------------------------------T------------------R---------- 760 (967)
Q Consensus 759 --------------------------------------------------~------------------~---------- 760 (967)
. +
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0 0
Q ss_pred -----------------------c--------CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 037068 761 -----------------------S--------PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809 (967)
Q Consensus 761 -----------------------~--------~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~ 809 (967)
+ ..+||-||||+...|.+++.+....-.....|+++.||+.||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 136899999999888888876433225788999999999999999999
Q ss_pred CCCeEEeccCCCcEEEcCCCeEEEEecccccccc----c--------------CccCCCCCCCCCCccChhccccCC---
Q 037068 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH----H--------------TYLSSKSTAGTPEWMAPEVLRNEP--- 868 (967)
Q Consensus 810 n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~----~--------------~~~~~~~~~GT~~YmAPE~l~g~~--- 868 (967)
|||||||||.|||++.++.|||+|||+|+... . ........+||..|+|||++.+..
T Consensus 717 --giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 --GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred --ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 89999999999999999999999999998611 0 000123467999999999997654
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCC-ChhHHHhhhhccccccCCCCC------CcHHHHHHHHHhhhcCCCCCcCHHH
Q 037068 869 ANEKCDVYSFGVILWELATLSVPWKGL-NPMQVVGAVGFQNRRLEIPDD------IDPAVAQIIRDCWQTEPHLRPSFAQ 941 (967)
Q Consensus 869 ~s~ksDVWSLGvlL~ELlTGk~PF~~~-~~~ei~~~i~~~~~~~~ip~~------ls~eL~dLI~~CLq~dPe~RPS~~E 941 (967)
|+.|+|+||||||++||+. ||... ....++..+. ...+|.. --+.-..+|+.+++.||.+|||+.|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR----~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR----KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc----cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 9999999999999999987 56532 2223333332 3333322 2245578999999999999999999
Q ss_pred HHHH
Q 037068 942 LMSR 945 (967)
Q Consensus 942 LLe~ 945 (967)
+|..
T Consensus 868 LL~s 871 (1351)
T KOG1035|consen 868 LLNS 871 (1351)
T ss_pred Hhhc
Confidence 9864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=303.85 Aligned_cols=273 Identities=23% Similarity=0.314 Sum_probs=216.2
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CC----hhhHHHHHHHHHHHHHcCCCceeEEeeeeec-
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FS----GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR- 760 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s----~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~- 760 (967)
.+.++|-++.+||+|||+.||+|-+ ..+.||||+-.... +. ....+...+|.+|.+.|.||.||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4557899999999999999999965 57789999754322 11 1123457889999999999999999999864
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---CCeEEEEecc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---NWVVKVCDFG 837 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~---~g~VKLsDFG 837 (967)
.+.+|-|+|||+|.+|..+|++ .+.++++.+..|+.||+.||.||.+..+.|||-||||.|||+-+ -|.|||+|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 5678999999999999999987 56799999999999999999999999889999999999999954 4799999999
Q ss_pred cccccccCccC-------CCCCCCCCCccChhccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHH-hh--
Q 037068 838 LSRIKHHTYLS-------SKSTAGTPEWMAPEVLRNE----PANEKCDVYSFGVILWELATLSVPWKGLNPMQVV-GA-- 903 (967)
Q Consensus 838 LAr~~~~~~~~-------~~~~~GT~~YmAPE~l~g~----~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~-~~-- 903 (967)
+++.+++.... +...+||.+|++||.|.-+ ..+.|+||||+||++|..+.|+.||......+-+ ..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99987654332 3456799999999998543 3678999999999999999999999876543322 11
Q ss_pred -hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH---HHHHHHHhhcCCCCCCC
Q 037068 904 -VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR---LRCLQRLLVDRSNSTNQ 962 (967)
Q Consensus 904 -i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~---L~~L~~l~~~~~~~~~~ 962 (967)
+......++..+.++.+..+||++||++.-++|....++..+ |-.+++....+++.+.-
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs~~~a~ 761 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGSPAGAA 761 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCCCcccc
Confidence 111223344446789999999999999999999999998775 23444444444444433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=336.92 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=194.3
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
...|...+.||+|+||.||+|+. .+..||||++..... ....|++++++++||||+++++++.+.+..++||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 35677778999999999999975 578999998754321 1124688899999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS-HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~-n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
||+++|+|.++++. +++..+..|+.||+.||+|||.. .++|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred eCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999999963 88999999999999999999954 3479999999999999998888775 666543321
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh--HHHhhhh--ccc------cccCC----
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM--QVVGAVG--FQN------RRLEI---- 913 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~--ei~~~i~--~~~------~~~~i---- 913 (967)
.....+|+.|||||++.+..++.++|||||||++|||+||+.||...... ....... ... ....+
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 12346889999999999999999999999999999999999998543211 1111000 000 00111
Q ss_pred --CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 914 --PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 914 --p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
+.....++.+++.+||+.+|++||++.|+++.|+.+.+..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 1112235778999999999999999999999999886644
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=293.74 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=204.0
Q ss_pred cCCeeE-eEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHH-cCCCceeEEeeeeec----cC
Q 037068 691 WEDLQI-GERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVVLFMGAVTR----SP 762 (967)
Q Consensus 691 ~e~y~i-~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~-L~HpNIVkLig~~~~----~~ 762 (967)
+++|.+ .++||-|-.|+|-...+ ++..+|+|++.+. ....+|+++.-. -.|+|||.++++|+. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 477777 46799999999988754 5778999987543 245567777544 379999999999875 34
Q ss_pred ceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc---CCCeEEEEeccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD---KNWVVKVCDFGL 838 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd---~~g~VKLsDFGL 838 (967)
.+.+|||.|+||.|+..+.+++ ..++|..+..|+.||+.|+.|||+.| |.||||||+|+|.+ .+..+||+|||+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccc
Confidence 5889999999999999987654 56999999999999999999999996 99999999999996 456899999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHhhhhccccccCCC
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP----MQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~----~ei~~~i~~~~~~~~ip 914 (967)
|+.-.. .....+.+-||+|.|||++..++|+...|+||+||+||-|++|.+||-.... ..+...|......++-|
T Consensus 211 AK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 211 AKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 986543 2345667889999999999999999999999999999999999999965432 23444454333333332
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 915 --DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 915 --~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
..+|+..+++|+.+|..+|.+|.|+.++++|-+.-+
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 468999999999999999999999999999865443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-33 Score=296.07 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=201.7
Q ss_pred CCeeEeEEeecCCceEEEEeecC------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-cCce
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-SPHF 764 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-~~~l 764 (967)
..|++.++||+|+||.||+|..+ .+.+|||++..+.-.........+|+.+++.++|+||+.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 57888999999999999999331 3369999987653333334567789999999999999999999987 7789
Q ss_pred EEEEeecCCCchhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC----CeEEEEec
Q 037068 765 SILTEFLPRGSLYRLLHR----PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN----WVVKVCDF 836 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~----~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~----g~VKLsDF 836 (967)
++++||.+. +|.++|+- ....++...+..|+.||+.|+.|||++ .|+||||||.||||..+ |.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N--WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN--WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh--heeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999987 78888753 235799999999999999999999998 79999999999999766 99999999
Q ss_pred ccccccccCcc---CCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChh-------------H
Q 037068 837 GLSRIKHHTYL---SSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPM-------------Q 899 (967)
Q Consensus 837 GLAr~~~~~~~---~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-------------e 899 (967)
|++|.+.+.-. +....+.|.+|.|||++.|.. |+.+.|||++||++.||+|-++-|.+.... .
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99998776432 344566899999999998875 899999999999999999988887654321 1
Q ss_pred HHhhhhcc----cccc-CCC--------------------------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 900 VVGAVGFQ----NRRL-EIP--------------------------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 900 i~~~i~~~----~~~~-~ip--------------------------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+.+.+... +..+ ..| +.-++...+|+.++|++||.+|.|+++.|++.-.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 11111100 0000 011 1134557899999999999999999999998654
Q ss_pred HH
Q 037068 949 LQ 950 (967)
Q Consensus 949 L~ 950 (967)
..
T Consensus 341 ~~ 342 (438)
T KOG0666|consen 341 TE 342 (438)
T ss_pred cc
Confidence 43
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=268.54 Aligned_cols=237 Identities=31% Similarity=0.511 Sum_probs=198.0
Q ss_pred CceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCchhhhhc
Q 037068 704 SYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH 781 (967)
Q Consensus 704 ~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL~~lL~ 781 (967)
+||.||++... +..+++|++........ ...+.+|++++++++|+||+++++++......++++||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999774 68899999865433221 6788999999999999999999999999899999999999999999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccCh
Q 037068 782 RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861 (967)
Q Consensus 782 ~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAP 861 (967)
... .+++..++.++.+++.+|.|||+. +++|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSN--GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHc--CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 633 389999999999999999999998 79999999999999999999999999998765432 23456688899999
Q ss_pred hccccCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChhHHHhhhhccccccCCCC-CCcHHHHHHHHHhhhcCCCCCcCH
Q 037068 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKG-LNPMQVVGAVGFQNRRLEIPD-DIDPAVAQIIRDCWQTEPHLRPSF 939 (967)
Q Consensus 862 E~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~-~~~~ei~~~i~~~~~~~~ip~-~ls~eL~dLI~~CLq~dPe~RPS~ 939 (967)
|.+.+..++.++|||+||+++|+|++|..||.. .+.......+........... .++.++.+++.+||..+|++||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 999988899999999999999999999999987 444444444332211111111 188999999999999999999999
Q ss_pred HHHHHH
Q 037068 940 AQLMSR 945 (967)
Q Consensus 940 ~ELLe~ 945 (967)
.+++++
T Consensus 236 ~~~~~~ 241 (244)
T smart00220 236 EEALQH 241 (244)
T ss_pred HHHhhC
Confidence 999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=294.59 Aligned_cols=254 Identities=32% Similarity=0.598 Sum_probs=209.8
Q ss_pred cCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHH--cCCCceeEEeeeeeccC----ce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR--LRHPNVVLFMGAVTRSP----HF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~--L~HpNIVkLig~~~~~~----~l 764 (967)
..+.++.+.||+|.||.||+|++.|..||||+|... ....+.+|.+|++. |+|+||+.|++.-..+. ++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 378899999999999999999999999999998543 24567889999886 49999999999876543 68
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS------HPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~------n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
+||.+|.+.|+|+++|.+ ..++....++++..++.||.+||.. .|.|.|||||..||||.+++...|+|+||
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999986 6789999999999999999999952 46799999999999999999999999999
Q ss_pred ccccccC----ccCCCCCCCCCCccChhccccCC------CCchhHHHHHHHHHHHHHh----C------CCCCCCC---
Q 037068 839 SRIKHHT----YLSSKSTAGTPEWMAPEVLRNEP------ANEKCDVYSFGVILWELAT----L------SVPWKGL--- 895 (967)
Q Consensus 839 Ar~~~~~----~~~~~~~~GT~~YmAPE~l~g~~------~s~ksDVWSLGvlL~ELlT----G------k~PF~~~--- 895 (967)
|...... .......+||.+|||||++...- .-..+||||||.+|||+.. | +.||...
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9765433 22345678999999999986432 1235899999999999874 2 4677543
Q ss_pred --ChhHHHhhhhccccccCCCCCCc-----HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 896 --NPMQVVGAVGFQNRRLEIPDDID-----PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 896 --~~~ei~~~i~~~~~~~~ip~~ls-----~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
..+++.+.+..+..++.+|.... ..+..+|+.||..||.-|.|+-.|-+.|.++.+
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 23566666666777777775432 356789999999999999999999999988865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=271.57 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=211.1
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|.-.++||+|.||+||+++. +...||+|.+.-.+.++.......+||.+++.++|.|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678899999999999976 456799999887766666677889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
|.. +|..+...-++.++...+..++.|+++||.+.|+++ +.||||||.|+||+.+|.+|++|||+++.+.-....-.
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 965 788888777888999999999999999999999996 99999999999999999999999999998876655566
Q ss_pred CCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcccccc---------CCC-----
Q 037068 851 STAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRL---------EIP----- 914 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~---------~ip----- 914 (967)
..+.|.+|.+|.++.|.. |++..|+||.||++.|+.. |++.|.+.+....+..+-+.-..+ .+|
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 678899999999998865 8999999999999999987 677788888766555443211000 111
Q ss_pred -------------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 915 -------------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 915 -------------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+.+...-++++.+.|.-+|.+|.++++.++|
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1123345799999999999999999998876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=310.84 Aligned_cols=252 Identities=28% Similarity=0.467 Sum_probs=217.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeec-----
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTR----- 760 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~----- 760 (967)
...+-|++.+.||.|.+|.||+++. .++.+|+|++.. ....-++++-|.+|++.+ +|||++.++++|..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~---~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP---TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC---CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 3456788999999999999999865 688899998643 334446677789999887 79999999998863
Q ss_pred cCceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
+++++||||||.+|+..++++.. +..+.|..+..|+..++.||.+||.+ .++|||||=.|||++.++.|||+|||++
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n--kviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN--KVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc--ceeeecccCceEEEeccCcEEEeeeeee
Confidence 56899999999999999998764 56799999999999999999999998 5999999999999999999999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-cccCC
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRNE-----PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-RRLEI 913 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g~-----~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-~~~~i 913 (967)
...+.+.....+..|||.|||||++... .|+.++|+||||++..||--|.+|+-.+.+...+..|-... ..+.-
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 9998888888889999999999999654 46778999999999999999999999999988776654221 12233
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 914 p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
|+..+.++.++|..||.+|-++||++.++++|
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 56788999999999999999999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=284.48 Aligned_cols=249 Identities=21% Similarity=0.363 Sum_probs=215.7
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh-hhHHHHHHHHHHHHHc-CCCceeEEeeeeec
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-DSLSQFKCEAEIMLRL-RHPNVVLFMGAVTR 760 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~ 760 (967)
..|..-..+|.+.+.||.|+|.+|..++. +.+.+|+|++++.-++. ..+.=...|..+..+. +||++|-+..+|.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 45667778999999999999999999976 46779999987764433 3455567788887776 89999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+..+++|.||.+||+|..++.+ ...+++..+..+...|+.||.|||+. |||+||||..|||+|..|++||+|+|+++
T Consensus 323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~r--giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHER--GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhc--CeeeeeccccceEEccCCceeecccchhh
Confidence 9999999999999999888865 56799999999999999999999998 89999999999999999999999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-------ChhHHHhhhhccccccCC
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL-------NPMQVVGAVGFQNRRLEI 913 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~-------~~~ei~~~i~~~~~~~~i 913 (967)
.--.....+.+++|||.|.|||++++..|...+|+|+|||+|+||+.|+.||+-. +.+..+.++. ..++..+
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-lekqiri 478 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-LEKQIRI 478 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-hhhcccc
Confidence 7655555688899999999999999999999999999999999999999999632 2233333332 4567889
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCc
Q 037068 914 PDDIDPAVAQIIRDCWQTEPHLRP 937 (967)
Q Consensus 914 p~~ls~eL~dLI~~CLq~dPe~RP 937 (967)
|..++-....+++..|++||++|.
T Consensus 479 prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhc
Confidence 999999999999999999999994
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=292.98 Aligned_cols=257 Identities=32% Similarity=0.518 Sum_probs=211.3
Q ss_pred CCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc--CCCceeEEeeeeeccC----ceE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL--RHPNVVLFMGAVTRSP----HFS 765 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L--~HpNIVkLig~~~~~~----~l~ 765 (967)
...++.+.||+|.||.||+|+.+++.||||+|. ....+.+.+|.+|++.. +|+||++|++.-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 456677889999999999999999999999964 45677889999998864 8999999999877655 799
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS-------HPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~-------n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
||++|.+.|+|.++|+. ..++|....+|+..+++||+|||+. +|.|+|||||..||||.++++..|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999985 5689999999999999999999974 35799999999999999999999999999
Q ss_pred ccccccC--ccCCCCCCCCCCccChhccccCCC------CchhHHHHHHHHHHHHHhCCC------------CCC-----
Q 037068 839 SRIKHHT--YLSSKSTAGTPEWMAPEVLRNEPA------NEKCDVYSFGVILWELATLSV------------PWK----- 893 (967)
Q Consensus 839 Ar~~~~~--~~~~~~~~GT~~YmAPE~l~g~~~------s~ksDVWSLGvlL~ELlTGk~------------PF~----- 893 (967)
|..+... .......+||.+|||||++.+... -.+.||||+|.|||||++.-. ||.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9876532 233455889999999999976532 236899999999999998422 333
Q ss_pred CCChhHHHhhhhccccccCCCCC-----CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 894 GLNPMQVVGAVGFQNRRLEIPDD-----IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 894 ~~~~~ei~~~i~~~~~~~~ip~~-----ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
....+++...+.....++.+|.. -...+.+.+..||.-||+-|.|+.=+.+.+.++......
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 12234555555556667777753 235678999999999999999999999999998777653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=286.77 Aligned_cols=269 Identities=26% Similarity=0.435 Sum_probs=228.8
Q ss_pred cchhhhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEE
Q 037068 682 GEVAEWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754 (967)
Q Consensus 682 ~~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkL 754 (967)
.++++..+..+++++...+-+|.||+||+|.+. .+.|.+|.++. .-+.-.+..+..|.-++..+.|||+..+
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 455667778889999999999999999999542 23466665443 2355567778889999999999999999
Q ss_pred eeeeec-cCceEEEEeecCCCchhhhhc-----CCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc
Q 037068 755 MGAVTR-SPHFSILTEFLPRGSLYRLLH-----RPN--HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD 826 (967)
Q Consensus 755 ig~~~~-~~~l~LVmEy~~gGsL~~lL~-----~~~--~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd 826 (967)
.+++.+ ....++++.++..|+|..++. +.+ ..++..+...++.|++.|++|||.+ ||||.||.++|++|+
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~--~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH--GVIHKDIAARNCVID 430 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc--Ccccchhhhhcceeh
Confidence 998765 456888999999999999997 322 3467788889999999999999998 899999999999999
Q ss_pred CCCeEEEEeccccccccc-CccCC-CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhh
Q 037068 827 KNWVVKVCDFGLSRIKHH-TYLSS-KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGA 903 (967)
Q Consensus 827 ~~g~VKLsDFGLAr~~~~-~~~~~-~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~ 903 (967)
+..++||+|=.++|..-. .+... .....+..||+||.+.+..|+..+|||||||+||||+| |+.||...++.++...
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 999999999999986433 22222 22335669999999999999999999999999999999 8999999999999888
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 904 i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
++ .++++..|.+||+++..+|..||...|++||+++|+...|.+++..+.
T Consensus 511 lk-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 511 LK-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred Hh-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 75 789999999999999999999999999999999999999999987653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=283.51 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=204.4
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--------c
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--------S 761 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--------~ 761 (967)
..|.-..+||+|.||.||+|+. .++.||+|++...+.....-....+|++++..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4555568899999999999976 47789998876655444445567789999999999999999998753 2
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
..+|+||.+|++ +|..++.+....++..++.+++.++..||.|+|+. .|+|||+||.|+||+.+|.+||+|||++|.
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~--kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN--KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh--hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 348999999976 89999998888999999999999999999999998 599999999999999999999999999987
Q ss_pred cccCccCC----CCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc----------
Q 037068 842 KHHTYLSS----KSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF---------- 906 (967)
Q Consensus 842 ~~~~~~~~----~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~---------- 906 (967)
+....... ...+.|.+|.+||.+.|. .|+++.|||..||+|.||+|+.+-+.+....+.+..|..
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 54332211 224569999999998876 589999999999999999999998888776655544431
Q ss_pred ---------cccc-cCCCC-------------CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 907 ---------QNRR-LEIPD-------------DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 907 ---------~~~~-~~ip~-------------~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+.-. .++|+ .-+++..+|+.++|..||.+|+.+.+++.|-.
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 0000 01111 12457789999999999999999999998853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=303.40 Aligned_cols=242 Identities=23% Similarity=0.338 Sum_probs=201.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~L 766 (967)
+++.|.+...+|.|+|+.|.++.. +++..++|++.+.. ....+|+.++... +||||+++.+.+.++.+.++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 457888889999999999998865 57889999986652 1223466565554 79999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE-cCCCeEEEEecccccccccC
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV-DKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL-d~~g~VKLsDFGLAr~~~~~ 845 (967)
|||++.++-|.+.+.... .....+..|+.+|+.|+.|||++ |||||||||+|||+ ++.++++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~--gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQ--GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhc--CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999998777665422 22277778999999999999998 89999999999999 69999999999999866544
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhccccccCCCCCCcHHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
....+-|..|.|||++....|+..+||||||++||+|++|+.||...... ++...+ ...++...+|.+.++|
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKdL 542 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKDL 542 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHHH
Confidence 23456788999999999999999999999999999999999999877655 333333 2233347899999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
|++||+.||.+|+++.+++.|-..
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999998766
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=295.18 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=203.1
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
-+....-|..++.||-|+||+|.++.. +...||.|.+.+.+ .....+..++.|..||.....+-||+||..|.+.+.
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 345556788999999999999999965 45569999887654 345667788999999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc-
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK- 842 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~- 842 (967)
+|+||+|++||++..+|.+ .+-|.|..+..++.++.+|+++.|.. |+|||||||+|||||.+|+|||+||||+.-+
T Consensus 704 LYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkm--GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhc--cceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999999999876 55689999999999999999999998 8999999999999999999999999998521
Q ss_pred --ccC------cc---------------------------------CCCCCCCCCCccChhccccCCCCchhHHHHHHHH
Q 037068 843 --HHT------YL---------------------------------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVI 881 (967)
Q Consensus 843 --~~~------~~---------------------------------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvl 881 (967)
++. .. .....+||+.|+|||++....|+..+|+||.||+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 110 00 0012349999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHhhhhccccccCC--CCCCcHHHHHHHHHhhhcCCCCCc
Q 037068 882 LWELATLSVPWKGLNPMQVVGAVGFQNRRLEI--PDDIDPAVAQIIRDCWQTEPHLRP 937 (967)
Q Consensus 882 L~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~i--p~~ls~eL~dLI~~CLq~dPe~RP 937 (967)
||||+.|+.||....+.+....+.-....+.+ ..++++++.+||.+++. +++.|.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99999999999988877665554433333333 45799999999976543 355554
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=280.05 Aligned_cols=243 Identities=29% Similarity=0.461 Sum_probs=199.8
Q ss_pred eEEeecCCceEEEEe--ecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCC
Q 037068 697 GERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 697 ~k~LGeG~FG~VYka--~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
.+.||+|+|+.|--+ ..++..||||++.+. ..-...++.+|++++.+. .|+||++|++||+++...|||||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 357999999999866 347999999998765 344567889999999998 699999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---eEEEEecccccccccCcc---
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---VVKVCDFGLSRIKHHTYL--- 847 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---~VKLsDFGLAr~~~~~~~--- 847 (967)
|+|..+|.+ ...+++..+.+++.+|+.||.+||.+ ||.||||||+|||..... -|||+||.+..-......
T Consensus 161 GplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~k--gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 161 GPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTK--GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred chHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhc--CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999999876 45699999999999999999999998 899999999999996554 689999999764332211
Q ss_pred ----CCCCCCCCCCccChhcc---cc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------------hHHHhh
Q 037068 848 ----SSKSTAGTPEWMAPEVL---RN--EPANEKCDVYSFGVILWELATLSVPWKGLNP---------------MQVVGA 903 (967)
Q Consensus 848 ----~~~~~~GT~~YmAPE~l---~g--~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~---------------~ei~~~ 903 (967)
...+.+|+-.|||||+. .+ ..|+.+.|.|||||++|-|++|.+||.+.-. ..+...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 12234577799999985 33 3589999999999999999999999976432 122333
Q ss_pred hhccccccCCCC----CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 904 VGFQNRRLEIPD----DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 904 i~~~~~~~~ip~----~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
| +....++|+ .++.+..++++.+|..++.+|.++.+++.|-
T Consensus 318 I--QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 318 I--QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred H--hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 3 344556664 5899999999999999999999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=282.91 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=202.9
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHH-cCCCceeEEeeeeeccCc
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~-L~HpNIVkLig~~~~~~~ 763 (967)
|.+..++++-...||.|+||+|+|..+ .|+..|||++..... +....++..|.+...+ -+.||||++||....++.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 444556677778899999999999976 588999999876543 4445667777776554 479999999999999999
Q ss_pred eEEEEeecCCCchhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 764 FSILTEFLPRGSLYRLLHR----PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~----~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
.+|-||.|. .+|..+.+. .+..++|..+-.|..-.+.||.||.+.. .|||||+||+|||++..|.|||||||++
T Consensus 138 cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 138 CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeecccch
Confidence 999999995 477666542 3566899999999999999999998875 7999999999999999999999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHhhhhc-cccccCCCC
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRNE--PANEKCDVYSFGVILWELATLSVPWKGLNP-MQVVGAVGF-QNRRLEIPD 915 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g~--~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~-~ei~~~i~~-~~~~~~ip~ 915 (967)
-.+.++.. ....+|-..|||||.+... .|+.++||||||++|||+.||+.||.+.+. .+.+..+.. ....+..+.
T Consensus 216 GqLv~SiA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 216 GQLVDSIA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred HhHHHHHH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence 76655432 3345688889999999543 489999999999999999999999988764 222222221 111222233
Q ss_pred ---CCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 916 ---DIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 916 ---~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..+..+..+|.-||.+|-..||.+.+++++
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 378899999999999999999999999876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=300.85 Aligned_cols=250 Identities=18% Similarity=0.238 Sum_probs=171.5
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecC------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeee----
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWH------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGA---- 757 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~---- 757 (967)
....++|.+.+.||+|+||.||+|.+. +..||||++..... .+....| .++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 345689999999999999999999763 57899998753221 1111111 1222223333332222
Q ss_pred --eeccCceEEEEeecCCCchhhhhcCCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCeEEe
Q 037068 758 --VTRSPHFSILTEFLPRGSLYRLLHRPNHQ-------------------LDERRRMRMALDVAKGMNYLHTSHPTIVHR 816 (967)
Q Consensus 758 --~~~~~~l~LVmEy~~gGsL~~lL~~~~~~-------------------Lse~~i~~I~~QIa~aL~YLHs~n~GIVHR 816 (967)
......++|||||+.+++|.+++...... ..+..+..++.||+.||.|||++ +|+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~--gIiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST--GIVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC--CEEeC
Confidence 23456799999999999999988653211 12344668999999999999998 79999
Q ss_pred ccCCCcEEEcC-CCeEEEEecccccccccC-ccCCCCCCCCCCccChhccccCC----------------------CCch
Q 037068 817 DLKSPNLLVDK-NWVVKVCDFGLSRIKHHT-YLSSKSTAGTPEWMAPEVLRNEP----------------------ANEK 872 (967)
Q Consensus 817 DLKPsNILLd~-~g~VKLsDFGLAr~~~~~-~~~~~~~~GT~~YmAPE~l~g~~----------------------~s~k 872 (967)
||||+|||++. ++.+||+|||+++..... ........+|+.|||||.+.... ++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 689999999999854322 22345567899999999764322 3346
Q ss_pred hHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc-------------------ccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 873 CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-------------------RLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 873 sDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~-------------------~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
+|||||||+||||+++..|+.... ......+..... .+.+....+...++||.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 799999999999999776654321 111111110000 001111223456799999999999
Q ss_pred CCCcCHHHHHHHH
Q 037068 934 HLRPSFAQLMSRL 946 (967)
Q Consensus 934 e~RPS~~ELLe~L 946 (967)
++|||+.++|+|-
T Consensus 439 ~kR~ta~e~L~Hp 451 (566)
T PLN03225 439 RQRISAKAALAHP 451 (566)
T ss_pred ccCCCHHHHhCCc
Confidence 9999999999984
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=281.22 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=199.3
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-C-C----ceeEEeeeee
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-H-P----NVVLFMGAVT 759 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-H-p----NIVkLig~~~ 759 (967)
.++.++|.+.+.+|+|+||+|....+ .+..||||+++.. ....+...-|+++++++. + | -++++.+||.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 34578999999999999999998855 4678999987542 123345567999999993 2 2 3788889999
Q ss_pred ccCceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc------------
Q 037068 760 RSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD------------ 826 (967)
Q Consensus 760 ~~~~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd------------ 826 (967)
..++.|||+|.+ |-++++++..++ .+++...+..|+.||++++.+||+. +++|-||||+|||+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~--kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL--KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc--ceeecCCChheEEEeccceEEEeccCC
Confidence 999999999987 558999998743 5689999999999999999999999 799999999999993
Q ss_pred --------CCCeEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh
Q 037068 827 --------KNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM 898 (967)
Q Consensus 827 --------~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ 898 (967)
.+..|||+|||.|+...+.. ...+.|..|.|||++.+-.++.++||||+||+|+||+||...|...+..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 13479999999998665542 4567899999999999999999999999999999999999999877654
Q ss_pred HHH---hhhh----------------ccccccCCCCC-------------------------CcHHHHHHHHHhhhcCCC
Q 037068 899 QVV---GAVG----------------FQNRRLEIPDD-------------------------IDPAVAQIIRDCWQTEPH 934 (967)
Q Consensus 899 ei~---~~i~----------------~~~~~~~ip~~-------------------------ls~eL~dLI~~CLq~dPe 934 (967)
+-+ +.+. +...++.+|+. ...+|.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 422 1111 00112222210 113588999999999999
Q ss_pred CCcCHHHHHHHH
Q 037068 935 LRPSFAQLMSRL 946 (967)
Q Consensus 935 ~RPS~~ELLe~L 946 (967)
+|+|+.|+|.|-
T Consensus 396 ~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 396 RRITLREALSHP 407 (415)
T ss_pred ccccHHHHhcCH
Confidence 999999999884
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=287.29 Aligned_cols=257 Identities=20% Similarity=0.207 Sum_probs=185.5
Q ss_pred hccCCeeEeEEeecCCceEEEEeec------------------CCCeEEEEEeecCCCCh------------hhHHHHHH
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW------------------HGTEVAVKKFLDQDFSG------------DSLSQFKC 738 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~------------------~g~~VAVKkl~~~~~s~------------~~~~~~~~ 738 (967)
+..++|.+.++||+|+||.||+|.. .++.||||++....... ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3468999999999999999999853 34579999975432110 01122345
Q ss_pred HHHHHHHcCCCce-----eEEeeeeec--------cCceEEEEeecCCCchhhhhcCCC---------------------
Q 037068 739 EAEIMLRLRHPNV-----VLFMGAVTR--------SPHFSILTEFLPRGSLYRLLHRPN--------------------- 784 (967)
Q Consensus 739 Ei~ILk~L~HpNI-----VkLig~~~~--------~~~l~LVmEy~~gGsL~~lL~~~~--------------------- 784 (967)
|+.++.+++|.++ ++++++|.. .+..+|||||+.+++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777766654 667777643 356899999999999999886421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc-CCCCCCCCCCccCh
Q 037068 785 --HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL-SSKSTAGTPEWMAP 861 (967)
Q Consensus 785 --~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~-~~~~~~GT~~YmAP 861 (967)
..+++..+..++.||+.+|.|||+. +|+||||||+|||++.++.+||+|||+++....... ......+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~--~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI--GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1245677889999999999999998 799999999999999999999999999975433211 11223358899999
Q ss_pred hccccCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCCCCChhHHH-----------hhhhcc
Q 037068 862 EVLRNEPA----------------------NEKCDVYSFGVILWELATLSV-PWKGLNPMQVV-----------GAVGFQ 907 (967)
Q Consensus 862 E~l~g~~~----------------------s~ksDVWSLGvlL~ELlTGk~-PF~~~~~~ei~-----------~~i~~~ 907 (967)
|.+..... ..+.||||+||++|+|+++.. ||......... ......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 99854321 124699999999999999875 77543211100 001111
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCC---CCCcCHHHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEP---HLRPSFAQLMSRLR 947 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dP---e~RPS~~ELLe~L~ 947 (967)
...+.....+++..++|+.++|..+| .+|+|+.|+|+|-.
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 22333445678999999999999876 68999999999854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=240.82 Aligned_cols=211 Identities=39% Similarity=0.660 Sum_probs=185.9
Q ss_pred eecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCchh
Q 037068 700 IGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLY 777 (967)
Q Consensus 700 LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL~ 777 (967)
||+|++|.||++... ++.+++|++....... ....+.+|+.+++.+.|++|+++++++......+++|||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999886 8899999986543221 3567899999999999999999999999989999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-CCeEEEEecccccccccCccCCCCCCCCC
Q 037068 778 RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856 (967)
Q Consensus 778 ~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-~g~VKLsDFGLAr~~~~~~~~~~~~~GT~ 856 (967)
.++......+++..++.++.+++++|.+||+. |++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN--GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 99886545689999999999999999999998 7999999999999999 89999999999986654432234456788
Q ss_pred CccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 037068 857 EWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHL 935 (967)
Q Consensus 857 ~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~ 935 (967)
.|++||.+... .++.+.|+|+||+++++| ..+.+++.+||..+|.+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~ 204 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCccc
Confidence 99999999887 788999999999999999 58889999999999999
Q ss_pred CcCHHHHHHHH
Q 037068 936 RPSFAQLMSRL 946 (967)
Q Consensus 936 RPS~~ELLe~L 946 (967)
||++.++++++
T Consensus 205 R~~~~~l~~~~ 215 (215)
T cd00180 205 RPSAKEILEHL 215 (215)
T ss_pred CcCHHHHhhCC
Confidence 99999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=265.60 Aligned_cols=248 Identities=26% Similarity=0.424 Sum_probs=197.6
Q ss_pred eEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc-----CceEEE
Q 037068 695 QIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-----PHFSIL 767 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~-----~~l~LV 767 (967)
+-.+.||-|+||.||.+++ +|+.||+|++.....+-..-+.+.+|++++.-++|.|++..++..... ..+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3447799999999999987 589999999876544444567789999999999999999988876543 247888
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY- 846 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~- 846 (967)
+|.|.. +|..+|-. ...++...+.-++.||++||+|||+. +|.||||||.|+|++.+..+||||||++|......
T Consensus 136 TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA--~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTA--NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhc--chhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 898854 78888876 34688899999999999999999999 69999999999999999999999999999765432
Q ss_pred cCCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-------------------
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF------------------- 906 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~------------------- 906 (967)
......+.|-+|.|||++.|.+ |+...||||+||++.||+..+..|...++-+.++.|..
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 2223345688999999998865 89999999999999999999999988877665544320
Q ss_pred --cccccCCC-----------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 907 --QNRRLEIP-----------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 907 --~~~~~~ip-----------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.....+.| ..-..+...++.++|..+|++|.+..+.+.++
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00011111 12234567888999999999999999988875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=247.83 Aligned_cols=215 Identities=29% Similarity=0.480 Sum_probs=176.8
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCc
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~ 763 (967)
+++..+++..+..||.|++|.|-+.++ .|+..|+|.+...- +.+..+++..|+.+..+. ..|++|.|||.+.+++.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 344446666778899999999877755 68999999987653 445567778888886654 79999999999999999
Q ss_pred eEEEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 764 FSILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.+|.||.|.. +|..+.++ .+..++|..+-+|+..++.||.|||++- .+||||+||+||||+..|++|+||||.+-
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999954 78777643 4678999999999999999999999984 79999999999999999999999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccC----CCCchhHHHHHHHHHHHHHhCCCCCCC-CChhHHHhhhh
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNE----PANEKCDVYSFGVILWELATLSVPWKG-LNPMQVVGAVG 905 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~----~~s~ksDVWSLGvlL~ELlTGk~PF~~-~~~~ei~~~i~ 905 (967)
.+.++-. .....|-..|||||.+..+ .|+.|+||||||++++||.+++.||.. ..+.+.+.++.
T Consensus 198 ~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 198 YLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred eehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 7665432 2235677889999998543 688999999999999999999999975 45666666654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=274.45 Aligned_cols=255 Identities=21% Similarity=0.264 Sum_probs=205.1
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC------CCceeEEee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR------HPNVVLFMG 756 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~------HpNIVkLig 756 (967)
.-.+.+-.+|.+....|+|-|++|.+|.+ .|..||||++... +-..+.=..|++||++|+ --|+++|+-
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 33456678999999999999999999976 5789999998653 223345567999999995 348899999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-CeEEE
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRP--NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKV 833 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~--~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-g~VKL 833 (967)
.|...+++|||+|-+ ..+|.++|++. +..|....+..++.|++-||..|... ||+|.||||.||||+++ ..+||
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c--~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC--GVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc--CeeecccCccceEeccCcceeee
Confidence 999999999999977 55899999864 45688899999999999999999998 79999999999999865 68999
Q ss_pred EecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc----
Q 037068 834 CDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR---- 909 (967)
Q Consensus 834 sDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~---- 909 (967)
||||.|-...... ...+..+..|.|||+|.|.+|++..|+||+||+||||+||+.-|.+..+.+++........
T Consensus 579 CDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 579 CDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred ccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 9999997554432 2334456689999999999999999999999999999999999999888776644320000
Q ss_pred -----------cc-------------------------CCC-C----------CCc-------HHHHHHHHHhhhcCCCC
Q 037068 910 -----------RL-------------------------EIP-D----------DID-------PAVAQIIRDCWQTEPHL 935 (967)
Q Consensus 910 -----------~~-------------------------~ip-~----------~ls-------~eL~dLI~~CLq~dPe~ 935 (967)
.+ -.| . .++ ..|.+|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 00 001 0 011 35789999999999999
Q ss_pred CcCHHHHHHHHH
Q 037068 936 RPSFAQLMSRLR 947 (967)
Q Consensus 936 RPS~~ELLe~L~ 947 (967)
|.|..+.|+|-.
T Consensus 737 Rit~nqAL~HpF 748 (752)
T KOG0670|consen 737 RITVNQALKHPF 748 (752)
T ss_pred cCCHHHHhcCCc
Confidence 999999998853
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=258.33 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=199.3
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------Cc
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------PH 763 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------~~ 763 (967)
.+|.-.+.+|.|.. .|..+-+ .+++||+|++.....+....++..+|..++..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57888889999999 6666644 689999999876655566678899999999999999999999998653 35
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.|+|||+|.. +|...+. ..++-.++..|+.|++.|++|||+. ||+||||||+||++..++.+||.|||+|+...
T Consensus 96 ~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~--~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSA--GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc--ceeecccCcccceecchhheeeccchhhcccC
Confidence 7999999954 7877765 3467788999999999999999999 89999999999999999999999999998766
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh------------------
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG------------------ 905 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~------------------ 905 (967)
.. ......+.|..|.|||++.+-.|...+||||+||++.||++|..-|.+.+.-.....+.
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 55 34566788999999999999889999999999999999999999888765432211111
Q ss_pred ---------cccc--ccCCCC-----------CCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 906 ---------FQNR--RLEIPD-----------DIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 906 ---------~~~~--~~~ip~-----------~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+.. .-.+|. .-...+++++.+||-.+|++|.+++++|.|
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 000111 112357899999999999999999999988
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=282.16 Aligned_cols=251 Identities=30% Similarity=0.492 Sum_probs=220.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|.+..++|.|+||.|||+++ ++...|+|+++... ......+..|+-+++..+|+||+.+++.|.....++|.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 347899999999999999999987 57889999886543 44566778899999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
||||.+|+|.++..- -+.+++.++..+.+..++||+|||++ |-+|||||=.|||+++.|.+|++|||.+..+...-.
T Consensus 91 MEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~--gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQ--GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcC--CcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 999999999998765 46799999999999999999999998 789999999999999999999999999988777766
Q ss_pred CCCCCCCCCCccChhcc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc---CCCCCCcHHH
Q 037068 848 SSKSTAGTPEWMAPEVL---RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL---EIPDDIDPAV 921 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l---~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~---~ip~~ls~eL 921 (967)
....+.||++|||||+. +.+-|..++|||++|++..|+---++|.....+++........+.++ +-+...++.+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 77889999999999986 45568999999999999999999899988888887776665444333 3344678899
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+|++.+|.++|++||+++.+|.|
T Consensus 248 h~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheec
Confidence 999999999999999999999886
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=247.96 Aligned_cols=245 Identities=20% Similarity=0.328 Sum_probs=196.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeecc--Cce
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRS--PHF 764 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~--~~l 764 (967)
..++|++.+++|.|-|+.||.|.. ++..++||+++. -..+.+.+|+.||++|. ||||+++++...+. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 347899999999999999999974 577899998754 23567899999999995 99999999998774 357
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-CCeEEEEecccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSRIKH 843 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-~g~VKLsDFGLAr~~~ 843 (967)
.||+||+++.+...+.. .++...+..++.+++.||.|+|+. ||.|||+||.|++||. .-.++|+|+|+|...+
T Consensus 111 aLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~--GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSM--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhc--CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 89999999988877764 388899999999999999999999 8999999999999985 4689999999999877
Q ss_pred cCccCCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCC-CCCh-hHHHhhhh------------c--
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWK-GLNP-MQVVGAVG------------F-- 906 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~-~~~~-~ei~~~i~------------~-- 906 (967)
... .-...+.+..|-.||++.+-+ |++.-|+|||||++..|+..+.||. +.++ .+.+.... .
T Consensus 185 p~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 185 PGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred CCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 643 233455677899999997754 8999999999999999999988874 3332 22221111 0
Q ss_pred ------------ccc-----ccCCC---CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 907 ------------QNR-----RLEIP---DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 907 ------------~~~-----~~~ip---~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
... ++..+ ...+++..+|+.++|.+|-.+|+|+.|.+.|-
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 000 00011 12468999999999999999999999999984
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-28 Score=284.85 Aligned_cols=239 Identities=28% Similarity=0.448 Sum_probs=190.5
Q ss_pred eEEeecCCceE-EEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEeecCCC
Q 037068 697 GERIGIGSYGE-VYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 697 ~k~LGeG~FG~-VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
.+.+|.|.-|+ ||+|.+.++.||||.+... ....+.+|+.+++.- .|||||++++.-.+...+||..|.|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 35689999875 7999999999999997543 345678899999887 799999999999999999999999965
Q ss_pred chhhhhcCC--CCCC-CHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-----CCeEEEEecccccccccCc
Q 037068 775 SLYRLLHRP--NHQL-DERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-----NWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 775 sL~~lL~~~--~~~L-se~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-----~g~VKLsDFGLAr~~~~~~ 846 (967)
+|.+++... .... .....+.++.|++.||.+||+. +||||||||.||||+. ...++|+|||+++......
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl--~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL--KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc--ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 899999873 1111 1144577899999999999998 7999999999999975 2589999999998765433
Q ss_pred c---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChhHHHhhhhcccccc-CCCCCCcHHH
Q 037068 847 L---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRL-EIPDDIDPAV 921 (967)
Q Consensus 847 ~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~ei~~~i~~~~~~~-~ip~~ls~eL 921 (967)
. ......||.+|+|||++.....+.++|||||||++|..++| ..||...-..+.. |......+ .+....+.+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCccceeeeccCchHHH
Confidence 2 24456799999999999999889999999999999999996 8999876544322 21122211 1222222388
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||.+|++.+|..||++.++|.|
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCC
Confidence 999999999999999999999977
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=233.68 Aligned_cols=208 Identities=32% Similarity=0.538 Sum_probs=176.4
Q ss_pred eeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 694 LQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
|.+.+.||.|++|.||++... ++.+++|.+...... .....+.+|+..+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567899999999999999774 588999998654322 25678899999999999999999999999889999999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-cCCC
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-LSSK 850 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-~~~~ 850 (967)
.+++|..++......+++..++.++.+++.+|.+||++ +++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL--GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999999876433389999999999999999999998 79999999999999999999999999998765432 1223
Q ss_pred CCCCCCCccChhcc-ccCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChh-HHHhhh
Q 037068 851 STAGTPEWMAPEVL-RNEPANEKCDVYSFGVILWELATLSVPWKG-LNPM-QVVGAV 904 (967)
Q Consensus 851 ~~~GT~~YmAPE~l-~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~-~~~~-ei~~~i 904 (967)
...++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++. .+.+.+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 45678899999998 666788899999999999999999999977 4444 444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=270.82 Aligned_cols=199 Identities=26% Similarity=0.431 Sum_probs=172.6
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC------ChhhHHHHHHHHHHHHHcC---CCceeEEeeeee
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF------SGDSLSQFKCEAEIMLRLR---HPNVVLFMGAVT 759 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~------s~~~~~~~~~Ei~ILk~L~---HpNIVkLig~~~ 759 (967)
..+|..++.+|+|+||.|+.+.++ ...|+||.+.+... ....+..+-.||.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 367899999999999999999774 56789998876432 2223445677999999997 999999999999
Q ss_pred ccCceEEEEeec-CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 760 RSPHFSILTEFL-PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 760 ~~~~l~LVmEy~-~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
+++.+||+||-. ++.+|+++|.. +..++|..+..|+.||+.|+++||++ ||||||||-+||.++.+|.+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~--~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQ--GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhcccccccc--CceecccccccEEEecCCeEEEeeccc
Confidence 999999999965 45599999976 66799999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKG 894 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~ 894 (967)
+...... ....++||..|.|||++.|++| ...-|||+||++||-++....||-.
T Consensus 717 aa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9766554 2566889999999999999987 5668999999999999999888753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=248.55 Aligned_cols=131 Identities=22% Similarity=0.312 Sum_probs=108.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-----C---CceeEEeeeee
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-----H---PNVVLFMGAVT 759 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-----H---pNIVkLig~~~ 759 (967)
...+|.+.++||.|.|++||++.+ ..+.||+|+.+... .-.+....||++|++++ | .+||+|+++|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 348999999999999999999976 46789999875321 12345678999999883 2 37999999997
Q ss_pred c----cCceEEEEeecCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE
Q 037068 760 R----SPHFSILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV 825 (967)
Q Consensus 760 ~----~~~l~LVmEy~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL 825 (967)
. +.++|+|+|++ |.+|..+|.. ....++...+..|+.||+.||.|||+.. ||||-||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 5 45799999998 5577777655 3467999999999999999999999986 99999999999997
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=221.37 Aligned_cols=165 Identities=22% Similarity=0.332 Sum_probs=132.8
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|.+++...+..+++..++.|+.||+.||.|||++ + ||+|||++.++.+|+ ||+++...... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ--A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--C------CcccEeEcCccceee--ccceEeecccc-----CC
Confidence 689999987667799999999999999999999998 4 999999999999999 99998654422 26
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhcccccc-----CCCCCCcH--HHHHHH
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRL-----EIPDDIDP--AVAQII 925 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~~-----~ip~~ls~--eL~dLI 925 (967)
||+.|||||++.+..++.++|||||||++|||+||+.||...... .....+....... ..+..++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999999999999999999999999999999999765432 2222221111111 11223333 699999
Q ss_pred HHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 926 RDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.+||..+|.+||++.++++++..+....
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 9999999999999999999998886543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=249.26 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=195.2
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeec
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTR 760 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~ 760 (967)
+....+.|.+.++||+|+|++||++.+ +++.||+|.+... .....+.+|+++|..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 444557899999999999999999954 3567999987443 3456788999999999 69999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEEEecccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLS 839 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKLsDFGLA 839 (967)
++...+||||+++..-.+++.. ++...+..+++.++.||.++|.+ |||||||||+|+|.+ ..+.-.|.|||+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~--GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN--GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc--CccccCCCccccccccccCCceEEechhH
Confidence 9999999999999998888765 77899999999999999999998 899999999999997 4578899999998
Q ss_pred ccccc---------------Cc--------------------c---------CCCCCCCCCCccChhccccC-CCCchhH
Q 037068 840 RIKHH---------------TY--------------------L---------SSKSTAGTPEWMAPEVLRNE-PANEKCD 874 (967)
Q Consensus 840 r~~~~---------------~~--------------------~---------~~~~~~GT~~YmAPE~l~g~-~~s~ksD 874 (967)
...+. .. . .....+||++|.|||++... ..++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 72100 00 0 00123499999999998665 4788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChh-----H---------HHhhhh-------cc---------------cc---------
Q 037068 875 VYSFGVILWELATLSVPWKGLNPM-----Q---------VVGAVG-------FQ---------------NR--------- 909 (967)
Q Consensus 875 VWSLGvlL~ELlTGk~PF~~~~~~-----e---------i~~~i~-------~~---------------~~--------- 909 (967)
|||.||+++-+++++.||...... + +.+... ++ ..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999998542211 0 000000 00 00
Q ss_pred c----c-CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 R----L-EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 ~----~-~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
. . ...+..+..+.+|+.+||+.||.+|.|+++.|+|-
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0 0 00112345789999999999999999999999883
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=275.97 Aligned_cols=197 Identities=19% Similarity=0.197 Sum_probs=144.9
Q ss_pred HcCC-CceeEEeeee-------eccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEe
Q 037068 745 RLRH-PNVVLFMGAV-------TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816 (967)
Q Consensus 745 ~L~H-pNIVkLig~~-------~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHR 816 (967)
.+.| +||++++++| .....++++|||+ +++|.+++......+++..++.++.||+.||.|||++ |||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--gIvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ--GIVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC--Ceeec
Confidence 3455 5778888877 2334577888887 5699999987666799999999999999999999988 79999
Q ss_pred ccCCCcEEEcCC-------------------CeEEEEecccccccccCc----------------cCCCCCCCCCCccCh
Q 037068 817 DLKSPNLLVDKN-------------------WVVKVCDFGLSRIKHHTY----------------LSSKSTAGTPEWMAP 861 (967)
Q Consensus 817 DLKPsNILLd~~-------------------g~VKLsDFGLAr~~~~~~----------------~~~~~~~GT~~YmAP 861 (967)
||||+||||+.. +.+||+|||+++...... .......||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999653 455666666665321100 001123578999999
Q ss_pred hccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHH
Q 037068 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQ 941 (967)
Q Consensus 862 E~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~E 941 (967)
|++.+..++.++|||||||+||||++|..|+..... ....+......... ....+...+++.+||+.+|.+||++.|
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 999999999999999999999999999888764321 11111111111111 112456778999999999999999999
Q ss_pred HHHHHH
Q 037068 942 LMSRLR 947 (967)
Q Consensus 942 LLe~L~ 947 (967)
+++|-.
T Consensus 262 il~h~~ 267 (793)
T PLN00181 262 LLQSEF 267 (793)
T ss_pred Hhhchh
Confidence 998753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-23 Score=212.38 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=204.0
Q ss_pred eeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChh-hHHHHHHHHHHHHHcCCC-ceeEEeeeeeccCceEEEEeec
Q 037068 694 LQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGD-SLSQFKCEAEIMLRLRHP-NVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~-~~~~~~~Ei~ILk~L~Hp-NIVkLig~~~~~~~l~LVmEy~ 771 (967)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++++.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 678899999999999999877 7889998876654433 567899999999999988 7999999997777789999999
Q ss_pred CCCchhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-eEEEEecccccccccCcc-
Q 037068 772 PRGSLYRLLHRPN--HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-VVKVCDFGLSRIKHHTYL- 847 (967)
Q Consensus 772 ~gGsL~~lL~~~~--~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-~VKLsDFGLAr~~~~~~~- 847 (967)
.++++..++.... ..+....+..++.|++.++.|+|+. +++||||||+||+++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~--~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999997776543 2689999999999999999999999 799999999999999888 799999999985544332
Q ss_pred -----CCCCCCCCCCccChhcccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHhhhhccccc-cC--
Q 037068 848 -----SSKSTAGTPEWMAPEVLRN---EPANEKCDVYSFGVILWELATLSVPWKGLNP----MQVVGAVGFQNRR-LE-- 912 (967)
Q Consensus 848 -----~~~~~~GT~~YmAPE~l~g---~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~----~ei~~~i~~~~~~-~~-- 912 (967)
......||..|++||.+.+ ..+....|+|++|++++++++|..||..... ......+...... ..
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2456789999999999988 5788999999999999999999999887763 3443333322222 11
Q ss_pred CCCCC----cHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 913 IPDDI----DPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 913 ip~~l----s~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..... ...+.+++..++..+|..|.+..+...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 2578999999999999999998887776
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-23 Score=228.11 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=200.4
Q ss_pred CeeEeEEeecCCceEEEEeecCC---CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC----CceeEEeeee-eccCce
Q 037068 693 DLQIGERIGIGSYGEVYRADWHG---TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH----PNVVLFMGAV-TRSPHF 764 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~g---~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H----pNIVkLig~~-~~~~~l 764 (967)
+|.+.++||+|+||.||++.+.. ..+|+|........ .. ..+..|+.++..+.. .++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~-~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS-KP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC-CC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998743 36888876543211 11 167778999988862 6899999998 467778
Q ss_pred EEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-----CeEEEEeccc
Q 037068 765 SILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-----WVVKVCDFGL 838 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-----g~VKLsDFGL 838 (967)
+|||+.+ |.+|.++..... ..++..++..|+.|++.+|++||+. |++||||||.|+++... ..+.|.|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~--G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK--GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc--CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999966 779999886544 7899999999999999999999998 89999999999999754 4799999999
Q ss_pred cc--ccccCcc-------C-CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc
Q 037068 839 SR--IKHHTYL-------S-SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN 908 (967)
Q Consensus 839 Ar--~~~~~~~-------~-~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~ 908 (967)
++ ....... . ...+.||..|+++....+...+.+.|+||++.++.|++.|..||...........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 3211110 1 234569999999999999999999999999999999999999998766432222222111
Q ss_pred cccC---CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 909 RRLE---IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 909 ~~~~---ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.... .....+.++..++..+-..+...+|....+...|+.+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111 23445678888888888899999999999999988776543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=226.48 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=187.4
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEee-eeeccCceEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMG-AVTRSPHFSI 766 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig-~~~~~~~l~L 766 (967)
.+.|.|.+.||+|-||.+.+++++ .+.+++|.+.... .....|.+|..---.| .|.||+.-|+ .|+..+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 378999999999999999999885 5679999876542 3456777776655455 5899998777 4666778899
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc--CCCeEEEEeccccccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD--KNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd--~~g~VKLsDFGLAr~~~~ 844 (967)
++||++.|+|..-+.. ..+-|....+++.|++.||.|+|+.| +||||||.+||||- +.-.|||||||+++..+.
T Consensus 100 ~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999988765 45788889999999999999999996 99999999999993 344899999999976554
Q ss_pred CccCCCCCCCCCCccChhcccc---C--CCCchhHHHHHHHHHHHHHhCCCCCCCCChh--HHHhhhhc-cccccCCCC-
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRN---E--PANEKCDVYSFGVILWELATLSVPWKGLNPM--QVVGAVGF-QNRRLEIPD- 915 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g---~--~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~--ei~~~i~~-~~~~~~ip~- 915 (967)
... ...-+..|.+||.... + ...+.+|||.||+++|.++||..||.....+ .......+ .++....|+
T Consensus 176 tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 176 TVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred eeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 321 1223556899998643 2 2467899999999999999999999853322 11222222 233345554
Q ss_pred --CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 916 --DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 916 --~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.+++.+..+.++-|..++++|--..+..+..
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 4788999999999999999994444444443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=209.94 Aligned_cols=257 Identities=18% Similarity=0.278 Sum_probs=212.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~L 766 (967)
..-.|.++++||+|+||+++.|+. ++.+||||.-+.+ ....++..|.+.++.| ..++|...|.+-..+-+-.|
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 345899999999999999999965 7999999974432 3346788899999998 57899999988888878889
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-----CCeEEEEecccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-----NWVVKVCDFGLSRI 841 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-----~g~VKLsDFGLAr~ 841 (967)
|||.+ |-+|.++..--+..|+.+++..++.|++.-++|+|+++ +|+|||||+|+||.. ...|.|+|||+|+.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99977 67999998766778999999999999999999999995 999999999999953 45799999999987
Q ss_pred cccCc-------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh---HHHhhhhcccccc
Q 037068 842 KHHTY-------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM---QVVGAVGFQNRRL 911 (967)
Q Consensus 842 ~~~~~-------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~---ei~~~i~~~~~~~ 911 (967)
+.+.. .......||-+||+-....|...+.+.|+-+||-++..++-|..||.+.-.. +-.+.|.......
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 65432 3345567999999999999999999999999999999999999999886433 3333443222211
Q ss_pred ---CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 912 ---EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 912 ---~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.+...+|.++..-|+..-..+-.+-|..+-+...+..+.+..
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 234678999999999999999999999999888888887655
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=214.47 Aligned_cols=254 Identities=27% Similarity=0.598 Sum_probs=215.6
Q ss_pred CCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
.++.+..+|.+...|..|+|++.|..+++|++............|..|.-.++-+.||||+.+++.|....++.++..||
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 45566778999999999999999999999998777666666677888888888899999999999999999999999999
Q ss_pred CCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 772 PRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 772 ~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.|+|+..+... +...+-.++.+++.+|++|+.|||+..|-|----|....|+||++.+.+|+ ++-+++-.+ ..
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfq----e~ 344 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ----EV 344 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeee----cc
Confidence 999999999863 334677889999999999999999987556666799999999999887774 221211111 12
Q ss_pred CCCCCCCccChhccccCCCC---chhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 851 STAGTPEWMAPEVLRNEPAN---EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~~~s---~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
...-.|.||+||.++..+.+ ..+|+|||++++|||.|...||....+++.--.+..++.+..+|+.+++.+..||.-
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~i 424 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNI 424 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHH
Confidence 33457899999999887654 468999999999999999999999999988778888999999999999999999999
Q ss_pred hhhcCCCCCcCHHHHHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
|+..||.+||.+..|+-.|++.+
T Consensus 425 cmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 425 CMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999988877653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=218.04 Aligned_cols=165 Identities=17% Similarity=0.135 Sum_probs=127.9
Q ss_pred hccCCeeEeEEeecCCceEEEEeec---CCCeEEEEEeecCCC---ChhhHHHHHHHHHHHHHcCCCceeE-Eeeeeecc
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW---HGTEVAVKKFLDQDF---SGDSLSQFKCEAEIMLRLRHPNVVL-FMGAVTRS 761 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~---~g~~VAVKkl~~~~~---s~~~~~~~~~Ei~ILk~L~HpNIVk-Lig~~~~~ 761 (967)
...++|.+.+.||+|+||+||+|.+ .++.+|||++..... .......+.+|++++++++|+||++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 4557899999999999999999965 356679998653211 2234567899999999999999985 5442
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEecc-CCCcEEEcCCCeEEEEeccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDL-KSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDL-KPsNILLd~~g~VKLsDFGLAr 840 (967)
+..+|||||+.+++|... .. . . ...++.|++++|.|||++ ||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-~---~---~~~~~~~i~~aL~~lH~~--gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-H---G---DPAWFRSAHRALRDLHRA--GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-c---c---hHHHHHHHHHHHHHHHHC--CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 458999999999999732 11 1 1 146789999999999998 8999999 9999999999999999999998
Q ss_pred ccccCccC--------CCCCCCCCCccChhccccC
Q 037068 841 IKHHTYLS--------SKSTAGTPEWMAPEVLRNE 867 (967)
Q Consensus 841 ~~~~~~~~--------~~~~~GT~~YmAPE~l~g~ 867 (967)
........ .....+++.|++||.+.-.
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 65433211 1234578889999998543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=197.81 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=208.7
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC-CceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH-PNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H-pNIVkLig~~~~~~~l~ 765 (967)
+....|.+.++||.|+||.+|.|.. .|..||||.-.... .-.++..|.++++.|.+ ..|..+..+..+...-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 4558999999999999999999965 68999999754332 22456779999999964 67777777777788889
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc---CCCeEEEEeccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD---KNWVVKVCDFGLSRIK 842 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd---~~g~VKLsDFGLAr~~ 842 (967)
+||+.+ |-+|.+++.--...++.++++-++-|++.-++|+|.+ ++|||||||+|+|.. ....+.|+|||+|+.+
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r--~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR--NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh--ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 999977 6799999877667899999999999999999999998 699999999999995 3468999999999875
Q ss_pred ccC-------ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHh---hhhc---ccc
Q 037068 843 HHT-------YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVG---AVGF---QNR 909 (967)
Q Consensus 843 ~~~-------~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~---~i~~---~~~ 909 (967)
.+. +.......||.+|.+-....+-..+.+.|+-|+|.+|..+--|..||.+.......+ .|.. ...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 442 223445679999999998888888999999999999999999999999876643322 2211 111
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 910 ~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
...+.+..|.++...+..|-..--++-|...-|-+.++.|.+.+.
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 112346789999999999999999999998888888877766554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=234.47 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=189.0
Q ss_pred eEeEEeecCCceEEEEeec--CCCeEEEEEeec---CCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 695 QIGERIGIGSYGEVYRADW--HGTEVAVKKFLD---QDFSG-DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~---~~~s~-~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.....+|.|++|.|+.+.. ....++.|.+.. ..... .....+..|..+-..|+|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999997776643 233344443321 11111 22223677778888899999998888887766666669
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-- 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-- 846 (967)
|||+. +|+.++.. ...+....+-.++.|++.|++|||+. ||.|||||++|++++.+|.+||+|||.+..+.-..
T Consensus 401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~--GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSM--GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhc--CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 99999876 34688899999999999999999999 89999999999999999999999999987654322
Q ss_pred --cCCCCCCCCCCccChhccccCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCChhHHH-hhhhc-ccc-----ccCCCCC
Q 037068 847 --LSSKSTAGTPEWMAPEVLRNEPANE-KCDVYSFGVILWELATLSVPWKGLNPMQVV-GAVGF-QNR-----RLEIPDD 916 (967)
Q Consensus 847 --~~~~~~~GT~~YmAPE~l~g~~~s~-ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~-~~i~~-~~~-----~~~ip~~ 916 (967)
.......|+..|+|||.+.+..|++ ..||||.|++++.|++|+.||......+.. ..... ... ...+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 3456678999999999999999876 479999999999999999999876544321 11110 111 1112245
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
++.+.+.+|.+||+.+|.+|.|+++|++-
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhC
Confidence 78889999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-21 Score=221.42 Aligned_cols=224 Identities=26% Similarity=0.408 Sum_probs=187.4
Q ss_pred eecCCceEEEEeec-----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEEEeecCC
Q 037068 700 IGIGSYGEVYRADW-----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 700 LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+|+|.||.|++++. .+.-+|.|.+.+.............|..++...+ ||+++++...++.+..++++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999997743 4667888887654332222224556788888886 99999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~ 853 (967)
|+|...+.+ ...+++.....+...++-+++++|+. ||+|||+|++||+++.+|++|+.|||+++..-.... .+
T Consensus 82 g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l--~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~c 154 (612)
T KOG0603|consen 82 GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKL--GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----AC 154 (612)
T ss_pred chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchh--HHHHhcccccceeecccCccccCCchhhhHhHhhhh----cc
Confidence 999988876 45578888888999999999999998 899999999999999999999999999986544322 28
Q ss_pred CCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 037068 854 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEP 933 (967)
Q Consensus 854 GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dP 933 (967)
||..|||||+++ ......|.||||++++||+||..||.. ++...| ....+..|..++..+.+++++++..+|
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 999999999998 456789999999999999999999998 333333 334677889999999999999999999
Q ss_pred CCCcC
Q 037068 934 HLRPS 938 (967)
Q Consensus 934 e~RPS 938 (967)
.+|.-
T Consensus 227 ~nrLg 231 (612)
T KOG0603|consen 227 ENRLG 231 (612)
T ss_pred HHHhc
Confidence 99963
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=5e-19 Score=188.79 Aligned_cols=175 Identities=14% Similarity=0.121 Sum_probs=135.5
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCCh-hhHHH------HHHHHHHHHHcCCCceeEEeeeeec
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSG-DSLSQ------FKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~-~~~~~------~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
.+..++|.+.+.||.|+||.||++...++.+|||.+....... ..... +.+|+..+.++.|++|..+.+++..
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3466899999999999999999987778889999986543222 22222 5789999999999999998887653
Q ss_pred c--------CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEE
Q 037068 761 S--------PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVK 832 (967)
Q Consensus 761 ~--------~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VK 832 (967)
. +..+|||||++|.+|.++.. +++ ....+|+.+|..||+. |++|||+||+||+++.++ ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~--gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH--GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc--CCccCCCChHHEEEeCCC-EE
Confidence 2 35889999999999988742 233 2456999999999998 799999999999999888 99
Q ss_pred EEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHH
Q 037068 833 VCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELA 886 (967)
Q Consensus 833 LsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELl 886 (967)
|+|||..+........ ..+.....+..++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988654322111 01333444667999999999887554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=7e-19 Score=182.43 Aligned_cols=140 Identities=21% Similarity=0.197 Sum_probs=106.8
Q ss_pred eEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhh------------------------HHHHHHHHHHHHHcCCCce
Q 037068 697 GERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDS------------------------LSQFKCEAEIMLRLRHPNV 751 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~------------------------~~~~~~Ei~ILk~L~HpNI 751 (967)
...||+|+||.||+|.. +|+.||||++......... ......|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999976 5889999998654211111 1223459999999987776
Q ss_pred eEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCeEEeccCCCcEEEcCCCe
Q 037068 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL-HTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 752 VkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YL-Hs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
........ ...+|||||++++++...+.. ...+++..+..++.|++.+|.|| |+. ||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~--giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDC--RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEE-CCc
Confidence 43222222 224899999998877654332 35689999999999999999999 677 799999999999998 478
Q ss_pred EEEEeccccccc
Q 037068 831 VKVCDFGLSRIK 842 (967)
Q Consensus 831 VKLsDFGLAr~~ 842 (967)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=187.46 Aligned_cols=232 Identities=23% Similarity=0.277 Sum_probs=153.7
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCC----------CceeEEeee--
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRH----------PNVVLFMGA-- 757 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~H----------pNIVkLig~-- 757 (967)
.+..++.||.|+++.||.+++ +++.+|+|++..... .....+++++|......+.+ -.++.-++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 567788999999999999987 468999999876543 23456777777766555322 122222221
Q ss_pred -------eecc---C-----ceEEEEeecCCCchhhhhc---CCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCeEEe
Q 037068 758 -------VTRS---P-----HFSILTEFLPRGSLYRLLH---RPNH---QLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816 (967)
Q Consensus 758 -------~~~~---~-----~l~LVmEy~~gGsL~~lL~---~~~~---~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHR 816 (967)
+... . ..+++|+-+ .++|..++. .... .+.....+.+..|+++.+++||.. |+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~--GlVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY--GLVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--TEEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc--ceEec
Confidence 1111 1 346788877 558877753 1111 233344456779999999999999 89999
Q ss_pred ccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccChhcccc--------CCCCchhHHHHHHHHHHHHHhC
Q 037068 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN--------EPANEKCDVYSFGVILWELATL 888 (967)
Q Consensus 817 DLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g--------~~~s~ksDVWSLGvlL~ELlTG 888 (967)
||+|+|++++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|+||+++|.|+++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999988766554332 234478999998743 2478899999999999999999
Q ss_pred CCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 037068 889 SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936 (967)
Q Consensus 889 k~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~R 936 (967)
..||....+...... .+.....+++.++.||+.+|+.||++|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999997754322211 233344788999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=175.59 Aligned_cols=141 Identities=22% Similarity=0.217 Sum_probs=109.3
Q ss_pred eEEeecCCceEEEEeec-CCCeEEEEEeecCCCChh------------------------hHHHHHHHHHHHHHcCCCce
Q 037068 697 GERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGD------------------------SLSQFKCEAEIMLRLRHPNV 751 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~------------------------~~~~~~~Ei~ILk~L~HpNI 751 (967)
.+.||+|+||.||+|.+ +|+.||||++........ ....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999976 489999999875421100 01224678999999999887
Q ss_pred eEEeeeeeccCceEEEEeecCCCchhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCeEEeccCCCcEEEcCCC
Q 037068 752 VLFMGAVTRSPHFSILTEFLPRGSLYRL-LHRPNHQLDERRRMRMALDVAKGMNYLHT-SHPTIVHRDLKSPNLLVDKNW 829 (967)
Q Consensus 752 VkLig~~~~~~~l~LVmEy~~gGsL~~l-L~~~~~~Lse~~i~~I~~QIa~aL~YLHs-~n~GIVHRDLKPsNILLd~~g 829 (967)
.....+... ..+|||||++++++... +. ...++...+..++.|++.+|.+||. . ||+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~--givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEA--GLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCChhhEEEE-CC
Confidence 543333322 24899999998855433 33 3457888999999999999999999 6 899999999999999 78
Q ss_pred eEEEEeccccccccc
Q 037068 830 VVKVCDFGLSRIKHH 844 (967)
Q Consensus 830 ~VKLsDFGLAr~~~~ 844 (967)
.++|+|||+++....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-18 Score=210.83 Aligned_cols=245 Identities=20% Similarity=0.224 Sum_probs=180.0
Q ss_pred CeeEeEEeecCCceEEEEeecCCCeEEEEEeecCC--CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~--~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
+|...+-||.+.|=+|.++++....|+||++.+++ .+-....+...|++ .+.++|||.+++.-+-..+..-|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 67888999999999999999987789999998764 22233344444555 4556999999999988888888899999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc--cccCccC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLS 848 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~--~~~~~~~ 848 (967)
..+ +|++.+.. ..-+..-+...|+.||+.||...|.. ||+|+|||.+||||+.=+=+.|+||.--+. ....+..
T Consensus 103 vkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~--gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKL--GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHc--CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 866 78888875 33366677788999999999999998 799999999999999888889999975542 1111111
Q ss_pred -----CCCCCCCCCccChhccccC----------C-CCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcccccc
Q 037068 849 -----SKSTAGTPEWMAPEVLRNE----------P-ANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRL 911 (967)
Q Consensus 849 -----~~~~~GT~~YmAPE~l~g~----------~-~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~ 911 (967)
..+......|.|||.|... . .+++-||||+||++.||++ |++||.-. +.+..........
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYRSGNADDP 255 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHhccCccCH
Confidence 1112234479999998542 1 4678899999999999998 68887532 1111110000000
Q ss_pred --CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 --EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 --~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
-+.+.-+..+++||..|++.||.+|.++++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0011125589999999999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=175.51 Aligned_cols=185 Identities=15% Similarity=0.135 Sum_probs=140.1
Q ss_pred EeEEeecCCceEEEEeecCCCeEEEEEeecCCCChh--hHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEEEeecC
Q 037068 696 IGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGD--SLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~--~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LVmEy~~ 772 (967)
+...|+.|+||+||.+...+..++.+.+.....-.. ....+.+|+++|++|. |++|++++++ +..+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 567899999999999887888888777654332111 1224789999999994 5889999886 34799999999
Q ss_pred CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEecc-CCCcEEEcCCCeEEEEecccccccccCccC---
Q 037068 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDL-KSPNLLVDKNWVVKVCDFGLSRIKHHTYLS--- 848 (967)
Q Consensus 773 gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDL-KPsNILLd~~g~VKLsDFGLAr~~~~~~~~--- 848 (967)
|.+|...+.. . ...++.|++.+|.++|++ ||+|||| ||.|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~--GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR-------G-DLAYFRAARRLLQQLHRC--GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh-------h-hHHHHHHHHHHHHHHHHC--cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9998755321 1 135788999999999999 8999999 799999999999999999999854432210
Q ss_pred ----------CCCCCCCCCccChhccccC-CCC-chhHHHHHHHHHHHHHhCCCCCCC
Q 037068 849 ----------SKSTAGTPEWMAPEVLRNE-PAN-EKCDVYSFGVILWELATLSVPWKG 894 (967)
Q Consensus 849 ----------~~~~~GT~~YmAPE~l~g~-~~s-~ksDVWSLGvlL~ELlTGk~PF~~ 894 (967)
..-...++.|+.|+...-. ..+ ...+.++.|+-+|+++|+..++-.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0012267888888865433 233 578999999999999999987644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=204.82 Aligned_cols=253 Identities=21% Similarity=0.220 Sum_probs=184.9
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC---CCceeEEeeee
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR---HPNVVLFMGAV 758 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~---HpNIVkLig~~ 758 (967)
....++.-.+.|.|.+.||+|+||+||+|.. +++.||+|+-......+--+ -.+++.+|+ -+-|+.+..++
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHH
Confidence 3345566778999999999999999999965 58889999855443222111 233444444 23455666666
Q ss_pred eccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-------CCCeE
Q 037068 759 TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-------KNWVV 831 (967)
Q Consensus 759 ~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-------~~g~V 831 (967)
.-.+.-+||+||.+.|+|.+++. ..+.+++..++.++.|+++.++.||.. +|||+||||+|+||. ..--+
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~--~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM--GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc--ceecccCCcceeEeecccCCCCcccce
Confidence 66777899999999999999998 477899999999999999999999999 799999999999994 23479
Q ss_pred EEEeccccccc--ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc
Q 037068 832 KVCDFGLSRIK--HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR 909 (967)
Q Consensus 832 KLsDFGLAr~~--~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~ 909 (967)
+|+|||.+-.+ ..........++|-.+-.+|+..|.++++.+|.|.|+.+++-|+.|++-= ....-. ...
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------~~~g~~-~~~ 912 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------VKNGSS-WMV 912 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------hcCCcc-eec
Confidence 99999998532 12223566778999999999999999999999999999999999986421 000000 011
Q ss_pred ccCCCCCCcHHHH-HHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 910 RLEIPDDIDPAVA-QIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 910 ~~~ip~~ls~eL~-dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
...++.....+++ +++..+|+.|=..=|...+|...|+.+..
T Consensus 913 ~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 913 KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1113333444443 67788888444444777777777766643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=193.98 Aligned_cols=210 Identities=33% Similarity=0.558 Sum_probs=168.5
Q ss_pred HHHcCCCceeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCc
Q 037068 743 MLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPN 822 (967)
Q Consensus 743 Lk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsN 822 (967)
|+.+.|.|+.+|++.+.++...++|.+||..|+|.+.+......+++.....++++|+.||.|||.-. ..+|+.|++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecccc
Confidence 35678999999999999999999999999999999999987888999999999999999999999874 34999999999
Q ss_pred EEEcCCCeEEEEecccccccccC--ccCCCCCCCCCCccChhccccCC-------CCchhHHHHHHHHHHHHHhCCCCCC
Q 037068 823 LLVDKNWVVKVCDFGLSRIKHHT--YLSSKSTAGTPEWMAPEVLRNEP-------ANEKCDVYSFGVILWELATLSVPWK 893 (967)
Q Consensus 823 ILLd~~g~VKLsDFGLAr~~~~~--~~~~~~~~GT~~YmAPE~l~g~~-------~s~ksDVWSLGvlL~ELlTGk~PF~ 893 (967)
++++..+.+||+|||+....... ........-..-|.|||.+++.. .+.+.||||||++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998765421 11111122345799999997742 3567999999999999999999997
Q ss_pred CCC----hhHHHhhhhcccc---ccCCC--CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 894 GLN----PMQVVGAVGFQNR---RLEIP--DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 894 ~~~----~~ei~~~i~~~~~---~~~ip--~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
... +.++...+...+. ++.+. ....+++..++..||..+|.+||++.++-..++.+....
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 632 3344444432122 22222 145668999999999999999999999999998886654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-16 Score=165.35 Aligned_cols=136 Identities=22% Similarity=0.382 Sum_probs=114.1
Q ss_pred EEeecCCceEEEEeecCCCeEEEEEeecCCCChh------hHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 698 ERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGD------SLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~------~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
+.||+|++|.||+|.+.+..+++|+......... ....+.+|+.++..+.|++|.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999998899999998654332211 1245788999999999999877666666777889999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
+|++|.+++.... + .+..++.+++.+|.+||+. |++|+|++|.|||++ ++.++|+|||.++.
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~--~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA--GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC--CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986422 2 7888999999999999998 799999999999999 78999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-17 Score=199.56 Aligned_cols=205 Identities=30% Similarity=0.445 Sum_probs=152.3
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
..+|..++.|..|+||.||.++++ .+++|+|+ .+++. +.+- |+.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-------hhhc--cccccCCccee----------------
Confidence 368889999999999999999775 77888853 22211 0000 22222333333
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-- 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-- 846 (967)
|+-..+++.. +.++.. ++.+++|||+. ||+|||+||+|++|+.-|++|+.|||+++......
T Consensus 136 -----gDc~tllk~~-g~lPvd--------mvla~Eylh~y--givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -----GDCATLLKNI-GPLPVD--------MVLAVEYLHSY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -----chhhhhcccC-CCCcch--------hhHHhHhhccC--CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4555555542 223322 27789999987 89999999999999999999999999987421110
Q ss_pred -------------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-cccccC
Q 037068 847 -------------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRLE 912 (967)
Q Consensus 847 -------------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~~ 912 (967)
...+..+|||.|.|||++..+-|...+|+|++|+++||++-|..||.+..+++++..+.- ....++
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 112345799999999999999999999999999999999999999999999988876532 112222
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCc
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRP 937 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RP 937 (967)
-.+.++++.+++|.++|+.+|..|-
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 2345789999999999999999994
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-16 Score=166.67 Aligned_cols=134 Identities=18% Similarity=0.280 Sum_probs=104.2
Q ss_pred eEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-----CCCceeEEeeeeeccC---ceE-EE
Q 037068 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-----RHPNVVLFMGAVTRSP---HFS-IL 767 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-----~HpNIVkLig~~~~~~---~l~-LV 767 (967)
.+.||+|+||.||.-...+.. +||++.... ....+.+.+|+.+++.+ .||||++++++++++. ..+ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 467999999999973333444 688875532 22356789999999999 5799999999998863 333 78
Q ss_pred Eee--cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCeEEeccCCCcEEEcC----CCeEEEEecccc
Q 037068 768 TEF--LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM-NYLHTSHPTIVHRDLKSPNLLVDK----NWVVKVCDFGLS 839 (967)
Q Consensus 768 mEy--~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL-~YLHs~n~GIVHRDLKPsNILLd~----~g~VKLsDFGLA 839 (967)
+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~--~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN--RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5579999999752 36555 35678888888 999999 7999999999999974 348999995544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=174.06 Aligned_cols=195 Identities=24% Similarity=0.352 Sum_probs=144.7
Q ss_pred CCCceeEEeeeeec---------------------------cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHH
Q 037068 747 RHPNVVLFMGAVTR---------------------------SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDV 799 (967)
Q Consensus 747 ~HpNIVkLig~~~~---------------------------~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QI 799 (967)
+|||||++..+|.+ +..+|+||..... +|..++.. ...+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc--CCCchHHHHHHHHHH
Confidence 68999988876532 2357899987755 78888874 346777888899999
Q ss_pred HHHHHHHHhcCCCeEEeccCCCcEEE--cCC--CeEEEEeccccccccc-----CccC-CCCCCCCCCccChhccccCC-
Q 037068 800 AKGMNYLHTSHPTIVHRDLKSPNLLV--DKN--WVVKVCDFGLSRIKHH-----TYLS-SKSTAGTPEWMAPEVLRNEP- 868 (967)
Q Consensus 800 a~aL~YLHs~n~GIVHRDLKPsNILL--d~~--g~VKLsDFGLAr~~~~-----~~~~-~~~~~GT~~YmAPE~l~g~~- 868 (967)
+.|+.|||.+ ||.|||||.+|||| +++ ..+.|+|||.+-..+. .+.+ .-...|.-.-||||+...-+
T Consensus 351 LEav~hL~~h--gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 351 LEAVTHLHKH--GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHc--cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 89999999999999 333 4789999997643222 1111 12234677899999986432
Q ss_pred -----CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHH
Q 037068 869 -----ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943 (967)
Q Consensus 869 -----~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELL 943 (967)
.-.|+|.|+.|.+.||+++...||-....+.....--.+..-+.+|+.+++.+++++...|+.||.+|++..-..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 134899999999999999999999875443322221123334567889999999999999999999998865544
Q ss_pred HHH
Q 037068 944 SRL 946 (967)
Q Consensus 944 e~L 946 (967)
..|
T Consensus 509 Nvl 511 (598)
T KOG4158|consen 509 NVL 511 (598)
T ss_pred hHH
Confidence 443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=161.93 Aligned_cols=133 Identities=21% Similarity=0.334 Sum_probs=108.3
Q ss_pred EeecCCceEEEEeecCCCeEEEEEeecCCCCh------hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecC
Q 037068 699 RIGIGSYGEVYRADWHGTEVAVKKFLDQDFSG------DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~------~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~ 772 (967)
.||+|+||.||+|.+.+..+++|+........ ....++.+|++++..+.|+++....-++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999876543221 123567889999999988876544444455666799999999
Q ss_pred CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 773 gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
|++|.+++..... .++.|++.+|.+||+. |++|+|++|.||+++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~--gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKA--GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHC--CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988764211 7899999999999998 799999999999999 889999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.8e-16 Score=166.18 Aligned_cols=146 Identities=23% Similarity=0.158 Sum_probs=112.4
Q ss_pred ccCCeeEeEEeecCCceEEEEee---cCCCeEEEEEeecCCCChh----------------------hHHHHHHHHHHHH
Q 037068 690 LWEDLQIGERIGIGSYGEVYRAD---WHGTEVAVKKFLDQDFSGD----------------------SLSQFKCEAEIML 744 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~---~~g~~VAVKkl~~~~~s~~----------------------~~~~~~~Ei~ILk 744 (967)
...-|.+.+.||+|+||.||+|. ..|+.||||++........ ....+..|+.+++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33358899999999999999997 3689999999865421100 1123578999999
Q ss_pred HcCCCc--eeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-eEEeccCCC
Q 037068 745 RLRHPN--VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT-IVHRDLKSP 821 (967)
Q Consensus 745 ~L~HpN--IVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~G-IVHRDLKPs 821 (967)
++.+.+ +.+++++ ...+|||||+.+++|...+.. ...+....+..++.||+.+|.+||.+ | |+||||||+
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--g~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKE--GELVHGDLSEY 178 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhc--CCEEeCCCChh
Confidence 997533 3444443 235899999999888766432 33466677789999999999999998 7 999999999
Q ss_pred cEEEcCCCeEEEEecccccccc
Q 037068 822 NLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 822 NILLd~~g~VKLsDFGLAr~~~ 843 (967)
||+++ ++.++|+|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999986443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=181.72 Aligned_cols=139 Identities=19% Similarity=0.299 Sum_probs=114.7
Q ss_pred CCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCCh------hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSG------DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~------~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
..|...+.||+|+||+||++.+.+..+++|+........ ...+.+.+|+++++.++|++|+..+.++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 344567899999999999998887777777654332211 12356889999999999999988777777777789
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
+||||+++++|.+++. ....++.|++.+|.|||+. ||+||||||+|||+ .++.++|+|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~--giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA--GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC--CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999998875 3467899999999999998 79999999999999 6789999999999653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=155.77 Aligned_cols=138 Identities=21% Similarity=0.174 Sum_probs=107.6
Q ss_pred CeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCCh--------------------hhHHHHHHHHHHHHHcCCCc-
Q 037068 693 DLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSG--------------------DSLSQFKCEAEIMLRLRHPN- 750 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~--------------------~~~~~~~~Ei~ILk~L~HpN- 750 (967)
-|.+.+.||+|+||.||++.. +++.||||++....... ........|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 377889999999999999977 58899999875432100 01123677899999997774
Q ss_pred -eeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC
Q 037068 751 -VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW 829 (967)
Q Consensus 751 -IVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g 829 (967)
+...++. ...++||||+.+++|..+... .....++.+|+.++.++|+. ||+||||||.||+++.++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~--gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH--GIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC--CCCcCCCCcccEEEcCCC
Confidence 4444442 346899999999998776431 33567889999999999997 799999999999999999
Q ss_pred eEEEEecccccccc
Q 037068 830 VVKVCDFGLSRIKH 843 (967)
Q Consensus 830 ~VKLsDFGLAr~~~ 843 (967)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-14 Score=138.55 Aligned_cols=134 Identities=18% Similarity=0.179 Sum_probs=113.4
Q ss_pred EeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC--CceeEEeeeeeccCceEEEEeecCC
Q 037068 696 IGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH--PNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H--pNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.+.||+|.++.||++...+..+++|.+..... ...+..|+.+++.+.| .++++++.++...+..+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457899999999999998888999998654321 4568889999999976 5889999988888889999999998
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH-PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n-~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
+.+..+ +......++.+++.+|.+||... ++++|+||+|.||++++.+.++++|||.++.
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777554 45666788999999999999852 3799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.4e-16 Score=177.19 Aligned_cols=166 Identities=25% Similarity=0.403 Sum_probs=129.5
Q ss_pred ceEEEEeecCCCchhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHR--PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~--~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.++|.|++|...+|.++|.. .....+......++.|++.+++| + |.+|||+||.||+...+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k--~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K--GLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c--cchhhhccccccccccchhhhhhhhhhee
Confidence 58899999999999999964 34557788899999999999999 3 79999999999999999999999999987
Q ss_pred ccccCc------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCC
Q 037068 841 IKHHTY------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEI 913 (967)
Q Consensus 841 ~~~~~~------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~i 913 (967)
...... .......||..||+||.+.+..|+.++|||+||++|+||+. -..+|....... ......+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~-------d~r~g~i 477 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLT-------DIRDGII 477 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhh-------hhhcCCC
Confidence 544332 23445679999999999999999999999999999999998 233332221111 1122233
Q ss_pred CC---CCcHHHHHHHHHhhhcCCCCCcCHH
Q 037068 914 PD---DIDPAVAQIIRDCWQTEPHLRPSFA 940 (967)
Q Consensus 914 p~---~ls~eL~dLI~~CLq~dPe~RPS~~ 940 (967)
|+ .-.++-..|+.+++...|.+||++.
T Consensus 478 p~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 478 PPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred ChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 31 1234556899999999999999433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=145.57 Aligned_cols=138 Identities=25% Similarity=0.212 Sum_probs=97.9
Q ss_pred eEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHH----------------------HHHHHHHHHHcCCCc--e
Q 037068 697 GERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQ----------------------FKCEAEIMLRLRHPN--V 751 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~----------------------~~~Ei~ILk~L~HpN--I 751 (967)
.+.||+|+||+||+|... ++.||||++............ ...|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999875 889999987653222111111 135666666664433 3
Q ss_pred eEEeeeeeccCceEEEEeecCCCchhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCeEEeccCCCcEEEcCCC
Q 037068 752 VLFMGAVTRSPHFSILTEFLPRGSLYR-LLHRPNHQLDERRRMRMALDVAKGMNYLHT-SHPTIVHRDLKSPNLLVDKNW 829 (967)
Q Consensus 752 VkLig~~~~~~~l~LVmEy~~gGsL~~-lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs-~n~GIVHRDLKPsNILLd~~g 829 (967)
.+.++. ...++||||+.++.+.. .+.... . ...+..++.+++.++.++|. + ||+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~--~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREA--GLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhcc--CcCcCCCChhhEEEE-CC
Confidence 444443 24689999999854322 121111 1 15678899999999999999 6 799999999999999 89
Q ss_pred eEEEEeccccccccc
Q 037068 830 VVKVCDFGLSRIKHH 844 (967)
Q Consensus 830 ~VKLsDFGLAr~~~~ 844 (967)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.5e-16 Score=186.12 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=197.3
Q ss_pred CCeeEeEEeecCCceEEEEeec---CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW---HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~---~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LV 767 (967)
..|.+.+.||+|+|+.|-.... ....+|+|.+............+..|..+-+.+. |.|++.+++........++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4566677799999999987754 2344666655444334445566777888888886 99999999999999999999
Q ss_pred EeecCCCchhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCeEEeccCCCcEEEcCCC-eEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLL-HRPNHQLDERRRMRMALDVAKGMNYLH-TSHPTIVHRDLKSPNLLVDKNW-VVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL-~~~~~~Lse~~i~~I~~QIa~aL~YLH-s~n~GIVHRDLKPsNILLd~~g-~VKLsDFGLAr~~~~ 844 (967)
++|..++++...+ .......+......++.|+..++.|+| .. ++.||||||+|.+++..+ .+|++|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~--~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN--GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc--ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999988 433336778888899999999999999 65 899999999999999999 999999999986544
Q ss_pred ---CccCCCCCCC-CCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-c--ccCCCCC
Q 037068 845 ---TYLSSKSTAG-TPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-R--RLEIPDD 916 (967)
Q Consensus 845 ---~~~~~~~~~G-T~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-~--~~~ip~~ 916 (967)
........+| ++.|+|||...+. ......|+||.|+++.-+++|..||...........-.... . .......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 2223445668 9999999999884 45678999999999999999999998765443211110011 1 2334567
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
++....+++.+++..+|..|.+.+++...
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred CChhhhhcccccccCCchhcccccccccc
Confidence 88899999999999999999998887654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=148.69 Aligned_cols=136 Identities=18% Similarity=0.233 Sum_probs=105.7
Q ss_pred EEee-cCCceEEEEeecCCCeEEEEEeecCCC-----------ChhhHHHHHHHHHHHHHcCCCce--eEEeeeeecc-C
Q 037068 698 ERIG-IGSYGEVYRADWHGTEVAVKKFLDQDF-----------SGDSLSQFKCEAEIMLRLRHPNV--VLFMGAVTRS-P 762 (967)
Q Consensus 698 k~LG-eG~FG~VYka~~~g~~VAVKkl~~~~~-----------s~~~~~~~~~Ei~ILk~L~HpNI--VkLig~~~~~-~ 762 (967)
..|| .||.|+||++...+..++||.+..... +......+.+|+.++.+|.|++| ++.+++.... .
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 888889998888889999998854221 12234568889999999998875 6677664332 2
Q ss_pred c---eEEEEeecCC-CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 763 H---FSILTEFLPR-GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 763 ~---l~LVmEy~~g-GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
. .++||||+++ .+|.+++.. ..+++. .+.||+.+|.+||++ ||+||||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~--GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDA--GVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHC--CCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2 3599999997 689888764 345544 357899999999998 899999999999999989999999998
Q ss_pred ccc
Q 037068 839 SRI 841 (967)
Q Consensus 839 Ar~ 841 (967)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-12 Score=152.90 Aligned_cols=250 Identities=24% Similarity=0.203 Sum_probs=188.9
Q ss_pred hccCCeeEeEEeec--CCceEEEEeec----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeecc
Q 037068 689 ILWEDLQIGERIGI--GSYGEVYRADW----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRS 761 (967)
Q Consensus 689 i~~e~y~i~k~LGe--G~FG~VYka~~----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~ 761 (967)
+.-..+.+.+.+|. |.+|.||.++. .+..+|+|+-....-.......-.+|+.-.+++ .|+|.++.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34457778899999 99999999876 356788887332211122222334455556666 499999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCeEEeccCCCcEEEcCC-CeEEEEec
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK----GMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDF 836 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~----aL~YLHs~n~GIVHRDLKPsNILLd~~-g~VKLsDF 836 (967)
+.+++-+|++. .+|..+......-++...++.++.+... ||.++|.. .++|-|+||.||+...+ ...+++||
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~--~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN--NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC--cccccccchhheecccccceeecCCc
Confidence 99999999885 6888888777777899999999999999 99999998 49999999999999988 89999999
Q ss_pred ccccccccCccCC-----CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChhHHHhhhhcccc
Q 037068 837 GLSRIKHHTYLSS-----KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL--NPMQVVGAVGFQNR 909 (967)
Q Consensus 837 GLAr~~~~~~~~~-----~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~--~~~ei~~~i~~~~~ 909 (967)
|+...+.+..... ....|...|++||.+++. ++...|+|++|.++.+-.++..++... +....... ...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~---~~i 343 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ---GYI 343 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---ccC
Confidence 9998765543222 223688899999988665 788999999999999999987655443 11111110 112
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 ~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..++....+.++...+..++..+|..|++.+.++.+
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 333444567788889999999999999997766554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-10 Score=137.51 Aligned_cols=164 Identities=18% Similarity=0.250 Sum_probs=127.9
Q ss_pred CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHH
Q 037068 714 HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRM 793 (967)
Q Consensus 714 ~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~ 793 (967)
.+.+|.|+.+.... +.....+.+-++-++.++||||+++++.+...+.+|||+|-+. .|..++++ +....+.
T Consensus 36 ~~~~vsVF~~~~~~--~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSN--GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCC--chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence 57788888765543 2445667788899999999999999999999999999999874 47777765 3366777
Q ss_pred HHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchh
Q 037068 794 RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKC 873 (967)
Q Consensus 794 ~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ks 873 (967)
..+.||+.||.+||... +++|++|.-.-|+|+..|..||++|-++...............-..|..|+.+.... -..
T Consensus 108 ~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence 78999999999998653 699999999999999999999999998865443332222222333567777654333 457
Q ss_pred HHHHHHHHHHHHHhC
Q 037068 874 DVYSFGVILWELATL 888 (967)
Q Consensus 874 DVWSLGvlL~ELlTG 888 (967)
|.|.|||+++|++.|
T Consensus 185 D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhHHHHHHHHhCc
Confidence 999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.9e-11 Score=139.85 Aligned_cols=141 Identities=23% Similarity=0.237 Sum_probs=95.0
Q ss_pred EEeecCCceEEEEeec-CCCeEEEEEeecCCCC---------------------------h-hhHH----------HHHH
Q 037068 698 ERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFS---------------------------G-DSLS----------QFKC 738 (967)
Q Consensus 698 k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s---------------------------~-~~~~----------~~~~ 738 (967)
+.||.|++|.||+|+. +|+.||||+....... . ...+ .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999987 5899999987432100 0 0000 1344
Q ss_pred HHHHHHHc----CCCceeEEeeee-eccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhcCCC
Q 037068 739 EAEIMLRL----RHPNVVLFMGAV-TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK-GMNYLHTSHPT 812 (967)
Q Consensus 739 Ei~ILk~L----~HpNIVkLig~~-~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~-aL~YLHs~n~G 812 (967)
|...+.++ +|.+-+.+-..+ ......+|||||++|++|.++........+ ...++.+++. .+..+|.. |
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~--g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD--G 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC--C
Confidence 55555544 222222222222 224457999999999999887643222222 2345555555 46788887 7
Q ss_pred eEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 813 IVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
++|+|++|.||+++.++.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.8e-11 Score=118.41 Aligned_cols=129 Identities=19% Similarity=0.098 Sum_probs=96.1
Q ss_pred eEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCcee-EEeeeeeccCceEEEEeecCCCc
Q 037068 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV-LFMGAVTRSPHFSILTEFLPRGS 775 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIV-kLig~~~~~~~l~LVmEy~~gGs 775 (967)
.+.|+.|.++.||+++..+..+++|....... ....+..|+.+++.+.+.+++ +++.+.. ...++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 36789999999999998899999998643321 123457799999988655544 4554433 34589999999987
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---CCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 776 LYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH---PTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 776 L~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n---~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+.... . ....++.+++.+|..||... .+++|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 75430 1 11345679999999999873 1369999999999999 6789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.9e-10 Score=134.01 Aligned_cols=144 Identities=17% Similarity=0.162 Sum_probs=92.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCC---------------------------CCh-----hhHHH
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQD---------------------------FSG-----DSLSQ 735 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~---------------------------~s~-----~~~~~ 735 (967)
...+|.. +.||.|++|.||+|+.+ |+.||||++...- .+. +..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456666 78999999999999773 8999999986431 000 01112
Q ss_pred ------HHHHHHHHHHc----CCCceeEEeeeeec-cCceEEEEeecCCCchhhhh--cCCCC---CCCHHHHHHHHHHH
Q 037068 736 ------FKCEAEIMLRL----RHPNVVLFMGAVTR-SPHFSILTEFLPRGSLYRLL--HRPNH---QLDERRRMRMALDV 799 (967)
Q Consensus 736 ------~~~Ei~ILk~L----~HpNIVkLig~~~~-~~~l~LVmEy~~gGsL~~lL--~~~~~---~Lse~~i~~I~~QI 799 (967)
+.+|...+.++ .+.+.+.+=.++.+ ....+|||||+.|+.|.++. ...+. .+.+..+..++.||
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 23333333333 23333333233322 44678999999999998753 22121 23344444555555
Q ss_pred HHHHHHHHhcCCCeEEeccCCCcEEEcCCC----eEEEEecccccccc
Q 037068 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNW----VVKVCDFGLSRIKH 843 (967)
Q Consensus 800 a~aL~YLHs~n~GIVHRDLKPsNILLd~~g----~VKLsDFGLAr~~~ 843 (967)
+ .. |++|+|+||.||+++.++ .++++|||++....
T Consensus 277 f-------~~--GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RD--GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hC--CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 34 899999999999999887 99999999986554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.1e-11 Score=131.24 Aligned_cols=198 Identities=23% Similarity=0.396 Sum_probs=141.0
Q ss_pred HHHcCCCceeEEeeeeecc-----CceEEEEeecCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeE
Q 037068 743 MLRLRHPNVVLFMGAVTRS-----PHFSILTEFLPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814 (967)
Q Consensus 743 Lk~L~HpNIVkLig~~~~~-----~~l~LVmEy~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIV 814 (967)
+..+-|.|||++..+|.+. ....++.|||..|+|..+|++. ...+....-.+|+.||+.||.|||+..|.|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4455799999999988653 3578899999999999999753 3457778888999999999999999999999
Q ss_pred EeccCCCcEEEcCCCeEEEEecccccccccCc-----cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCC
Q 037068 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-----LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS 889 (967)
Q Consensus 815 HRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-----~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk 889 (967)
|+++.-+.|++..+|.||+.---- ...+... .......+-++|.+||.=.....+..+|||+||+...||.-+.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 999999999999999999842211 1111110 0122234678999999877667788999999999999998775
Q ss_pred CC-CCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 890 VP-WKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 890 ~P-F~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.- -...........+. +... ..-...-+.++++|++-.|..||++.+++-|.
T Consensus 280 iq~tnseS~~~~ee~ia--~~i~---~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIA--NVII---GLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eccCCCcceeehhhhhh--hhee---eccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 42 22211111111110 0000 00112235689999999999999999998773
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.8e-11 Score=146.54 Aligned_cols=251 Identities=22% Similarity=0.262 Sum_probs=187.5
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
+..-.+.+.+.+-+-.|.++.++.++-. +...++|....... .....+.+..+-.++-.-++|.++....-+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 5556688889899999999999987553 33344443322111 11122333333333333456777776666666677
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.+|+++|+++++|...++... ..+......++..+.++++|||... +.|||++|.|+|+..+++.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999988643 5666777778889999999999874 8999999999999999999999998433210
Q ss_pred cC----c---------------------------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 037068 844 HT----Y---------------------------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPW 892 (967)
Q Consensus 844 ~~----~---------------------------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF 892 (967)
.. . .......+|+.|.+||.+.+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 0122345899999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhhc-cccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHH
Q 037068 893 KGLNPMQVVGAVGF-QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFA 940 (967)
Q Consensus 893 ~~~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ 940 (967)
....+.++...+.. ....+.-|...+++..+++...+..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999988876642 2223344567899999999999999999997654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.1e-11 Score=138.64 Aligned_cols=252 Identities=20% Similarity=0.195 Sum_probs=183.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeec---CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW---HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~---~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
....+|.++..||.|.|+.|++... .+..|++|.+.+.-.....-..-..|+.+...+ -|.+++.++..|......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3557889999999999999998743 356788887655433222222233456666555 588889888888888888
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-CeEEEEecccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIKH 843 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-g~VKLsDFGLAr~~~ 843 (967)
+|-.|||.++++...+. ....+++..++++..|++.++.++|+. .++|+|+||+||++.++ +..++.|||......
T Consensus 342 ~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~--~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSK--LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccch--hhhcccccccceeeccchhhhhccccccccccc
Confidence 89999999998876652 234578888999999999999999988 79999999999999875 889999999886422
Q ss_pred cCccCCCCCCCCCCcc--ChhccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 844 HTYLSSKSTAGTPEWM--APEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 844 ~~~~~~~~~~GT~~Ym--APE~l~g~~~s~ksDVWSLGvlL~ELlTGk~-PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.. ......+-+++ +++......+-.+.|+|+||..+.+.+++.. ++..... ........+.......+
T Consensus 419 ~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~------~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 FS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS------LTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred ee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc------eeeecccccCCCchHHh
Confidence 21 11122233444 5555666778889999999999999999864 3332221 11122233333444588
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
+..+...+...++..||.+.++..+...++..
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 88999999999999999999998887766544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.7e-09 Score=110.96 Aligned_cols=137 Identities=20% Similarity=0.153 Sum_probs=97.8
Q ss_pred EEeecCCceEEEEeecC--------CCeEEEEEeecCC---------------CC-----hhhHHH----HHHHHHHHHH
Q 037068 698 ERIGIGSYGEVYRADWH--------GTEVAVKKFLDQD---------------FS-----GDSLSQ----FKCEAEIMLR 745 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~--------g~~VAVKkl~~~~---------------~s-----~~~~~~----~~~Ei~ILk~ 745 (967)
..||.|--+.||.|... +..+|||++.... +. ...... ..+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999643 3689999875310 00 111222 3389999998
Q ss_pred cCC--CceeEEeeeeeccCceEEEEeecCCCchh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCeEEeccCCC
Q 037068 746 LRH--PNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYL-HTSHPTIVHRDLKSP 821 (967)
Q Consensus 746 L~H--pNIVkLig~~~~~~~l~LVmEy~~gGsL~-~lL~~~~~~Lse~~i~~I~~QIa~aL~YL-Hs~n~GIVHRDLKPs 821 (967)
+.. -++.+.+++ ...+|||||+.++.+. ..+++ ..+++.....+..+++.+|.+| |.. |+||+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~--glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKEC--NLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHH
Confidence 853 345566654 4578999999775442 22322 2355566777889999999999 777 7999999999
Q ss_pred cEEEcCCCeEEEEecccccccc
Q 037068 822 NLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 822 NILLd~~g~VKLsDFGLAr~~~ 843 (967)
|||++ ++.++|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.9e-09 Score=109.19 Aligned_cols=141 Identities=20% Similarity=0.217 Sum_probs=107.3
Q ss_pred EEeecCCceEEEEeecCC-CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCC--ceeEEeeeeecc---CceEEEEeec
Q 037068 698 ERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP--NVVLFMGAVTRS---PHFSILTEFL 771 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~g-~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~Hp--NIVkLig~~~~~---~~l~LVmEy~ 771 (967)
+.|+.|.++.||++...+ ..+++|........ .....+..|..+++.+.+. ++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999997765 78999986443211 2345678899999999653 356677776553 3678999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS------------------------------------------ 809 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~------------------------------------------ 809 (967)
+|.++...+.. ..+++.....++.+++++|.+||+.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888776532 3467777778888888888888842
Q ss_pred ------------CCCeEEeccCCCcEEEcC--CCeEEEEecccccc
Q 037068 810 ------------HPTIVHRDLKSPNLLVDK--NWVVKVCDFGLSRI 841 (967)
Q Consensus 810 ------------n~GIVHRDLKPsNILLd~--~g~VKLsDFGLAr~ 841 (967)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.7e-10 Score=109.08 Aligned_cols=58 Identities=19% Similarity=0.178 Sum_probs=48.0
Q ss_pred hhhcccccceecccCCCCChhhHhhHH-HHHhhhhccccccccCcccCCCCCcccCCccccccCCCCC
Q 037068 558 AEQHKKLEPNVINCDLSLSSDTAGERF-VLVGNELKLNNATSVNTVPVNPPGVVAGASCEKEIPGSPL 624 (967)
Q Consensus 558 ~~~~~~~~y~lvqCtpdls~~~c~~cl-~~i~~~~~~~~~~~~~~~~~~~ggrvlg~SC~~rye~~pf 624 (967)
.....++ |||+||++||++.+|..|| .++..++ .+|+.+.||+|+.++|.+||+.++|
T Consensus 48 ~~~~~~v-Ygl~qC~~Dls~~dC~~Cl~~a~~~~~--------~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 48 GSGPDTV-YGLAQCRGDLSPSDCRACLADAVANIS--------SCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp -ST---E-EEEEEE-TTS-HHHHHHHHHHHHCCHH--------HHTTSBSSEEEEESSEEEEEESS--
T ss_pred CCCCCeE-EEEEEcCCCCChhhhHHHHHHHHHHHH--------HhCCCCceEEEECCCEEEEEECCCC
Confidence 3356677 9999999999999999999 9999999 9999999999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7e-09 Score=107.17 Aligned_cols=132 Identities=22% Similarity=0.316 Sum_probs=100.3
Q ss_pred EEeecCCceEEEEeecCCCeEEEEEeecCCCChhh------HHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeec
Q 037068 698 ERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDS------LSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~------~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
..|++|+-..+|.+.+.|..+.+|.=..+.+-... .....+|.+++.+++--.|..-+=++.+.....|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35789999999999888888888765554443222 345778999999886555544343445666788999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+|..|.+++... . ..++..|=.-+.-||.. ||||+||.++||++..++ +.++||||+.
T Consensus 82 ~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~--givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 82 EGELLKDALEEA----R----PDLLREVGRLVGKLHKA--GIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred CChhHHHHHHhc----c----hHHHHHHHHHHHHHHhc--CeecCCCccceEEEeCCc-EEEEECCccc
Confidence 999999888763 1 34555566667779998 899999999999998765 9999999996
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.2e-08 Score=101.25 Aligned_cols=143 Identities=20% Similarity=0.259 Sum_probs=104.7
Q ss_pred EeEEeecCCceEEEEeecCCCeEEEEEeecCCCChh------hHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 696 IGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGD------SLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~------~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
....|-+|+-+.|+++.+.|+.+.||.-..+.+-.. ...+.++|++++.++.--.|.--.=++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 457789999999999999999988886544443222 23567889999998865455433334455556789999
Q ss_pred ecCC-CchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---eEEEEeccccc
Q 037068 770 FLPR-GSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---VVKVCDFGLSR 840 (967)
Q Consensus 770 y~~g-GsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---~VKLsDFGLAr 840 (967)
|+++ -++.+++.... ..........++.+|=..+.-||.+ +|||+||..+||++..++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n--diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN--DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC--CeecccccccceEEecCCCcCceEEEeecchh
Confidence 9977 36677765432 2233333367888899999999999 699999999999996443 56899999985
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2e-07 Score=107.95 Aligned_cols=210 Identities=17% Similarity=0.236 Sum_probs=153.1
Q ss_pred eEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec----cCceEEEEeecCC-Cchhh
Q 037068 706 GEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR----SPHFSILTEFLPR-GSLYR 778 (967)
Q Consensus 706 G~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~----~~~l~LVmEy~~g-GsL~~ 778 (967)
.+.|++.. +|..|++|++.-. ..........-+++++++.|.|||+|.++|.. +..+++|++|.++ ++|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~--r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGD--RDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccc--cccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 46788854 6888999988221 11111223345788999999999999998873 4468999999875 47766
Q ss_pred hhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 779 LLHR--------------PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 779 lL~~--------------~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+... .+...++..+|.++.||..||.++|+. |+..+-|.+.+||++.+..++|+-+|.......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss--GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS--GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc--CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5432 123478899999999999999999999 799999999999999988999999888776544
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCChhHH-HhhhhccccccCCCCCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGLNPMQV-VGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~-PF~~~~~~ei-~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
... |.+.. ..+-|.=.||.+++.|.||.. -|......+. ... +-...+.+++
T Consensus 446 d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D~r 499 (655)
T KOG3741|consen 446 DPT--------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTDLR 499 (655)
T ss_pred CCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHHHH
Confidence 320 11221 236799999999999999853 3433333322 112 2345788999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+++......++++ -++.+++.++
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHHH
Confidence 9999999999987 5777877764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.4e-07 Score=105.07 Aligned_cols=252 Identities=16% Similarity=0.212 Sum_probs=165.1
Q ss_pred eEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeee------eccC-ceEE
Q 037068 695 QIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAV------TRSP-HFSI 766 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~------~~~~-~l~L 766 (967)
..++.||+|+-+.+|-.-.-+.. +.|++...... ...+ -+..|.+. .||-+-.-+.|= -+.+ .+.+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa--~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPA--AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhch-hheeecCCCch--HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34677999999999966433333 34666543211 1111 12223332 455433212221 1122 2667
Q ss_pred EEeecCCCc-hhhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 767 LTEFLPRGS-LYRLLH-----RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 767 VmEy~~gGs-L~~lL~-----~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+|..+.+.. +..+++ +......|...++.++.|+.+...||.+ |.+-+|++++|+|+++++.|.|.|=..-.
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~--Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH--GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc--CCcccccCccceeeecCceEEEEccccee
Confidence 888777652 233332 1123478999999999999999999999 89999999999999999999998754322
Q ss_pred ccccCccCCCCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChh-----HHHhhhh----
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATL-SVPWKGLNPM-----QVVGAVG---- 905 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~-----ei~~~i~---- 905 (967)
.. .........+|...|.+||.-+ +..-+...|.|.||+++++++.| +.||.+.... -....|.
T Consensus 166 i~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 166 IN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred ec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 22 2233345567889999999854 33456778999999999999987 8999764321 0000110
Q ss_pred ----cccc-cc----CCC-CCCcHHHHHHHHHhhhc--CCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 906 ----FQNR-RL----EIP-DDIDPAVAQIIRDCWQT--EPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 906 ----~~~~-~~----~ip-~~ls~eL~dLI~~CLq~--dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
..+. .. .+| ..+++.+..|..+|+.. ++.-|||++.++..|..+++.++.
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 0111 11 122 35789999999999975 367899999999999999887764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.7e-07 Score=101.43 Aligned_cols=135 Identities=19% Similarity=0.120 Sum_probs=96.1
Q ss_pred CceEEEEeecCCCeEEEEEeecCCCCh---------hhHHHHHHHHHHHHHcCCCce--eEEeeeeec-----cCceEEE
Q 037068 704 SYGEVYRADWHGTEVAVKKFLDQDFSG---------DSLSQFKCEAEIMLRLRHPNV--VLFMGAVTR-----SPHFSIL 767 (967)
Q Consensus 704 ~FG~VYka~~~g~~VAVKkl~~~~~s~---------~~~~~~~~Ei~ILk~L~HpNI--VkLig~~~~-----~~~l~LV 767 (967)
....|+++...|+.+.||......... .....+.+|...+..|...+| .+.+.+... ...-+||
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334466777788889999764322110 011136788888888743333 234444432 2347899
Q ss_pred EeecCCC-chhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-------CCeEEEEeccc
Q 037068 768 TEFLPRG-SLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-------NWVVKVCDFGL 838 (967)
Q Consensus 768 mEy~~gG-sL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-------~g~VKLsDFGL 838 (967)
||++++. +|.+++... ....+......++.+|+..+.-||.. ||+|+|+++.|||++. +..+.|+||+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~--Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA--GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC--cCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 9999886 888887531 23456677788999999999999999 8999999999999975 46899999998
Q ss_pred cc
Q 037068 839 SR 840 (967)
Q Consensus 839 Ar 840 (967)
++
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 85
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.7e-07 Score=93.47 Aligned_cols=125 Identities=29% Similarity=0.257 Sum_probs=80.9
Q ss_pred EEEeec-CCCeEEEEEeecC---------------CC-------C--hhhHHHHHHHHHHHHHcCCC--ceeEEeeeeec
Q 037068 708 VYRADW-HGTEVAVKKFLDQ---------------DF-------S--GDSLSQFKCEAEIMLRLRHP--NVVLFMGAVTR 760 (967)
Q Consensus 708 VYka~~-~g~~VAVKkl~~~---------------~~-------s--~~~~~~~~~Ei~ILk~L~Hp--NIVkLig~~~~ 760 (967)
||.|.. .+..+|||+.... .+ . ........+|.+.|.++..- ++.+.+++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 788865 5778999987531 00 0 01134578899999999765 455666542
Q ss_pred cCceEEEEeecC--CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 761 SPHFSILTEFLP--RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL-HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 761 ~~~l~LVmEy~~--gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YL-Hs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
..+|||||+. |..+..+.... ++......++.+++..+..+ |.. ||||+||.+.|||++++ .+.|+|||
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~--givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA--GIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT--TEEESS-STTSEEEETT-CEEE--GT
T ss_pred --CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc--CceecCCChhhEEeecc-eEEEEecC
Confidence 3579999998 66665554321 11344566777888866664 666 89999999999999988 99999999
Q ss_pred ccccc
Q 037068 838 LSRIK 842 (967)
Q Consensus 838 LAr~~ 842 (967)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 88644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=7.1e-08 Score=114.93 Aligned_cols=148 Identities=18% Similarity=0.284 Sum_probs=108.3
Q ss_pred HHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc-CccCC--------CCCCCCCCccChhccccC
Q 037068 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH-TYLSS--------KSTAGTPEWMAPEVLRNE 867 (967)
Q Consensus 797 ~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~-~~~~~--------~~~~GT~~YmAPE~l~g~ 867 (967)
.+++.||.|+|..- ++||++|.|++|.++.++.+||+.|+.+..... ..... ....-...|.|||++.+.
T Consensus 106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 45559999999874 899999999999999999999999998754322 11000 011234579999999998
Q ss_pred CCCchhHHHHHHHHHHHHHhC-CCCCCCCChh--HHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHH
Q 037068 868 PANEKCDVYSFGVILWELATL-SVPWKGLNPM--QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944 (967)
Q Consensus 868 ~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~--ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe 944 (967)
..+.++|+||||+++|.+..| +.-+...... ..................+++++++=|.+++..++..||++.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 899999999999999999854 4444433221 1111111223344556789999999999999999999998777654
Q ss_pred H
Q 037068 945 R 945 (967)
Q Consensus 945 ~ 945 (967)
.
T Consensus 265 ~ 265 (700)
T KOG2137|consen 265 I 265 (700)
T ss_pred c
Confidence 3
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.2e-06 Score=92.20 Aligned_cols=106 Identities=28% Similarity=0.304 Sum_probs=81.9
Q ss_pred HHHHHHHHHHHHHcCCCce--eEEeeeeecc----CceEEEEeecCCC-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 037068 733 LSQFKCEAEIMLRLRHPNV--VLFMGAVTRS----PHFSILTEFLPRG-SLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805 (967)
Q Consensus 733 ~~~~~~Ei~ILk~L~HpNI--VkLig~~~~~----~~l~LVmEy~~gG-sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~Y 805 (967)
.....+|...+..|..-+| .+.+++.+.. ...+||+|++++. +|.+++..... ++......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 3467778888877743333 3455554432 2358999999874 79998875222 6677788899999999999
Q ss_pred HHhcCCCeEEeccCCCcEEEcCCC---eEEEEecccccc
Q 037068 806 LHTSHPTIVHRDLKSPNLLVDKNW---VVKVCDFGLSRI 841 (967)
Q Consensus 806 LHs~n~GIVHRDLKPsNILLd~~g---~VKLsDFGLAr~ 841 (967)
||++ ||+|+|+++.|||++.++ .+.++||+.++.
T Consensus 134 lH~~--gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDA--GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHC--cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 899999999999998887 999999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.7e-07 Score=77.93 Aligned_cols=54 Identities=22% Similarity=0.209 Sum_probs=46.3
Q ss_pred cccccchhhHHHHHHHhhhcCCceeEeeccccc---------cCCCCceEEEEcCCCceeeeec
Q 037068 273 LDVGLSRHRALLFKVLADRINLPCMLVKGSYYT---------GTDDGAVNLIKLDNGSEYIIDL 327 (967)
Q Consensus 273 l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~---------~~~~~a~~~v~~~~~~~~~~dl 327 (967)
-+.|.|.++|.||..++..+||||++|.|.+-. ....|+|++|.+ +++||.+|-
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~-~~~W~~~D~ 66 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYL-EGGWVPVDP 66 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEE-CCCeEEEeC
Confidence 467999999999999999999999999993221 246699999998 599999995
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.7e-05 Score=94.40 Aligned_cols=143 Identities=19% Similarity=0.173 Sum_probs=91.6
Q ss_pred EEeecCCceEEEEeecC-CCeEEEEEeecCC---------------------------CCh-hhH----HH------HHH
Q 037068 698 ERIGIGSYGEVYRADWH-GTEVAVKKFLDQD---------------------------FSG-DSL----SQ------FKC 738 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~---------------------------~s~-~~~----~~------~~~ 738 (967)
+.|+.++-|.||+|+.+ |+.||||+....- .+. ..+ +. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999886 8999999875310 110 001 11 223
Q ss_pred HHHHHHHc-----CCCceeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCe
Q 037068 739 EAEIMLRL-----RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813 (967)
Q Consensus 739 Ei~ILk~L-----~HpNIVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GI 813 (967)
|..-+.++ +.++|.---=++...+...|+|||++|..+.++.......++.+.+...+.++.--.-+- . |+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~--d--gf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR--D--GF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh--c--Cc
Confidence 33333333 123332111122334567899999999999888543345566555554444433322222 2 79
Q ss_pred EEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 814 VHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+|.|..|.||+++.+|.+.+.|||+......
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999865443
|
|
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.9e-07 Score=102.55 Aligned_cols=54 Identities=24% Similarity=0.527 Sum_probs=47.0
Q ss_pred ccccchhhHHHHHHHhhhcCCceeEeeccccccCC---------CCceEEEEcCCCceeeeeccCC
Q 037068 274 DVGLSRHRALLFKVLADRINLPCMLVKGSYYTGTD---------DGAVNLIKLDNGSEYIIDLMGA 330 (967)
Q Consensus 274 ~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~~---------~~a~~~v~~~~~~~~~~dlm~~ 330 (967)
-.+||..||.|||.||..+||||.+|+| |-|+. +||||.|++ |++||.||.--.
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIeg--f~k~~~~~~~~~~iNHaWN~Vki-D~~yy~VDtTwg 270 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEG--FLKSPIYYTRDININHAWNIVKI-DNEYYLVDTTWG 270 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEee--cccccccccCCccccceeeEEEE-CCeEEEEeeecC
Confidence 4689999999999999999999999999 64444 499999999 459999997643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.2e-06 Score=90.10 Aligned_cols=136 Identities=26% Similarity=0.227 Sum_probs=96.5
Q ss_pred eeEeEEeecCCceEEEEeec-CCCeEEEEEeecC------------------CCCh--hhHHHHHHHHHHHHHcCCC--c
Q 037068 694 LQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQ------------------DFSG--DSLSQFKCEAEIMLRLRHP--N 750 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~------------------~~s~--~~~~~~~~Ei~ILk~L~Hp--N 750 (967)
..+++.||.|--+.||.|.. +|.++|||.-... ..+. -......+|.++|..|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999977 5999999954210 0111 1234578899999998644 5
Q ss_pred eeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 751 IVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
+.+-+++ +...+||||++|-.|...-- +....-.++..|+.-+.-+-.. ||||+|+.+-||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~--GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRR--GIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHc--CccccCCchheEEEecCCC
Confidence 6666655 45789999999976655421 2333334445555555554444 8999999999999999999
Q ss_pred EEEEecccccc
Q 037068 831 VKVCDFGLSRI 841 (967)
Q Consensus 831 VKLsDFGLAr~ 841 (967)
+.++||-.+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976643
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.2e-06 Score=82.37 Aligned_cols=52 Identities=27% Similarity=0.329 Sum_probs=43.9
Q ss_pred cccccchhhHHHHHHHhhhcCCceeEeeccccccC------------CCCceEEEEcCCCceeeee
Q 037068 273 LDVGLSRHRALLFKVLADRINLPCMLVKGSYYTGT------------DDGAVNLIKLDNGSEYIID 326 (967)
Q Consensus 273 l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~------------~~~a~~~v~~~~~~~~~~d 326 (967)
-++|.|.++|.||..|+..+||||++|.| |.+. +.|+|++|.+.++.||.+|
T Consensus 49 ~~~G~C~~~a~l~~allr~~Gipar~v~g--~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D 112 (113)
T PF01841_consen 49 SGRGDCEDYASLFVALLRALGIPARVVSG--YVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD 112 (113)
T ss_dssp CEEESHHHHHHHHHHHHHHHT--EEEEEE--EEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred cCCCccHHHHHHHHHHHhhCCCceEEEEE--EcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence 35699999999999999999999999999 4442 2399999999889999998
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.6e-05 Score=84.68 Aligned_cols=139 Identities=14% Similarity=0.062 Sum_probs=102.1
Q ss_pred eecCCceEEEEeecCCCeEEEEEeecCC---CC-hhhHHHHHHHHHHHHHcCCCc--eeEEeeeee---cc--CceEEEE
Q 037068 700 IGIGSYGEVYRADWHGTEVAVKKFLDQD---FS-GDSLSQFKCEAEIMLRLRHPN--VVLFMGAVT---RS--PHFSILT 768 (967)
Q Consensus 700 LGeG~FG~VYka~~~g~~VAVKkl~~~~---~s-~~~~~~~~~Ei~ILk~L~HpN--IVkLig~~~---~~--~~l~LVm 768 (967)
-|.||-+-|++....|..+-+|.-...- .- +.....+.+|+..+.+|...+ +.+.+ ++. .. -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 3568999999998888888888764211 00 234567999999999885333 33444 222 11 2367999
Q ss_pred eecCC-CchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe--EEEEecccccc
Q 037068 769 EFLPR-GSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV--VKVCDFGLSRI 841 (967)
Q Consensus 769 Ey~~g-GsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~--VKLsDFGLAr~ 841 (967)
|-+.+ .+|.+++.+. -.+.+......++.+|+..+.-||+. |+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~--Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV--NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 4888887542 23457777789999999999999999 7999999999999986666 99999987653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.7e-05 Score=82.31 Aligned_cols=140 Identities=17% Similarity=0.192 Sum_probs=94.0
Q ss_pred hccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChh-hH------HHHHHHHHHHHHc---CCCceeEEeeee
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGD-SL------SQFKCEAEIMLRL---RHPNVVLFMGAV 758 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~-~~------~~~~~Ei~ILk~L---~HpNIVkLig~~ 758 (967)
+...+|.+.+.+-......|.+-...++.+.+|.........+ .. ....+.+..+..+ .-..+..++-+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4557899999998888888988888999999997654321111 01 1122333333333 333333333322
Q ss_pred e-----ccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEE
Q 037068 759 T-----RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKV 833 (967)
Q Consensus 759 ~-----~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKL 833 (967)
. -....+++|||++|..|.++.. +++ .+...|..++.-||+. |++|+|..|.|+++++++ +++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~--G~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH--GFYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc--CCccCCCCcCcEEEECCc-EEE
Confidence 2 2234679999999988876643 232 2445677889999999 899999999999998654 999
Q ss_pred Eeccccc
Q 037068 834 CDFGLSR 840 (967)
Q Consensus 834 sDFGLAr 840 (967)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.5e-05 Score=77.80 Aligned_cols=140 Identities=19% Similarity=0.231 Sum_probs=84.4
Q ss_pred eEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCC--ceeEEeeeeec---cCceEEEEeec
Q 037068 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP--NVVLFMGAVTR---SPHFSILTEFL 771 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~Hp--NIVkLig~~~~---~~~l~LVmEy~ 771 (967)
.+.|+.|..+.||++...++.+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999887789999985322 3456788899999888433 24566654322 33478999999
Q ss_pred CCCchhh----------------hhc---CC---CCCCCHHH---------HHH------------HHHHHHH-HHHHHH
Q 037068 772 PRGSLYR----------------LLH---RP---NHQLDERR---------RMR------------MALDVAK-GMNYLH 807 (967)
Q Consensus 772 ~gGsL~~----------------lL~---~~---~~~Lse~~---------i~~------------I~~QIa~-aL~YLH 807 (967)
++..+.. .+. .. ...+.... ... ....+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 111 11 11111100 000 0112222 344444
Q ss_pred h-----cCCCeEEeccCCCcEEEc-CCCeEEEEeccccc
Q 037068 808 T-----SHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSR 840 (967)
Q Consensus 808 s-----~n~GIVHRDLKPsNILLd-~~g~VKLsDFGLAr 840 (967)
+ ....++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 223699999999999999 66777899998774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.7e-05 Score=81.66 Aligned_cols=135 Identities=13% Similarity=0.165 Sum_probs=83.6
Q ss_pred EEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce--eEEeeeeeccCceEEEEeecCCCc
Q 037068 698 ERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV--VLFMGAVTRSPHFSILTEFLPRGS 775 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI--VkLig~~~~~~~l~LVmEy~~gGs 775 (967)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-++ .+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 35567788754321 23456889999998864433 567777777777889999999863
Q ss_pred -hhhhhc---------------------C---CCCCCCHHHHHHHHHH----------HHH-HHHHHH--hcCCCeEEec
Q 037068 776 -LYRLLH---------------------R---PNHQLDERRRMRMALD----------VAK-GMNYLH--TSHPTIVHRD 817 (967)
Q Consensus 776 -L~~lL~---------------------~---~~~~Lse~~i~~I~~Q----------Ia~-aL~YLH--s~n~GIVHRD 817 (967)
+...+. . ....+... ...+..+ +.. ...+|. ...+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 211111 1 00111110 0011000 111 122222 2223589999
Q ss_pred cCCCcEEEcCCCeEEEEeccccc
Q 037068 818 LKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 818 LKPsNILLd~~g~VKLsDFGLAr 840 (967)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.96 E-value=8e-05 Score=79.65 Aligned_cols=137 Identities=22% Similarity=0.201 Sum_probs=84.7
Q ss_pred EeecCCc-eEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEEEeecCCCch
Q 037068 699 RIGIGSY-GEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSILTEFLPRGSL 776 (967)
Q Consensus 699 ~LGeG~F-G~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LVmEy~~gGsL 776 (967)
.|-.|.. ..||+....+..+.||...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 7899997766778888754321 335677999988884 33455788877766678999999999877
Q ss_pred hhhhc-------------------CC---CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----
Q 037068 777 YRLLH-------------------RP---NHQLDER--RRMRMAL--------------------DVAKGMNYLHT---- 808 (967)
Q Consensus 777 ~~lL~-------------------~~---~~~Lse~--~i~~I~~--------------------QIa~aL~YLHs---- 808 (967)
..... .. ...+... ....... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 64321 00 0011100 0000000 01111222211
Q ss_pred -cCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 809 -SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 809 -~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12469999999999999998888999998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=6.3e-06 Score=97.77 Aligned_cols=180 Identities=21% Similarity=0.198 Sum_probs=133.2
Q ss_pred EEeecCCceEEEEeecCC-CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc-eeEEeeeeeccCceEEEEeecCCC-
Q 037068 698 ERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN-VVLFMGAVTRSPHFSILTEFLPRG- 774 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~g-~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN-IVkLig~~~~~~~l~LVmEy~~gG- 774 (967)
...++|++++++|.+... +....+.+... ....-++++|.+++||| .+..++-+..+....++++|+.++
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 446799999999987643 33334433211 33445789999999999 677777777788899999999887
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCC
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG 854 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~G 854 (967)
+-...+......+.......+.+.-+++++|||+.. =+||| ||+.++ +..|..||+....+.... ..+...+
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~ 392 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIG 392 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-ccccCCC
Confidence 332222222333555556667777888999999863 48998 777765 688999999987766554 4667889
Q ss_pred CCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 037068 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPW 892 (967)
Q Consensus 855 T~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF 892 (967)
|+.|++||+.....+..+.|+|++++--.++--|.+|-
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 99999999999999999999999998777777776663
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00015 Score=86.62 Aligned_cols=141 Identities=21% Similarity=0.190 Sum_probs=90.4
Q ss_pred EEeecCCceEEEEeecC-CCeEEEEEeecCC------------------------CC-----hhhHHH------HHHHHH
Q 037068 698 ERIGIGSYGEVYRADWH-GTEVAVKKFLDQD------------------------FS-----GDSLSQ------FKCEAE 741 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~------------------------~s-----~~~~~~------~~~Ei~ 741 (967)
+.||.-+.|.||+|+.+ |..||||+-...- ++ .+..+. |.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 57999999999999874 7779999764310 00 000111 233333
Q ss_pred HHHH----cCCCc------eeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037068 742 IMLR----LRHPN------VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811 (967)
Q Consensus 742 ILk~----L~HpN------IVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~ 811 (967)
-..+ +.|-+ |.+++-. ......|+||||+|..+.++-.-....++...+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~---- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT---- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc----
Confidence 3322 33444 2233222 234578999999999887764433456777766665555444333333
Q ss_pred CeEEeccCCCcEEEc----CCCeEEEEeccccccccc
Q 037068 812 TIVHRDLKSPNLLVD----KNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 812 GIVHRDLKPsNILLd----~~g~VKLsDFGLAr~~~~ 844 (967)
|++|+|=.|.||++. .++.+.+.|||+.....+
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 799999999999998 367999999999875443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00077 Score=70.55 Aligned_cols=100 Identities=19% Similarity=0.216 Sum_probs=79.9
Q ss_pred HHHHHHHHcCC-CceeEEeeeeeccCceEEEEeecCCCchhhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-
Q 037068 738 CEAEIMLRLRH-PNVVLFMGAVTRSPHFSILTEFLPRGSLYRL---LHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT- 812 (967)
Q Consensus 738 ~Ei~ILk~L~H-pNIVkLig~~~~~~~l~LVmEy~~gGsL~~l---L~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~G- 812 (967)
+|..+++.+.+ +++.+++|.|. .++|.||...+++... +.+ -...+|..+.+|+.++++.+++|+....|
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888865 69999999984 4689999987766432 111 12368999999999999999999874333
Q ss_pred eEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 813 IVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
+...|++++|+-+++++++|++|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999977543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00095 Score=84.37 Aligned_cols=144 Identities=19% Similarity=0.257 Sum_probs=90.4
Q ss_pred eEEeecCCceEEEEeecCC----CeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCce--eEEeeeeecc---CceEE
Q 037068 697 GERIGIGSYGEVYRADWHG----TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNV--VLFMGAVTRS---PHFSI 766 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g----~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNI--VkLig~~~~~---~~l~L 766 (967)
.+.|+.|.+..+|+.+..+ ..+++|+...... ......+.+|.++++.+. |.+| .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 5778999999999886643 3677777543221 112346789999999995 6665 6778777654 46889
Q ss_pred EEeecCCCchhh--------------------hh---cCCC----------CC--CCHHHHHHHHH--------------
Q 037068 767 LTEFLPRGSLYR--------------------LL---HRPN----------HQ--LDERRRMRMAL-------------- 797 (967)
Q Consensus 767 VmEy~~gGsL~~--------------------lL---~~~~----------~~--Lse~~i~~I~~-------------- 797 (967)
||||++|..+.+ .+ +... .. .-...+..|..
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999998764321 01 1100 00 00112222211
Q ss_pred -HHHHHHHHHHhcC---------CCeEEeccCCCcEEEcC--CCeEEEEecccccc
Q 037068 798 -DVAKGMNYLHTSH---------PTIVHRDLKSPNLLVDK--NWVVKVCDFGLSRI 841 (967)
Q Consensus 798 -QIa~aL~YLHs~n---------~GIVHRDLKPsNILLd~--~g~VKLsDFGLAr~ 841 (967)
.+...+++|..+- +.+||+|+++.|||++. ...+-|.||+++..
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 1233456775422 25999999999999974 23467999999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00038 Score=75.65 Aligned_cols=148 Identities=22% Similarity=0.149 Sum_probs=92.7
Q ss_pred hccCCeeEeEEe---ecCCceEEEEeec-CCCeEEEEEeecCCCChh-----------------hHHH-----HHHHHHH
Q 037068 689 ILWEDLQIGERI---GIGSYGEVYRADW-HGTEVAVKKFLDQDFSGD-----------------SLSQ-----FKCEAEI 742 (967)
Q Consensus 689 i~~e~y~i~k~L---GeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~-----------------~~~~-----~~~Ei~I 742 (967)
.+.++..+.... ..|--..||+|.. .+..+|||++........ ...+ ...|..-
T Consensus 42 ~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~N 121 (268)
T COG1718 42 RLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRN 121 (268)
T ss_pred HHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHH
Confidence 344555555554 4555567999865 588999999864211100 0000 2345555
Q ss_pred HHHcC--CCceeEEeeeeeccCceEEEEeecCCCc-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccC
Q 037068 743 MLRLR--HPNVVLFMGAVTRSPHFSILTEFLPRGS-LYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK 819 (967)
Q Consensus 743 Lk~L~--HpNIVkLig~~~~~~~l~LVmEy~~gGs-L~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLK 819 (967)
|+++. +-.+.+-+.+. .-.|||||+.... -.-.|+. ..+....+..+..++++.+.-|-... ++||+||.
T Consensus 122 L~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a-~LVHgDLS 194 (268)
T COG1718 122 LKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEA-GLVHGDLS 194 (268)
T ss_pred HHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhc-Ccccccch
Confidence 55552 22233333332 2469999996541 1112222 23344467788889999998887632 79999999
Q ss_pred CCcEEEcCCCeEEEEeccccccccc
Q 037068 820 SPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 820 PsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
.=|||+. ++.+.|+|||.|....+
T Consensus 195 EyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 195 EYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred hhheEEE-CCeEEEEECccccccCC
Confidence 9999999 88999999999875543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00067 Score=70.47 Aligned_cols=132 Identities=22% Similarity=0.230 Sum_probs=90.6
Q ss_pred eeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCcee-EEeeeeeccCceEEEEeecC
Q 037068 694 LQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV-LFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIV-kLig~~~~~~~l~LVmEy~~ 772 (967)
..+.+.|++|++|.||++.+.+..+|+|+-.. +.....+..|.+++..+.-.++. ++|.+-. -++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence 34567899999999999999999999998533 34456788899999999776664 4444422 345699999
Q ss_pred CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccC-CCcEEEcCCCeEEEEecccccccc
Q 037068 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK-SPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 773 gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLK-PsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
|-.|...... .+.+++..++ ..---|... ||-|.-|. |...+|..++.+.|+||.-|+...
T Consensus 96 G~~L~~~~~~----~~rk~l~~vl----E~a~~LD~~--GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 96 GRPLGKLEIG----GDRKHLLRVL----EKAYKLDRL--GIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred Ccchhhhhhc----ccHHHHHHHH----HHHHHHHHh--ccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 9888776542 1344444433 332233333 77777774 454555555599999999887443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.001 Score=71.18 Aligned_cols=73 Identities=18% Similarity=0.175 Sum_probs=45.4
Q ss_pred EEeecCCce-EEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCC---ceeEEeeeeecc---CceEEEEee
Q 037068 698 ERIGIGSYG-EVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP---NVVLFMGAVTRS---PHFSILTEF 770 (967)
Q Consensus 698 k~LGeG~FG-~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~Hp---NIVkLig~~~~~---~~l~LVmEy 770 (967)
+.|+.|+.. .||+. +..+++|.... ......+.+|.++++.+... -+.+.++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSA----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCc----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777776 58876 34567775332 11244788899999888532 234444443332 235889999
Q ss_pred cCCCchh
Q 037068 771 LPRGSLY 777 (967)
Q Consensus 771 ~~gGsL~ 777 (967)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0024 Score=67.88 Aligned_cols=128 Identities=30% Similarity=0.435 Sum_probs=91.4
Q ss_pred cCCeeEeEEeecCCc-eEEEEeecCCCeEEEEEeecCC----------CCh---------hhHHHHHHHHHHHHHc---C
Q 037068 691 WEDLQIGERIGIGSY-GEVYRADWHGTEVAVKKFLDQD----------FSG---------DSLSQFKCEAEIMLRL---R 747 (967)
Q Consensus 691 ~e~y~i~k~LGeG~F-G~VYka~~~g~~VAVKkl~~~~----------~s~---------~~~~~~~~Ei~ILk~L---~ 747 (967)
..+++..+.||.|.- |.||+++..|+.+|+|.+..-. ... ....-|..|.+...+| +
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 378999999999999 9999999999999999943211 000 1123477888887776 4
Q ss_pred CCce--eEEeeeeecc------------------CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037068 748 HPNV--VLFMGAVTRS------------------PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807 (967)
Q Consensus 748 HpNI--VkLig~~~~~------------------~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLH 807 (967)
+.++ |+.+||..-. ....||.||..... .+.. .-+.+|.+-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHH
Confidence 5566 8899887322 12457888775532 1222 34557777888899
Q ss_pred hcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 808 s~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
.. ||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~--gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KL--GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HC--CeeeccCcccccc-----CCEEEecccC
Confidence 98 8999999999986 3478899864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.001 Score=84.07 Aligned_cols=201 Identities=18% Similarity=0.208 Sum_probs=143.0
Q ss_pred hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc----eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 037068 731 DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH----FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806 (967)
Q Consensus 731 ~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~----l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YL 806 (967)
..+.....|+..+.++.|+|++.++.|-..... ..+..+|+..-++...+.. -...+....+.+..++..||.|+
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHH
Confidence 344556678888889999999999988655332 3355678888888887765 45678888899999999999999
Q ss_pred HhcCCCeEEeccCCC---cEEEcCCCeEEEE--ecccccccccCccCCCCCCCCCCccChhccccCCCCch--hHHHHHH
Q 037068 807 HTSHPTIVHRDLKSP---NLLVDKNWVVKVC--DFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK--CDVYSFG 879 (967)
Q Consensus 807 Hs~n~GIVHRDLKPs---NILLd~~g~VKLs--DFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~k--sDVWSLG 879 (967)
|+.+ ..|.-|..+ +...+..+.+.++ ||+.+....+... ......+..|.++|......+..+ .|+|.+|
T Consensus 303 h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 303 HSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred HHhc--cceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhhhhhHHHHHH
Confidence 9984 555555555 4445566777777 8988876655433 233445667888888876665544 7999999
Q ss_pred HHHHHHHhCCCCCCCCC-hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 880 VILWELATLSVPWKGLN-PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 880 vlL~ELlTGk~PF~~~~-~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.....+..|..+-.... +... .+......+.+++.+|+..++++|+++.+++.+..
T Consensus 380 ll~~~~~~~~~i~~~~~~~~~~------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVPVSL------------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred HHHhhhhhcCcccccccchhhh------------hccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 99999988765422111 1100 11112227888999999999999999999999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0035 Score=66.39 Aligned_cols=129 Identities=19% Similarity=0.231 Sum_probs=89.2
Q ss_pred EEeecCCceEEEEeecCCCeEEEEEeecCC--------------CChhhHHHHHHHHHHHHHcC------CCceeEEeee
Q 037068 698 ERIGIGSYGEVYRADWHGTEVAVKKFLDQD--------------FSGDSLSQFKCEAEIMLRLR------HPNVVLFMGA 757 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~g~~VAVKkl~~~~--------------~s~~~~~~~~~Ei~ILk~L~------HpNIVkLig~ 757 (967)
..||+|+.=.||.--. +...+||+..... .......+..+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 5689999999996542 3345678765543 11223456667777776665 7889999999
Q ss_pred eeccCceEEEEeecCC------CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---C
Q 037068 758 VTRSPHFSILTEFLPR------GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---N 828 (967)
Q Consensus 758 ~~~~~~l~LVmEy~~g------GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~---~ 828 (967)
.+++..+.+|+|.+.. -+|.+++.+ ..+++ .....+.+ -.+||-++ .|+.+||+|.||++.. +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L~~---f~~~l~~~--~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQALDE---FKRYLLDH--HIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHHHH---HHHHHHHc--CCeecCCCcccEEEEecCCC
Confidence 9999889999998642 267777754 34555 44444444 44566666 4999999999999953 2
Q ss_pred C-eEEEEe
Q 037068 829 W-VVKVCD 835 (967)
Q Consensus 829 g-~VKLsD 835 (967)
. .+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 2 677777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0043 Score=69.29 Aligned_cols=80 Identities=16% Similarity=-0.017 Sum_probs=57.0
Q ss_pred CeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC---CceeEEeeeeec---cCceEE
Q 037068 693 DLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH---PNVVLFMGAVTR---SPHFSI 766 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H---pNIVkLig~~~~---~~~l~L 766 (967)
...-.+.||.|..+.||+....+..+.+|..+. . .....+..|...++.|.. -.+.++++++.. .+..+|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 344457799999999999876555667776322 1 123467889999988843 356788877654 366899
Q ss_pred EEeecCCCch
Q 037068 767 LTEFLPRGSL 776 (967)
Q Consensus 767 VmEy~~gGsL 776 (967)
|||+++++++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.22 E-value=7.1e-05 Score=95.52 Aligned_cols=202 Identities=13% Similarity=0.041 Sum_probs=133.6
Q ss_pred HHHHHHHHHHcCCCceeEEeeeeec--cCceEEEEeecCCCchhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 037068 736 FKCEAEIMLRLRHPNVVLFMGAVTR--SPHFSILTEFLPRGSLYRLLHRPN---HQLDERRRMRMALDVAKGMNYLHTSH 810 (967)
Q Consensus 736 ~~~Ei~ILk~L~HpNIVkLig~~~~--~~~l~LVmEy~~gGsL~~lL~~~~---~~Lse~~i~~I~~QIa~aL~YLHs~n 810 (967)
...|...++...|+++.....-... ....+++++|+.+|.+...+-+.- ..++..-+.....+.+....-.|+.+
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3444445556689888765554332 345789999999999999886532 22333444444444466666666532
Q ss_pred -C--CeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh
Q 037068 811 -P--TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT 887 (967)
Q Consensus 811 -~--GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT 887 (967)
. -.+|++||+.|.+|..+-.+|+.++|+.+.............+++.|+.|++.+.-.++.++|+|..|+.+|+..-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 1 2799999999999999999999999999955544444556778899999999988889999999999999999988
Q ss_pred CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcC
Q 037068 888 LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPS 938 (967)
Q Consensus 888 Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS 938 (967)
|..+|...........+ .......++...|.+.-.....+|-+.-..||.
T Consensus 1436 ~n~~fi~flq~~Lkgii-dn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1436 GNAYFIFFLQPALKGII-DNHTFFSIEKLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred ccHHHHHHHHHHHcCcc-cccccccccccCCCcccHHHHHHHHHHhhhcch
Confidence 88777544332222222 233334444444444333333333333344554
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0018 Score=71.21 Aligned_cols=139 Identities=19% Similarity=0.124 Sum_probs=85.3
Q ss_pred eEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc--eeEEeee------eeccCceEEEE
Q 037068 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--VVLFMGA------VTRSPHFSILT 768 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN--IVkLig~------~~~~~~l~LVm 768 (967)
.+.|..|....+|+....+..+++|+... .....+..|+.++..|.+.+ +.+++.. ...++..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45677787789999877777888997643 12345677888888884332 4444432 12345678999
Q ss_pred eecCCCchhh----hh----------cC--CC--C------CCCHHHH----------HHHHHHHHHHHHHHHh-----c
Q 037068 769 EFLPRGSLYR----LL----------HR--PN--H------QLDERRR----------MRMALDVAKGMNYLHT-----S 809 (967)
Q Consensus 769 Ey~~gGsL~~----lL----------~~--~~--~------~Lse~~i----------~~I~~QIa~aL~YLHs-----~ 809 (967)
+|++|..+.. .+ +. .. . ...+... ......+..++.++.. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 11 00 00 0 0011000 0011123334455443 1
Q ss_pred CCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 810 n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
..+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2379999999999999998888999998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0067 Score=64.35 Aligned_cols=73 Identities=15% Similarity=0.190 Sum_probs=47.0
Q ss_pred eEEeecCCceEEEEeecC---CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeeeeccCceEEEEeecC
Q 037068 697 GERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-VLFMGAVTRSPHFSILTEFLP 772 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~---g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-VkLig~~~~~~~l~LVmEy~~ 772 (967)
.+.|..|-...+|++... +..|++|+..... ...-...+|+.+++.+...++ .+++..+. -.++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeC
Confidence 356777888899998765 4678888654321 111233568889888854333 45554432 248999999
Q ss_pred CCch
Q 037068 773 RGSL 776 (967)
Q Consensus 773 gGsL 776 (967)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0055 Score=66.31 Aligned_cols=134 Identities=16% Similarity=0.111 Sum_probs=77.0
Q ss_pred eecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeeeeccCceEEEEeecCCCchhh
Q 037068 700 IGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-VLFMGAVTRSPHFSILTEFLPRGSLYR 778 (967)
Q Consensus 700 LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-VkLig~~~~~~~l~LVmEy~~gGsL~~ 778 (967)
+..|-...+|+....+..+++|...... ....-...+|..+++.+...++ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4557777899888777788888643221 1110134678889988854333 34444332 368999999876542
Q ss_pred h--------------h---cC---CCCCCCHH-HHHHHHHHH---------HHHHHHHHhc------CCCeEEeccCCCc
Q 037068 779 L--------------L---HR---PNHQLDER-RRMRMALDV---------AKGMNYLHTS------HPTIVHRDLKSPN 822 (967)
Q Consensus 779 l--------------L---~~---~~~~Lse~-~i~~I~~QI---------a~aL~YLHs~------n~GIVHRDLKPsN 822 (967)
. + +. ....++.. .+..+..++ ...+..+-.. .+.++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1 11 01112221 111221111 1112222111 2358999999999
Q ss_pred EEEcCCCeEEEEeccccc
Q 037068 823 LLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 823 ILLd~~g~VKLsDFGLAr 840 (967)
|+++.++ ++|+||..+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999877 7899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.015 Score=64.95 Aligned_cols=139 Identities=15% Similarity=0.114 Sum_probs=77.6
Q ss_pred eEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc--eeEEee------eeeccCceEEEE
Q 037068 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--VVLFMG------AVTRSPHFSILT 768 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN--IVkLig------~~~~~~~l~LVm 768 (967)
.+.|+.|....+|+.+..+..+++|++. ... .+.+..|+.+++.|...+ +.+.+. +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec--cCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 3457777778999987766688899764 122 233445666666663222 233332 112345678999
Q ss_pred eecCCCchhh-----------hhc---C--CC------C--CCCH-HHHHH------------HHHH-HHHHHHHHHh--
Q 037068 769 EFLPRGSLYR-----------LLH---R--PN------H--QLDE-RRRMR------------MALD-VAKGMNYLHT-- 808 (967)
Q Consensus 769 Ey~~gGsL~~-----------lL~---~--~~------~--~Lse-~~i~~------------I~~Q-Ia~aL~YLHs-- 808 (967)
+|++|..+.. .+. . .. . .+.+ ..... .+.+ +...++.+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 9998874321 111 0 00 0 0101 11110 1111 1112233321
Q ss_pred ---cCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 809 ---SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 809 ---~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
...++||+|+.|.||+++.+...-|+||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 22479999999999999977666899999875
|
|
| >PF04473 DUF553: Transglutaminase-like domain; InterPro: IPR007562 This entry represents a transglutaminase-like domain found in a family of uncharacterised archaeal proteins that had previously been called DUF553 and UPF0252 | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0021 Score=65.38 Aligned_cols=55 Identities=18% Similarity=0.257 Sum_probs=45.0
Q ss_pred ecccccchhhHHHHHHHhhhcCCceeEeeccccccCCCCceEEEEcCCCceeeeec
Q 037068 272 CLDVGLSRHRALLFKVLADRINLPCMLVKGSYYTGTDDGAVNLIKLDNGSEYIIDL 327 (967)
Q Consensus 272 ~l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~~~~a~~~v~~~~~~~~~~dl 327 (967)
..++|+|+.||+|...|--.+|+.-.-|-+--|.+..+|||+.|++ ||.+|++|-
T Consensus 72 ~~k~GiC~DYA~Lta~lLl~~g~~~~yi~~~~~~~~~~Haa~aV~i-ng~~yvlDq 126 (153)
T PF04473_consen 72 KYKKGICGDYAILTAALLLNMGYSPVYILHIEFDNDPGHAAVAVKI-NGKYYVLDQ 126 (153)
T ss_pred HcCCeeeHHHHHHHHHHHHHCCCCceEEEEEecCCCCCeEEEEEEE-CCEEEEEeC
Confidence 3578999999999999999999855333354455555899999999 999999994
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.018 Score=64.12 Aligned_cols=142 Identities=20% Similarity=0.183 Sum_probs=83.1
Q ss_pred eEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc--eeEEeee------eeccCceEE
Q 037068 695 QIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--VVLFMGA------VTRSPHFSI 766 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN--IVkLig~------~~~~~~l~L 766 (967)
...+.++.|....+|+.+..+..+++|+.... . ....+..|..++..|...+ +.+++.. ....+..++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~-~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTTDVGRYILTLYEKR-V---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred eeccccCCccccceEEEEeCCCcEEEEEecCC-C---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 33566777777899998766667888875432 1 1334556777777774222 3444432 122456789
Q ss_pred EEeecCCCchhh-----------hh---cCCCCC----------CC-HHHHH------------HHHHHHHHHHHHHHh-
Q 037068 767 LTEFLPRGSLYR-----------LL---HRPNHQ----------LD-ERRRM------------RMALDVAKGMNYLHT- 808 (967)
Q Consensus 767 VmEy~~gGsL~~-----------lL---~~~~~~----------Ls-e~~i~------------~I~~QIa~aL~YLHs- 808 (967)
+++|++|..+.. .+ +..... +. +.... .....+...++++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 999998865321 01 110000 00 00000 011123345555542
Q ss_pred ----cCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 809 ----SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 809 ----~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
..++++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23489999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG1305 Transglutaminase-like enzymes, putative cysteine proteases [Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.003 Score=69.16 Aligned_cols=51 Identities=25% Similarity=0.307 Sum_probs=43.4
Q ss_pred cccchhhHHHHHHHhhhcCCceeEeeccccccCC--------------CCceEEEEcCCCceeeeec
Q 037068 275 VGLSRHRALLFKVLADRINLPCMLVKGSYYTGTD--------------DGAVNLIKLDNGSEYIIDL 327 (967)
Q Consensus 275 ~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~~--------------~~a~~~v~~~~~~~~~~dl 327 (967)
.|+|+|.|-||=.||..+|||||+|.| |+... .|+|.+|.+....|+-+|-
T Consensus 194 ~G~C~d~a~l~val~Ra~GIpAR~V~G--y~~~~~~~~~~~~~~~~~~~Haw~ev~~~~~gW~~~Dp 258 (319)
T COG1305 194 RGVCRDFAHLLVALLRAAGIPARYVSG--YLGAEVEPLSGRPLVRNDDAHAWAEVYLPGRGWVPLDP 258 (319)
T ss_pred CcccccHHHHHHHHHHHcCCcceeeec--cccCCCCcccccccccCcccceeeeeecCCCccEeecC
Confidence 899999999999999999999999999 54333 2999999994446888873
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.021 Score=63.12 Aligned_cols=136 Identities=21% Similarity=0.254 Sum_probs=79.2
Q ss_pred EEeecCCceEEEEeecC--------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeeeeccCceEEEE
Q 037068 698 ERIGIGSYGEVYRADWH--------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-VLFMGAVTRSPHFSILT 768 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~--------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-VkLig~~~~~~~l~LVm 768 (967)
+.|..|-...+|+.+.. ++.+++|+..... .......+|.++++.+...++ .++++.+. + .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence 44555666688888654 3678888854321 122345778888888854333 35555553 2 3589
Q ss_pred eecCCCchhhh-h----------------cCCCCC--------CC--HHHHHH--------------------------H
Q 037068 769 EFLPRGSLYRL-L----------------HRPNHQ--------LD--ERRRMR--------------------------M 795 (967)
Q Consensus 769 Ey~~gGsL~~l-L----------------~~~~~~--------Ls--e~~i~~--------------------------I 795 (967)
||++|..+... + +..... .+ +..+.. +
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99888766431 1 010000 01 001100 1
Q ss_pred HHHHHHHHHHHHh-------cCCCeEEeccCCCcEEEcCC----CeEEEEeccccc
Q 037068 796 ALDVAKGMNYLHT-------SHPTIVHRDLKSPNLLVDKN----WVVKVCDFGLSR 840 (967)
Q Consensus 796 ~~QIa~aL~YLHs-------~n~GIVHRDLKPsNILLd~~----g~VKLsDFGLAr 840 (967)
...+...+++|.. ...+++|+|+.+.|||++.+ +.++++||..+.
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 1222233444432 23479999999999999874 889999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.048 Score=62.31 Aligned_cols=135 Identities=17% Similarity=0.243 Sum_probs=75.8
Q ss_pred EeecCCceEEEEeecC------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeeeeccCceEEEEeec
Q 037068 699 RIGIGSYGEVYRADWH------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-VLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-VkLig~~~~~~~l~LVmEy~ 771 (967)
.|-.|-.-.+|++... ++.+++|+..... ...+ ...+|..+++.+...++ .++++.+..+ .|.+|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3434666677777532 3568888754321 2222 23678899888865444 3566665332 579999
Q ss_pred CCCchhhh-h----------------cCCC---C--CCCHHHHHHHHHHH-----------------HHHHHHHH----h
Q 037068 772 PRGSLYRL-L----------------HRPN---H--QLDERRRMRMALDV-----------------AKGMNYLH----T 808 (967)
Q Consensus 772 ~gGsL~~l-L----------------~~~~---~--~Lse~~i~~I~~QI-----------------a~aL~YLH----s 808 (967)
++.+|... + +... . ...+..+..+..++ ...+..|. .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87666421 0 1101 0 11122232332221 11122222 1
Q ss_pred --cCCCeEEeccCCCcEEEcC-CCeEEEEeccccc
Q 037068 809 --SHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSR 840 (967)
Q Consensus 809 --~n~GIVHRDLKPsNILLd~-~g~VKLsDFGLAr 840 (967)
....++|+|+++.|||+++ ++.++++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1236999999999999986 4789999998875
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.1 Score=60.96 Aligned_cols=77 Identities=22% Similarity=0.078 Sum_probs=52.8
Q ss_pred eEEeecCCceEEEEeecCC--CeEEEEEeecCC----CC-hhhHHHHHHHHHHHHHcC---CCceeEEeeeeeccCceEE
Q 037068 697 GERIGIGSYGEVYRADWHG--TEVAVKKFLDQD----FS-GDSLSQFKCEAEIMLRLR---HPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g--~~VAVKkl~~~~----~s-~~~~~~~~~Ei~ILk~L~---HpNIVkLig~~~~~~~l~L 766 (967)
.+.||.|.+..||++...+ +.++||.-.... .. ....+....|.+.|+.+. -.++.+++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 3679999999999998754 379999753211 00 224566777888888762 24566777663 355789
Q ss_pred EEeecCCCc
Q 037068 767 LTEFLPRGS 775 (967)
Q Consensus 767 VmEy~~gGs 775 (967)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.059 Score=61.90 Aligned_cols=143 Identities=20% Similarity=0.226 Sum_probs=95.0
Q ss_pred EeEEeecCCceEEEEeec-CCCeEEEEEeecC-----------------------CCChhhHHH-HHHHHHHHHHcCCCc
Q 037068 696 IGERIGIGSYGEVYRADW-HGTEVAVKKFLDQ-----------------------DFSGDSLSQ-FKCEAEIMLRLRHPN 750 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~-----------------------~~s~~~~~~-~~~Ei~ILk~L~HpN 750 (967)
+-..|..|--..||.|.. .|..+|||+++.. ......+.. ...|++-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345677888889999966 5888999987531 001111221 456777788876555
Q ss_pred eeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 751 IVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
|.----+.. ....|||+|+.... .-.-.-....++...+..+-.|++.-|.-|-+.. ++||.||.--|+|+. +|.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdg-w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c-~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDG-WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC-RLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCC-CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh-ceeccchhhhhheEE-CCE
Confidence 431111111 13479999985321 1111112456778889999999999999997654 799999999999995 468
Q ss_pred EEEEecccccccc
Q 037068 831 VKVCDFGLSRIKH 843 (967)
Q Consensus 831 VKLsDFGLAr~~~ 843 (967)
+.|+|.+.+.-.+
T Consensus 303 lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 303 LYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEccccccCC
Confidence 9999999886443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.11 Score=59.08 Aligned_cols=147 Identities=18% Similarity=0.209 Sum_probs=84.2
Q ss_pred eEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc--eeEEeeeeeccC--ceEEEEee
Q 037068 695 QIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--VVLFMGAVTRSP--HFSILTEF 770 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN--IVkLig~~~~~~--~l~LVmEy 770 (967)
.+.+.+-.|..-.+|....+++.+++. .+.............+|..+++.+.--- +...++.|..+. ..+.||+|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred ceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 344445344444556555557778777 3322223344566778899998875322 234555555544 67999999
Q ss_pred cCCCchhhhhcCC-----------------------------C--CCCCHHHHHHHHH--------------HHHHHHHH
Q 037068 771 LPRGSLYRLLHRP-----------------------------N--HQLDERRRMRMAL--------------DVAKGMNY 805 (967)
Q Consensus 771 ~~gGsL~~lL~~~-----------------------------~--~~Lse~~i~~I~~--------------QIa~aL~Y 805 (967)
+.|..+...+... . .......+..+.. ....-..|
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 9884322211100 0 0000111111111 12233455
Q ss_pred HHhcC------CCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 806 LHTSH------PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 806 LHs~n------~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
|+.+. +.++|+|+.+.||+|+.++-+-|.||+++..-
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 55432 26999999999999999888999999998643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.083 Score=58.37 Aligned_cols=29 Identities=28% Similarity=0.358 Sum_probs=25.5
Q ss_pred CCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 811 ~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.011 Score=66.82 Aligned_cols=135 Identities=19% Similarity=0.156 Sum_probs=89.0
Q ss_pred CeeEeEEeecCCceEEEEeec-CCCeEEEEEeecC------------------CCChhhH--HHHHHHHHHHHHcC-CCc
Q 037068 693 DLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQ------------------DFSGDSL--SQFKCEAEIMLRLR-HPN 750 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~------------------~~s~~~~--~~~~~Ei~ILk~L~-HpN 750 (967)
-+.+++.||-|--+-||.+-+ .|++.++|.-... ..+...+ -...+|...|+.|. |.+
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 356789999999999999866 4888888742210 0111111 23456777888774 322
Q ss_pred -eeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC
Q 037068 751 -VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW 829 (967)
Q Consensus 751 -IVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g 829 (967)
+.+.+++ +..++|||++.+-.|...-.- .+... +...+..-+.-|-.+ |+||+|.+--||+|++++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~--GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANH--GLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHc--CceecccchheeEEecCC
Confidence 2344443 457899999998877655322 12222 333334444455555 899999999999999999
Q ss_pred eEEEEeccccc
Q 037068 830 VVKVCDFGLSR 840 (967)
Q Consensus 830 ~VKLsDFGLAr 840 (967)
.++++||-...
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999998643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.15 Score=56.54 Aligned_cols=30 Identities=27% Similarity=0.547 Sum_probs=25.2
Q ss_pred CeEEeccCCCcEEEcCCC-eEEEEecccccc
Q 037068 812 TIVHRDLKSPNLLVDKNW-VVKVCDFGLSRI 841 (967)
Q Consensus 812 GIVHRDLKPsNILLd~~g-~VKLsDFGLAr~ 841 (967)
.++|+|+.+.|||+++++ ..-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 589999999999999744 457999998853
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.24 Score=56.31 Aligned_cols=141 Identities=16% Similarity=0.212 Sum_probs=78.4
Q ss_pred CeeEeEEeecCCceEEEEeecCC-----CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeeeeccCceEE
Q 037068 693 DLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-VLFMGAVTRSPHFSI 766 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~~g-----~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-VkLig~~~~~~~l~L 766 (967)
.+++ +.|-.|=.-.+|+....+ ..|++|+..... . ..-...+|..+++.+..-++ .++++++. ++ +
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~ 87 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---M 87 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---E
Confidence 4444 444446677888886433 378888764321 1 12234568888888865555 45666653 22 5
Q ss_pred EEeecCCCchhh--h-----h----------cCCC----CCC-CHHHHHHHHHHH----------------------HHH
Q 037068 767 LTEFLPRGSLYR--L-----L----------HRPN----HQL-DERRRMRMALDV----------------------AKG 802 (967)
Q Consensus 767 VmEy~~gGsL~~--l-----L----------~~~~----~~L-se~~i~~I~~QI----------------------a~a 802 (967)
|.+|+++..|.. + + +... ... -+..+..+..++ ..-
T Consensus 88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 167 (330)
T PLN02421 88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE 167 (330)
T ss_pred eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence 889987765521 0 1 1101 111 122222222221 111
Q ss_pred HHHHHh------cCCCeEEeccCCCcEEEcC-CCeEEEEecccccc
Q 037068 803 MNYLHT------SHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSRI 841 (967)
Q Consensus 803 L~YLHs------~n~GIVHRDLKPsNILLd~-~g~VKLsDFGLAr~ 841 (967)
+..+.. ....++|.|+.+.|||+++ ++.++++||..|..
T Consensus 168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 222211 1124899999999999974 57899999998853
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.23 Score=55.51 Aligned_cols=30 Identities=20% Similarity=0.253 Sum_probs=27.3
Q ss_pred CCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 811 ~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.++||+|+.+.|||++.++.+.++||..++
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 379999999999999999999999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.15 Score=55.26 Aligned_cols=117 Identities=11% Similarity=0.094 Sum_probs=75.6
Q ss_pred CCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCCCchhhhhcC
Q 037068 703 GSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR 782 (967)
Q Consensus 703 G~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~ 782 (967)
|+..+.-.++.+=.+..+|++..-... -...-+.++.+++++++ .|+++..- ..-.+.+++|+|..-..
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~-~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCC-INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcc-cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 344444444443345566776554332 12334577888888764 57877743 34457799999854211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 783 PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 783 ~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
.. ..++.-=+.+|.-.|+.+.+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 142 -------~~-~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -------NF-SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -------ch-hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 11 1122222567888897777899999999999999999999998763
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.64 Score=54.64 Aligned_cols=76 Identities=14% Similarity=-0.016 Sum_probs=52.3
Q ss_pred EeEEeecCCceEEEEeecCCCeEEEEEeecCCC--Ch---hhHHHHHHHHHHHHHcC---CCceeEEeeeeeccCceEEE
Q 037068 696 IGERIGIGSYGEVYRADWHGTEVAVKKFLDQDF--SG---DSLSQFKCEAEIMLRLR---HPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~--s~---~~~~~~~~Ei~ILk~L~---HpNIVkLig~~~~~~~l~LV 767 (967)
..+.||.|....||+....++.++||.-..... .. -...+...|...|+.+. ..++.+++.++. +..+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 357799999999999987777899997652211 11 13444555677776653 246778888877 346788
Q ss_pred EeecCC
Q 037068 768 TEFLPR 773 (967)
Q Consensus 768 mEy~~g 773 (967)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.20 E-value=0.22 Score=55.78 Aligned_cols=76 Identities=26% Similarity=0.218 Sum_probs=47.9
Q ss_pred eeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC---CCceeEEeeeeeccCceEEEEee
Q 037068 694 LQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR---HPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~---HpNIVkLig~~~~~~~l~LVmEy 770 (967)
.+-.+.|+-|....+|+.+..++.+.||+-.. .....+..|..-|+.|. --.+.+.+.+....+.-+|||||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 34456799899999999998899999998542 22345667788887773 44567888888777777999999
Q ss_pred cCCC
Q 037068 771 LPRG 774 (967)
Q Consensus 771 ~~gG 774 (967)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.22 Score=52.31 Aligned_cols=30 Identities=33% Similarity=0.541 Sum_probs=21.6
Q ss_pred CeEEeccCCCcEEE-cCCCeEEEEecccccc
Q 037068 812 TIVHRDLKSPNLLV-DKNWVVKVCDFGLSRI 841 (967)
Q Consensus 812 GIVHRDLKPsNILL-d~~g~VKLsDFGLAr~ 841 (967)
.++|+||.+.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 59999999999999 8899999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.04 E-value=0.47 Score=54.90 Aligned_cols=74 Identities=18% Similarity=0.109 Sum_probs=47.5
Q ss_pred EeecCCceEEEEeecCC--CeEEEEEeecCC-----CChhhHHHHHHHHHHHHHcC--CC-ceeEEeeeeeccCceEEEE
Q 037068 699 RIGIGSYGEVYRADWHG--TEVAVKKFLDQD-----FSGDSLSQFKCEAEIMLRLR--HP-NVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 699 ~LGeG~FG~VYka~~~g--~~VAVKkl~~~~-----~s~~~~~~~~~Ei~ILk~L~--Hp-NIVkLig~~~~~~~l~LVm 768 (967)
.||.|....||++...+ +.++||.-.... ..+-...+..-|...|+... -| ++.++|.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999997754 478888653211 11234455666788887663 34 44455544 344567999
Q ss_pred eecCCC
Q 037068 769 EFLPRG 774 (967)
Q Consensus 769 Ey~~gG 774 (967)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.01 E-value=0.16 Score=60.54 Aligned_cols=156 Identities=22% Similarity=0.276 Sum_probs=93.2
Q ss_pred HHHHHHHHHHHHcCCCceeEEeeeeecc-CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037068 734 SQFKCEAEIMLRLRHPNVVLFMGAVTRS-PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812 (967)
Q Consensus 734 ~~~~~Ei~ILk~L~HpNIVkLig~~~~~-~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~G 812 (967)
.++.-...+++.+.|+|...++++-... ....+|||++ +.+|.+++..+. +-... +. -| +
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~~-----~~----~ 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDES-------LL-----AH----G 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhh-------hc-----cc----c
Confidence 3455567889999999999999887653 3477889988 558998887533 11110 00 11 2
Q ss_pred eEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 037068 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPW 892 (967)
Q Consensus 813 IVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF 892 (967)
+.|- | .++++| -++ ... |- +..+|+|||++|.++.|++-|..-|
T Consensus 88 ~~~~-----~-------~~~~td-~~~----t~~--------------~~-----~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 88 VLHL-----N-------IIYITD-HFL----TKY--------------PS-----PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred ccee-----h-------hhhccc-ccc----ccC--------------CC-----CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 3332 1 122233 000 000 00 0113999999999999999988777
Q ss_pred CCCChhHHHhhhhcccccc----------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHH
Q 037068 893 KGLNPMQVVGAVGFQNRRL----------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944 (967)
Q Consensus 893 ~~~~~~ei~~~i~~~~~~~----------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe 944 (967)
......+....+....... .+-..++..+..+..+|+...|..||...++.+
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 6655444333322111100 111246677788999999999999887666554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.74 E-value=0.28 Score=56.53 Aligned_cols=110 Identities=15% Similarity=0.201 Sum_probs=71.8
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
..|++|++- |++|..+ + .....++..|+.+.+..+.-+.... .+=|||+.-.||||+ +|+|.|+||-++|..
T Consensus 300 y~yl~~kdh-gt~is~i-k----~~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 300 YLYLHFKDH-GTPISII-K----ADRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred EEEEEEecC-Cceeeee-e----cccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee-cCceEEEEeeeeecc
Confidence 456777764 4444333 2 1356788889999888887777664 689999999999999 999999999999854
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCC
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS 889 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk 889 (967)
........ ...--|-.+. +.-+..-+||-+ |-.|+.|.
T Consensus 372 ~~q~~isy-----~rldhp~lF~-G~dd~QFeIYrl---Mr~l~~g~ 409 (488)
T COG5072 372 YSQGIISY-----NRLDHPDLFN-GVDDYQFEIYRL---MRRLLKGR 409 (488)
T ss_pred cCCceeec-----cccCchhhhc-CccceeeeHHHH---HHHHhcCc
Confidence 33322111 1223344454 334666777764 33444443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 967 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-102 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-101 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-45 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-40 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-40 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-40 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-39 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-39 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-39 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-39 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-39 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-39 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-39 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-39 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-39 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-39 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-39 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-39 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-39 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-39 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-39 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-39 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-39 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-39 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-39 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-39 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-39 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-38 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-38 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-38 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-38 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-38 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-38 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-38 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-38 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-38 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-38 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-38 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-38 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-38 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-38 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-37 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-35 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-35 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-35 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-35 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-35 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-35 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-35 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-35 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-35 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-35 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-35 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-35 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-34 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-34 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-34 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-34 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-34 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-33 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-33 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-33 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-33 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-33 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-33 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-33 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-33 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-33 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-33 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-33 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-33 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-33 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-33 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-32 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-32 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-32 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-32 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-32 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-32 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-32 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-32 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-32 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-32 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-32 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-32 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-32 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-32 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-32 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-32 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-32 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-32 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-32 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-32 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-32 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-32 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-32 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-31 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-31 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-31 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-31 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-31 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-31 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-31 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-31 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-31 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-31 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-31 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-31 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-31 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-31 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-31 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-31 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-31 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-31 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-31 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-31 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-31 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-31 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-31 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-31 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-31 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-31 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-31 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-31 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-31 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-31 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-31 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-31 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-31 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-31 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-31 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-31 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-31 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-31 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-31 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-31 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-31 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-31 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-31 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-31 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-31 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-31 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-31 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-31 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-31 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-31 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-31 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-31 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-30 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-30 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-30 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-30 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-30 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-30 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-30 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-30 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-30 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-30 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-30 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-30 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-30 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-30 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-30 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-30 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-30 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-30 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-30 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-30 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-30 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-30 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-30 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-30 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-30 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-29 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-29 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-29 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-29 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-29 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-29 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-29 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-29 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-29 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-29 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-29 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-29 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-29 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-29 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-29 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-29 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-29 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-29 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-29 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-29 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-29 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-29 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-28 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-28 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-28 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-28 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-28 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-28 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-28 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-28 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-28 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-28 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-28 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-28 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-28 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-28 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-28 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-28 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-28 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-28 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-28 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-27 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-27 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-27 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-27 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-27 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-27 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-27 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-27 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-27 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-27 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-27 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-27 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-27 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-27 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-27 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-27 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-27 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-26 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-26 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-26 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-26 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-26 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-26 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-26 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-26 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-26 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-26 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-26 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-26 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-25 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-25 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-25 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-25 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-25 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-25 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-25 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-25 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-25 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-24 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-24 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-24 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-24 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-24 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-24 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-24 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-23 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-23 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-23 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-23 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-23 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-23 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-23 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-23 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-23 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-23 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-23 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-23 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-23 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-23 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-23 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-23 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-23 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-23 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-23 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-23 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-23 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-23 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-23 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-23 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-22 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-22 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-22 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-22 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-22 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-22 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-22 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-22 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-22 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-21 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-21 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-21 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-21 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-21 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-21 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-21 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-21 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-20 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-20 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-20 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-20 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-20 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-20 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-20 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-20 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-20 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-20 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-19 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-16 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-16 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-16 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-13 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 480 bits (1238), Expect = e-163
Identities = 178/290 (61%), Positives = 217/290 (74%), Gaps = 2/290 (0%)
Query: 674 SDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSL 733
+ + + +I W DL I E+IG GS+G V+RA+WHG++VAVK ++QDF + +
Sbjct: 19 ENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV 78
Query: 734 SQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN--HQLDERR 791
++F E IM RLRHPN+VLFMGAVT+ P+ SI+TE+L RGSLYRLLH+ QLDERR
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 792 RMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKS 851
R+ MA DVAKGMNYLH +P IVHR+LKSPNLLVDK + VKVCDFGLSR+K T+LSSKS
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 852 TAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL 911
AGTPEWMAPEVLR+EP+NEK DVYSFGVILWELATL PW LNP QVV AVGF+ +RL
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258
Query: 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTN 961
EIP +++P VA II CW EP RPSFA +M LR L + V N ++
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 433 bits (1116), Expect = e-146
Identities = 79/272 (29%), Positives = 137/272 (50%), Gaps = 11/272 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
I ++ L ++ GE+++ W G ++ VK +D+S F E +
Sbjct: 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI 63
Query: 746 LRHPNVVLFMGAVTRSP--HFSILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKG 802
HPNV+ +GA P H +++T ++P GSLY +LH N +D+ + ++ ALD+A+G
Sbjct: 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARG 123
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPE 862
M +LHT P I L S ++++D++ ++ + S P W+APE
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPE 178
Query: 863 VLRNEPAN---EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919
L+ +P + D++SF V+LWEL T VP+ L+ M++ V + R IP I P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
V+++++ C +P RP F ++ L +Q
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 432 bits (1112), Expect = e-145
Identities = 99/272 (36%), Positives = 151/272 (55%), Gaps = 15/272 (5%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFL--DQDFSGDSLSQFKCEAEIML 744
EI + +L + E IGIG +G+VYRA W G EVAVK + ++ + EA++
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMN 804
L+HPN++ G + P+ ++ EF G L R+L ++ + A+ +A+GMN
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMN 119
Query: 805 YLHTSHP-TIVHRDLKSPNLLVDK--------NWVVKVCDFGLSRIKHHTYLSSKSTAGT 855
YLH I+HRDLKS N+L+ + N ++K+ DFGL+R H T + S AG
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGA 177
Query: 856 PEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD 915
WMAPEV+R ++ DV+S+GV+LWEL T VP++G++ + V V L IP
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
A+++ DCW +PH RPSF ++ +L
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 430 bits (1107), Expect = e-144
Identities = 93/289 (32%), Positives = 157/289 (54%), Gaps = 13/289 (4%)
Query: 672 GQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGD 731
G + +WEI + +G+RIG GS+G VY+ WHG +VAVK +
Sbjct: 4 GHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ 62
Query: 732 SLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERR 791
L FK E ++ + RH N++LFMG T P +I+T++ SLY LH + + ++
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 792 RMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKS 851
+ +A A+GM+YLH I+HRDLKS N+ + ++ VK+ DFGL+ K S +
Sbjct: 122 LIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 852 TA--GTPEWMAPEVLRNE---PANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVG 905
G+ WMAPEV+R + P + + DVY+FG++L+EL T +P+ +N Q++ VG
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239
Query: 906 FQNRR---LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
+ ++ + + +++ +C + + RPSF ++++ + L R
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-142
Identities = 92/300 (30%), Positives = 142/300 (47%), Gaps = 18/300 (6%)
Query: 678 NPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFK 737
+ + EW+I +E L+IGE IG G +G+VY WHG EVA++ + + D L FK
Sbjct: 19 SQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFK 77
Query: 738 CEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
E + RH NVVLFMGA PH +I+T +LY ++ LD + ++A
Sbjct: 78 REVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQ 137
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST----- 852
++ KGM YLH I+H+DLKS N+ D N V + DFGL I +
Sbjct: 138 EIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 853 AGTPEWMAPEVLRN---------EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGA 903
G +APE++R P ++ DV++ G I +EL P+K ++
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254
Query: 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQF 963
+G + + ++ I+ CW E RP+F +LM L L + S+ + +
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 415 bits (1068), Expect = e-138
Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 21/278 (7%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDS-----LSQFKC 738
+ +++ ++IG G +G V++ + VA+K + D G++ +F+
Sbjct: 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALD 798
E IM L HPN+V G + P ++ EF+P G LY L H + ++R+ LD
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDK-----NWVVKVCDFGLSRIKHHTYLSSKSTA 853
+A G+ Y+ +P IVHRDL+SPN+ + KV DFGLS+ H+
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLL 187
Query: 854 GTPEWMAPEVL--RNEPANEKCDVYSFGVILWELATLSVPWKGLNP--MQVVGAVGFQNR 909
G +WMAPE + E EK D YSF +IL+ + T P+ + ++ + + +
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247
Query: 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
R IP+D P + +I CW +P RP F+ ++ L
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 412 bits (1061), Expect = e-137
Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 17/299 (5%)
Query: 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+ DL GE +G G +G+ + T + F ++ F E ++M
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVM 61
Query: 744 LRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
L HPNV+ F+G + + + +TE++ G+L ++ + Q +R+ A D+A GM
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--------------KHHTYLSS 849
YLH+ + I+HRDL S N LV +N V V DFGL+R+ K
Sbjct: 122 AYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QN 908
+ G P WMAPE++ +EK DV+SFG++L E+ P + +
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239
Query: 909 RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSELP 967
P + P+ I C +P RPSF +L L L+ L Q +L
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLD 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-131
Identities = 80/271 (29%), Positives = 132/271 (48%), Gaps = 14/271 (5%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
I ++++++ E +G G++G V +A W +VA+K+ + F E + R
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE----RKAFIVELRQLSR 57
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH--RPNHQLDERRRMRMALDVAKGM 803
+ HPN+V GA ++ E+ GSLY +LH P M L ++G+
Sbjct: 58 VNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 804 NYLHTSHPT-IVHRDLKSPNLLVDKNW-VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
YLH+ P ++HRDLK PNLL+ V+K+CDFG + + G+ WMAP
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAP 172
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN-PMQVVGAVGFQNRRLEIPDDIDPA 920
EV +EKCDV+S+G+ILWE+ T P+ + P + R + ++
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
+ ++ CW +P RPS +++ + L R
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-120
Identities = 85/320 (26%), Positives = 139/320 (43%), Gaps = 53/320 (16%)
Query: 674 SDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSL 733
S S P+L + + +Q+ ++IG G YGEV+ W G +VAVK F +
Sbjct: 23 SGSGLPLL----VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE----- 73
Query: 734 SQFKCEAEI--MLRLRHPNVVLFMGAVTRS----PHFSILTEFLPRGSLYRLLHRPNHQL 787
+ + E EI + +RH N++ F+ A + ++T++ GSLY L L
Sbjct: 74 ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTL 131
Query: 788 DERRRMRMALDVAKGMNYLHT------SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841
D + +++A G+ +LHT P I HRDLKS N+LV KN + D GL+
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191
Query: 842 ----KHHTYLSSKSTAGTPEWMAPEVL------RNEPANEKCDVYSFGVILWELAT---- 887
+ + + GT +M PEVL + + D+YSFG+ILWE+A
Sbjct: 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
Query: 888 ------LSVPWKGLNPMQ-----VVGAVGFQNRRLEIP-----DDIDPAVAQIIRDCWQT 931
+P+ L P + V + R P D+ + +++ +CW
Sbjct: 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311
Query: 932 EPHLRPSFAQLMSRLRCLQR 951
P R + ++ L +
Sbjct: 312 NPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-117
Identities = 83/301 (27%), Positives = 136/301 (45%), Gaps = 49/301 (16%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEI--MLR 745
+ D+ + E +G G YGEV+R W G VAVK F +D + E E+ +
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVM 58
Query: 746 LRHPNVVLFMGAVTRSPH----FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK 801
LRH N++ F+ + S H ++T + GSLY L LD +R+ L +A
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIAS 116
Query: 802 GMNYLHT------SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY----LSSKS 851
G+ +LH P I HRDLKS N+LV KN + D GL+ + + + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 852 TAGTPEWMAPEVLRNEP------ANEKCDVYSFGVILWELAT----------LSVPWKGL 895
GT +MAPEVL + ++ D+++FG++LWE+A P+ +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236
Query: 896 NP-----MQVVGAVGFQNRRLEIPDDID-----PAVAQIIRDCWQTEPHLRPSFAQLMSR 945
P + V +R IP+ ++A+++++CW P R + ++
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 946 L 946
L
Sbjct: 297 L 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-114
Identities = 87/320 (27%), Positives = 143/320 (44%), Gaps = 53/320 (16%)
Query: 674 SDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSL 733
S S P+L + + + E IG G +GEV+R W G EVAVK F ++
Sbjct: 28 SGSGLPLL----VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----E 78
Query: 734 SQFKCEAEI--MLRLRHPNVVLFMGAVTR----SPHFSILTEFLPRGSLYRLLHRPNHQL 787
+ EAEI + LRH N++ F+ A + +++++ GSL+ L+R + +
Sbjct: 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTV 136
Query: 788 DERRRMRMALDVAKGMNYLHTSH------PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841
+++AL A G+ +LH P I HRDLKS N+LV KN + D GL+
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 842 KHHTY----LSSKSTAGTPEWMAPEVLRNE------PANEKCDVYSFGVILWELATLS-- 889
++ GT +MAPEVL + + ++ D+Y+ G++ WE+A
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
Query: 890 --------VPWKGLNPM-----QVVGAVGFQNRRLEIP-----DDIDPAVAQIIRDCWQT 931
+P+ L P ++ V Q R IP + +A+I+R+CW
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316
Query: 932 EPHLRPSFAQLMSRLRCLQR 951
R + ++ L L +
Sbjct: 317 NGAARLTALRIKKTLSQLSQ 336
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-107
Identities = 78/309 (25%), Positives = 125/309 (40%), Gaps = 49/309 (15%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEI--M 743
LQ+ E G +G V++A VAVK F QD ++ E E+ +
Sbjct: 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS-----WQNEYEVYSL 72
Query: 744 LRLRHPNVVLFMGAVTRSPH----FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDV 799
++H N++ F+GA R ++T F +GSL L + + +A +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETM 130
Query: 800 AKGMNYLHT--------SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH--HTYLSS 849
A+G+ YLH P I HRD+KS N+L+ N + DFGL+ + +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 850 KSTAGTPEWMAPEVLRNEP-----ANEKCDVYSFGVILWELATLSVPWKGLNP------- 897
GT +MAPEVL A + D+Y+ G++LWELA+ G
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 898 ---------MQVVGAVGFQNRRLEIPDDIDP-----AVAQIIRDCWQTEPHLRPSFAQLM 943
+ V + +R + D + + I +CW + R S +
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 944 SRLRCLQRL 952
R+ +QRL
Sbjct: 311 ERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-104
Identities = 85/327 (25%), Positives = 130/327 (39%), Gaps = 60/327 (18%)
Query: 680 MLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCE 739
M +E + ++L++ E IG G YG VY+ VAVK F + F E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINE 55
Query: 740 AEIML--RLRHPNVVLFMGAVTRSP-----HFSILTEFLPRGSLYRLLHRPNHQLDERRR 792
I + H N+ F+ R + ++ E+ P GSL + L H D
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSS 113
Query: 793 MRMALDVAKGMNYLHT-------SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845
R+A V +G+ YLHT P I HRDL S N+LV + + DFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 846 YL--------SSKSTAGTPEWMAPEVLRN-------EPANEKCDVYSFGVILWELA---T 887
L ++ S GT +MAPEVL E A ++ D+Y+ G+I WE+ T
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 888 LSVPWKGLNPMQV---------------VGAVGFQNRRLEIPDDIDP------AVAQIIR 926
P + + Q+ V + +R + P+ ++ + I
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 927 DCWQTEPHLRPSFAQLMSRLRCLQRLL 953
DCW + R + R+ L +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 2e-75
Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 12/281 (4%)
Query: 671 NGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRA-DW-HGTEVAVKKFLDQDF 728
N Q D I + + L+ IG GS+ VY+ D EVA + D+
Sbjct: 5 NQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL 64
Query: 729 SGDSLSQFKCEAEIMLRLRHPNVVLFMGA----VTRSPHFSILTEFLPRGSLYRLLHRPN 784
+ +FK EAE++ L+HPN+V F + V ++TE + G+L L R
Sbjct: 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 124
Query: 785 HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKH 843
+ + + KG+ +LHT P I+HRDLK N+ + VK+ D GL+ +K
Sbjct: 125 V-MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVV-G 902
++ +K+ GTPE+MAPE+ + +E DVY+FG+ + E+AT P+ +
Sbjct: 184 ASF--AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
Query: 903 AVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
V + P V +II C + R S L+
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 3e-75
Identities = 89/271 (32%), Positives = 139/271 (51%), Gaps = 9/271 (3%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG--TEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+W + EDL +GE+IG G++GEV+ T VAVK + D ++F EA I+
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARIL 166
Query: 744 LRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
+ HPN+V +G T+ I+ E + G L +L + ++M D A GM
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTP-EWMAP 861
YL + +HRDL + N LV + V+K+ DFG+SR Y +S P +W AP
Sbjct: 227 EYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 862 EVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
E L + + DV+SFG++LWE +L + P+ L+ Q V + RL P+ A
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
V +++ CW EP RPSF+ + L+ +++
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 2e-73
Identities = 84/265 (31%), Positives = 133/265 (50%), Gaps = 9/265 (3%)
Query: 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+W I +L + IG G +G V+ W +VA+K + + S F EAE+M
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAM--SEEDFIEEAEVM 57
Query: 744 LRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
++L HP +V G ++TEF+ G L L + M LDV +GM
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPE 862
YL + ++HRDL + N LV +N V+KV DFG++R +S + P +W +PE
Sbjct: 118 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 175
Query: 863 VLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
V + K DV+SFGV++WE+ + +P++ + +VV + RL P V
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHV 234
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRL 946
QI+ CW+ P RP+F++L+ +L
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQL 259
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-72
Identities = 83/265 (31%), Positives = 129/265 (48%), Gaps = 9/265 (3%)
Query: 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
WEI +DL + +G G +G V W G +VA+K + + S +F EA++M
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSM--SEDEFIEEAKVM 73
Query: 744 LRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
+ L H +V G T+ I+TE++ G L L H+ ++ + M DV + M
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPE 862
YL + +HRDL + N LV+ VVKV DFGLSR +S + P W PE
Sbjct: 134 EYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 191
Query: 863 VLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
VL + K D+++FGV++WE+ +L +P++ + + Q RL P V
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKV 250
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRL 946
I+ CW + RP+F L+S +
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNI 275
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-72
Identities = 85/302 (28%), Positives = 145/302 (48%), Gaps = 22/302 (7%)
Query: 679 PMLGEVAEWEIL--WEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGD 731
+L EV + I IG G +G VY ++ + A+K L +
Sbjct: 6 ALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQ 64
Query: 732 SLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-PHFSILTEFLPRGSLYRLLHRPNHQLDER 790
+ F E +M L HPNV+ +G + +L ++ G L + + P +
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK 124
Query: 791 RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSS 849
+ L VA+GM YL VHRDL + N ++D+++ VKV DFGL+R I Y S
Sbjct: 125 DLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182
Query: 850 KSTAGT--P-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVG 905
+ P +W A E L+ K DV+SFGV+LWEL T + P++ ++P + +
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
Query: 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSE 965
Q RRL P+ ++ Q+++ CW+ +P +RP+F L+ +++++ + + + +
Sbjct: 243 -QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE---VEQIV--SALLGDHYVQ 296
Query: 966 LP 967
LP
Sbjct: 297 LP 298
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 4e-72
Identities = 86/268 (32%), Positives = 136/268 (50%), Gaps = 9/268 (3%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
E+ E++ + + +G G +G V W G +VAVK + + S +F EA+ M++
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKM-IKEGSM--SEDEFFQEAQTMMK 59
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
L HP +V F G ++ I+TE++ G L L L+ + + M DV +GM +
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPEVL 864
L + +HRDL + N LVD++ VKV DFG++R S P +W APEV
Sbjct: 120 LESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 865 RNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923
+ K DV++FG+++WE+ +L +P+ +VV V Q RL P + Q
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQ 236
Query: 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
I+ CW P RP+F QL+S + L+
Sbjct: 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-71
Identities = 83/306 (27%), Positives = 141/306 (46%), Gaps = 27/306 (8%)
Query: 671 NGQSDSINP-----MLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAV 720
+ S + P + ++ + I L +G+ +G G +G V + +VAV
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 721 KKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-----PHFSILTEFLPRGS 775
K + S + +F EA M HPNV+ +G P ++ F+ G
Sbjct: 68 KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 776 LYRLL--HRPN---HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830
L+ L R + + ++ +D+A GM YL + +HRDL + N ++ +
Sbjct: 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMT 185
Query: 831 VKVCDFGLSR-IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL 888
V V DFGLS+ I Y A P +W+A E L + K DV++FGV +WE+AT
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
Query: 889 -SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL- 946
P+ G+ ++ + RL+ P+D + +I+ CW+T+P RP+F+ L +L
Sbjct: 246 GMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 947 RCLQRL 952
+ L+ L
Sbjct: 305 KLLESL 310
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 3e-71
Identities = 97/318 (30%), Positives = 160/318 (50%), Gaps = 30/318 (9%)
Query: 676 SINPMLGEVA------EWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKK 722
S+NP A EWE+ E + + +G GS+G VY G T VA+K
Sbjct: 3 SVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 62
Query: 723 FLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL-- 780
+++ S +F EA +M +VV +G V++ ++ E + RG L L
Sbjct: 63 -VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 781 HRPNH-------QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKV 833
RP + ++MA ++A GM YL+ + VHRDL + N +V +++ VK+
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKI 179
Query: 834 CDFGLSR-IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SV 890
DFG++R I Y P WM+PE L++ DV+SFGV+LWE+ATL
Sbjct: 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239
Query: 891 PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL-RCL 949
P++GL+ QV+ V + L+ PD+ + +++R CWQ P +RPSF +++S + +
Sbjct: 240 PYQGLSNEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298
Query: 950 QRLLVDRSNSTNQFSELP 967
+ + S ++ ++LP
Sbjct: 299 EPGFREVSFYYSEENKLP 316
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 3e-71
Identities = 85/272 (31%), Positives = 130/272 (47%), Gaps = 18/272 (6%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCEA 740
++ I ED+ + +G G +GEVY + VAVK +D + D+ +F EA
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKFMSEA 64
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
IM L HP++V +G + P + I+ E P G L L R + L + +L +
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGT--P- 856
K M YL + + VHRD+ N+LV VK+ DFGLSR I+ Y + T P
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS---VTRLPI 178
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPD 915
+WM+PE + DV+ F V +WE+ + P+ L V+G + + RL PD
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPD 237
Query: 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
P + ++ CW +P RP F +L+ L
Sbjct: 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-70
Identities = 90/265 (33%), Positives = 147/265 (55%), Gaps = 15/265 (5%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
W + ++L++ + IG G +G+V D+ G +VAVK + + F EA +M +
Sbjct: 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQ 70
Query: 746 LRHPNVVLFMGAVTRS-PHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGM 803
LRH N+V +G + I+TE++ +GSL L R L ++ +LDV + M
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPE 862
YL ++ VHRDL + N+LV ++ V KV DFGL++ S++ T P +W APE
Sbjct: 131 EYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EAS-STQDTGKLPVKWTAPE 184
Query: 863 VLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
LR + + K DV+SFG++LWE+ + VP+ + VV V + +++ PD PAV
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 243
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRL 946
+++++CW + +RPSF QL +L
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 5e-70
Identities = 83/314 (26%), Positives = 136/314 (43%), Gaps = 24/314 (7%)
Query: 674 SDSINP-MLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQD 727
S I+ + ++ + I + +G +G G +G V A +VAVK
Sbjct: 4 SLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI 63
Query: 728 FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------PHFSILTEFLPRGSLYRLL- 780
+ + +F EA M HP+V +G RS P ++ F+ G L+ L
Sbjct: 64 IASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL 123
Query: 781 -HRPN---HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDF 836
R L + +R +D+A GM YL + + +HRDL + N ++ ++ V V DF
Sbjct: 124 ASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADF 181
Query: 837 GLSR-IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWK 893
GLSR I Y + P +W+A E L + DV++FGV +WE+ T P+
Sbjct: 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 894 GLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL-RCLQRL 952
G+ ++ + RL+ P + V ++ CW +P RPSF L L L L
Sbjct: 242 GIENAEIYNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
Query: 953 LVDRSNSTNQFSEL 966
V ++ + +
Sbjct: 301 SVLSTSQDPLYINI 314
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 6e-70
Identities = 91/301 (30%), Positives = 140/301 (46%), Gaps = 21/301 (6%)
Query: 673 QSDSINP-MLGEVAEWEIL--WEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFL 724
++NP ++ V I + E IG G +G VY AVK L
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-L 61
Query: 725 DQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-PHFSILTEFLPRGSLYRLLHRP 783
++ +SQF E IM HPNV+ +G RS ++ ++ G L +
Sbjct: 62 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121
Query: 784 NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IK 842
H + + L VAKGM YL + VHRDL + N ++D+ + VKV DFGL+R +
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179
Query: 843 HHTYLSSKSTAGT--P-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPM 898
Y S + G P +WMA E L+ + K DV+SFGV+LWEL T + P+ +N
Sbjct: 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239
Query: 899 QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSN 958
+ + Q RRL P+ + +++ CW + +RPSF++L+SR + +
Sbjct: 240 DITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR---ISAIFSTFIG 295
Query: 959 S 959
Sbjct: 296 E 296
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 7e-70
Identities = 97/266 (36%), Positives = 146/266 (54%), Gaps = 11/266 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG--TEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+WE+ D+ + ++G G YGEVY W VAVK L +D + +F EA +M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTM--EVEEFLKEAAVM 63
Query: 744 LRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDVAKG 802
++HPN+V +G TR P F I+TEF+ G+L L N Q + + MA ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAP 861
M YL + +HRDL + N LV +N +VKV DFGLSR+ ++ + A P +W AP
Sbjct: 124 MEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 862 EVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
E L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEK 240
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMSRL 946
V +++R CWQ P RPSFA++
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-69
Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 19/284 (6%)
Query: 685 AEWEIL-WEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFK 737
A IL + + + +G G++G VY+ W VA+K+ L + S + +
Sbjct: 7 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEIL 65
Query: 738 CEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
EA +M + +P+V +G S ++T+ +P G L + + + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTP 856
+AKGMNYL +VHRDL + N+LV VK+ DFGL++ + P
Sbjct: 125 QIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 857 -EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIP 914
+WMA E + + + DV+S+GV +WEL T S P+ G+ ++ + + RL P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQP 241
Query: 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL----RCLQRLLV 954
V I+R CW + RP F +L+ R QR LV
Sbjct: 242 PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-69
Identities = 86/291 (29%), Positives = 135/291 (46%), Gaps = 30/291 (10%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKC 738
I D+ + +G G++G+V+ A+ + VAVK +D + + F+
Sbjct: 9 VQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQR 66
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPN------------ 784
EAE++ L+H ++V F G ++ E++ G L + L H P+
Sbjct: 67 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 785 -HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IK 842
+L + + +A +A GM YL + H VHRDL + N LV N +VK+ DFG+SR +
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 843 HHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQV 900
Y P WM PE + + DV+SFGVILWE+ T PW L+ +V
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
Query: 901 VGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
+ + Q R LE P V ++ CWQ EP R + ++ L L +
Sbjct: 245 IECIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-69
Identities = 92/286 (32%), Positives = 151/286 (52%), Gaps = 17/286 (5%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIML 744
EWE+ E L++ ER+G G +GEV+ ++G T+VAVK L Q S F EA +M
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSM--SPDAFLAEANLMK 63
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNH-QLDERRRMRMALDVAKGM 803
+L+H +V VT+ P + I+TE++ GSL L P+ +L + + MA +A+GM
Sbjct: 64 QLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTP-EWMAPE 862
++ + +HRDL++ N+LV K+ DFGL+R+ +++ A P +W APE
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 863 VLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
+ K DV+SFG++L E+ T +P+ G+ +V+ + + R+ PD+ +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEEL 239
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSELP 967
Q++R CW+ P RP+F L S L + Q+ P
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFT------ATEGQYQPQP 279
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 3e-69
Identities = 86/285 (30%), Positives = 134/285 (47%), Gaps = 24/285 (8%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKC 738
E+ +++ + +G G++GEVY G +VAVK L + S F
Sbjct: 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLM 82
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPNH----QLDERRR 792
EA I+ + H N+V +G +S IL E + G L L RP L
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 793 MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---NWVVKVCDFGLSR-IKHHTYLS 848
+ +A D+A G YL +H +HRD+ + N L+ V K+ DFG++R I +Y
Sbjct: 143 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 849 SKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGF 906
A P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT- 259
Query: 907 QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL-RCLQ 950
R++ P + V +I+ CWQ +P RP+FA ++ R+ C Q
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 3e-69
Identities = 86/271 (31%), Positives = 124/271 (45%), Gaps = 13/271 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQ-FKCE 739
I +DL++ E++G GS+G V R +W VAVK S F E
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDV 799
M L H N++ G V P ++TE P GSL L + R A+ V
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTP- 856
A+GM YL + +HRDL + NLL+ +VK+ DFGL R ++ + + P
Sbjct: 131 AEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPD 915
W APE L+ + D + FGV LWE+ T PW GLN Q++ + + RL P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248
Query: 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
D + ++ CW +P RP+F L L
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 3e-69
Identities = 94/290 (32%), Positives = 137/290 (47%), Gaps = 29/290 (10%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKC 738
I D+ + +G G++G+V+ A+ H VAVK ++ S + F+
Sbjct: 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQR 92
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPNH----------- 785
EAE++ L+H ++V F G T ++ E++ G L R L H P+
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 786 -QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKH 843
L + + +A VA GM YL H VHRDL + N LV + VVK+ DFG+SR I
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 844 HTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVV 901
Y P WM PE + + DV+SFGV+LWE+ T PW L+ + +
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 902 GAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
+ Q R LE P P V I+R CWQ EP R S + +RL+ L +
Sbjct: 271 DCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-69
Identities = 95/266 (35%), Positives = 144/266 (54%), Gaps = 11/266 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG--TEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+WE+ D+ + ++G G YGEVY W VAVK L +D + +F EA +M
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTM--EVEEFLKEAAVM 270
Query: 744 LRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKG 802
++HPN+V +G TR P F I+TEF+ G+L L N ++ + MA ++
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAP 861
M YL + +HR+L + N LV +N +VKV DFGLSR + TY + +W AP
Sbjct: 331 MEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 862 EVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
E L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEK 447
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMSRL 946
V +++R CWQ P RPSFA++
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 4e-69
Identities = 90/270 (33%), Positives = 128/270 (47%), Gaps = 13/270 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCEA 740
EI + I + IG G GEV VA+K L ++ F EA
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA-LKAGYTERQRRDFLSEA 101
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
IM + HPN++ G VTR I+TE++ GSL L + Q + + M V
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGT-P-E 857
GM YL VHRDL + N+LVD N V KV DFGLSR ++ + +T G P
Sbjct: 162 AGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDD 916
W APE + + DV+SFGV++WE+ P+ + V+ +V + RL P
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
A+ Q++ DCW + RP F+Q++S L
Sbjct: 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-69
Identities = 79/269 (29%), Positives = 131/269 (48%), Gaps = 12/269 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCEA 740
++EI E +++G IG G +G+V++ + VA+K S +F EA
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 67
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
M + HP++V +G +T +P + I+ E G L L + LD + A ++
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWM 859
+ YL + VHRD+ + N+LV N VK+ DFGLSR ++ TY + +WM
Sbjct: 127 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 860 APEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
APE + DV+ FGV +WE+ P++G+ V+G + RL +P +
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
P + ++ CW +P RP F +L ++L
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 8e-69
Identities = 87/291 (29%), Positives = 148/291 (50%), Gaps = 17/291 (5%)
Query: 666 LLMTCNGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVK--KF 723
L+ + + W + ++L++ + IG G +G+V D+ G +VAVK K
Sbjct: 167 LIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK- 225
Query: 724 LDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-PHFSILTEFLPRGSLYRLLHR 782
+ + F EA +M +LRH N+V +G + I+TE++ +GSL L
Sbjct: 226 -----NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280
Query: 783 PN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841
L ++ +LDV + M YL ++ VHRDL + N+LV ++ V KV DFGL++
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK- 337
Query: 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQV 900
+ + +W APE LR + + K DV+SFG++LWE+ + VP+ + V
Sbjct: 338 --EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 395
Query: 901 VGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
V V + +++ PD PAV ++++CW + RP+F QL +L ++
Sbjct: 396 VPRVE-KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 9e-69
Identities = 84/286 (29%), Positives = 130/286 (45%), Gaps = 29/286 (10%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCE 739
EI ++ E +G +G+VY+ G VA+K L G +F+ E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHE 62
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPN------------- 784
A + RL+HPNVV +G VT+ S++ + G L+ L P+
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 785 HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKH 843
L+ + + +A GM YL + H +VH+DL + N+LV VK+ D GL R +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 844 HTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVV 901
Y + P WMAPE + + D++S+GV+LWE+ + P+ G + VV
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 902 GAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
+ + L PDD V ++ +CW P RP F + SRLR
Sbjct: 241 EMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 1e-68
Identities = 89/314 (28%), Positives = 139/314 (44%), Gaps = 24/314 (7%)
Query: 657 DLMPMINSGLLMTCNGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHG- 715
L + S ++ N E+ +++ + +G G++GEVY G
Sbjct: 36 KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 95
Query: 716 ------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769
+VAVK L + S F EA I+ + H N+V +G +S IL E
Sbjct: 96 PNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154
Query: 770 FLPRGSLYRLL--HRPNH----QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNL 823
+ G L L RP L + +A D+A G YL +H +HRD+ + N
Sbjct: 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNC 212
Query: 824 LVDK---NWVVKVCDFGLSR-IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSF 878
L+ V K+ DFG++R I Y A P +WM PE K D +SF
Sbjct: 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272
Query: 879 GVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRP 937
GV+LWE+ +L +P+ + +V+ V R++ P + V +I+ CWQ +P RP
Sbjct: 273 GVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 331
Query: 938 SFAQLMSRL-RCLQ 950
+FA ++ R+ C Q
Sbjct: 332 NFAIILERIEYCTQ 345
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 3e-68
Identities = 88/275 (32%), Positives = 137/275 (49%), Gaps = 13/275 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCEA 740
E+ ++ I + +G G +GEV VA+K L ++ F EA
Sbjct: 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT-LKVGYTEKQRRDFLGEA 97
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
IM + HPN++ G VT+S I+TE++ GSL L + + Q + + M +A
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT--P-E 857
GM YL VHRDL + N+L++ N V KV DFGL R+ ++ +T G P
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDD 916
W +PE + DV+S+G++LWE+ + P+ ++ V+ AV + RL P D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
A+ Q++ DCWQ + + RP F Q++S L L R
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 4e-68
Identities = 96/349 (27%), Positives = 148/349 (42%), Gaps = 50/349 (14%)
Query: 653 ESAADLMPMINSGLLMT-------CNGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSY 705
ESAA + + S LL+ +NP ++ E +++ IG G++
Sbjct: 4 ESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNP---KLLSLEYPRNNIEYVRDIGEGAF 60
Query: 706 GEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV 758
G V++A G T VAVK L ++ S D + F+ EA +M +PN+V +G
Sbjct: 61 GRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119
Query: 759 TRSPHFSILTEFLPRGSLYRLL--HRPN---------------------HQLDERRRMRM 795
+L E++ G L L P+ L ++ +
Sbjct: 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAG 854
A VA GM YL VHRDL + N LV +N VVK+ DFGLSR I Y +
Sbjct: 180 ARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDA 237
Query: 855 TP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLE 912
P WM PE + + DV+++GV+LWE+ + P+ G+ +V+ V L
Sbjct: 238 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILA 296
Query: 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTN 961
P++ + ++R CW P RPSF + LQR+ +
Sbjct: 297 CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI---LQRMCERAEGTVG 342
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-68
Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 14/286 (4%)
Query: 686 EWEILWEDLQIGE-RIGIGSYGEVYRADWHG----TEVAVKKFLDQDFSGDSLSQFKCEA 740
+ + ++L I + +G G++G V + + +VA+K L Q + EA
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 61
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
+IM +L +P +V +G ++ E G L++ L ++ + V+
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTP-E 857
GM YL + VHRDL + N+L+ K+ DFGLS+ +Y +++S P +
Sbjct: 121 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDD 916
W APE + + + DV+S+GV +WE + P+K + +V+ + Q +R+E P +
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 237
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQ 962
P + ++ DCW + RP F + R+R L + +
Sbjct: 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 4e-68
Identities = 88/288 (30%), Positives = 137/288 (47%), Gaps = 18/288 (6%)
Query: 673 QSDSINPMLGE---VAEWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFL 724
++NP L + + E IG G +G VY AVK L
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-L 125
Query: 725 DQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-PHFSILTEFLPRGSLYRLLHRP 783
++ +SQF E IM HPNV+ +G RS ++ ++ G L +
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185
Query: 784 NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IK 842
H + + L VAKGM +L + VHRDL + N ++D+ + VKV DFGL+R +
Sbjct: 186 THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243
Query: 843 HHTYLSSKSTAGT--P-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPM 898
+ S + G P +WMA E L+ + K DV+SFGV+LWEL T + P+ +N
Sbjct: 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303
Query: 899 QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+ + Q RRL P+ + +++ CW + +RPSF++L+SR+
Sbjct: 304 DITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 6e-68
Identities = 75/294 (25%), Positives = 129/294 (43%), Gaps = 18/294 (6%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCEA 740
+L+ + +G G +G V++ W V +K ++ S
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
+ L H ++V +G S ++T++LP GSL + + L + + + +A
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTP-EW 858
KGM YL +VHR+L + N+L+ V+V DFG++ + S A TP +W
Sbjct: 126 KGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917
MA E + + DV+S+GV +WEL T + P+ GL +V + + RL P
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQIC 242
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRL----RCLQRLLVDRSNSTNQFSELP 967
V ++ CW + ++RP+F +L + R R LV + S + P
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGP 296
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 8e-68
Identities = 85/286 (29%), Positives = 151/286 (52%), Gaps = 17/286 (5%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIML 744
WEI E L++ +++G G +GEV+ A ++ T+VAVK + S+ F EA +M
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT-MKPGSM--SVEAFLAEANVMK 238
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL-HRPNHQLDERRRMRMALDVAKGM 803
L+H +V VT+ P + I+TEF+ +GSL L + + + + +A+GM
Sbjct: 239 TLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPE 862
++ + +HRDL++ N+LV + V K+ DFGL+R I+ + Y + + +W APE
Sbjct: 298 AFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 863 VLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
+ K DV+SFG++L E+ T +P+ G++ +V+ A+ + R+ P++ +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEEL 414
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSELP 967
I+ CW+ P RP+F + S L + +Q+ E+P
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYT------ATESQYEEIP 454
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 8e-68
Identities = 86/271 (31%), Positives = 134/271 (49%), Gaps = 14/271 (5%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCE 739
EI + + IG G +GEVY+ VA+K L ++ F E
Sbjct: 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGE 96
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDV 799
A IM + H N++ G +++ I+TE++ G+L + L + + + + M +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 156
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT--P- 856
A GM YL + VHRDL + N+LV+ N V KV DFGLSR+ ++ +T+G P
Sbjct: 157 AAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPD 915
W APE + DV+SFG+++WE+ T P+ L+ +V+ A+ RL P
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPM 273
Query: 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
D A+ Q++ CWQ E RP FA ++S L
Sbjct: 274 DCPSAIYQLMMQCWQQERARRPKFADIVSIL 304
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 1e-67
Identities = 92/285 (32%), Positives = 145/285 (50%), Gaps = 13/285 (4%)
Query: 666 LLMTCNGQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFL 724
L C + + WEI E L++ ++G G +GEV+ W+G T VA+K
Sbjct: 160 LTTVCPTSKPQTQGLAKD--AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 725 DQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL-HRP 783
S + F EA++M +LRH +V V+ P + I+TE++ +GSL L
Sbjct: 218 PGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGET 273
Query: 784 NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IK 842
L + + MA +A GM Y+ + VHRDL++ N+LV +N V KV DFGL+R I+
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 331
Query: 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVV 901
+ Y + + +W APE K DV+SFG++L EL T VP+ G+ +V+
Sbjct: 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
Query: 902 GAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
V + R+ P + ++ ++ CW+ EP RP+F L + L
Sbjct: 392 DQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-67
Identities = 95/310 (30%), Positives = 154/310 (49%), Gaps = 35/310 (11%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG---------TEVAVKKFLDQDFSGDSLSQF 736
WE+ + L +G+ +G G++G+V A+ G T+VAVK L D + LS
Sbjct: 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDL 121
Query: 737 KCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSL---------------YRLL 780
E E+M + +H N++ +GA T+ ++ E+ +G+L Y
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 781 HRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840
H P QL + + A VA+GM YL + +HRDL + N+LV ++ V+K+ DFGL+R
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 841 -IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNP 897
I H Y + P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 898 MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRS 957
++ + + R++ P + + ++RDCW P RP+F QL+ L R++ S
Sbjct: 300 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVALTS 355
Query: 958 NSTNQFSELP 967
N +
Sbjct: 356 NQEMGYYHHH 365
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-67
Identities = 95/319 (29%), Positives = 157/319 (49%), Gaps = 43/319 (13%)
Query: 676 SINPMLGEVA--------EWEILWEDLQIGERIGIGSYGEVYRADWHG---------TEV 718
S +PML V+ +WE + L +G+ +G G++G+V A+ G V
Sbjct: 11 SQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70
Query: 719 AVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLY 777
AVK L D + LS E E+M + +H N++ +GA T+ ++ E+ +G+L
Sbjct: 71 AVKM-LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 778 RLL--HRPN-------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPN 822
L RP Q+ + + +A+GM YL + +HRDL + N
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARN 187
Query: 823 LLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGV 880
+LV +N V+K+ DFGL+R I + Y + P +WMAPE L + + DV+SFGV
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 881 ILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSF 939
++WE+ TL P+ G+ ++ + + R++ P + + ++RDCW P RP+F
Sbjct: 248 LMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 940 AQLMSRLRCLQRLLVDRSN 958
QL+ L R+L +N
Sbjct: 307 KQLVED---LDRILTLTTN 322
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 1e-67
Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 40/304 (13%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKC 738
+WE ++L +G+ +G G +G+V +A T VAVK L ++ S L
Sbjct: 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLLS 75
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSL---------------------- 776
E ++ ++ HP+V+ GA ++ ++ E+ GSL
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 777 -YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835
L H L + A +++GM YL +VHRDL + N+LV + +K+ D
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISD 193
Query: 836 FGLSR-IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPW 892
FGLSR + +S P +WMA E L + + DV+SFGV+LWE+ TL P+
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 893 KGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952
G+ P ++ + R+E PD+ + +++ CW+ EP RP FA + L+++
Sbjct: 254 PGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD---LEKM 309
Query: 953 LVDR 956
+V R
Sbjct: 310 MVKR 313
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-67
Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 30/292 (10%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH------GTEVAVKKFLDQDFSGDSLSQFKCE 739
L+ +G G +G+V + G +VAVK L + G+ ++ K E
Sbjct: 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKE 73
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFS--ILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
EI+ L H N+V + G T ++ EFLP GSL L + ++++ +++++ A+
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV 133
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGT 855
+ KGM+YL + VHRDL + N+LV+ VK+ DFGL++ Y + K +
Sbjct: 134 QICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 856 P-EWMAPEVLRNEPANEKCDVYSFGVILWELATL---------------SVPWKGLNPMQ 899
P W APE L DV+SFGV L EL T + +
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 900 VVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
+V + + +RL P + V Q++R CW+ +P R SF L+ L +
Sbjct: 252 LVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-67
Identities = 93/299 (31%), Positives = 150/299 (50%), Gaps = 33/299 (11%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG----TEVAVKKFLDQDFSGDSLSQFKCEAE 741
+ W D++ + IG G++G+V +A + A+K+ + + S D F E E
Sbjct: 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELE 77
Query: 742 IMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSL---------------YRLLHRPNH 785
++ +L HPN++ +GA + + E+ P G+L + + +
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 786 QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845
L ++ + A DVA+GM+YL +HRDL + N+LV +N+V K+ DFGLSR
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR-GQEV 194
Query: 846 YLSSKSTAGT-P-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVG 902
Y K T G P WMA E L DV+S+GV+LWE+ +L P+ G+ ++
Sbjct: 195 Y--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252
Query: 903 AVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTN 961
+ Q RLE P + D V ++R CW+ +P+ RPSFAQ++ L R+L +R N
Sbjct: 253 KLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS---LNRMLEERKTYVN 307
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 6e-67
Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 32/293 (10%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCE 739
+ L+ +++G G++G V + VAVKK L + + L F+ E
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHS-TEEHLRDFERE 61
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFS--ILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
EI+ L+H N+V + G + + ++ E+LP GSL L + ++D + ++
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGT 855
+ KGM YL T +HRDL + N+LV+ VK+ DFGL+++ + + K +
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 856 P-EWMAPEVLRNEPANEKCDVYSFGVILWELATLS----------------VPWKGLNPM 898
P W APE L + DV+SFGV+L+EL T +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 899 QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
++ + N RL PD + I+ +CW + RPSF L R+ ++
Sbjct: 240 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-66
Identities = 71/286 (24%), Positives = 131/286 (45%), Gaps = 14/286 (4%)
Query: 686 EWEILWEDLQIGER-IGIGSYGEVYRADWHG----TEVAVKKFLDQDFSGDSLSQFKCEA 740
E + + L + ++ +G G++G V + + VAVK ++ + EA
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
+M +L +P +V +G ++ E G L + L + N + ++ + + V+
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVS 127
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTP-E 857
GM YL S+ VHRDL + N+L+ K+ DFGLS+ Y +++ P +
Sbjct: 128 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDD 916
W APE + + K DV+SFGV++WE + P++G+ +V + + R+ P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQ 962
+ ++ CW + RP FA + RLR +V+ + +
Sbjct: 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHH 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-66
Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 32/288 (11%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCE 739
+ L+ +++G G++G V + VAVKK Q + + L F+ E
Sbjct: 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFERE 92
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFS--ILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
EI+ L+H N+V + G + + ++ E+LP GSL L + ++D + ++
Sbjct: 93 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGT 855
+ KGM YL T +HRDL + N+LV+ VK+ DFGL+++ + Y K +
Sbjct: 153 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
Query: 856 P-EWMAPEVLRNEPANEKCDVYSFGVILWELATLS----------------VPWKGLNPM 898
P W APE L + DV+SFGV+L+EL T +
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 899 QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
++ + N RL PD + I+ +CW + RPSF L R+
Sbjct: 271 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-66
Identities = 96/336 (28%), Positives = 160/336 (47%), Gaps = 43/336 (12%)
Query: 659 MPMINSGLLMTCNGQSDSINPMLGEVA--------EWEILWEDLQIGERIGIGSYGEVYR 710
M + +T S + PML V+ +WE + L +G+ +G G +G+V
Sbjct: 40 MNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVM 99
Query: 711 ADWHG---------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTR 760
A+ G VAVK L D + LS E E+M + +H N++ +GA T+
Sbjct: 100 AEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158
Query: 761 SPHFSILTEFLPRGSL---------------YRLLHRPNHQLDERRRMRMALDVAKGMNY 805
++ E+ +G+L Y + P Q+ + + +A+GM Y
Sbjct: 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTP-EWMAPEV 863
L + +HRDL + N+LV +N V+K+ DFGL+R I + Y + P +WMAPE
Sbjct: 219 LASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEA 276
Query: 864 LRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
L + + DV+SFGV++WE+ TL P+ G+ ++ + + R++ P + +
Sbjct: 277 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELY 335
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSN 958
++RDCW P RP+F QL+ L R+L +N
Sbjct: 336 MMMRDCWHAVPSQRPTFKQLVED---LDRILTLTTN 368
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-66
Identities = 67/297 (22%), Positives = 124/297 (41%), Gaps = 32/297 (10%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHG---------TEVAVKKFLDQDFSGDSLSQFK 737
+I EDL E +G G++ ++++ TEV +K LD+ + F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV-LDKA-HRNYSESFF 60
Query: 738 CEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
A +M +L H ++VL G ++ EF+ GSL L + + ++ ++ +A
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDK--------NWVVKVCDFGLSRIKHHTYLSS 849
+A M++L + ++H ++ + N+L+ + +K+ D G+S +
Sbjct: 121 QLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----TVLP 173
Query: 850 KSTAGTP-EWMAPEVLRNEPA-NEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGF 906
K W+ PE + N N D +SFG LWE+ + P L+ + +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE- 232
Query: 907 QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQF 963
+L P +A +I +C EP RPSF ++ L L + S +
Sbjct: 233 DRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHH 287
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 7e-66
Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 18/296 (6%)
Query: 685 AEWEILWE-DLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFK 737
A IL E + + + +G G++G VY+ W VA+K+ L + S + +
Sbjct: 7 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEIL 65
Query: 738 CEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
EA +M + +P+V +G S ++T+ +P G L + + + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTP 856
+AKGMNYL +VHRDL + N+LV VK+ DFGL++ + P
Sbjct: 125 QIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 857 -EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIP 914
+WMA E + + + DV+S+GV +WEL T S P+ G+ ++ + + RL P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQP 241
Query: 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR---LLVDRSNSTNQFSELP 967
V I+ CW + RP F +L+ + R + P
Sbjct: 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSP 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 8e-66
Identities = 80/303 (26%), Positives = 134/303 (44%), Gaps = 34/303 (11%)
Query: 673 QSDSINPMLGEVA--EWEILWEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFL 724
+L + L+ +G G +G+V + VAVK L
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-L 68
Query: 725 DQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS--ILTEFLPRGSLYRLLHR 782
D S +K E +I+ L H +++ + G + S ++ E++P GSL L R
Sbjct: 69 KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR 128
Query: 783 PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI- 841
H + + + A + +GM YLH H +HRDL + N+L+D + +VK+ DFGL++
Sbjct: 129 --HSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184
Query: 842 -KHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL----------- 888
+ H Y + +P W APE L+ DV+SFGV L+EL T
Sbjct: 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244
Query: 889 ----SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ + +++ + + RL PD V ++++CW+TE RP+F L+
Sbjct: 245 LELIGIAQGQMTVLRLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
Query: 945 RLR 947
L+
Sbjct: 304 ILK 306
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-65
Identities = 90/265 (33%), Positives = 141/265 (53%), Gaps = 11/265 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIML 744
WEI E L++ ++G G +GEV+ W+G T VA+K S + F EA++M
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMK 317
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL-HRPNHQLDERRRMRMALDVAKGM 803
+LRH +V V+ P + I+TE++ +GSL L L + + MA +A GM
Sbjct: 318 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPE 862
Y+ + VHRDL++ N+LV +N V KV DFGL+R I+ + Y + + +W APE
Sbjct: 377 AYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 863 VLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
K DV+SFG++L EL T VP+ G+ +V+ V + R+ P + ++
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 493
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRL 946
++ CW+ EP RP+F L + L
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-65
Identities = 82/307 (26%), Positives = 128/307 (41%), Gaps = 31/307 (10%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCE 739
L+ ++G G++G V + VAVK+ Q D F+ E
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQRE 74
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFS--ILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
+I+ L +V + G S ++ E+LP G L L R +LD R + +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGT 855
+ KGM YL + VHRDL + N+LV+ VK+ DFGL+++ Y + +
Sbjct: 135 QICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 856 P-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGF------- 906
P W APE L + + + DV+SFGV+L+EL T +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 907 ------QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNST 960
+ +RL P V ++++ CW P RPSF+ L +L L R T
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS--GSRGCET 310
Query: 961 NQFSELP 967
+ F+ P
Sbjct: 311 HAFTAHP 317
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-65
Identities = 84/301 (27%), Positives = 140/301 (46%), Gaps = 34/301 (11%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKC 738
+WE L G+ +G G++G+V A +G VAVK L
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMS 75
Query: 739 EAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPN----------- 784
E +++ L H N+V +GA T ++TE+ G L L R +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 785 ----HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840
LD + + VAKGM +L + + +HRDL + N+L+ + K+CDFGL+R
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 841 -IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNP 897
IK+ + K A P +WMAPE + N + DV+S+G+ LWEL +L S P+ G+
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 898 MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRS 957
+ + R+ P+ + I++ CW +P RP+F Q++ +++ + + +
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL---IEKQISEST 310
Query: 958 N 958
N
Sbjct: 311 N 311
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 6e-65
Identities = 84/291 (28%), Positives = 134/291 (46%), Gaps = 30/291 (10%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKC 738
+WE +LQ G+ +G G++G+V A G +VAVK L D
Sbjct: 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMS 98
Query: 739 EAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPNHQ--------- 786
E +IM L +H N+V +GA T ++TE+ G L L +
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 787 --LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKH 843
R + + VA+GM +L + + +HRD+ + N+L+ V K+ DFGL+R I +
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 844 HTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKG-LNPMQV 900
+ K A P +WMAPE + + + DV+S+G++LWE+ +L P+ G L +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 901 VGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL-RCLQ 950
V ++ P + I++ CW EP RP+F Q+ S L Q
Sbjct: 277 YKLVK-DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 8e-65
Identities = 79/270 (29%), Positives = 130/270 (48%), Gaps = 12/270 (4%)
Query: 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCE 739
++EI E +++G IG G +G+V++ + VA+K S +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQE 441
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDV 799
A M + HP++V +G +T +P + I+ E G L L LD + A +
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEW 858
+ + YL + VHRD+ + N+LV N VK+ DFGLSR ++ TY + +W
Sbjct: 501 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917
MAPE + DV+ FGV +WE+ P++G+ V+G + RL +P +
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 617
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
P + ++ CW +P RP F +L ++L
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 9e-65
Identities = 88/328 (26%), Positives = 138/328 (42%), Gaps = 40/328 (12%)
Query: 666 LLMTCNGQSDSINPMLGEV-AEWEILWEDLQIGERIGIGSYGEVYRADWHG-------TE 717
+ + + + ++ E +WE E+L+ G+ +G G++G+V A +G +
Sbjct: 18 VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 77
Query: 718 VAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSL 776
VAVK L + E ++M +L H N+V +GA T S ++ E+ G L
Sbjct: 78 VAVKM-LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
Query: 777 YRLL--HRPN--------------------HQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
L R + L + A VAKGM +L V
Sbjct: 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT-P-EWMAPEVLRNEPANEK 872
HRDL + N+LV VVK+CDFGL+R P +WMAPE L K
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254
Query: 873 CDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQT 931
DV+S+G++LWE+ +L P+ G+ + +++ P + I++ CW
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 314
Query: 932 EPHLRPSFAQLMSRLRCLQRLLVDRSNS 959
+ RPSF L S L L D +
Sbjct: 315 DSRKRPSFPNLTSF---LGCQLADAEEA 339
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-64
Identities = 91/302 (30%), Positives = 144/302 (47%), Gaps = 35/302 (11%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKC 738
+WE + L++G+ +G G++G+V AD G VAVK L + +
Sbjct: 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMS 79
Query: 739 EAEIMLRL-RHPNVVLFMGAVTRS-PHFSILTEFLPRGSLYRLL--HRPN---------- 784
E +I++ + H NVV +GA T+ ++ EF G+L L R
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 785 ---HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR- 840
L + + VAKGM +L + +HRDL + N+L+ + VVK+CDFGL+R
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 841 IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGL-NP 897
I K A P +WMAPE + + + DV+SFGV+LWE+ +L + P+ G+
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 898 MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRS 957
+ + + R+ PD P + Q + DCW EP RP+F++L+ L LL +
Sbjct: 258 EEFCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH---LGNLLQANA 313
Query: 958 NS 959
Sbjct: 314 QQ 315
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-60
Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 686 EWEILWEDLQIGE-RIGIGSYGEVYRADWHG----TEVAVKKFLDQDFSGDSLSQFKCEA 740
+ + ++L I + +G G++G V + + +VA+K L Q + EA
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 387
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
+IM +L +P +V +G ++ E G L++ L ++ + V+
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTP-E 857
GM YL + VHR+L + N+L+ K+ DFGLS+ +Y +++S P +
Sbjct: 447 MGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDD 916
W APE + + + DV+S+GV +WE + P+K + +V+ + Q +R+E P +
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
P + ++ DCW + RP F + R+R
Sbjct: 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-59
Identities = 54/257 (21%), Positives = 123/257 (47%), Gaps = 6/257 (2%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
E ++IG GS+G+ G + +K+ S + + E ++ ++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDVAKGMNYLHT 808
N+V + + + I+ ++ G L++ ++ E + + + + + ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
I+HRD+KS N+ + K+ V++ DFG++R+ + T +++ GTP +++PE+ N+P
Sbjct: 144 RK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928
N K D+++ G +L+EL TL ++ + +V + + + ++
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQL 260
Query: 929 WQTEPHLRPSFAQLMSR 945
++ P RPS ++ +
Sbjct: 261 FKRNPRDRPSVNSILEK 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-56
Identities = 67/262 (25%), Positives = 122/262 (46%), Gaps = 12/262 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKK-FLDQDFSGDSLSQFKCEAEIMLRLRH 748
+ +I ++IG G + EVYRA G VA+KK + + + E +++ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL---HRPNHQLDERRRMRMALDVAKGMNY 805
PNV+ + + +I+ E G L R++ + + ER + + + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
+H+ ++HRD+K N+ + VVK+ D GL R ++ S GTP +M+PE +
Sbjct: 152 MHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKG--LNPMQVVGAVGFQNRRLEIPDDI-DPAVA 922
N K D++S G +L+E+A L P+ G +N + + Q +P D +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPLPSDHYSEELR 268
Query: 923 QIIRDCWQTEPHLRPSFAQLMS 944
Q++ C +P RP +
Sbjct: 269 QLVNMCINPDPEKRPDVTYVYD 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-55
Identities = 68/264 (25%), Positives = 120/264 (45%), Gaps = 11/264 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
ED ++ IG GSYG + G + K+ + E ++ L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 750 NVVLFMGAV--TRSPHFSILTEFLPRGSLYRLL---HRPNHQLDERRRMRMALDVAKGMN 804
N+V + + + I+ E+ G L ++ + LDE +R+ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 805 YLHTSHP---TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
H T++HRDLK N+ +D VK+ DFGL+RI +H +K+ GTP +M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 244
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSR 945
+II + + RPS +++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILEN 268
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-53
Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 19/261 (7%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+ R+G GS+GEV+R D G + AVKK + F + E L P
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSP 110
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+V GAV P +I E L GSL +L+ + L E R + +G+ YLHT
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 810 HPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRI-----KHHTYLSSKSTAGTPEWMAPEV 863
I+H D+K+ N+L+ + +CDFG + + L+ GT MAPEV
Sbjct: 170 R--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 864 LRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVA 922
+ +P + K D++S ++ + PW + + + EIP P A
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 923 QIIRDCWQTEPHLRPSFAQLM 943
Q I++ + EP R S +L
Sbjct: 288 QAIQEGLRKEPVHRASAMELR 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-53
Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 682 GEVAEWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCE 739
++ E++ +++ +G G+YG VY D +A+K+ ++D E
Sbjct: 12 SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEE 69
Query: 740 AEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQL--DERRRMRMAL 797
+ L+H N+V ++G+ + + I E +P GSL LL L +E+
Sbjct: 70 IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHHTYLSSKSTAGTP 856
+ +G+ YLH + IVHRD+K N+L++ + V+K+ DFG S+ +++ GT
Sbjct: 130 QILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187
Query: 857 EWMAPEVLRNEP--ANEKCDVYSFG-VILWELATLSVPWKGL-NPMQVVGAVGFQNRRLE 912
++MAPE++ P + D++S G I+ E+AT P+ L P + VG E
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAMFKVGMFKVHPE 246
Query: 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
IP+ + I C++ +P R L+
Sbjct: 247 IPESMSAEAKAFILKCFEPDPDKRACANDLL 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-53
Identities = 59/274 (21%), Positives = 118/274 (43%), Gaps = 38/274 (13%)
Query: 692 EDLQIGERIGIGSYGEVYRA----DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
D + E IG G +G+V++A D G +K+ ++ + + E + + +L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRID--GKTYVIKR---VKYNNEKAER---EVKALAKLD 62
Query: 748 HPNVVLFMGAVTRSPHFS----------------ILTEFLPRGSLYRLLH-RPNHQLDER 790
H N+V + G + I EF +G+L + + R +LD+
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 791 RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850
+ + + KG++Y+H+ +++RDLK N+ + VK+ DFGL +
Sbjct: 123 LALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRT 179
Query: 851 STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR 910
+ GT +M+PE + ++ ++ D+Y+ G+IL EL + + R
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF-TDLRD 233
Query: 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
I D D +++ +P RP+ ++++
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 64/271 (23%), Positives = 103/271 (38%), Gaps = 28/271 (10%)
Query: 692 EDLQIGERIGIGSYGEVY----RADWHGTEVAVKKFLDQDFSGDS-LSQFKCEAEIMLRL 746
+ Q R+G GSYGEV+ + D G AVK+ F G ++ E ++
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKED--GRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKV 113
Query: 747 -RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
+HP V A + TE SL + L E + D + +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA----GTPEWMAP 861
LH+ +VH D+K N+ + K+ DFGL L + G P +MAP
Sbjct: 173 LHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVE-----LGTAGAGEVQEGDPRYMAP 225
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPA 920
E+L DV+S G+ + E+A G Q + Q E +
Sbjct: 226 ELL-QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLSSE 280
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
+ ++ + +P LR + L+ L L++
Sbjct: 281 LRSVLVMMLEPDPKLRATAEALL-ALPVLRQ 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-52
Identities = 54/267 (20%), Positives = 116/267 (43%), Gaps = 22/267 (8%)
Query: 695 QIGERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--V 751
I ++IG G +V++ + A+K ++ +L ++ E + +L+ + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ + ++ E L L + +D R ++ + ++ +H
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG- 128
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
IVH DLK N L+ ++K+ DFG++ T + S GT +M PE +++ +
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 870 -----------NEKCDVYSFGVILWELATLSVPWKGL-NPMQVVGAVGFQNRRLEIPDDI 917
+ K DV+S G IL+ + P++ + N + + A+ N +E PD
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ + +++ C + +P R S +L++
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 6e-52
Identities = 54/267 (20%), Positives = 116/267 (43%), Gaps = 22/267 (8%)
Query: 695 QIGERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--V 751
I ++IG G +V++ + A+K ++ +L ++ E + +L+ + +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ + ++ E L L + +D R ++ + ++ +H
Sbjct: 91 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG- 147
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
IVH DLK N L+ ++K+ DFG++ T + S GT +M PE +++ +
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 870 -----------NEKCDVYSFGVILWELATLSVPWKGL-NPMQVVGAVGFQNRRLEIPDDI 917
+ K DV+S G IL+ + P++ + N + + A+ N +E PD
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ + +++ C + +P R S +L++
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-51
Identities = 53/267 (19%), Positives = 115/267 (43%), Gaps = 22/267 (8%)
Query: 695 QIGERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--V 751
I ++IG G +V++ + A+K ++ +L ++ E + +L+ + +
Sbjct: 59 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ + ++ E L L + +D R ++ + ++ +H
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG- 175
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
IVH DLK N L+ ++K+ DFG++ T + S G +M PE +++ +
Sbjct: 176 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 870 N-----------EKCDVYSFGVILWELATLSVPWKGL-NPMQVVGAVGFQNRRLEIPDDI 917
+ K DV+S G IL+ + P++ + N + + A+ N +E PD
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ + +++ C + +P R S +L++
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-50
Identities = 55/280 (19%), Positives = 99/280 (35%), Gaps = 40/280 (14%)
Query: 692 EDLQIGERIGIGSYGEVYRA----DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL- 746
+ E+IG G +G V++ D G A+K+ E L
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLD--GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL---HRPNHQLDERRRMRMALDVAKGM 803
+H +VV + A H I E+ GSL + +R E + L V +G+
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKN-------------------WVVKVCDFGLSRIKHH 844
Y+H+ +VH D+K N+ + + + K+ D G
Sbjct: 129 RYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 845 TYLSSKSTAGTPEWMAPEVLR-NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGA 903
+ G ++A EVL+ N K D+++ + + A + + +
Sbjct: 187 P----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI-- 240
Query: 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
Q R IP + ++++ +P RPS L+
Sbjct: 241 --RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-49
Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 45/288 (15%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH 748
D + +G G++G+V +A + A+KK + + LS E ++ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKA-RNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNH 61
Query: 749 PNVVLFMGAVTRSPHFS-------------ILTEFLPRGSLYRLLHRPNHQLDERRRMRM 795
VV + A +F I E+ G+LY L+H N R+
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA-- 853
+ + ++Y+H+ I+HRDLK N+ +D++ VK+ DFGL++ H + K +
Sbjct: 122 FRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 854 ------------GTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQV 900
GT ++A EVL NEK D+YS G+I +E+ G+ + +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNI 237
Query: 901 VGAVGFQNRRLEIP----DDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ + ++ +E P D+ +IIR +P+ RP L++
Sbjct: 238 LKKL--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 9e-49
Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 26/281 (9%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+ +++G G + V H G A+K+ L + + + EA++ HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHP 86
Query: 750 NVVLFMGAVTRSP----HFSILTEFLPRGSLYRLL---HRPNHQLDERRRMRMALDVAKG 802
N++ + R +L F RG+L+ + + L E + + + L + +G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA--------- 853
+ +H HRDLK N+L+ + D G S+
Sbjct: 147 LEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 854 GTPEWMAPEVL---RNEPANEKCDVYSFGVILWELATLSVPWKGLN-PMQVVGAVGFQNR 909
T + APE+ + +E+ DV+S G +L+ + P+ + V
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
Query: 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950
+ A+ Q++ +PH RP L+S+L LQ
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-46
Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 37/286 (12%)
Query: 694 LQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPN 750
L++ + G + VY A G E A+K+ L + + E M +L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPN 87
Query: 751 VVLFMGAVTRSPHFS-------ILTEFLPRGSLYRLL--HRPNHQLDERRRMRMALDVAK 801
+V F A + S +L L +G L L L +++ +
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA-------- 853
+ ++H P I+HRDLK NLL+ +K+CDFG + H S S
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 854 ----GTPEWMAPEVL---RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF 906
TP + PE++ N P EK D+++ G IL+ L P++ +++V
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV----- 262
Query: 907 QNRRLEIPDD--IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950
N + IP +IR Q P R S A+++ +L+ +
Sbjct: 263 -NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 31/277 (11%)
Query: 700 IGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV 758
IG G +G+VY+ G +VA+K+ + S + +F+ E E + RHP++V +G
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKR-RTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 759 TRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALDVAKGMNYLHTSHPTIVH 815
++ +++ G+L R L+ + + +R+ + + A+G++YLHT I+H
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIH 162
Query: 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST--AGTPEWMAPEVLRNEPANEKC 873
RD+KS N+L+D+N+V K+ DFG+S+ + ST GT ++ PE EK
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS 222
Query: 874 DVYSFGVILWELATLSVPWKGLNPMQVVGAVG--------FQNRRLE------IPDDIDP 919
DVYSFGV+L+E+ + V N +LE + D I P
Sbjct: 223 DVYSFGVVLFEVLCARSA---IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279
Query: 920 A----VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952
C RPS ++ +L RL
Sbjct: 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 56/285 (19%), Positives = 109/285 (38%), Gaps = 40/285 (14%)
Query: 692 EDLQIGERIGIGSYGEVYRA----DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
D + + +G G +G V+ A D A+K+ + + + E + + +L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVD--DCNYAIKR-IRLPNRELAREKVMREVKALAKLE 61
Query: 748 HPNVVLFMGAVTRSPHFS------------ILTEFLPRGSLYRLLH--RPNHQLDERRRM 793
HP +V + A I + + +L ++ + + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 794 RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA 853
+ L +A+ + +LH+ ++HRDLK N+ + VVKV DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 854 ------------GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVV 901
GT +M+PE + + K D++S G+IL+EL L + ++ +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVRTL 237
Query: 902 GAVGFQNRRL-EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945
V +N + + P +++D P RP ++
Sbjct: 238 TDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 74/256 (28%), Positives = 129/256 (50%), Gaps = 14/256 (5%)
Query: 692 EDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
E E+IG GS+GEV++ + VA+K +D + + D + + E ++ + P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
V + G+ + I+ E+L GS LL LDE + + ++ KG++YLH+
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSE 138
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
+HRD+K+ N+L+ ++ VK+ DFG++ T + + GTP WMAPEV++
Sbjct: 139 K--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF---QNRRLEIPDDIDPAVAQIIR 926
+ K D++S G+ ELA P L+PM+V+ F +N + + + + +
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVL----FLIPKNNPPTLEGNYSKPLKEFVE 252
Query: 927 DCWQTEPHLRPSFAQL 942
C EP RP+ +L
Sbjct: 253 ACLNKEPSFRPTAKEL 268
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-43
Identities = 61/256 (23%), Positives = 114/256 (44%), Gaps = 7/256 (2%)
Query: 692 EDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+D + +G G+ G V++ G +A K + + +Q E +++ P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+V F GA SI E + GSL ++L + ++ E+ ++++ V KG+ YL
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK 150
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
H I+HRD+K N+LV+ +K+CDFG+S + + S GT +M+PE L+
Sbjct: 151 H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHY 207
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929
+ + D++S G+ L E+A P + ++ G Q P + +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 930 QTEPHLRPSFAQLMSR 945
+ + +L+
Sbjct: 268 GMDSRPPMAIFELLDY 283
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 46/278 (16%)
Query: 700 IGIGSYGEVYRAD-WHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV 758
+G G +G+VY+ GT VAVK+ ++ G QF+ E E++ H N++ G
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE-LQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 759 TRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALDVAKGMNYLH-TSHPTIV 814
++ ++ GS+ L LD +R R+AL A+G+ YLH P I+
Sbjct: 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTPEWMAPEVLRNEPANEK 872
HRD+K+ N+L+D+ + V DFGL+++ T++++ GT +APE L ++EK
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 215
Query: 873 CDVYSFGVILWELATLSVPWKGLNPMQVVGAVG-------------FQNRRLEIPDDIDP 919
DV+ +GV+L EL T G + + ++LE +D
Sbjct: 216 TDVFGYGVMLLELIT------GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE--ALVDV 267
Query: 920 A------------VAQIIRDCWQTEPHLRPSFAQLMSR 945
+ Q+ C Q+ P RP MS
Sbjct: 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPK----MSE 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 15/265 (5%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
+WE + +G G++G+VY+A G A K ++ S + L + E EI+
Sbjct: 18 NEVWEIV---GELGDGAFGKVYKAKNKETGALAAAKV-IETK-SEEELEDYIVEIEILAT 72
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
HP +V +GA I+ EF P G++ ++ + L E + + + + +N+
Sbjct: 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
LH+ I+HRDLK+ N+L+ +++ DFG+S T S GTP WMAPEV+
Sbjct: 133 LHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 866 NEPA-----NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDP 919
E + K D++S G+ L E+A + P LNPM+V+ + + L P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250
Query: 920 AVAQIIRDCWQTEPHLRPSFAQLMS 944
++ P RPS AQL+
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 19/273 (6%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
W+ EDL+ IG G+YG V + G +AVK+ + Q + +++
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVV 74
Query: 744 LRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR----PNHQLDERRRMRMALD 798
+R P +V F GA+ R I E + S + + + E ++ L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEW 858
K +N+L + I+HRD+K N+L+D++ +K+CDFG+S + ++ AG +
Sbjct: 134 TVKALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPY 191
Query: 859 MAPEVLRNEPANE----KCDVYSFGVILWELATLSVPWKGLNPM--QVVGAVGFQNRRLE 912
MAPE + + + + DV+S G+ L+ELAT P+ N + Q+ V +L
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251
Query: 913 IPDDID--PAVAQIIRDCWQTEPHLRPSFAQLM 943
++ + P+ + C + RP + +L+
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-42
Identities = 59/290 (20%), Positives = 109/290 (37%), Gaps = 25/290 (8%)
Query: 672 GQSDSINPMLGEVAEWEILWEDL--QIGERIGIGSYGEVYRAD-WHGTEVAVKKFLDQDF 728
G S S+ G+ ++ + + +G G+ G + + +VAVK+ L + F
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61
Query: 729 SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQL 787
+ E +++ HPNV+ + I E +L + + +
Sbjct: 62 --SFADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAH 115
Query: 788 DERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV-----DKNWVVKVCDFGLSRI- 841
+ + G+ +LH+ + IVHRDLK N+L+ + DFGL +
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 842 --KHHTYLSSKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSV-PWKGL 895
H++ GT W+APE+L E D++S G + + + + P+
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233
Query: 896 NPMQVVGAVG-FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
Q +G L D ++I +P RPS ++
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 61/267 (22%), Positives = 114/267 (42%), Gaps = 12/267 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIML 744
++ DL+ +G G+ G+V++ V K + + + + + + +++L
Sbjct: 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78
Query: 745 RL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
+ P +V G + I E + +L R + ER +M + + K +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEV 863
YL H I HRD+K N+L+D+ +K+CDFG+S + +AG +MAPE
Sbjct: 138 YYLKEKHGVI-HRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPER 195
Query: 864 LRNEPANE-----KCDVYSFGVILWELATLSVPWKGLNP-MQVVGA-VGFQNRRLEIPDD 916
+ + + DV+S G+ L ELAT P+K +V+ + + L
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLM 943
++DC + RP + +L+
Sbjct: 256 FSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 70/263 (26%), Positives = 120/263 (45%), Gaps = 16/263 (6%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH---GTEVAVKK-FLDQDFSGDSLSQFKCEAE 741
+W + ED +IG +G G +G VY A +A+K F Q Q + E E
Sbjct: 5 QWAL--EDFEIGRPLGKGKFGNVYLAR-EKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 742 IMLRLRHPNVV-LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
I LRHPN++ L+ + + IL E+ P G++YR L + + DE+R ++A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELA 119
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMA 860
++Y H+ ++HRD+K NLL+ +K+ DFG S H GT +++
Sbjct: 120 NALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLP 175
Query: 861 PEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
PE++ +EK D++S GV+ +E P++ + + PD +
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEG 233
Query: 921 VAQIIRDCWQTEPHLRPSFAQLM 943
+I + P RP +++
Sbjct: 234 ARDLISRLLKHNPSQRPMLREVL 256
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 34/278 (12%)
Query: 692 EDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+D ++ E IG G+ V A +VA+K+ ++ + S+ + E + M + HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLL-------HRPNHQLDERRRMRMALDVAKG 802
N+V + + ++ + L GS+ ++ + LDE + +V +G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG----LSRIKHHTYLSSKST-AGTPE 857
+ YLH + +HRD+K+ N+L+ ++ V++ DFG L+ T + T GTP
Sbjct: 134 LEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 858 WMAPEVL-RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF---QNR--RL 911
WMAPEV+ + + K D++SFG+ ELAT + P+ PM+V+ QN L
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL----MLTLQNDPPSL 247
Query: 912 EIPDDIDPAVAQ-------IIRDCWQTEPHLRPSFAQL 942
E + + +I C Q +P RP+ A+L
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 19/266 (7%)
Query: 692 EDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RH 748
+DL+ +G G+YG V + G +AVK+ + + + + +I +R
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSL---YRLLHRPNHQLDERRRMRMALDVAKGMNY 805
P V F GA+ R I E + SL Y+ + + E ++A+ + K + +
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST-AGTPEWMAPEVL 864
LH+ +++HRD+K N+L++ VK+CDFG+S +K AG +MAPE +
Sbjct: 125 LHSKL-SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDIDAGCKPYMAPERI 181
Query: 865 RNEPA----NEKCDVYSFGVILWELATLSVPWKGL-NPMQVVGA-VGFQNRRLEIPDDID 918
E + K D++S G+ + ELA L P+ P Q + V + +L D
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP-ADKFS 240
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMS 944
C + RP++ +LM
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 36/278 (12%)
Query: 699 RIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSL---SQFKCEAEIMLRLRHPNVVLFM 755
++G G +G VY+ + T VAVKK L + QF E ++M + +H N+V +
Sbjct: 38 KMGEGGFGVVYKGYVNNTTVAVKK-LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ--LDERRRMRMALDVAKGMNYLHTSHPTI 813
G + ++ ++P GSL L + L R ++A A G+N+LH +H
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--H 154
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST--AGTPEWMAPEVLRNEPANE 871
+HRD+KS N+L+D+ + K+ DFGL+R + ++ GT +MAPE LR E
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITP 213
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQ--------VVGAVGFQNRRLEIPDDIDPA--- 920
K D+YSFGV+L E+ T GL + + ++ I D ID
Sbjct: 214 KSDIYSFGVVLLEIIT------GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267
Query: 921 --------VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950
+ + C + + RP ++ L+ +
Sbjct: 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 9e-42
Identities = 63/259 (24%), Positives = 120/259 (46%), Gaps = 14/259 (5%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKF-LDQDFSGDSLSQFKCEAEIML 744
+ + E+IG G+ G VY A G EVA+++ L Q + + E +M
Sbjct: 19 KKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMR 72
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMN 804
++PN+V ++ + ++ E+L GSL ++ +DE + + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALE 130
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
+LH++ ++HRD+KS N+L+ + VK+ DFG + GTP WMAPEV+
Sbjct: 131 FLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 865 RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQ 923
+ K D++S G++ E+ P+ NP++ + + L+ P+ +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 924 IIRDCWQTEPHLRPSFAQL 942
+ C + + R S +L
Sbjct: 249 FLNRCLEMDVEKRGSAKEL 267
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-42
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 20/283 (7%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRAD--WHGTEVAVKKF-LDQDFSGDSLSQFKCEAEIML 744
E +++ L E++G GSYG VY+A G VA+K+ ++ D L + E IM
Sbjct: 28 EEVFDVL---EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQ 79
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMN 804
+ P+VV + G+ ++ I+ E+ GS+ ++ N L E + KG+
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
YLH +HRD+K+ N+L++ K+ DFG++ T + GTP WMAPEV+
Sbjct: 140 YLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 865 RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQ 923
+ N D++S G+ E+A P+ ++PM+ + + P+
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257
Query: 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSEL 966
++ C P R + QL LQ V + + +L
Sbjct: 258 FVKQCLVKSPEQRATATQL------LQHPFVRSAKGVSILRDL 294
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 66/255 (25%), Positives = 111/255 (43%), Gaps = 11/255 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGT--EVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRH 748
L +IG GS G V A + +VAVK L + E IM +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQH 101
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
NVV + +L EFL G+L ++ +L+E + + V + + YLH
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHA 159
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
++HRD+KS ++L+ + VK+ DFG KS GTP WMAPEV+
Sbjct: 160 QG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQIIRD 927
+ D++S G+++ E+ P+ +P+Q + + +L+ + P + +
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277
Query: 928 CWQTEPHLRPSFAQL 942
+P R + +L
Sbjct: 278 MLVRDPQERATAQEL 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 68/297 (22%), Positives = 120/297 (40%), Gaps = 55/297 (18%)
Query: 696 IGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+ + +G G+ V+R H G A+K F + + E E++ +L H N+V
Sbjct: 13 LSDILGQGATANVFRG-RHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 753 -LFMGAV---TRSPHFSILTEFLPRGSLYRLLHRPNHQ--LDERRRMRMALDVAKGMNYL 806
LF A+ T + H ++ EF P GSLY +L P++ L E + + DV GMN+L
Sbjct: 71 KLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 807 HTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPE 862
+ IVHR++K N++ D V K+ DFG +R S GT E++ P+
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-VSLYGTEEYLHPD 185
Query: 863 VLR--------NEPANEKCDVYSFGVILWELATLSVPW-----------------KGLNP 897
+ + D++S GV + AT S+P+ G
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 898 MQVVGAVGFQNRRLE----------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ G +N ++ + + + ++ + + + F Q +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-41
Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 21/274 (7%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
++ ER+G G +G V R H G +VA+K+ Q+ S + ++ E +IM +L HPNV
Sbjct: 17 EMKERLGTGGFGYVLRW-IHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 752 V-LF-----MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ--LDERRRMRMALDVAKGM 803
V + + + + E+ G L + L++ + L E + D++ +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKN---WVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMA 860
YLH + I+HRDLK N+++ + K+ D G ++ L GT +++A
Sbjct: 135 RYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-TEFVGTLQYLA 191
Query: 861 PEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
PE+L + D +SFG + +E T P+ + I D
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954
A T HL A + R LQ +L+
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERW--LQCMLM 283
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 12/257 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRA--DWHGTEVAVKK-FLDQDFSGDSLSQFKCEAEIMLRLRH 748
+D IG +G G +G VY A + +A+K F Q Q + E EI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 749 PNVVLFMGAV-TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
PN++ R + +L EF PRG LY+ L + + + DE+R ++A ++Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLML-EFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH 131
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNE 867
++HRD+K NLL+ +K+ DFG S H L ++ GT +++ PE++ +
Sbjct: 132 ERK--VIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPPEMIEGK 187
Query: 868 PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927
+EK D++ GV+ +E P+ + + + N L+ P + +I
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--VNVDLKFPPFLSDGSKDLISK 245
Query: 928 CWQTEPHLRPSFAQLMS 944
+ P R +M
Sbjct: 246 LLRYHPPQRLPLKGVME 262
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-40
Identities = 71/320 (22%), Positives = 125/320 (39%), Gaps = 55/320 (17%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
+ + +G G+ V+R H G A+K F + + E E++ +L H N+
Sbjct: 12 LLSDILGQGATANVFRG-RHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 752 V-LFMGAV---TRSPHFSILTEFLPRGSLYRLLHRPNHQ--LDERRRMRMALDVAKGMNY 805
V LF A+ T + H ++ EF P GSLY +L P++ L E + + DV GMN+
Sbjct: 70 VKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 806 LHTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
L + IVHR++K N++ D V K+ DFG +R S GT E++ P
Sbjct: 128 LRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-VSLYGTEEYLHP 184
Query: 862 EVLRNEPA--------NEKCDVYSFGVILWELATLSVPW-----------------KGLN 896
++ D++S GV + AT S+P+ G
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 897 PMQVVGAVGFQNRRLE----------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
+ G +N ++ + + + ++ + + + F Q +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 947 RCLQRLLVDRSNSTNQFSEL 966
+ +V S Q +
Sbjct: 305 SDILHRMVIHVFSLQQMTAH 324
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 60/283 (21%), Positives = 125/283 (44%), Gaps = 24/283 (8%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDS--LSQFKCEAEIMLRLRHPN 750
+I +++G G VY A+ +VA+K + L +F+ E +L H N
Sbjct: 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 751 VV-LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+V + ++ ++ E++ +L + + L + + G+ + H
Sbjct: 73 IVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA-GTPEWMAPEVLRNEP 868
IVHRD+K N+L+D N +K+ DFG+++ T L+ + GT ++ +PE + E
Sbjct: 131 R--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD-------DIDPAV 921
+E D+YS G++L+E+ P+ G + + ++ + +P+ DI ++
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA----IKHIQDSVPNVTTDVRKDIPQSL 244
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFS 964
+ +I + + R Q M L +L + + + +
Sbjct: 245 SNVILRATEKDKANRYKTIQEM--KDDLSSVLHENRANEDVYE 285
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-40
Identities = 80/290 (27%), Positives = 126/290 (43%), Gaps = 32/290 (11%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKF-LDQDFSGDSLSQFKCEAEIML 744
E L+ DL IG GS+G VY A + VA+KK S + E +
Sbjct: 53 EKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMN 804
+LRHPN + + G R ++ E+ GS LL L E + +G+
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST-AGTPEWMAPEV 863
YLH+ + ++HRD+K+ N+L+ + +VK+ DFG + + ++ ++ GTP WMAPEV
Sbjct: 169 YLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEV 221
Query: 864 LRNE---PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
+ + K DV+S G+ ELA P +N M + + + E P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNESPALQSGH 277
Query: 921 VAQIIRD----CWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQFSEL 966
++ R+ C Q P RP+ L L+ V R +L
Sbjct: 278 WSEYFRNFVDSCLQKIPQDRPTSEVL------LKHRFVLRERPPTVIMDL 321
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-39
Identities = 50/247 (20%), Positives = 96/247 (38%), Gaps = 16/247 (6%)
Query: 668 MTCNGQSDSINPMLGEVAEWEILWEDLQIGERIGIG--SYGEVYRA-DWH-GTEVAVKKF 723
M + N ++ + ++ IG G V A G V V++
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI 60
Query: 724 LDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL-HR 782
+ S + ++ + E + HPN+V + ++T F+ GS L+
Sbjct: 61 NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH 120
Query: 783 PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS--- 839
++E + V K ++Y+H VHR +K+ ++L+ + V + +
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSM 178
Query: 840 ---RIKHHT-YLSSKSTAGTPEWMAPEVLRNEPA--NEKCDVYSFGVILWELATLSVPWK 893
+ + K + W++PEVL+ + K D+YS G+ ELA VP+K
Sbjct: 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
Query: 894 GLNPMQV 900
+ Q+
Sbjct: 239 DMPATQM 245
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 695 QIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNV 751
++ E +G G+YG+VY+ G A+K D +GD + K E ++ + H N+
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKV---MDVTGDEEEEIKQEINMLKKYSHHRNI 83
Query: 752 VLFMGAVTRSPHFS------ILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMN 804
+ GA + ++ EF GS+ L+ + L E + ++ +G++
Sbjct: 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
+LH ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 144 HLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 865 RNEPA-----NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF---QNR--RLEIP 914
+ + K D++S G+ E+A + P ++PM+ + F +N RL+
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPAPRLK-S 256
Query: 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLM--------SRLRCLQRLLVDR 956
I C RP+ QLM R ++ L D
Sbjct: 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDH 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 67/264 (25%), Positives = 115/264 (43%), Gaps = 23/264 (8%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQD--FSGDSLSQFKCEAEIMLRL 746
ED ++G +G GS+ VYRA+ G EVA+K +D+ + + + + E +I +L
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAE-SIHTGLEVAIK-MIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806
+HP+++ S + ++ E G + R L E + GM YL
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS------RIKHHTYLSSKSTAGTPEWMA 860
H+ I+HRDL NLL+ +N +K+ DFGL+ KH+T GTP +++
Sbjct: 129 HSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT------LCGTPNYIS 180
Query: 861 PEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920
PE+ + DV+S G + + L P+ + V E+P +
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIE 238
Query: 921 VAQIIRDCWQTEPHLRPSFAQLMS 944
+I + P R S + ++
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVLD 262
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 70/271 (25%), Positives = 124/271 (45%), Gaps = 35/271 (12%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDS--LSQFKCEAEIMLRLRHPN 750
++GE +G G EV+ A +VAVK L D + D +F+ EA+ L HP
Sbjct: 15 ELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 751 VVLFMGAV---------TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK 801
+V AV + I+ E++ +L ++H + +R + + D +
Sbjct: 74 IV----AVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQ 127
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA---GTPEW 858
+N+ H + I+HRD+K N+++ VKV DFG++R + S TA GT ++
Sbjct: 128 ALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP---- 914
++PE R + + + DVYS G +L+E+ T P+ G +P+ V +Q+ R +
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----YQHVREDPIPPSA 241
Query: 915 --DDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+ + + ++ P R A M
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVK---------------KFLDQDFSGDSLSQF 736
D +I + G + ++ + A+K D+ F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 737 KCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMA 796
K E +I+ +++ + G +T I+ E++ S+ + LD+ +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIP 149
Query: 797 LDVAK--------GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848
+ V K +Y+H + I HRD+K N+L+DKN VK+ DFG S +
Sbjct: 150 IQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI- 207
Query: 849 SKSTAGTPEWMAPEVLRNEP--ANEKCDVYSFGVILWELATLSVP 891
K + GT E+M PE NE K D++S G+ L+ + VP
Sbjct: 208 -KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 66/255 (25%), Positives = 109/255 (42%), Gaps = 12/255 (4%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRHP 749
G +G G + + + A K + + + E I L H
Sbjct: 18 VRGRFLGKGGFAKCFEIS-DADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+VV F G + ++ E R SL L R L E + G YLH +
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
++HRDLK NL ++++ VK+ DFGL+ + K GTP ++APEVL +
Sbjct: 135 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929
+ + DV+S G I++ L P++ + + + IP I+P A +I+
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAASLIQKML 250
Query: 930 QTEPHLRPSFAQLMS 944
QT+P RP+ +L++
Sbjct: 251 QTDPTARPTINELLN 265
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-37
Identities = 66/255 (25%), Positives = 109/255 (42%), Gaps = 12/255 (4%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRHP 749
G +G G + + + A K + + + E I L H
Sbjct: 44 VRGRFLGKGGFAKCFEIS-DADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+VV F G + ++ E R SL L R L E + G YLH +
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
++HRDLK NL ++++ VK+ DFGL+ + K GTP ++APEVL +
Sbjct: 161 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929
+ + DV+S G I++ L P++ + + + IP I+P A +I+
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAASLIQKML 276
Query: 930 QTEPHLRPSFAQLMS 944
QT+P RP+ +L++
Sbjct: 277 QTDPTARPTINELLN 291
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 6/233 (2%)
Query: 721 KKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRG-SLYRL 779
+F+ G Q K + + + + + + + L
Sbjct: 123 NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182
Query: 780 LHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839
L + + VAKGM +L + +HRDL + N+L+ + VVK+CDFGL+
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 840 R-IKHHTYLSSKSTAGTP-EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLN 896
R I K A P +WMAPE + + + DV+SFGV+LWE+ +L + P+ G+
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 897 PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949
+ + R+ PD P + Q + DCW EP RP+F++L+ L L
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 8e-18
Identities = 35/187 (18%), Positives = 67/187 (35%), Gaps = 15/187 (8%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCE 739
+WE + L++G+ +G G++G+V AD G K L + + E
Sbjct: 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 75
Query: 740 AEIMLRL-RHPNVVLFMGAVTRSPH-FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
+I++ + H NVV +GA T+ ++ EF G+L L ++
Sbjct: 76 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP--YKTKGA 133
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE 857
+G +Y+ + DLK + + F + +
Sbjct: 134 RFRQGKDYVG-----AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
Query: 858 WMAPEVL 864
++ E L
Sbjct: 189 FLTLEHL 195
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 2e-36
Identities = 41/293 (13%), Positives = 83/293 (28%), Gaps = 49/293 (16%)
Query: 694 LQIGERIGIGSYGEVYRA-DWH-GTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLR--- 747
L G +G A D G V + +++ Q K E + LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 748 -------------------HPNVVLFMGAVTRSPHFSILTEFL----PRGSLYRLLH--- 781
P + +L+ F + +L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 782 ---RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838
+ L R+++ L V + + LH +VH L+ ++++D+ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 839 SRIKHHTYLSSKSTA-GTPEWMAPEVLRNEPANEK-----CDVYSFGVILWELATLSVPW 892
+ +S PE A +L + D ++ G+ ++ + +P
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 893 KGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945
+ + +I V ++ + R Q M
Sbjct: 318 TDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 32/282 (11%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDS--LSQFKCEAEIMLRLRHPN 750
++ +G G G+VY A D VA+K + + S D ++ + EA RL+ P+
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 751 VVLFMGAV-----TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
VV + + + + L +L R L R + + + ++
Sbjct: 96 VV----PIHDFGEIDGQLY-VDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDA 149
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA-GTPEWMAPEVL 864
H + HRD+K N+LV + + DFG++ L+ GT +MAPE
Sbjct: 150 AHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 865 RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP------DDID 918
A + D+Y+ +L+E T S P++G + + V+ + IP I
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVM----GAHINQAIPRPSTVRPGIP 262
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSR--LRCLQRLLVDRSN 958
A +I P R +S L DR+
Sbjct: 263 VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRAT 304
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-36
Identities = 37/296 (12%), Positives = 76/296 (25%), Gaps = 50/296 (16%)
Query: 693 DLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHP 749
L++ E + +G V+ D + A+K F + + S L + RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 750 NVVLFM-----------GAVTRSPHFSILTEF--------------LPRGSLYRLLHR-- 782
+ AV P F+ L+ L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 783 ----PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838
+ + + L + +VH NL + + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 839 SRIKHHTYLSSKSTAGTPEWMAPEVL---RNEPANEKCDVYSFGVILWELATLSVPWKGL 895
+ + P AP + + G+ ++ + L +P+ +
Sbjct: 241 LWKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 896 NP-------MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
P + G + + V +I + R + M
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 71/256 (27%), Positives = 118/256 (46%), Gaps = 15/256 (5%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
++ + IG G++ +V A H G EVA+K + SL + E IM L HPN+
Sbjct: 18 RLLKTIGKGNFAKVKLA-RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 752 V-LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
V LF T + ++ E+ G ++ L + ++ E+ + + Y H
Sbjct: 77 VKLFEVIETEKTLY-LIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWMAPEVLRNEP- 868
IVHRDLK+ NLL+D + +K+ DFG S L + G P + APE+ + +
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKY 190
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928
+ DV+S GVIL+ L + S+P+ G N ++ V + IP + +++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRF 248
Query: 929 WQTEPHLRPSFAQLMS 944
P R + Q+M
Sbjct: 249 LVLNPIKRGTLEQIMK 264
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 46/252 (18%), Positives = 93/252 (36%), Gaps = 25/252 (9%)
Query: 709 YRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768
++ + + + S + + M N V + + + I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 769 EFLPRGSLYRLLHRPNHQ--LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD 826
+ + +L ++R + + + + +A+ + +LH+ ++HRDLK N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT 198
Query: 827 KNWVVKVCDFGLSRIKHHTYLSSKSTA------------GTPEWMAPEVLRNEPANEKCD 874
+ VVKV DFGL GT +M+PE + + K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 875 VYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDID---PAVAQIIRDCWQT 931
++S G+IL+EL + ++++ V R L+ P P +++D
Sbjct: 259 IFSLGLILFELLYSFST--QMERVRIITDV----RNLKFPLLFTQKYPQEHMMVQDMLSP 312
Query: 932 EPHLRPSFAQLM 943
P RP ++
Sbjct: 313 SPTERPEATDII 324
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 51/383 (13%), Positives = 104/383 (27%), Gaps = 80/383 (20%)
Query: 620 PGSPLPAAAEFCQRQPENALVSVKQPVYTDLGKESAADLMPMINSGLLMTCNGQSDSINP 679
PG E R P+ + + + + + + L GQ +
Sbjct: 19 PGDV--VIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWN----------TGQPFRVES 66
Query: 680 MLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWH---GTEVAVKKF-LDQDFSGDSLSQ 735
LGE L G +G A G V + +++ Q
Sbjct: 67 ELGERPR------TLVRGTVLGQEDPYAYLEA-TDQETGESFEVHVPYFTERPPSNAIKQ 119
Query: 736 FKCEAEIMLRLR----------------------HPNVVLFMGAVTRSPHFSILTEFL-- 771
K E + LR P + +L+ F
Sbjct: 120 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 179
Query: 772 --PRGSLYRLLH------RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNL 823
+ +L + L R+++ L V + + LH +VH L+ ++
Sbjct: 180 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDI 237
Query: 824 LVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL-----------RNEPANEK 872
++D+ V + F ++ + + PE+ R
Sbjct: 238 VLDQRGGVFLTGFEHLVRDGARV----VSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 873 CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTE 932
D ++ G++++ + +P + + +I V ++ +
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYP 347
Query: 933 PHLRPSFAQLMSR--LRCLQRLL 953
R Q M L+ L
Sbjct: 348 KEDRLLPLQAMETPEYEQLRTEL 370
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+ E +G G++ V R T E A K + S + + EA I +L+HPN+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
++ ++ + + G L+ ++ R E + + + Y H++
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG- 125
Query: 812 TIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNE 867
IVHR+LK NLL+ K VK+ DFGL+ + AGTP +++PEVL+ +
Sbjct: 126 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKD 182
Query: 868 PANEKCDVYSFGVIL 882
P ++ D+++ GVIL
Sbjct: 183 PYSKPVDIWACGVIL 197
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 47/324 (14%), Positives = 108/324 (33%), Gaps = 55/324 (16%)
Query: 673 QSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGT-------EVAVKKFLD 725
+ P + E+++ + + + +G G++ +VY A + +K
Sbjct: 46 EWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-- 103
Query: 726 QDFSGDSLSQFKCEAEIMLRLR---HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHR 782
+ +F ++M RL+ + F A ++ E G+L ++
Sbjct: 104 ---KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINL 160
Query: 783 ----PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV-----------DK 827
P + + + A+ + + +H I+H D+K N ++ D
Sbjct: 161 YKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDL 218
Query: 828 NWVVKVCDFGLSRIKHH----TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILW 883
+ + + D G S T ++K T + E+L N+P N + D + ++
Sbjct: 219 SAGLALIDLGQSIDMKLFPKGTIFTAK--CETSGFQCVEMLSNKPWNYQIDYFGVAATVY 276
Query: 884 ELATLSVPWKGLNPMQVVGAVGFQ------------NRRLEIPDDIDPAVAQIIRDCWQT 931
+ + + F+ + L IPD ++R +
Sbjct: 277 CMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336
Query: 932 EPHLRPSFAQLMSRLRCLQRLLVD 955
+++R L+ L+
Sbjct: 337 VFQQH-----YTNKIRALRNRLIV 355
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+ E +G G++ V R T E A K + S + + EA I +L+HPN+V
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
++ ++ + + G L+ ++ R E + + + Y H++
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNG- 148
Query: 812 TIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNE 867
IVHR+LK NLL+ K VK+ DFGL+ + AGTP +++PEVL+ +
Sbjct: 149 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKD 205
Query: 868 PANEKCDVYSFGVIL 882
P ++ D+++ GVIL
Sbjct: 206 PYSKPVDIWACGVIL 220
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 58/273 (21%), Positives = 118/273 (43%), Gaps = 36/273 (13%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKF------LDQDFSGDSLSQFKCEAEIMLR 745
+ + +G G+ GEV A + +VA++ + D + E EI+ +
Sbjct: 138 IMSKTLGSGACGEVKLA-FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMN 804
L HP ++ + + I+ E + G L+ +++ +L E + +
Sbjct: 197 LNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQ 253
Query: 805 YLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRI-KHHTYLSSKSTAGTPEWMA 860
YLH + I+HRDLK N+L+ +++ ++K+ DFG S+I + + ++ GTP ++A
Sbjct: 254 YLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLA 309
Query: 861 PEVLRNEPA---NEKCDVYSFGVILWELATLS-VP--WKGLNPMQVVGAVGFQNRRLEIP 914
PEVL + N D +S GVIL+ LS P + + + + + +
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFIC--LSGYPPFSEHRTQVSLKDQI--TSGKYNFI 365
Query: 915 ----DDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
++ +++ +P R + + +
Sbjct: 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-33
Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 10/194 (5%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
Q+ E +G G++ V R E A + S + + EA I L+HPN+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+++ H ++ + + G L+ ++ R E + + + + H
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMG- 130
Query: 812 TIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
+VHR+LK NLL+ K VK+ DFGL+ + AGTP +++PEVLR +P
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 869 ANEKCDVYSFGVIL 882
+ D+++ GVIL
Sbjct: 190 YGKPVDLWACGVIL 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK----KFLDQDFSGDSLSQFKCEAEIMLRLR 747
IGE +G G + V + G E A K + G S + + E I+ ++
Sbjct: 15 DIGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYL 806
H NV+ ++ E + G L+ L + + L E + G+NYL
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYL 131
Query: 807 HTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAP 861
HT I H DLK N+++ +K+ DFGL+ I+ K+ GTPE++AP
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAP 187
Query: 862 EVLRNEPANEKCDVYSFGVIL 882
E++ EP + D++S GVI
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 67/195 (34%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
I +G GS+GEV + T E AVK S E E++ +L HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ S F I+ E G L+ ++ R E R+ V G+ Y+H +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHN- 141
Query: 812 TIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNE 867
IVHRDLK N+L+ +K+ +K+ DFGLS + +T + + GT ++APEVLR
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-G 197
Query: 868 PANEKCDVYSFGVIL 882
+EKCDV+S GVIL
Sbjct: 198 TYDEKCDVWSAGVIL 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK----KFLDQDFSGDSLSQFKCEAEIMLRLR 747
++GE +G G + V + G E A K + L G S + + E I+ +R
Sbjct: 8 EMGEELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYL 806
HPN++ ++ E + G L+ L + + L E + + G++YL
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYL 124
Query: 807 HTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAP 861
H+ I H DLK N+++ N +K+ DFG++ I+ K+ GTPE++AP
Sbjct: 125 HSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAP 180
Query: 862 EVLRNEPANEKCDVYSFGVIL 882
E++ EP + D++S GVI
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
E +G G++ EV+ T A+K DS + E ++ +++H N+V
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLKKIKHENIV 69
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ H+ ++ + + G L+ R+L R E+ + V + YLH +
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG- 126
Query: 812 TIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
IVHRDLK NLL ++N + + DFGLS+++ + + + GTP ++APEVL +P
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVLAQKP 183
Query: 869 ANEKCDVYSFGVIL 882
++ D +S GVI
Sbjct: 184 YSKAVDCWSIGVIT 197
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-33
Identities = 76/258 (29%), Positives = 123/258 (47%), Gaps = 14/258 (5%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
Q +++G G+YGEV T E A+K S S S+ E ++ L HPN++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
++ ++ E G L+ ++HR + +E + V G+ YLH +
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 812 TIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
IVHRDLK NLL+ +K+ ++K+ DFGLS + + K GT ++APEVLR +
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLR-KK 213
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQIIR 926
+EKCDV+S GVIL+ L P+ G +++ V + P ++ +I+
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 927 DCWQTEPHLRPSFAQLMS 944
Q + R S Q +
Sbjct: 274 QMLQFDSQRRISAQQALE 291
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-33
Identities = 57/285 (20%), Positives = 102/285 (35%), Gaps = 44/285 (15%)
Query: 696 IGERIGIGSYGEVYRAD-WHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVL 753
+ +G GS G V + G VAVK+ L D E +++ HPNV+
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALM---EIKLLTESDDHPNVIR 73
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNH------QLDERRRMRMALDVAKGMNYLH 807
+ + T I E +L L+ N E + + +A G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 808 TSHPTIVHRDLKSPNLLVD-------------KNWVVKVCDFGLSRI----KHHTYLSSK 850
+ I+HRDLK N+LV +N + + DFGL + + +
Sbjct: 133 SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 851 STAGTPEWMAPEVLRN-------EPANEKCDVYSFGVILWELATLSVP--WKGLNPMQVV 901
+ +GT W APE+L D++S G + + + + + +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 902 --GAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
G + + +I +P RP+ +++
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 20/201 (9%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK----KFLDQDFSGDSLSQFKCEAEIMLRLR 747
GE +G G + V + G + A K + G S + E I+ ++
Sbjct: 14 DTGEELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYL 806
HPNV+ ++ E + G L+ L + + L E + G+ YL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYL 130
Query: 807 HTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAP 861
H+ I H DLK N+++ +K+ DFGL+ I K+ GTPE++AP
Sbjct: 131 HSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAP 186
Query: 862 EVLRNEPANEKCDVYSFGVIL 882
E++ EP + D++S GVI
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 72/286 (25%), Positives = 112/286 (39%), Gaps = 47/286 (16%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK------------------------KFLDQD 727
+ + IG GSYG V A + T A+K
Sbjct: 16 TLKDEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 728 FSGDSLSQFKCEAEIMLRLRHPNVV-LF--MGAVTRSPHFSILTEFLPRGSLYRLLHRPN 784
+ Q E I+ +L HPNVV L + H ++ E + +G + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLK- 132
Query: 785 HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--K 842
L E + D+ KG+ YLH I+HRD+K NLLV ++ +K+ DFG+S
Sbjct: 133 -PLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 843 HHTYLSSKSTAGTPEWMAPEVLRNEPAN---EKCDVYSFGVILWELATLSVPWKGLNPMQ 899
L +T GTP +MAPE L + DV++ GV L+ P+ M
Sbjct: 190 SDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 900 VVGAVGFQNRRLEIPD--DIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+ + +++ LE PD DI + +I P R ++
Sbjct: 248 LHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-33
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 13/222 (5%)
Query: 672 GQSDSINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGT--EVAVK---KFLDQ 726
G S +L + + + ++ E IG G + V R T + AVK
Sbjct: 4 GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63
Query: 727 DFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHR--P 783
G S K EA I L+HP++V + + ++ EF+ L ++ R
Sbjct: 64 SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA 123
Query: 784 NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSR 840
E + + + Y H ++ I+HRD+K +L+ + + VK+ FG++
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVIL 882
+ L + GTP +MAPEV++ EP + DV+ GVIL
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 20/201 (9%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK----KFLDQDFSGDSLSQFKCEAEIMLRLR 747
IGE +G G + V + G E A K + G + + E I+ ++
Sbjct: 15 DIGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYL 806
HPN++ ++ E + G L+ L + L E + G+NYL
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ES-LSEEEATSFIKQILDGVNYL 131
Query: 807 HTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAP 861
HT I H DLK N+++ +K+ DFGL+ I+ K+ GTPE++AP
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAP 187
Query: 862 EVLRNEPANEKCDVYSFGVIL 882
E++ EP + D++S GVI
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 26/265 (9%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQD---FSGDSLSQFKCEAEIMLRLRH 748
+G+ +G GSYG+V AVK L + + + K E +++ RLRH
Sbjct: 8 LMGDLLGEGSYGKVKEV-LDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 749 PNVV-LF--MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKG 802
NV+ L + + + ++ E+ G L P + +D G
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVM-EYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID---G 121
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS--KSTAGTPEWMA 860
+ YLH+ IVH+D+K NLL+ +K+ G++ H +++ G+P +
Sbjct: 122 LEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 861 PEVLRNEP--ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
PE+ + K D++S GV L+ + T P++G N ++ + IP D
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKGSYAIPGDCG 237
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLM 943
P ++ +++ + EP R S Q+
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIR 262
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 49/195 (25%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 697 GERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH-PNVV 752
+ +G G + V + G E A K + D ++ E ++ + P V+
Sbjct: 34 SKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ ++ E+ G ++ L + E +R+ + +G+ YLH ++
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN- 151
Query: 812 TIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNE 867
IVH DLK N+L+ +K+ DFG+SR I H L + GTPE++APE+L +
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYD 208
Query: 868 PANEKCDVYSFGVIL 882
P D+++ G+I
Sbjct: 209 PITTATDMWNIGIIA 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 64/267 (23%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 698 ERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVL 753
+ +G+G G+V H G + A+K D + + E + + P++V
Sbjct: 35 QVLGLGVNGKVLECF-HRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVC 86
Query: 754 FMGA----VTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
+ I+ E + G L+ R+ R + ER + D+ + +LH+
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 809 SHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
+ I HRD+K NLL +K+ V+K+ DFG ++ L ++ TP ++APEVL
Sbjct: 147 HN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAPEVLG 202
Query: 866 NEPANEKCDVYSFGVILWELATLS--VPWKGLNPMQVVGAVGFQNRRLEIP------DDI 917
E ++ CD++S GVI++ L L P+ + + + R + ++
Sbjct: 203 PEKYDKSCDMWSLGVIMYIL--LCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMS 944
Q+IR +T+P R + Q M+
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-32
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
I E +G G++G V+R G K F++ + D K E IM +L HP +
Sbjct: 54 DILEELGSGAFGVVHRCV-EKATGRVFVAK-FINTPYPLD-KYTVKNEISIMNQLHHPKL 110
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+ A ++ EFL G L+ R+ ++++ E + +G+ ++H
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 811 PTIVHRDLKSPNLLV--DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNE 867
IVH D+K N++ K VK+ DFGL+ + + K T T E+ APE++ E
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDRE 225
Query: 868 PANEKCDVYSFGVIL 882
P D+++ GV+
Sbjct: 226 PVGFYTDMWAIGVLG 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 79/260 (30%), Positives = 122/260 (46%), Gaps = 18/260 (6%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
I +G GS+GEV + E AVK S E E++ +L HPN+
Sbjct: 25 NIVCMLGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+ + S F I+ E G L+ ++ R + E R+ V G+ Y+H +
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 811 PTIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRN 866
IVHRDLK N+L+ +K+ +K+ DFGLS + +T + + GT ++APEVLR
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR- 196
Query: 867 EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQI 924
+EKCDV+S GVIL+ L + + P+ G N ++ V ++P I +
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 925 IRDCWQTEPHLRPSFAQLMS 944
IR P LR + Q +
Sbjct: 257 IRKMLTFHPSLRITATQCLE 276
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK-------KFLDQDFSGDSLSQFKCEAEIML 744
+ E +G G V R H E AVK + + E +I+
Sbjct: 20 EPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 745 RL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKG 802
++ HPN++ + F ++ + + +G L+ L + L E+ ++ + +
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEV 136
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAP 861
+ LH + IVHRDLK N+L+D + +K+ DFG S + L + GTP ++AP
Sbjct: 137 ICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAP 192
Query: 862 EVLRNEPA------NEKCDVYSFGVIL 882
E++ ++ D++S GVI+
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 68/305 (22%), Positives = 111/305 (36%), Gaps = 58/305 (19%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK---KFLDQDFSGDSLSQFKCEAEIMLRLRH 748
+ IG GSYG V A A+K K + + + + K E +M +L H
Sbjct: 29 HLKGAIGQGSYGVVRVA-IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLY------------------------------- 777
PN+ + ++ E G L
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 778 --------RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV--DK 827
+ E+ + + ++YLH I HRD+K N L +K
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNK 205
Query: 828 NWVVKVCDFGLSRI----KHHTYLSSKSTAGTPEWMAPEVLR--NEPANEKCDVYSFGVI 881
++ +K+ DFGLS+ + Y + AGTP ++APEVL NE KCD +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 882 LWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQIIRDCWQTEPHLRPSF 939
L L +VP+ G+N + V + E P + + P ++ + R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 940 AQLMS 944
+ +
Sbjct: 326 MRALQ 330
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKF------LDQDFSGDSLSQFKCEAEIMLR 745
+ + +G G+ GEV A + +VA+K + D + E EI+ +
Sbjct: 13 IMSKTLGSGACGEVKLA-FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMN 804
L HP ++ + + I+ E + G L+ +++ +L E + +
Sbjct: 72 LNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQ 128
Query: 805 YLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRI-KHHTYLSSKSTAGTPEWMA 860
YLH + I+HRDLK N+L+ +++ ++K+ DFG S+I + + ++ GTP ++A
Sbjct: 129 YLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLA 184
Query: 861 PEVLRNEPA---NEKCDVYSFGVIL 882
PEVL + N D +S GVIL
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 54/271 (19%), Positives = 101/271 (37%), Gaps = 44/271 (16%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK----KFLDQDFSGDSLSQFKCEAEIMLRLR 747
Q+G +G G +G VY VA+K + + ++ E ++ ++
Sbjct: 46 QVGPLLGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 748 H--PNVVLFMGAVTRSPHFSILTEF-LPRGSLYRLLHRPNHQLDE---RRRMRMALDVAK 801
V+ + R F ++ E P L+ + L E R V +
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQ---VLE 160
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMA 860
+ + H ++HRD+K N+L+D N +K+ DFG + T GT +
Sbjct: 161 AVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSP 216
Query: 861 PEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR------LEI 913
PE +R V+S G++L+++ V G + F++ +
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDM--------------VCGDIPFEHDEEIIRGQVFF 262
Query: 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ +IR C P RP+F ++ +
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 66/257 (25%), Positives = 133/257 (51%), Gaps = 16/257 (6%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRHP 749
+G+ +G+G++G+V + H G +VAVK L++ S D + + K E + + RHP
Sbjct: 14 VLGDTLGVGTFGKVKIGE-HQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 750 NVV-LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
+++ L+ T + F ++ E++ G L+ + + + +++E R+ + ++Y H
Sbjct: 72 HIIKLYQVISTPTDFF-MVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHR 129
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
+VHRDLK N+L+D + K+ DFGLS + +++ G+P + APEV+
Sbjct: 130 HM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEVISGRL 186
Query: 869 -ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927
A + D++S GVIL+ L ++P+ + + + + IP+ ++ +VA ++
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVATLLMH 244
Query: 928 CWQTEPHLRPSFAQLMS 944
Q +P R + +
Sbjct: 245 MLQVDPLKRATIKDIRE 261
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 18/194 (9%)
Query: 697 GERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVV 752
+ +G GS+ + H AVK + + + E + HPN+V
Sbjct: 16 DKPLGEGSFSICRKC-VHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIV 69
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
H ++ E L G L+ R+ + E + + ++++H
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG- 126
Query: 812 TIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
+VHRDLK NLL + N +K+ DFG +R+K K+ T + APE+L
Sbjct: 127 -VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185
Query: 869 ANEKCDVYSFGVIL 882
+E CD++S GVIL
Sbjct: 186 YDESCDLWSLGVIL 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 55/196 (28%), Positives = 85/196 (43%), Gaps = 18/196 (9%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPN 750
++ E IG+GSY R H E AVK E EI+LR +HPN
Sbjct: 25 EVKEDIGVGSYSVCKRC-IHKATNMEFAVKIIDKSKRDP------TEEIEILLRYGQHPN 77
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
++ + ++TE + G L + R ER + + K + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITKTVEYLHAQG 136
Query: 811 PTIVHRDLKSPNLLV----DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN 866
+VHRDLK N+L +++CDFG ++ + T ++APEVL
Sbjct: 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 867 EPANEKCDVYSFGVIL 882
+ + CD++S GV+L
Sbjct: 195 QGYDAACDIWSLGVLL 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 74/261 (28%), Positives = 116/261 (44%), Gaps = 19/261 (7%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFL-DQDFSGDSLSQFKCEAEIMLRLRHPN 750
+ +G GS+GEV G E AVK Q E +++ +L HPN
Sbjct: 29 KGQRVLGKGSFGEVILC-KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
++ +F ++ E G L+ ++ R + E R+ V G+ Y+H +
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN 145
Query: 810 HPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLR 865
IVHRDLK NLL+ K+ +++ DFGLS + + K GT ++APEVL
Sbjct: 146 K--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYYIAPEVLH 201
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQ 923
+EKCDV+S GVIL+ L + P+ G N ++ V E+P + +
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
Query: 924 IIRDCWQTEPHLRPSFAQLMS 944
+IR P +R S +
Sbjct: 261 LIRKMLTYVPSMRISARDALD 281
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
+ + +G G+YGEV A + VAVK +D + D K E I L H NV
Sbjct: 10 DLVQTLGEGAYGEVQLAV-NRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK--------GM 803
V F G + E+ G L+ + + M A+ G+
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRI---------EPDIGMPEPDAQRFFHQLMAGV 118
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS--KSTAGTPEWMAP 861
YLH I HRD+K NLL+D+ +K+ DFGL+ + + GT ++AP
Sbjct: 119 VYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 862 EVLRNEP-ANEKCDVYSFGVILWELATLSVPW 892
E+L+ E DV+S G++L + +PW
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 61/263 (23%), Positives = 109/263 (41%), Gaps = 28/263 (10%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK-----KFL-DQDFSGDSLSQFKCEAEIMLR 745
+G G++G V+ A EV VK K L D L + E I+ R
Sbjct: 27 STMSPLGSGAFGFVWTAV-DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGS-LY-RLLHRPNHQLDERRRMRMALDVAKGM 803
+ H N++ + F ++ E G L+ + P LDE + + +
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAV 143
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPE 862
YL I+HRD+K N+++ +++ +K+ DFG + ++ + GT E+ APE
Sbjct: 144 GYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPE 199
Query: 863 VLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
VL P + +++S GV L+ L P+ L + V A + P + +
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEA------AIHPPYLVSKEL 251
Query: 922 AQIIRDCWQTEPHLRPSFAQLMS 944
++ Q P R + +L++
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVT 274
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 693 DLQIGERIGIGSYGEVYRADWH---GTEVAVK-----KFLDQDFSGDSLSQFKCEAEIML 744
+ E +G G +G+V++ + G ++A K D++ + K E +M
Sbjct: 90 TVSKTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMKDKE-------EVKNEISVMN 141
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGM 803
+L H N++ A ++ E++ G L+ R++ ++ L E + + +G+
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGI 200
Query: 804 NYLHTSHPTIVHRDLKSPNLLV--DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMA 860
++H + I+H DLK N+L +K+ DFGL+R K L K GTPE++A
Sbjct: 201 RHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLA 256
Query: 861 PEVLRNEPANEKCDVYSFGVIL 882
PEV+ + + D++S GVI
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 21/197 (10%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVK---KFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
++ +G G+ VYR GT A+K K +D+ + E ++LRL HP
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-------IVRTEIGVLLRLSHP 108
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
N++ S++ E + G L+ R++ + ER + + + YLH
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHE 166
Query: 809 SHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
+ IVHRDLK NLL + +K+ DFGLS+I H L K+ GTP + APE+LR
Sbjct: 167 NG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM-KTVCGTPGYCAPEILR 223
Query: 866 NEPANEKCDVYSFGVIL 882
+ D++S G+I
Sbjct: 224 GCAYGPEVDMWSVGIIT 240
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-31
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 25/200 (12%)
Query: 696 IGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNV 751
+ +G+G G+V + ++ + A+K D + + E E+ R + P++
Sbjct: 66 TSQVLGLGINGKVLQI-FNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 117
Query: 752 VLFMGA----VTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYL 806
V + I+ E L G L+ R+ R + ER + + + + YL
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 807 HTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPE 862
H+ + I HRD+K NLL N ++K+ DFG ++ H L + TP ++APE
Sbjct: 178 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPE 233
Query: 863 VLRNEPANEKCDVYSFGVIL 882
VL E ++ CD++S GVI+
Sbjct: 234 VLGPEKYDKSCDMWSLGVIM 253
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 43/194 (22%), Positives = 87/194 (44%), Gaps = 14/194 (7%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
I E +G G +G V+R + K F+ G K E I+ RH N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKV--KGTDQVLVKKEISILNIARHRNIL 64
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ ++ EF+ ++ R+ +L+ER + V + + +LH+ +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 812 TIVHRDLKSPNLLV--DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
I H D++ N++ ++ +K+ +FG +R +K + PE+ APEV +++
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 869 ANEKCDVYSFGVIL 882
+ D++S G ++
Sbjct: 180 VSTATDMWSLGTLV 193
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-31
Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 25/269 (9%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVK-----------KFLDQDFSGDSLSQFKCEAE 741
++G G+YGEV E A+K D + E
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 742 IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVA 800
++ L HPN++ +F ++TEF G L+ ++++R H+ DE + +
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQIL 156
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE 857
G+ YLH + IVHRD+K N+L+ + +K+ DFGLS Y + GT
Sbjct: 157 SGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAY 213
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--D 915
++APEVL+ + NEKCDV+S GVI++ L P+ G N ++ V +
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK 272
Query: 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+I ++I+ + + R + + ++
Sbjct: 273 NISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 56/273 (20%), Positives = 101/273 (36%), Gaps = 46/273 (16%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK----KFLDQDFSGDSLSQFKCEAEIMLRLR 747
++G +G G +G V+ +VA+K + E ++ ++
Sbjct: 34 RLGPLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 748 ----HPNVVLFMGAVTRSPHFSILTEF-LPRGSLYRLLHRPNHQLDE---RRRMRMALDV 799
HP V+ + F ++ E LP L+ + L E R V
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFG---QV 148
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEW 858
+ + H+ +VHRD+K N+L+D + K+ DFG + H GT +
Sbjct: 149 VAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVY 204
Query: 859 MAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR------L 911
PE + V+S G++L+++ V G + F+ + L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDM--------------VCGDIPFERDQEILEAEL 250
Query: 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
P + P +IR C +P RPS +++
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVK------KFLDQDFSGDSLSQFKCEAEIMLR 745
+ IG G V R H G E AVK + L + + + E I+ +
Sbjct: 97 DPKDVIGRGVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 746 LR-HPNVVLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGM 803
+ HP+++ + + S ++ + + +G L+ L + L E+ + + + +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAV 213
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPE 862
++LH ++ IVHRDLK N+L+D N +++ DFG S ++ L + GTP ++APE
Sbjct: 214 SFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPE 269
Query: 863 VLRNEPA------NEKCDVYSFGVIL 882
+L+ ++ D+++ GVIL
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
+ + +G G+YGEV A + VAVK +D + D K E I L H NV
Sbjct: 10 DLVQTLGEGAYGEVQLAV-NRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRM-RMALDVAKGMNYLHTS 809
V F G + E+ G L+ R+ + +R + G+ YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGI 124
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS--KSTAGTPEWMAPEVLRNE 867
I HRD+K NLL+D+ +K+ DFGL+ + + GT ++APE+L+
Sbjct: 125 G--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 868 P-ANEKCDVYSFGVILWELATLSVPW 892
E DV+S G++L + +PW
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-30
Identities = 54/262 (20%), Positives = 99/262 (37%), Gaps = 34/262 (12%)
Query: 695 QIGERIGIGSYGEVYRA-DW--HGTEVAVKKFL---DQDFSGDSLSQFKCEAEIMLRLRH 748
++ I G G +Y A D +G V +K + D + + E + + + H
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEA----QAMAMAERQFLAEVVH 138
Query: 749 PNVVL-----FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
P++V P I+ E++ SL R + L + L++ +
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPAL 195
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEV 863
+YLH+ +V+ DLK N+++ + + K+ D G S GTP + APE+
Sbjct: 196 SYLHSIG--LVYNDLKPENIMLTEEQL-KLIDLGAVS----RINSFGYLYGTPGFQAPEI 248
Query: 864 LRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923
+R P D+Y+ G L L G + + + +
Sbjct: 249 VRTGPT-VATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYDSYGR 299
Query: 924 IIRDCWQTEPHLRPSFAQLMSR 945
++R +P R + A+ MS
Sbjct: 300 LLRRAIDPDPRQRFTTAEEMSA 321
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
++G G++G+V+ + + E +K +++D S + Q + E E++ L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIK-TINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQ--LDERRRMRMALDVAKGMNYLHTS 809
+ I+ E G L R++ L E + + + Y H+
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 810 HPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLR 865
H +VH+DLK N+L + +K+ DFGL+ K + + AGT +MAPEV +
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFK 199
Query: 866 NEPANEKCDVYSFGVIL 882
KCD++S GV++
Sbjct: 200 -RDVTFKCDIWSAGVVM 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+ IG GS+GEV A GT A KK + +FK E EIM L HPN++
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNII 69
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+ ++ E G L+ R++H+ E R+ DV + Y H +
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLN- 126
Query: 812 TIVHRDLKSPNLLV---DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNE 867
+ HRDLK N L + +K+ DFGL+ K + ++ GTP +++P+VL
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEG- 182
Query: 868 PANEKCDVYSFGVIL 882
+CD +S GV++
Sbjct: 183 LYGPECDEWSAGVMM 197
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-30
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
I E +G G++G V+R T A K F+ D + E + M LRHP +V
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAK-FVMTPHESD-KETVRKEIQTMSVLRHPTLV 217
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
A ++ EF+ G L+ ++ N + E + V KG+ ++H ++
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN- 275
Query: 812 TIVHRDLKSPNLLV--DKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
VH DLK N++ ++ +K+ DFGL+ + + K T GT E+ APEV +P
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKP 332
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNP 897
D++S GV+ + L LS GL+P
Sbjct: 333 VGYYTDMWSVGVLSYIL--LS----GLSP 355
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 56/265 (21%), Positives = 113/265 (42%), Gaps = 40/265 (15%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDF--SGDSLSQFKCEAEIMLRLR 747
ED + G+ +G GS+ V A T E A+K L++ + + E ++M RL
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 748 HPNVV-----------LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMA 796
HP V L+ + G L + + + + R A
Sbjct: 89 HPFFVKLYFTFQDDEKLYF-----------GLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA--G 854
++ + YLH I+HRDLK N+L++++ +++ DFG +++ +++ + G
Sbjct: 138 -EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN---RRL 911
T ++++PE+L + A + D+++ G I+++L P++ N + FQ
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEY 249
Query: 912 EIPDDIDPAVAQIIRDCWQTEPHLR 936
+ P+ P ++ + R
Sbjct: 250 DFPEKFFPKARDLVEKLLVLDATKR 274
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 698 ERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVL 753
+ +G G++ V + E AVK Q G S+ E E++ + + H NV+
Sbjct: 19 DVLGEGAHARVQTCI-NLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
+ F ++ E + GS+ +H+ H +E + DVA +++LH I
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLHNKG--I 132
Query: 814 VHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSS-------KSTAGTPEWMAPEV 863
HRDLK N+L ++ VK+CDF L S + G+ E+MAPEV
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 864 LRNEPA-----NEKCDVYSFGVIL 882
+ +++CD++S GVIL
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 72/258 (27%), Positives = 122/258 (47%), Gaps = 21/258 (8%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRHP 749
I E +G GS+G+V A H +VA+K F+ + D + + E + LRHP
Sbjct: 12 IIRETLGEGSFGKVKLAT-HYKTQQKVALK-FISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 750 NVV-LFMGAVTRSP-HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
+++ L+ V +P ++ E+ G L+ + ++ E R + + Y H
Sbjct: 70 HIIKLY--DVITTPTDIVMVIEYAG-GELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCH 125
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI-KHHTYLSSKSTAGTPEWMAPEVLRN 866
IVHRDLK NLL+D N VK+ DFGLS I +L K++ G+P + APEV+
Sbjct: 126 RHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEVING 181
Query: 867 EP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
+ A + DV+S G++L+ + +P+ + V + +PD + P +I
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLI 239
Query: 926 RDCWQTEPHLRPSFAQLM 943
R +P R + ++
Sbjct: 240 RRMIVADPMQRITIQEIR 257
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-28
Identities = 69/256 (26%), Positives = 133/256 (51%), Gaps = 16/256 (6%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRHP 749
+G+ +G+G++G+V H G +VAVK L++ S D + + + E + + RHP
Sbjct: 19 ILGDTLGVGTFGKVKVGK-HELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 750 NVV-LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
+++ L+ T S F ++ E++ G L+ + + N +LDE+ R+ + G++Y H
Sbjct: 77 HIIKLYQVISTPSDIF-MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHR 134
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
+VHRDLK N+L+D + K+ DFGLS + +++ G+P + APEV+
Sbjct: 135 HM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEVISGRL 191
Query: 869 -ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927
A + D++S GVIL+ L ++P+ + + + + P ++P+V +++
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVISLLKH 249
Query: 928 CWQTEPHLRPSFAQLM 943
Q +P R + +
Sbjct: 250 MLQVDPMKRATIKDIR 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 75/274 (27%), Positives = 120/274 (43%), Gaps = 46/274 (16%)
Query: 695 QIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
+ IG G++G VAVK ++++ + D + E LRHPN+
Sbjct: 23 DFVKDIGSGNFGVARLMR-DKLTKELVAVK-YIERGAAIDE--NVQREIINHRSLRHPNI 78
Query: 752 VLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK--------GM 803
V F + H +I+ E+ G LY + R + D A+ G+
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERI---------CNAGRFSEDEARFFFQQLLSGV 129
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWV--VKVCDFGLSRI-KHHTYLSSKSTAGTPEWMA 860
+Y H+ I HRDLK N L+D + +K+CDFG S+ H+ KST GTP ++A
Sbjct: 130 SYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIA 185
Query: 861 PEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPM-------QVVGAVGFQNRRLE 912
PEVL + + DV+S GV L+ + + P++ Q + +V +
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS----- 240
Query: 913 IPDD--IDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
IPDD I P +I + +P R S ++ +
Sbjct: 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWHGTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHP 749
E E+IG G+YG VY+A + +G A+KK L+++ G + + E I+ L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKGMNYL 806
N+V + ++ E L + L +LL L+ + + L G+ Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYC 116
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGTPE----WM 859
H ++HRDLK NLL+++ +K+ DFGL+R I Y T E W
Sbjct: 117 HDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--------THEIVTLWY 166
Query: 860 -APEVLRNEPA-NEKCDVYSFGVILWELAT 887
AP+VL + D++S G I E+
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 52/264 (19%), Positives = 114/264 (43%), Gaps = 20/264 (7%)
Query: 679 PMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTE--VAVKKFLDQDF--SGDSLS 734
P++ + E + +D +I + IG G++ EV T A+K +++ +S
Sbjct: 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI-MNKWDMLKRGEVS 106
Query: 735 QFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERR-RM 793
F+ E ++++ + A + ++ E+ G L LL + ++ R
Sbjct: 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF 166
Query: 794 RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKST 852
+A ++ ++ +H VHRD+K N+L+D+ +++ DFG +++ + S
Sbjct: 167 YLA-EIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 853 AGTPEWMAPEVLRNEPANEK-------CDVYSFGVILWELATLSVPWKGLNPMQVVGAVG 905
GTP++++PE+L+ CD ++ GV +E+ P+ + + G +
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
Query: 906 FQNRRLEIP---DDIDPAVAQIIR 926
L +P + + I+
Sbjct: 284 HYKEHLSLPLVDEGVPEEARDFIQ 307
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRH 748
+ + E+IG G+YG V++A T VA+K+ LD D G S + E ++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKGMNY 805
N+V + +++ EF + L + N LD + + L KG+ +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGF 116
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGTPE----W 858
H+ + ++HRDLK NLL+++N +K+ +FGL+R I Y + E W
Sbjct: 117 CHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--------SAEVVTLW 166
Query: 859 M-APEVLRNEPA-NEKCDVYSFGVILWELATLSVP 891
P+VL + D++S G I ELA P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWHGTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRHP 749
E Q E++G G+YG VY+A D G VA+K+ LD + G + + E ++ L HP
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHP 79
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKGMNYL 806
N+V + + +++ EF+ + L ++L L + + + L +G+ +
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHC 135
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGTPE----WM 859
H I+HRDLK NLL++ + +K+ DFGL+R I +Y T E W
Sbjct: 136 HQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--------THEVVTLWY 185
Query: 860 -APEVLRNEPA-NEKCDVYSFGVILWELAT 887
AP+VL + D++S G I E+ T
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 55/244 (22%), Positives = 107/244 (43%), Gaps = 25/244 (10%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVKKFLDQD--FSGDSLSQFKCEAEIMLRLR 747
ED +I + IG G++GEV + A+K L++ + F+ E ++++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI-LNKWEMLKRAETACFREERDVLVNGD 132
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERR------RMRMALDVAK 801
+ A + ++ ++ G L LL + +L E M +A+D
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID--- 189
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWMA 860
+H H VHRD+K N+L+D N +++ DFG ++ + S GTP++++
Sbjct: 190 ---SVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 861 PEVLRNEPANEK-----CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD 915
PE+L+ + CD +S GV ++E+ P+ + ++ G + R + P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
Query: 916 DIDP 919
+
Sbjct: 305 QVTD 308
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 58/254 (22%), Positives = 115/254 (45%), Gaps = 23/254 (9%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVKKFLDQDFSGDSLSQFKC---EAEIMLRL 746
+ + +G GS+G V + A+K Q L Q + E I+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTLNEKRILQAV 98
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806
P +V + + + ++ E++ G ++ L R + E A + YL
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYL 157
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWMAPEVLR 865
H+ +++RDLK NLL+D+ ++V DFG + R+K T+ + GTPE +APE++
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIIL 211
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN---RRLEIPDDIDPAVA 922
++ N+ D ++ GV+++E+A P+ P+Q+ ++ ++ P +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSHFSSDLK 266
Query: 923 QIIRDCWQTEPHLR 936
++R+ Q + R
Sbjct: 267 DLLRNLLQVDLTKR 280
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH---GTEVAVKKF-LDQDFSGDSLSQFKCEA--EI-ML 744
E + +IG GSYG V++ + G VA+KKF +D K A EI ML
Sbjct: 3 EKYEKIGKIGEGSYGVVFKC-RNRDTGQIVAIKKFLESEDDPV-----IKKIALREIRML 56
Query: 745 R-LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVA 800
+ L+HPN+V + R ++ E+ ++ L R + E + L
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL--- 112
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE--- 857
+ +N+ H + +HRD+K N+L+ K+ V+K+CDFG +R+ L+ S E
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVAT 165
Query: 858 -WM-APEVLRNEPA-NEKCDVYSFGVILWELAT 887
W +PE+L + DV++ G + EL +
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 59/249 (23%), Positives = 113/249 (45%), Gaps = 12/249 (4%)
Query: 678 NPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTE--VAVKKFLDQD-FSGDSLS 734
+ ++ + + ED ++ + IG G++GEV T A+K + +
Sbjct: 55 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 735 QFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMR 794
F E +IM P VV A + ++ E++P G L L+ + + E+
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARF 172
Query: 795 MALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTA 853
+V ++ +H+ +HRD+K N+L+DK+ +K+ DFG ++ + +
Sbjct: 173 YTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 854 GTPEWMAPEVLRNEPANEK----CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR 909
GTP++++PEVL+++ + CD +S GV L+E+ P+ + + +
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290
Query: 910 RLEIPDDID 918
L PDD D
Sbjct: 291 SLTFPDDND 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH---GTEVAVKKF-LDQDFSGDSLSQFKCEA--EI-ML 744
E + +G GSYG V + + G VA+KKF D K A EI +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKC-RNKDTGRIVAIKKFLESDDDKM-----VKKIAMREIKLL 78
Query: 745 R-LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVA 800
+ LRH N+V + + + ++ EF+ ++ L + LD ++ + +
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII--- 134
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE--- 857
G+ + H+ + I+HRD+K N+LV ++ VVK+CDFG +R L++ E
Sbjct: 135 NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVAT 187
Query: 858 -WM-APEVLRNEPA-NEKCDVYSFGVILWELAT 887
W APE+L + + DV++ G ++ E+
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 46/199 (23%), Positives = 80/199 (40%), Gaps = 44/199 (22%)
Query: 696 IGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNV 751
+ +G+G G+V + + + A+K D + + E E+ R + P++
Sbjct: 22 TSQVLGLGINGKVLQIF-NKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 73
Query: 752 VLFMGA----VTRSPHFSILTEFLPRGSLY-RLLHRPNHQLDERRRMRMALDVAKGMNYL 806
V + I+ E L G L+ R+ R + ER + + + + YL
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 807 HTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEV 863
H+ + I HRD+K NLL N ++K+ DFG A E
Sbjct: 134 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKET 170
Query: 864 LRNEPANEKCDVYSFGVIL 882
E ++ CD++S GVI+
Sbjct: 171 TG-EKYDKSCDMWSLGVIM 188
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 692 EDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKF-LDQDFSGDSLSQFKCEA--EIML-- 744
+ +IG G++GEV++A G +VA+KK ++ + G F A EI +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-----FPITALREIKILQ 71
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLY-----------RLLHRPNHQLDERRR- 792
L+H NVV + +GS+Y LL +
Sbjct: 72 LLKHENVVNLIEICRTKAS----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 793 --MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850
M+M L G+ Y+H + I+HRD+K+ N+L+ ++ V+K+ DFGL+R +S+
Sbjct: 128 RVMQMLL---NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQ 181
Query: 851 STAGTPE----WM-APEVLRNEPA-NEKCDVYSFGVILWELAT 887
T W PE+L E D++ G I+ E+ T
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 19/246 (7%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL 753
+G G++G+V T + K+ + D ++ E ++ RHP +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTA 212
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
+ + E+ G L+ L R E R ++ ++YLH+ +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK-NV 270
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKC 873
V+RDLK NL++DK+ +K+ DFGL + + K+ GTPE++APEVL +
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 330
Query: 874 DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDCWQ 930
D + GV+++E+ +P+ + ++ F+ + P + P ++ +
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEIRFPRTLGPEAKSLLSGLLK 385
Query: 931 TEPHLR 936
+P R
Sbjct: 386 KDPKQR 391
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 49/220 (22%), Positives = 87/220 (39%), Gaps = 39/220 (17%)
Query: 696 IGERIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
G ++G G+YG VY+A + A+K+ S + E ++ L+HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNV 80
Query: 752 VLFMGAVTRSPHFSI--LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK-------- 801
+ + L ++ L+ ++ ++ +++ + K
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGLSR---IKHHTYLSSKSTAG 854
G++YLH + ++HRDLK N+LV + VK+ D G +R
Sbjct: 140 GIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-----ADL 192
Query: 855 TPE----WM-APEVLRNEPA-NEKCDVYSFGVILWELATL 888
P W APE+L + D+++ G I EL T
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKK--FLDQDFSGDSLSQFKC----EAEIM 743
+ + + +G G + VY+A D + VA+KK + + D E +++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG---INRTALREIKLL 66
Query: 744 LRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVA 800
L HPN++ + A + S++ +F+ L ++ + L + M M L
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL--- 122
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGTPE 857
+G+ YLH I+HRDLK NLL+D+N V+K+ DFGL++ + Y T +
Sbjct: 123 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------THQ 172
Query: 858 ----WM-APEVLRNEPA-NEKCDVYSFGVILWELAT 887
W APE+L D+++ G IL EL
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 35/213 (16%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVKKF-LDQD--FSGDSLSQFKCEAEIMLRL 746
E +++G G+Y VY+ T+ VA+K+ L+ + ++ E ++ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDE---RRRMRMALDVAKGM 803
+H N+V + +++ E+L + L + L + ++ + + L +G+
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGL 113
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGTPE--- 857
Y H ++HRDLK NLL+++ +K+ DFGL+R I TY E
Sbjct: 114 AYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--------DNEVVT 163
Query: 858 -WM-APEVLRNEPA-NEKCDVYSFGVILWELAT 887
W P++L + + D++ G I +E+AT
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 33/263 (12%), Positives = 74/263 (28%), Gaps = 44/263 (16%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGD--SLSQFKCEAEIMLRLRHPN 750
++ G + ++A D +VA+ F+D L + + R+ P
Sbjct: 34 RLLIFHGGVPPLQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
V + V ++ E++ GSL + +R +A + H +
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG 149
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPAN 870
+ + V + V + + AN
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPA--------TMP-------------------DAN 180
Query: 871 EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPD------DIDPAVAQI 924
+ D+ G L+ L P + ++ + + DI ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-ERDTAGQPIEPADIDRDIPFQISAV 239
Query: 925 IRDCWQTEPHLRPSFAQLMSRLR 947
Q + +R + L +
Sbjct: 240 AARSVQGDGGIRSASTLLNLMQQ 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 46/217 (21%)
Query: 695 QIGERIGIGSYGEVYRA-DWHGTEVAVKK-FLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+ IG GS+G V++A EVA+KK D+ F E +IM ++HPNVV
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIVKHPNVV 95
Query: 753 L---FMGAVTRSPHFSIL---TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK----- 801
F + L E++P ++YR + + M + + K
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYA-----KLKQTMPMLLIKLYMYQ 149
Query: 802 ---GMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIKHHT-----YLSSKST 852
+ Y+H+ I HRD+K NLL+D V+K+ DFG ++I Y+ S+
Sbjct: 150 LLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-- 205
Query: 853 AGTPEWM-APEV-LRNEPANEKCDVYSFGVILWELAT 887
+ APE+ D++S G ++ EL
Sbjct: 206 -----YYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 56/247 (22%), Positives = 108/247 (43%), Gaps = 22/247 (8%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV- 752
+G G++G+V T + K+ + D ++ E+ ++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK---DEVAHTVTESRVLQNTRHPFLTA 69
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
L T ++ E+ G L+ L R E R ++ + YLH+
Sbjct: 70 LKYAFQTHDRLCFVM-EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEK 872
+V+RD+K NL++DK+ +K+ DFGL + + K+ GTPE++APEVL +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 873 CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDCW 929
D + GV+++E+ +P+ + ++ F+ + P + P ++
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 930 QTEPHLR 936
+ +P R
Sbjct: 241 KKDPKQR 247
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 56/246 (22%), Positives = 97/246 (39%), Gaps = 15/246 (6%)
Query: 700 IGIGSYGEVYRADWHGTEV--AVKKFLDQDF--SGDSLSQFKCEAEIMLRLRHPNVVLFM 755
+G G +GEV T A KK L++ + E +I+ ++ VV
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 756 GAVTRSPHFSILTEFLPRGSL-YRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIV 814
A ++ + G L + + H E R + A ++ G+ LH IV
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IV 308
Query: 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST-AGTPEWMAPEVLRNEPANEKC 873
+RDLK N+L+D + +++ D GL+ H + GT +MAPEV++NE
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 874 DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDCWQ 930
D ++ G +L+E+ P++ V + E + P +
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 931 TEPHLR 936
+P R
Sbjct: 426 KDPAER 431
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVKKF-LDQD--FSGDSLSQFKCEAEIMLRL 746
+ E++G G+Y VY+ T VA+K+ LD + ++ E +M L
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKEL 60
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRR--------MRMALD 798
+H N+V + +++ EF+ L + + R L
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL- 118
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR---IKHHTYLSSKSTAGT 855
+G+ + H + I+HRDLK NLL++K +K+ DFGL+R I +T+ +
Sbjct: 119 --QGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--------S 166
Query: 856 PE----WM-APEVLRNEPA-NEKCDVYSFGVILWELAT 887
E W AP+VL + D++S G IL E+ T
Sbjct: 167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-22
Identities = 46/217 (21%), Positives = 82/217 (37%), Gaps = 40/217 (18%)
Query: 695 QIGERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEA-------EIML-- 744
+ I GSYG V D G VA+K+ + G +++ EI L
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84
Query: 745 RLRHPNVVLFMGAVT--RSPHFS---ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDV 799
HPN++ P ++TE + L +++H + + +
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWM 859
G++ LH + +VHRDL N+L+ N + +CDF L+R
Sbjct: 144 LLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAR-----------EDTADANK 190
Query: 860 ----------APEVLRN-EPANEKCDVYSFGVILWEL 885
APE++ + + D++S G ++ E+
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWHGTE--VAVKKF-LDQDFSGDSLSQFKCEAEIMLRLR 747
+ + IG G+YG+V++A D VA+K+ + G LS + E ++ L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLE 69
Query: 748 ---HPNVV-----LFMGAVTRSPHFSILTEFLPRGSLYRLL-HRPNHQLDE---RRRMRM 795
HPNVV + R +++ E + + L L P + + M
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH--TYLSSKSTA 853
L +G+++LH+ +VHRDLK N+LV + +K+ DFGL+RI
Sbjct: 129 LL---RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL------- 176
Query: 854 GTPE----WM-APEVLRNEPANEKCDVYSFGVILWELAT 887
T W APEVL D++S G I E+
Sbjct: 177 -TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 5e-22
Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 61/273 (22%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVK---KFLDQDFSGDSLSQFKCEAEIMLRL 746
+D QI +G GS+G V+ A+K K + + E ++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--EIVVRLKQVEHTNDERLMLSIV 63
Query: 747 RHPNVV-----------LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRM 795
HP ++ +FM + +++ G L+ LL R+ R
Sbjct: 64 THPFIIRMWGTFQDAQQIFM-----------IMDYIEGGELFSLL---------RKSQRF 103
Query: 796 ALDVAK--------GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTY 846
VAK + YLH+ I++RDLK N+L+DKN +K+ DFG + + TY
Sbjct: 104 PNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161
Query: 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF 906
+ GTP+++APEV+ +P N+ D +SFG++++E+ P+ N M+ +
Sbjct: 162 ----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----Y 212
Query: 907 QN---RRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
+ L P + V ++ + R
Sbjct: 213 EKILNAELRFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-21
Identities = 58/248 (23%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 700 IGIGSYGEVYRADWHGTEV--AVKKFLDQDF--SGDSLSQFKCEAEIMLRLRHPNVV-LF 754
+G G +GEV+ T A KK L++ E +I+ ++ +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKK-LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALDVAKGMNYLHTSHP 811
T++ ++ + G + ++ + E R + + G+ +LH +
Sbjct: 252 YAFETKTDLCLVM-TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
I++RDLK N+L+D + V++ D GL+ +K AGTP +MAPE+L E +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDC 928
D ++ GV L+E+ P++ + Q + + PD PA
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 929 WQTEPHLR 936
Q +P R
Sbjct: 428 LQKDPEKR 435
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 64/248 (25%), Positives = 116/248 (46%), Gaps = 23/248 (9%)
Query: 700 IGIGSYGEVYRADWHGTE--VAVK----KFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV 752
+G GS+G+V+ A++ T A+K + D D + E ++ HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLT 81
Query: 753 -LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
+F T+ F ++ E+L G L + H+ D R A ++ G+ +LH+
Sbjct: 82 HMFCTFQTKENLFFVM-EYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG- 138
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
IV+RDLK N+L+DK+ +K+ DFG+ + + + GTP+++APE+L + N
Sbjct: 139 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 197
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDC 928
D +SFGV+L+E+ P+ G + ++ F P ++ ++
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEKEAKDLLVKL 252
Query: 929 WQTEPHLR 936
+ EP R
Sbjct: 253 FVREPEKR 260
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 34/215 (15%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTE--VAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRH 748
+ + ++G G+YGEVY+A T VA+K+ L+ + G + + E ++ L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQH 92
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLL--HRPNHQLDERRRMRMALDVAKGMNYL 806
N++ + + ++ E+ L + + + + + + G+N+
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI---NGVNFC 148
Query: 807 HTSHPTIVHRDLKSPNLLVDKNW-----VVKVCDFGLSR---IKHHTYLSSKSTAGTPE- 857
H +HRDLK NLL+ + V+K+ DFGL+R I + T E
Sbjct: 149 H--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--------THEI 198
Query: 858 ---WM-APEVLRNEPA-NEKCDVYSFGVILWELAT 887
W PE+L + D++S I E+
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 66/222 (29%), Positives = 89/222 (40%), Gaps = 42/222 (18%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKF-LDQDFSGDSLSQFKCEA--EIML-- 744
+ IG+G+YG VY+A D H G VA+K + G E+ L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG--GLPISTVREVALLR 66
Query: 745 ---RLRHPNVVLFMGAVTRSPHFSILT-----EFLPRGSLYRLL-HRPNHQLDE---RRR 792
HPNVV M S + E + + L L P L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 793 MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH--TYLSSK 850
MR L +G+++LH + IVHRDLK N+LV VK+ DFGL+RI +
Sbjct: 126 MRQFL---RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL---- 176
Query: 851 STAGTPE----WM-APEVLRNEPANEKCDVYSFGVILWELAT 887
TP W APEVL D++S G I E+
Sbjct: 177 ----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 57/260 (21%), Positives = 110/260 (42%), Gaps = 43/260 (16%)
Query: 700 IGIGSYGEVYRADWHGTEV--AVK---KFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV-- 752
IG GS+G+V + T+ A+K K + + + E +IM L HP +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNK--QKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 753 ---------LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
+FM + + L G L L + H +E ++ + ++ +
Sbjct: 81 WYSFQDEEDMFM-----------VVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMAL 128
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWMAPE 862
+YL I+HRD+K N+L+D++ V + DF ++ + T +++ + GT +MAPE
Sbjct: 129 DYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPE 184
Query: 863 VLRNEPA---NEKCDVYSFGVILWELATLSVPWKGL---NPMQVVGAVGFQNRRLEIPDD 916
+ + + D +S GV +EL P+ + ++V F+ + P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVVTYPSA 242
Query: 917 IDPAVAQIIRDCWQTEPHLR 936
+ +++ + P R
Sbjct: 243 WSQEMVSLLKKLLEPNPDQR 262
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-21
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 47/218 (21%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKC-EAEIMLRLRHPNV 751
+ IG GS+G VY+A G VA+KK L QD +FK E +IM +L H N+
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-QD------KRFKNRELQIMRKLDHCNI 109
Query: 752 VL---FMGAVTRSPHFSIL---TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK---- 801
V F + L +++P ++YR+ + R + + + K
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYS-----RAKQTLPVIYVKLYMY 163
Query: 802 ----GMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIKHHT-----YLSSKS 851
+ Y+H+ I HRD+K NLL+D + V+K+CDFG ++ Y+ S+
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 220
Query: 852 TAGTPEWM-APEV-LRNEPANEKCDVYSFGVILWELAT 887
+ APE+ DV+S G +L EL
Sbjct: 221 ------YYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-21
Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 43/219 (19%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKK-FLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
Q+ G G++G V + G VA+KK D F L + + L HPN+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLHHPNI 81
Query: 752 V----LFMGAVTRSPH---FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK--- 801
V F R +++ E++P +L+R + ++ + K
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFL 135
Query: 802 -----GMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSRIKHHT-----YLSSK 850
+ LH + HRD+K N+LV++ + +K+CDFG ++ + Y+ S+
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
Query: 851 STAGTPEWM-APEVLRNEPA-NEKCDVYSFGVILWELAT 887
+ APE++ D++S G I E+
Sbjct: 196 -------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 9e-21
Identities = 59/250 (23%), Positives = 111/250 (44%), Gaps = 24/250 (9%)
Query: 700 IGIGSYGEVY---RADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+G G YG+V+ + T V K + ++ + K E I+ ++HP
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPF 82
Query: 751 VV-LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
+V L T + IL E+L G L+ L R +++ +A +++ + +LH
Sbjct: 83 IVDLIYAFQTGGKLYLIL-EYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQK 140
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
I++RDLK N++++ VK+ DFGL + H + + GT E+MAPE+L
Sbjct: 141 G--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIR 926
N D +S G +++++ T + P+ G N + +L +P + +++
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----IDKILKCKLNLPPYLTQEARDLLK 253
Query: 927 DCWQTEPHLR 936
+ R
Sbjct: 254 KLLKRNAASR 263
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 18/246 (7%)
Query: 700 IGIGSYGEVY---RADWHGTEV--AVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV-L 753
+G GS+G+V+ + A+K + K E +I++ + HP +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTI 813
T + IL +FL G L+ L + +E + +A ++A +++LH+ I
Sbjct: 92 HYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLG--I 147
Query: 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKC 873
++RDLK N+L+D+ +K+ DFGLS+ + S GT E+MAPEV+ +
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 207
Query: 874 DVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDCWQ 930
D +SFGV+++E+ T ++P++G + + +L +P + P ++R ++
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKET-----MTMILKAKLGMPQFLSPEAQSLLRMLFK 262
Query: 931 TEPHLR 936
P R
Sbjct: 263 RNPANR 268
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+ +L + Q + IG G+ G V A D VA+KK L + F + ++ + E++
Sbjct: 20 TFTVL-KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK-LSRPFQNQTHAK-RAYRELV 76
Query: 744 L--RLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRMRM 795
L + H N++ + T I+ E + +L +++ LD R +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME---LDHERMSYL 132
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855
+ G+ +LH++ I+HRDLK N++V + +K+ DFGL+R + S T
Sbjct: 133 LYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART------AGTSFMMT 184
Query: 856 PEWM-----APEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM 898
P + APEV+ E D++S G I+ E+ V + G + +
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 4e-20
Identities = 56/248 (22%), Positives = 116/248 (46%), Gaps = 23/248 (9%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV 752
+G GS+G+V ++ GT+ + K + QD D + E ++ + P +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD---DDVECTMVEKRVLALPGKPPFLT 405
Query: 753 -LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
L T + ++ E++ G L + + + E + A ++A G+ +L +
Sbjct: 406 QLHSCFQTMDRLYFVM-EYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG- 462
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
I++RDLK N+++D +K+ DFG+ + +++K+ GTP+++APE++ +P +
Sbjct: 463 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDC 928
D ++FGV+L+E+ P++G + ++ FQ + P + I +
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVAICKGL 576
Query: 929 WQTEPHLR 936
P R
Sbjct: 577 MTKHPGKR 584
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-20
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKK---FLDQDFSGDSLSQFKCEA 740
+ I D Q+ +G G+YG V A G VA+KK F F+ +L
Sbjct: 6 VYNIS-SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR------ 58
Query: 741 EIML--RLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRR 792
EI + +H N++ + R F I+ E + L+R++ D+ +
Sbjct: 59 EIKILKHFKHENIITIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVI-STQMLSDDHIQ 115
Query: 793 --MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850
+ L + + LH S+ ++HRDLK NLL++ N +KVCDFGL+RI + +
Sbjct: 116 YFIYQTL---RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 851 STAGTPEWM----------APEVLRNEPA-NEKCDVYSFGVILWEL 885
G M APEV+ + DV+S G IL EL
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 23/248 (9%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV 752
+G GS+G+V A T V K + QD D + E I+ HP +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD---DDVECTMTEKRILSLARNHPFLT 87
Query: 753 -LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
LF T F ++ EF+ G L + + + + DE R A ++ + +LH
Sbjct: 88 QLFCCFQTPDRLFFVM-EFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKG- 144
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
I++RDLK N+L+D K+ DFG+ + +++ + GTP+++APE+L+
Sbjct: 145 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDC 928
D ++ GV+L+E+ P++ N + F+ N + P + I++
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILNDEVVYPTWLHEDATGILKSF 258
Query: 929 WQTEPHLR 936
P +R
Sbjct: 259 MTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 56/248 (22%), Positives = 116/248 (46%), Gaps = 23/248 (9%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV 752
+G GS+G+V ++ GT+ + K + QD D + E ++ + P +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD---DDVECTMVEKRVLALPGKPPFLT 84
Query: 753 -LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
L T + ++ E++ G L + + + E + A ++A G+ +L +
Sbjct: 85 QLHSCFQTMDRLYFVM-EYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG- 141
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
I++RDLK N+++D +K+ DFG+ + +++K+ GTP+++APE++ +P +
Sbjct: 142 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---NRRLEIPDDIDPAVAQIIRDC 928
D ++FGV+L+E+ P++G + ++ FQ + P + I +
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVAICKGL 255
Query: 929 WQTEPHLR 936
P R
Sbjct: 256 MTKHPGKR 263
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-19
Identities = 55/228 (24%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+ +L + Q + IG G+ G V A VA+KK L + F + ++ + E++
Sbjct: 57 TFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK-LSRPFQNQTHAK-RAYRELV 113
Query: 744 L--RLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRMRM 795
L + H N++ + T ++ E + +L +++ LD R +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME---LDHERMSYL 169
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855
+ G+ +LH++ I+HRDLK N++V + +K+ DFGL+R + S T
Sbjct: 170 LYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART------AGTSFMMT 221
Query: 856 PEWM-----APEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM 898
P + APEV+ E D++S G I+ E+ + + G + +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 269
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 27/250 (10%)
Query: 700 IGIGSYGEVYRADWHGTEV--AVK----KFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV 752
IG GS+G+V A EV AVK K + + E ++L+ ++HP +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLV 102
Query: 753 -LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
L T + +L +++ G L+ L R E R A ++A + YLH+ +
Sbjct: 103 GLHFSFQTADKLYFVL-DYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLN- 159
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA--GTPEWMAPEVLRNEPA 869
IV+RDLK N+L+D + + DFGL K + +S ++ GTPE++APEVL +P
Sbjct: 160 -IVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN---RRLEIPDDIDPAVAQIIR 926
+ D + G +L+E+ P+ N ++ + N + L++ +I + ++
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKPLQLKPNITNSARHLLE 271
Query: 927 DCWQTEPHLR 936
Q + R
Sbjct: 272 GLLQKDRTKR 281
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 6e-19
Identities = 60/252 (23%), Positives = 113/252 (44%), Gaps = 22/252 (8%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV 752
IG GSY +V T+ V K+ ++ D + + + E + + HP +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLV 73
Query: 753 -LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
L T S F ++ E++ G L + R +L E + +++ +NYLH
Sbjct: 74 GLHSCFQTESRLFFVI-EYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG- 130
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
I++RDLK N+L+D +K+ D+G+ + ++ + GTP ++APE+LR E
Sbjct: 131 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG----FQ---NRRLEIPDDIDPAVAQI 924
D ++ GV+++E+ P+ + FQ +++ IP + A +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 249
Query: 925 IRDCWQTEPHLR 936
++ +P R
Sbjct: 250 LKSFLNKDPKER 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 26/254 (10%)
Query: 700 IGIGSYGEVYRADWHGTE------VAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVV 752
IG GSY +V T+ V K+ ++ D + + + E + + HP +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLV 116
Query: 753 -LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP 811
L T S F ++ E++ G L + R +L E + +++ +NYLH
Sbjct: 117 GLHSCFQTESRLFFVI-EYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG- 173
Query: 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA--GTPEWMAPEVLRNEPA 869
I++RDLK N+L+D +K+ D+G+ K ++ GTP ++APE+LR E
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG----FQ---NRRLEIPDDIDPAVA 922
D ++ GV+++E+ P+ + FQ +++ IP + A
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290
Query: 923 QIIRDCWQTEPHLR 936
+++ +P R
Sbjct: 291 SVLKSFLNKDPKER 304
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 52/248 (20%), Positives = 94/248 (37%), Gaps = 79/248 (31%)
Query: 695 QIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKC-EAEIMLRLRHPNV 751
+G+ +G GS+G V G A+KK L QD ++K E +IM L H N+
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-QDP------RYKNRELDIMKVLDHVNI 62
Query: 752 V-----------------------------------LFMGAVTRSPHFSIL---TEFLPR 773
+ + L E++P
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP- 121
Query: 774 GSLYRLLHRPNHQLDERRRMRMALD--------VAKGMNYLHTSHPTIVHRDLKSPNLLV 825
+L+++L R + ++ + + + ++H+ I HRD+K NLLV
Sbjct: 122 DTLHKVLKSFI-----RSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLV 174
Query: 826 D-KNWVVKVCDFGLSRIKHHT-----YLSSKSTAGTPEWM-APEVLRNEPA-NEKCDVYS 877
+ K+ +K+CDFG ++ + Y+ S+ + APE++ D++S
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSR-------FYRAPELMLGATEYTPSIDLWS 227
Query: 878 FGVILWEL 885
G + EL
Sbjct: 228 IGCVFGEL 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRADWHGT--EVAVK------KFLDQDFSGDSLSQFKCE 739
E + +I IG GS+G+V +A VA+K FL+Q + E
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA---------QIE 100
Query: 740 AEIMLRLRHP------NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRR 792
++ + +V H ++ E L +LY LL N + +
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLT 159
Query: 793 MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV--DKNWVVKVCDFGLS---RIKHHTYL 847
+ A + + +L T +I+H DLK N+L+ K +K+ DFG S + + Y+
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT 887
S+ + +PEVL P + D++S G IL E+ T
Sbjct: 220 QSRF------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 56/235 (23%), Positives = 91/235 (38%), Gaps = 45/235 (19%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQ--FKCEAE 741
+ ++ I IG GSYG VY A D + VA+KK F + + E
Sbjct: 21 NVHVP-DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILR---E 75
Query: 742 IML--RLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRM 793
I + RL+ ++ + I+ E L +L P +E +
Sbjct: 76 ITILNRLKSDYIIRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT 133
Query: 794 RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI------------ 841
+ ++ G N++H S I+HRDLK N L++++ VKVCDFGL+R
Sbjct: 134 IL-YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 842 KHHTYLSSKSTAGTPEWM----------APEVLRNEPA-NEKCDVYSFGVILWEL 885
+ + APE++ + + D++S G I EL
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-18
Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 48/239 (20%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKK-FLDQDFSGDSLSQFKCEAEI 742
+W+I + +I IG GSYG V A D VA+KK + D + EI
Sbjct: 48 DWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR---EI 103
Query: 743 ML--RLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRMR 794
+ RL H +VV + + ++ E +L P + + +
Sbjct: 104 AILNRLNHDHVVKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTL 161
Query: 795 MALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAG 854
+ ++ G+ Y+H++ I+HRDLK N LV+++ VKVCDFGL+R + +
Sbjct: 162 L-YNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 855 TPEWM---------------------------APEVLRNEPA-NEKCDVYSFGVILWEL 885
+P APE++ + E DV+S G I EL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 8e-18
Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 19/248 (7%)
Query: 700 IGIGSYGEVYRADWHGTEV--AVKKFLDQDF--SGDSLSQFKCEAEIMLRL---RHPNVV 752
IG G +GEVY T A+K LD+ + E ++ + P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKC-LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
A S + + + G L+ L + + E A ++ G+ ++H
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL-RNEPANE 871
+V+RDLK N+L+D++ V++ D GL+ + ++ GT +MAPEVL + +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPM---QVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928
D +S G +L++L P++ ++ +E+PD P + ++
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 428
Query: 929 WQTEPHLR 936
Q + + R
Sbjct: 429 LQRDVNRR 436
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 68/295 (23%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
WE+ + +G G+YG V A D G +VA+KK L + F + ++ + E++
Sbjct: 19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK-LSRPFQSEIFAK-RAYRELL 75
Query: 744 L--RLRHPNVVL---FMGAVTRSPHFS---ILTEFLPRGSLYRLLHRPNHQLDERRRMRM 795
L ++H NV+ + +F ++ F+ L +++ + E + +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG---LKFSEEKIQYL 131
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT---YLSSKST 852
+ KG+ Y+H++ +VHRDLK NL V+++ +K+ DFGL+R Y+ ++
Sbjct: 132 VYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-- 187
Query: 853 AGTPEW-MAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR 910
W APEV+ + N+ D++S G I+ E+ T +KG + + + +
Sbjct: 188 -----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL------TQI 236
Query: 911 LEI-----PDDIDPAVAQIIRDCWQTEPHLRP-SFAQLMSR-----LRCLQRLLV 954
L++ + + + + Q+ P F QL R L+++L
Sbjct: 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLE 291
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 71/295 (24%), Positives = 132/295 (44%), Gaps = 47/295 (15%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
WE+ + + +G G+YG V A D G +VA+KK L + F + ++ + E+
Sbjct: 20 AWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK-LYRPFQSELFAK-RAYRELR 76
Query: 744 L--RLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRMRM 795
L +RH NV+ + T ++ F+ L +L+ + +L E R +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK--HEKLGEDRIQFL 133
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855
+ KG+ Y+H + I+HRDLK NL V+++ +K+ DFGL+R + T
Sbjct: 134 VYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMT 183
Query: 856 PE----WM-APEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPM----QVVGAVG 905
W APEV+ N + D++S G I+ E+ T +KG + + +++ G
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243
Query: 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRP-SFAQLMSR-----LRCLQRLLV 954
+ + + ++ + P L FA +++ + L+++LV
Sbjct: 244 TPP-----AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 293
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 59/237 (24%), Positives = 109/237 (45%), Gaps = 46/237 (19%)
Query: 682 GEVAEWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQ--FK 737
G V + +L ++ +++G G+YG V+++ D G VAVKK D F + +Q F+
Sbjct: 1 GRV-DRHVL-RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFR 57
Query: 738 CEAEIMLRLR----HPNVVLFMGAVTRSPHFS---ILTEFLPRGSLYRLLHRPNHQLDER 790
EIM+ L H N+V + V R+ + ++ +++ L+ ++ + L+
Sbjct: 58 ---EIMI-LTELSGHENIVNLL-NVLRADNDRDVYLVFDYME-TDLHAVIR--ANILEPV 109
Query: 791 RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--------- 841
+ + + K + YLH+ ++HRD+K N+L++ VKV DFGLSR
Sbjct: 110 HKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 842 --KHHTYLSSKSTAGTPEWM----------APEVLRNEPA-NEKCDVYSFGVILWEL 885
++++ + APE+L + D++S G IL E+
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 49/232 (21%), Positives = 89/232 (38%), Gaps = 51/232 (21%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKK--FLDQDFSGDSLSQFKCEAE 741
+++ + +G G G V+ A D VA+KK D +L E
Sbjct: 6 GFDLG-SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR------E 58
Query: 742 IML--RLRHPNVV-----------LFMGAVTRSPHFS---ILTEFLPRGSLYRLLHRPNH 785
I + RL H N+V V + I+ E++ L +L
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--QG 115
Query: 786 QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHH 844
L E + +G+ Y+H+++ ++HRDLK NL ++ ++ V+K+ DFGL+R
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR---- 169
Query: 845 TYLSSKSTAGTPEWM----------APEVLRNEPA-NEKCDVYSFGVILWEL 885
+ +P +L + + D+++ G I E+
Sbjct: 170 ---IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 39/175 (22%), Positives = 79/175 (45%), Gaps = 12/175 (6%)
Query: 769 EFLPRGSLYRLLHRPNHQLDERR-RMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK 827
+++ G L+ L + + E ++ + ++ + +LH I++RD+K N+L+D
Sbjct: 139 DYINGGELFTHLSQ-RERFTEHEVQIYVG-EIVLALEHLHKLG--IIYRDIKLENILLDS 194
Query: 828 NWVVKVCDFGLSRIKHHTYLSSKST-AGTPEWMAPEVLRNEPA--NEKCDVYSFGVILWE 884
N V + DFGLS+ GT E+MAP+++R + ++ D +S GV+++E
Sbjct: 195 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 885 LATLSVPWKGLNPMQVVGAVGFQN---RRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
L T + P+ + + P ++ +I+ +P R
Sbjct: 255 LLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 44/224 (19%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRA-DWH-GTEVAVKK---FLDQDFSGDSLSQFKCEA 740
+++ IG G+YG V A D VA+KK F Q + +L + K
Sbjct: 22 VFDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK--- 77
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRR-- 792
I+LR RH N++ + R+P I+ + + LY+LL + H ++
Sbjct: 78 -ILLRFRHENIIGIN-DIIRAPTIEQMKDVYIVQDLME-TDLYKLL-KTQHLSNDHICYF 133
Query: 793 MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST 852
+ L +G+ Y+H+++ ++HRDLK NLL++ +K+CDFGL+R +
Sbjct: 134 LYQIL---RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPD 181
Query: 853 AGTPEWM----------APEVLRNEPA-NEKCDVYSFGVILWEL 885
++ APE++ N + D++S G IL E+
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 41/226 (18%), Positives = 89/226 (39%), Gaps = 50/226 (22%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVK------KFLDQDFSGDSLSQFKCEAEIMLRL 746
+ ++G G + V+ A D T VA+K + + + E +++ R+
Sbjct: 22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA---------EDEIKLLQRV 72
Query: 747 R-----------HPNVV----LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDER 790
+++ F H ++ E L +L L+ + H+ +
Sbjct: 73 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLI 131
Query: 791 RRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD------KNWVVKVCDFGLSRIKHH 844
+++ + G++Y+H I+H D+K N+L++ +K+ D G +
Sbjct: 132 YVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 845 ---TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT 887
+ ++ E+ +PEVL P D++S +++EL T
Sbjct: 191 HYTNSIQTR------EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 68/296 (22%), Positives = 127/296 (42%), Gaps = 49/296 (16%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRAD--WHGTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
WE+ E Q +G G+YG V A G VAVKK L + F ++ + E+
Sbjct: 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQSIIHAK-RTYRELR 80
Query: 744 L--RLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRMRM 795
L ++H NV+ + T + ++T + L ++ +L + +
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK--CQKLTDDHVQFL 137
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855
+ +G+ Y+H++ I+HRDLK NL V+++ +K+ DFGL+R + T
Sbjct: 138 IYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTADEMT 187
Query: 856 PE----W-MAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR 909
W APE++ N N+ D++S G I+ EL T + G + + +
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL------KL 241
Query: 910 RLEI-----PDDIDPAVAQIIRDCWQTEPHLRP-SFAQLMSR-----LRCLQRLLV 954
L + + + ++ R+ Q+ + +FA + + L+++LV
Sbjct: 242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVK------KFLDQDFSGDSLSQFKCEAEIMLRL 746
++ + IG GS+G+V +A H VA+K +F Q E I+ L
Sbjct: 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ---------AAEEIRILEHL 150
Query: 747 RH------PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALDV 799
R NV+ + T H + E L +LY L+ + Q + A +
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLV--DKNWVVKVCDFGLS---RIKHHTYLSSKSTAG 854
+ ++ LH + I+H DLK N+L+ +KV DFG S + +TY+ S+
Sbjct: 210 LQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--- 264
Query: 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELAT 887
+ APEV+ D++S G IL EL T
Sbjct: 265 ---YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKC---- 738
EW +D Q+ ++G G Y EV+ A + +V VK L K
Sbjct: 31 EWGNQ-DDYQLVRKLGRGKYSEVFEA-INITNNEKVVVKI----------LKPVKKKKIK 78
Query: 739 -EAEIMLRLR-HPNVVLFMGAVTRSPHF--SILTEFLPRGSLYRLLHRPNHQLDERRRMR 794
E +I+ LR PN++ V +++ E + +L D R M
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-DIRFYMY 137
Query: 795 MALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHHT-----YLS 848
L K ++Y H S I+HRD+K N+++D ++ +++ D+GL+ H ++
Sbjct: 138 EIL---KALDYCH-SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 849 SKSTAGTPEWM-APEVLRNEPA-NEKCDVYSFGVILWELATLSVP 891
S+ + PE+L + + D++S G +L + P
Sbjct: 193 SR-------YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 2e-12
Identities = 94/657 (14%), Positives = 192/657 (29%), Gaps = 179/657 (27%)
Query: 349 LDVREFPDHTETSVISHMELDDGTETPTI---SRPMPDRIPEVGSTGSEEASFVGKITNK 405
D ++ D + S++S E+D + + + + ++ FV ++
Sbjct: 33 FDCKDVQDMPK-SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQK--FVEEVLRI 89
Query: 406 DESELADKNQTEKFEKDFGQLSPALSNPCEGTSGTSRKPSSAQKK---KVKSVSKYVISA 462
+ L +TE S +R + + + +KY +S
Sbjct: 90 NYKFLMSPIKTE----------------QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 463 AKDPEFARKLHAVLLQSGASPPPDLFLD--------------INSQDLGEWKMLEQVHLA 508
+ KL LL+ P ++ +D S + + KM ++
Sbjct: 134 ---LQPYLKLRQALLE--LRPAKNVLIDGVLGSGKTWVALDVCLSYKV-QCKMDFKIFWL 187
Query: 509 DGKNVDNDVQCLS--NRFLSNHEQSHASSVGVESSNYLNYESRKRQPAEWFAE-QHKK-L 564
+ KN ++ L + L + + S S+ L S + + ++ L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 565 -------EPNVIN-----CDLSLSSDTAGERFVLVGNELKLNNATSVNTVPVNPP----- 607
N C + L++ RF V + L T ++ +
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTT-----RFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 608 --GVVA---GASCEKEIP-----GSPLPAA--AEFCQRQP---ENALVSVKQPVYTDLG- 651
++ + ++P +P + AE + +N K L
Sbjct: 303 VKSLLLKYLDCRPQ-DLPREVLTTNPRRLSIIAESIRDGLATWDN----WKHVNCDKLTT 357
Query: 652 --KESAADLMPMINSGLLMTCNGQSDSIN-PM--LGEVAEWEILWEDLQIGERIGIGSYG 706
+ S L P + + S + P L ++W D+
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL------SLIWFDV---------IKS 402
Query: 707 EVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766
+V V V K SL + + P T S SI
Sbjct: 403 DV--------MVVVNKLHKY-----SLVE-----------KQPK------ESTISIP-SI 431
Query: 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM-----NYLHTSHPTIVH------ 815
E + LHR + + + D + Y + SH I H
Sbjct: 432 YLELKVKLENEYALHR---SIVDHYNIPKTFDSDDLIPPYLDQYFY-SH--IGHHLKNIE 485
Query: 816 ---RDLKSPNLLVDKNWV-VKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANE 871
R + +D ++ K+ + + S +T ++ P + N+P E
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAW---NASGSILNTLQQLKFYKPYICDNDPKYE 542
Query: 872 K--CDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926
+ + F L ++ + K + ++ + I ++ A Q+ R
Sbjct: 543 RLVNAILDF---LPKIEENLICSKYTDLLR----IALMAEDEAIFEE---AHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 3e-09
Identities = 110/646 (17%), Positives = 187/646 (28%), Gaps = 214/646 (33%)
Query: 76 VDFNLLEEEFQ----VQLALAISASDPDAREKVESAQIDAAKRMSLGCRSASVTETDALV 131
+DF E ++Q + + + D ++ V+ D K + S E D ++
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKD-VQ----DMPKSI------LSKEEIDHII 55
Query: 132 ----EFLSLRYWSYSAVNYDEKIVDGFYDV-----YG-ITSNSVSQGKMPLLVDLQAISL 181
++ ++ E++V F + Y + S ++ + P ++ I
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 182 SDNL--DYEVIV---VNRL-----VDPNLKELEKRAYNVSVECRYSDLGPILSG---LIQ 228
D L D +V V+RL + L EL + A NV + LG SG +
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLEL-RPAKNVLI---DGVLG---SGKTWVAL 168
Query: 229 KIA--DLVVERMGGPV-----GNAEE----------IYGRWTLRRTQLRNSLNTNILPLG 271
+ V +M + N + + T + + L +
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 272 CLDVGLSRH-------RALLFKVLAD----RI----NLPC-MLVKGSYYTGTDDGAVNLI 315
+ L R LL VL + + NL C +L+ T T V
Sbjct: 229 SIQAELRRLLKSKPYENCLL--VLLNVQNAKAWNAFNLSCKILL-----T-TRFKQVTDF 280
Query: 316 KLDNGSEYIIDLMGAPGTLIPAEVPSCLLQNAGLDVREFPDHTET------SVIS----- 364
L + I L TL P EV S LL+ ++ P T S+I+
Sbjct: 281 -LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRD 339
Query: 365 ---------HMELDDGTET---------PTISRPM-------PD--RIPEVGSTGSEEAS 397
H+ D T P R M P IP +
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTI--------- 390
Query: 398 FVGKI--TNKDESELADKNQTEKFEKDFGQLSPALSNPCEGTSGTSRKPSSAQKKKVKSV 455
+ + + +S+ + S P E T PS + KVK
Sbjct: 391 -LLSLIWFDVIKSD------VMVVVNKLHKYSLVEKQPKESTISI---PSIYLELKVKLE 440
Query: 456 SKYVISAAKDPEFARKLHAVLLQS----------GASPPPD---LFLDI-----NSQDLG 497
++Y LH ++ PP + I N +
Sbjct: 441 NEY------------ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE 488
Query: 498 EWKMLEQVHLADGKNVDNDVQCLSNRFLSN---HEQSHASSVGVESS------NYLNY-- 546
+ V L D RFL H+ + ++ G + Y Y
Sbjct: 489 RMTLFRMVFL--------DF-----RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC 535
Query: 547 -----ESRKRQPAEWFAEQHKKLEPNVINCD------LSLSSDTAG 581
R F + E N+I ++L ++
Sbjct: 536 DNDPKYERLVNAILDFLPKI---EENLICSKYTDLLRIALMAEDEA 578
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 4e-06
Identities = 43/307 (14%), Positives = 94/307 (30%), Gaps = 76/307 (24%)
Query: 693 DLQIGERIGIGSYGEVYRADWHGTEVAVKKFLD----QDFSGDSLSQFKCEAEIMLRLRH 748
D + GE Y Y+ E A D QD LS K E + ++ +
Sbjct: 8 DFETGEH----QYQ--YKDILSVFEDAFVDNFDCKDVQDMPKSILS--KEEIDHIIMSKD 59
Query: 749 P-NVVLFMGAVTRSPHFSILTEFLPRGSL---YRLLHRPNHQLDERRRMRMALDVAKGMN 804
+ L + S ++ +F+ L Y+ L P + M + + + +
Sbjct: 60 AVSGTLRLFWTLLSKQEEMVQKFV-EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ-RD 117
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL-------SSKSTAGTPE 857
L+ + ++ ++ L ++ + S K+
Sbjct: 118 RLYNDNQVFAKYNVSRLQPY----LKLRQA---LLELRPAKNVLIDGVLGSGKT------ 164
Query: 858 WMAPEVLRNEPANEKCD--VY--SFG------VILWELATLSVPWKGLNPMQVVGAVGFQ 907
W+A +V + K D ++ + +L L L ++P +
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL---LYQIDPNWTSRSDHSS 221
Query: 908 NRRLEIPDDIDPAVAQ------------IIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV- 954
N +L I I + + ++ + + +F L C ++L+
Sbjct: 222 NIKLRI-HSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWN-AFN-----LSC--KILLT 271
Query: 955 --DRSNS 959
+ +
Sbjct: 272 TRFKQVT 278
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 3e-12
Identities = 33/194 (17%), Positives = 51/194 (26%), Gaps = 48/194 (24%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVKK------FLDQDFSGDSLSQFKCEAEIMLR 745
E LQ E+IG G +GEV++ T VA+K L + + E I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 746 L---------RHPNVVLFMGA------------------------------VTRSPHFSI 766
L R + + I
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD 826
+ EF G L + + + S HRDL N+L+
Sbjct: 140 VLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASLR-FEHRDLHWGNVLLK 196
Query: 827 KNWVVKVCDFGLSR 840
K + K+ +
Sbjct: 197 KTSLKKLHYTLNGK 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 52/231 (22%), Positives = 85/231 (36%), Gaps = 56/231 (24%)
Query: 695 QIGERIGIGSYGEVYRA---DWHGTEVAVK------KFLDQDFSGDSLSQFKCEAEIMLR 745
+I + +G G++G+V G VAVK ++ + + E +++
Sbjct: 17 EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---------RSEIQVLEH 67
Query: 746 LRHP------NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRRMRMALD 798
L V + H I+ E L S Y + +MA
Sbjct: 68 LNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPN-LLVDKNWV------------------VKVCDFG-- 837
+ K +N+LH++ + H DLK N L V ++ +KV DFG
Sbjct: 127 ICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 838 -LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT 887
H T +S++ APEV+ ++ CDV+S G IL E
Sbjct: 185 TYDDEHHSTLVSTRHYR------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 38/225 (16%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH---- 748
++G RIG GS+G ++ + +VA+K + Q + E L
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 749 PNVVLFMGAVTRSPHFSIL-TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM---- 803
PNV F G + ++L + L SL LL + ++ AK M
Sbjct: 69 PNVYYF-G---QEGLHNVLVIDLLGP-SLEDLLDLCGRKFS----VKTVAMAAKQMLARV 119
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNW-----VVKVCDFGLSRI-------KHHTYLSSKS 851
+H +V+RD+K N L+ + ++ V DFG+ + +H Y K+
Sbjct: 120 QSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 852 TAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN 896
+GT +M+ + + D+ + G + S+PW+GL
Sbjct: 178 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 52/233 (22%), Positives = 85/233 (36%), Gaps = 60/233 (25%)
Query: 695 QIGERIGIGSYGEVYRADWHGT---EVAVK------KFLDQDFSGDSLSQFKCEAEIMLR 745
+I +G G++G+V H +VA+K K+ + + E ++ +
Sbjct: 22 EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---------RLEINVLKK 72
Query: 746 LRHP------NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMA 796
++ VL H I E L + + L N Q L R M A
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHM--A 129
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPN-LLVD------------------KNWVVKVCDFG 837
+ + +LH + + H DLK N L V+ KN ++V DFG
Sbjct: 130 YQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 838 ---LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT 887
H T ++++ PEV+ + CDV+S G IL+E
Sbjct: 188 SATFDHEHHTTIVATRHY------RPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 64/237 (27%)
Query: 695 QIGERIGIGSYGEVYRADWHGT--EVAVK------KFLDQDFSGDSLSQFKCEAEIMLRL 746
+ ++G G++G V AVK K+ K EA+I+ ++
Sbjct: 38 LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---------KIEADILKKI 88
Query: 747 RH-----PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALD 798
++ N+V + G H ++ E L SLY ++ R N+ +++ + ++
Sbjct: 89 QNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLY--CIE 145
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPN-LLVD------------------------KNWVVKV 833
+ K +NYL + H DLK N LL D K+ +K+
Sbjct: 146 ILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 834 CDFG---LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT 887
DFG H + ++++ + APEV+ N + D++SFG +L EL T
Sbjct: 204 IDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 48/224 (21%), Positives = 90/224 (40%), Gaps = 36/224 (16%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH---- 748
++G++IG G++GE+ + + VA+ K Q E +L
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNEYVAI-KLEPMK---SRAPQLHLEYRFYKQLGSGDGI 67
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM----N 804
P V F G ++ + L SL L + ++ L +A +
Sbjct: 68 PQVYYF-G---PCGKYNAMVLELLGPSLEDLFDLCDRTFS----LKTVLMIAIQLISRME 119
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNW-----VVKVCDFGLSRI-------KHHTYLSSKST 852
Y+H+ + +++RD+K N L+ + V+ + DF L++ KH Y KS
Sbjct: 120 YVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177
Query: 853 AGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN 896
GT +M+ + + + D+ + G + S+PW+GL
Sbjct: 178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 50/217 (23%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH---- 748
++G +IG GS+G++Y D G EVA+K + Q E++I ++
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
P + G ++++ L SL L + + + + + +A + + Y+H+
Sbjct: 68 PTIRWC-G---AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 809 SHPTIVHRDLKSPNLLVDKNW---VVKVCDFGLSRI-------KHHTYLSSKSTAGTPEW 858
+ +HRD+K N L+ +V + DFGL++ +H Y +K+ GT +
Sbjct: 124 KN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL 895
+ + + D+ S G +L S+PW+GL
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 51/305 (16%), Positives = 95/305 (31%), Gaps = 90/305 (29%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRA--DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
++ + ++G G + V+ + VA+K + ++ E ++
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKS 89
Query: 746 LR-----HPN---VVLFMGAVT-RSP---HFSILTEFLPRGSLYRLLHR-PNHQLDERRR 792
+R PN VV + H ++ E L L + + + L
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 793 MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV--------------------------- 825
++ V +G++YLH + I+H D+K N+L+
Sbjct: 149 KKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 826 ----------------------DKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTPEWMAP 861
+ VK+ D G + KH T T ++ +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSL 262
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
EVL N D++S + +ELAT F+ E + +
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYL--------------FEPHSGEEYTRDEDHI 308
Query: 922 AQIIR 926
A II
Sbjct: 309 ALIIE 313
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 695 QIGERIGIGSYGEVYRA-DWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH---- 748
++G +IG GS+GE+Y + EVA+K + Q E++I L+
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 749 PNVVLFMGAVTRSPHFSIL-TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
PNV F +++L + L SL L + + +L + + +A + + ++H
Sbjct: 66 PNVRWF----GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 808 TSHPTIVHRDLKSPNLLVDKNW---VVKVCDFGLSRI-------KHHTYLSSKSTAGTPE 857
+ +HRD+K N L+ V + DFGL++ +H Y +K+ GT
Sbjct: 121 SKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN 896
+ + + + D+ S G +L S+PW+GL
Sbjct: 179 YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 37/228 (16%), Positives = 78/228 (34%), Gaps = 30/228 (13%)
Query: 696 IGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754
+G IG G +G +Y AD + V E + R P +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 755 MGAVTRSPHFSI-------LTEFLPRG-----------SLYRLLHRPNHQLDERRRMRMA 796
+ + + L + + L ++ + + ++++
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLS 158
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKV--CDFGLSRI-------KHHTYL 847
L + + Y+H VH D+K+ NLL++ +V D+GL+ K +
Sbjct: 159 LRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL 895
+ GT E+ + + + + D+ G + + T +PW+
Sbjct: 217 PKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 41/231 (17%), Positives = 80/231 (34%), Gaps = 37/231 (16%)
Query: 695 QIGERIGIGSYGEVYRA--DWHGTEVAVK--KFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+G++IG G +G +Y A + A K Q+ E + R+ +
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-----GPLFSELKFYQRVAKKD 94
Query: 751 VVLFMGAVTRSPHFSILT-----EFLPRGSLYRL------------LHRPNHQLDERRRM 793
+ + + I +G YR + N + +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 794 RMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKV--CDFGLSRI-------KHH 844
++ + + + Y+H + VH D+K+ NLL+ +V D+GLS K +
Sbjct: 155 QLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL 895
K GT E+ + + + + + DV G + +PW+
Sbjct: 213 QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 42/228 (18%), Positives = 77/228 (33%), Gaps = 30/228 (13%)
Query: 696 IGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFS---GDSLSQFKCEAEIMLRLRHPNVV 752
+ + G +Y A T Q FS + E R P V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 753 LFMGAVTRSPHFSI--LTEFLPRGSLYRLL--------------HRPNHQLDERRRMRMA 796
+ +P +I F YR L P H L ER +++A
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVA 165
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKV--CDFGLSRI-----KHHTYLSS 849
+ + +LH + VH ++ + N+ VD +V +G + KH Y+
Sbjct: 166 CRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223
Query: 850 KSTA--GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL 895
+ G E+++ ++ + + + D+ S G + + +PW
Sbjct: 224 SRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 967 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.08 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.91 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.86 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 97.65 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.42 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.13 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.1 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 96.84 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.69 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 96.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.49 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.31 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.19 | |
| 2q3z_A | 687 | Transglutaminase 2; transglutaminase 2, tissue tra | 96.08 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.03 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.0 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.98 | |
| 1vjj_A | 692 | Protein-glutamine glutamyltransferase E; transglut | 95.67 | |
| 1g0d_A | 695 | Protein-glutamine gamma-glutamyltransferase; tissu | 95.34 | |
| 1ex0_A | 731 | Coagulation factor XIII A chain; transglutaminase, | 94.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.28 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.16 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=461.01 Aligned_cols=263 Identities=33% Similarity=0.608 Sum_probs=224.0
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
..|++..+++++.++||+|+||+||+|++++ .||||++.....+....+.|.+|+.++++++|||||++++++.+ +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 3588899999999999999999999998765 69999987666666778889999999999999999999998764 568
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+||||||++|+|.+++......+++..++.|+.||+.||+|||++ +||||||||+||||++++++||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~--~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK--NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999999987777899999999999999999999998 799999999999999999999999999987543
Q ss_pred C--ccCCCCCCCCCCccChhcccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc-c---cCCCC
Q 037068 845 T--YLSSKSTAGTPEWMAPEVLRN---EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-R---LEIPD 915 (967)
Q Consensus 845 ~--~~~~~~~~GT~~YmAPE~l~g---~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~-~---~~ip~ 915 (967)
. ........||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+.......+..... . ..++.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 2 223445689999999999964 4689999999999999999999999998776544433322222 2 24567
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
.+++++.+||.+||+.||++|||+.||+++|+.|+.
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 899999999999999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=469.91 Aligned_cols=252 Identities=21% Similarity=0.422 Sum_probs=222.1
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||+||+|++ +++.||||++..........+.+.+|+.++++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 7999999999999999999976 48899999998777677778889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 770 FLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||++|+|.+++... ...+++..++.|+.||+.||+|||++ |||||||||+||||+.++++||+|||+|+........
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR--KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999999999653 45679999999999999999999998 7999999999999999999999999999876554333
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..++...+. .....+++..+++++.+||.+|
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-~~~~~~~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999998888777665 3334567788999999999999
Q ss_pred hhcCCCCCcCHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L 946 (967)
|+.||++|||+.|+++|-
T Consensus 261 L~~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 261 FKRNPRDRPSVNSILEKG 278 (350)
T ss_dssp TCSSGGGSCCHHHHHTSH
T ss_pred ccCChhHCcCHHHHhcCH
Confidence 999999999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=459.32 Aligned_cols=260 Identities=35% Similarity=0.561 Sum_probs=223.9
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
.+..++|.+.++||+|+||+||+|++. ++.||||++... +....++|.+|+++|++++|||||+++++|.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 345578999999999999999999753 567999998643 45567789999999999999999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRP--------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD 826 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~--------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd 826 (967)
.+.++||||||++|+|.+++... ...+++..++.|+.||+.||.|||++ +||||||||+||||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHhhEEEC
Confidence 99999999999999999998653 24589999999999999999999998 699999999999999
Q ss_pred CCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhh
Q 037068 827 KNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGA 903 (967)
Q Consensus 827 ~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~ 903 (967)
.++++||+|||+|+...... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..++...
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999998654332 22345679999999999999999999999999999999999 8999999998888777
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 904 i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
+. .+.+++.|..+++++.+||.+||+.||++|||+.||+++|+.+.+.
T Consensus 273 i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 IT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 64 5567888999999999999999999999999999999999988653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=456.95 Aligned_cols=259 Identities=31% Similarity=0.553 Sum_probs=227.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
+..++|.+.++||+|+||+||+|++. +..||||++... +....++|.+|+++|++++|||||++++++.+.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 45578999999999999999999753 567999998643 455677899999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC
Q 037068 762 PHFSILTEFLPRGSLYRLLHRP------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW 829 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g 829 (967)
+.++||||||++|+|.++|... ...+++..++.|+.||+.||.|||++ +||||||||+||||+.++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ--HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccCHhhEEECCCC
Confidence 9999999999999999999642 35699999999999999999999998 699999999999999999
Q ss_pred eEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhc
Q 037068 830 VVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGF 906 (967)
Q Consensus 830 ~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~ 906 (967)
++||+|||+|+....... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~- 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986544322 2334568999999999999999999999999999999999 899999999888877765
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 907 QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 907 ~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
.+..++.|..+++++.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus 245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 4566788999999999999999999999999999999999887653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=454.39 Aligned_cols=258 Identities=31% Similarity=0.542 Sum_probs=226.6
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
++..+++++.++||+|+||+||+|++ +++.||||++... ......++|.+|+.++++++|||||++++++.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 34557889999999999999999975 3567999998654 344456789999999999999999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRP---------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV 825 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~---------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL 825 (967)
++.++||||||++|+|.++|... ...+++..++.|+.||+.||+|||++ +||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH--HVVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCccccceEE
Confidence 99999999999999999999642 24589999999999999999999998 69999999999999
Q ss_pred cCCCeEEEEecccccccccC--ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHh
Q 037068 826 DKNWVVKVCDFGLSRIKHHT--YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVG 902 (967)
Q Consensus 826 d~~g~VKLsDFGLAr~~~~~--~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~ 902 (967)
++++++||+|||+|+..... ........||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.+..++..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999865432 223445679999999999999999999999999999999998 899999999888877
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 903 AVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 903 ~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+. .+..++.|..+++++.+||.+||+.||++|||+.||+++|+.+
T Consensus 259 ~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 765 5566788999999999999999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=459.29 Aligned_cols=269 Identities=31% Similarity=0.559 Sum_probs=232.0
Q ss_pred cchhhhhhccCCeeEeEEeecCCceEEEEeecCC-------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC-CceeE
Q 037068 682 GEVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH-PNVVL 753 (967)
Q Consensus 682 ~~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g-------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H-pNIVk 753 (967)
....+|++..++|++.+.||+|+||+||+|++.+ +.||||++... ........+.+|+.+|++++| ||||+
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 3556899999999999999999999999997643 46999998654 344556789999999999955 89999
Q ss_pred Eeeeeec-cCceEEEEeecCCCchhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEec
Q 037068 754 FMGAVTR-SPHFSILTEFLPRGSLYRLLHRP---------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRD 817 (967)
Q Consensus 754 Lig~~~~-~~~l~LVmEy~~gGsL~~lL~~~---------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRD 817 (967)
++++|.+ ++.++||||||++|+|.++|+.. ...+++..++.|+.||+.||+|||++ +|||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~--~iiHRD 210 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRD 210 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT--TCCCSC
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC--CeecCc
Confidence 9999876 45689999999999999999642 24589999999999999999999998 699999
Q ss_pred cCCCcEEEcCCCeEEEEecccccccccC--ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 037068 818 LKSPNLLVDKNWVVKVCDFGLSRIKHHT--YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKG 894 (967)
Q Consensus 818 LKPsNILLd~~g~VKLsDFGLAr~~~~~--~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~ 894 (967)
|||+||||++++++||+|||+|+..... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999865432 223345678999999999999999999999999999999998 8999998
Q ss_pred CChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 895 LNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 895 ~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
....+.+......+.+++.|..+++++.++|.+||+.||++|||+.||+++|..+.+.-
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 77555444444466788899999999999999999999999999999999999886543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=454.69 Aligned_cols=264 Identities=28% Similarity=0.364 Sum_probs=227.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..+.|.+.++||+|+||+||+|++ +|+.||||++...... .+|+.++++++|||||++++++.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 346799999999999999999976 4889999998764322 3599999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-eEEEEecccccccccCc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-VVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-~VKLsDFGLAr~~~~~~ 846 (967)
||||++|+|.+++.+ .+.+++..++.|+.||+.||+|||++ |||||||||+||||+.+| ++||+|||+|+......
T Consensus 129 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999999976 45799999999999999999999998 799999999999999887 69999999998764322
Q ss_pred c-----CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc-cCCCCCCcHH
Q 037068 847 L-----SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR-LEIPDDIDPA 920 (967)
Q Consensus 847 ~-----~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~-~~ip~~ls~e 920 (967)
. .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..++...+...... ..+|..++++
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 1 223467999999999999999999999999999999999999999988776666655433322 3578899999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQF 963 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~~~~~~~~ 963 (967)
+.+||.+||++||.+|||+.||+++|.........-.-+|..-
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 9999999999999999999999999999888776666666543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=457.46 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=222.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+.|++.++||+|+||+||+|++ +|+.||||++...... ..+.+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999977 5889999998754322 34567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
||++|+|.+++.+ ..+++..++.|+.||+.||+|||++ |||||||||+||||+.++++||+|||+|+.........
T Consensus 152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 9999999999975 4699999999999999999999998 79999999999999999999999999999876655556
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~C 928 (967)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+... ...+..+..+++++.+||.+|
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999998888777666432 123344567899999999999
Q ss_pred hhcCCCCCcCHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L 946 (967)
|+.||++|||+.|+++|-
T Consensus 308 L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHP 325 (346)
T ss_dssp SCSSTTTSCCHHHHTTCG
T ss_pred cCCChhHCcCHHHHhcCH
Confidence 999999999999999984
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=443.73 Aligned_cols=248 Identities=31% Similarity=0.491 Sum_probs=213.9
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec----cCceEEE
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR----SPHFSIL 767 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~----~~~l~LV 767 (967)
|++.++||+|+||+||+|.+ ++..||||++..........+.+.+|+.++++|+|||||+++++|.. ...++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 47788999999999999976 47789999998776677777889999999999999999999999865 3458999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEEEecccccccccCc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||++|+|.+++.+ ...+++..+..|+.||+.||+|||+++++||||||||+||||+ .++.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999999976 4579999999999999999999999855599999999999998 4799999999999865443
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
.....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.... .+...+........++..+++++.+||
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 2445789999999999875 5999999999999999999999999875543 444444333333456677899999999
Q ss_pred HHhhhcCCCCCcCHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||+.||++|||+.|+++|
T Consensus 264 ~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=453.32 Aligned_cols=249 Identities=21% Similarity=0.388 Sum_probs=222.9
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||+||+|++ +++.||||++.+... .....+.+.+|++++++++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999976 588999999875432 2334678999999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC--c
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--Y 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~--~ 846 (967)
|||++|+|.+++.+ .+.+++..+..|+.||+.||+|||++ |||||||||+||||+.++++||+|||+|+..... .
T Consensus 112 Ey~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~--~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999976 45799999999999999999999998 7999999999999999999999999999876432 2
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++...+.. ..+.+|..+++++.+||.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDLVE 266 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTCCHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCcccCHHHHHHHH
Confidence 334567899999999999999999999999999999999999999999888887777643 346778899999999999
Q ss_pred HhhhcCCCCCcCHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~ 945 (967)
+||+.||++|||+.|++.+
T Consensus 267 ~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 267 KLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHSCSSGGGSTTSGGGTCH
T ss_pred HHccCCHhHCcChHHHcCC
Confidence 9999999999999987554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=452.60 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=215.9
Q ss_pred CCeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
++|++.+.||+|+||+||+|++ .++.||||++.+..........+.+|+.++++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 6899999999999999999965 36789999987654433344567889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
|||||++|+|.+++.+ .+.+++..+..|+.||+.||+|||++ |||||||||+|||++.++++||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999976 45799999999999999999999998 79999999999999999999999999998765554
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+. ...+.+|..+++++.+||.
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCcCCHHHHHHHH
Confidence 45567889999999999999999999999999999999999999999998888777764 3356778899999999999
Q ss_pred HhhhcCCCCCcC-----HHHHHHHH
Q 037068 927 DCWQTEPHLRPS-----FAQLMSRL 946 (967)
Q Consensus 927 ~CLq~dPe~RPS-----~~ELLe~L 946 (967)
+||+.||++||| ++|+++|-
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp 283 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHS 283 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCc
Confidence 999999999998 57888873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=437.50 Aligned_cols=249 Identities=27% Similarity=0.452 Sum_probs=206.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||+||+|++ +++.||||++.+.... ......+.+|+.++++++|||||++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999976 5889999998765433 344667999999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+ +|+|.+++.+ ...+++..+..++.||+.||+|||++ ||+||||||+||||+.++++||+|||+|+...... .
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRH--KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-F 167 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCChHHeEECCCCCEEEeecCCCeecCCCC-c
Confidence 999 6799998876 45799999999999999999999998 79999999999999999999999999998765433 2
Q ss_pred CCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
....+||+.|||||++.+..+ +.++|||||||++|||+||+.||.+.+..+....+. .....+|..+++++.+||.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 245 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKR 245 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 445789999999999998886 579999999999999999999999988877776664 34566788999999999999
Q ss_pred hhhcCCCCCcCHHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L~ 947 (967)
||+.||++|||+.|+++|-+
T Consensus 246 ~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 246 MLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp HSCSSGGGSCCHHHHHHCHH
T ss_pred HccCChhHCcCHHHHHcCcc
Confidence 99999999999999999853
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=459.46 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=223.9
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.+.|++.++||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 36799999999999999999976 488999999975432 23456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|||++|+|.+++.. ..+++..+..|+.||+.||+|||++ |||||||||+||||+.+|++||+|||+|+........
T Consensus 228 Ey~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~--~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999999975 4699999999999999999999998 7999999999999999999999999999977665555
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~ 927 (967)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+... ...+..+..+++++.+||.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 66788999999999999999999999999999999999999999998888777766432 22445567899999999999
Q ss_pred hhhcCCCCCcCHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L 946 (967)
||+.||++|||+.|+|+|-
T Consensus 384 ~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCG
T ss_pred HcCCChhHCcCHHHHhcCH
Confidence 9999999999999999984
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=427.58 Aligned_cols=255 Identities=30% Similarity=0.512 Sum_probs=203.6
Q ss_pred CCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC----ceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP----HFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~----~l~LV 767 (967)
.+|.+.++||+|+||+||+|+++|+.||||++.... ........|+.++.+++|||||++++++.+++ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 578999999999999999999999999999985431 11222344666667889999999999998654 57999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS------HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~------n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
||||++|+|.++++. ..+++..+++|+.|++.||.|||++ .++||||||||+||||+.++++||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999975 4589999999999999999999975 34799999999999999999999999999987
Q ss_pred cccCcc----CCCCCCCCCCccChhccccC------CCCchhHHHHHHHHHHHHHhCCCCCCCCC---------------
Q 037068 842 KHHTYL----SSKSTAGTPEWMAPEVLRNE------PANEKCDVYSFGVILWELATLSVPWKGLN--------------- 896 (967)
Q Consensus 842 ~~~~~~----~~~~~~GT~~YmAPE~l~g~------~~s~ksDVWSLGvlL~ELlTGk~PF~~~~--------------- 896 (967)
...... ......||+.|||||++.+. .++.++|||||||+||||+||..||....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 644321 22345799999999999765 36779999999999999999977654221
Q ss_pred hhHHHhhhhccccccCCCCC-----CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 897 PMQVVGAVGFQNRRLEIPDD-----IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 897 ~~ei~~~i~~~~~~~~ip~~-----ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
..+....+.....++.+|.. +++.+.+||.+||+.||++|||+.||++.|+++.+
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 12233333334445555543 34578999999999999999999999999998865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=420.83 Aligned_cols=247 Identities=22% Similarity=0.365 Sum_probs=193.1
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC-------
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP------- 762 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~------- 762 (967)
++|++.+.||+|+||+||+|++ +++.||||++.... .....+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 5799999999999999999976 48899999986543 3445677899999999999999999999987544
Q ss_pred -----ceEEEEeecCCCchhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEe
Q 037068 763 -----HFSILTEFLPRGSLYRLLHRPN--HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835 (967)
Q Consensus 763 -----~l~LVmEy~~gGsL~~lL~~~~--~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsD 835 (967)
.+|||||||.+|+|.+++.... ...++..++.|+.||+.||+|||++ |||||||||+||||+.++++||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~--~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC--cCccccCcHHHeEECCCCcEEEcc
Confidence 3799999999999999997643 2356677899999999999999998 799999999999999999999999
Q ss_pred cccccccccCcc------------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHh
Q 037068 836 FGLSRIKHHTYL------------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVG 902 (967)
Q Consensus 836 FGLAr~~~~~~~------------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~ 902 (967)
||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||...... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999987543221 1234579999999999999999999999999999999997 77643221 1111
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 903 AVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 903 ~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+. ....++.+...++.+.+||.+||+.||++|||+.|+++|
T Consensus 239 ~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 DVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 221 111112223456778899999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=427.98 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=213.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec------cC
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR------SP 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~------~~ 762 (967)
.++|++.+.||+|+||+||+|++ +|+.||||++............+.+|+.+|++|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 47899999999999999999976 58899999997665555667788999999999999999999998753 36
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+|||||||. |+|.+++.+ ...+++..+..|+.||+.||.|||++ |||||||||+|||++.++.+||+|||+|+..
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~--~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7899999996 679999876 56799999999999999999999998 7999999999999999999999999999865
Q ss_pred ccC----ccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc-------
Q 037068 843 HHT----YLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR------- 910 (967)
Q Consensus 843 ~~~----~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~------- 910 (967)
... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+......
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 432 2234567899999999998876 4699999999999999999999999998877665544311000
Q ss_pred -----------------cC-----CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 911 -----------------LE-----IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 911 -----------------~~-----ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.. +...+++++.+||.+||+.||++|||+.|+|+|-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 00 1135789999999999999999999999999984
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=399.43 Aligned_cols=269 Identities=65% Similarity=1.117 Sum_probs=229.9
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
..+++..++|++.+.||+|+||+||+|+++++.||||++............+.+|+.++++++||||+++++++...+.+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 45667789999999999999999999999999999999987766677778899999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNH--QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~--~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
++||||+.+|+|.+++..... .+++..++.++.||+.||.|||+++++|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999986432 389999999999999999999998222999999999999999999999999999876
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+........+|..+++++.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 55544455678999999999999999999999999999999999999999999988887777667777888999999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
++|.+||+.+|.+|||+.++++.|+.+.+..
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999886543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=409.25 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=201.4
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCc
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~ 763 (967)
..++|++.++||+|+||+||+|++ +++.||||++.... ...++.+|+++++.+ +||||++++++|.+.+.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 457899999999999999999965 25679999986532 345678899999998 69999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-CeEEEEeccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIK 842 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-g~VKLsDFGLAr~~ 842 (967)
++|||||+++|+|.+++. .+++..+..++.||+.||+|||++ |||||||||+|||++.+ +.+||+|||+|+..
T Consensus 95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~--gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF--GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 999999999999999985 489999999999999999999998 79999999999999876 89999999999854
Q ss_pred ccCcc----------------------------CCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCC
Q 037068 843 HHTYL----------------------------SSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWK 893 (967)
Q Consensus 843 ~~~~~----------------------------~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~ 893 (967)
.+... .....+||+.|||||++.+.. |+.++||||+||++|||+||+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 43211 123457999999999998764 8999999999999999999999996
Q ss_pred CCCh-hHHHhhhhc----------------------------------------------------cccccCCCCCCcHH
Q 037068 894 GLNP-MQVVGAVGF----------------------------------------------------QNRRLEIPDDIDPA 920 (967)
Q Consensus 894 ~~~~-~ei~~~i~~----------------------------------------------------~~~~~~ip~~ls~e 920 (967)
.... .+.+..+.. .....+....++++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 5432 222111100 00001122457899
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+.+||++||+.||++|+|++|+|+|-
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~Hp 354 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLHP 354 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 99999999999999999999999873
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=434.09 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=222.1
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+.+.++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 47899999999999999999976 58899999986543 344567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC--CeEEEEecccccccccCc
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN--WVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~--g~VKLsDFGLAr~~~~~~ 846 (967)
|||++|+|.+++.+....+++..+..|+.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~--~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999999987677899999999999999999999999 79999999999999854 899999999998765442
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCcHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDIDPAVAQI 924 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls~eL~dL 924 (967)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....+......+ ..+..+++++.+|
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2345689999999999999999999999999999999999999999999888877765433322 2345789999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~ 945 (967)
|++||+.||.+|||+.|+|+|
T Consensus 391 i~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=430.52 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=211.1
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC----ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF----SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~----s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|++.+.||+|+||+||+|++ +|+.||||++.+... ..........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 47899999999999999999976 588999999865422 112222233345666677999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
|||||||+||+|..+|.+ .+.+++..+..|+.||+.||+|||++ |||||||||+||||+.+|++||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~--gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999976 45799999999999999999999998 799999999999999999999999999987654
Q ss_pred CccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---hHHHhhhhccccccCCCCCCcHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNP---MQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~---~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
. .....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+. .++...+ ......+|..++++
T Consensus 345 ~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 345 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPE 420 (689)
T ss_dssp C--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTTSCHH
T ss_pred C--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCccCCHH
Confidence 3 2456789999999999964 5799999999999999999999999976433 2232222 23456788899999
Q ss_pred HHHHHHHhhhcCCCCCcC-----HHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPS-----FAQLMSRL 946 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS-----~~ELLe~L 946 (967)
+.+||.+||+.||.+|++ +.||++|-
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 999999999999999998 79999884
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=394.03 Aligned_cols=268 Identities=30% Similarity=0.572 Sum_probs=232.0
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEE
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLF 754 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkL 754 (967)
..|++..++|.+.+.||+|+||.||+|++. +..||||++... ........+.+|+.+++.+ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 346677789999999999999999999752 346999987644 3445567899999999999 89999999
Q ss_pred eeeeeccCceEEEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccC
Q 037068 755 MGAVTRSPHFSILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK 819 (967)
Q Consensus 755 ig~~~~~~~l~LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLK 819 (967)
++++...+.+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ ||+|||||
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlk 230 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLA 230 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCC
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--Ceeccccc
Confidence 999999999999999999999999987532 3589999999999999999999998 79999999
Q ss_pred CCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 037068 820 SPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLN 896 (967)
Q Consensus 820 PsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~ 896 (967)
|+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999999998654432 22334557889999999999999999999999999999999 999999988
Q ss_pred hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcC
Q 037068 897 PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDR 956 (967)
Q Consensus 897 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~ 956 (967)
..+....+. .......|..+++++.++|.+||+.+|.+||++.|++++|+.+.....++
T Consensus 311 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~~ 369 (370)
T 2psq_A 311 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369 (370)
T ss_dssp GGGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhccC
Confidence 777766554 45566788899999999999999999999999999999999998877653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=371.59 Aligned_cols=260 Identities=33% Similarity=0.589 Sum_probs=230.2
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.|.+..++|++.+.||+|+||.||++.+ .++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 4667778999999999999999999987 567899999865432 245688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+++++|.+++......+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC--CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999987677899999999999999999999998 799999999999999999999999999986543
Q ss_pred C-ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 T-YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~-~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
. ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......|..+++.+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVY 237 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHHHH
Confidence 3 223345567889999999999999999999999999999999 999999988887776664 3445667778899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
+++.+||+.+|++|||+.+++++|+.+.+
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=389.32 Aligned_cols=252 Identities=26% Similarity=0.432 Sum_probs=225.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
...++|++.+.||+|+||.||+|++ +++.||||++.....+......+.+|+.+++.++||||+++++++...+.+++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457999999999999999999976 68899999998776666777889999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 92 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999865 35699999999999999999999998 79999999999999999999999999998655432
Q ss_pred cCCCCCCCCCCccChhccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPAN-EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s-~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++++.+||
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIPFYMSTDCENLL 245 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHH
Confidence 24567899999999999988875 89999999999999999999999998887776664 234567788999999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L 946 (967)
++||+.||.+|||+.|+++|-
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCT
T ss_pred HHHCCCChhHCcCHHHHhcCH
Confidence 999999999999999999884
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=387.83 Aligned_cols=270 Identities=31% Similarity=0.546 Sum_probs=230.6
Q ss_pred ccchhhhhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCcee
Q 037068 681 LGEVAEWEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVV 752 (967)
Q Consensus 681 l~~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIV 752 (967)
+.....|++..++|++.+.||+|+||.||+|++ .++.||||++... ........+.+|+.+++++ +||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCccee
Confidence 445678999999999999999999999999963 3468999998644 3445567799999999999 899999
Q ss_pred EEeeeeeccC-ceEEEEeecCCCchhhhhcCCCC----------------------------------------------
Q 037068 753 LFMGAVTRSP-HFSILTEFLPRGSLYRLLHRPNH---------------------------------------------- 785 (967)
Q Consensus 753 kLig~~~~~~-~l~LVmEy~~gGsL~~lL~~~~~---------------------------------------------- 785 (967)
++++++...+ .+++||||+.+|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999988755 48999999999999999976432
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC-
Q 037068 786 -------------------QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT- 845 (967)
Q Consensus 786 -------------------~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~- 845 (967)
.+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 189999999999999999999998 7999999999999999999999999999865332
Q ss_pred -ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 846 -YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 846 -~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+..............|..+++++.+
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 327 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 222334567889999999999999999999999999999998 999998877655544444455667788889999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
+|.+||+.||.+|||+.+++++|+.+.+..
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=368.94 Aligned_cols=259 Identities=30% Similarity=0.597 Sum_probs=229.5
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--Cce
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--PHF 764 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~~l 764 (967)
+.+..++|++.+.||+|+||.||+|+++++.||||++............+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 345568999999999999999999999999999999987766667778899999999999999999999999876 788
Q ss_pred EEEEeecCCCchhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNH-QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~-~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
++||||+++|+|.+++..... .+++..++.++.||+.||.|||++++.|+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987443 5899999999999999999999983339999999999999999999999999875422
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCc---hhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANE---KCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~---ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.....||+.|+|||.+.+..++. ++|||||||++|||++|+.||...........+........+|..++++
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 23456899999999998765544 8999999999999999999999988887766666666777888999999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
+.++|.+||+.||++|||+.++++.|+.+.
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=382.08 Aligned_cols=263 Identities=33% Similarity=0.518 Sum_probs=228.6
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
++..++|.+.+.||+|+||.||+|.+. +..||||++... ........+.+|+.++++++||||+++++++.+.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 455689999999999999999999763 345999998643 34556678999999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
..++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999987677899999999999999999999998 7999999999999999999999999999876
Q ss_pred ccCcc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCc
Q 037068 843 HHTYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 843 ~~~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls 918 (967)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .....+.+..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCcC
Confidence 44321 2233446788999999999999999999999999999999 999999988887776664 445667788899
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
+++.++|.+||+.||++|||+.+|++.|+.+.+...
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 999999999999999999999999999999976543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=388.28 Aligned_cols=274 Identities=31% Similarity=0.570 Sum_probs=237.5
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCcee
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVV 752 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIV 752 (967)
....|++..++|.+.+.||+|+||+||+|++. +..||||++... ........+.+|+++++++ +||||+
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhh
Confidence 33567888899999999999999999999752 246999998654 3455667899999999999 999999
Q ss_pred EEeeeeeccCceEEEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEec
Q 037068 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRD 817 (967)
Q Consensus 753 kLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRD 817 (967)
++++++...+..++||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++ ||+|||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~D 216 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRD 216 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSC
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--CEecCC
Confidence 99999999999999999999999999987533 4599999999999999999999998 799999
Q ss_pred cCCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 037068 818 LKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKG 894 (967)
Q Consensus 818 LKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~ 894 (967)
|||+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp CCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654432 22344567889999999999999999999999999999999 9999999
Q ss_pred CChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcCCCCC
Q 037068 895 LNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNST 960 (967)
Q Consensus 895 ~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~~~~~ 960 (967)
....+....+. .......+..+++++.+||.+||+.||++|||+.+++++|+.+.....+.....
T Consensus 297 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 297 VPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp CCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred CCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 88877776654 455667788899999999999999999999999999999999998877666544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=377.84 Aligned_cols=265 Identities=31% Similarity=0.503 Sum_probs=224.3
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
+..++|.+.+.||+|+||+||+|.+ +++.||+|++.. .+......+.+|+.++++++||||+++++++.+++..++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 3457999999999999999999976 478899998744 345667889999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999999987677899999999999999999999998 79999999999999999999999999998654332
Q ss_pred cC--------------CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh-cccccc
Q 037068 847 LS--------------SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG-FQNRRL 911 (967)
Q Consensus 847 ~~--------------~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~-~~~~~~ 911 (967)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||............. ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 21 114579999999999999999999999999999999999999987654332211100 011122
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcCC
Q 037068 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRS 957 (967)
Q Consensus 912 ~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~~ 957 (967)
..+..+++.+.++|.+||+.||++|||+.++++.|+.++..+....
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 3567889999999999999999999999999999999988775443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=377.74 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=221.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|++.+.||+|+||+||+|.+ +++.||||++..... ...+.+.+|+.++++++||||+++++++...+.+++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 347899999999999999999965 588999999865432 2346788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999999975 3589999999999999999999998 799999999999999999999999999987665555
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-cccccCCCCCCcHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~ 926 (967)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. .......+..+++.+.++|.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 55667899999999999999999999999999999999999999998887665544432 23345567789999999999
Q ss_pred HhhhcCCCCCcCHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L 946 (967)
+||+.||++|||+.|+++|-
T Consensus 252 ~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCG
T ss_pred HHccCChhHCcCHHHHhhCh
Confidence 99999999999999999873
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=368.15 Aligned_cols=257 Identities=38% Similarity=0.714 Sum_probs=214.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFS--GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s--~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
+..++|++.+.||+|+||.||+|.+.++.||||++...... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 44689999999999999999999999999999998654322 2345778999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CeEEeccCCCcEEEcC--------CCeEEEEecc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHP-TIVHRDLKSPNLLVDK--------NWVVKVCDFG 837 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~-GIVHRDLKPsNILLd~--------~g~VKLsDFG 837 (967)
||||+.+++|.+++.. ..+++..++.++.||+.||.|||+++. +|+||||||+|||++. ++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999999864 569999999999999999999999821 1999999999999985 7789999999
Q ss_pred cccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
+++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.........+..+
T Consensus 162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 162 LAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp C---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 998654432 234579999999999999999999999999999999999999999988877776666566677788899
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
++.+.++|.+||+.||.+|||+.+++++|+.|
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=370.09 Aligned_cols=263 Identities=31% Similarity=0.554 Sum_probs=228.4
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
...|++..++|++.+.||+|+||.||++++. +..||||++..... ....+.+|+.++++++|+||+++++++...+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 3567788899999999999999999999875 45799999865432 2456889999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
..++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999999999999987666799999999999999999999998 7999999999999999999999999999865
Q ss_pred ccC-ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 843 HHT-YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 843 ~~~-~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
... ........+|+.|+|||++.+..++.++||||||+++|+|+| |+.||......+....+. .......|..+++.
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEK 249 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHH
Confidence 432 222344567889999999999999999999999999999998 999999988877766654 44556667888999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
+.++|.+||+.+|.+|||+.+++++|..+.+.
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999999999999999988653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=393.12 Aligned_cols=264 Identities=32% Similarity=0.571 Sum_probs=231.1
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
..|++..++|.+.+.||+|+||.||+|++ +++.||||++... ........+.+|+.++++++||||+++++++...+
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 35777889999999999999999999987 4788999987643 34445567889999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+++|+|.+++...+..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999999986566799999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCccCC--CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 843 HHTYLSS--KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 843 ~~~~~~~--~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
....... ....+++.|+|||++.+..++.++|||||||++|||+| |..||......+....+. ...+.+.|..+++
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 342 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPD 342 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 4332211 12235678999999999999999999999999999998 999999988877666554 4556778889999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
++.++|.+||+.||++|||+.+|++.|+.+.+.
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 999999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=381.21 Aligned_cols=267 Identities=30% Similarity=0.501 Sum_probs=230.2
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeecCC-------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEe
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g-------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLi 755 (967)
.+..+++..++|++.+.||+|+||.||+|++.+ +.||||++... ........+.+|+.++++++||||++++
T Consensus 38 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 38 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 345677788999999999999999999997753 67999998644 3445567899999999999999999999
Q ss_pred eeeeccCceEEEEeecCCCchhhhhcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037068 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPN-----------------------HQLDERRRMRMALDVAKGMNYLHTSHPT 812 (967)
Q Consensus 756 g~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------------------~~Lse~~i~~I~~QIa~aL~YLHs~n~G 812 (967)
+++...+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ |
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~ 194 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--K 194 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--T
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC--C
Confidence 99999999999999999999999987532 5689999999999999999999998 7
Q ss_pred eEEeccCCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CC
Q 037068 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LS 889 (967)
Q Consensus 813 IVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk 889 (967)
|+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999998654322 22344567899999999999999999999999999999999 99
Q ss_pred CCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 890 VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 890 ~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.||......+....+. .......|..+++++.++|.+||+.||.+||++.+++++|+.+.+..
T Consensus 275 ~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CcCCCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 9999988877766654 34455678889999999999999999999999999999999886544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=369.47 Aligned_cols=264 Identities=29% Similarity=0.518 Sum_probs=217.7
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT 759 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~ 759 (967)
.+|++..++|++.+.||+|+||.||+|.+. +..||+|++... ......+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 456777899999999999999999999763 345899986543 34455678999999999999999999999984
Q ss_pred ccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 760 RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 760 ~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
++..++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccccHHHEEECCCCCEEECccccc
Confidence 5578999999999999999987666799999999999999999999998 7999999999999999999999999999
Q ss_pred cccccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 840 RIKHHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 840 r~~~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .......+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~ 242 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 242 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCC
Confidence 8654432 12333457789999999999999999999999999999997 999999888777666654 34456678889
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
++++.++|.+||+.||++|||+.+++++|..+.+..
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=367.55 Aligned_cols=259 Identities=33% Similarity=0.594 Sum_probs=226.8
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecCC-CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~g-~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+++..++|++.+.||+|+||.||++++.+ ..||+|++..... ....+.+|+.++++++||||+++++++......+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 45567899999999999999999998764 4799999865432 3456889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+++++|.+++......+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH--QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999987666799999999999999999999998 7999999999999999999999999999865443
Q ss_pred c-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 846 Y-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 846 ~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+. .......|..+++.+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHH
Confidence 2 22344557788999999999899999999999999999999 999999988877766554 44455667788999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
+|.+||+.+|.+|||+.+++++|+.+++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9999999999999999999999988754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=370.63 Aligned_cols=267 Identities=28% Similarity=0.476 Sum_probs=229.5
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMG 756 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig 756 (967)
..|++..++|.+.+.||+|+||.||+|++ .++.||||++... ......+.+.+|+.+++++ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 56788889999999999999999999974 3568999998644 2344567899999999999 9999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccC
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNH-----------------QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK 819 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~~-----------------~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLK 819 (967)
++...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++ ||+|||||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlk 172 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLA 172 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCS
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCc
Confidence 99999999999999999999999875432 489999999999999999999998 79999999
Q ss_pred CCcEEEcCCCeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 037068 820 SPNLLVDKNWVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLN 896 (967)
Q Consensus 820 PsNILLd~~g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~ 896 (967)
|+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999986544322 1234457889999999999999999999999999999999 999998876
Q ss_pred hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 897 PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 897 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
.................+..+++++.++|.+||+.||.+|||+.+++++|+++.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 5544444433445556677899999999999999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=386.01 Aligned_cols=251 Identities=23% Similarity=0.420 Sum_probs=222.6
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|++.+.||+|+||+||+++. +++.||||++.+... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 47899999999999999999976 488999999865321 223456788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+++|+|..++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++++||+|||+++.......
T Consensus 84 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 999999999999875 45689999999999999999999998 799999999999999999999999999986544444
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. ....+|..+++++.++|.+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHH
Confidence 45667899999999999999999999999999999999999999999888777666543 3456788899999999999
Q ss_pred hhhcCCCCCc-----CHHHHHHHH
Q 037068 928 CWQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RP-----S~~ELLe~L 946 (967)
||+.||++|| ++.++++|-
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCC
Confidence 9999999999 899999984
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=371.49 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=212.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh------------------------hhHHHHHHHHHHH
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG------------------------DSLSQFKCEAEIM 743 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~------------------------~~~~~~~~Ei~IL 743 (967)
..++|++.+.||+|+||.||+|.+ .++.||||++....... ...+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 457999999999999999999965 57889999987543211 1245688999999
Q ss_pred HHcCCCceeEEeeeeec--cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCC
Q 037068 744 LRLRHPNVVLFMGAVTR--SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSP 821 (967)
Q Consensus 744 k~L~HpNIVkLig~~~~--~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPs 821 (967)
++++||||+++++++.. ...+++||||+++++|.+++. ...+++..++.++.||+.||.|||++ ||+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQ--KIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHH
Confidence 99999999999999986 567999999999999988765 35699999999999999999999998 7999999999
Q ss_pred cEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccChhccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChh
Q 037068 822 NLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP---ANEKCDVYSFGVILWELATLSVPWKGLNPM 898 (967)
Q Consensus 822 NILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~---~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ 898 (967)
|||++.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999987655443345568999999999998765 378999999999999999999999988777
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 899 QVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 899 ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.....+.......+....+++++.++|.+||+.||++|||+.|+++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 666555444334444467899999999999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=370.88 Aligned_cols=265 Identities=30% Similarity=0.539 Sum_probs=230.3
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEee
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig 756 (967)
...|++..++|.+.+.||+|+||.||+|.+ .++.||||++... ........+.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 356777889999999999999999999964 2367999987643 34556678999999999999999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCe
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPN-----------------------HQLDERRRMRMALDVAKGMNYLHTSHPTI 813 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GI 813 (967)
++...+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ ||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i 171 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--KL 171 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT--TE
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC--CC
Confidence 9999999999999999999999987532 2389999999999999999999998 79
Q ss_pred EEeccCCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCC
Q 037068 814 VHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSV 890 (967)
Q Consensus 814 VHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~ 890 (967)
+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998654332 22334567889999999999999999999999999999999 999
Q ss_pred CCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 891 PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 891 PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
||...........+. .......+..+++++.++|.+||+.||.+||++.+++++|+.+...
T Consensus 252 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 252 PYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 999988777666554 4445667788999999999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=378.72 Aligned_cols=267 Identities=30% Similarity=0.476 Sum_probs=224.8
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMG 756 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig 756 (967)
..|++..++|.+.+.||+|+||.||+|++ .+..||||++.... .......+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 46788889999999999999999999975 24579999986432 334456789999999999 8999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCeE
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNH----------------------QLDERRRMRMALDVAKGMNYLHTSHPTIV 814 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~~----------------------~Lse~~i~~I~~QIa~aL~YLHs~n~GIV 814 (967)
++...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++ ||+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~iv 194 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCV 194 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC--Ccc
Confidence 99999999999999999999999976432 378999999999999999999998 799
Q ss_pred EeccCCCcEEEcCCCeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCC
Q 037068 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVP 891 (967)
Q Consensus 815 HRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~P 891 (967)
||||||+||||+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|+|+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999986543321 2233457889999999999999999999999999999998 9999
Q ss_pred CCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 892 WKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 892 F~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
|.....................|..+++++.++|.+||+.||.+|||+.+++++|+.+.+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 988776554444444555667788899999999999999999999999999999998866543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=361.39 Aligned_cols=260 Identities=33% Similarity=0.595 Sum_probs=228.5
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
+|.+..++|++.+.||+|+||.||++.+ .++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 3566778999999999999999999987 466899999865432 246788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+++++|.+++......+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999999987667799999999999999999999998 799999999999999999999999999986543
Q ss_pred C-ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 845 T-YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~-~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
. ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......|..+++.+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVY 235 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHH
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCcHHHH
Confidence 2 222344567889999999999999999999999999999999 899999988877766654 3445566778899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
+++.+||+.+|++|||+.+++++|..+.+
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=373.90 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=212.5
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
+...++|++.++||+|+||+||+|++ +++.||+|++............+.+|+.++++++||||+++++++.....+++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 44568999999999999999999987 57889999987655455556788999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+ +|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999985 88888877677799999999999999999999998 79999999999999999999999999998765544
Q ss_pred cCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc----------------
Q 037068 847 LSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR---------------- 909 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~---------------- 909 (967)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 44555678999999999976 5689999999999999999999999988766554433321000
Q ss_pred ---c---------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 ---R---------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 ---~---------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. ..+...+++++.+||.+||+.||++|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 01123577899999999999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=394.25 Aligned_cols=258 Identities=33% Similarity=0.638 Sum_probs=226.6
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC-c
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP-H 763 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~-~ 763 (967)
..|++..++|++.+.||+|+||.||+|+++++.||||++.... ..+.+.+|+.++++++||||+++++++.... .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 4577888999999999999999999999999999999986532 3467889999999999999999999987654 7
Q ss_pred eEEEEeecCCCchhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNH-QLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~-~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
++|||||+.+|+|.+++..... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999976443 479999999999999999999998 7999999999999999999999999999854
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
... .....+++.|+|||++.+..++.++|||||||++|||+| |+.||......+....+. .+.++..|..+++++
T Consensus 340 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 340 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 415 (450)
T ss_dssp C---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHH
Confidence 332 223467889999999999999999999999999999998 999999888777766654 456777889999999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
.++|.+||+.||.+|||+.+|++.|+.+...
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999988653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=375.35 Aligned_cols=272 Identities=28% Similarity=0.464 Sum_probs=214.2
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeecCC-----CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeee
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGA 757 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g-----~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~ 757 (967)
.+.++.+..++|++.+.||+|+||.||+|++.. ..||||++..........+.+.+|+.++++++||||++++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 445667778999999999999999999997642 279999987665555667889999999999999999999999
Q ss_pred eeccCce------EEEEeecCCCchhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc
Q 037068 758 VTRSPHF------SILTEFLPRGSLYRLLHRP-----NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD 826 (967)
Q Consensus 758 ~~~~~~l------~LVmEy~~gGsL~~lL~~~-----~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd 826 (967)
+...... ++||||+.+++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCMLA 171 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEC
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC--CcccCCCCcceEEEc
Confidence 9876554 9999999999999998532 22589999999999999999999998 799999999999999
Q ss_pred CCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhh
Q 037068 827 KNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGA 903 (967)
Q Consensus 827 ~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~ 903 (967)
.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+....
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 99999999999998654332 12233457789999999999999999999999999999999 9999999888777666
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcCC
Q 037068 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRS 957 (967)
Q Consensus 904 i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~~ 957 (967)
+. .......+..+++++.++|.+||+.||++|||+.++++.|+++....-...
T Consensus 252 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 252 LI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp HH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred Hh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 54 444566778899999999999999999999999999999999976554333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=370.26 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=216.5
Q ss_pred hccCCeeEeEEeecCCceEEEEeec------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-- 760 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-- 760 (967)
+..++|++.+.||+|+||+||++++ .++.||||++... .......+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4458999999999999999999973 4778999998643 34556789999999999999999999999865
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
...+++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 3568999999999999999987666799999999999999999999998 79999999999999999999999999998
Q ss_pred ccccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh----------------HHH
Q 037068 841 IKHHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM----------------QVV 901 (967)
Q Consensus 841 ~~~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~----------------ei~ 901 (967)
...... .......+|+.|+|||.+.+..++.++||||||+++|||+||..||...... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 654332 1223345777899999999999999999999999999999999998753221 111
Q ss_pred hhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 902 GAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 902 ~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
..+ ......+.|..+++++.++|.+||+.||++|||+.++++.|+.+.+.+
T Consensus 243 ~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHH-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111 234466678899999999999999999999999999999999997654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=366.42 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=212.4
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.++++++||||+++++++..++.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999977 47889999998766556666788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.+ +|...+......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9976 56665555567799999999999999999999998 79999999999999999999999999998776554455
Q ss_pred CCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCC-CCCCChhHHHhhhhcc--------------------
Q 037068 850 KSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVP-WKGLNPMQVVGAVGFQ-------------------- 907 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~P-F~~~~~~ei~~~i~~~-------------------- 907 (967)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...+.......+...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 6678999999999998766 89999999999999999998777 5555544443332210
Q ss_pred -------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 -------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 -------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.........+++++.+||.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00011223578999999999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=368.88 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=209.9
Q ss_pred CCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
++|++.+.||+|+||.||+|++. ++.||||++............+.+|+.++++++||||+++++++...+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999874 78999999866544444456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.+ +|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 975 89999887667899999999999999999999998 799999999999999999999999999987654433344
Q ss_pred CCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-c---------------c----
Q 037068 851 STAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-N---------------R---- 909 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~---------------~---- 909 (967)
...+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+... + .
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 56789999999999764 5899999999999999999999999987765544333210 0 0
Q ss_pred -------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 -------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 -------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.......+++++.+||.+||+.||++|||+.|+++|-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0012245789999999999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.07 Aligned_cols=270 Identities=30% Similarity=0.572 Sum_probs=232.0
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeec---------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCcee
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADW---------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVV 752 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~---------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIV 752 (967)
+...|++..++|.+.+.||+|+||.||+|++ .+..||||++... ........+.+|+.+++++ +||||+
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 3456777889999999999999999999975 3567999987643 3455667899999999999 899999
Q ss_pred EEeeeeeccCceEEEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEec
Q 037068 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRD 817 (967)
Q Consensus 753 kLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRD 817 (967)
++++++...+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ ||+|||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~D 182 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRD 182 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT--TEECSC
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CeeCCC
Confidence 99999999999999999999999999997643 2489999999999999999999998 799999
Q ss_pred cCCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 037068 818 LKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKG 894 (967)
Q Consensus 818 LKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~ 894 (967)
|||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 99999999999999999999998654432 12334557889999999999999999999999999999999 9999999
Q ss_pred CChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcC
Q 037068 895 LNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDR 956 (967)
Q Consensus 895 ~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~ 956 (967)
....+....+. .......+..+++++.++|.+||+.+|.+|||+.+++++|..+.....+.
T Consensus 263 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 263 IPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp CCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred CCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 88777665554 34456677889999999999999999999999999999999998776544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=369.93 Aligned_cols=271 Identities=30% Similarity=0.531 Sum_probs=229.2
Q ss_pred ccchhhhhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCcee
Q 037068 681 LGEVAEWEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVV 752 (967)
Q Consensus 681 l~~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIV 752 (967)
......|++..++|.+.+.||+|+||.||+|++ .++.||||++... ........+.+|+.+++++ +||||+
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCee
Confidence 345567888889999999999999999999963 3568999998654 3445567789999999999 799999
Q ss_pred EEeeeeeccC-ceEEEEeecCCCchhhhhcCCCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCeEEe
Q 037068 753 LFMGAVTRSP-HFSILTEFLPRGSLYRLLHRPNH---------------QLDERRRMRMALDVAKGMNYLHTSHPTIVHR 816 (967)
Q Consensus 753 kLig~~~~~~-~l~LVmEy~~gGsL~~lL~~~~~---------------~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHR 816 (967)
++++++...+ .+++||||+.+++|.+++..... .+++..++.++.||+.||.|||++ ||+||
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~ 172 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHR 172 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT--TCCCS
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC--Ccccc
Confidence 9999987654 59999999999999999976433 288999999999999999999998 79999
Q ss_pred ccCCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 037068 817 DLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWK 893 (967)
Q Consensus 817 DLKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~ 893 (967)
||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999998654322 12234557889999999999999999999999999999998 999998
Q ss_pred CCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 894 GLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 894 ~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
....................+..+++++.++|.+||+.||.+|||+.+++++|+.+.+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 8765444333333455567778899999999999999999999999999999999976543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=366.69 Aligned_cols=263 Identities=33% Similarity=0.648 Sum_probs=211.5
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
...+++..++|++.++||+|+||.||+|++.+ .||||++............+.+|+.++++++|+||++++++. ....
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 34567788999999999999999999998755 599999877666667778899999999999999999999965 5567
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCccceEEECCCCCEEEccceeccccc
Confidence 8999999999999999987777899999999999999999999998 79999999999999999999999999997554
Q ss_pred cC--ccCCCCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhh-hhccccc---cCCC
Q 037068 844 HT--YLSSKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGA-VGFQNRR---LEIP 914 (967)
Q Consensus 844 ~~--~~~~~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~-i~~~~~~---~~ip 914 (967)
.. ........||+.|+|||++. +..++.++||||||+++|+|++|+.||........... +...... ...+
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 31 12234456999999999986 66789999999999999999999999988665443332 2211111 2234
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
..+++++.+||.+||+.+|.+|||+.++++.|+.+.
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 578999999999999999999999999999998874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=387.17 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=216.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
+..++|++.+.||+|+||+||+|++ +++.||||++.+... .......+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3458999999999999999999976 478999999865321 233456788999999998 799999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+|+|..++.+ ...+++..++.++.||+.||+|||++ ||+||||||+||||+.++++||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999876 45699999999999999999999998 799999999999999999999999999986554
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++++.++
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHH
Confidence 4444566789999999999999999999999999999999999999999998888777764 34556778899999999
Q ss_pred HHHhhhcCCCCCcCH------HHHHHHH
Q 037068 925 IRDCWQTEPHLRPSF------AQLMSRL 946 (967)
Q Consensus 925 I~~CLq~dPe~RPS~------~ELLe~L 946 (967)
|.+||+.||.+||++ .++++|-
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 999999999999998 8888874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=392.91 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=223.4
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|++.+.||+|+||.||++.+ +++.+|+|++............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 447899999999999999999965 588999999987766666677899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc---CCCeEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD---KNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd---~~g~VKLsDFGLAr~~~~ 844 (967)
|||+.+|+|.+.+.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+++....
T Consensus 89 ~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~--givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999998876 45699999999999999999999998 799999999999998 568999999999987665
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC--CCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~eL~ 922 (967)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+.+ ..+++++.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 5444556789999999999999999999999999999999999999999988887777765443333322 47899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+||.+||+.||.+|||+.|+++|-
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred HHHHHHcCCChhHCCCHHHHhcCc
Confidence 999999999999999999999873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=361.67 Aligned_cols=263 Identities=25% Similarity=0.468 Sum_probs=228.0
Q ss_pred hhhccCCeeEeE-EeecCCceEEEEeec----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 687 WEILWEDLQIGE-RIGIGSYGEVYRADW----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 687 ~ei~~e~y~i~k-~LGeG~FG~VYka~~----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
+.+..++|.+.+ .||+|+||.||+|.+ .+..||||++... ......+.+.+|+.++++++||||+++++++ ..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 445567888877 999999999999965 4667999998654 3455677899999999999999999999999 45
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
+..++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC--CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 679999999999999999987677799999999999999999999998 799999999999999999999999999986
Q ss_pred cccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 842 KHHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 842 ~~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .......|..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 238 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCc
Confidence 54322 12233457889999999998899999999999999999998 999999888777665554 44566778899
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
++++.++|.+||+.+|.+||++.+++++|+.+.....
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999976654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=375.50 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=211.2
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDF--SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~--s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
.+..++|++.+.||+|+||.||+++. .++.||+|++..... .......+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 34558999999999999999999965 578899999876432 22344567889999999999999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.+.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC--CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999999875 45689999999999999999999998 79999999999999999999999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..++++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~ 247 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPYLTQE 247 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCTTSCHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHH
Confidence 654443345567899999999999999999999999999999999999999999887776665532 345677889999
Q ss_pred HHHHHHHhhhcCCCCCc-----CHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RP-----S~~ELLe~L 946 (967)
+.++|.+||+.||.+|| ++.++++|-
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 99999999999999999 889999884
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=380.56 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=222.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|.+.+.||+|+||.||++.+ +++.||+|++............+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 347899999999999999999976 478999999987766666778899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC---CeEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN---WVVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~---g~VKLsDFGLAr~~~~ 844 (967)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+++....
T Consensus 107 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999998876 45689999999999999999999998 79999999999999754 4699999999986654
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC--CCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~eL~ 922 (967)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+.+ ..+++++.
T Consensus 184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 184 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred Cc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 32 2345689999999999999999999999999999999999999999988777766664333332222 46899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+||.+||+.||++|||+.++++|-.
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcc
Confidence 9999999999999999999998843
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=380.51 Aligned_cols=253 Identities=24% Similarity=0.392 Sum_probs=220.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh----hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG----DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~----~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
..++|.+.+.||+|+||.||++++ +++.||||++....... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 347899999999999999999976 48899999987654322 235778999999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC----eEEEEecccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW----VVKVCDFGLS 839 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g----~VKLsDFGLA 839 (967)
+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999976 45799999999999999999999998 799999999999998776 8999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCC
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDI 917 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~l 917 (967)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+ ..+..+
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 167 HEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp EECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred eEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 8765432 2445679999999999999999999999999999999999999999988877776664332222 223578
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++++.+||.+||+.||.+|||+.|+++|-
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 99999999999999999999999999873
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=383.92 Aligned_cols=262 Identities=32% Similarity=0.540 Sum_probs=217.5
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
++..++|.+.+.||+|+||.||+|++. +..||||++... ........+.+|+.++++++||||+++++++...+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 345578999999999999999999753 567999997543 34556678999999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
..++||||+++++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999987777899999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCcc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCc
Q 037068 843 HHTYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 843 ~~~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls 918 (967)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+. .....+.+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 44321 1222345788999999999999999999999999999998 999999988877766654 444566677899
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.++.++|.+||+.+|.+||++.++++.|+.+.+..
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=383.12 Aligned_cols=262 Identities=29% Similarity=0.481 Sum_probs=226.3
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
++..++|++.+.||+|+||+||+|++ .++.||||++... ........+.+|+.++++++||||+++++++..
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 45568999999999999999999974 3457999997543 345556678899999999999999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---eE
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPN------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---VV 831 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---~V 831 (967)
....++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999987532 4589999999999999999999998 799999999999998544 69
Q ss_pred EEEecccccccccC--ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccc
Q 037068 832 KVCDFGLSRIKHHT--YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQN 908 (967)
Q Consensus 832 KLsDFGLAr~~~~~--~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~ 908 (967)
||+|||+++..... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. ..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999999854322 122334567899999999999999999999999999999998 999999998887776664 44
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 909 RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 909 ~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.....+..+++.+.+||.+||+.+|.+|||+.+|+++|+.+.+..
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 566678889999999999999999999999999999999997654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.66 Aligned_cols=256 Identities=33% Similarity=0.619 Sum_probs=216.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhh-----HHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDS-----LSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~-----~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
+..++|++.+.||+|+||+||+|++ +++.||||++......... ...+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 3458999999999999999999977 5888999998654332221 16789999999999999999999998765
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe-----EEEEec
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV-----VKVCDF 836 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~-----VKLsDF 836 (967)
. ++||||+.+++|.+++......+++..++.++.||+.||.|||+++++|+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 4 799999999999999887777899999999999999999999998222999999999999987776 999999
Q ss_pred ccccccccCccCCCCCCCCCCccChhccc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHH--HhhhhccccccC
Q 037068 837 GLSRIKHHTYLSSKSTAGTPEWMAPEVLR--NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV--VGAVGFQNRRLE 912 (967)
Q Consensus 837 GLAr~~~~~~~~~~~~~GT~~YmAPE~l~--g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei--~~~i~~~~~~~~ 912 (967)
|+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||........ ...+........
T Consensus 174 g~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 174 GLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp TTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred Ccccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999754432 34567999999999984 45578999999999999999999999987665443 333334555667
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
++..+++++.++|.+||+.||.+|||+.++++.|+++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 8889999999999999999999999999999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.97 Aligned_cols=264 Identities=34% Similarity=0.622 Sum_probs=231.7
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
+..|++..++|++.+.||+|+||.||+|.+. +..||+|++... ....+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4578888899999999999999999999774 778999998643 33567789999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+..++||||+.+++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH--TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC--CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999998753 45689999999999999999999999 79999999999999999999999999998
Q ss_pred ccccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCc
Q 037068 841 IKHHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 841 ~~~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls 918 (967)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+. .......+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCC
Confidence 655332 22334456889999999999999999999999999999999 999999988777666554 445566778899
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
+.+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999886554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=366.57 Aligned_cols=272 Identities=28% Similarity=0.467 Sum_probs=222.0
Q ss_pred cccchhhhhhccCCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEE
Q 037068 680 MLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLF 754 (967)
Q Consensus 680 ~l~~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkL 754 (967)
+...+..+.+..++|.+.+.||+|+||.||+|... +..||||++............+.+|+.++++++||||+++
T Consensus 22 l~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 22 LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp --CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence 34456677788899999999999999999999653 3479999987665566667889999999999999999999
Q ss_pred eeeeeccC-----ceEEEEeecCCCchhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEE
Q 037068 755 MGAVTRSP-----HFSILTEFLPRGSLYRLLHR-----PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLL 824 (967)
Q Consensus 755 ig~~~~~~-----~l~LVmEy~~gGsL~~lL~~-----~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNIL 824 (967)
++++.... ..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIl 179 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR--NFLHRDLAARNCM 179 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCSGGGEE
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEE
Confidence 99987654 35999999999999998842 345699999999999999999999998 7999999999999
Q ss_pred EcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 037068 825 VDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVV 901 (967)
Q Consensus 825 Ld~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~ 901 (967)
++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 9999999999999998654322 12233457889999999999999999999999999999999 89999988877766
Q ss_pred hhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 902 GAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 902 ~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
..+. .......+..+++++.++|.+||..||.+|||+.+++++|+.+.+.+.
T Consensus 260 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 260 DYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 6554 444566778899999999999999999999999999999999977653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=374.55 Aligned_cols=253 Identities=19% Similarity=0.304 Sum_probs=220.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|.+.+.||+|+||.||++.+ +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 358999999999999999999976 4778999987532 34456788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC--CCeEEEEecccccccccC
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK--NWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~--~g~VKLsDFGLAr~~~~~ 845 (967)
|||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999999987666899999999999999999999998 7999999999999987 789999999999876543
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC--CCCCCcHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE--IPDDIDPAVAQ 923 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~--ip~~ls~eL~d 923 (967)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+......+. ....+++++.+
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred C-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 2 23345689999999999999899999999999999999999999999888777666543322221 22478999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+|.+||+.||.+|||+.|+++|-.-
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHcCCChhHCcCHHHHhcChhh
Confidence 9999999999999999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.31 Aligned_cols=262 Identities=31% Similarity=0.510 Sum_probs=222.6
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
+.+..++|.+.+.||+|+||.||+|.+. +..||+|++... ......+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 4556689999999999999999999753 234999987654 344556789999999999999999999999865
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
+..++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 457899999999999999987666799999999999999999999998 799999999999999999999999999986
Q ss_pred cccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 842 KHHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 842 ~~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+. .......+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCH
Confidence 54432 22334557889999999999999999999999999999998 999998877766665543 3445667788999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.+.++|.+||..||.+|||+.+++++|+.+.+.-
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=358.65 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=223.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
+.++|++.+.||+|+||.||+|.+ .++.||+|++............+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 458999999999999999999966 478999999987766667778899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe---EEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV---VKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~---VKLsDFGLAr~~~~ 844 (967)
|||+.+++|.+.+.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999888765 35689999999999999999999998 7999999999999976554 99999999976654
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCC--CCCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI--PDDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~i--p~~ls~eL~ 922 (967)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+......... ...+++++.
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 161 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred Cc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 33 234567999999999999999999999999999999999999999998887777666544333332 247899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
++|.+||+.||++|||+.|+++|-.-
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred HHHHHHcccChhhCCCHHHHhcCccc
Confidence 99999999999999999999998543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=370.33 Aligned_cols=267 Identities=29% Similarity=0.484 Sum_probs=228.6
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecCC-------CeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMG 756 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g-------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig 756 (967)
..|++..++|.+.+.||+|+||.||+|.+.+ ..||+|++.... .......+.+|+.+++++ +||||+++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4678888999999999999999999997632 379999886542 445567899999999999 8999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcE
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRP-------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNL 823 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~-------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNI 823 (967)
++...+.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NI 195 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNV 195 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGC
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCcccceE
Confidence 999999999999999999999998642 34589999999999999999999998 799999999999
Q ss_pred EEcCCCeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 037068 824 LVDKNWVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQV 900 (967)
Q Consensus 824 LLd~~g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei 900 (967)
|++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999999986543221 2234456889999999999999999999999999999999 9999988766555
Q ss_pred HhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 901 VGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 901 ~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
...+.........|..+++.+.++|.+||+.||.+|||+.+++++|+.+.....
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 444444455566777889999999999999999999999999999999876554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.30 Aligned_cols=260 Identities=30% Similarity=0.494 Sum_probs=217.3
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
.+..++|++.+.||+|+||.||+|++ .++.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 34457899999999999999999973 57789999986543 344567889999999999999999999999876
Q ss_pred --CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 762 --PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 762 --~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
..+++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC--CcccCCCchheEEEcCCCCEEECccccc
Confidence 668999999999999999976667799999999999999999999998 7999999999999999999999999999
Q ss_pred cccccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------------hhHHHh
Q 037068 840 RIKHHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN--------------PMQVVG 902 (967)
Q Consensus 840 r~~~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~--------------~~ei~~ 902 (967)
+...... .......+|..|+|||++.+..++.++||||||+++|+|+||..||.... ......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 8665432 22345668889999999999999999999999999999999998864321 111111
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 903 AVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 903 ~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
...........+..+++++.++|.+||+.||.+|||+.++++.|+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 222244566778899999999999999999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=371.01 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=218.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh----hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG----DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~----~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|.+.+.||+|+||.||++.+ +++.||||++....... ...+.+.+|+.++++++||||+++++++.....+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 36799999999999999999976 48899999987654321 2467789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC----eEEEEeccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW----VVKVCDFGLSR 840 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g----~VKLsDFGLAr 840 (967)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHC--CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999975 45799999999999999999999998 799999999999998877 89999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCc
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDID 918 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls 918 (967)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+....... ..+..++
T Consensus 167 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 167 KIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp ECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 765432 2345679999999999999999999999999999999999999999888776665554322221 1235789
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+.+.+||.+||+.||++|||+.++++|-
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 9999999999999999999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.67 Aligned_cols=257 Identities=28% Similarity=0.510 Sum_probs=216.1
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCe----EEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTE----VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~----VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|++.+.||+|+||+||+|++ +++. ||+|.+... ........+.+|+.++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 47899999999999999999976 3443 577776433 23445678999999999999999999999998754 7
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++|+||+.+|+|.+++......+++..++.|+.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 899999999999999987777899999999999999999999998 799999999999999999999999999986543
Q ss_pred Ccc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 845 TYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 845 ~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+. .......+..++.++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 248 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDV 248 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCHHH
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCHHH
Confidence 322 2234456889999999999999999999999999999999 999999888777665554 445566778899999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
.+++.+||+.+|.+||++.+++++|..+.+.
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999988653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=357.02 Aligned_cols=264 Identities=32% Similarity=0.567 Sum_probs=227.5
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
.+|++..++|++.+.||+|+||.||+|... +..||||++.... ...+.+.+|+.++++++||||+++++++.. +.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 357888899999999999999999999875 4579999986543 235678899999999999999999998864 56
Q ss_pred eEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 899999999999999987532 3689999999999999999999998 7999999999999999999999999999876
Q ss_pred ccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 843 HHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 843 ~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .......+..++++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHH
Confidence 5432 22344567889999999999999999999999999999999 999999988777666554 34455667889999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
+.+++.+||..+|++|||+.++++.|+.+......
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999999776543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.35 Aligned_cols=260 Identities=22% Similarity=0.388 Sum_probs=217.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+..++|++.+.||+|+||.||++++ .++.||+|++..... .....+.+.+|+.++++++||||+++++++...+.++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 4558999999999999999999975 578999999865432 3455678999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999876 35699999999999999999999998 7999999999999999999999999999865443
Q ss_pred c-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc---ccCCCCCCcHHH
Q 037068 846 Y-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR---RLEIPDDIDPAV 921 (967)
Q Consensus 846 ~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~---~~~ip~~ls~eL 921 (967)
. .......||+.|+|||++.+..++.++||||||+++|+|+||+.||................. ....+..+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 2 223446799999999999999999999999999999999999999998877655433322211 123456789999
Q ss_pred HHHHHHhhhcCCCCCc-CHHHHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRP-SFAQLMSRLRCLQR 951 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RP-S~~ELLe~L~~L~~ 951 (967)
.++|.+||+.||.+|| +++++++.|..+..
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 9999999999999998 89999988877643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=358.40 Aligned_cols=261 Identities=18% Similarity=0.255 Sum_probs=219.7
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
.+..++|++.+.||+|+||.||+|.+ .++.||||++..... ...+.+|+.+++.+ +|+||+++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 34568999999999999999999974 688999999865432 23467899999999 899999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe-----EEEEecccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV-----VKVCDFGLS 839 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~-----VKLsDFGLA 839 (967)
++||||+ +++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||+|||++
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999999 9999999987666799999999999999999999998 7999999999999987765 999999999
Q ss_pred cccccCcc-------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---hHHHhhhhcc--
Q 037068 840 RIKHHTYL-------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP---MQVVGAVGFQ-- 907 (967)
Q Consensus 840 r~~~~~~~-------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~---~ei~~~i~~~-- 907 (967)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 86554321 23456799999999999999999999999999999999999999988543 2222222211
Q ss_pred -ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 908 -NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 908 -~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
.........+++++.++|.+||+.||++||++.+|++.|+.+.+....
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 111223457899999999999999999999999999999999877643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=376.11 Aligned_cols=251 Identities=22% Similarity=0.389 Sum_probs=217.1
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~L 766 (967)
.++|++.+.||+|+||.||+|++ +++.||||++.+... .......+.+|+.+++++ +||||+++++++.+.+.+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 46899999999999999999976 478899999976543 344567788999999998 89999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+|+|..++.. ...+++..++.++.||+.||+|||++ ||+||||||+||||+.++++||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999999875 35699999999999999999999998 79999999999999999999999999998654444
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------ChhHHHhhhhccccccCCCCCC
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL---------NPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~---------~~~ei~~~i~~~~~~~~ip~~l 917 (967)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+ ......+|..+
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~ 242 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSL 242 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCCTTS
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCCCCC
Confidence 4456678999999999999999999999999999999999999999752 122222233 23456678899
Q ss_pred cHHHHHHHHHhhhcCCCCCcCH------HHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSF------AQLMSRL 946 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~------~ELLe~L 946 (967)
++++.++|.+||+.||.+||++ .++++|-
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 9999999999999999999984 7888874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=381.97 Aligned_cols=253 Identities=24% Similarity=0.429 Sum_probs=220.3
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCc
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~ 763 (967)
....++|.+.+.||+|+||+||+|++ +++.||||++.+... .......+..|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34568999999999999999999976 478899999865321 123456678899999887 99999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++++||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999999875 35699999999999999999999998 79999999999999999999999999998654
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++.+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKD 247 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHHH
Confidence 443445667899999999999999999999999999999999999999999888877766643 345677889999999
Q ss_pred HHHHhhhcCCCCCcCHH-HHHHH
Q 037068 924 IIRDCWQTEPHLRPSFA-QLMSR 945 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~-ELLe~ 945 (967)
+|.+||+.||++||++. +|++|
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHhcCCHhHcCCChHHHHcC
Confidence 99999999999999997 78766
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=372.76 Aligned_cols=248 Identities=24% Similarity=0.424 Sum_probs=219.8
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|++.+.||+|+||+||+++. +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 47899999999999999999976 588999999865321 123456788899999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++++||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999999976 45699999999999999999999998 7999999999999999999999999999865432
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++.++|.+
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHH
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHH
Confidence 3456799999999999999999999999999999999999999998887777666542 3456788899999999999
Q ss_pred hhhcCCCCCc-----CHHHHHHHH
Q 037068 928 CWQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RP-----S~~ELLe~L 946 (967)
||+.||.+|| ++.++++|-
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HhccCHHHcCCCcCCCHHHHhcCc
Confidence 9999999999 899999884
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=390.12 Aligned_cols=261 Identities=30% Similarity=0.568 Sum_probs=228.6
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
...|++..++|++.+.||+|+||.||+|.+. +..||||++.... ...+.+.+|+.++++++||||+++++++. .+
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 3568888899999999999999999999875 6789999986533 34678999999999999999999999986 56
Q ss_pred ceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.++|||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 7899999999999999997532 3688999999999999999999998 799999999999999999999999999987
Q ss_pred cccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 842 KHHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 842 ~~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
..... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+....+. ...+.+.|..+++
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 412 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPE 412 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCH
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 64332 22334557889999999999999999999999999999999 999999988887776664 4556777889999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
++.++|.+||+.||++|||+.+|++.|+.+..
T Consensus 413 ~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999987743
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=374.35 Aligned_cols=263 Identities=29% Similarity=0.434 Sum_probs=213.8
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC---
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP--- 762 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~--- 762 (967)
.+.+..++|++.+.||+|+||+||+|++.++.||||++... .........|+.++++++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred ccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 45556689999999999999999999999999999998543 233445667899999999999999999998754
Q ss_pred -ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCeEEeccCCCcEEEcCCCeEEE
Q 037068 763 -HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS--------HPTIVHRDLKSPNLLVDKNWVVKV 833 (967)
Q Consensus 763 -~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~--------n~GIVHRDLKPsNILLd~~g~VKL 833 (967)
.+++||||+.+|+|.+++.. ..+++..++.++.||+.||.|||+. .+||+||||||+|||++.++.+||
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred ceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 37999999999999999975 3599999999999999999999986 236999999999999999999999
Q ss_pred EecccccccccCcc--CCCCCCCCCCccChhccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------
Q 037068 834 CDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNE-----PANEKCDVYSFGVILWELATLSVPWKGLNP--------- 897 (967)
Q Consensus 834 sDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~-----~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~--------- 897 (967)
+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999986544322 23346799999999999874 456788999999999999999999976432
Q ss_pred -------hHHHhhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 898 -------MQVVGAVGFQNRRLEIPD-----DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 898 -------~ei~~~i~~~~~~~~ip~-----~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
......+........++. ..++++.+||.+||+.||++|||+.++++.|+.+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 112222222222222222 23466999999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=368.13 Aligned_cols=263 Identities=32% Similarity=0.521 Sum_probs=222.9
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecCC------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~g------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
++..++|.+.+.||+|+||.||+|.+.. ..||||++... ........+.+|+.++++++||||+++++++...
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 5566899999999999999999997632 24999998643 3445566789999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
+..+|||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999987667899999999999999999999998 799999999999999999999999999986
Q ss_pred cccCcc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 842 KHHTYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 842 ~~~~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+. .....+.+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 275 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 275 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCcccC
Confidence 543321 1223446789999999999999999999999999999999 999999888877766654 34456677889
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
++.+.++|.+||+.+|.+||++.+++++|+.+.+...
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 9999999999999999999999999999999876543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=367.50 Aligned_cols=263 Identities=32% Similarity=0.548 Sum_probs=227.0
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEee
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMG 756 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig 756 (967)
..+|++..++|++.+.||+|+||.||+|.+. ++.||||++... ........+.+|+.++++++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3567888899999999999999999999654 567999987643 33445567899999999999999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRP---------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK 827 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~---------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~ 827 (967)
++...+..++||||+.+++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAE 173 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECT
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CCccCCCccceEEEcC
Confidence 999999999999999999999998642 14578999999999999999999998 7999999999999999
Q ss_pred CCeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhh
Q 037068 828 NWVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAV 904 (967)
Q Consensus 828 ~g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i 904 (967)
++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 99999999999986543321 2233456889999999999999999999999999999999 89999998887776655
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 905 GFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 905 ~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
. .......+..+++.+.++|.+||+.||.+|||+.+++++|+.+.
T Consensus 254 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 254 M-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 4 34445667889999999999999999999999999999998763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.23 Aligned_cols=258 Identities=26% Similarity=0.473 Sum_probs=218.4
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCe----EEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTE----VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~----VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
..++|++.+.||+|+||+||+|.+. ++. ||+|.+.... .......+.+|+.++++++||||+++++++. ++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 3478999999999999999999763 443 7777764332 2233345678999999999999999999886 556
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.++||||+.+|+|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT--TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC--CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 8999999999999999987666799999999999999999999998 79999999999999999999999999998764
Q ss_pred cCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 844 HTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 844 ~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
... .......+|+.|+|||++.+..++.++|||||||++|+|+| |+.||......+....+. .......|..++++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTID 245 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCcHH
Confidence 432 22344567889999999999999999999999999999999 999999888777666554 44566777889999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
+.++|.+||+.||.+|||+.+++++|+.+.+.
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999988643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.87 Aligned_cols=264 Identities=26% Similarity=0.466 Sum_probs=223.5
Q ss_pred hhhhccCCeeEeE-EeecCCceEEEEeec----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 686 EWEILWEDLQIGE-RIGIGSYGEVYRADW----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 686 ~~ei~~e~y~i~k-~LGeG~FG~VYka~~----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
++.+..++|.+.+ .||+|+||.||+|.+ .++.||||++..........+.+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3445567899988 999999999999944 357799999876554555577899999999999999999999998 5
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.+..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhC--CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 6678999999999999999976 45699999999999999999999998 79999999999999999999999999998
Q ss_pred ccccCcc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCC
Q 037068 841 IKHHTYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDD 916 (967)
Q Consensus 841 ~~~~~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ 916 (967)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. .......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 6543321 1223446789999999999889999999999999999999 999999988877666554 4456677888
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
+++++.++|.+||+.||.+||++.++++.|+.+.....
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999999976654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=363.21 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=208.3
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 37899999999999999999977 4889999998776555556677889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+++|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++........
T Consensus 82 e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999988765 45699999999999999999999998 7999999999999999999999999999876654444
Q ss_pred CCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-------------------c
Q 037068 849 SKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-------------------N 908 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-------------------~ 908 (967)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 456679999999999976 56899999999999999999999999988766544332210 0
Q ss_pred cccCCC----------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 RRLEIP----------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 ~~~~ip----------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
...+.+ ..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 011111 3578899999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=356.92 Aligned_cols=260 Identities=29% Similarity=0.561 Sum_probs=221.6
Q ss_pred CeeEeEEeecCCceEEEEeec--CCC---eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce-EE
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGT---EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF-SI 766 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~---~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l-~L 766 (967)
.|.+.+.||+|+||.||+|.+ .+. .||+|++... ......+.+.+|+.++++++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 456779999999999999975 222 6999987543 3445667889999999999999999999999876654 99
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC-
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT- 845 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~- 845 (967)
||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999988777899999999999999999999998 7999999999999999999999999999865432
Q ss_pred ---ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 846 ---YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 846 ---~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
........+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...+.......+. .......+..+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHH
Confidence 1223445678899999999999999999999999999999995 56677666666655543 445566778899999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcC
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDR 956 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~ 956 (967)
.++|.+||+.||.+|||+.++++.|+.+.+.+...
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 99999999999999999999999999998776543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=380.15 Aligned_cols=253 Identities=20% Similarity=0.371 Sum_probs=221.1
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
...++|++.+.||+|+||+||+|+++ ++.||||++.+... .......+..|..+++.+ +||||+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34589999999999999999999874 67899999865321 123456788899999887 899999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+++|+|..++.. ...+++..++.++.||+.||+|||++ ||+||||||+||||+.++++||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999999875 34699999999999999999999998 799999999999999999999999999986544
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++.+|
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAI 251 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHH
Confidence 44445667899999999999999999999999999999999999999999888877766643 3456788999999999
Q ss_pred HHHhhhcCCCCCcC-----HHHHHHHH
Q 037068 925 IRDCWQTEPHLRPS-----FAQLMSRL 946 (967)
Q Consensus 925 I~~CLq~dPe~RPS-----~~ELLe~L 946 (967)
|.+||+.||.+||+ +.+|++|-
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 99999999999994 68888874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=361.37 Aligned_cols=251 Identities=32% Similarity=0.587 Sum_probs=206.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHH--cCCCceeEEeeeeec----cCc
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR--LRHPNVVLFMGAVTR----SPH 763 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~--L~HpNIVkLig~~~~----~~~ 763 (967)
..++|++.+.||+|+||+||+|+++++.||||++.. .....+..|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 457999999999999999999999999999999753 234556677788777 799999999998654 345
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCeEEeccCCCcEEEcCCCeEEEEe
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH--------TSHPTIVHRDLKSPNLLVDKNWVVKVCD 835 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLH--------s~n~GIVHRDLKPsNILLd~~g~VKLsD 835 (967)
+++||||+.+|+|.+++.. ..+++..++.++.||+.||.||| ++ +|+||||||+|||++.++.+||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~--~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP--AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC--EEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC--CeecCCCChHhEEEcCCCCEEEee
Confidence 8999999999999999964 46999999999999999999999 66 799999999999999999999999
Q ss_pred cccccccccCcc----CCCCCCCCCCccChhccccC------CCCchhHHHHHHHHHHHHHhC----------CCCCCCC
Q 037068 836 FGLSRIKHHTYL----SSKSTAGTPEWMAPEVLRNE------PANEKCDVYSFGVILWELATL----------SVPWKGL 895 (967)
Q Consensus 836 FGLAr~~~~~~~----~~~~~~GT~~YmAPE~l~g~------~~s~ksDVWSLGvlL~ELlTG----------k~PF~~~ 895 (967)
||+++....... ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999976543322 13345799999999999877 455799999999999999999 8888654
Q ss_pred Ch-----hHHHhhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 896 NP-----MQVVGAVGFQNRRLEIPD-----DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 896 ~~-----~ei~~~i~~~~~~~~ip~-----~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.. ......+........+|. .+++++.++|.+||+.||++|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 32 222222222333333432 3567899999999999999999999999999886
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=383.83 Aligned_cols=253 Identities=21% Similarity=0.395 Sum_probs=216.2
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
+..++|++.+.||+|+||+||+|++ +++.||+|++.+.... ......+..|..+++++ +||||+++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 3457899999999999999999976 4778999998765432 23345678899999887 899999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+|||||+++|+|..++.+ ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++++||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999999875 45699999999999999999999998 799999999999999999999999999986444
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------hHHHhhhhccccccCCCC
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP---------MQVVGAVGFQNRRLEIPD 915 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~---------~ei~~~i~~~~~~~~ip~ 915 (967)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+ ......+|.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~ 283 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPR 283 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCCT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCCC
Confidence 44456678899999999999999999999999999999999999999964321 1222222 234567888
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcC------HHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPS------FAQLMSRL 946 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS------~~ELLe~L 946 (967)
.+++++.+||++||+.||.+||+ +.+|++|-
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 99999999999999999999998 47888874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=375.36 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=213.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC---CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD---FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~---~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
..++|++.+.||+|+||+||++.+ +++.||||++.... ......+.+.+|+.+++.++||||+++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346899999999999999999976 58899999986432 1122457789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---eEEEEeccc
Q 037068 765 SILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---VVKVCDFGL 838 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---~VKLsDFGL 838 (967)
++||||+++++|.+++.. .+..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999887753 234589999999999999999999998 799999999999997655 499999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCC
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDD 916 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ 916 (967)
++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .+....+....... .....
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence 9877655444556789999999999999999999999999999999999999998754 33333332221111 11256
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+++++.+||.+||+.||++|||+.++++|-
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 899999999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=362.58 Aligned_cols=254 Identities=26% Similarity=0.458 Sum_probs=218.8
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee--ccCceEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT--RSPHFSI 766 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~--~~~~l~L 766 (967)
.++|++.+.||+|+||.||++++ +++.||+|++..........+.+.+|+.++++++||||+++++++. ....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36899999999999999999976 5788999999876666667788999999999999999999999874 4567999
Q ss_pred EEeecCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-----eEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 767 LTEFLPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSHPT-----IVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n~G-----IVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
||||+++++|.+++... ...+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR--SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc--cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999998642 34599999999999999999999998 6 99999999999999999999999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCc
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls 918 (967)
++.............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+. ......++..++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 241 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYS 241 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCCCTTSC
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-hcccccCCcccC
Confidence 9865443222234568999999999999999999999999999999999999999988776665554 334456778899
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+++.++|.+||+.||++|||+.++++++.
T Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 242 DELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 99999999999999999999999998764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.53 Aligned_cols=257 Identities=34% Similarity=0.644 Sum_probs=216.9
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-cCce
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-SPHF 764 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-~~~l 764 (967)
.|.+..++|++.+.||+|+||.||+++++++.||||++... ...+.+.+|+.++++++||||+++++++.. .+..
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 45667789999999999999999999999999999997543 245678899999999999999999998755 4579
Q ss_pred EEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999999987532 2378999999999999999999998 79999999999999999999999999997554
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
.. .....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||......+....+. .......+..+++.+.
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHH
Confidence 33 223467889999999999999999999999999999998 999999888776665553 3445677788999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
++|.+||+.||.+|||+.++++.|+.+...
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=392.96 Aligned_cols=260 Identities=35% Similarity=0.650 Sum_probs=229.7
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
...|++..++|++.+.||+|+||.||+|.+. +..||||++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3567888899999999999999999999774 7789999986543 2467789999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+.++|||||+.+|+|.+++... ...+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChhhEEECCCCcEEEeecccce
Confidence 9999999999999999999753 45689999999999999999999998 79999999999999999999999999998
Q ss_pred ccccC-ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCc
Q 037068 841 IKHHT-YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 841 ~~~~~-~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls 918 (967)
..... ........+|+.|+|||++.+..++.++|||||||+||||+| |..||.+.+..++...+. ...+...|..++
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 445 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 445 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 76433 222344556789999999999999999999999999999999 999999988877766554 455677888999
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999999999765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=358.95 Aligned_cols=259 Identities=31% Similarity=0.525 Sum_probs=219.6
Q ss_pred CCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee-ccCceE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT-RSPHFS 765 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~-~~~~l~ 765 (967)
.+|++.+.||+|+||.||+|.+. ...+|+|.+... ........+.+|+.++++++||||+++++++. .++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 57999999999999999999753 224888887543 34455678999999999999999999999854 566789
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999987777899999999999999999999998 7999999999999999999999999999865432
Q ss_pred c----cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 846 Y----LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 846 ~----~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++ +.+||...+..+....+. .......|..+++.
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCHH
Confidence 2 12334557889999999999999999999999999999999 667887777666555443 44555667889999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
+.++|.+||+.+|++|||+.++++.|+.+.+...
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.14 Aligned_cols=263 Identities=25% Similarity=0.452 Sum_probs=209.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
..++|++.+.||+|+||.||+|.. +++.||||++.... ........+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346899999999999999999975 58899999987543 344556788999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 767 LTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998864 356689999999999999999999998 79999999999999999999999999998765
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hhHHHhhhhccccccCCCCCCcHHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN--PMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~--~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
..........||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+.........+..+++++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 54444455679999999999999999999999999999999999999997643 2233333332222222336789999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
.++|.+||..||.+|||+.+++++|++++....
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999987764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=369.93 Aligned_cols=253 Identities=26% Similarity=0.337 Sum_probs=210.9
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||+||+|.+ .++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47999999999999999999966 588999999865432 223456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC--c
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--Y 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~--~ 846 (967)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... .
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999975 45699999999999999999999998 7999999999999999999999999999865422 2
Q ss_pred cCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHH-HhhhhccccccCCCCCCcHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQV-VGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei-~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ................+++.+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22345679999999999988775 7789999999999999999999987655322 222222222233335789999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
|.+||+.||.+|||+.|++++-.
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHccCChhhCcCHHHHhhChh
Confidence 99999999999999999998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=370.20 Aligned_cols=264 Identities=28% Similarity=0.463 Sum_probs=219.0
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
+.+...++|.+.+.||+|+||.||+|++. ++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34556789999999999999999999874 789999987553 334567889999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPN---HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~---~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--AIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC--CeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999987533 3589999999999999999999998 799999999999999999999999999986
Q ss_pred cccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc------c------
Q 037068 842 KHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF------Q------ 907 (967)
Q Consensus 842 ~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~------~------ 907 (967)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+......+ .
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 44322 122334589999999999999999999999999999999999999987554332111100 0
Q ss_pred ---ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 908 ---NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 908 ---~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.....++..++..+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 0011122345678999999999999999999999999999987653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=375.75 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=213.5
Q ss_pred hccCCeeEeEEeecC--CceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 689 ILWEDLQIGERIGIG--SYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 689 i~~e~y~i~k~LGeG--~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
...++|++.+.||+| +||.||++++ +++.||||++............+.+|+.+++.++||||+++++++...+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 345799999999999 9999999987 488999999987766666778899999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999998753 35699999999999999999999998 79999999999999999999999999986432
Q ss_pred cCc-------cCCCCCCCCCCccChhcccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc------
Q 037068 844 HTY-------LSSKSTAGTPEWMAPEVLRN--EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN------ 908 (967)
Q Consensus 844 ~~~-------~~~~~~~GT~~YmAPE~l~g--~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~------ 908 (967)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 11233478999999999987 578999999999999999999999998766544433221100
Q ss_pred --------------------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 --------------------------------------RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 --------------------------------------~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
...+.+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0112345678999999999999999999999999988
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=390.08 Aligned_cols=253 Identities=22% Similarity=0.418 Sum_probs=212.3
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+..++|++.+.||+|+||.||++++ .++.||||++.... ........+.+|+.+++.++||||+++++++...+.++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 4457899999999999999999976 57899999986532 12334566788999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT-SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs-~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
|||||+++|+|..++.. ...+++..++.++.||+.||+|||+ + ||+||||||+||||+.++.+||+|||+++....
T Consensus 225 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999999875 4569999999999999999999998 6 799999999999999999999999999986544
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. ....+|..+++++.+|
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~l 379 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKSL 379 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHH
Confidence 44445667899999999999999999999999999999999999999999888777766643 3456788899999999
Q ss_pred HHHhhhcCCCCCc-----CHHHHHHHH
Q 037068 925 IRDCWQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 925 I~~CLq~dPe~RP-----S~~ELLe~L 946 (967)
|.+||+.||.+|| ++.|+++|-
T Consensus 380 i~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 380 LSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 9999999999999 999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.32 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=195.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|++.+.||+|+||.||+|++ .++.||||++..... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36899999999999999999975 688999999864321 122356788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999987667899999999999999999999998 799999999999999999999999999987654433
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ......|..++.++.++|.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHHHHH
Confidence 3445679999999999999999999999999999999999999998776555444332 23445677899999999999
Q ss_pred hhhcCCCCCcCHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L 946 (967)
||+.||++|||+.++++|-
T Consensus 246 ~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp HSCSSGGGSCCHHHHTTST
T ss_pred HcccCHhhCCCHHHHhcCc
Confidence 9999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=365.19 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=217.1
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
.|...+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 377888999999999999976 58899999986543 33456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.+++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..........
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 999999999874 4699999999999999999999998 799999999999999999999999999987655444455
Q ss_pred CCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-cccCCCCCCcHHHHHHHHHhh
Q 037068 851 STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-RRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-~~~~ip~~ls~eL~dLI~~CL 929 (967)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... .....+..+++++.++|.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 6789999999999999999999999999999999999999999888776665543221 122334468899999999999
Q ss_pred hcCCCCCcCHHHHHHHHH
Q 037068 930 QTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~L~ 947 (967)
+.||++|||+.++++|..
T Consensus 280 ~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 280 VRDPQERATAQELLDHPF 297 (321)
T ss_dssp CSSTTTSCCHHHHHTSGG
T ss_pred cCChhhCcCHHHHhcChh
Confidence 999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=376.84 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=221.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
..++|++.+.||+|+||.||++++ +++.||||++.+... .......+.+|+.+++.++||||+++++++.+...+++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 347899999999999999999976 488999999865422 22345678899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+|+|.+++.+ ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++++||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999876 34699999999999999999999998 7999999999999999999999999999866443
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++.++|.
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHHH
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence 3456799999999999999999999999999999999999999999888777766643 345678889999999999
Q ss_pred HhhhcCCCCCcC-----HHHHHHHH
Q 037068 927 DCWQTEPHLRPS-----FAQLMSRL 946 (967)
Q Consensus 927 ~CLq~dPe~RPS-----~~ELLe~L 946 (967)
+||+.||.+||+ +.+|++|-
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHhhcCHHhccCCccCCHHHHHhCc
Confidence 999999999998 99999885
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=388.19 Aligned_cols=261 Identities=33% Similarity=0.582 Sum_probs=222.4
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecCC-CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g-~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
..|++..++|++.++||+|+||.||+|.+.+ ..||||++..... ..+.+.+|+.++++++||||+++++++.. +.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 4577888999999999999999999998864 5799999865432 34678999999999999999999999876 67
Q ss_pred eEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+|||||+.+|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 89999999999999999752 35689999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 843 HHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 843 ~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+....+. .+.+.+.|..+++.
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 4332 22334557889999999999999999999999999999999 999999988877776664 45567788899999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
+.++|.+||+.||++|||+.+|++.|+.+...
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 99999999999999999999999999877543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=368.04 Aligned_cols=256 Identities=20% Similarity=0.334 Sum_probs=213.7
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC--CceeEEeeeeeccCce
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH--PNVVLFMGAVTRSPHF 764 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H--pNIVkLig~~~~~~~l 764 (967)
.+..++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.++++++| +||+++++++.....+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 34567899999999999999999976 57789999998766666777889999999999976 9999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+ ++.+||+|||+++....
T Consensus 85 ~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~--~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEe-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99999 567899999976 45799999999999999999999998 799999999999997 57899999999986643
Q ss_pred Ccc--CCCCCCCCCCccChhcccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhccccc
Q 037068 845 TYL--SSKSTAGTPEWMAPEVLRN-----------EPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRR 910 (967)
Q Consensus 845 ~~~--~~~~~~GT~~YmAPE~l~g-----------~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~ 910 (967)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 322 2345679999999999865 67899999999999999999999999875432 333333334556
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 911 ~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
..+|...++++.+||.+||+.||.+|||+.++++|...
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 67788889999999999999999999999999998643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=365.18 Aligned_cols=256 Identities=19% Similarity=0.276 Sum_probs=214.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~L 766 (967)
..++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+|+.+++++ +|+||+++++++......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 457899999999999999999974 688999999865432 23577899999999 99999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe-----EEEEecccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV-----VKVCDFGLSRI 841 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~-----VKLsDFGLAr~ 841 (967)
||||+ +++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||+|||+++.
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99999 9999999987667899999999999999999999998 7999999999999998887 99999999986
Q ss_pred cccCcc-------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHH---Hhhhhcccccc
Q 037068 842 KHHTYL-------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV---VGAVGFQNRRL 911 (967)
Q Consensus 842 ~~~~~~-------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei---~~~i~~~~~~~ 911 (967)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 543322 12456799999999999999999999999999999999999999988654332 22221111111
Q ss_pred ---CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 912 ---EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 912 ---~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.....++ ++.++|.+||+.+|.+||++.+|++.|+.+.+..
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1123355 9999999999999999999999999999887765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=368.34 Aligned_cols=258 Identities=28% Similarity=0.516 Sum_probs=216.5
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCe----EEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTE----VAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~----VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
..++|++.+.||+|+||.||+|.+ +++. |++|.+... ........+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 347999999999999999999976 3444 466665433 23445678899999999999999999999998754
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.++|+||+.+|+|.+++......+++..++.|+.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 8899999999999999987777899999999999999999999998 79999999999999999999999999998654
Q ss_pred cCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 844 HTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 844 ~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .......+..++++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHH
Confidence 332 12334456889999999999999999999999999999999 999999988777666554 45566778889999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
+.++|.+||+.||.+||++.++++.|..+.+.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998743
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=390.96 Aligned_cols=262 Identities=21% Similarity=0.363 Sum_probs=223.6
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeee
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT 759 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~ 759 (967)
.+.++.+..++|++.++||+|+||+||+|+++ ++.||+|++.+... .......+.+|+.+++.++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556677899999999999999999999774 67899999864211 1112234788999999999999999999999
Q ss_pred ccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 760 RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 760 ~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
+.+.++|||||+.+|+|.+++.+....+++..++.++.||+.||.|||++ |||||||||+||||+.++++||+|||++
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~--giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC--CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999987667899999999999999999999998 7999999999999999999999999999
Q ss_pred cccccCc-cCCCCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCC
Q 037068 840 RIKHHTY-LSSKSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI 913 (967)
Q Consensus 840 r~~~~~~-~~~~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~i 913 (967)
+...... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+........+
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 7654332 2234568999999999997 567899999999999999999999999998888777766543334444
Q ss_pred C---CCCcHHHHHHHHHhhhcCCCC--CcCHHHHHHHH
Q 037068 914 P---DDIDPAVAQIIRDCWQTEPHL--RPSFAQLMSRL 946 (967)
Q Consensus 914 p---~~ls~eL~dLI~~CLq~dPe~--RPS~~ELLe~L 946 (967)
| ..+++++.+||++||..+|++ |+++.|+++|-
T Consensus 303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 4 358999999999999988888 99999999984
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.80 Aligned_cols=255 Identities=30% Similarity=0.629 Sum_probs=210.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
..++|++.+.||+|+||.||++++.++.||||++.. ....+.+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 347899999999999999999999999999999743 2345778999999999999999999998874 4899999
Q ss_pred ecCCCchhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhcC-CCeEEeccCCCcEEEcCCCe-EEEEecccccccccC
Q 037068 770 FLPRGSLYRLLHRPNH--QLDERRRMRMALDVAKGMNYLHTSH-PTIVHRDLKSPNLLVDKNWV-VKVCDFGLSRIKHHT 845 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~--~Lse~~i~~I~~QIa~aL~YLHs~n-~GIVHRDLKPsNILLd~~g~-VKLsDFGLAr~~~~~ 845 (967)
|+++++|.+++..... .+++..++.++.||++||.|||+.+ .||+||||||+|||++.++. +||+|||+++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999976432 4789999999999999999999932 27999999999999988775 899999999755432
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH--HHhhhhccccccCCCCCCcHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ--VVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e--i~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+ ........+..+++.+.+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTCCHHHHH
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCcccccCHHHHH
Confidence 233468999999999999999999999999999999999999998654322 22122 234455667789999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
+|.+||+.||.+|||+.+++++|+.+.+...
T Consensus 236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999976654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=357.92 Aligned_cols=253 Identities=25% Similarity=0.475 Sum_probs=217.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+..++|++.+.||+|+||.||+|.+ .+..||||++...... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 4558999999999999999999976 4668999998653221 223466889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~--~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT--TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999999875 35689999999999999999999998 7999999999999999999999999998654433
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
. .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+. .....+|..+++.+.+||
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 238 (279)
T 3fdn_A 163 R--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLI 238 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHH
T ss_pred c--ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHHHH
Confidence 2 344678999999999999999999999999999999999999999888777666553 344567788999999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
.+||+.||.+|||+.|+++|-.-
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHH
T ss_pred HHHhccChhhCCCHHHHhhCccc
Confidence 99999999999999999999653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=367.54 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=198.4
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++||||+++++++..++.+++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 6899999999999999999976 48899999986543 23344678889999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 770 FLPRGSLYRLLHRP-----NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 770 y~~gGsL~~lL~~~-----~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
|+. ++|.+++... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 998 5898887542 24589999999999999999999998 799999999999999999999999999987654
Q ss_pred CccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-c--------------
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-N-------------- 908 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~-------------- 908 (967)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+... +
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 44444566799999999999774 6899999999999999999999999988776554433210 0
Q ss_pred -c----------------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 909 -R----------------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 909 -~----------------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
. ....+..+++++.+||.+||+.||++|||+.|+++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 0 0112235788999999999999999999999999873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=370.01 Aligned_cols=273 Identities=34% Similarity=0.548 Sum_probs=222.4
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
.+..|++..++|++.+.||+|+||.||+|++.+ .+|+|++..........+.+.+|+.++++++|+||+++++++...+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 457788889999999999999999999998765 5999998765444444556778999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++ ++.+||+|||+++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999999987666799999999999999999999998 799999999999998 679999999998754
Q ss_pred ccC-----ccCCCCCCCCCCccChhcccc---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc
Q 037068 843 HHT-----YLSSKSTAGTPEWMAPEVLRN---------EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN 908 (967)
Q Consensus 843 ~~~-----~~~~~~~~GT~~YmAPE~l~g---------~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~ 908 (967)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 321 122334558999999999874 457899999999999999999999999988877766654333
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcCCCC
Q 037068 909 RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNS 959 (967)
Q Consensus 909 ~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~~~~ 959 (967)
.....+..+++++.++|.+||..||++|||+.++++.|+.+.+.......+
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~ 310 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence 333333468899999999999999999999999999999987765444333
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=363.50 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=210.2
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC--ce
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP--HF 764 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~--~l 764 (967)
...++|++.+.||+|+||+||+|++. ++.||||++..... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34578999999999999999999774 88999999865432 234567789999999999999999999987654 78
Q ss_pred EEEEeecCCCchhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE----cCCCeEEEEeccc
Q 037068 765 SILTEFLPRGSLYRLLHRPN--HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGL 838 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~--~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL----d~~g~VKLsDFGL 838 (967)
++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +..+.+||+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999997643 3399999999999999999999998 79999999999999 7888999999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccc--------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh----HHHhhhhc
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLR--------NEPANEKCDVYSFGVILWELATLSVPWKGLNPM----QVVGAVGF 906 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~--------g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~----ei~~~i~~ 906 (967)
++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||...... +....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 98765443 234567999999999986 577899999999999999999999999754432 22222111
Q ss_pred ccc-------------------cc----CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 907 QNR-------------------RL----EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 907 ~~~-------------------~~----~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
... .. .++..+++.+.++|++||+.||++|||+.|+++|..+-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 100 11 12234567889999999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=386.68 Aligned_cols=260 Identities=23% Similarity=0.377 Sum_probs=222.2
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
+..+.+..++|.+.+.||+|+||+||+|++ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 445667778999999999999999999977 477899999865211 11122347789999999999999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
...++|||||+++|+|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+||||+.++++||+|||+++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999999875 4589999999999999999999998 79999999999999999999999999998
Q ss_pred ccccCc-cCCCCCCCCCCccChhccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC-
Q 037068 841 IKHHTY-LSSKSTAGTPEWMAPEVLRNEP----ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP- 914 (967)
Q Consensus 841 ~~~~~~-~~~~~~~GT~~YmAPE~l~g~~----~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip- 914 (967)
...... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+........+|
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 655432 2344678999999999998765 7889999999999999999999999988887777665433333444
Q ss_pred -CCCcHHHHHHHHHhhhcCCCC--CcCHHHHHHHHH
Q 037068 915 -DDIDPAVAQIIRDCWQTEPHL--RPSFAQLMSRLR 947 (967)
Q Consensus 915 -~~ls~eL~dLI~~CLq~dPe~--RPS~~ELLe~L~ 947 (967)
..+++++.+||.+||+.+|.+ ||++.||++|-.
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 479999999999999999988 999999999853
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=394.60 Aligned_cols=269 Identities=25% Similarity=0.456 Sum_probs=228.1
Q ss_pred hhhhccCCeeEeE-EeecCCceEEEEeec----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 686 EWEILWEDLQIGE-RIGIGSYGEVYRADW----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 686 ~~ei~~e~y~i~k-~LGeG~FG~VYka~~----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
.+.+..+++.+.+ .||+|+||.||+|.+ .+..||||++... ......+.+.+|+.++++++||||+++++++..
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 3555667777777 899999999999965 2456999998654 234457789999999999999999999999876
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+.++|||||+.+|+|.+++......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 569999999999999999987677799999999999999999999998 79999999999999999999999999998
Q ss_pred ccccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCC
Q 037068 841 IKHHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDD 916 (967)
Q Consensus 841 ~~~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ 916 (967)
...... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...+..++...+. .+.+...|..
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~ 563 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTT
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCc
Confidence 654321 11223346789999999999999999999999999999998 999999988887776664 5567788889
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcCCCC
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNS 959 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~~~~ 959 (967)
+++++.+||.+||+.+|++||++.+|++.|+.+..........
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~ 606 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCC
Confidence 9999999999999999999999999999999998777554443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.05 Aligned_cols=260 Identities=33% Similarity=0.609 Sum_probs=220.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCe--EEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTE--VAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~--VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
..++|++.+.||+|+||.||+|++ .+.. ++||.+... ........+.+|+.+++++ +||||+++++++...+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 347899999999999999999976 3444 488987643 2334456788999999999 899999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC
Q 037068 765 SILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW 829 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g 829 (967)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCccceEEEcCCC
Confidence 99999999999999997643 4699999999999999999999998 799999999999999999
Q ss_pred eEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccc
Q 037068 830 VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQN 908 (967)
Q Consensus 830 ~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~ 908 (967)
.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+. ..
T Consensus 180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~ 257 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QG 257 (327)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GT
T ss_pred eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-cC
Confidence 9999999999744322 12334457889999999999999999999999999999998 999999988877766654 34
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 909 RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 909 ~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
.....+..+++++.++|.+||+.+|.+|||+.+++++|..+.+...
T Consensus 258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 4566778899999999999999999999999999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=376.43 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=216.4
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
..++|.+.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.+++.++||||+++++++...+.+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 347899999999999999999986 6789999998643211 1223568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 87 v~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 6788888765 35699999999999999999999999 79999999999999999999999999998665443
Q ss_pred cCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+ ......+|..+++++.+||
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHH
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHH
Confidence 2455679999999999998876 78999999999999999999999876655443333 2334567888999999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
++||+.||.+|||+.|+++|-.-
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HHHcCCChhHCcCHHHHHhChhh
Confidence 99999999999999999998653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=372.79 Aligned_cols=264 Identities=16% Similarity=0.177 Sum_probs=208.6
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChh---------hHHHHHHHHHHHHHcCCCcee
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGD---------SLSQFKCEAEIMLRLRHPNVV 752 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~---------~~~~~~~Ei~ILk~L~HpNIV 752 (967)
+..++|++.+.||+|+||.||+|.+. ++.||||++........ ....+..|+..++.++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34569999999999999999999763 46799999865421000 001233455556667899999
Q ss_pred EEeeeeecc----CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc--
Q 037068 753 LFMGAVTRS----PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-- 826 (967)
Q Consensus 753 kLig~~~~~----~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-- 826 (967)
++++++... ...+|||||+ +++|.+++......+++..++.|+.||+.||.|||++ ||+||||||+||||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH--EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeEEecCCHHHEEEecC
Confidence 999998764 4589999999 9999999987667899999999999999999999998 799999999999998
Q ss_pred CCCeEEEEecccccccccCcc-------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH
Q 037068 827 KNWVVKVCDFGLSRIKHHTYL-------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ 899 (967)
Q Consensus 827 ~~g~VKLsDFGLAr~~~~~~~-------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e 899 (967)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999986543321 1234459999999999999999999999999999999999999998643222
Q ss_pred HHhhhhcccccc---------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 900 VVGAVGFQNRRL---------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 900 i~~~i~~~~~~~---------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
............ -.+..+++++.++|..||+.+|.+||++.+|++.|..+.+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 111111000000 11256799999999999999999999999999999999876643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=386.55 Aligned_cols=260 Identities=20% Similarity=0.325 Sum_probs=220.6
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
+.++.+..++|++.+.||+|+||+||+++. +++.||||++.+... .......+.+|+.++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 445566779999999999999999999976 588999999865321 12233457889999999999999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.+.++|||||+++|+|.+++.+.+..+++..++.++.||+.||+|||++ ||+||||||+||||+.++++||+|||+++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999999986556799999999999999999999998 79999999999999999999999999998
Q ss_pred ccccCcc-CCCCCCCCCCccChhccc-------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC
Q 037068 841 IKHHTYL-SSKSTAGTPEWMAPEVLR-------NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE 912 (967)
Q Consensus 841 ~~~~~~~-~~~~~~GT~~YmAPE~l~-------g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ 912 (967)
....... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+........
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 6654322 234568999999999997 45689999999999999999999999999888777666643222233
Q ss_pred C---CCCCcHHHHHHHHHhhhcCCCCC---cCHHHHHHHH
Q 037068 913 I---PDDIDPAVAQIIRDCWQTEPHLR---PSFAQLMSRL 946 (967)
Q Consensus 913 i---p~~ls~eL~dLI~~CLq~dPe~R---PS~~ELLe~L 946 (967)
+ +..+++++.+||++||. +|.+| |++.++++|-
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 3 35799999999999999 99998 5999999884
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=354.91 Aligned_cols=253 Identities=29% Similarity=0.498 Sum_probs=224.0
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.+.|.+.+.||+|+||.||+|.+ .++.||||++.... .......+.+|+.+++.++||||+++++++.....+++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 36799999999999999999965 57899999986553 2345678999999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++.........
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999874 5699999999999999999999998 7999999999999999999999999999876655444
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. ......++..++..+.++|.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHHH
Confidence 556789999999999999999999999999999999999999999888776665543 3344556778999999999999
Q ss_pred hhcCCCCCcCHHHHHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~L~~L 949 (967)
|+.||.+|||+.+++++....
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHH
T ss_pred cCCChhhCcCHHHHhhChhhh
Confidence 999999999999999987544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.48 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=223.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
..++|.+.+.||+|+||.||++++. ++.||+|++..... .....+.+.+|+.++++++|+||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3478999999999999999999774 77899999876533 34456778999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 93 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999998865 45689999999999999999999998 79999999999999999999999999998765444
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. .....+|..+++.+.++|.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHHH
Confidence 44555779999999999999999999999999999999999999999887766655543 3345677889999999999
Q ss_pred HhhhcCCCCCcCHHHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+||+.||++|||+.+++++-.-
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHcccChhhCcCHHHHhhChhe
Confidence 9999999999999999998653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.43 Aligned_cols=262 Identities=27% Similarity=0.461 Sum_probs=218.3
Q ss_pred CCe-eEeEEeecCCceEEEEeec------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc--C
Q 037068 692 EDL-QIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS--P 762 (967)
Q Consensus 692 e~y-~i~k~LGeG~FG~VYka~~------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~--~ 762 (967)
++| ++.+.||+|+||+||++.+ +++.||||++... ........+.+|+.++++++||||+++++++... .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 444 9999999999999987743 4678999998654 3455667899999999999999999999999874 5
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+.+++|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred eEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 689999999999999999753 499999999999999999999998 7999999999999999999999999999876
Q ss_pred ccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH--------------HHhhhh
Q 037068 843 HHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ--------------VVGAVG 905 (967)
Q Consensus 843 ~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e--------------i~~~i~ 905 (967)
.... .......+|+.|+|||++.+..++.++|||||||++|+|+||..||....... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 5432 12334568889999999999999999999999999999999999987543211 011111
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcCCC
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSN 958 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~~~ 958 (967)
........+..+++++.+||.+||+.||++|||+.++++.|+.+.+.+....+
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 23445667788999999999999999999999999999999999888765443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=357.76 Aligned_cols=260 Identities=33% Similarity=0.552 Sum_probs=215.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC---CC--eEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH---GT--EVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~---g~--~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
+..++|++.+.||+|+||.||+|++. ++ .||||++..... .....+.+.+|+.++++++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 34579999999999999999999752 23 589998765432 2345678999999999999999999999998765
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 8999999999999999976556799999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCcc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCc
Q 037068 843 HHTYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 843 ~~~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls 918 (967)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.........+..++
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 43321 2234557889999999999989999999999999999999 9999999988887777765566667778899
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
+++.++|.+||+.||.+|||+.+++++|..+..
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 999999999999999999999999999988754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=359.40 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=214.0
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--C-------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--G-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT 759 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g-------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~ 759 (967)
+..++|.+.+.||+|+||.||+|.+. + ..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 34579999999999999999999763 2 46999987543 2345678899999999999999999999999
Q ss_pred ccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe--------E
Q 037068 760 RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV--------V 831 (967)
Q Consensus 760 ~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~--------V 831 (967)
..+..++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC--CeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999987666699999999999999999999998 7999999999999988876 9
Q ss_pred EEEecccccccccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhC-CCCCCCCChhHHHhhhhcccc
Q 037068 832 KVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNR 909 (967)
Q Consensus 832 KLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~ei~~~i~~~~~ 909 (967)
||+|||+++..... ....+|+.|+|||++.+ ..++.++|||||||++|||++| .+||...+........ ..
T Consensus 161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---ED 233 (289)
T ss_dssp EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HT
T ss_pred eeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---hc
Confidence 99999999754332 22347889999999987 6799999999999999999995 5666666655444332 23
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 910 ~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
...++...++++.++|.+||+.||.+|||+.+++++|+.+..
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 455667778899999999999999999999999999988743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.52 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=205.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~ 765 (967)
+..++|++.++||+|+||+||+|++ +++.||||++...............|+..+.++ +|+||+++++++.+.+.++
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 3447899999999999999999977 488999999866544445555566666666665 8999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+ +++|.+++...+..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999999 6689888877667799999999999999999999998 7999999999999999999999999999866543
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..||...... ..+........++..+++++.++|
T Consensus 211 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 211 G-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVL 285 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred C-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCCHHHHHHH
Confidence 2 2345679999999999886 6999999999999999999997666543322 222222223334567899999999
Q ss_pred HHhhhcCCCCCcCHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||+.||++|||+.++++|
T Consensus 286 ~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcCCChhhCcCHHHHHhC
Confidence 99999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=378.25 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=211.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHH-HHHcCCCceeEEeeeeeccCceE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEI-MLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~I-Lk~L~HpNIVkLig~~~~~~~l~ 765 (967)
..++|++.+.||+|+||+||++++ +++.||||++.+.... ......+..|..+ ++.++||||+++++++.+.+.++
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 347899999999999999999977 4778999998765432 2334556677776 46789999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+.+|+|..++.+ ...+++..++.++.||+.||+|||++ ||+||||||+||||+.++++||+|||+++.....
T Consensus 116 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999875 45689999999999999999999998 7999999999999999999999999999865544
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
........||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.. ....++..+++++.+||
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCSSSCHHHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHHHHH
Confidence 4456677899999999999999999999999999999999999999999888777766643 34567788999999999
Q ss_pred HHhhhcCCCCCcCH----HHHHHH
Q 037068 926 RDCWQTEPHLRPSF----AQLMSR 945 (967)
Q Consensus 926 ~~CLq~dPe~RPS~----~ELLe~ 945 (967)
.+||+.||.+||++ .++++|
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHcccCHHhCCCCCCCHHHHhCC
Confidence 99999999999986 466665
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.96 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=218.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh----hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG----DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~----~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|++.+.||+|+||.||++++ +++.||||++....... ...+.+.+|+.++++++||||+++++++.....+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46899999999999999999976 47899999987654322 2367789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC----eEEEEeccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW----VVKVCDFGLSR 840 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g----~VKLsDFGLAr 840 (967)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~--~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999976 45689999999999999999999998 799999999999999887 89999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCc
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDID 918 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls 918 (967)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+....... ..+..++
T Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 168 EIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp ECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred ecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 665432 2345679999999999999999999999999999999999999999888777666554222211 1235788
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+.+.++|.+||+.||++|||+.++++|-
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 9999999999999999999999999873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=369.95 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=201.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|++.+.||+|+||+||++++ +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 347999999999999999999977 578899999865432 235678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe--EEEEecccccccccC
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV--VKVCDFGLSRIKHHT 845 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~--VKLsDFGLAr~~~~~ 845 (967)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++. +||+|||+++.....
T Consensus 95 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~--~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 95 MEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999865 34699999999999999999999998 7999999999999987665 999999999754322
Q ss_pred ccCCCCCCCCCCccChhccccCCCCch-hHHHHHHHHHHHHHhCCCCCCCCChh----HHHhhhhccccccCCCCCCcHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEK-CDVYSFGVILWELATLSVPWKGLNPM----QVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~k-sDVWSLGvlL~ELlTGk~PF~~~~~~----ei~~~i~~~~~~~~ip~~ls~e 920 (967)
. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .....+.......+....++++
T Consensus 172 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 250 (361)
T 3uc3_A 172 S-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred C-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence 2 2345679999999999988888766 89999999999999999999875442 2233332222233333468999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+.+||.+||+.||++|||+.|+++|-.-
T Consensus 251 ~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 9999999999999999999999999654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=362.45 Aligned_cols=261 Identities=28% Similarity=0.474 Sum_probs=221.2
Q ss_pred hccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
+..++|++.+.||+|+||.||+|++ .+..||||++... ........+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 4558999999999999999999974 3567999998543 3455567889999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc---CCCeEE
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPN------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD---KNWVVK 832 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd---~~g~VK 832 (967)
...++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++ .+..+|
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999997543 4589999999999999999999998 799999999999998 445799
Q ss_pred EEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhcccc
Q 037068 833 VCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNR 909 (967)
Q Consensus 833 LsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~ 909 (967)
|+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|+| |..||......+....+. ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cCC
Confidence 99999997543322 12233557889999999999999999999999999999998 999999888777666554 444
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 910 RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 910 ~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
....+..+++.+.++|.+||+.||.+||++.+++++|+.+....
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 56677889999999999999999999999999999999987544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=365.38 Aligned_cols=256 Identities=26% Similarity=0.380 Sum_probs=211.7
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC---CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD---FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~---~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
...++|++.+.||+|+||.||+|.+ .+..||+|++.... ........+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3457899999999999999999966 57789999986532 234556789999999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCC---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 037068 764 FSILTEFLPRGSLYRLLHRP---------------------------------------NHQLDERRRMRMALDVAKGMN 804 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~---------------------------------------~~~Lse~~i~~I~~QIa~aL~ 804 (967)
.++||||+++|+|.+++... ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999988520 112467888999999999999
Q ss_pred HHHhcCCCeEEeccCCCcEEEcCCC--eEEEEecccccccccCc----cCCCCCCCCCCccChhcccc--CCCCchhHHH
Q 037068 805 YLHTSHPTIVHRDLKSPNLLVDKNW--VVKVCDFGLSRIKHHTY----LSSKSTAGTPEWMAPEVLRN--EPANEKCDVY 876 (967)
Q Consensus 805 YLHs~n~GIVHRDLKPsNILLd~~g--~VKLsDFGLAr~~~~~~----~~~~~~~GT~~YmAPE~l~g--~~~s~ksDVW 876 (967)
|||++ ||+||||||+||||+.++ .+||+|||+++...... .......||+.|+|||++.+ ..++.++|||
T Consensus 183 ~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 183 YLHNQ--GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHT--TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHC--CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 99998 799999999999998766 89999999998653321 12345679999999999975 6789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 877 SFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 877 SLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
||||++|||++|+.||......+....+.........+ ..+++++.+||.+||+.||.+||++.++++|-
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 99999999999999999988877766654433333333 34899999999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=377.15 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=215.7
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.+..++|++.+.||+|+||.||++++ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34558999999999999999999976 477899999865421 223456788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++++||+|||+++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999999976 45699999999999999999999998 799999999999999999999999999986644
Q ss_pred CccCCCCCCCCCCccChhcccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChh---HHHhhhhccccccCCCCCCc
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRN---EPANEKCDVYSFGVILWELATLSVPWKGLNPM---QVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g---~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~---ei~~~i~~~~~~~~ip~~ls 918 (967)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +....+ ......+|..++
T Consensus 168 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~s 244 (384)
T 4fr4_A 168 ET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWS 244 (384)
T ss_dssp TC-CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTSC
T ss_pred CC-ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcCC
Confidence 32 3456789999999999974 45899999999999999999999999754432 222222 234566788899
Q ss_pred HHHHHHHHHhhhcCCCCCcC-HHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPS-FAQLMSR 945 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS-~~ELLe~ 945 (967)
+++.+||.+||+.||.+||+ +.++++|
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 99999999999999999998 8888775
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=374.52 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=217.8
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 47899999999999999999976 47889999886432 334557889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC--CCeEEEEecccccccccCc
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK--NWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~--~g~VKLsDFGLAr~~~~~~ 846 (967)
||+.+|+|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++. .+.+||+|||+++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999999987666899999999999999999999998 7999999999999974 5789999999998765432
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc--ccCCCCCCcHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR--RLEIPDDIDPAVAQI 924 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~--~~~ip~~ls~eL~dL 924 (967)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..... ....+..+++++.+|
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 23345799999999999999999999999999999999999999999887766665543322 223345789999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L 946 (967)
|.+||+.||++|||+.++++|-
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 285 IKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp HHTTSCSSGGGSCCHHHHHTST
T ss_pred HHHHcCCChhHCcCHHHHhhCc
Confidence 9999999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.62 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=223.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
..++|.+.+.||+|+||.||++.+ .++.||+|++..... .....+.+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 347899999999999999999977 467899999876533 34556778999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 119 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999998875 35689999999999999999999998 79999999999999999999999999998765444
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. .....+|..+++++.+||.
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 273 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQ 273 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHHHH
Confidence 44556779999999999999999999999999999999999999999887766655543 2345677889999999999
Q ss_pred HhhhcCCCCCcCHHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+||+.||++|||+.++++|-.
T Consensus 274 ~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 274 KMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp HHTCSSGGGSCCGGGGGGSHH
T ss_pred HHccCChhHCcCHHHHhcCcc
Confidence 999999999999999999854
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=366.98 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=200.4
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
...++|++.+.||+|+||+||+|.+ +++.||||++............+.+|+.++++++||||+++++++.....++|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457999999999999999999965 58899999987655444455677899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE-----cCCCeEEEEecccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV-----DKNWVVKVCDFGLSRI 841 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL-----d~~g~VKLsDFGLAr~ 841 (967)
||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +..+.+||+|||+++.
T Consensus 111 v~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999974 99999876 44699999999999999999999998 79999999999999 4556799999999987
Q ss_pred cccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc-----------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR----------- 909 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~----------- 909 (967)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.....
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 65444444556789999999999875 489999999999999999999999998877655444321100
Q ss_pred -----ccCC------------CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 -----RLEI------------PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 -----~~~i------------p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.... +..+++++.+||.+||+.||++|||+.|+++|-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 0001 112678999999999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.93 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=206.5
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC---ChhhHHHHHHHHHHHHHc---CCCceeEEeeeeec
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF---SGDSLSQFKCEAEIMLRL---RHPNVVLFMGAVTR 760 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~---s~~~~~~~~~Ei~ILk~L---~HpNIVkLig~~~~ 760 (967)
...++|++.+.||+|+||+||+|++ +++.||||++..... .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4468999999999999999999985 588999999864332 112234566777777766 49999999999976
Q ss_pred cC-----ceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEE
Q 037068 761 SP-----HFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVC 834 (967)
Q Consensus 761 ~~-----~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLs 834 (967)
.. .+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCEEEe
Confidence 54 4899999997 59999887643 3499999999999999999999998 79999999999999999999999
Q ss_pred ecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc---c
Q 037068 835 DFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR---L 911 (967)
Q Consensus 835 DFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~---~ 911 (967)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...... .
T Consensus 163 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999998664432 234567899999999999999999999999999999999999999988876655443211000 0
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 912 ----------------------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 912 ----------------------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.....+++++.+||.+||+.||++|||+.|+++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 01235789999999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.17 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=216.4
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh----hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG----DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~----~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|.+.+.||+|+||.||++++ +++.||+|++....... ...+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 36799999999999999999977 47899999987654322 2367889999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC----eEEEEeccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW----VVKVCDFGLSR 840 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g----~VKLsDFGLAr 840 (967)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++
T Consensus 84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999865 45689999999999999999999998 799999999999998877 89999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCc
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDID 918 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls 918 (967)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......+....+....... ..+..++
T Consensus 161 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 161 KIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp ECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 654432 2344578999999999999999999999999999999999999999988776665554222211 2235788
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHH--HHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRL--RCLQR 951 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L--~~L~~ 951 (967)
+.+.++|.+||+.||.+|||+.++++|- +.+++
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 9999999999999999999999999973 44443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=372.54 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=201.5
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccC--ce
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSP--HF 764 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~--~l 764 (967)
..++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++++. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357999999999999999999965 5889999998765555666778889999999997 999999999997543 68
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+. ++|..++.. ..+++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++....
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999997 589998875 4689999999999999999999998 799999999999999999999999999986532
Q ss_pred C---------------------ccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHh
Q 037068 845 T---------------------YLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVG 902 (967)
Q Consensus 845 ~---------------------~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~ 902 (967)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 111234579999999999987 678999999999999999999999999887765554
Q ss_pred hhhcccc---------------------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCc
Q 037068 903 AVGFQNR---------------------------------------------RLEIPDDIDPAVAQIIRDCWQTEPHLRP 937 (967)
Q Consensus 903 ~i~~~~~---------------------------------------------~~~ip~~ls~eL~dLI~~CLq~dPe~RP 937 (967)
.+..... ....+..+++++.+||.+||+.||++||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 4321000 0011236789999999999999999999
Q ss_pred CHHHHHHH
Q 037068 938 SFAQLMSR 945 (967)
Q Consensus 938 S~~ELLe~ 945 (967)
|+.|+++|
T Consensus 322 t~~e~l~H 329 (388)
T 3oz6_A 322 SANDALKH 329 (388)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhCC
Confidence 99999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=367.61 Aligned_cols=249 Identities=29% Similarity=0.419 Sum_probs=215.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|.+.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5699999999999999999975 588899999876533 2344567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+. |+|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 9997 578888765567799999999999999999999998 799999999999999999999999999976543
Q ss_pred CCCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||...+.......+.........+..+++.+.+||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 23467999999999985 567899999999999999999999999988876665555433333344567899999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.+||+.||++|||+.++++|..
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHcccChhhCcCHHHHhhChh
Confidence 9999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=366.65 Aligned_cols=265 Identities=27% Similarity=0.439 Sum_probs=214.2
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
.+.+++...++|.+.+.||+|+||.||+|+. +++.||||++...... .....+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 4567788889999999999999999999976 4788999998654322 2223688999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhc-CCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPN---HQLDERRRMRMALDVAKGMNYLHTS-HPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~---~~Lse~~i~~I~~QIa~aL~YLHs~-n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
+..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ .+||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999997643 3499999999999999999999997 2359999999999999999999999999
Q ss_pred cccccccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hhHHHhhhh---cc-
Q 037068 838 LSRIKHHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN-----PMQVVGAVG---FQ- 907 (967)
Q Consensus 838 LAr~~~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~-----~~ei~~~i~---~~- 907 (967)
+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+. ..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 998664332 22344569999999999999999999999999999999999999996211 000111110 00
Q ss_pred --------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 908 --------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 908 --------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
......+...++.+.+++.+||+.||.+|||+.+++++|+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00111222345789999999999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=374.66 Aligned_cols=262 Identities=31% Similarity=0.537 Sum_probs=214.4
Q ss_pred CCeeEeEEeecCCceEEEEeecC---C--CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-cCceE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH---G--TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-SPHFS 765 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~---g--~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-~~~l~ 765 (967)
..|.+.+.||+|+||+||+|++. + ..||||.+... ......+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 35788999999999999999752 2 35889987543 344567789999999999999999999998654 56789
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+.+|+|.+++......+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC--CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999988777899999999999999999999998 7999999999999999999999999999865432
Q ss_pred cc----CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 846 YL----SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 846 ~~----~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.. ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+. .......|..+++.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 21 1233457889999999999999999999999999999999 688898877666555443 44566677889999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcCC
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRS 957 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~~ 957 (967)
+.++|.+||+.+|++|||+.+++++|..+...+..+.
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 9999999999999999999999999999987765443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=353.69 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=213.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec----cCc
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR----SPH 763 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~----~~~ 763 (967)
....|.+.+.||+|+||.||+|.+ .+..||+|++............+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 446789999999999999999976 46789999998776677778889999999999999999999998865 345
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEEEeccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIK 842 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKLsDFGLAr~~ 842 (967)
+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 8999999999999999975 3568999999999999999999999833399999999999997 7899999999999755
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhccccccCCCCCCcHHH
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .....+.........+...++++
T Consensus 183 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 183 RAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp CTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred ccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 433 2334679999999998875 5899999999999999999999999875543 33333332333344556778999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.++|.+||+.||.+|||+.++++|-
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHccCChhhCCCHHHHhhCc
Confidence 9999999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.11 Aligned_cols=253 Identities=25% Similarity=0.458 Sum_probs=220.0
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.+..++|++.+.||+|+||.||+|++. ++.||||++...... ......+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 445579999999999999999999774 678999998653211 22346788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHER--KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999999875 34689999999999999999999998 799999999999999999999999999975543
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. .....+|..+++++.++
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHHH
Confidence 2 2345679999999999999999999999999999999999999999887766655543 33456778899999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
|.+||+.||.+||++.++++|-.
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHH
T ss_pred HHHHhhcCHhhCCCHHHHhhCHH
Confidence 99999999999999999999854
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=363.21 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=208.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc---
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH--- 763 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~--- 763 (967)
..++|++.+.||+|+||.||++++ .++.||||++..... .......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 458999999999999999999975 578899999876533 33456678999999999999999999999876554
Q ss_pred -eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 764 -FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 764 -l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 4999999999999999875 35699999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCC
Q 037068 843 HHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDI 917 (967)
Q Consensus 843 ~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~l 917 (967)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||................... ..+..+
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 4332 12334568999999999999999999999999999999999999999888766654443222211 123568
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHH-HHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMS-RLRCLQ 950 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe-~L~~L~ 950 (967)
++++.++|.+||+.||++||+..+++. .+..+.
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 999999999999999999997665554 455543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=393.15 Aligned_cols=261 Identities=33% Similarity=0.583 Sum_probs=228.4
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecCC-CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWHG-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g-~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
...|++..++|++.++||+|+||.||+|.+.+ ..||||++..... ..+.+.+|+.+|++++|+||+++++++.. +
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 35688889999999999999999999998864 5799999865432 34678999999999999999999999876 6
Q ss_pred ceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.++|||||+.+|+|.+++... ...+++..++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+++.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 789999999999999999752 35689999999999999999999998 799999999999999999999999999986
Q ss_pred cccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 842 KHHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 842 ~~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
..... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....++...+. .+.+...+..+++
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 491 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 64322 22334557889999999999999999999999999999999 999999988887776664 4556777889999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999999999999987643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.99 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=215.1
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||.||+|.+. +..+|+|++..... ...+.+.+|+.++++++||||+++++++......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 368999999999999999999774 56899999876432 34567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE---cCCCeEEEEecccccccccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL---d~~g~VKLsDFGLAr~~~~~ 845 (967)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999998865 45689999999999999999999998 79999999999999 78899999999999866543
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC----CCCcHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP----DDIDPAV 921 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip----~~ls~eL 921 (967)
. ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+... ....+ ..+++.+
T Consensus 163 ~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 163 K-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQA 238 (277)
T ss_dssp S-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHH
T ss_pred c-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHH
Confidence 2 34456799999999998765 899999999999999999999999998877766655432 22233 2689999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.++|.+||+.||++|||+.++++|-.
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHH
Confidence 99999999999999999999999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=358.88 Aligned_cols=260 Identities=31% Similarity=0.559 Sum_probs=209.0
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc--CCCceeEEeeeeecc---
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL--RHPNVVLFMGAVTRS--- 761 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L--~HpNIVkLig~~~~~--- 761 (967)
.....++|++.+.||+|+||.||+|+++++.||||++... .......|.+++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3445589999999999999999999999999999998542 233445566666554 899999999998876
Q ss_pred -CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCeEEeccCCCcEEEcCCCeEEEE
Q 037068 762 -PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS------HPTIVHRDLKSPNLLVDKNWVVKVC 834 (967)
Q Consensus 762 -~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~------n~GIVHRDLKPsNILLd~~g~VKLs 834 (967)
..+++||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++ .+||+||||||+|||++.++.+||+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 679999999999999999975 3699999999999999999999987 3369999999999999999999999
Q ss_pred ecccccccccCccC----CCCCCCCCCccChhccccCCCCch------hHHHHHHHHHHHHHhC----------CCCCCC
Q 037068 835 DFGLSRIKHHTYLS----SKSTAGTPEWMAPEVLRNEPANEK------CDVYSFGVILWELATL----------SVPWKG 894 (967)
Q Consensus 835 DFGLAr~~~~~~~~----~~~~~GT~~YmAPE~l~g~~~s~k------sDVWSLGvlL~ELlTG----------k~PF~~ 894 (967)
|||+++........ .....||+.|+|||++.+..++.+ +|||||||++|||+|| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99999765433221 235679999999999988766654 9999999999999999 677765
Q ss_pred CCh-----hHHHhhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 895 LNP-----MQVVGAVGFQNRRLEIPD-----DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 895 ~~~-----~ei~~~i~~~~~~~~ip~-----~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
... ......+........+|. .+++++.++|.+||+.||.+|||+.+++++|+.+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 422 222222322333344443 56778999999999999999999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.45 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=201.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP------ 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~------ 762 (967)
.++|++.+.||+|+||.||+|++ +++.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 36899999999999999999977 58899999987543 3445678999999999999999999999886543
Q ss_pred ---------------------------------------------------ceEEEEeecCCCchhhhhcCCC--CCCCH
Q 037068 763 ---------------------------------------------------HFSILTEFLPRGSLYRLLHRPN--HQLDE 789 (967)
Q Consensus 763 ---------------------------------------------------~l~LVmEy~~gGsL~~lL~~~~--~~Lse 789 (967)
.+++||||+.+++|.+++.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 2799999999999999997643 23566
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc------------cCCCCCCCCCC
Q 037068 790 RRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY------------LSSKSTAGTPE 857 (967)
Q Consensus 790 ~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~------------~~~~~~~GT~~ 857 (967)
..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++...... .......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHhC--CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 77899999999999999998 79999999999999999999999999998765432 22344679999
Q ss_pred ccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCc
Q 037068 858 WMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRP 937 (967)
Q Consensus 858 YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RP 937 (967)
|+|||++.+..++.++|||||||++|||++|..|+... ......+. .......+...++++.++|.+||+.||++||
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 99999999999999999999999999999987764321 11111111 1111112234578889999999999999999
Q ss_pred CHHHHHHH
Q 037068 938 SFAQLMSR 945 (967)
Q Consensus 938 S~~ELLe~ 945 (967)
|+.|+++|
T Consensus 319 s~~~~l~~ 326 (332)
T 3qd2_B 319 EATDIIEN 326 (332)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhhc
Confidence 99999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.49 Aligned_cols=259 Identities=29% Similarity=0.460 Sum_probs=217.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee--ccC
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT--RSP 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~--~~~ 762 (967)
.++|++.+.||+|+||.||++++ .++.||||++... .....+.+.+|+.++++++|+||+++++++. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 37999999999999999999973 4678999998653 3455677899999999999999999999886 455
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+++++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR--RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 68999999999999999976556799999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH--------------HHhhhh
Q 037068 843 HHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ--------------VVGAVG 905 (967)
Q Consensus 843 ~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e--------------i~~~i~ 905 (967)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 4322 12344568889999999999999999999999999999999999986543321 111112
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
........+..+++++.++|.+||+.||++|||+.+++++|+.+....
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 244556678889999999999999999999999999999999886544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.14 Aligned_cols=246 Identities=21% Similarity=0.326 Sum_probs=211.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.++..+ +||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 47899999999999999999977 488999999887655555667888999999999 999999999999999999999
Q ss_pred EeecCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-----------------
Q 037068 768 TEFLPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK----------------- 827 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~----------------- 827 (967)
|||+++++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC--CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999998753 25689999999999999999999998 7999999999999984
Q ss_pred --CCeEEEEecccccccccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhh
Q 037068 828 --NWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV 904 (967)
Q Consensus 828 --~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i 904 (967)
...+||+|||+++..... ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+....... .+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HH
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HH
Confidence 448999999999866543 234589999999999876 56789999999999999999998776543322 22
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 905 GFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 905 ~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.......+|..+++++.++|.+||+.||++|||+.++++|-
T Consensus 241 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 241 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp -HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred -HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 13444567788999999999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=370.59 Aligned_cols=253 Identities=20% Similarity=0.336 Sum_probs=212.5
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC--CCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR--HPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~--HpNIVkLig~~~~~~~l~L 766 (967)
...+|.+.+.||+|+||.||++.+ .++.||||++............+.+|+.+++++. |+||+++++++...+.++|
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 446799999999999999999976 4788999999876666677788999999999996 5999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||| +.+++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||||+ ++.+||+|||+++......
T Consensus 134 v~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 5688999999763 4789999999999999999999998 799999999999996 5799999999998764332
Q ss_pred --cCCCCCCCCCCccChhcccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHhhhhccccccC
Q 037068 847 --LSSKSTAGTPEWMAPEVLRN-----------EPANEKCDVYSFGVILWELATLSVPWKGLNP-MQVVGAVGFQNRRLE 912 (967)
Q Consensus 847 --~~~~~~~GT~~YmAPE~l~g-----------~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~-~ei~~~i~~~~~~~~ 912 (967)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 12345679999999999875 4689999999999999999999999987543 233333433445566
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+|...++++.+||.+||+.||.+|||+.|+++|..
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 77788999999999999999999999999998854
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=361.99 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=212.7
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-----CCceeEEe
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-----HPNVVLFM 755 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-----HpNIVkLi 755 (967)
.+.+.....++|.+.++||+|+||+||+|++ .++.||||++.. .......+..|+.+++.+. ||||++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 4455667779999999999999999999987 578899999853 2344566788999999996 99999999
Q ss_pred eeeeccCceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-------
Q 037068 756 GAVTRSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK------- 827 (967)
Q Consensus 756 g~~~~~~~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~------- 827 (967)
+++...+.+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM--SLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCTTCCEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCcccEEEccccccccc
Confidence 9999999999999999 889999987643 4699999999999999999999998 7999999999999975
Q ss_pred ------------------CCeEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCC
Q 037068 828 ------------------NWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS 889 (967)
Q Consensus 828 ------------------~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk 889 (967)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 789999999999865432 34567899999999999999999999999999999999999
Q ss_pred CCCCCCChhHHHhhhhcccc------------------------ccCCCC--------------------CCcHHHHHHH
Q 037068 890 VPWKGLNPMQVVGAVGFQNR------------------------RLEIPD--------------------DIDPAVAQII 925 (967)
Q Consensus 890 ~PF~~~~~~ei~~~i~~~~~------------------------~~~ip~--------------------~ls~eL~dLI 925 (967)
.||...+..+....+..... ...+|. ..++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 99998776654433321100 011111 1237788999
Q ss_pred HHhhhcCCCCCcCHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||+.||.+|||+.|+|+|
T Consensus 337 ~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhcCChhhCCCHHHHhcC
Confidence 99999999999999999976
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=366.57 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=198.0
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
....++|.+.+.||+|+||.||+|++. ++.||||++.... ..+.+.+|+.++++++||||+++++++......+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 345578999999999999999999874 6789999986532 2356788999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---CCeEEEEeccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---NWVVKVCDFGLSRIK 842 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~---~g~VKLsDFGLAr~~ 842 (967)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+++..
T Consensus 125 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999999876 45689999999999999999999998 7999999999999975 889999999999865
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH-HHhhhhcccccc--CCCCCCcH
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ-VVGAVGFQNRRL--EIPDDIDP 919 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e-i~~~i~~~~~~~--~ip~~ls~ 919 (967)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+....... +....++.
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 202 EHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred Cccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 4432 2345679999999999999999999999999999999999999998766544 333332222211 23357899
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
++.+||.+||+.||++|||+.++++|
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.42 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=199.4
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
+++..++|++.+.||+|+||.||++++ +++.||||++............+..+..+++.++||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 345668999999999999999999977 688899999865543333344455555567788999999999999999999
Q ss_pred EEEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 765 SILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
++||||+++ +|.+++.. ....+++..++.++.||+.||.|||++. ||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-SVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS-CCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-CeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999999974 88777643 4567999999999999999999999962 599999999999999999999999999986
Q ss_pred cccCccCCCCCCCCCCccChhcc----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHhhhhccccccCCCCC
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVL----RNEPANEKCDVYSFGVILWELATLSVPWKGLN-PMQVVGAVGFQNRRLEIPDD 916 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l----~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~-~~ei~~~i~~~~~~~~ip~~ 916 (967)
..... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.... .................+..
T Consensus 160 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 160 LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred ccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 55432 23345799999999996 56678999999999999999999999998643 33333333222223333457
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+++++.++|.+||+.||++|||+.++++|-.-
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence 89999999999999999999999999997543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=370.70 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=210.0
Q ss_pred CeeE--eEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 693 DLQI--GERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 693 ~y~i--~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.|.+ .+.||+|+||.||+|++ .++.||+|++.... ....+.+.+|+.++++++||||+++++++...+.++|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3444 67899999999999976 58899999986542 345677899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE--cCCCeEEEEecccccccccCc
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV--DKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL--d~~g~VKLsDFGLAr~~~~~~ 846 (967)
||+++++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++......
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999999998876566799999999999999999999998 79999999999999 567899999999998765433
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCcHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDIDPAVAQI 924 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls~eL~dL 924 (967)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+ .....+++++.+|
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence 2344579999999999999999999999999999999999999999988777666554332222 2235689999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L 946 (967)
|.+||+.||.+|||+.|+++|-
T Consensus 323 i~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 323 ISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHcCCChhhCCCHHHHhcCc
Confidence 9999999999999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=394.02 Aligned_cols=263 Identities=26% Similarity=0.460 Sum_probs=222.8
Q ss_pred hhhccCCeeEe-EEeecCCceEEEEeec----CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 687 WEILWEDLQIG-ERIGIGSYGEVYRADW----HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 687 ~ei~~e~y~i~-k~LGeG~FG~VYka~~----~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
+.+....+.+. ++||+|+||.||+|.+ .++.||||++..........+.+.+|+.++++++||||+++++++..
T Consensus 363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA- 441 (635)
T ss_dssp SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 34444555554 4899999999999954 35679999987655555667889999999999999999999999864
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
+.++|||||+.+|+|.+++.. ...+++..++.|+.||+.||.|||++ |||||||||+||||+.++.+||+|||+++.
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~--~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHC--CEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 568999999999999999975 45699999999999999999999998 799999999999999999999999999986
Q ss_pred cccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 842 KHHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 842 ~~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+. .......|..+
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 597 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGC 597 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 54322 12233456789999999999999999999999999999998 999999998887776664 45567788899
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
++++.+||.+||+.||++||++.+|++.|+.+...+.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999999876654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=348.51 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=213.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeee-eccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV-TRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~-~~~~~l~L 766 (967)
..++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+|+.+++.++|++++..+.++ ......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 347999999999999999999984 688999999865432 23578899999999988876666655 55667899
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE---cCCCeEEEEecccccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL---d~~g~VKLsDFGLAr~~~ 843 (967)
||||+ +++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999 8999999986667899999999999999999999998 79999999999999 488999999999998655
Q ss_pred cCcc-------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh---HHHhhhhc---cccc
Q 037068 844 HTYL-------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM---QVVGAVGF---QNRR 910 (967)
Q Consensus 844 ~~~~-------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~---ei~~~i~~---~~~~ 910 (967)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 4322 234567999999999999999999999999999999999999999875432 22222211 1111
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 911 ~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
...+..+++++.++|.+||+.||.+|||+.++++.|+.+......
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 123467899999999999999999999999999999999776643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=348.73 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=209.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeee-eccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV-TRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~-~~~~~l~L 766 (967)
..++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.+++.++|++++..+.++ ......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 347899999999999999999974 6889999987554322 3467899999999888777666655 56677899
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE---cCCCeEEEEecccccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL---d~~g~VKLsDFGLAr~~~ 843 (967)
||||+ +++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99999 9999999986667799999999999999999999999 79999999999999 788999999999998654
Q ss_pred cCcc-------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH---HHhhhhc---cccc
Q 037068 844 HTYL-------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ---VVGAVGF---QNRR 910 (967)
Q Consensus 844 ~~~~-------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e---i~~~i~~---~~~~ 910 (967)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 4321 2345679999999999999999999999999999999999999998754321 1111111 1111
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 911 ~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
......+++++.++|.+||+.+|++|||+.++++.|+.+.+....
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 122367899999999999999999999999999999999876653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.14 Aligned_cols=254 Identities=24% Similarity=0.475 Sum_probs=211.9
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.+..++|.+.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 44568999999999999999999976 488999999865321 123456788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH--CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999875 34689999999999999999999999 799999999999999999999999999986654
Q ss_pred CccCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
.. ......+|+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+. .....+|..++..+.+
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVAT 240 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHHH
Confidence 32 2344578999999999988775 689999999999999999999999887776665553 2344567889999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+|.+||+.||.+|||+.++++|-.
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHccCChhhCCCHHHHHhChh
Confidence 999999999999999999999843
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=363.55 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=209.9
Q ss_pred cCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||.||++++. ++.||||++............+.+|+.++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 478999999999999999999774 789999998776655566677889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+++|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++........
T Consensus 104 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 104 EFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp ECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC--CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 99999999888765 45699999999999999999999998 7999999999999999999999999999876554444
Q ss_pred CCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-------------------cc
Q 037068 849 SKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-------------------QN 908 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-------------------~~ 908 (967)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.. ..
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 5567799999999999876 689999999999999999999999998876554333211 00
Q ss_pred cccC----------CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 909 RRLE----------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 909 ~~~~----------ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
...+ ....+++++.+||.+||+.||++|||+.|+++|-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000 1135789999999999999999999999999984
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=352.90 Aligned_cols=249 Identities=25% Similarity=0.456 Sum_probs=208.8
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|.+.+.||+|+||.||++++ .+..+|+|++.... .....+.+.+|+.++++++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 7899999999999999999976 47889999987653 33346788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE---cCCCeEEEEecccccccc
Q 037068 770 FLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 770 y~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL---d~~g~VKLsDFGLAr~~~ 843 (967)
|+.+++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998853 246799999999999999999999998 79999999999999 456889999999998654
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCC-CCCCcHHHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI-PDDIDPAVA 922 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~i-p~~ls~eL~ 922 (967)
... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+....+......... ...+++++.
T Consensus 179 ~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred Ccc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 432 234567999999999986 46899999999999999999999999998877766655433332222 234789999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
++|.+||+.||++|||+.|+++|
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=355.22 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=213.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
...++|.+.+.||+|+||.||+|.+. ++.||||++.... ....+.+|+.++++++||||+++++++...+.+++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34578999999999999999999764 8899999986542 34568889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999999875567799999999999999999999998 79999999999999999999999999998766554
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI 925 (967)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... ......+..+++.+.++|
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 4455667999999999999999999999999999999999999999988776554443221 223344566899999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~L 946 (967)
.+||..||.+|||+.++++|-
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTTSH
T ss_pred HHHccCChhhCcCHHHHHhCH
Confidence 999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.88 Aligned_cols=253 Identities=28% Similarity=0.459 Sum_probs=209.3
Q ss_pred EeEEeecCCceEEEEeecCCCeEEEEEeecCC--CChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 696 IGERIGIGSYGEVYRADWHGTEVAVKKFLDQD--FSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~--~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
..+.||+|+||.||+|..+++.||||++.... ........+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 114 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114 (307)
T ss_dssp TCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred cCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence 34899999999999999999999999986542 2234567899999999999999999999999999999999999999
Q ss_pred CchhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--cCC
Q 037068 774 GSLYRLLHRP--NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSS 849 (967)
Q Consensus 774 GsL~~lL~~~--~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~ 849 (967)
++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 9999998642 35689999999999999999999998 79999999999999999999999999998654322 123
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhh----hcc---------ccccCCCCC
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV----GFQ---------NRRLEIPDD 916 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i----~~~---------~~~~~ip~~ 916 (967)
....||+.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+ ... ......+..
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence 44679999999999876 4889999999999999999999999875543221111 100 011122334
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
.++.+.+++.+||+.+|.+|||+.+++++|+.+.+
T Consensus 272 ~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 56789999999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=366.85 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=203.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|.+.+.||+|+||.||+|++ +++.||||++..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 6899999999999999999976 478899999864321 1111234579999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+. ++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 997 589988887677799999999999999999999998 79999999999999999999999999998665444444
Q ss_pred CCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc------------------
Q 037068 850 KSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR------------------ 910 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~------------------ 910 (967)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 55678999999999977 56899999999999999999999999988876655443210000
Q ss_pred ----------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 911 ----------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 911 ----------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
...+..+++++.+||.+||+.||.+|||+.|+++|-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 0112357889999999999999999999999999843
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=383.68 Aligned_cols=253 Identities=25% Similarity=0.487 Sum_probs=221.7
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
...++|.+.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.++||||+++++++...+.++
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3458999999999999999999976 5889999998654221 234567899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 93 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999976 45699999999999999999999998 7999999999999999999999999999876543
Q ss_pred ccCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
. ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+. ......|..+++++.+|
T Consensus 170 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~L 246 (476)
T 2y94_A 170 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPSVISL 246 (476)
T ss_dssp C-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHHHHHH
T ss_pred c-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHHHHHH
Confidence 2 2445689999999999998875 789999999999999999999999887776666553 23456678899999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
|.+||+.||.+|||+.++++|-.
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHHcCCCchhCcCHHHHHhCHH
Confidence 99999999999999999999854
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=357.55 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=209.6
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeec--
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTR-- 760 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~-- 760 (967)
.+....++|++.+.||+|+||.||+|++ .++.||||++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3445668999999999999999999987 68899999986543 2346788999999999 89999999999976
Q ss_pred ----cCceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEe
Q 037068 761 ----SPHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835 (967)
Q Consensus 761 ----~~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsD 835 (967)
...+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEECC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999998753 35689999999999999999999998 799999999999999999999999
Q ss_pred cccccccccCccCCCCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc
Q 037068 836 FGLSRIKHHTYLSSKSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR 910 (967)
Q Consensus 836 FGLAr~~~~~~~~~~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~ 910 (967)
||++..............||+.|+|||++. +..++.++|||||||++|+|++|..||...........+......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 999987654433345567999999999997 567899999999999999999999999988876665544333333
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 911 ~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
...+..+++.+.++|.+||..||.+||++.++++|-
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 334567899999999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=362.78 Aligned_cols=255 Identities=23% Similarity=0.262 Sum_probs=208.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh---hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG---DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~---~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
..++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 347899999999999999999977 47899999986532221 1224678899999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+.+ +|..++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999986 89888887667799999999999999999999998 799999999999999999999999999987665
Q ss_pred CccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc-------------
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR------------- 910 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~------------- 910 (967)
.........||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+......
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 54445567899999999999764 5899999999999999999999999988776554443211000
Q ss_pred --------cC-----CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 911 --------LE-----IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 911 --------~~-----ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.. +...+++++.+||.+||+.||.+|||+.|+++|-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00 11456789999999999999999999999999853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=359.99 Aligned_cols=258 Identities=23% Similarity=0.368 Sum_probs=218.3
Q ss_pred hhhhccCCeeEe-EEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeecc
Q 037068 686 EWEILWEDLQIG-ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRS 761 (967)
Q Consensus 686 ~~ei~~e~y~i~-k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~ 761 (967)
..+.+.++|.+. +.||+|+||.||++.+ +++.||||++............+.+|+.+++.+ +||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556788887 8999999999999976 488999999877655555677899999999999 579999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---CCeEEEEecc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---NWVVKVCDFG 837 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~---~g~VKLsDFG 837 (967)
+.+++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~--givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 9999999999999999998653 46799999999999999999999998 7999999999999987 7899999999
Q ss_pred cccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc--ccCCCC
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR--RLEIPD 915 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~--~~~ip~ 915 (967)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..... ....+.
T Consensus 180 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 180 MSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp GCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred cccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 998765432 23456799999999999999999999999999999999999999999887766555443222 223445
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.+++.+.++|.+||+.||.+|||+.++++|-
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 7899999999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=364.44 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=215.2
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
++..++|++.+.||+|+||.||++.+. +..||+|++... ........+.+|+.++++++||||+++++++...+.++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 345689999999999999999999874 788999998654 34556678999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHH-CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhC-CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999999976 346899999999999999999999853 6999999999999999999999999999765432
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh--------------------
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG-------------------- 905 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~-------------------- 905 (967)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2344679999999999999999999999999999999999999998876554322211
Q ss_pred ---------------------ccccccCC-CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 906 ---------------------FQNRRLEI-PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 906 ---------------------~~~~~~~i-p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
........ +..+++++.+||.+||+.||++|||+.++++|-.-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 01111122 23578999999999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=355.08 Aligned_cols=252 Identities=31% Similarity=0.514 Sum_probs=211.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|++.+.||+|+||.||+|++. ++.||+|++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4478999999999999999999874 788999987643 234567888999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+.+++|..++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 999999999999876567799999999999999999999998 799999999999999999999999999865433322
Q ss_pred CCCCCCCCCCccChhcc-----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-cccCCCCCCcHHH
Q 037068 848 SSKSTAGTPEWMAPEVL-----RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-RRLEIPDDIDPAV 921 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l-----~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-~~~~ip~~ls~eL 921 (967)
......||+.|+|||++ .+..++.++||||||+++|+|++|+.||...+.......+.... .....+..++.++
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence 34456799999999998 46678999999999999999999999999988766655443222 2233456789999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.++|.+||+.||.+|||+.++++|
T Consensus 253 ~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHcccChhhCCCHHHHhcC
Confidence 999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=381.09 Aligned_cols=253 Identities=29% Similarity=0.430 Sum_probs=213.6
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|++.+.||+|+||+||+|++ .+..||||++............+.+|+.+++.++||||+++++++.....+++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 346899999999999999999977 477899999987655555567889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---CCeEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---NWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~---~g~VKLsDFGLAr~~~~ 844 (967)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+++....
T Consensus 115 ~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988865 35699999999999999999999998 7999999999999975 45699999999987654
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCC--CCCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI--PDDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~i--p~~ls~eL~ 922 (967)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......... ...+++.+.
T Consensus 192 ~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 192 QK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred Cc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 32 244567999999999986 46999999999999999999999999999888877766544333322 257899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+||++||+.||.+|||+.++++|-.
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCcc
Confidence 9999999999999999999999843
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=366.11 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=211.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~L 766 (967)
..++|++.+.||+|+||+||++.+ +++.||||++...... ..+|++++.++ +||||+++++++.+...+++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 347899999999999999999976 4788999998654322 34588888888 79999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC----CeEEEEeccccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN----WVVKVCDFGLSRIK 842 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~----g~VKLsDFGLAr~~ 842 (967)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+... +.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~--givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999999876 45699999999999999999999998 79999999999998533 35999999999876
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChhHHHhhhhcccccc--CCCCCC
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL---NPMQVVGAVGFQNRRL--EIPDDI 917 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~---~~~ei~~~i~~~~~~~--~ip~~l 917 (967)
...........||+.|+|||++.+..++.++|||||||++|||++|..||... ...++...+....... ..+..+
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 55544455678999999999999888999999999999999999999999863 3444554443222222 234678
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
++++.+||++||+.||++||++.++++|-.-.
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 99999999999999999999999999987653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=381.69 Aligned_cols=252 Identities=31% Similarity=0.496 Sum_probs=216.8
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||+||++++ +++.||||++............+.+|+.++++++||||+++++++.....+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 4889999998654333344677899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc---CCCeEEEEecccccccccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD---KNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd---~~g~VKLsDFGLAr~~~~~ 845 (967)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999988865 35699999999999999999999998 799999999999995 4568999999999866543
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC--CCCcHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQ 923 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~eL~d 923 (967)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.........| ..+++++.+
T Consensus 178 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 178 T-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred C-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence 2 2445679999999999986 49999999999999999999999999988887777665443333333 468999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
||.+||+.||.+|||+.++++|-.
T Consensus 256 li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred HHHHHcCCChhhCcCHHHHhcCHh
Confidence 999999999999999999999854
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=361.51 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=209.9
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-------- 760 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-------- 760 (967)
.++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 37899999999999999999976 57899999987665555555678899999999999999999999876
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.+.+++||||+.+ +|...+......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 3468999999975 78777777667799999999999999999999998 79999999999999999999999999998
Q ss_pred ccccC----ccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CC
Q 037068 841 IKHHT----YLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EI 913 (967)
Q Consensus 841 ~~~~~----~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~i 913 (967)
..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+....... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 65422 1223446789999999999764 58999999999999999999999999888766554443111100 00
Q ss_pred CCC----------------------------CcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 914 PDD----------------------------IDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 914 p~~----------------------------ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
... .++.+.+||.+||+.||++|||+.|+++|-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 000 267899999999999999999999999984
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=345.61 Aligned_cols=252 Identities=27% Similarity=0.342 Sum_probs=212.3
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 36899999999999999999976 488999999865432 344577899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc--
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-- 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-- 846 (967)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999875 45699999999999999999999998 79999999999999999999999999998653321
Q ss_pred cCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhH-HHhhhhccccccCCCCCCcHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQ-VVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e-i~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... ..............+..+++.+.++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 22345678999999999988765 779999999999999999999998765432 2222222222223335689999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L 946 (967)
|.+||+.||.+|||+.++++|-
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHCCCCchhCCCHHHHhcCc
Confidence 9999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=378.69 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=215.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh-----------hhHHHHHHHHHHHHHcCCCceeEEee
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-----------DSLSQFKCEAEIMLRLRHPNVVLFMG 756 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-----------~~~~~~~~Ei~ILk~L~HpNIVkLig 756 (967)
..++|.+.++||+|+||+||+|++ .++.||||++....... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 458999999999999999999976 47789999987654321 34567899999999999999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---eEEE
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---VVKV 833 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---~VKL 833 (967)
++.+...++|||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999998865 35699999999999999999999998 799999999999998765 7999
Q ss_pred EecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC-
Q 037068 834 CDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE- 912 (967)
Q Consensus 834 sDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~- 912 (967)
+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 191 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 191 VDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred EECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 9999998765432 3455679999999999874 589999999999999999999999999988887777654332222
Q ss_pred -CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 913 -IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 913 -ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
....+++++.+||++||+.||.+|||+.|+++|-.
T Consensus 269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 22578999999999999999999999999998854
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=364.03 Aligned_cols=245 Identities=22% Similarity=0.385 Sum_probs=187.8
Q ss_pred CCeeEe---EEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceE
Q 037068 692 EDLQIG---ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 692 e~y~i~---k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~ 765 (967)
++|.+. +.||+|+||.||++.+ .++.||||++... ....+.+|+.+++.+. ||||+++++++.+....+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 456664 7899999999999976 4789999998542 3467788999999996 999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---eEEEEeccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---VVKVCDFGLSRIK 842 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---~VKLsDFGLAr~~ 842 (967)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999976 45799999999999999999999998 799999999999997665 8999999999876
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------hHHHhhhhccccccCCC-
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP-------MQVVGAVGFQNRRLEIP- 914 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~-------~ei~~~i~~~~~~~~ip- 914 (967)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+. .+....+.. ....++
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--~~~~~~~ 237 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--GDFSFEG 237 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--TCCCCCS
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--CCCCCCc
Confidence 5554445567789999999999999999999999999999999999999987543 233333322 222222
Q ss_pred ---CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 915 ---DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 915 ---~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..+++++.+||.+||+.||.+|||+.++++|-
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 35899999999999999999999999998763
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=357.21 Aligned_cols=262 Identities=30% Similarity=0.520 Sum_probs=220.0
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
.+..++|++.+.||+|+||.||++++ .++.||||++... .......+.+|+.++++++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 34457899999999999999999973 4778999998653 345567899999999999999999999988764
Q ss_pred C--ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccc
Q 037068 762 P--HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839 (967)
Q Consensus 762 ~--~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLA 839 (967)
+ .+++||||+++++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 4 78999999999999999987667799999999999999999999998 7999999999999999999999999999
Q ss_pred cccccCcc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh----------------HH
Q 037068 840 RIKHHTYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM----------------QV 900 (967)
Q Consensus 840 r~~~~~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~----------------ei 900 (967)
+....... ......++..|+|||.+.+..++.++||||||+++|||+||..||...... ..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87644321 123345778899999999999999999999999999999999998643111 01
Q ss_pred HhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 901 VGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 901 ~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
...+ ......+.+..+++++.++|.+||+.||.+|||+.++++.|+.+++.+.
T Consensus 273 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 273 IELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHh-hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1111 2334556778899999999999999999999999999999999987753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=365.31 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=205.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP------ 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~------ 762 (967)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999976 5889999998665445556678899999999999999999999987653
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 7899999875 4689999999999999999999998 7999999999999999999999999999875
Q ss_pred ccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc--------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-------------- 907 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-------------- 907 (967)
... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 179 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 433 345678999999999987 67999999999999999999999999988765544332210
Q ss_pred ---------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 ---------------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 ---------------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.....+...+++++.+||.+||+.||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00112335678999999999999999999999999997
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=381.93 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=221.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
..++|++.+.||+|+||.||++++ +++.||||++...... ......+.+|+.++++++||||+++++++...+.+++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 447899999999999999999976 5889999998765433 3456789999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE---cCCCeEEEEecccccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL---d~~g~VKLsDFGLAr~~~ 843 (967)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999998876 45699999999999999999999998 79999999999999 567899999999998665
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC--CCCcHHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAV 921 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~eL 921 (967)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.........| ..+++++
T Consensus 181 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 181 ASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 432 2334579999999999976 69999999999999999999999999998888777765444333333 4689999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
.+||.+||+.+|.+|||+.++++|-.-
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 999999999999999999999998643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=354.52 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=197.8
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeee---
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVT--- 759 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~--- 759 (967)
.+++...+|++.+.||+|+||.||++++ +++.||||++... .......+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3455567999999999999999999987 6889999988553 3455677899999999995 999999999984
Q ss_pred -----ccCceEEEEeecCCCchhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEE
Q 037068 760 -----RSPHFSILTEFLPRGSLYRLLHR--PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVK 832 (967)
Q Consensus 760 -----~~~~l~LVmEy~~gGsL~~lL~~--~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VK 832 (967)
....+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+++++|+||||||+||||+.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 3345899999996 689888754 34569999999999999999999999832399999999999999999999
Q ss_pred EEecccccccccCccC------------CCCCCCCCCccChhcc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 037068 833 VCDFGLSRIKHHTYLS------------SKSTAGTPEWMAPEVL---RNEPANEKCDVYSFGVILWELATLSVPWKGLNP 897 (967)
Q Consensus 833 LsDFGLAr~~~~~~~~------------~~~~~GT~~YmAPE~l---~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~ 897 (967)
|+|||+++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999865432211 1144589999999998 567789999999999999999999999987654
Q ss_pred hHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 898 MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 898 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
..... .......+...++.+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 259 ~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 259 LRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 43322 22334445677888999999999999999999999999999997654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=356.29 Aligned_cols=258 Identities=32% Similarity=0.550 Sum_probs=214.2
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHH--cCCCceeEEeeeeeccC--
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR--LRHPNVVLFMGAVTRSP-- 762 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~--L~HpNIVkLig~~~~~~-- 762 (967)
.....++|.+.+.||+|+||.||+|+++++.||||++.. .....+.+|+++++. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 345568999999999999999999999999999999743 234567889999988 78999999999998765
Q ss_pred --ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCeEEeccCCCcEEEcCCCeEE
Q 037068 763 --HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH--------TSHPTIVHRDLKSPNLLVDKNWVVK 832 (967)
Q Consensus 763 --~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLH--------s~n~GIVHRDLKPsNILLd~~g~VK 832 (967)
.+++||||+.+|+|.+++.+ ..+++..++.++.||+.||.||| ++ +|+||||||+||||+.++.+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~--~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP--AIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC--EEECSCCSGGGEEECTTSCEE
T ss_pred cceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC--CeeeCCCCHHHEEECCCCCEE
Confidence 79999999999999999975 46899999999999999999999 55 799999999999999999999
Q ss_pred EEecccccccccCcc----CCCCCCCCCCccChhccccCC------CCchhHHHHHHHHHHHHHhC----------CCCC
Q 037068 833 VCDFGLSRIKHHTYL----SSKSTAGTPEWMAPEVLRNEP------ANEKCDVYSFGVILWELATL----------SVPW 892 (967)
Q Consensus 833 LsDFGLAr~~~~~~~----~~~~~~GT~~YmAPE~l~g~~------~s~ksDVWSLGvlL~ELlTG----------k~PF 892 (967)
|+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+|| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 999999986544321 234567999999999998763 33689999999999999999 7888
Q ss_pred CCCCh-----hHHHhhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 893 KGLNP-----MQVVGAVGFQNRRLEIPD-----DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 893 ~~~~~-----~ei~~~i~~~~~~~~ip~-----~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
..... ......+.....+..++. .+++.+.+||.+||+.||.+|||+.+++++|+.+.+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 76532 233333333333444443 34568999999999999999999999999999997654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=359.56 Aligned_cols=262 Identities=30% Similarity=0.457 Sum_probs=203.9
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHH--HHHcCCCceeEEeeeeec----
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEI--MLRLRHPNVVLFMGAVTR---- 760 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~I--Lk~L~HpNIVkLig~~~~---- 760 (967)
..+..++|++.+.||+|+||.||+|+.+++.||||++... ....+..|.++ ++.++|+||+++++++..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 3455689999999999999999999999999999998543 23334444444 445899999999985532
Q ss_pred -cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCeEEeccCCCcEEEcCCCeEE
Q 037068 761 -SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS-------HPTIVHRDLKSPNLLVDKNWVVK 832 (967)
Q Consensus 761 -~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~-------n~GIVHRDLKPsNILLd~~g~VK 832 (967)
...+++||||+++|+|.+++... .+++..++.++.||+.||.|||++ .+||+||||||+||||+.++.+|
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 33578999999999999999753 458999999999999999999987 23699999999999999999999
Q ss_pred EEecccccccccCc--------cCCCCCCCCCCccChhcccc-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 037068 833 VCDFGLSRIKHHTY--------LSSKSTAGTPEWMAPEVLRN-------EPANEKCDVYSFGVILWELATLSVPWKGLNP 897 (967)
Q Consensus 833 LsDFGLAr~~~~~~--------~~~~~~~GT~~YmAPE~l~g-------~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~ 897 (967)
|+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998654321 12234569999999999987 3566789999999999999999776533211
Q ss_pred ------------------hHHHhhhhccccccCCCCC------CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 898 ------------------MQVVGAVGFQNRRLEIPDD------IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 898 ------------------~ei~~~i~~~~~~~~ip~~------ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
......+.....+..+|.. +++++.+||.+||+.||++|||+.|+++.|..+...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1111112222333444443 4568999999999999999999999999999998776
Q ss_pred hc
Q 037068 954 VD 955 (967)
Q Consensus 954 ~~ 955 (967)
..
T Consensus 321 ~~ 322 (336)
T 3g2f_A 321 ER 322 (336)
T ss_dssp CC
T ss_pred Hh
Confidence 53
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=349.81 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=211.9
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
..+....++|.....||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 34445556666667999999999999976 57789999986543 344567889999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-CCeEEEEecccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN--HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLS 839 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~--~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-~g~VKLsDFGLA 839 (967)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+||+++. ++.+||+|||++
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC--CEEccCCChhhEEEECCCCCEEEeecccc
Confidence 9999999999999999987643 3467899999999999999999998 7999999999999987 899999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChhHH-HhhhhccccccCCCCC
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRNEP--ANEKCDVYSFGVILWELATLSVPWKGLNPMQV-VGAVGFQNRRLEIPDD 916 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g~~--~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei-~~~i~~~~~~~~ip~~ 916 (967)
+.............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ............++..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (295)
T 2clq_A 171 KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES 250 (295)
T ss_dssp EESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTT
T ss_pred cccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccccc
Confidence 87655443445667999999999997754 88999999999999999999999976543322 2222223345567888
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+++++.++|.+||+.||++||++.++++|
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=380.95 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=202.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------ 761 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------ 761 (967)
..++|++.+.||+|+||+||+|.+ +++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 358999999999999999999965 578899999976544556677899999999999999999999998654
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
..++|||||+.++ |...+.. .+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++.
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~--~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 3579999999765 6666543 489999999999999999999999 799999999999999999999999999987
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc------------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------------ 909 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------------ 909 (967)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 214 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 214 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred cCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 65432 24457899999999999999999999999999999999999999998876554443321000
Q ss_pred --------c-----cC----CCCC-----------CcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 --------R-----LE----IPDD-----------IDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 --------~-----~~----ip~~-----------ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
. .. +|.. .++++.+||.+||+.||++|||+.|+|+|-
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 0 00 0100 156799999999999999999999999984
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=366.03 Aligned_cols=255 Identities=20% Similarity=0.214 Sum_probs=202.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCCChh---------hHHHHHHHHHHHHHcCCCceeEEe
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDFSGD---------SLSQFKCEAEIMLRLRHPNVVLFM 755 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~s~~---------~~~~~~~Ei~ILk~L~HpNIVkLi 755 (967)
..++|.+.+.||+|+||.||+|.+ .+..+|||++........ ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 457899999999999999999977 457899999875432110 112366788889999999999999
Q ss_pred eeeec----cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC--
Q 037068 756 GAVTR----SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-- 829 (967)
Q Consensus 756 g~~~~----~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-- 829 (967)
+++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN--EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEESSSTT
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCcCHHHEEEccCCCC
Confidence 99887 67899999999 999999997643 799999999999999999999998 799999999999998877
Q ss_pred eEEEEecccccccccCcc-------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hhHH
Q 037068 830 VVKVCDFGLSRIKHHTYL-------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN--PMQV 900 (967)
Q Consensus 830 ~VKLsDFGLAr~~~~~~~-------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~--~~ei 900 (967)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999986543211 1244579999999999999999999999999999999999999996532 2221
Q ss_pred HhhhhccccccCCC---------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 901 VGAVGFQNRRLEIP---------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 901 ~~~i~~~~~~~~ip---------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
.... ......+| ..+++++.++|.+||+.||++||++.+|++.|+.+.
T Consensus 271 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111 11111222 278899999999999999999999999999998763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=364.17 Aligned_cols=245 Identities=23% Similarity=0.383 Sum_probs=211.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh------hhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG------DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~------~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
..++|++.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 347899999999999999999965 58889999987654322 1344577899999999999999999999999
Q ss_pred CceEEEEeecCCC-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 762 PHFSILTEFLPRG-SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 762 ~~l~LVmEy~~gG-sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+.+++||||+..| +|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999777 99999876 45699999999999999999999998 79999999999999999999999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ........|..+++
T Consensus 179 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~ 249 (335)
T 3dls_A 179 YLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVSK 249 (335)
T ss_dssp ECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCCH
T ss_pred ECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccCH
Confidence 665432 2344679999999999998876 8899999999999999999999976321 12233455677899
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++.+||.+||+.||++|||+.++++|-
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 999999999999999999999999984
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=373.47 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=191.8
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-----cCc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-----SPH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-----~~~ 763 (967)
.++|++.+.||+|+||+||+|.+ +++.||||++............+.+|+.++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 37999999999999999999965 58899999987655555667789999999999999999999999843 356
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+|+||||+ +++|..++.. ...+++..++.|+.||+.||.|||++ |||||||||+||||+.++.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~--~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhC--CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99999998 5689998876 45699999999999999999999998 79999999999999999999999999998654
Q ss_pred cCcc---------------------------CCCCCCCCCCccChhcc-ccCCCCchhHHHHHHHHHHHHHh--------
Q 037068 844 HTYL---------------------------SSKSTAGTPEWMAPEVL-RNEPANEKCDVYSFGVILWELAT-------- 887 (967)
Q Consensus 844 ~~~~---------------------------~~~~~~GT~~YmAPE~l-~g~~~s~ksDVWSLGvlL~ELlT-------- 887 (967)
.... .....+||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 2211 12345789999999986 56679999999999999999999
Q ss_pred ---CCCCCCCCChh--------------------HHHhhhh------------------------cc-----ccccCCCC
Q 037068 888 ---LSVPWKGLNPM--------------------QVVGAVG------------------------FQ-----NRRLEIPD 915 (967)
Q Consensus 888 ---Gk~PF~~~~~~--------------------ei~~~i~------------------------~~-----~~~~~ip~ 915 (967)
|+++|.+.+.. .....+. .. ........
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 66777654310 0000000 00 00011123
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.+++++.+||.+||+.||++|||+.|+|+|-
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 5689999999999999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=396.91 Aligned_cols=254 Identities=20% Similarity=0.379 Sum_probs=222.4
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCc
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~ 763 (967)
.+..++|.+.+.||+|+||+||+|++ +++.||||++.+... .......+..|..++..+ +|+||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34568999999999999999999976 467899999875321 223456678899999887 79999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+||||||+++|+|..++.. ...+++..++.|+.||+.||+|||++ |||||||||+||||+.++++||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999999976 35699999999999999999999998 79999999999999999999999999998654
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..++...+. .....+|..+++++.+
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 571 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVA 571 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHH
Confidence 44445667889999999999999999999999999999999999999999998888877775 3456778899999999
Q ss_pred HHHHhhhcCCCCCcCH-----HHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSF-----AQLMSRL 946 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~-----~ELLe~L 946 (967)
||++||+.||.+||++ .+|++|-
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 9999999999999987 8888773
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.68 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=214.0
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|.+.+.||+|+||.||++++ .++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 47899999999999999999976 48899999987543 223456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE---cCCCeEEEEecccccccccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL---d~~g~VKLsDFGLAr~~~~~ 845 (967)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999998865 34689999999999999999999998 79999999999999 78899999999999754432
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc--cCCCCCCcHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR--LEIPDDIDPAVAQ 923 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~--~~ip~~ls~eL~d 923 (967)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... ...+..+++++.+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 123345899999999999999999999999999999999999999988877766655433222 2344678999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+|.+||+.||++|||+.++++|-.
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHcCCChhHCcCHHHHhcCcc
Confidence 999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=346.46 Aligned_cols=250 Identities=23% Similarity=0.403 Sum_probs=210.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-------
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR------- 760 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~------- 760 (967)
...+|++.+.||+|+||.||+|.+ +++.||+|++.... ..+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 347899999999999999999977 48899999986532 346689999999999999999998854
Q ss_pred ---------cCceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 761 ---------SPHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 761 ---------~~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
...+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK--KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCHHHEEEcCCCC
Confidence 44589999999999999998653 35799999999999999999999998 7999999999999999999
Q ss_pred EEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc
Q 037068 831 VKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR 910 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~ 910 (967)
+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+ ..
T Consensus 161 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~----~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL----RD 233 (284)
T ss_dssp EEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH----HT
T ss_pred EEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh----hc
Confidence 9999999998665432 234567999999999999999999999999999999999999887532 1222222 12
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 911 ~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
..++..+++.+.++|.+||+.||.+|||+.+++++|+.+.+...
T Consensus 234 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 33567789999999999999999999999999999999875543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=354.68 Aligned_cols=261 Identities=21% Similarity=0.264 Sum_probs=209.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
..++|++.+.||+|+||.||++++ .++.||||++..... .......+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 348999999999999999999976 478899999865432 23345778999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999875 35699999999999999999999998 79999999999999999999999999997654432
Q ss_pred -cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc-ccCCCCCCcHHHHHH
Q 037068 847 -LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQI 924 (967)
Q Consensus 847 -~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~-~~~ip~~ls~eL~dL 924 (967)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..... ....+..+++++.++
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 223356789999999999999999999999999999999999999998776544444332222 224567789999999
Q ss_pred HHHhhhcCCCCCc-CHHHHHHHHHHHHHHh
Q 037068 925 IRDCWQTEPHLRP-SFAQLMSRLRCLQRLL 953 (967)
Q Consensus 925 I~~CLq~dPe~RP-S~~ELLe~L~~L~~l~ 953 (967)
|.+||+.||++|| ++.++++.|..+....
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 9999999999999 9999999998774433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=360.96 Aligned_cols=258 Identities=17% Similarity=0.199 Sum_probs=211.1
Q ss_pred cCCeeEeEEeecCCceEEEEeecC----------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeE-------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH----------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVL------- 753 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~----------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVk------- 753 (967)
.++|.+.+.||+|+||.||+|++. ++.||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 479999999999999999999763 678999998643 35778999999999999987
Q ss_pred --------Eeeeeec-cCceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcE
Q 037068 754 --------FMGAVTR-SPHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNL 823 (967)
Q Consensus 754 --------Lig~~~~-~~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNI 823 (967)
+++++.. +...++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~NI 190 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN--EYVHGNVTAENI 190 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCGGGE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHHHE
Confidence 5566655 67789999999 99999999764 36799999999999999999999998 799999999999
Q ss_pred EEcCCC--eEEEEecccccccccCcc-------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 037068 824 LVDKNW--VVKVCDFGLSRIKHHTYL-------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG 894 (967)
Q Consensus 824 LLd~~g--~VKLsDFGLAr~~~~~~~-------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~ 894 (967)
|++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 999999999986543221 12345799999999999999999999999999999999999999987
Q ss_pred CC--hhHHHhhhh-ccccccCCC------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhhcCCC
Q 037068 895 LN--PMQVVGAVG-FQNRRLEIP------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSN 958 (967)
Q Consensus 895 ~~--~~ei~~~i~-~~~~~~~ip------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~~~~ 958 (967)
.. ......... .......++ ..+++++.++|.+||+.||++|||+.++++.|..+.+.......
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 343 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPY 343 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTT
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcC
Confidence 64 222222211 011111111 25689999999999999999999999999999999877754433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=367.05 Aligned_cols=249 Identities=24% Similarity=0.416 Sum_probs=199.2
Q ss_pred cCCeeEe-EEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHH-cCCCceeEEeeeeec----cC
Q 037068 691 WEDLQIG-ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR-LRHPNVVLFMGAVTR----SP 762 (967)
Q Consensus 691 ~e~y~i~-k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~-L~HpNIVkLig~~~~----~~ 762 (967)
.++|.+. +.||+|+||+||++.+ +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3677776 7899999999999976 4788999998532 356678888754 589999999998875 56
Q ss_pred ceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---CCeEEEEeccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---NWVVKVCDFGL 838 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~---~g~VKLsDFGL 838 (967)
.++|||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 7899999999999999998643 4699999999999999999999998 7999999999999987 78999999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH----HHhhhhccccccC--
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ----VVGAVGFQNRRLE-- 912 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e----i~~~i~~~~~~~~-- 912 (967)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+........
T Consensus 211 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 211 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp CEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred ccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 98654332 2345678999999999999999999999999999999999999998765332 2222222222222
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
....+++++.+||++||+.||++|||+.++++|-...
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 2256899999999999999999999999999986543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=384.66 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=217.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~L 766 (967)
..++|.+.+.||+|+||+||++++ +++.||||++.+.... ......+.+|+.++++++||||+++++++.....+++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 447899999999999999999976 5889999998654221 2335678899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 767 LTEFLPRGSLYRLLHRP---NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~---~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
||||+++|+|..++... ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++++||+|||+++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~--gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc--CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999998653 34699999999999999999999998 79999999999999999999999999998766
Q ss_pred cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hhHHHhhhhccccccCCCCCCcH
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN----PMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~----~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..++...+. .....+|..+++
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~s~ 418 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKFSP 418 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTSCH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCcccCH
Confidence 55444455689999999999999999999999999999999999999998753 233333332 234567788999
Q ss_pred HHHHHHHHhhhcCCCCCcCH-----HHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSF-----AQLMSRL 946 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~-----~ELLe~L 946 (967)
++.+||.+||+.||.+||++ .+|++|-
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence 99999999999999999964 7888763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=359.45 Aligned_cols=252 Identities=22% Similarity=0.363 Sum_probs=215.6
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCCh---------------hhHHHHHHHHHHHHHcCCCcee
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSG---------------DSLSQFKCEAEIMLRLRHPNVV 752 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~---------------~~~~~~~~Ei~ILk~L~HpNIV 752 (967)
....++|.+.+.||+|+||.||+|+++++.||||++....... .....+.+|+.++++++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 4456899999999999999999999899999999986532211 1127889999999999999999
Q ss_pred EEeeeeeccCceEEEEeecCCCchhhh------hcCC-CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCeEEeccCCCcEE
Q 037068 753 LFMGAVTRSPHFSILTEFLPRGSLYRL------LHRP-NHQLDERRRMRMALDVAKGMNYLHT-SHPTIVHRDLKSPNLL 824 (967)
Q Consensus 753 kLig~~~~~~~l~LVmEy~~gGsL~~l------L~~~-~~~Lse~~i~~I~~QIa~aL~YLHs-~n~GIVHRDLKPsNIL 824 (967)
++++++...+..++||||+.+++|.++ +... ...+++..++.++.||+.||.|||+ + ||+||||||+|||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS--CEECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC--CEeecCCChHhEE
Confidence 999999999999999999999999998 5542 5679999999999999999999999 6 7999999999999
Q ss_pred EcCCCeEEEEecccccccccCccCCCCCCCCCCccChhccccC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCh-hHHH
Q 037068 825 VDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNE-PANE-KCDVYSFGVILWELATLSVPWKGLNP-MQVV 901 (967)
Q Consensus 825 Ld~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~-ksDVWSLGvlL~ELlTGk~PF~~~~~-~ei~ 901 (967)
++.++.+||+|||+++..... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||..... .+..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999875443 34456799999999999887 6666 99999999999999999999998766 5555
Q ss_pred hhhhccccccCCC-------------------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 902 GAVGFQNRRLEIP-------------------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 902 ~~i~~~~~~~~ip-------------------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..+... ...+| ..+++++.+||.+||+.||.+|||+.++++|
T Consensus 263 ~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 444322 22333 5689999999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=353.08 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=202.9
Q ss_pred cCCeeEe-EEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEE
Q 037068 691 WEDLQIG-ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 691 ~e~y~i~-k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~L 766 (967)
.++|.+. +.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++++ +||||+++++++...+.+++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3688885 7899999999999976 58899999986543 33456788999999995 79999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe---EEEEecccccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV---VKVCDFGLSRIKH 843 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~---VKLsDFGLAr~~~ 843 (967)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||+|||+++...
T Consensus 89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999876 35689999999999999999999998 7999999999999987765 9999999997543
Q ss_pred cCc-------cCCCCCCCCCCccChhcccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-------------
Q 037068 844 HTY-------LSSKSTAGTPEWMAPEVLRN-----EPANEKCDVYSFGVILWELATLSVPWKGLNPM------------- 898 (967)
Q Consensus 844 ~~~-------~~~~~~~GT~~YmAPE~l~g-----~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~------------- 898 (967)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 11223569999999999975 45788999999999999999999999875421
Q ss_pred --HHHhhhhccccccCCC----CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 899 --QVVGAVGFQNRRLEIP----DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 899 --ei~~~i~~~~~~~~ip----~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.....+. .....+| ..+++++.+||.+||+.||.+|||+.|+++|-
T Consensus 246 ~~~~~~~i~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 246 QNMLFESIQ--EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHh--ccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 1222222 1222333 46899999999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=366.72 Aligned_cols=252 Identities=25% Similarity=0.308 Sum_probs=201.3
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc-----Cc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-----PH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~-----~~ 763 (967)
.++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 48999999999999999999976 477899999876544556677899999999999999999999998765 56
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+++||||+. ++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~--givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 999999986 599999876 45699999999999999999999999 79999999999999999999999999998654
Q ss_pred cCcc----------------------CCCCCCCCCCccChhcc-ccCCCCchhHHHHHHHHHHHHHhCCC----------
Q 037068 844 HTYL----------------------SSKSTAGTPEWMAPEVL-RNEPANEKCDVYSFGVILWELATLSV---------- 890 (967)
Q Consensus 844 ~~~~----------------------~~~~~~GT~~YmAPE~l-~g~~~s~ksDVWSLGvlL~ELlTGk~---------- 890 (967)
.... ......||+.|+|||++ .+..++.++|||||||++|||++|..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 3221 12456799999999986 55679999999999999999998543
Q ss_pred -CCCCCCh-----------------hHH------------------------HhhhhccccccC-----CCCCCcHHHHH
Q 037068 891 -PWKGLNP-----------------MQV------------------------VGAVGFQNRRLE-----IPDDIDPAVAQ 923 (967)
Q Consensus 891 -PF~~~~~-----------------~ei------------------------~~~i~~~~~~~~-----ip~~ls~eL~d 923 (967)
+|.+.+. ... ...+........ ....+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 4433321 000 000000000111 11457999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L 946 (967)
||.+||+.||++|||+.|+|+|-
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp 363 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHP 363 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCG
T ss_pred HHHHHhcCCcccCCCHHHHhcCh
Confidence 99999999999999999999983
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=354.88 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=210.5
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee----c
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT----R 760 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~----~ 760 (967)
+.+..++|++.+.||+|+||.||+++. .++.||||++... .......+.+|+.+++.++||||+++++++. .
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 345567999999999999999999975 6889999988653 3455678899999999999999999999987 3
Q ss_pred cCceEEEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
....++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCCEEEEecC
Confidence 4478999999999999998865 356799999999999999999999998 79999999999999999999999999
Q ss_pred cccccccCccC---------CCCCCCCCCccChhccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHhh
Q 037068 838 LSRIKHHTYLS---------SKSTAGTPEWMAPEVLRNEP---ANEKCDVYSFGVILWELATLSVPWKGLNP--MQVVGA 903 (967)
Q Consensus 838 LAr~~~~~~~~---------~~~~~GT~~YmAPE~l~g~~---~s~ksDVWSLGvlL~ELlTGk~PF~~~~~--~ei~~~ 903 (967)
+++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 98754321110 12234799999999997654 68899999999999999999999964211 111111
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHH
Q 037068 904 VGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950 (967)
Q Consensus 904 i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~ 950 (967)
+. .....+.+..+++++.++|.+||+.||.+|||+.+++++|+.+.
T Consensus 260 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQ-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HH-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hh-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11 22334445678999999999999999999999999999998874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.85 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=211.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeeee--ccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF--SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT--RSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~--s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~--~~~~l 764 (967)
.++|.+.+.||+|+||.||++.+ +++.||+|++..... .......+.+|+.++++++|+||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999977 577899999865321 1234567899999999999999999999984 45679
Q ss_pred EEEEeecCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 765 SILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
++||||+.++ |.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999999887 6565543 356799999999999999999999998 79999999999999999999999999998654
Q ss_pred cC--ccCCCCCCCCCCccChhccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 844 HT--YLSSKSTAGTPEWMAPEVLRNEP--ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 844 ~~--~~~~~~~~GT~~YmAPE~l~g~~--~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
.. ........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+.. ....++..+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~~ 238 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSYAIPGDCGP 238 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCCCCSSSCH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--CCCCCCCccCH
Confidence 32 22234566899999999998754 37899999999999999999999999887776665542 34567788999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
.+.++|.+||+.||.+|||+.++++|-.-
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 99999999999999999999999998543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=344.01 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=215.8
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC---C----hhhHHHHHHHHHHHHHcC-CCceeEEeeee
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF---S----GDSLSQFKCEAEIMLRLR-HPNVVLFMGAV 758 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~---s----~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~ 758 (967)
...++|++.+.||+|+||.||+|.+ +++.||||++..... . ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3458999999999999999999977 478899999865431 1 123456889999999995 99999999999
Q ss_pred eccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 759 TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 759 ~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
......++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999999875 45689999999999999999999998 799999999999999999999999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLR------NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE 912 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~------g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ 912 (967)
++...... ......+|+.|+|||++. ...++.++||||||+++|+|++|+.||...........+........
T Consensus 171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 171 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred hhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 98655432 234567899999999985 45688999999999999999999999998887766655543333333
Q ss_pred CC--CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 913 IP--DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 913 ip--~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.+ ..+++.+.++|.+||+.||.+|||+.++++|-
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 22 46899999999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=351.57 Aligned_cols=259 Identities=28% Similarity=0.463 Sum_probs=196.1
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
..|.+..++|.+.+.||+|+||.||++.+ +++.||||++.... .......+.+|+.++++++||||+++++++...+
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 34677789999999999999999999976 58899999875432 2234567888999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEe
Q 037068 763 HFSILTEFLPRGSLYRLLHR-------PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~-------~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsD 835 (967)
..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCCChhhEEEcCCCCEEEEe
Confidence 99999999999999999863 345689999999999999999999998 799999999999999999999999
Q ss_pred cccccccccCc-----cCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc
Q 037068 836 FGLSRIKHHTY-----LSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR 909 (967)
Q Consensus 836 FGLAr~~~~~~-----~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~ 909 (967)
||+++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99987654321 11234579999999999876 5689999999999999999999999998776655433221111
Q ss_pred --------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 --------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 --------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.......+++++.++|.+||+.||.+|||+.++++|-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 1123456889999999999999999999999999873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=361.93 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=205.8
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc----
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS---- 761 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~---- 761 (967)
+...++|++.+.||+|+||+||+|.+ +++.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 44568999999999999999999966 5889999998654221 23699999999999999999998542
Q ss_pred ----------------------------------CceEEEEeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHH
Q 037068 762 ----------------------------------PHFSILTEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMN 804 (967)
Q Consensus 762 ----------------------------------~~l~LVmEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~ 804 (967)
..+++||||+. ++|.+.+.. .+..+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 33889999998 477766642 3567999999999999999999
Q ss_pred HHHhcCCCeEEeccCCCcEEEc-CCCeEEEEecccccccccCccCCCCCCCCCCccChhccccCC-CCchhHHHHHHHHH
Q 037068 805 YLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVIL 882 (967)
Q Consensus 805 YLHs~n~GIVHRDLKPsNILLd-~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL 882 (967)
|||++ ||+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++
T Consensus 156 ~LH~~--gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSL--GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTT--TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHC--cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99998 799999999999997 68999999999998664433 244567899999999988754 89999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHhhhhcc---------------------------ccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 037068 883 WELATLSVPWKGLNPMQVVGAVGFQ---------------------------NRRLEIPDDIDPAVAQIIRDCWQTEPHL 935 (967)
Q Consensus 883 ~ELlTGk~PF~~~~~~ei~~~i~~~---------------------------~~~~~ip~~ls~eL~dLI~~CLq~dPe~ 935 (967)
|||++|+.||.+.+..+....+... .....++..+++++.+||.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999988766554433210 0011245668999999999999999999
Q ss_pred CcCHHHHHHH--HHHHHH
Q 037068 936 RPSFAQLMSR--LRCLQR 951 (967)
Q Consensus 936 RPS~~ELLe~--L~~L~~ 951 (967)
|||+.|+++| ++.++.
T Consensus 313 R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SCCHHHHHTSGGGHHHHH
T ss_pred CCCHHHHhcCHHHHHHHh
Confidence 9999999988 455544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=358.93 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=216.3
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC--Ch----hhHHHHHHHHHHHHHc-CCCceeEEeee
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF--SG----DSLSQFKCEAEIMLRL-RHPNVVLFMGA 757 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~--s~----~~~~~~~~Ei~ILk~L-~HpNIVkLig~ 757 (967)
.....++|.+.+.||+|+||.||+|.+ +|+.||||++..... .. .....+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 444567899999999999999999976 488999999865432 11 1245678999999999 89999999999
Q ss_pred eeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 758 VTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 758 ~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
+......++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~--gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEEecC
Confidence 9999999999999999999999875 45699999999999999999999998 79999999999999999999999999
Q ss_pred cccccccCccCCCCCCCCCCccChhcccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRN------EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL 911 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g------~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~ 911 (967)
++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 246 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 246 FSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred cccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 998665432 2345679999999999864 357889999999999999999999999887766665554332222
Q ss_pred CC--CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 EI--PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 ~i--p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.. +..+++.+.++|.+||+.||++|||+.++++|
T Consensus 325 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22 24688999999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.85 Aligned_cols=260 Identities=20% Similarity=0.292 Sum_probs=207.4
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCC---------hhhHHHHHHHHHHHHHcCCCcee
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFS---------GDSLSQFKCEAEIMLRLRHPNVV 752 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s---------~~~~~~~~~Ei~ILk~L~HpNIV 752 (967)
.+.+.....++|.+.+.||+|+||.||+|.+ .++.||||++...... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3456677889999999999999999999965 5888999998653322 12247789999999999999999
Q ss_pred EEeeeeec-----cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC
Q 037068 753 LFMGAVTR-----SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK 827 (967)
Q Consensus 753 kLig~~~~-----~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~ 827 (967)
++++++.. ...+++||||+. |+|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGNILLAD 169 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECT
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--cCEecCCChHHEEEcC
Confidence 99999853 335899999998 588888877667899999999999999999999998 7999999999999999
Q ss_pred CCeEEEEecccccccccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc
Q 037068 828 NWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF 906 (967)
Q Consensus 828 ~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~ 906 (967)
++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp TCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999997544332 2345678999999999987 6789999999999999999999999998776554443321
Q ss_pred cc----------------------c--------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 907 QN----------------------R--------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 907 ~~----------------------~--------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.. . ....+..+++.+.+||.+||+.||.+|||+.|+++|-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 00 0 0012345688999999999999999999999999983
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.10 Aligned_cols=257 Identities=15% Similarity=0.161 Sum_probs=212.5
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEee-------cCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC---CCceeE
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRAD-------WHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR---HPNVVL 753 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~-------~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~---HpNIVk 753 (967)
...+++..++|.+.+.||+|+||+||+|. ..++.||||++... ...++..|+.+++.++ |+||++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhh
Confidence 35567778899999999999999999993 25788999997542 3456788889998886 999999
Q ss_pred EeeeeeccCceEEEEeecCCCchhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC--
Q 037068 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHR----PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-- 827 (967)
Q Consensus 754 Lig~~~~~~~l~LVmEy~~gGsL~~lL~~----~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-- 827 (967)
+++++...+..+|||||+++|+|.+++.. ....+++..++.|+.||+.||+|||++ |||||||||+||||+.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECGGG
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEecccc
Confidence 99999999999999999999999999964 356799999999999999999999998 7999999999999988
Q ss_pred ---------CCeEEEEecccccccc--cCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 037068 828 ---------NWVVKVCDFGLSRIKH--HTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLN 896 (967)
Q Consensus 828 ---------~g~VKLsDFGLAr~~~--~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~ 896 (967)
++.+||+|||+++... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 8999999999997543 22223455779999999999999999999999999999999999999996543
Q ss_pred hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC-cCHHHHHHHHHHHHHHh
Q 037068 897 PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR-PSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 897 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~R-PS~~ELLe~L~~L~~l~ 953 (967)
..... + ... .. ....++.+.+++..||+.+|.+| |++.++.+.|..+....
T Consensus 290 ~~~~~--~--~~~-~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 290 GGECK--P--EGL-FR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp TTEEE--E--CSC-CT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCcee--e--chh-cc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 22110 0 000 00 11246788999999999999999 57888888888776553
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=347.35 Aligned_cols=258 Identities=20% Similarity=0.326 Sum_probs=213.5
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC--CCceeEEeeeeecc
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR--HPNVVLFMGAVTRS 761 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~--HpNIVkLig~~~~~ 761 (967)
..+.+..++|++.+.||+|+||.||++.+ +++.||||++............+.+|+.++++++ |+||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 34556668899999999999999999976 4778999999776666677788999999999996 59999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
+..++||| +.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+++ +.+||+|||+++.
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred CEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999999 567899999876 45789999999999999999999998 7999999999999965 8999999999986
Q ss_pred cccCcc--CCCCCCCCCCccChhcccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhcc
Q 037068 842 KHHTYL--SSKSTAGTPEWMAPEVLRN-----------EPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQ 907 (967)
Q Consensus 842 ~~~~~~--~~~~~~GT~~YmAPE~l~g-----------~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~ 907 (967)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence 543321 2234578999999999876 46889999999999999999999999876432 233333334
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 908 NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 908 ~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
.....++...++++.++|.+||+.||.+||++.+++++-.
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 4556677888999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=348.02 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=208.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeec---CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc---CCCceeEEeeeee----
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW---HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL---RHPNVVLFMGAVT---- 759 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~---~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L---~HpNIVkLig~~~---- 759 (967)
..++|++.+.||+|+||.||+|++ .++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347899999999999999999976 367899999875443333333456677777766 8999999999987
Q ss_pred -ccCceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 760 -RSPHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 760 -~~~~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
....+++||||+. |+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCHHHeEEcCCCCEEEecCc
Confidence 5567999999998 5999988754 34599999999999999999999998 79999999999999999999999999
Q ss_pred cccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc----------
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---------- 907 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~---------- 907 (967)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...
T Consensus 166 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 166 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp SCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred ccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 998654332 234567899999999999999999999999999999999999999988766554433210
Q ss_pred ---------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 ---------------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 ---------------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.....++..+++.+.+||.+||+.||++|||+.++++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00012335688999999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=359.86 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=200.8
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC-----
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP----- 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~----- 762 (967)
..++|++.+.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 347999999999999999999965 5788999998765555566778899999999999999999999987654
Q ss_pred -ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 763 -HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 763 -~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.+++||||+.+ +|.+++.. .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 68999999975 78887753 489999999999999999999998 799999999999999999999999999986
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc------------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------------ 909 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------------ 909 (967)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 177 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 54432 23456799999999999999999999999999999999999999998876555443321100
Q ss_pred --------ccC--------------CCC------CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 910 --------RLE--------------IPD------DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 910 --------~~~--------------ip~------~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
... .|. ..++++.+||.+||+.||.+|||+.|+++|-.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000 011 12578999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.20 Aligned_cols=252 Identities=31% Similarity=0.494 Sum_probs=216.2
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|++.+.||+|+||.||+|++ .++.||||++............+.+|+.++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 447999999999999999999976 588999999876554455677899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC---CeEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN---WVVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~---g~VKLsDFGLAr~~~~ 844 (967)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++.+ +.+||+|||+++....
T Consensus 100 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999999988765 34689999999999999999999998 79999999999999754 4799999999986543
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCC--CCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip--~~ls~eL~ 922 (967)
.. ......+|+.|+|||.+.+. ++.++||||||+++|+|++|..||...+..+....+.........+ ..+++++.
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 177 NT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp CS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred CC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 32 22334578899999998765 8999999999999999999999999988777666654333333332 57899999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++|.+||+.||++|||+.+++++-
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHcccChhhCcCHHHHhcCH
Confidence 999999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=367.48 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=199.3
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC------hhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS------GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s------~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
...++|.+.+.||+|+||+||+|.+ +++.||||++...... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3458999999999999999999966 4789999998764321 1222357889999999999999999999754
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC---CeEEEEecc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN---WVVKVCDFG 837 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~---g~VKLsDFG 837 (967)
+.+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCCCcceEEEeecc
Confidence 458999999999999998876 45799999999999999999999998 79999999999999754 459999999
Q ss_pred cccccccCccCCCCCCCCCCccChhcccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH-HHhhhhcccc--cc
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRN---EPANEKCDVYSFGVILWELATLSVPWKGLNPMQ-VVGAVGFQNR--RL 911 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g---~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e-i~~~i~~~~~--~~ 911 (967)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+..... ..
T Consensus 288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 288 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 998765432 2345679999999999864 568889999999999999999999998754432 2222221111 11
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 912 ~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..+..+++.+.+||.+||+.||++|||+.|+++|-
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 22256899999999999999999999999999973
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=370.35 Aligned_cols=253 Identities=14% Similarity=0.112 Sum_probs=201.0
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCC-CChhhHHHHHHHHH---HHHHcCCCceeEEe-----
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQD-FSGDSLSQFKCEAE---IMLRLRHPNVVLFM----- 755 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~-~s~~~~~~~~~Ei~---ILk~L~HpNIVkLi----- 755 (967)
+....++|++.+.||+|+||.||+|++ +++.||||++.... ......+.+.+|+. ++++++||||++++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 334457899999999999999999986 48899999987543 23445678899995 45556899999998
Q ss_pred --eeeeccC-----------------ceEEEEeecCCCchhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 037068 756 --GAVTRSP-----------------HFSILTEFLPRGSLYRLLHRPN------HQLDERRRMRMALDVAKGMNYLHTSH 810 (967)
Q Consensus 756 --g~~~~~~-----------------~l~LVmEy~~gGsL~~lL~~~~------~~Lse~~i~~I~~QIa~aL~YLHs~n 810 (967)
+++...+ ..+|||||+ +|+|.+++.... ..+++..++.|+.||+.||.|||++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 225 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY- 225 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-
Confidence 5555443 378999999 679999987521 1233588889999999999999998
Q ss_pred CCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccChhccccC-----------CCCchhHHHHHH
Q 037068 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNE-----------PANEKCDVYSFG 879 (967)
Q Consensus 811 ~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~-----------~~s~ksDVWSLG 879 (967)
||+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++.+. .++.++||||||
T Consensus 226 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 226 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred -CeecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 7999999999999999999999999999864432 334567 999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH--HHHHHHH
Q 037068 880 VILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR--LRCLQRL 952 (967)
Q Consensus 880 vlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~--L~~L~~l 952 (967)
|++|||++|+.||...........+ ...+..+++++.+||.+||+.||++|||+.++++| ++.+.+.
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 9999999999999876654433222 22346789999999999999999999999999986 4444443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=368.24 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=211.6
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC--ce
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP--HF 764 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~--~l 764 (967)
...++|.+.+.||+|+||+||+|++. ++.||||++..... ......+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34578999999999999999999774 88999999865432 234567789999999999999999999988654 68
Q ss_pred EEEEeecCCCchhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE----cCCCeEEEEeccc
Q 037068 765 SILTEFLPRGSLYRLLHRPN--HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV----DKNWVVKVCDFGL 838 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~--~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL----d~~g~VKLsDFGL 838 (967)
++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC--CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999997633 3499999999999999999999998 79999999999999 7888999999999
Q ss_pred ccccccCccCCCCCCCCCCccChhcccc--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHhhhhc
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRN--------EPANEKCDVYSFGVILWELATLSVPWKGLNP----MQVVGAVGF 906 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g--------~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~----~ei~~~i~~ 906 (967)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 98765433 2345679999999999875 5678899999999999999999999975332 222222211
Q ss_pred ccc-------------------ccC----CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 907 QNR-------------------RLE----IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 907 ~~~-------------------~~~----ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
... ..+ ++..+++.+.++|++||+.||++||++.++++.+..+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 100 011 1123567889999999999999999999999999888654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=365.49 Aligned_cols=250 Identities=14% Similarity=0.089 Sum_probs=190.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHc--CCCceeEEe-------eee
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRL--RHPNVVLFM-------GAV 758 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L--~HpNIVkLi-------g~~ 758 (967)
..+|.+.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45699999999999999999975 578899999987654 334456778886665555 699988855 333
Q ss_pred ecc-----------------CceEEEEeecCCCchhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCeEE
Q 037068 759 TRS-----------------PHFSILTEFLPRGSLYRLLHRPNHQLDERRR------MRMALDVAKGMNYLHTSHPTIVH 815 (967)
Q Consensus 759 ~~~-----------------~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i------~~I~~QIa~aL~YLHs~n~GIVH 815 (967)
... ..++|||||+. |+|.+++...+..+.+..+ +.++.||+.||.|||++ ||+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--~ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--TEEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC--CCcc
Confidence 322 33899999998 8999999764444555555 67789999999999998 7999
Q ss_pred eccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccChhcccc--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 037068 816 RDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN--EPANEKCDVYSFGVILWELATLSVPWK 893 (967)
Q Consensus 816 RDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g--~~~s~ksDVWSLGvlL~ELlTGk~PF~ 893 (967)
|||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998664332 13456799999999987 679999999999999999999999998
Q ss_pred CCChhHHHhh-----hh--ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 894 GLNPMQVVGA-----VG--FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 894 ~~~~~ei~~~-----i~--~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
...+...... .. ......+.+..+++.+.+||.+||+.||++|||+.++++|-
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 7754321100 00 01122233357899999999999999999999999999873
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=384.39 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=217.5
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+..++|.+.+.||+|+||.||+|++ +++.||||++.+... .......+.+|+.++++++||||+++++++.+.+.++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4557899999999999999999976 588999999865422 1233566889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
|||||+++|+|..++.... ..+++..++.++.||+.||+|||++ |||||||||+||||+.++++||+|||+++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~--gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999987643 4599999999999999999999998 799999999999999999999999999987654
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHhhhhccccccCCCCCCcHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP----MQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~----~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .++...+. .....+|..++++
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSPQ 415 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCHH
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCHH
Confidence 32 23446899999999999999999999999999999999999999987642 23333332 2345667889999
Q ss_pred HHHHHHHhhhcCCCCCc-----CHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRP-----SFAQLMSRL 946 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RP-----S~~ELLe~L 946 (967)
+.+||.+||+.||.+|| ++.|+++|-
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 99999999999999999 889999883
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=364.34 Aligned_cols=253 Identities=21% Similarity=0.362 Sum_probs=210.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCC--ChhhHHHHHHHHHHHHHc-CCCceeEEeeeeecc
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDF--SGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRS 761 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~--s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~ 761 (967)
..++|++.+.||+|+||.||+++. .++.||||++..... .......+.+|+.+++++ +|+||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 347899999999999999999976 578999999864321 112334567799999999 799999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
..++|||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999876 34699999999999999999999998 799999999999999999999999999986
Q ss_pred cccC-ccCCCCCCCCCCccChhccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHhhhhccccccCCC
Q 037068 842 KHHT-YLSSKSTAGTPEWMAPEVLRNE--PANEKCDVYSFGVILWELATLSVPWKGLNP----MQVVGAVGFQNRRLEIP 914 (967)
Q Consensus 842 ~~~~-~~~~~~~~GT~~YmAPE~l~g~--~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~----~ei~~~i~~~~~~~~ip 914 (967)
.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+ ......+|
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~ 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYP 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCCCC
Confidence 5332 2223446799999999999863 478999999999999999999999975432 2222222 22345677
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCc-----CHHHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRP-----SFAQLMSRLR 947 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RP-----S~~ELLe~L~ 947 (967)
..+++.+.+||.+||+.||++|| ++.++++|..
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 88999999999999999999999 9999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=383.96 Aligned_cols=265 Identities=29% Similarity=0.520 Sum_probs=226.0
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeee
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV 758 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~ 758 (967)
...+++..++|++.+.||+|+||.||+|.+. +..||||++... ......+.+.+|+.++++++||||+++++++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3456777899999999999999999999763 345899986543 3445567899999999999999999999998
Q ss_pred eccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccc
Q 037068 759 TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838 (967)
Q Consensus 759 ~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGL 838 (967)
. ++..++||||+.+|+|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccchHhEEEeCCCCEEEEecCC
Confidence 5 4568999999999999999987666799999999999999999999998 799999999999999999999999999
Q ss_pred ccccccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCC
Q 037068 839 SRIKHHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDD 916 (967)
Q Consensus 839 Ar~~~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ 916 (967)
++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ......+|..
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 616 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPN 616 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTT
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 98664432 22233457789999999999999999999999999999997 999999988877766654 3455677889
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
+++.+.++|.+||+.||.+|||+.+|++.|..+.+..
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=357.37 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=206.6
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce----
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF---- 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l---- 764 (967)
.++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 48999999999999999999965 588999999876655556677899999999999999999999999876654
Q ss_pred --EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 765 --SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 765 --~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
++||||+. ++|..++.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999997 588888743 499999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------------ 909 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------------ 909 (967)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 195 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred ccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 433 345678999999999987 6789999999999999999999999998876554443321000
Q ss_pred -----------------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 -----------------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 -----------------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
....+..+++++.+||.+||+.||++|||+.|+++|-
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 0012345789999999999999999999999999984
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.34 Aligned_cols=244 Identities=20% Similarity=0.314 Sum_probs=202.0
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeec--cCceE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTR--SPHFS 765 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~--~~~l~ 765 (967)
.++|++.+.||+|+||.||+|.+ .++.||||++... ....+.+|+.++++++ ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 37899999999999999999965 5889999997532 3467889999999996 9999999999987 56789
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-eEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-VVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-~VKLsDFGLAr~~~~ 844 (967)
+||||+.+++|..++.. +++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++....
T Consensus 110 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999999864 88999999999999999999998 799999999999999666 999999999986554
Q ss_pred CccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHhhhh-------------ccc-
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNP-MQVVGAVG-------------FQN- 908 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~-~ei~~~i~-------------~~~- 908 (967)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+. ...
T Consensus 184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 2445678999999999987 6789999999999999999999999954332 11111100 000
Q ss_pred ---------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 909 ---------------------RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 909 ---------------------~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.....+..+++++.+||.+||+.||++|||+.|+++|-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 00111223789999999999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=346.92 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=207.6
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec---CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCC------ceeEEeee
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW---HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP------NVVLFMGA 757 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~---~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~Hp------NIVkLig~ 757 (967)
.....++|++.+.||+|+||.||++.+ .++.||||++... ....+.+.+|+.+++.++|+ +|++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 344568999999999999999999965 4778999998532 34456788999999998655 49999999
Q ss_pred eeccCceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---------
Q 037068 758 VTRSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK--------- 827 (967)
Q Consensus 758 ~~~~~~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~--------- 827 (967)
+...+.+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHEEEeccccccccCC
Confidence 99999999999999 889998887543 4689999999999999999999998 7999999999999987
Q ss_pred ----------CCeEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 037068 828 ----------NWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNP 897 (967)
Q Consensus 828 ----------~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~ 897 (967)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999865432 3456789999999999999999999999999999999999999998876
Q ss_pred hHHHhhhhcccc------------------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCC
Q 037068 898 MQVVGAVGFQNR------------------------------------------RLEIPDDIDPAVAQIIRDCWQTEPHL 935 (967)
Q Consensus 898 ~ei~~~i~~~~~------------------------------------------~~~ip~~ls~eL~dLI~~CLq~dPe~ 935 (967)
.+....+..... ....+...++++.+||.+||+.||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 554332211000 00112234678999999999999999
Q ss_pred CcCHHHHHHH
Q 037068 936 RPSFAQLMSR 945 (967)
Q Consensus 936 RPS~~ELLe~ 945 (967)
|||+.|+++|
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.61 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=201.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC------hhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS------GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s------~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
..++|.+.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 347899999999999999999976 4678999998654321 12234578999999999999999999998765
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---eEEEEeccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---VVKVCDFGL 838 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---~VKLsDFGL 838 (967)
. .++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 4 8999999999999998875 45799999999999999999999998 799999999999998665 499999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH-HHhhhhcccc--ccC
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ-VVGAVGFQNR--RLE 912 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e-i~~~i~~~~~--~~~ 912 (967)
++....... .....||+.|+|||++. +..++.++|||||||++|+|++|..||....... ....+..... ...
T Consensus 164 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 164 SKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp CEECCCCHH-HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred ceecccccc-cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 986543321 22346899999999974 5678999999999999999999999998655432 2222211111 112
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+..+++++.++|.+||+.||++||++.++++|
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 235689999999999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.14 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=207.9
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc-----Cc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-----PH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~-----~~ 763 (967)
.++|++.+.||+|+||.||+|.+ +++.||||++... ........+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 47999999999999999999965 5778999998643 2344557789999999999999999999998654 36
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999997 589998875 4599999999999999999999998 79999999999999999999999999998654
Q ss_pred cCcc---CCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc-----------
Q 037068 844 HTYL---SSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN----------- 908 (967)
Q Consensus 844 ~~~~---~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~----------- 908 (967)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 3321 1244579999999998755 458999999999999999999999999887665544332100
Q ss_pred -------------cc-----cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 909 -------------RR-----LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 909 -------------~~-----~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.. ..+...+++++.+||.+||+.||++|||+.|+++|-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00 011246789999999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=345.75 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=195.2
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
..|....++|++.+.||+|+||.||+|.+ +++.||||++............+..+..+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 34566678999999999999999999977 4889999998765443333444555556778889999999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+ ++.+..+.......+++..++.++.||+.||.|||+++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH-CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC-CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999999999 55666666554567999999999999999999999842 6999999999999999999999999999765
Q ss_pred ccCccCCCCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHhhhhccccccCCC--
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLN-PMQVVGAVGFQNRRLEIP-- 914 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~-~~ei~~~i~~~~~~~~ip-- 914 (967)
.... ......+|+.|+|||++. +..++.++|||||||++|+|++|+.||.... ..+....+. ......++
T Consensus 176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~ 253 (318)
T 2dyl_A 176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPGH 253 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCSS
T ss_pred cCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCcc
Confidence 4432 233457999999999994 5568899999999999999999999998743 333333332 22222233
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 915 ~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..+++++.++|.+||+.||.+||++.++++|-
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 46899999999999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.68 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=205.9
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc-----
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH----- 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~----- 763 (967)
.++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 47899999999999999999976 58899999987655555566788999999999999999999999987654
Q ss_pred -eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 764 -FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 764 -l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
+++||||+. ++|..++.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 588888753 489999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc--------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-------------- 907 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-------------- 907 (967)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 177 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 177 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 432 334678999999999987 67899999999999999999999999987765443332110
Q ss_pred ------------c---cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 908 ------------N---RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 908 ------------~---~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
. .....+..+++++.+||.+||+.||++|||+.++++|-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0 01123356799999999999999999999999999884
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=361.47 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=192.2
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------C
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------P 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------~ 762 (967)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 48999999999999999999965 588999999866544555667889999999999999999999998653 5
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999998 6899998875 5699999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------------ 909 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------------ 909 (967)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.....
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 432 334679999999999987 6789999999999999999999999998876554433321000
Q ss_pred ---------ccC--------CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 910 ---------RLE--------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 910 ---------~~~--------ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
... ....+++.+.+||.+||+.||.+|||+.++++|-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 000 1135688999999999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=356.45 Aligned_cols=251 Identities=19% Similarity=0.246 Sum_probs=201.7
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC--------CCceeEEeee
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR--------HPNVVLFMGA 757 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~--------HpNIVkLig~ 757 (967)
....++|++.++||+|+||+||+|++ .++.||||++.. .......+.+|+.+++.++ |+||++++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 34568999999999999999999965 578899999853 2345667889999999985 7889999999
Q ss_pred ee----ccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC----
Q 037068 758 VT----RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---- 829 (967)
Q Consensus 758 ~~----~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---- 829 (967)
+. ....+++||||+.++.+..++......+++..++.|+.||+.||.|||++. ||+||||||+||||+.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT-CEECCCCSGGGEEECCCHHHHH
T ss_pred eeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHeeEeccchhhh
Confidence 87 556799999999554444444444467999999999999999999999973 599999999999998775
Q ss_pred ---------------------------------------------eEEEEecccccccccCccCCCCCCCCCCccChhcc
Q 037068 830 ---------------------------------------------VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864 (967)
Q Consensus 830 ---------------------------------------------~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l 864 (967)
.+||+|||+++..... .....||+.|+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence 8999999999866543 3445789999999999
Q ss_pred ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH------HHhhhhc-cc-----------------------------
Q 037068 865 RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ------VVGAVGF-QN----------------------------- 908 (967)
Q Consensus 865 ~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e------i~~~i~~-~~----------------------------- 908 (967)
.+..++.++|||||||++|||+||+.||....... ....+.. .+
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999998654321 1111100 00
Q ss_pred ----------cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 ----------RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 ----------~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.....+...++.+.+||.+||+.||++|||+.|+++|
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011233446788999999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.76 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=201.7
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeee--------
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVT-------- 759 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~-------- 759 (967)
..++|.+.+.||+|+||.||+|.+. ++.||||++... +......+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 4589999999999999999999774 788999988643 3456678899999999999999999999873
Q ss_pred ------ccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEE
Q 037068 760 ------RSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVK 832 (967)
Q Consensus 760 ------~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VK 832 (967)
.....++||||+. |+|.+++.+ ..+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCeEE
Confidence 3467899999997 699999864 5689999999999999999999998 799999999999997 577999
Q ss_pred EEecccccccccCc---cCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc
Q 037068 833 VCDFGLSRIKHHTY---LSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN 908 (967)
Q Consensus 833 LsDFGLAr~~~~~~---~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~ 908 (967)
|+|||+++...... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998654321 12233457999999999865 678999999999999999999999999887655443332110
Q ss_pred c----------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 909 R----------------------------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 909 ~----------------------------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
. ....+..+++++.++|.+||+.||++|||+.++++|-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 0 00123468999999999999999999999999999743
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.47 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=205.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc-----C
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS-----P 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~-----~ 762 (967)
..++|++.+.||+|+||.||+|.+. ++.||||++... ........+.+|+.++++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3479999999999999999999764 788999998543 2344556788999999999999999999987654 6
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
..++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999997 589998875 4699999999999999999999998 7999999999999999999999999999865
Q ss_pred ccCcc----------CCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-c--
Q 037068 843 HHTYL----------SSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-N-- 908 (967)
Q Consensus 843 ~~~~~----------~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~-- 908 (967)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... +
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43211 1223578999999998765 67899999999999999999999999988755433222100 0
Q ss_pred ---------------------cc------cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 909 ---------------------RR------LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 909 ---------------------~~------~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.. ...+..+++++.+||.+||+.||++|||+.++++|-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00 011246889999999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=360.21 Aligned_cols=250 Identities=24% Similarity=0.273 Sum_probs=208.3
Q ss_pred hccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc------CCCceeEEeeeeec
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL------RHPNVVLFMGAVTR 760 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L------~HpNIVkLig~~~~ 760 (967)
....+|++.+.||+|+||.||+|.+ .++.||||++.. .......+.+|+.+++.+ +|+||+++++++..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3457899999999999999999966 478899999854 234456778899998887 57799999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe--EEEEecc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV--VKVCDFG 837 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~--VKLsDFG 837 (967)
...+++||||+. ++|.+++.... ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++. +||+|||
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH--TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999999996 58888876543 4599999999999999999999999 7999999999999998887 9999999
Q ss_pred cccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc--------
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-------- 909 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~-------- 909 (967)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 99765433 3456799999999999999999999999999999999999999998876554433221000
Q ss_pred -------------------------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCcCHH
Q 037068 910 -------------------------------------------------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFA 940 (967)
Q Consensus 910 -------------------------------------------------~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ 940 (967)
...++...++++.+||.+||+.||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0001223478899999999999999999999
Q ss_pred HHHHHHH
Q 037068 941 QLMSRLR 947 (967)
Q Consensus 941 ELLe~L~ 947 (967)
|+|+|-.
T Consensus 405 e~L~Hpw 411 (429)
T 3kvw_A 405 QALRHPW 411 (429)
T ss_dssp HHHTSTT
T ss_pred HHhCChh
Confidence 9999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=360.84 Aligned_cols=247 Identities=24% Similarity=0.307 Sum_probs=199.9
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------C
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------P 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------~ 762 (967)
..+|.+.+.||+|+||.||+|++ +++.||||++..... ...+|++++++++|+||+++++++... .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 35799999999999999999977 488999999865321 123699999999999999999988542 2
Q ss_pred ceEEEEeecCCCchhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-CCeEEEEeccc
Q 037068 763 HFSILTEFLPRGSLYRLLH---RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGL 838 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~---~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-~g~VKLsDFGL 838 (967)
.+++||||+.+ +|..++. .....+++..++.++.||+.||.|||++ ||+||||||+||||+. ++.+||+|||+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChhhEEEeCCCCeEEeccchh
Confidence 36799999986 5655543 3456799999999999999999999998 7999999999999995 46899999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc----------
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---------- 907 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~---------- 907 (967)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 204 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 204 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654432 23456789999999999765 6999999999999999999999999987765443322110
Q ss_pred -----ccccC------------CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 908 -----NRRLE------------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 908 -----~~~~~------------ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
..... ++..+++++.+||.+||+.||.+|||+.|+++|-.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 00111 23467899999999999999999999999998853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=358.20 Aligned_cols=248 Identities=22% Similarity=0.273 Sum_probs=201.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc-----
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH----- 763 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~----- 763 (967)
...+|.+.+.||+|+||+||+|++ .+..+|+|++...... ..+|+.+++.++||||+++++++...+.
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 446899999999999999999987 4556999988654321 2359999999999999999999865443
Q ss_pred -eEEEEeecCCCchhhhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEEEecccc
Q 037068 764 -FSILTEFLPRGSLYRLL--HRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLS 839 (967)
Q Consensus 764 -l~LVmEy~~gGsL~~lL--~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKLsDFGLA 839 (967)
+++||||+.++.+..+. ......+++..++.++.||+.||.|||++ ||+||||||+||||+ .++.+||+|||++
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 88999999876444333 22356799999999999999999999998 799999999999999 7999999999999
Q ss_pred cccccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-----------
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ----------- 907 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~----------- 907 (967)
+...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 190 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8764432 24456789999999999775 4899999999999999999999999988765544332210
Q ss_pred ----cccc------------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 908 ----NRRL------------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 908 ----~~~~------------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.... .++..+++++.+||.+||+.||.+|||+.|+++|-
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 0000 12345889999999999999999999999999983
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.17 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=199.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-------- 760 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-------- 760 (967)
.++|++.+.||+|+||.||+|++ +++.||||++.. .......+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 36899999999999999999975 588999999854 23456778999999999999999999998754
Q ss_pred -----cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEe
Q 037068 761 -----SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCD 835 (967)
Q Consensus 761 -----~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsD 835 (967)
...+++||||+.+++|.+++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC--CeecccCCHHhEEEcCCCCEEEee
Confidence 4568999999999999999987666788999999999999999999998 799999999999999999999999
Q ss_pred cccccccccC--------------ccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC-ChhH
Q 037068 836 FGLSRIKHHT--------------YLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGL-NPMQ 899 (967)
Q Consensus 836 FGLAr~~~~~--------------~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~-~~~e 899 (967)
||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||... +...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9999765422 1122345689999999999865 68999999999999999998 55432 2223
Q ss_pred HHhhhhccc--cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 900 VVGAVGFQN--RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 900 i~~~i~~~~--~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
....+.... ....++...++.+.++|.+||+.||.+|||+.++++|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 333332111 12234456788899999999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.06 Aligned_cols=253 Identities=19% Similarity=0.229 Sum_probs=194.0
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc-
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH- 763 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~- 763 (967)
.....++|++.+.||+|+||.||+|++ +++.||||++..... ......++++.++.++||||+++++++...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445568999999999999999999976 478999998865432 22345668888899999999999999876433
Q ss_pred ------eEEEEeecCCCchhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCeEEeccCCCcEEEcC-CCeE
Q 037068 764 ------FSILTEFLPRGSLYRLLH---RPNHQLDERRRMRMALDVAKGMNYLH--TSHPTIVHRDLKSPNLLVDK-NWVV 831 (967)
Q Consensus 764 ------l~LVmEy~~gGsL~~lL~---~~~~~Lse~~i~~I~~QIa~aL~YLH--s~n~GIVHRDLKPsNILLd~-~g~V 831 (967)
+++||||+.++ |...+. .....+++..++.++.||+.||.||| ++ ||+||||||+||||+. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~--~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV--NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT--CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC--CeecCcCCHHHEEEeCCCCcE
Confidence 78999999875 443332 24567899999999999999999999 66 8999999999999996 8999
Q ss_pred EEEecccccccccCccCCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc--
Q 037068 832 KVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN-- 908 (967)
Q Consensus 832 KLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~-- 908 (967)
||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+....
T Consensus 172 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp EECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999998765433 234567899999999987654 8999999999999999999999999887765544432100
Q ss_pred ----------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 909 ----------------------------RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 909 ----------------------------~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
.....+...++++.+||.+||+.||.+|||+.|+++|-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 00112233678999999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.65 Aligned_cols=259 Identities=26% Similarity=0.449 Sum_probs=189.4
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHH-HHHHcCCCceeEEeeeeecc
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAE-IMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~-ILk~L~HpNIVkLig~~~~~ 761 (967)
..|.+..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+..|+. +++.++||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 456677799999999999999999999774 8899999987543 3344455666666 66777999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 762 PHFSILTEFLPRGSLYRLLHR----PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~----~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
+..++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||++. ||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH-SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC-CEeECCCCHHHEEEcCCCCEEEccCC
Confidence 999999999985 77776642 3567899999999999999999999972 59999999999999999999999999
Q ss_pred cccccccCccCCCCCCCCCCccChhcc----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhccccccC
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVL----RNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRLE 912 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l----~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~~~ 912 (967)
+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... +....+ .......
T Consensus 172 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~ 249 (327)
T 3aln_A 172 ISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDPPQ 249 (327)
T ss_dssp SSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-CCSCCCC
T ss_pred Cceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-hcCCCCC
Confidence 998664432 23334799999999998 4667899999999999999999999999875432 111111 1122222
Q ss_pred C----CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHH
Q 037068 913 I----PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 913 i----p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~ 948 (967)
+ +..+++.+.+||.+||+.||.+|||+.+++++-.-
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 2 24689999999999999999999999999998543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=364.57 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=212.6
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC-CceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH-PNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H-pNIVkLig~~~~~~~l~L 766 (967)
..++|++.++||+|+||.||+|++ .++.||||++...... ..+..|+++++.+.| ++|..+..++......+|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 357999999999999999999975 4889999987654322 246789999999976 555566666677778899
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE---cCCCeEEEEecccccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL---d~~g~VKLsDFGLAr~~~ 843 (967)
||||+ +++|.+++......+++..++.|+.||+.||.|||++ |||||||||+|||| +.++.+||+|||+++...
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99999 8999999987667899999999999999999999998 79999999999999 688999999999998755
Q ss_pred cCcc-------CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhH---HHhhhhc---cccc
Q 037068 844 HTYL-------SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQ---VVGAVGF---QNRR 910 (967)
Q Consensus 844 ~~~~-------~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e---i~~~i~~---~~~~ 910 (967)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... ....+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4321 2235679999999999999999999999999999999999999998765422 2222111 1111
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 911 LEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 911 ~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
..++..+++++.+||.+||+.+|++||++.+|++.|+.+....
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 2234678999999999999999999999999999999987654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.04 Aligned_cols=248 Identities=22% Similarity=0.442 Sum_probs=200.0
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh----hhHHHHHHHHHHHHHc----CCCceeEEe
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG----DSLSQFKCEAEIMLRL----RHPNVVLFM 755 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~----~~~~~~~~Ei~ILk~L----~HpNIVkLi 755 (967)
..+...++|++.+.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+++++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455668999999999999999999976 57889999986543221 1233456799999998 899999999
Q ss_pred eeeeccCceEEEEee-cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEE
Q 037068 756 GAVTRSPHFSILTEF-LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKV 833 (967)
Q Consensus 756 g~~~~~~~l~LVmEy-~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKL 833 (967)
+++...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH--TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 789999999876 44699999999999999999999999 799999999999999 8899999
Q ss_pred EecccccccccCccCCCCCCCCCCccChhccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC
Q 037068 834 CDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPAN-EKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE 912 (967)
Q Consensus 834 sDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s-~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ 912 (967)
+|||+++...... .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||.... +.. .....
T Consensus 182 ~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~------~~~~~ 251 (312)
T 2iwi_A 182 IDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EIL------EAELH 251 (312)
T ss_dssp CCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HTCCC
T ss_pred EEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HHh------hhccC
Confidence 9999998765432 3456799999999999877764 58999999999999999999997532 111 22445
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
++..+++++.++|.+||+.||++|||+.++++|-
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 6778999999999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=342.59 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=203.2
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecC--C-CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc------eeEEeeee
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWH--G-TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN------VVLFMGAV 758 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~--g-~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN------IVkLig~~ 758 (967)
....++|++.+.||+|+||+||+|.+. + +.||||++.. .......+.+|+.++++++|++ ++.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 345689999999999999999999763 4 5799999853 2344567888999999987655 89999999
Q ss_pred eccCceEEEEeecCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE------------
Q 037068 759 TRSPHFSILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV------------ 825 (967)
Q Consensus 759 ~~~~~l~LVmEy~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL------------ 825 (967)
...+.++|||||+. ++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+||||
T Consensus 92 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 NFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeccccccccccc
Confidence 99999999999994 556555544 345799999999999999999999998 79999999999999
Q ss_pred -------cCCCeEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh
Q 037068 826 -------DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM 898 (967)
Q Consensus 826 -------d~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ 898 (967)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999865433 34567999999999999999999999999999999999999999987765
Q ss_pred HHHhhhhccccc------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCC
Q 037068 899 QVVGAVGFQNRR------------------------------------------LEIPDDIDPAVAQIIRDCWQTEPHLR 936 (967)
Q Consensus 899 ei~~~i~~~~~~------------------------------------------~~ip~~ls~eL~dLI~~CLq~dPe~R 936 (967)
+....+...... .......++++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 443322110000 00111235689999999999999999
Q ss_pred cCHHHHHHHH
Q 037068 937 PSFAQLMSRL 946 (967)
Q Consensus 937 PS~~ELLe~L 946 (967)
||+.|+++|-
T Consensus 326 pt~~e~l~hp 335 (355)
T 2eu9_A 326 ITLAEALLHP 335 (355)
T ss_dssp CCHHHHTTSG
T ss_pred cCHHHHhcCh
Confidence 9999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=352.50 Aligned_cols=254 Identities=24% Similarity=0.282 Sum_probs=206.8
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CC-----ceeEEeee
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HP-----NVVLFMGA 757 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-Hp-----NIVkLig~ 757 (967)
..+...++|++.+.||+|+||+||+|.+ .++.||||++.. .......+..|+.+++.++ |+ +|++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3445668999999999999999999976 477899999853 2344567788999998884 55 49999999
Q ss_pred eeccCceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc--CCCeEEEE
Q 037068 758 VTRSPHFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD--KNWVVKVC 834 (967)
Q Consensus 758 ~~~~~~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd--~~g~VKLs 834 (967)
+...+.++|||||+.+ +|.+++.... ..+++..++.++.||+.||.|||.+..||+||||||+||||+ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999999964 9999887643 569999999999999999999996444899999999999994 57889999
Q ss_pred ecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc---
Q 037068 835 DFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--- 911 (967)
Q Consensus 835 DFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--- 911 (967)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+....+......+
T Consensus 204 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 204 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp CCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99999876433 345679999999999999999999999999999999999999999887665544332100000
Q ss_pred -------------CCCC----------------------------------------------CCcHHHHHHHHHhhhcC
Q 037068 912 -------------EIPD----------------------------------------------DIDPAVAQIIRDCWQTE 932 (967)
Q Consensus 912 -------------~ip~----------------------------------------------~ls~eL~dLI~~CLq~d 932 (967)
.+|. ..++++.+||.+||+.|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 0000 01147899999999999
Q ss_pred CCCCcCHHHHHHHH
Q 037068 933 PHLRPSFAQLMSRL 946 (967)
Q Consensus 933 Pe~RPS~~ELLe~L 946 (967)
|++|||+.|+|+|-
T Consensus 361 P~~Rpta~e~L~hp 374 (382)
T 2vx3_A 361 PKTRIQPYYALQHS 374 (382)
T ss_dssp TTTSCCHHHHTTSG
T ss_pred hhhCCCHHHHhcCc
Confidence 99999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.16 Aligned_cols=249 Identities=21% Similarity=0.387 Sum_probs=208.8
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh----hhHHHHHHHHHHHHHcC--CCceeEEee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG----DSLSQFKCEAEIMLRLR--HPNVVLFMG 756 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~----~~~~~~~~Ei~ILk~L~--HpNIVkLig 756 (967)
...+...++|++.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34556678999999999999999999965 57889999987654322 12245667999999996 599999999
Q ss_pred eeeccCceEEEEeecCC-CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEEE
Q 037068 757 AVTRSPHFSILTEFLPR-GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVC 834 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~g-GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKLs 834 (967)
++...+..++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++ +++.+||+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999999986 899999876 45689999999999999999999998 799999999999999 78999999
Q ss_pred ecccccccccCccCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCC
Q 037068 835 DFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI 913 (967)
Q Consensus 835 DFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~i 913 (967)
|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... ......
T Consensus 193 Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~------~~~~~~ 262 (320)
T 3a99_A 193 DFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII------RGQVFF 262 (320)
T ss_dssp CCTTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HCCCCC
T ss_pred eCcccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--hhh------cccccc
Confidence 999998765432 344679999999999987776 688999999999999999999997542 111 123345
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 914 PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 914 p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+..+++++.++|.+||+.||++|||+.+++++-
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 678899999999999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.63 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=178.7
Q ss_pred ccCCeeEeE-EeecCCceEEEEeecC--CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec----cC
Q 037068 690 LWEDLQIGE-RIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR----SP 762 (967)
Q Consensus 690 ~~e~y~i~k-~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~----~~ 762 (967)
..++|.+.+ .||+|+||.||+|.+. ++.||||++... . .........++.++|+||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 447899955 6999999999999774 889999998542 1 122223334566799999999999876 44
Q ss_pred ceEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---CCeEEEEeccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---NWVVKVCDFGL 838 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~---~g~VKLsDFGL 838 (967)
.+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 5899999999999999998653 4699999999999999999999998 7999999999999975 45699999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhh----hhcccc--ccC
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGA----VGFQNR--RLE 912 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~----i~~~~~--~~~ 912 (967)
++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||........... +..... ...
T Consensus 178 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 178 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred ceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 9865433 23456789999999999988899999999999999999999999987654433211 111111 112
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
....+++++.+||.+||+.||.+|||+.++++|-.--
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 292 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 2257899999999999999999999999999986543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.05 Aligned_cols=250 Identities=18% Similarity=0.270 Sum_probs=201.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-----------CCceeEEee
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-----------HPNVVLFMG 756 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-----------HpNIVkLig 756 (967)
..++|.+.+.||+|+||.||+|++ .++.||||++.. .......+.+|+.++++++ |+||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 347999999999999999999975 578999999853 2344567888999999886 899999999
Q ss_pred eeeccC----ceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-----
Q 037068 757 AVTRSP----HFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD----- 826 (967)
Q Consensus 757 ~~~~~~----~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd----- 826 (967)
++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++. ||+||||||+||||+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT-CEECSCCSGGGEEEEEEETT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC-CEEecCCChHHeEEeccCCC
Confidence 987654 789999999 88999998753 456999999999999999999999962 599999999999994
Q ss_pred -CCCeEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh------H
Q 037068 827 -KNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM------Q 899 (967)
Q Consensus 827 -~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~------e 899 (967)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999866543 33457899999999999999999999999999999999999999865421 1
Q ss_pred HHhhhhc----------------------------------------cccccCCCCCCcHHHHHHHHHhhhcCCCCCcCH
Q 037068 900 VVGAVGF----------------------------------------QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSF 939 (967)
Q Consensus 900 i~~~i~~----------------------------------------~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~ 939 (967)
....+.. ......++..+++++.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111100 001122344567889999999999999999999
Q ss_pred HHHHHHHH
Q 037068 940 AQLMSRLR 947 (967)
Q Consensus 940 ~ELLe~L~ 947 (967)
.|+++|-.
T Consensus 329 ~ell~hp~ 336 (373)
T 1q8y_A 329 GGLVNHPW 336 (373)
T ss_dssp HHHHTCGG
T ss_pred HHHhhChh
Confidence 99999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=352.60 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=185.0
Q ss_pred cCCeeE-eEEeecCCceEEEEeecC----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--cCc
Q 037068 691 WEDLQI-GERIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--SPH 763 (967)
Q Consensus 691 ~e~y~i-~k~LGeG~FG~VYka~~~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--~~~ 763 (967)
.+.|.+ +++||+|+||+||+|++. ++.||||++..... ...+.+|+.++++++||||+++++++.. ...
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 356776 568999999999999753 67899999865432 2457789999999999999999999954 667
Q ss_pred eEEEEeecCCCchhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE----cCCCeE
Q 037068 764 FSILTEFLPRGSLYRLLHR--------PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV----DKNWVV 831 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~--------~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL----d~~g~V 831 (967)
++|||||+.+ +|.+++.. ....+++..++.|+.||+.||.|||++ ||+||||||+|||| +.++.+
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--CEeCCCcCHHHeEEecCCCCCCcE
Confidence 9999999975 77777642 123599999999999999999999998 79999999999999 677999
Q ss_pred EEEecccccccccCc---cCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChh---------
Q 037068 832 KVCDFGLSRIKHHTY---LSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPM--------- 898 (967)
Q Consensus 832 KLsDFGLAr~~~~~~---~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~--------- 898 (967)
||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999998764321 223456799999999999874 5899999999999999999999999765432
Q ss_pred HHHhhhh-cccc-------------------------cc----------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHH
Q 037068 899 QVVGAVG-FQNR-------------------------RL----------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQL 942 (967)
Q Consensus 899 ei~~~i~-~~~~-------------------------~~----------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~EL 942 (967)
..+..+. ..+. .. ......++.+.+||.+||+.||.+|||+.|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 1111110 0000 00 0011236789999999999999999999999
Q ss_pred HHHHHH
Q 037068 943 MSRLRC 948 (967)
Q Consensus 943 Le~L~~ 948 (967)
|+|-.-
T Consensus 332 L~hp~f 337 (405)
T 3rgf_A 332 MQDPYF 337 (405)
T ss_dssp HTSGGG
T ss_pred hcChhh
Confidence 998643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=352.96 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=197.5
Q ss_pred hhhccCCeeEeEEeecCCceE-EEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 687 WEILWEDLQIGERIGIGSYGE-VYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~-VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
+.+...+|.+.+.||+|+||+ ||++..+++.||||++..... ..+.+|+.+++++ +||||+++++++.+....
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 344456799999999999998 556677899999999865322 2345799999999 799999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-----CCeEEEEecccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-----NWVVKVCDFGLS 839 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-----~g~VKLsDFGLA 839 (967)
+|||||+. |+|.+++......+.+..++.++.||+.||.|||++ ||+||||||+||||+. ...+||+|||++
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT--TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC--cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999996 599999987666666677789999999999999998 7999999999999953 236889999999
Q ss_pred cccccCc---cCCCCCCCCCCccChhccc---cCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccc-c
Q 037068 840 RIKHHTY---LSSKSTAGTPEWMAPEVLR---NEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRR-L 911 (967)
Q Consensus 840 r~~~~~~---~~~~~~~GT~~YmAPE~l~---g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~-~ 911 (967)
+...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||...........+...... .
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 8654332 2234567999999999997 4567889999999999999999 89999776555443333211111 1
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 912 ~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..+...+..+.+||.+||+.||.+|||+.++++|
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 2223456778999999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=324.81 Aligned_cols=232 Identities=16% Similarity=0.100 Sum_probs=192.9
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+..++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.++++++||||+++++++...+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999874 789999998765432 455678999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
+||||+++++|.+++.. ......+..|+.||+.||+|||++ ||+||||||+||||+.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~--givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHC--CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999999964 246667899999999999999998 79999999999999999999997443
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-ccccc----CCCCCCcHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRL----EIPDDIDPA 920 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~----~ip~~ls~e 920 (967)
|++ .++.++|||||||++|||+||+.||...+.......... ..... ..+..++++
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 343 378999999999999999999999998765432211100 01111 233578999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
+.++|.+||+.||++| |+.++++.|..+....
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 9999999999999999 9999999999986543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=342.38 Aligned_cols=244 Identities=23% Similarity=0.365 Sum_probs=188.7
Q ss_pred CCeeEeEEeecCCceEEEEe-ecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka-~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+.|.+.+.||+|+||+||.+ ..+++.||||++... ..+.+.+|+.+++++ +||||+++++++.....++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 55677899999999999654 567999999998643 245678899999886 89999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-------------Ce
Q 037068 770 FLPRGSLYRLLHRPNHQ------LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-------------WV 830 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~------Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-------------g~ 830 (967)
|+. |+|.+++...... .++..++.++.||+.||.|||++ ||+||||||+||||+.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCcccccccccCCCceE
Confidence 996 6999999764321 13334678999999999999998 79999999999999754 48
Q ss_pred EEEEecccccccccCcc----CCCCCCCCCCccChhcccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChh
Q 037068 831 VKVCDFGLSRIKHHTYL----SSKSTAGTPEWMAPEVLRN-------EPANEKCDVYSFGVILWELAT-LSVPWKGLNPM 898 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~~----~~~~~~GT~~YmAPE~l~g-------~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ 898 (967)
+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987654321 1234579999999999976 668999999999999999999 99999866543
Q ss_pred HHHhhhhccccccC-C----CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 899 QVVGAVGFQNRRLE-I----PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 899 ei~~~i~~~~~~~~-i----p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+.. .+. ...... . +..+++++.++|.+||+.||.+|||+.++++|
T Consensus 247 ~~~-i~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ESN-IIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHH-HHH-TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH-Hhc-CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 321 111 111111 1 12356889999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=343.25 Aligned_cols=252 Identities=16% Similarity=0.125 Sum_probs=193.0
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CCeEEEEEeecCC-CChhhHHHHHHHHHHHHHcCC-Ccee------------
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQD-FSGDSLSQFKCEAEIMLRLRH-PNVV------------ 752 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~~-~s~~~~~~~~~Ei~ILk~L~H-pNIV------------ 752 (967)
.....|.+.+.||+|+||+||+|++. ++.||||++.... ......+.+.+|+.+++.++| +|+.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34456889999999999999999864 8899999886332 223346778999999999976 2211
Q ss_pred ---E------Eeeeeec-----cCceEEEEeecCCCchhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037068 753 ---L------FMGAVTR-----SPHFSILTEFLPRGSLYRLLH------RPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812 (967)
Q Consensus 753 ---k------Lig~~~~-----~~~l~LVmEy~~gGsL~~lL~------~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~G 812 (967)
. ++.++.. ...++++|+++ +++|.+++. ..+..+++..++.++.||+.||.|||++ |
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--G 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--T
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--C
Confidence 1 1111111 12356777755 679998884 3345578889999999999999999998 7
Q ss_pred eEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCCCCCCccChhcc----------ccCCCCchhHHHHHHHHH
Q 037068 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL----------RNEPANEKCDVYSFGVIL 882 (967)
Q Consensus 813 IVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l----------~g~~~s~ksDVWSLGvlL 882 (967)
||||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999999865543 344567 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH--HHHHHHHh
Q 037068 883 WELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR--LRCLQRLL 953 (967)
Q Consensus 883 ~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~--L~~L~~l~ 953 (967)
|||+||+.||...+..+....+ ......+++++.+||.+||+.||++||++.+++++ ++.+.+.+
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred HHHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 9999999999877654433322 22234678999999999999999999999998876 55554443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.61 Aligned_cols=227 Identities=24% Similarity=0.433 Sum_probs=184.5
Q ss_pred CCeeEe-EEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHH-HHcCCCceeEEeeeeec----cCc
Q 037068 692 EDLQIG-ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIM-LRLRHPNVVLFMGAVTR----SPH 763 (967)
Q Consensus 692 e~y~i~-k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~IL-k~L~HpNIVkLig~~~~----~~~ 763 (967)
++|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 667776 7899999999999976 5789999998532 3566788888 55699999999999876 667
Q ss_pred eEEEEeecCCCchhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---CCeEEEEecccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPN-HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---NWVVKVCDFGLS 839 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~-~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~---~g~VKLsDFGLA 839 (967)
+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999997643 4699999999999999999999998 7999999999999997 789999999998
Q ss_pred cccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--cccccCCC---
Q 037068 840 RIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF--QNRRLEIP--- 914 (967)
Q Consensus 840 r~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~--~~~~~~ip--- 914 (967)
+... +..++.++|||||||++|||++|+.||.............. .......+
T Consensus 168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 6432 23477899999999999999999999987665443222211 11122233
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 915 -DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 915 -~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
..+++++.++|.+||+.||.+|||+.++++|-.-.
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 56899999999999999999999999999986543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=358.63 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=201.0
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeec---CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADW---HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~---~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
..++..++|++.+.||+|+||+||++.+ .++.||||++... ........+.+|+.++++++||||+++++++...+
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 3445668999999999999999999976 4788999987643 34455667899999999999999999999998766
Q ss_pred c-----eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 763 H-----FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 763 ~-----l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
. .||||||+.+++|.+++.. .+++..++.|+.||+.||.|||++ |||||||||+||||+.+ .+||+|||
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~--giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC--CCeecccChHHeEEeCC-cEEEEecc
Confidence 5 7999999999999988754 699999999999999999999998 79999999999999885 99999999
Q ss_pred cccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........ .........
T Consensus 227 ~a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~~ 293 (681)
T 2pzi_A 227 AVSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKT 293 (681)
T ss_dssp TCEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTCHHHHH
T ss_pred cchhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------ccccccccc
Confidence 99866543 4467999999999998764 8999999999999999999988875321100 000000124
Q ss_pred cHHHHHHHHHhhhcCCCCCc-CHHHHHHHHHHHHHHh
Q 037068 918 DPAVAQIIRDCWQTEPHLRP-SFAQLMSRLRCLQRLL 953 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RP-S~~ELLe~L~~L~~l~ 953 (967)
++.+.++|.+||+.||.+|| +++++.+.|..+.+..
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 57899999999999999999 5677777777765443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.35 Aligned_cols=242 Identities=17% Similarity=0.174 Sum_probs=189.9
Q ss_pred hccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCC------ChhhHHHHHHHHHHHHHcC---------CCceeE
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDF------SGDSLSQFKCEAEIMLRLR---------HPNVVL 753 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~------s~~~~~~~~~Ei~ILk~L~---------HpNIVk 753 (967)
+..++|++.+.||+|+||+||+|+++++.||||++..... .....+.+.+|+.+++.++ |+||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 3457899999999999999999999999999999976532 2334577899999999886 666665
Q ss_pred Eeee-----------------eec-------------cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 037068 754 FMGA-----------------VTR-------------SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803 (967)
Q Consensus 754 Lig~-----------------~~~-------------~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL 803 (967)
++++ +.. .+.++|||||+.+|++.+.+.+ ..+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 5554 433 6789999999999977666643 5689999999999999999
Q ss_pred HHHH-hcCCCeEEeccCCCcEEEcCCC--------------------eEEEEecccccccccCccCCCCCCCCCCccChh
Q 037068 804 NYLH-TSHPTIVHRDLKSPNLLVDKNW--------------------VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPE 862 (967)
Q Consensus 804 ~YLH-s~n~GIVHRDLKPsNILLd~~g--------------------~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE 862 (967)
.||| ++ ||+||||||+||||+.++ .+||+|||+|+..... ...||+.|+|||
T Consensus 175 ~~lH~~~--~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHH--CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHhC--CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 9999 78 799999999999999877 9999999999876543 347999999999
Q ss_pred ccccCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCh-hHHHhhhh----cccc-ccCCCCCCcHHHHHHHHHhhhcCCCC
Q 037068 863 VLRNEPANEKCDVYSFGVI-LWELATLSVPWKGLNP-MQVVGAVG----FQNR-RLEIPDDIDPAVAQIIRDCWQTEPHL 935 (967)
Q Consensus 863 ~l~g~~~s~ksDVWSLGvl-L~ELlTGk~PF~~~~~-~ei~~~i~----~~~~-~~~ip~~ls~eL~dLI~~CLq~dPe~ 935 (967)
++.+.. +.++|||||+++ .+++++|..||..... ......+. .... ....+..+++++.+||++||+.|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 998776 899999998777 7788889999854211 11111111 1100 11112357889999999999977
Q ss_pred CcCHHHHH-HH
Q 037068 936 RPSFAQLM-SR 945 (967)
Q Consensus 936 RPS~~ELL-e~ 945 (967)
|+.|+| +|
T Consensus 324 --sa~e~l~~H 332 (336)
T 2vuw_A 324 --SATDLLCQH 332 (336)
T ss_dssp --SHHHHHHHC
T ss_pred --CHHHHHhcC
Confidence 999999 65
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=352.11 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=200.1
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec------cC
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR------SP 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~------~~ 762 (967)
.++|++.+.||+|+||.||+|.+ .++.||||++... ........+.+|+.++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999976 5789999987543 455667789999999999999999999998765 66
Q ss_pred ceEEEEeecCCCchhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC---eEEEEecc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPN--HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW---VVKVCDFG 837 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~--~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g---~VKLsDFG 837 (967)
..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~--gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT--TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999997643 3689999999999999999999998 799999999999998665 49999999
Q ss_pred cccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHh---------h-hhc-
Q 037068 838 LSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVG---------A-VGF- 906 (967)
Q Consensus 838 LAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~---------~-i~~- 906 (967)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... . ...
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998765443 2345679999999999999999999999999999999999999997643221100 0 000
Q ss_pred -c------ccccC----CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 907 -Q------NRRLE----IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 907 -~------~~~~~----ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. ....+ ++..+++.+.++|.+||..||++|||+.++++|
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 0 00111 223467899999999999999999999996544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=299.96 Aligned_cols=186 Identities=13% Similarity=0.078 Sum_probs=133.5
Q ss_pred EEeecCCceEEEEeec--CCCeEEEEEeecCCCC--------hhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCceEE
Q 037068 698 ERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS--------GDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 698 k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s--------~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l~L 766 (967)
..++.|++|.+..++. .|..++||.+.+.... ....+++.+|+++|+++ +|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4577888887776643 6899999999765221 23356799999999999 79999999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~ 846 (967)
||||++|++|.++|.+ ++.+++. +|+.||+.||+|||++ |||||||||+||||+.+|++||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~--GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQ--GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHT--TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHC--CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999986 4567665 4789999999999999 79999999999999999999999999998776554
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCC
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSV 890 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~ 890 (967)
......+||+.|||||++.+. +..++|+|++|+++++|.++..
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 455567799999999999765 6778999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-26 Score=266.17 Aligned_cols=186 Identities=16% Similarity=0.209 Sum_probs=148.5
Q ss_pred eEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhh------HHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 695 QIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDS------LSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~------~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
...+.||+|+||.||+++..++.+++|+.......... .+.+.+|++++++++||||+++..++...+..+|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 34678999999999999889999999987654433221 345899999999999999996555555677789999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+++++|.+++.. +..++.||+.||+|||++ ||+||||||+|||++. .+||+|||+++........
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~--gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN--DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT--TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC--cCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999875 568999999999999998 7999999999999998 9999999999876543211
Q ss_pred -------CCCCCCCCCccChhcccc--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 037068 849 -------SKSTAGTPEWMAPEVLRN--EPANEKCDVYSFGVILWELATLSVPWK 893 (967)
Q Consensus 849 -------~~~~~GT~~YmAPE~l~g--~~~s~ksDVWSLGvlL~ELlTGk~PF~ 893 (967)
.....||+.|||||++.+ ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 134679999999999987 557788999999999888888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=212.20 Aligned_cols=150 Identities=20% Similarity=0.117 Sum_probs=119.2
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCCh----------------hhHHHHHHHHHHHHHcCCCc
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSG----------------DSLSQFKCEAEIMLRLRHPN 750 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~----------------~~~~~~~~Ei~ILk~L~HpN 750 (967)
......|.+.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 33456778889999999999999987 47889999985432111 13456889999999998 4
Q ss_pred eeEEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCe
Q 037068 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWV 830 (967)
Q Consensus 751 IVkLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~ 830 (967)
+++.+++.. +..++||||+++++|.+ +.. .....++.||+.||.|||++ ||+||||||+||||+ ++.
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~--giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEEE-TTE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC--CCEeCCCCHHHEEEE-CCc
Confidence 666665433 56799999999999998 432 22457999999999999998 799999999999999 999
Q ss_pred EEEEecccccccccCccCCCCCCCCCCccChhccc
Q 037068 831 VKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865 (967)
Q Consensus 831 VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~ 865 (967)
+||+|||+++. +..++|||++.
T Consensus 231 vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE-------------CCCCCHHHHHH
Confidence 99999999963 33578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.6e-18 Score=180.59 Aligned_cols=138 Identities=22% Similarity=0.188 Sum_probs=106.3
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCe--EEEEEeecCCCCh----------------------hhHHHHHHHHHHHHHc
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTE--VAVKKFLDQDFSG----------------------DSLSQFKCEAEIMLRL 746 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~--VAVKkl~~~~~s~----------------------~~~~~~~~Ei~ILk~L 746 (967)
-|.+.+.||+|+||.||+|.+ .|+. ||||++....... .....+.+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999987 6888 9999875431110 1123578899999999
Q ss_pred CCCce--eEEeeeeeccCceEEEEeecCC-C----chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCeEEecc
Q 037068 747 RHPNV--VLFMGAVTRSPHFSILTEFLPR-G----SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH-TSHPTIVHRDL 818 (967)
Q Consensus 747 ~HpNI--VkLig~~~~~~~l~LVmEy~~g-G----sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLH-s~n~GIVHRDL 818 (967)
+|++| ..++++ ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| ++ ||+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~--givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA--ELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS--CEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC--CEEeCCC
Confidence 87754 344432 357899999942 3 66665432 234567889999999999999 77 7999999
Q ss_pred CCCcEEEcCCCeEEEEeccccccc
Q 037068 819 KSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 819 KPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.4e-15 Score=172.68 Aligned_cols=136 Identities=14% Similarity=0.134 Sum_probs=98.2
Q ss_pred CeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCC------------ChhhHHH--------HHHHHHHHHHcCCCce
Q 037068 693 DLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDF------------SGDSLSQ--------FKCEAEIMLRLRHPNV 751 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~------------s~~~~~~--------~~~Ei~ILk~L~HpNI 751 (967)
=|.+.+.||.|+||.||+|.. .|+.||||++..... ....... ...|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 389999999999999999976 588999998753210 0001111 2345666666644443
Q ss_pred e--EEeeeeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC
Q 037068 752 V--LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW 829 (967)
Q Consensus 752 V--kLig~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g 829 (967)
. ..+++ ...+|||||+.|++|..+... .....++.||+.+|.|||++ |||||||||.||||++++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~--gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKH--GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHEEEeCCC
Confidence 2 22222 234799999999998776432 12456789999999999998 799999999999998776
Q ss_pred ----------eEEEEecccccc
Q 037068 830 ----------VVKVCDFGLSRI 841 (967)
Q Consensus 830 ----------~VKLsDFGLAr~ 841 (967)
.+.|+||+.+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 489999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=7.6e-11 Score=124.13 Aligned_cols=142 Identities=16% Similarity=0.082 Sum_probs=112.7
Q ss_pred cCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEEEe
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LVmE 769 (967)
.+.|.+...++.|+++.||++...++.+++|+...... .....+.+|+.+++.+. +..+.++++++...+..++|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 35788999999999999999987788999998754211 11235788999999984 6677889999888888999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH--------------------------------------- 810 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n--------------------------------------- 810 (967)
|++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999999876421 1223467889999999999810
Q ss_pred ------------------CCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 811 ------------------PTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 811 ------------------~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
++++|+|++|.||+++.+..+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 359999999999999877667899998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=8.4e-10 Score=114.53 Aligned_cols=135 Identities=21% Similarity=0.173 Sum_probs=99.3
Q ss_pred CCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc--eeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--VVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN--IVkLig~~~~~~~l~LVm 768 (967)
..+.+....+.|..+.||++... |+.+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 45666444445666999999754 567999986432 1235678999999985444 456888888778899999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH-------------------------------------- 810 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n-------------------------------------- 810 (967)
||++|.+|. ... .+. ..++.+++..|..||+..
T Consensus 95 e~i~G~~l~--~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998884 221 122 256777888888888642
Q ss_pred ------------------CCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 811 ------------------PTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 811 ------------------~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
++++|+|++|.||+++.++.++|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 139999999999999887777899999875
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.00 E-value=5.6e-11 Score=111.80 Aligned_cols=55 Identities=13% Similarity=0.081 Sum_probs=52.4
Q ss_pred cccccceecccCCCCChhhHhhHH-HHHhhhhccccccccCcccCCCCCcccCCccccccCCCCC
Q 037068 561 HKKLEPNVINCDLSLSSDTAGERF-VLVGNELKLNNATSVNTVPVNPPGVVAGASCEKEIPGSPL 624 (967)
Q Consensus 561 ~~~~~y~lvqCtpdls~~~c~~cl-~~i~~~~~~~~~~~~~~~~~~~ggrvlg~SC~~rye~~pf 624 (967)
..+| |||+||++|+++.+|..|| .++..++ .+|+.+.||+|+.++|.+||+.++|
T Consensus 53 ~~~v-ygl~qC~~Dls~~~C~~Cl~~a~~~~~--------~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 53 APTA-YGRATCKQSISQSDCTACLSNLVNRIF--------SICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp CCCE-EEEEEECTTSCHHHHHHHHHHHHTTHH--------HHTTSBSSEEEEETTEEEEEESSCC
T ss_pred CceE-EEEEEEcCCCCHHHHHHHHHHHHHHHH--------HHCCCCceEEEECCCEEEEEeCCcC
Confidence 4567 9999999999999999999 9999999 8999999999999999999999987
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.5e-09 Score=118.23 Aligned_cols=143 Identities=17% Similarity=0.171 Sum_probs=108.0
Q ss_pred eEeEEeecCCceEEEEeecCCCeEEEEEee--cCCCChhhHHHHHHHHHHHHHcCC--CceeEEeeeeecc---CceEEE
Q 037068 695 QIGERIGIGSYGEVYRADWHGTEVAVKKFL--DQDFSGDSLSQFKCEAEIMLRLRH--PNVVLFMGAVTRS---PHFSIL 767 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~~g~~VAVKkl~--~~~~s~~~~~~~~~Ei~ILk~L~H--pNIVkLig~~~~~---~~l~LV 767 (967)
...+.|+.|.++.||+++..+..+++|+.. .... ......+.+|..+++.|.+ ..+.+++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999998888889999764 2211 1123467889999999964 4577888887765 458999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS-------------------------------------- 809 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~-------------------------------------- 809 (967)
|||++|..+.+.. -..+++.....++.+++..|..||..
T Consensus 120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998775421 12367888889999999999999972
Q ss_pred ------------------CCCeEEeccCCCcEEEcCCC--eEEEEecccccc
Q 037068 810 ------------------HPTIVHRDLKSPNLLVDKNW--VVKVCDFGLSRI 841 (967)
Q Consensus 810 ------------------n~GIVHRDLKPsNILLd~~g--~VKLsDFGLAr~ 841 (967)
.++++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 24799999999999998764 369999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.71 E-value=5.7e-08 Score=105.05 Aligned_cols=185 Identities=20% Similarity=0.183 Sum_probs=123.1
Q ss_pred EEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCc--eeEEeeeeeccC---ceEEEEeec
Q 037068 698 ERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPN--VVLFMGAVTRSP---HFSILTEFL 771 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpN--IVkLig~~~~~~---~l~LVmEy~ 771 (967)
+.++.|.+..||++. ..+++|+... ......+.+|..+++.+ .+.. +.+++......+ ..|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999985 5688887432 23456789999999988 3333 334554443333 358999999
Q ss_pred CCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 037068 772 PRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS------------------------------------------ 809 (967)
Q Consensus 772 ~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~------------------------------------------ 809 (967)
+|.+|..... ..++......++.|++..|..||+.
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988875332 2367777888888888888888861
Q ss_pred --------------CCCeEEeccCCCcEEEcC--CCeEEEEecccccccccCccCCCCCCCCCCccChhcccc-----CC
Q 037068 810 --------------HPTIVHRDLKSPNLLVDK--NWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN-----EP 868 (967)
Q Consensus 810 --------------n~GIVHRDLKPsNILLd~--~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g-----~~ 868 (967)
.+.++|+|++|.||+++. +..+.|+||+.+..-+.... .........-..|+.... +.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhccccCHHHHHHHHHHcCC
Confidence 135899999999999998 56789999999875432110 000000000022332111 01
Q ss_pred C---------CchhHHHHHHHHHHHHHhCCCCCC
Q 037068 869 A---------NEKCDVYSFGVILWELATLSVPWK 893 (967)
Q Consensus 869 ~---------s~ksDVWSLGvlL~ELlTGk~PF~ 893 (967)
. ....+.|+++.++|.+.+|..+|.
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 123689999999999999987763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=9.5e-06 Score=88.28 Aligned_cols=135 Identities=19% Similarity=0.147 Sum_probs=94.3
Q ss_pred eEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCC---ceeEEeeeee-ccCceEEEEeecC
Q 037068 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP---NVVLFMGAVT-RSPHFSILTEFLP 772 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~Hp---NIVkLig~~~-~~~~l~LVmEy~~ 772 (967)
.+.++.|....||+. +..+++|+.. .......+.+|..+|+.|.+. .+.+.+.+.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356888999999988 6778888732 233456789999999999642 2456666553 4556789999999
Q ss_pred CCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 037068 773 RGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS------------------------------------------- 809 (967)
Q Consensus 773 gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~------------------------------------------- 809 (967)
|..|...... .++......++.++...|..||+.
T Consensus 97 G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9888763211 234455555555555555555532
Q ss_pred ---------------CCCeEEeccCCCcEEEcC---CC-eEEEEecccccc
Q 037068 810 ---------------HPTIVHRDLKSPNLLVDK---NW-VVKVCDFGLSRI 841 (967)
Q Consensus 810 ---------------n~GIVHRDLKPsNILLd~---~g-~VKLsDFGLAr~ 841 (967)
.+.++|+|+++.||+++. ++ .+.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 125799999999999987 34 458999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.8e-05 Score=83.13 Aligned_cols=132 Identities=17% Similarity=0.194 Sum_probs=93.3
Q ss_pred EeecCCce-EEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEEEEeecCCC
Q 037068 699 RIGIGSYG-EVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 699 ~LGeG~FG-~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
.+..|..+ .||+... .+..+++|+-.. .....+..|..+|+.|. +--+.+++.++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556555 6898754 356788887542 23556888999999884 223567888888888999999999998
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH-------------------------------------------- 810 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n-------------------------------------------- 810 (967)
++.+..... ......+..++...|..||...
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 877654321 1122345556666666666310
Q ss_pred ------------CCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 811 ------------PTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 811 ------------~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 137999999999999988778899999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=6.2e-05 Score=82.68 Aligned_cols=84 Identities=7% Similarity=-0.071 Sum_probs=55.3
Q ss_pred eEeEEe-ecCCceEEEEeecC--------CCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcC-C--CceeEEeeeeecc
Q 037068 695 QIGERI-GIGSYGEVYRADWH--------GTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLR-H--PNVVLFMGAVTRS 761 (967)
Q Consensus 695 ~i~k~L-GeG~FG~VYka~~~--------g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~-H--pNIVkLig~~~~~ 761 (967)
...+.| +.|....+|+.... +..+++|+...... .......+.+|..+++.|. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88889999988654 66788887533210 0001134667888888874 2 2456777776554
Q ss_pred ---CceEEEEeecCCCchhh
Q 037068 762 ---PHFSILTEFLPRGSLYR 778 (967)
Q Consensus 762 ---~~l~LVmEy~~gGsL~~ 778 (967)
+..++||||++|..+.+
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 45789999999876643
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=97.87 E-value=8.2e-06 Score=89.35 Aligned_cols=84 Identities=19% Similarity=0.255 Sum_probs=61.1
Q ss_pred HHHHHHHHHHHHHHhcC---CCCCCchhhhhhHHHHHHHHHHhhcCceeeeeecccccchhhHHHHHHHhhhcCCceeEe
Q 037068 223 LSGLIQKIADLVVERMG---GPVGNAEEIYGRWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKVLADRINLPCMLV 299 (967)
Q Consensus 223 ~~~~~~~la~lv~~~mg---g~~~~~~~~~~~~~~~~~~l~~~~~~~v~plg~l~~g~~~~~a~lfk~~~d~~~~~~~lv 299 (967)
..+.+++|.+.|.+++. +.......... -| .-++|+|+++|.||-.||..+|||||+|
T Consensus 142 ~~~~~~ai~~~v~~~~~Y~~~~~~~~~~a~~-------~l------------~~~~G~C~d~A~l~val~Ra~GIPAR~V 202 (293)
T 3isr_A 142 VYSKVLAITDWIYNNVEYISGSTNSQTSAFD-------TI------------TERAGVCRDFAHLGIALCRALSIPARYF 202 (293)
T ss_dssp HHHHHHHHHHHHHHHSEECTTSCCTTCCHHH-------HH------------HHCEECHHHHHHHHHHHHHHTTCCEEEE
T ss_pred HHHHHHHHHHHHHhhcEEeccCCCCCCCHHH-------hh------------cCCcEehHHHHHHHHHHHHHCCCCEEEE
Confidence 35778888888888763 11111111111 11 2379999999999999999999999999
Q ss_pred eccccccC----CCCceEEEEcCCCceeeeecc
Q 037068 300 KGSYYTGT----DDGAVNLIKLDNGSEYIIDLM 328 (967)
Q Consensus 300 ~G~~y~~~----~~~a~~~v~~~~~~~~~~dlm 328 (967)
.| |... +.|||++|.+. |.|+-||-=
T Consensus 203 sG--y~~~~~~~~~HAW~Evyl~-ggWv~~DpT 232 (293)
T 3isr_A 203 TG--YAFKLNPPDFHACFEAYIG-GNWIIFDAT 232 (293)
T ss_dssp EE--EETTCSSCCEEEEEEEEET-TEEEEECTT
T ss_pred EE--ECCCCCCCCeEEEEEEEEC-CcEEEEECC
Confidence 99 5443 45999999994 589999964
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.86 E-value=7.9e-05 Score=80.38 Aligned_cols=138 Identities=14% Similarity=0.063 Sum_probs=80.6
Q ss_pred eEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC--CceeEEee------eeeccCceEEEE
Q 037068 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH--PNVVLFMG------AVTRSPHFSILT 768 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H--pNIVkLig------~~~~~~~l~LVm 768 (967)
.+.|+.|....||++...+..+++|+... . ...+..|..+++.|.. -.+.+++. +....+..++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHR---P---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECS---C---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCC---C---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 35676677889999977666789998753 1 1334456666665531 12333443 113456688999
Q ss_pred eecCCCchh-----------hhh---cC--CCC--C---------CCHHH------------------------------
Q 037068 769 EFLPRGSLY-----------RLL---HR--PNH--Q---------LDERR------------------------------ 791 (967)
Q Consensus 769 Ey~~gGsL~-----------~lL---~~--~~~--~---------Lse~~------------------------------ 791 (967)
+|++|..+. ..+ +. ... . ..+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 001 10 000 0 11111
Q ss_pred -HHHHHHHHHHHHHHHHh-----------cCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 792 -RMRMALDVAKGMNYLHT-----------SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 792 -i~~I~~QIa~aL~YLHs-----------~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+..+..++..++.+|+. ..++++|+|+++.|||++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234456667763 23479999999999999888899999999774
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=3.2e-05 Score=84.32 Aligned_cols=52 Identities=13% Similarity=0.051 Sum_probs=47.4
Q ss_pred cccccchhhHHHHHHHhhhcCCceeEeeccccccCCCCceEEEEcCC-CceeeeeccC
Q 037068 273 LDVGLSRHRALLFKVLADRINLPCMLVKGSYYTGTDDGAVNLIKLDN-GSEYIIDLMG 329 (967)
Q Consensus 273 l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~~~~a~~~v~~~~-~~~~~~dlm~ 329 (967)
-++|+|+++|.||-.||-.+|||||+|.| | +.|||++|.+.. ..|+-||--.
T Consensus 138 ~r~G~C~d~A~lf~al~Ra~GIpAR~V~G--y---~~HaW~Evy~~g~~gWv~~Dpt~ 190 (295)
T 2f4m_A 138 TRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPSQQRWLHCDACE 190 (295)
T ss_dssp HCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETTTTEEEEEETTT
T ss_pred cCCEeeHHHHHHHHHHHHHCCCCEEEEcC--C---CCEEEEEEEECCCCeEEEEeCCc
Confidence 47899999999999999999999999999 4 799999999966 5899999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00016 Score=80.86 Aligned_cols=76 Identities=16% Similarity=0.163 Sum_probs=49.3
Q ss_pred eEEeecCCceEEEEeec--CCCeEEEEEeecCCC--C---hhhHHHHHHHHHHHHHcCC--Cc-eeEEeeeeeccCceEE
Q 037068 697 GERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF--S---GDSLSQFKCEAEIMLRLRH--PN-VVLFMGAVTRSPHFSI 766 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~--s---~~~~~~~~~Ei~ILk~L~H--pN-IVkLig~~~~~~~l~L 766 (967)
.+.||.|.++.||++.. .++.++||....... . ......+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 56899999999999954 467899997643211 0 1123456778899888732 33 3455543 3445689
Q ss_pred EEeecCCC
Q 037068 767 LTEFLPRG 774 (967)
Q Consensus 767 VmEy~~gG 774 (967)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00073 Score=74.36 Aligned_cols=77 Identities=25% Similarity=0.198 Sum_probs=61.3
Q ss_pred eEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC---CCceeEEeeeeeccCceEEEEeec
Q 037068 695 QIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR---HPNVVLFMGAVTRSPHFSILTEFL 771 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~---HpNIVkLig~~~~~~~l~LVmEy~ 771 (967)
.-.+.|+.|.+..+|+....+..+++|+.... ....+..|...|+.|. ...+.+.+.+....+..++||||+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 34577999999999999888888999986432 3566888999998883 356778888887778899999999
Q ss_pred CCCch
Q 037068 772 PRGSL 776 (967)
Q Consensus 772 ~gGsL 776 (967)
++..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0011 Score=75.16 Aligned_cols=77 Identities=14% Similarity=0.101 Sum_probs=47.0
Q ss_pred CCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCCC--CCCCccChhccccC---CCCchhHHHHHHHHHHH
Q 037068 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA--GTPEWMAPEVLRNE---PANEKCDVYSFGVILWE 884 (967)
Q Consensus 810 n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~~--GT~~YmAPE~l~g~---~~s~ksDVWSLGvlL~E 884 (967)
.+.++|+|++|.|||++.++ ++|+||+.+..-..... ..... -...|++|+..... ......++..+...+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34799999999999998776 99999998875332110 00000 01235555544311 12234566677888887
Q ss_pred HHhC
Q 037068 885 LATL 888 (967)
Q Consensus 885 LlTG 888 (967)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0024 Score=67.18 Aligned_cols=137 Identities=17% Similarity=0.198 Sum_probs=94.3
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT-SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST 852 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs-~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~~~ 852 (967)
-+|.++|...+.++++.++|.++.|.+..|.-+-. .+ -..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------
Confidence 48999999889999999999999999999877622 11 12344567999999999987653 1110
Q ss_pred CCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhc-
Q 037068 853 AGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQT- 931 (967)
Q Consensus 853 ~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~- 931 (967)
.....+.+||... ...+.+.=|||||+++|.-+--..| ...+..+++.|..||..|...
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhcc
Confidence 1123466888763 3456889999999999987763322 122346899999999999866
Q ss_pred ------------------------CCCCCcCHHHHHHH
Q 037068 932 ------------------------EPHLRPSFAQLMSR 945 (967)
Q Consensus 932 ------------------------dPe~RPS~~ELLe~ 945 (967)
.+..|.++++|++.
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHHH
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHHH
Confidence 34678898888754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00093 Score=72.09 Aligned_cols=142 Identities=13% Similarity=0.092 Sum_probs=80.8
Q ss_pred eEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc--eeEEeee------eeccCceEE
Q 037068 695 QIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--VVLFMGA------VTRSPHFSI 766 (967)
Q Consensus 695 ~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN--IVkLig~------~~~~~~l~L 766 (967)
.-.+.|+.|....+|+....+..+++|+.... . ....+..|..+++.|...+ +.+++.. ....+..++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~-~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKR-V---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCC-C---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 34567888888999999776667889987542 1 1234556888887774222 2333321 122356789
Q ss_pred EEeecCCCchhh------------------hhcCCCCC----CC---HHHHHH------------HHHHHHHHHHHHHhc
Q 037068 767 LTEFLPRGSLYR------------------LLHRPNHQ----LD---ERRRMR------------MALDVAKGMNYLHTS 809 (967)
Q Consensus 767 VmEy~~gGsL~~------------------lL~~~~~~----Ls---e~~i~~------------I~~QIa~aL~YLHs~ 809 (967)
+|+|++|..+.. ........ .. +...+. +...+...+++|+..
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999998865321 00010000 11 111000 011244455566532
Q ss_pred -----CCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 810 -----HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 810 -----n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.++++|+|+.+.|||++.+..+.|+||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2379999999999999987667899998775
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0034 Score=73.54 Aligned_cols=51 Identities=16% Similarity=0.259 Sum_probs=45.8
Q ss_pred ccccchhhHHHHHHHhhhcCCceeEeeccccccCC----------CCceEEEEcCCCceeeeec
Q 037068 274 DVGLSRHRALLFKVLADRINLPCMLVKGSYYTGTD----------DGAVNLIKLDNGSEYIIDL 327 (967)
Q Consensus 274 ~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~~----------~~a~~~v~~~~~~~~~~dl 327 (967)
+.|.|...|+||..|+..+||||++|-+ |++.+ +|+|+.|++ ||+||++|-
T Consensus 283 ~~G~C~d~a~Ll~AllRa~GIpA~~v~~--~t~~~~~~~~~lp~~nh~i~~v~~-~g~~y~lDa 343 (506)
T 3kd4_A 283 AYGTPLEIAQLLNVMLNAAGIPSEVLAV--YPGHLDTDACGLAAIQTLAVKATV-DGKDQYLSA 343 (506)
T ss_dssp TEECHHHHHHHHHHHHHHTTCCEEEEEE--EETTSCGGGCCSTTCCEEEEEEEE-TTEEEEESS
T ss_pred CCcchHHHHHHHHHHHHHCCCCcEEEEE--EcCCCCCccCCCCCCCEEEEEEEE-CCEEEEEec
Confidence 4699999999999999999999999998 55432 699999998 899999998
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0028 Score=68.89 Aligned_cols=138 Identities=14% Similarity=0.119 Sum_probs=71.4
Q ss_pred EEeecCCceE-EEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCC--ceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGE-VYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP--NVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~-VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~Hp--NIVkLig~~~~~~~l~LVmEy~~g 773 (967)
+.|+.|.... +|+.... +..+++|...... ...+..|+.+++.+... .+.+++.+....+ +++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 3455554444 6677654 6677777543221 02334567777766322 2455666543333 789999977
Q ss_pred CchhhhhcC---------------------C----CCCCCHHHHH-------H-H------------HHHHHHHHHHHH-
Q 037068 774 GSLYRLLHR---------------------P----NHQLDERRRM-------R-M------------ALDVAKGMNYLH- 807 (967)
Q Consensus 774 GsL~~lL~~---------------------~----~~~Lse~~i~-------~-I------------~~QIa~aL~YLH- 807 (967)
..+.+.+.. . -..++..... . + ...+...+..|.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 665433211 0 0112221110 0 0 011222233331
Q ss_pred ---hcCCCeEEeccCCCcEEEcCC----CeEEEEeccccccc
Q 037068 808 ---TSHPTIVHRDLKSPNLLVDKN----WVVKVCDFGLSRIK 842 (967)
Q Consensus 808 ---s~n~GIVHRDLKPsNILLd~~----g~VKLsDFGLAr~~ 842 (967)
...+.++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999874 68999999988643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0043 Score=66.19 Aligned_cols=81 Identities=19% Similarity=0.140 Sum_probs=56.1
Q ss_pred ccCCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCC---ceeEEeeeeeccCceE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP---NVVLFMGAVTRSPHFS 765 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~Hp---NIVkLig~~~~~~~l~ 765 (967)
...+..-.+.+|.|..+.||+.+. +|+.|++|+..... ......+..|...|+.|... -+.+.+.+. .-+
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 445677788999999999999976 57899999754332 12223467899999988421 234555542 347
Q ss_pred EEEeecCCCch
Q 037068 766 ILTEFLPRGSL 776 (967)
Q Consensus 766 LVmEy~~gGsL 776 (967)
+||||+.++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987643
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0014 Score=72.49 Aligned_cols=53 Identities=13% Similarity=0.002 Sum_probs=46.8
Q ss_pred ecccccchhhHHHHHHHhhhcCCceeEeeccccccCCCCceEEEEcCC-CceeeeeccC
Q 037068 272 CLDVGLSRHRALLFKVLADRINLPCMLVKGSYYTGTDDGAVNLIKLDN-GSEYIIDLMG 329 (967)
Q Consensus 272 ~l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~~~~a~~~v~~~~-~~~~~~dlm~ 329 (967)
..++|.|.|+|.||-.++-.+|||+|+|-| ..+|+|++|.+.. ++|.=||-..
T Consensus 178 ~tr~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~~rWv~vDp~~ 231 (335)
T 1x3z_A 178 ETRKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFLNRWVHVDSCE 231 (335)
T ss_dssp HHCEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTTTEEEEEETTT
T ss_pred HhCCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCCCCEEEECCCC
Confidence 346899999999999999999999999998 5699999999976 4798899664
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.02 Score=61.48 Aligned_cols=135 Identities=13% Similarity=0.042 Sum_probs=74.8
Q ss_pred eEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeeeeccCceEEEEeec-CCC
Q 037068 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-VLFMGAVTRSPHFSILTEFL-PRG 774 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-VkLig~~~~~~~l~LVmEy~-~gG 774 (967)
.+.|+.|....+|+. ..+++|+..... .......+|..+++.+...++ .+++.+. .+.-++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 578999999999998 668888764321 111123457777777642223 4566543 33357899999 665
Q ss_pred chhhh--------h----------cCCCCC----CCH-HHHHHHHH--------------HHHHHHHHHH------hcCC
Q 037068 775 SLYRL--------L----------HRPNHQ----LDE-RRRMRMAL--------------DVAKGMNYLH------TSHP 811 (967)
Q Consensus 775 sL~~l--------L----------~~~~~~----Lse-~~i~~I~~--------------QIa~aL~YLH------s~n~ 811 (967)
+|... + +..... +.. ..+..+.. .+...+..|. ...+
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 54310 0 111110 111 11111111 1111111111 1223
Q ss_pred CeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 812 GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5566789999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0084 Score=66.30 Aligned_cols=73 Identities=15% Similarity=0.155 Sum_probs=43.1
Q ss_pred eEEeecCCceEEEEeecCC----------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc-eeEEeeeeeccCceE
Q 037068 697 GERIGIGSYGEVYRADWHG----------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN-VVLFMGAVTRSPHFS 765 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g----------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN-IVkLig~~~~~~~l~ 765 (967)
.+.|+.|..-.+|++...+ +.+++|+.... .........|..+++.|...+ ..++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4678888888999987543 67888875331 111112356888888874333 346665442 36
Q ss_pred EEEeecCCCch
Q 037068 766 ILTEFLPRGSL 776 (967)
Q Consensus 766 LVmEy~~gGsL 776 (967)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.31 E-value=0.012 Score=67.22 Aligned_cols=73 Identities=18% Similarity=0.283 Sum_probs=49.2
Q ss_pred EeEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeeeeccCceE
Q 037068 696 IGERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-VLFMGAVTRSPHFS 765 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-VkLig~~~~~~~l~ 765 (967)
-.+.|+.|-...||++... +..+++|+.... .....+..|..+++.|...++ .++++.+.. .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4567888888999999753 467888886321 112445579999988843334 567766543 3
Q ss_pred EEEeecCCCch
Q 037068 766 ILTEFLPRGSL 776 (967)
Q Consensus 766 LVmEy~~gGsL 776 (967)
+|+||++|..|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.016 Score=65.47 Aligned_cols=137 Identities=16% Similarity=0.184 Sum_probs=81.6
Q ss_pred eEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEE
Q 037068 697 GERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~L 766 (967)
.+.|..|-...+|++... ++.+++|+.... ......+.+|..+++.|. +.-..++++.+.. .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 356777888889988653 367888874221 123455668999998884 3223567766654 29
Q ss_pred EEeecCCCchhhh-h----------------cCC----CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 037068 767 LTEFLPRGSLYRL-L----------------HRP----NHQLD--ERRRMRMALDVAK-------------------GMN 804 (967)
Q Consensus 767 VmEy~~gGsL~~l-L----------------~~~----~~~Ls--e~~i~~I~~QIa~-------------------aL~ 804 (967)
||||++|..|..- + +.. ..... +..+.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998665311 0 111 11122 3455555554422 233
Q ss_pred HHHh----c--CCCeEEeccCCCcEEEcCC----CeEEEEeccccc
Q 037068 805 YLHT----S--HPTIVHRDLKSPNLLVDKN----WVVKVCDFGLSR 840 (967)
Q Consensus 805 YLHs----~--n~GIVHRDLKPsNILLd~~----g~VKLsDFGLAr 840 (967)
.|.+ . ...++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3332 1 1369999999999999876 789999998875
|
| >2q3z_A Transglutaminase 2; transglutaminase 2, tissue transglutaminase, TG2, transferas; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1kv3_A 3ly6_A* | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0027 Score=76.27 Aligned_cols=52 Identities=12% Similarity=0.036 Sum_probs=44.4
Q ss_pred cccccchhhHHHHHHHhhhcCCceeEeecccccc----------------------------CCCCceEEEEcC------
Q 037068 273 LDVGLSRHRALLFKVLADRINLPCMLVKGSYYTG----------------------------TDDGAVNLIKLD------ 318 (967)
Q Consensus 273 l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~----------------------------~~~~a~~~v~~~------ 318 (967)
.+.|+|+++|-+|-+++-.+|||||+|.| |.. ++-|||++|-+.
T Consensus 272 ~k~G~C~dfA~~~~~llRalGIPAR~VsG--y~~~~~~~~~l~~d~~~~~~g~~~~~~~d~~~~~HAW~Ev~~~rpDLp~ 349 (687)
T 2q3z_A 272 VKYGQCWVFAAVACTVLRCLGIPTRVVTN--YNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQP 349 (687)
T ss_dssp EEEECHHHHHHHHHHHHHHHTCCEEEEEE--EEEECC--CCHHHHHHHC---------CCCCBSEEEEEEEEECCTTSST
T ss_pred cceeehHHHHHHHHHHHHhCCCCcEEEee--cccccccccccccccccCCCCceeeecCCcccceeEEEEEEcccCCCCC
Confidence 78999999999999999999999999999 431 125999999996
Q ss_pred C-Cceeeee
Q 037068 319 N-GSEYIID 326 (967)
Q Consensus 319 ~-~~~~~~d 326 (967)
. +-|..||
T Consensus 350 g~~GW~~~D 358 (687)
T 2q3z_A 350 GYEGWQALD 358 (687)
T ss_dssp TCCEEEEEC
T ss_pred CCCCEEEEC
Confidence 3 5688888
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.035 Score=64.13 Aligned_cols=73 Identities=14% Similarity=0.089 Sum_probs=47.5
Q ss_pred eEEeecCCceEEEEeecCC--CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeeeeccCceEEEEeecCC
Q 037068 697 GERIGIGSYGEVYRADWHG--TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-VLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g--~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-VkLig~~~~~~~l~LVmEy~~g 773 (967)
.+.|+.|-...+|++...+ ..+++|+..... .. .-...+|..+++.|...++ .++++.+. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCC
Confidence 4678888889999998765 778888764321 11 1112578999999865555 46777663 2 359999987
Q ss_pred Cch
Q 037068 774 GSL 776 (967)
Q Consensus 774 GsL 776 (967)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.024 Score=62.36 Aligned_cols=32 Identities=19% Similarity=0.338 Sum_probs=28.2
Q ss_pred CCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 811 ~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999887643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.98 E-value=0.04 Score=59.36 Aligned_cols=138 Identities=12% Similarity=0.100 Sum_probs=79.0
Q ss_pred EEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc--eeEEeee-----eeccCceEEEEe
Q 037068 698 ERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN--VVLFMGA-----VTRSPHFSILTE 769 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN--IVkLig~-----~~~~~~l~LVmE 769 (967)
..|+ |....||++... |+.+++|....... ....+..|..+++.|...+ +.+++.. ...++..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 888899998764 55799998753322 2345667888888774222 3444433 122445678999
Q ss_pred ecCCCchhh-----h------h-------cCC----CCCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 037068 770 FLPRGSLYR-----L------L-------HRP----NHQLDERRR----MRM---------------ALDVAKGMNYLHT 808 (967)
Q Consensus 770 y~~gGsL~~-----l------L-------~~~----~~~Lse~~i----~~I---------------~~QIa~aL~YLHs 808 (967)
|++|..+.. + + ... ...++.... ..+ ...+-..++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998754321 0 0 000 011221111 001 1111122333322
Q ss_pred -----cCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 809 -----SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 809 -----~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
..+.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223689999999999999 4 899999988754
|
| >1vjj_A Protein-glutamine glutamyltransferase E; transglutaminase 3, X-RAY crystallography, metalloenzyme, calcium ION; HET: GDP; 1.90A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1sgx_A* 1l9m_A 1l9n_A* 1nud_A 1nuf_A 1nug_A 1rle_A* | Back alignment and structure |
|---|
Probab=95.67 E-value=0.0063 Score=73.07 Aligned_cols=54 Identities=15% Similarity=0.132 Sum_probs=44.1
Q ss_pred cccccchhhHHHHHHHhhhcCCceeEeecc--------------ccccC------------CCCceEEEEcCC-------
Q 037068 273 LDVGLSRHRALLFKVLADRINLPCMLVKGS--------------YYTGT------------DDGAVNLIKLDN------- 319 (967)
Q Consensus 273 l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~--------------~y~~~------------~~~a~~~v~~~~------- 319 (967)
+|.|+|+|+|-+|-+++-.+|||||+|.|- ||... +-|||+++-+..
T Consensus 267 V~~G~C~~fA~~~~~~lR~lGIPaR~Vtgy~s~~d~~~nL~~d~~~~~~g~~~~~~~dsIW~~HaW~E~w~~rpDLp~~~ 346 (692)
T 1vjj_A 267 VRYGQCWVFAGTLNTALRSLGIPSRVITNFNSAHDTDRNLSVDVYYDPMGNPLDKGSDSVWNFHVWNEGWFVRSDLGPSY 346 (692)
T ss_dssp EEEECHHHHHHHHHHHHHHHTCCEEEEEEEEEEECSSSSSEEEEEECTTSCBCCCCSCEEEEEEEEEEEEECCTTTCGGG
T ss_pred ccceeeHHHHHHHHHHHHhCCCCeeEEcccccccCCCCCcccceeeccCCcccccccccccceeEEEEEeccccCCCCCC
Confidence 578999999999999999999999999994 22211 249999999853
Q ss_pred Cceeeee
Q 037068 320 GSEYIID 326 (967)
Q Consensus 320 ~~~~~~d 326 (967)
+.|+.||
T Consensus 347 ~gW~~~D 353 (692)
T 1vjj_A 347 GGWQVLD 353 (692)
T ss_dssp CEEEEEC
T ss_pred CCEEEEC
Confidence 5688887
|
| >1g0d_A Protein-glutamine gamma-glutamyltransferase; tissue transglutaminase,acyltransferase; 2.50A {Pagrus major} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 | Back alignment and structure |
|---|
Probab=95.34 E-value=0.0085 Score=71.86 Aligned_cols=52 Identities=8% Similarity=0.051 Sum_probs=43.3
Q ss_pred cccccchhhHHHHHHHhhhcCCceeEeeccccccC------------------------------CCCceEEEEcCC---
Q 037068 273 LDVGLSRHRALLFKVLADRINLPCMLVKGSYYTGT------------------------------DDGAVNLIKLDN--- 319 (967)
Q Consensus 273 l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~------------------------------~~~a~~~v~~~~--- 319 (967)
+|.|.|.|+|-+|-+++-.+|||||+|.| |.+. +-|||+++-+..
T Consensus 267 V~~G~C~~fA~v~~t~lR~lGIPaR~Vtg--y~sa~d~~~nL~id~~~~~~g~~~~~~~~~dsiw~~HaW~E~w~~rpDL 344 (695)
T 1g0d_A 267 VKYGQCWVFAAVACTVLRCLGIPTRPITN--FASAHDVDGNLSVDFLLNERLESLDSRQRSDSSWNFHCWVESWMSREDL 344 (695)
T ss_dssp EEEECHHHHHHHHHHHHHHHTCCEEEEEE--EEETTTTTTCSEEEEEECTTSCBSCTTCCBCSSEEEEEEEEEEECCTTS
T ss_pred ccceeeHHHHHHHHHHHHhCCCCeeEEcc--ccccCCCCCccceeeeecccCceecccccCCcceeeEEEEEeecccCCC
Confidence 67899999999999999999999999999 4221 238999999853
Q ss_pred ----Cceeeee
Q 037068 320 ----GSEYIID 326 (967)
Q Consensus 320 ----~~~~~~d 326 (967)
+-|..||
T Consensus 345 p~~~~gWq~~D 355 (695)
T 1g0d_A 345 PEGNDGWQVLD 355 (695)
T ss_dssp CTTCCEEEEEE
T ss_pred CCCCCCeEEEc
Confidence 5688887
|
| >1ex0_A Coagulation factor XIII A chain; transglutaminase, blood coagulation, mutant, W279F, oxyanion, transferase; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1evu_A 1fie_A 1f13_A 1ggt_A 1ggu_A 1ggy_A 1qrk_A | Back alignment and structure |
|---|
Probab=94.69 E-value=0.022 Score=68.83 Aligned_cols=30 Identities=17% Similarity=0.231 Sum_probs=28.5
Q ss_pred ecccccchhhHHHHHHHhhhcCCceeEeec
Q 037068 272 CLDVGLSRHRALLFKVLADRINLPCMLVKG 301 (967)
Q Consensus 272 ~l~~g~~~~~a~lfk~~~d~~~~~~~lv~G 301 (967)
.+|.|.|.|+|-+|-++.-.+|||||+|.|
T Consensus 308 PV~~G~C~~fA~v~~~~lR~lGIPaRvVtg 337 (731)
T 1ex0_A 308 PVRYGQCWVFAGVFNTFLRCLGIPARIVTN 337 (731)
T ss_dssp CEEEECHHHHHHHHHHHHHHHTCCEEEEEE
T ss_pred ccceeeehhHHHHHHHHHHhCCCCeeEEcc
Confidence 367899999999999999999999999999
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.67 E-value=0.69 Score=52.87 Aligned_cols=138 Identities=16% Similarity=0.187 Sum_probs=81.9
Q ss_pred EeEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCc-eeEEeeeeeccCceE
Q 037068 696 IGERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN-VVLFMGAVTRSPHFS 765 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpN-IVkLig~~~~~~~l~ 765 (967)
-.+.|..|-...+|+.... ++.+++++..... ...-...+|..+++.|...+ ..++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3466777888899998765 5788888753321 11112356888888874323 345665432 27
Q ss_pred EEEeecCCCchhh--h------------hc---C--------C---CCCC-CHHHHHHHHHHH-----------------
Q 037068 766 ILTEFLPRGSLYR--L------------LH---R--------P---NHQL-DERRRMRMALDV----------------- 799 (967)
Q Consensus 766 LVmEy~~gGsL~~--l------------L~---~--------~---~~~L-se~~i~~I~~QI----------------- 799 (967)
+||||++|..|.. + +. . . .... -+..+.++..++
T Consensus 147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 226 (424)
T 3mes_A 147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS 226 (424)
T ss_dssp EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence 8999999876421 0 00 0 0 1111 133333443322
Q ss_pred --HHHHHHHHh----------------------cCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 800 --AKGMNYLHT----------------------SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 800 --a~aL~YLHs----------------------~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
...+.+|.+ ....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 222333321 1125999999999999 8888999999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.28 E-value=0.52 Score=52.99 Aligned_cols=30 Identities=23% Similarity=0.383 Sum_probs=25.6
Q ss_pred CeEEeccCCCcEEE------cCCCeEEEEecccccc
Q 037068 812 TIVHRDLKSPNLLV------DKNWVVKVCDFGLSRI 841 (967)
Q Consensus 812 GIVHRDLKPsNILL------d~~g~VKLsDFGLAr~ 841 (967)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 47899999999999 4567899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.16 E-value=4.5 Score=42.17 Aligned_cols=116 Identities=11% Similarity=0.132 Sum_probs=79.3
Q ss_pred CCCceeEEeeeeeccCceEEEEeecCCC-chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEE
Q 037068 747 RHPNVVLFMGAVTRSPHFSILTEFLPRG-SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLV 825 (967)
Q Consensus 747 ~HpNIVkLig~~~~~~~l~LVmEy~~gG-sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILL 825 (967)
.||+++.. .+-..++.+.+.++.-..+ +... ++ .++....++++.+|+....+++.. +|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~~r----~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNRTR----YTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGGSS----EECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhcCc----eEEEEecceEEE
Confidence 78988866 4556666676766654433 3333 33 367889999999999988666644 788899999999
Q ss_pred cCCCeEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 037068 826 DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG 894 (967)
Q Consensus 826 d~~g~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~ 894 (967)
+.++.+++.--|+-.. ++|. ..+...=+-.+=|++..+++++..|..
T Consensus 113 ~~~~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CTTSCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred cCCCCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999976664321 2222 122233344566788889998888753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 967 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-85 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-78 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-74 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-73 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-72 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-71 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-71 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-71 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-71 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-70 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-70 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-69 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-69 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-69 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-69 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-68 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-67 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-67 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-67 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-66 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-65 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-65 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-62 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-61 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-60 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-60 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-59 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-58 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-52 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-49 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 271 bits (695), Expect = 9e-85
Identities = 90/277 (32%), Positives = 154/277 (55%), Gaps = 13/277 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
+WEI + +G+RIG GS+G VY+ WHG VAVK + L FK E ++ +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
RH N++LFMG T +P +I+T++ SLY LH + + + + +A A+GM+Y
Sbjct: 61 TRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH--TYLSSKSTAGTPEWMAPEV 863
LH +I+HRDLKS N+ + ++ VK+ DFGL+ +K + +G+ WMAPEV
Sbjct: 120 LH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 864 LRNE---PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL----EIPDD 916
+R + P + + DVY+FG++L+EL T +P+ +N + + + ++ +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953
A+ +++ +C + + RP F Q+++ + L R L
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (647), Expect = 5e-78
Identities = 88/268 (32%), Positives = 144/268 (53%), Gaps = 13/268 (4%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL 746
W + ++L++ + IG G +G+V D+ G +VAVK + + F EA +M +L
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQL 57
Query: 747 RHPNVVLFMGAVTRSP-HFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMN 804
RH N+V +G + I+TE++ +GSL L R L ++ +LDV + M
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 805 YLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
YL VHRDL + N+LV ++ V KV DFGL++ T + +W APE L
Sbjct: 118 YLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEAL 172
Query: 865 RNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923
R + + K DV+SFG++LWE+ + VP+ + VV V + +++ PD PAV +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231
Query: 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
++++CW + +RPSF QL +L ++
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 5e-74
Identities = 88/265 (33%), Positives = 144/265 (54%), Gaps = 11/265 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIML 744
EWE+ E L++ ER+G G +GEV+ ++ T+VAVK S D F EA +M
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMK 63
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGM 803
+L+H +V VT+ P + I+TE++ GSL L P +L + + MA +A+GM
Sbjct: 64 QLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPE 862
++ + +HRDL++ N+LV K+ DFGL+R I+ + Y + + +W APE
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 863 VLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
+ K DV+SFG++L E+ T +P+ G+ +V+ + + R+ PD+ +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEEL 239
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRL 946
Q++R CW+ P RP+F L S L
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 5e-73
Identities = 82/262 (31%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 689 ILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
I +DL + +G G +G V W +VA+K + S D +F EA++M+ L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
H +V G T+ I+TE++ G L L H+ ++ + M DV + M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRN 866
+HRDL + N LV+ VVKV DFGLSR + Y SS + W PEVL
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 867 EPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
+ K D+++FGV++WE+ +L +P++ + + Q RL P V I+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 926 RDCWQTEPHLRPSFAQLMSRLR 947
CW + RP+F L+S +
Sbjct: 235 YSCWHEKADERPTFKILLSNIL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 1e-72
Identities = 85/312 (27%), Positives = 135/312 (43%), Gaps = 37/312 (11%)
Query: 671 NGQSDSINPM-LGEVAEWEILWEDLQIGERIGIGSYGEVYRADWHGT-------EVAVKK 722
+ + ++ +WE E+L+ G+ +G G++G+V A +G +VAVK
Sbjct: 15 DNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM 74
Query: 723 FLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH 781
L + E ++M +L H N+V +GA T S ++ E+ G L L
Sbjct: 75 -LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 782 RPNHQ----------------------LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK 819
+ L + A VAKGM +L + VHRDL
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLA 191
Query: 820 SPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYS 877
+ N+LV VVK+CDFGL+R Y+ + +WMAPE L K DV+S
Sbjct: 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 878 FGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLR 936
+G++LWE+ +L P+ G+ + +++ P + I++ CW + R
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311
Query: 937 PSFAQLMSRLRC 948
PSF L S L C
Sbjct: 312 PSFPNLTSFLGC 323
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 1e-72
Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 11/262 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
ED ++ IG GSYG + G + K+ + E ++ L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 750 NVVLFMGAVT--RSPHFSILTEFLPRGSLYRLLHRPNHQ---LDERRRMRMALDVAKGMN 804
N+V + + + I+ E+ G L ++ + + LDE +R+ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 805 YLH---TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
H T++HRDLK N+ +D VK+ DFGL+RI +H +K+ GTP +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDEL 242
Query: 922 AQIIRDCWQTEPHLRPSFAQLM 943
+II + + RPS +++
Sbjct: 243 NEIITRMLNLKDYHRPSVEEIL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 236 bits (603), Expect = 2e-71
Identities = 92/276 (33%), Positives = 136/276 (49%), Gaps = 15/276 (5%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGT-----EVAVKKFLDQDFSGDSLSQFKCEAE 741
EI ++I + IG G +GEV VA+K L ++ F EA
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEAS 79
Query: 742 IMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK 801
IM + HPNV+ G VT+S I+TEF+ GSL L + + Q + + M +A
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI-----KHHTYLSSKSTAGTP 856
GM YL VHRDL + N+LV+ N V KV DFGLSR TY S+
Sbjct: 140 GMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 857 EWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPD 915
W APE ++ DV+S+G+++WE+ + P+ + V+ A+ Q+ RL P
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPM 256
Query: 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
D A+ Q++ DCWQ + + RP F Q+++ L + R
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 4e-71
Identities = 70/271 (25%), Positives = 127/271 (46%), Gaps = 14/271 (5%)
Query: 686 EWEILWEDLQIGER-IGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEA 740
+ + ++L I + +G G++G V + + +VA+K L Q + EA
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 60
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
+IM +L +P +V +G V ++ ++ E G L++ L ++ + V+
Sbjct: 61 QIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI---KHHTYLSSKSTAGTPE 857
GM YL VHRDL + N+L+ K+ DFGLS+ Y + + +
Sbjct: 120 MGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDD 916
W APE + + + DV+S+GV +WE + P+K + +V+ + Q +R+E P +
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
P + ++ DCW + RP F + R+R
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 7e-71
Identities = 80/269 (29%), Positives = 132/269 (49%), Gaps = 12/269 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTE-----VAVKKFLDQDFSGDSLSQFKCEA 740
++EI E +++G IG G +G+V++ + E VA+K S +F EA
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 59
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
M + HP++V +G +T +P + I+ E G L L + LD + A ++
Sbjct: 60 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWM 859
+ YL + VHRD+ + N+LV N VK+ DFGLSR ++ TY + +WM
Sbjct: 119 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 860 APEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
APE + DV+ FGV +WE+ P++G+ V+G + RL +P +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 235
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
P + ++ CW +P RP F +L ++L
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 234 bits (598), Expect = 7e-71
Identities = 93/280 (33%), Positives = 143/280 (51%), Gaps = 9/280 (3%)
Query: 676 SINPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSL 733
+++P +WE+ D+ + ++G G YGEVY W VAVK +
Sbjct: 1 AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEV 57
Query: 734 SQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ-LDERRR 792
+F EA +M ++HPN+V +G TR P F I+TEF+ G+L L N Q +
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 793 MRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKS 851
+ MA ++ M YL + +HRDL + N LV +N +VKV DFGLSR + TY +
Sbjct: 118 LYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175
Query: 852 TAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL 911
+W APE L + K DV++FGV+LWE+AT + + V + ++ R+
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235
Query: 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
E P+ V +++R CWQ P RPSFA++ + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 1e-70
Identities = 89/265 (33%), Positives = 140/265 (52%), Gaps = 11/265 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIML 744
WEI E L++ ++G G +GEV+ W+GT VA+K S + F EA++M
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMK 67
Query: 745 RLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLD-ERRRMRMALDVAKGM 803
+LRH +V V+ P + I+TE++ +GSL L + + + MA +A GM
Sbjct: 68 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPE 862
Y+ VHRDL++ N+LV +N V KV DFGL+R I+ + Y + + +W APE
Sbjct: 127 AYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 863 VLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921
K DV+SFG++L EL T VP+ G+ +V+ V + R+ P + ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 243
Query: 922 AQIIRDCWQTEPHLRPSFAQLMSRL 946
++ CW+ EP RP+F L + L
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 1e-70
Identities = 87/272 (31%), Positives = 127/272 (46%), Gaps = 13/272 (4%)
Query: 689 ILWEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFS-GDSLSQFKCEAEI 742
I +DL++ E++G GS+G V R +W VAVK S +++ F E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 743 MLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
M L H N++ G V +P ++TE P GSL L + R A+ VA+G
Sbjct: 65 MHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI---KHHTYLSSKSTAGTPEWM 859
M YL + +HRDL + NLL+ +VK+ DFGL R Y+ + W
Sbjct: 124 MGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 860 APEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918
APE L+ + D + FGV LWE+ T PW GLN Q++ + + RL P+D
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQ 950
+ ++ CW +P RP+F L L Q
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 2e-70
Identities = 91/296 (30%), Positives = 146/296 (49%), Gaps = 29/296 (9%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRADWHGT----EVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+ W D++ + IG G++G+V +A + A+K+ + + S D F E E++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 64
Query: 744 LRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---------------L 787
+L HPN++ +GA + + E+ P G+L L + L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 788 DERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847
++ + A DVA+GM+YL +HRDL + N+LV +N+V K+ DFGLSR Y+
Sbjct: 125 SSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGF 906
WMA E L DV+S+GV+LWE+ +L P+ G+ ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 907 QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNSTNQ 962
Q RLE P + D V ++R CW+ +P+ RPSFAQ+ L L R+L +R N
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI---LVSLNRMLEERKTYVNT 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (594), Expect = 2e-70
Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 12/259 (4%)
Query: 694 LQIGERIGIGSYGEVYRADWHGT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
L+ IG GS+ VY+ T EVA + D+ + +FK EAE++ L+HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 752 VLFMGA----VTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
V F + V ++TE + G+L L R + + + KG+ +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 808 TSHPTIVHRDLKSPN-LLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN 866
T P I+HRDLK N + VK+ D GL+ +K ++ +K+ GTPE+MAPE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEE 187
Query: 867 EPANEKCDVYSFGVILWELATLSVPWKGL-NPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
+E DVY+FG+ + E+AT P+ N Q+ V + P V +II
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 926 RDCWQTEPHLRPSFAQLMS 944
C + R S L++
Sbjct: 247 EGCIRQNKDERYSIKDLLN 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 1e-69
Identities = 84/262 (32%), Positives = 131/262 (50%), Gaps = 9/262 (3%)
Query: 689 ILWEDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
I +L + IG G +G V+ W + +VA+K + S + F EAE+M++L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
HP +V G ++ EF+ G L L + M LDV +GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR-IKHHTYLSSKSTAGTPEWMAPEVLRN 866
++HRDL + N LV +N V+KV DFG++R + Y SS T +W +PEV
Sbjct: 119 --EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 867 EPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
+ K DV+SFGV++WE+ + +P++ + +VV + RL P V QI+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235
Query: 926 RDCWQTEPHLRPSFAQLMSRLR 947
CW+ P RP+F++L+ +L
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLA 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 1e-69
Identities = 74/261 (28%), Positives = 121/261 (46%), Gaps = 12/261 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+ +I +G G++G+VY+A A K + S + L + E +I+ HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHP 69
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
N+V + A + IL EF G++ ++ L E + + +NYLH +
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL----- 864
I+HRDLK+ N+L + +K+ DFG+S T S GTP WMAPEV+
Sbjct: 130 K--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 865 RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQ 923
++ P + K DV+S G+ L E+A + P LNPM+V+ + L P
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 924 IIRDCWQTEPHLRPSFAQLMS 944
++ C + R + +QL+
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 2e-69
Identities = 65/262 (24%), Positives = 118/262 (45%), Gaps = 12/262 (4%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSL-SQFKCEAEI 742
+W + ED +IG +G G +G VY A +A+K + Q + E EI
Sbjct: 2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 743 MLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKG 802
LRHPN++ G + ++ E+ P G++YR L + + DE+R ++A
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANA 118
Query: 803 MNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPE 862
++Y H+ ++HRD+K NLL+ +K+ DFG S + + GT +++ PE
Sbjct: 119 LSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPE 174
Query: 863 VLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
++ +EK D++S GV+ +E P++ + + PD +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGAR 232
Query: 923 QIIRDCWQTEPHLRPSFAQLMS 944
+I + P RP +++
Sbjct: 233 DLISRLLKHNPSQRPMLREVLE 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 231 bits (589), Expect = 2e-69
Identities = 88/310 (28%), Positives = 137/310 (44%), Gaps = 43/310 (13%)
Query: 677 INPMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFS 729
+NP L E +++ IG G++G V++A T VAVK L ++ S
Sbjct: 1 LNPKL---LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEAS 56
Query: 730 GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ--- 786
D + F+ EA +M +PN+V +G +L E++ G L L +
Sbjct: 57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 787 --------------------LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD 826
L ++ +A VA GM YL VHRDL + N LV
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVG 174
Query: 827 KNWVVKVCDFGLSRIKHH--TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWE 884
+N VVK+ DFGLSR + Y + + A WM PE + + DV+++GV+LWE
Sbjct: 175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234
Query: 885 LATLSV-PWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+ + + P+ G+ +V+ V L P++ + ++R CW P RPSF +
Sbjct: 235 IFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI- 292
Query: 944 SRLRCLQRLL 953
R LQR+
Sbjct: 293 --HRILQRMC 300
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 1e-68
Identities = 68/265 (25%), Positives = 122/265 (46%), Gaps = 14/265 (5%)
Query: 692 EDLQIGER-IGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL 746
+ L + ++ +G G++G V + + VAVK ++ + EA +M +L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 747 RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806
+P +V +G ++ E G L + L + H + ++ + + V+ GM YL
Sbjct: 66 DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL 123
Query: 807 HTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI---KHHTYLSSKSTAGTPEWMAPEV 863
S+ VHRDL + N+L+ K+ DFGLS+ + Y + +W APE
Sbjct: 124 EESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 864 LRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
+ + K DV+SFGV++WE + P++G+ +V + + R+ P +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMY 240
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRLR 947
++ CW + RP FA + RLR
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 1e-67
Identities = 90/309 (29%), Positives = 142/309 (45%), Gaps = 19/309 (6%)
Query: 669 TCNGQSDSINP-MLGEVAEWEILWEDLQI--GERIGIGSYGEVYRA-----DWHGTEVAV 720
T + ++NP ++ V I L + E IG G +G VY D AV
Sbjct: 1 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 721 KKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP-HFSILTEFLPRGSLYRL 779
K L++ +SQF E IM HPNV+ +G RS ++ ++ G L
Sbjct: 61 KS-LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119
Query: 780 LHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS 839
+ H + + L VAKGM +L VHRDL + N ++D+ + VKV DFGL+
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 840 RIKHH----TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKG 894
R + + + +WMA E L+ + K DV+SFGV+LWEL T + P+
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237
Query: 895 LNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL-RCLQRLL 953
+N + + Q RRL P+ + +++ CW + +RPSF++L+SR+ +
Sbjct: 238 VNTFDITVYL-LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
Query: 954 VDRSNSTNQ 962
+ N
Sbjct: 297 GEHYVHVNA 305
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 2e-67
Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 23/281 (8%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKC 738
EWE+ E + + +G GS+G VY T VA+K +++ S +F
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLN 72
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ---------LDE 789
EA +M +VV +G V++ ++ E + RG L L
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 790 RRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849
+ ++MA ++A GM YL+ VHRDL + N +V +++ VK+ DFG++R + T
Sbjct: 133 SKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 850 KSTA--GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGF 906
K WM+PE L++ DV+SFGV+LWE+ATL+ P++GL+ QV+ V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-M 249
Query: 907 QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
+ L+ PD+ + +++R CWQ P +RPSF +++S ++
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 7e-67
Identities = 80/304 (26%), Positives = 133/304 (43%), Gaps = 37/304 (12%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKC 738
+WE L G+ +G G++G+V A + VAVK L
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMS 75
Query: 739 EAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQ----------- 786
E +++ L H N+V +GA T ++TE+ G L L R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 787 ------LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840
LD + + VAKGM +L + + +HRDL + N+L+ + K+CDFGL+R
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 841 I--KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPW-KGLNP 897
Y+ + +WMAPE + N + DV+S+G+ LWEL +L G+
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 898 MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRS 957
+ + R+ P+ + I++ CW +P RP+F Q+ ++ +++ + S
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI---VQLIEKQI---S 307
Query: 958 NSTN 961
STN
Sbjct: 308 ESTN 311
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 6e-66
Identities = 85/276 (30%), Positives = 133/276 (48%), Gaps = 14/276 (5%)
Query: 687 WEILWEDLQIGERIGIGSYGEVYRADWHGT------EVAVKKFLDQDFSGDSLSQFKCEA 740
EI + + IG G +GEVY+ + VA+K L ++ F EA
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEA 60
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
IM + H N++ G +++ I+TE++ G+L + L + + + + M +A
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTA---GTPE 857
GM YL + VHRDL + N+LV+ N V KV DFGLSR+ ++ +T+
Sbjct: 121 AGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATLSVPW-KGLNPMQVVGAVGFQNRRLEIPDD 916
W APE + DV+SFG+++WE+ T L+ +V+ A+ RL P D
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 237
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952
A+ Q++ CWQ E RP FA ++S L L R
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-65
Identities = 89/289 (30%), Positives = 145/289 (50%), Gaps = 32/289 (11%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGT---------EVAVKKFLDQDFSGDSLSQF 736
WE+ + L +G+ +G G++G+V A+ G +VAVK L D + LS
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDL 65
Query: 737 KCEAEIMLRL-RHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLH-------------- 781
E E+M + +H N++ +GA T+ ++ E+ +G+L L
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 782 -RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840
P QL + + A VA+GM YL +HRDL + N+LV ++ V+K+ DFGL+R
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 841 IKHH--TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNP 897
HH Y + + +WMAPE L + + DV+SFGV+LWE+ TL P+ G+
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 898 MQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946
++ + + R++ P + + ++RDCW P RP+F QL+ L
Sbjct: 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 7e-65
Identities = 71/269 (26%), Positives = 125/269 (46%), Gaps = 14/269 (5%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGT------EVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
+ + + +G G++G VY+ W VA+K+ L + S + + EA +M
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYVMAS 67
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
+ +P+V +G S ++T+ +P G L + + + + + +AKGMNY
Sbjct: 68 VDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI--KHHTYLSSKSTAGTPEWMAPEV 863
L +VHRDL + N+LV VK+ DFGL+++ ++ +WMA E
Sbjct: 127 LEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 864 LRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922
+ + + DV+S+GV +WEL T S P+ G+ ++ + + RL P V
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVY 243
Query: 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
I+ CW + RP F +L+ + R
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (558), Expect = 7e-65
Identities = 70/272 (25%), Positives = 110/272 (40%), Gaps = 13/272 (4%)
Query: 679 PMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKF-LDQDFSGDSLSQ 735
P + E+ + + IG GS+G VY A VA+KK S +
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 736 FKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRM 795
E + +LRHPN + + G R ++ E+ + L L E +
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAV 120
Query: 796 ALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGT 855
+G+ YLH+ + ++HRD+K+ N+L+ + +VK+ DFG + I S GT
Sbjct: 121 THGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGT 174
Query: 856 PEWMAPEVLR---NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE 912
P WMAPEV+ + K DV+S G+ ELA P +N M + +
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ C Q P RP+ L+
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (552), Expect = 2e-64
Identities = 89/304 (29%), Positives = 146/304 (48%), Gaps = 35/304 (11%)
Query: 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWHGT-------EVAVKKFLDQDFSGDSLSQ 735
+ ++WE + L++G+ +G G++G+V AD G VAVK L + +
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRA 62
Query: 736 FKCEAEIMLR-LRHPNVVLFMGAVTRSP-HFSILTEFLPRGSLYRLLHRPNHQ------- 786
E +I++ H NVV +GA T+ ++ EF G+L L ++
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 787 --------LDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGL 838
L + + VAKGM +L + +HRDL + N+L+ + VVK+CDFGL
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGL 180
Query: 839 SRI--KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSV-PWKGL 895
+R K Y+ +WMAPE + + + DV+SFGV+LWE+ +L P+ G+
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 896 NPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955
+ + R+ PD P + Q + DCW EP RP+F++L+ L LL
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH---LGNLL-- 295
Query: 956 RSNS 959
++N+
Sbjct: 296 QANA 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 9e-64
Identities = 62/256 (24%), Positives = 115/256 (44%), Gaps = 9/256 (3%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+ E+IG G+ G VY A G EVA+++ Q E +M ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNP 77
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
N+V ++ + ++ E+L GSL ++ DE + + + + + +LH++
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSN 135
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
++HRD+KS N+L+ + VK+ DFG + GTP WMAPEV+ +
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR-RLEIPDDIDPAVAQIIRDC 928
K D++S G++ E+ P+ NP++ + + L+ P+ + + C
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 929 WQTEPHLRPSFAQLMS 944
+ R S +L+
Sbjct: 254 LDMDVEKRGSAKELLQ 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-63
Identities = 66/301 (21%), Positives = 115/301 (38%), Gaps = 49/301 (16%)
Query: 688 EILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLR 745
E+ +D + +G G+ G V++ G +A K + + +Q E +++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHE 60
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
P +V F GA SI E + GSL ++L + ++ E+ ++++ V KG+ Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
L H I+HRD+K N+LV+ +K+CDFG+S + + S GT +M+PE L+
Sbjct: 120 LREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ 176
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR---------------- 909
+ + D++S G+ L E+A P + ++ G Q
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 910 --------------------------RLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
+ C P R QLM
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 944 S 944
Sbjct: 297 V 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-63
Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 45/300 (15%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV 751
+ + E IG G +GEV+R W G EVAVK F ++ + + E + LRH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 59
Query: 752 VLFMGAVTRS----PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
+ F+ A + +++++ GSL+ L+R + + +++AL A G+ +LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLH 117
Query: 808 T------SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI----KHHTYLSSKSTAGTPE 857
P I HRDLKS N+LV KN + D GL+ ++ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 858 WMAPEVLRNE------PANEKCDVYSFGVILWELATLSVPWKGLNPMQ------------ 899
+MAPEVL + + ++ D+Y+ G++ WE+A Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 900 ---VVGAVGFQNRRLEIPDDIDP-----AVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951
+ V Q R IP+ +A+I+R+CW R + ++ L L +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-62
Identities = 69/259 (26%), Positives = 106/259 (40%), Gaps = 10/259 (3%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
ED + + +G G+YGEV A VAVK +D + D K E I L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHE 63
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
NVV F G + E+ G L+ + + + E R + G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKST--AGTPEWMAPEVLRNE 867
I HRD+K NLL+D+ +K+ DFGL+ + + GT ++APE+L+
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 868 P-ANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRLEIPDDIDPAVAQII 925
E DV+S G++L + +PW + Q + L ID A ++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 926 RDCWQTEPHLRPSFAQLMS 944
P R + +
Sbjct: 241 HKILVENPSARITIPDIKK 259
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-62
Identities = 52/264 (19%), Positives = 105/264 (39%), Gaps = 10/264 (3%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRH 748
ED + G+ +G GS+ V A E A+K + + E ++M RL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
P V + G L + + + DE ++ + YLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH- 125
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH--TYLSSKSTAGTPEWMAPEVLRN 866
I+HRDLK N+L++++ +++ DFG +++ + S GT ++++PE+L
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 867 EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926
+ A + D+++ G I+++L P++ N + + + P+ P ++
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 242
Query: 927 DCWQTEPHLRPSFAQLMSRLRCLQ 950
+ R ++
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 209 bits (533), Expect = 6e-61
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 12/272 (4%)
Query: 679 PMLGEVAEWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQF 736
P E+ +L + I E +G G++G V+R G A K + S
Sbjct: 14 PQPVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETV 70
Query: 737 KCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMA 796
+ E + M LRHP +V A ++ EF+ G L+ + ++++ E +
Sbjct: 71 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 130
Query: 797 LDVAKGMNYLHTSHPTIVHRDLKSPNLLV--DKNWVVKVCDFGLSRIKHHTYLSSKSTAG 854
V KG+ ++H ++ VH DLK N++ ++ +K+ DFGL+ S K T G
Sbjct: 131 RQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTG 187
Query: 855 TPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV--GFQNRRLE 912
T E+ APEV +P D++S GV+ + L + P+ G N + + V N
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 247
Query: 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
I IR +P+ R + Q +
Sbjct: 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-60
Identities = 49/260 (18%), Positives = 105/260 (40%), Gaps = 12/260 (4%)
Query: 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR 747
L+E I E +G G +G V+R K G K E I+ R
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIAR 59
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
H N++ + ++ EF+ ++ ++ +L+ER + V + + +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 808 TSHPTIVHRDLKSPNLLVD--KNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
+ + I H D++ N++ ++ +K+ +FG +R + + PE+ APEV +
Sbjct: 120 SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQ 176
Query: 866 NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDIDPAVAQ 923
++ + D++S G +++ L + P+ Q++ + E +I
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 924 IIRDCWQTEPHLRPSFAQLM 943
+ E R + ++ +
Sbjct: 237 FVDRLLVKERKSRMTASEAL 256
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 206 bits (524), Expect = 9e-60
Identities = 62/268 (23%), Positives = 118/268 (44%), Gaps = 12/268 (4%)
Query: 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEA 740
EV + + + I E +G G++G V+R G K ++ + D K E
Sbjct: 21 EVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLD-KYTVKNEI 77
Query: 741 EIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
IM +L HP ++ A ++ EFL G L+ + ++++ E +
Sbjct: 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVD--KNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEW 858
+G+ ++H IVH D+K N++ + K VK+ DFGL+ + + +T T E+
Sbjct: 138 EGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEF 194
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDD 916
APE++ EP D+++ GV+ + L + P+ G + ++ + V + +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ P I++ Q EP R + +
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 5e-59
Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 9/254 (3%)
Query: 692 EDLQIGERIGIGSYGEVYRADWHGT--EVAVKKF-LDQDFSGDSLSQFKCEAEIMLR-LR 747
ED + + +G GS+G+V+ A++ T A+K D D + E ++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 748 HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH 807
HP + + + E+L G L + H+ D R A ++ G+ +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH 120
Query: 808 TSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNE 867
+ IV+RDLK N+L+DK+ +K+ DFG+ + + + GTP+++APE+L +
Sbjct: 121 SKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 868 PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927
N D +SFGV+L+E+ P+ G + ++ ++ + P ++ ++
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVK 236
Query: 928 CWQTEPHLRPSFAQ 941
+ EP R
Sbjct: 237 LFVREPEKRLGVRG 250
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 2e-58
Identities = 66/260 (25%), Positives = 116/260 (44%), Gaps = 12/260 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+ + +G G++ EV A+ VA+K + + + E ++ +++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
N+V H ++ + + G L+ + ER R+ V + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126
Query: 810 HPTIVHRDLKSPNLLV---DKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN 866
IVHRDLK NLL D++ + + DFGLS+++ + S + GTP ++APEVL
Sbjct: 127 G--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQ 183
Query: 867 EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP--DDIDPAVAQI 924
+P ++ D +S GVI + L P+ N ++ + + P DDI +
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 925 IRDCWQTEPHLRPSFAQLMS 944
IR + +P R + Q +
Sbjct: 244 IRHLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 195 bits (497), Expect = 6e-57
Identities = 60/272 (22%), Positives = 114/272 (41%), Gaps = 22/272 (8%)
Query: 691 WEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKF-------LDQDFSGDSLSQFKCEAE 741
+E+ + E +G G V R E AVK + + E +
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 742 IMLRLR-HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
I+ ++ HPN++ + F ++ + + +G L+ L L E+ ++ +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALL 120
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMA 860
+ + LH + IVHRDLK N+L+D + +K+ DFG S + GTP ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLA 177
Query: 861 PEVLRNEPA------NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIP 914
PE++ ++ D++S GVI++ L S P+ M ++ + N + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 915 --DDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
DD V ++ +P R + + ++
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 191 bits (485), Expect = 8e-55
Identities = 60/253 (23%), Positives = 110/253 (43%), Gaps = 11/253 (4%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRH 748
+D QI +G GS+G V+ G A+K + + E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
P ++ G + ++ +++ G L R + + A +V + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH- 121
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
I++RDLK N+L+DKN +K+ DFG ++ + GTP+++APEV+ +P
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKP 177
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928
N+ D +SFG++++E+ P+ N M+ + N L P + V ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRL 235
Query: 929 WQTEPHLRPSFAQ 941
+ R Q
Sbjct: 236 ITRDLSQRLGNLQ 248
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 4e-54
Identities = 56/253 (22%), Positives = 107/253 (42%), Gaps = 8/253 (3%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKF-LDQDFSGDSLSQFKCEAEIMLRLRH 748
D + +G G++G+V G A+K + + D ++ E+ ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
P + A + E+ G L+ L R E R ++ + YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH- 122
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
+V+RD+K NL++DK+ +K+ DFGL + + K+ GTPE++APEVL +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928
D + GV+++E+ +P+ + ++ + + P + P ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGL 239
Query: 929 WQTEPHLRPSFAQ 941
+ +P R
Sbjct: 240 LKKDPKQRLGGGP 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 187 bits (475), Expect = 6e-54
Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 19/277 (6%)
Query: 690 LWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGD--SLSQFKCEAEIMLR 745
L + ++GE +G G EV+ A +VAVK L D + D +F+ EA+
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV-LRADLARDPSFYLRFRREAQNAAA 63
Query: 746 LRHPNVVLFMGAV----TRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK 801
L HP +V P I+ E++ +L ++H + +R + + D +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQ 122
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI---KHHTYLSSKSTAGTPEW 858
+N+ H + I+HRD+K N+++ VKV DFG++R ++ + + GT ++
Sbjct: 123 ALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 859 MAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR--LEIPDD 916
++PE R + + + DVYS G +L+E+ T P+ G +P+ V ++ +
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953
+ + ++ P R A M L R+
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEM--RADLVRVH 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-52
Identities = 63/262 (24%), Positives = 102/262 (38%), Gaps = 16/262 (6%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKF----LDQDFSGDSLSQFKCEAEIMLRLRH 748
GE +G G + V + G + A K G S + E I+ ++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
PNV+ ++ E + G L+ L L E + G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLH- 130
Query: 809 SHPTIVHRDLKSPNLLVDKNWV----VKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
I H DLK N+++ V +K+ DFGL+ K+ GTPE++APE++
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIV 188
Query: 865 RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDIDPAVA 922
EP + D++S GVI + L + + P+ G + + V N E +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 923 QIIRDCWQTEPHLRPSFAQLMS 944
IR +P R + +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (466), Expect = 2e-52
Identities = 53/271 (19%), Positives = 105/271 (38%), Gaps = 24/271 (8%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
++G +IG GS+G++Y G EVA+K + Q E++I ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGI 65
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ ++++ L SL L + + + + + +A + + Y+H+ +
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 813 IVHRDLKSPNLLV---DKNWVVKVCDFGLSRI-------KHHTYLSSKSTAGTPEWMAPE 862
+HRD+K N L+ K +V + DFGL++ +H Y +K+ GT + +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 863 VLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV------GFQNRRLEIPDD 916
+ + D+ S G +L S+PW+GL +
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947
A + C +P ++ L R
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-52
Identities = 61/266 (22%), Positives = 116/266 (43%), Gaps = 27/266 (10%)
Query: 696 IGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVV 752
+ +G+G G+V + + A+K + + E E+ R + P++V
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIV 68
Query: 753 ----LFMGAVTRSPHFSILTEFLPRGSLYRLLH-RPNHQLDERRRMRMALDVAKGMNYLH 807
++ I+ E L G L+ + R + ER + + + + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 808 TSHPTIVHRDLKSPNLLVDK---NWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL 864
+ + I HRD+K NLL N ++K+ DFG ++ S + TP ++APEVL
Sbjct: 129 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVL 185
Query: 865 RNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEI------PDDID 918
E ++ CD++S GVI++ L P+ + + + + + R + ++
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQLMS 944
V +IR+ +TEP R + + M+
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 182 bits (463), Expect = 4e-52
Identities = 51/279 (18%), Positives = 97/279 (34%), Gaps = 27/279 (9%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
++G RIG GS+G ++ +VA+K + Q + E L +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGI 63
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ + ++L L SL LL + + A + + +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 813 IVHRDLKSPNLLVDK-----NWVVKVCDFGLSRI-------KHHTYLSSKSTAGTPEWMA 860
+V+RD+K N L+ + ++ V DFG+ + +H Y K+ +GT +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 861 PEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV------VGAVGFQNRRLEIP 914
+ + D+ + G + S+PW+GL +G E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 915 DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR-CLQRL 952
+ + P + L L+RL
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 8e-52
Identities = 49/260 (18%), Positives = 97/260 (37%), Gaps = 22/260 (8%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKF----LDQDFSGDSLSQFKCEAEIMLRLR- 747
Q+G +G G +G VY VA+K + + ++ E ++ ++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 748 -HPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYL 806
V+ + R F ++ E L E V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 807 HTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLR 865
H ++HRD+K N+L+D N +K+ DFG + T + GT + PE +R
Sbjct: 127 HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DFDGTRVYSPPEWIR 182
Query: 866 NEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924
V+S G++L+++ +P++ + ++ + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHL 234
Query: 925 IRDCWQTEPHLRPSFAQLMS 944
IR C P RP+F ++ +
Sbjct: 235 IRWCLALRPSDRPTFEEIQN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 176 bits (446), Expect = 6e-49
Identities = 54/258 (20%), Positives = 101/258 (39%), Gaps = 13/258 (5%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQF----KCEAEIMLR 745
D + IG G +GEVY G A+K + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 746 LRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNY 805
P +V A S + + + G L+ L + E A ++ G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEH 122
Query: 806 LHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVL- 864
+H + +V+RDLK N+L+D++ V++ D GL+ ++ GT +MAPEVL
Sbjct: 123 MH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 178
Query: 865 RNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRLEIPDDIDPAVAQ 923
+ + D +S G +L++L P++ + +E+PD P +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 924 IIRDCWQTEPHLRPSFAQ 941
++ Q + + R
Sbjct: 239 LLEGLLQRDVNRRLGCLG 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 60/283 (21%), Positives = 107/283 (37%), Gaps = 32/283 (11%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
E+ Q E+IG G+YG VY+A G VA+KK + S E ++ L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
N+V + + ++ EFL + + + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP- 868
++HRDLK NLL++ +K+ DFGL+R + T + APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVV----------------GAVGFQNRRLE 912
+ D++S G I E+ T + G + + + G + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 913 IP-----------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
P +D ++ +P+ R S ++
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 5e-48
Identities = 54/261 (20%), Positives = 113/261 (43%), Gaps = 16/261 (6%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDS-LSQFKCEAEIMLRLRH 748
+ + +G GS+G V G A+K Q + E I+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 749 PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
P +V + + + ++ E++ G ++ L R + E A + YLH+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEP 868
+++RDLK NLL+D+ ++V DFG ++ + GTPE +APE++ ++
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKG 214
Query: 869 ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928
N+ D ++ GV+++E+A P+ P+Q+ + + ++ P + ++R+
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNL 272
Query: 929 WQTEP-----HLRPSFAQLMS 944
Q + +L+ + +
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKN 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-48
Identities = 66/289 (22%), Positives = 111/289 (38%), Gaps = 39/289 (13%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-- 746
+ + IG G+YG+V++A G VA+K+ Q E ++ L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 747 -RHPNVVLFMGAVTRSP-----HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVA 800
HPNVV T S +++ E + + L P + M +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 801 KGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMA 860
+G+++LH+ +VHRDLK N+LV + +K+ DFGL+RI + ++ S T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
Query: 861 PEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV---------------- 904
PEVL D++S G I E+ ++G + + +G +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 905 ---------GFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ DID ++ C P R S +S
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (430), Expect = 8e-48
Identities = 60/282 (21%), Positives = 106/282 (37%), Gaps = 32/282 (11%)
Query: 692 EDLQIGERIGIGSYGEVYRA-DWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
E E+IG G+YG VY+A + +G A+KK + S E I+ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 751 VVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSH 810
+V + ++ E L L +LL L+ L + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 811 PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNE-PA 869
++HRDLK NLL+++ +K+ DFGL+R T + AP+VL
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 870 NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV------------------------- 904
+ D++S G I E+ + + G++ + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 905 --GFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+D + ++ + +P+ R + Q +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-45
Identities = 53/263 (20%), Positives = 107/263 (40%), Gaps = 16/263 (6%)
Query: 692 EDLQIGERIGIGSYGEVYRA-----DWHGTEVAVKKFLDQDFSGDS--LSQFKCEAEIML 744
E+ ++ + +G G+YG+V+ G A+K + + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 745 RLRH-PNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGM 803
+R P +V A ++ +++ G L+ L + + E ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLAL 142
Query: 804 NYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLS-RIKHHTYLSSKSTAGTPEWMAPE 862
+LH I++RD+K N+L+D N V + DFGLS + GT E+MAP+
Sbjct: 143 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 863 VLR--NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV--GFQNRRLEIPDDID 918
++R + ++ D +S GV+++EL T + P+ + P ++
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 919 PAVAQIIRDCWQTEPHLRPSFAQ 941
+I+ +P R
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-45
Identities = 60/278 (21%), Positives = 105/278 (37%), Gaps = 35/278 (12%)
Query: 698 ERIGIGSYGEVYRADWH--GTEVAVKKF---LDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+ +G G + VY+A VA+KK + E +++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 753 LFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPT 812
+ A + S++ +F+ L ++ + L L +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH--QHW 120
Query: 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRN-EPANE 871
I+HRDLK NLL+D+N V+K+ DFGL++ + T + APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 872 KCDVYSFGVILWELATLSVPWKGLNPMQVVGAV-------------------------GF 906
D+++ G IL EL G + + + + F
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 907 QNRRL-EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLM 943
L I + +I+ + P R + Q +
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-43
Identities = 61/289 (21%), Positives = 107/289 (37%), Gaps = 44/289 (15%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
IG G+YG V A + VA+KK + + E +I+LR RH N++
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 753 LFMGAVTRSPHFS----ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHT 808
+ L L LY+LL L + +G+ Y+H+
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS 127
Query: 809 SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI---KHHTYLSSKSTAGTPEWMAPEVLR 865
++ ++HRDLK NLL++ +K+CDFGL+R+ H T + APE++
Sbjct: 128 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 866 NE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV-------------------- 904
N + D++S G IL E+ + + G + + + +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 905 ---------GFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ + + D ++ PH R Q ++
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 8e-43
Identities = 56/284 (19%), Positives = 107/284 (37%), Gaps = 34/284 (11%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+ + E+IG G+YG V++A VA+K+ D S E ++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 750 NVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS 809
N+V + +++ EF + N LD + KG+ + H+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKK-YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 810 HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPA 869
+ ++HRDLK NLL+++N +K+ +FGL+R + T + P+VL
Sbjct: 121 N--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 870 -NEKCDVYSFGVILWELATLSVPW-KGLNPMQVVGAV----------------------- 904
+ D++S G I ELA P G + + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 905 ----GFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ + ++ ++++ + P R S + +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 60/298 (20%), Positives = 114/298 (38%), Gaps = 48/298 (16%)
Query: 692 EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP 749
+ +IG G++GEV++A G +VA+KK L ++ E +I+ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 750 NVVLFMGAVTRSP--------HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAK 801
NVV + ++ +F LL + R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 802 GMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI----KHHTYLSSKSTAGTPE 857
G+ Y+H + I+HRD+K+ N+L+ ++ V+K+ DFGL+R K+ + T
Sbjct: 129 GLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 858 WMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV------------ 904
+ PE+L E D++ G I+ E+ T S +G + +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 905 -------------GFQNRRLEIPDDI-----DPAVAQIIRDCWQTEPHLRPSFAQLMS 944
+ ++ ++ D + DP +I +P R ++
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 9e-41
Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 43/295 (14%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
WE+ + + +G G+YG V A G +VA+KK S + E ++
Sbjct: 13 AWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 744 LRLRHPNVVLFMGAVTRSPHFSILTEFL----PRGSLYRLLHRPNHQLDERRRMRMALDV 799
+RH NV+ + T T+F G+ L + + +L E R + +
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 800 AKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWM 859
KG+ Y+H + HRDLK NL V+++ +K+ DFGL+R T +
Sbjct: 131 LKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYR 185
Query: 860 APEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL------- 911
APEV+ N + D++S G I+ E+ T +KG + + + +
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 912 ----------------------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
I + P ++ + R + + ++
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-39
Identities = 52/290 (17%), Positives = 90/290 (31%), Gaps = 46/290 (15%)
Query: 693 DLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPN 750
+ IG GS+G VY+A G VA+KK L E +IM +L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 751 VVLFMGAVTRS------PHFSILTEFLPRGSLYRLLH--RPNHQLDERRRMRMALDVAKG 802
+V S + +++ +++P H R L + +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 803 MNYLHTSHPTIVHRDLK-SPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAP 861
+ Y+H+ I HRD+K LL V+K+CDFG ++ +
Sbjct: 135 LAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 862 EVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV----------------- 904
+ DV+S G +L EL + G + + + +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 905 ----------GFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
P + + P R + + +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-37
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 45/296 (15%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
WE+ E Q +G G+YG V A G VAVKK S + E ++
Sbjct: 13 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 744 LRLRHPNVVLFMGAVTRSPHFS-----ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALD 798
++H NV+ + T + L L L ++ +L + +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQ 129
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPEW 858
+ +G+ Y+H++ I+HRDLK NL V+++ +K+ DFGL+R T +
Sbjct: 130 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWY 184
Query: 859 MAPEV-LRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVV---------------- 901
APE+ L N+ D++S G I+ EL T + G + + +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 902 -----GAVGFQNRRLEIP--------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMS 944
A + ++P +P ++ + R + AQ ++
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 4e-36
Identities = 53/282 (18%), Positives = 105/282 (37%), Gaps = 17/282 (6%)
Query: 686 EWEILWEDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIM 743
+ +L + Q + IG G+ G V A VA+KK + + E +M
Sbjct: 12 TFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 744 LRLRHPNVVLFMGAVTRSPHFS------ILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
+ H N++ + T ++ E + + D R +
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLY 126
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSKSTAGTPE 857
+ G+ +LH I+HRDLK N++V + +K+ DFGL+R +++ + T
Sbjct: 127 QMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRY 183
Query: 858 WMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917
+ APEV+ E D++S G I+ E+ + + G + + V + P+ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV-IEQLGTPCPEFM 242
Query: 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLVDRSNS 959
+ + +F +L ++ +
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (336), Expect = 7e-35
Identities = 52/308 (16%), Positives = 108/308 (35%), Gaps = 58/308 (18%)
Query: 683 EVAEWEILW---EDLQIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFK 737
+ + W +D Q+ ++G G Y EV+ A +V VK + K
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIK 77
Query: 738 CEAEIMLRLR-HPNVVLFMGAVTR--SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMR 794
E +I+ LR PN++ V S +++ E + +L L +
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 133
Query: 795 MALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHHTYLSSKSTA 853
++ K ++Y H+ I+HRD+K N+++D ++ +++ D+GL+ H
Sbjct: 134 YMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRV 190
Query: 854 GTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNP--------MQVVGAV 904
+ + PE+L + + D++S G +L + P+ + +V+G
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 905 GFQNR----------------------------RLEIPDDIDPAVAQIIRDCWQTEPHLR 936
+ E + P + + + R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 937 PSFAQLMS 944
+ + M
Sbjct: 311 LTAREAME 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 3e-28
Identities = 45/318 (14%), Positives = 99/318 (31%), Gaps = 76/318 (23%)
Query: 695 QIGERIGIGSYGEVYRADWH--GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV 752
+ ++G G + V+ A T VA+K + E +++ R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 753 L---------------FMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMAL 797
F H ++ E L L + + + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 798 DVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN------WVVKVCDFGLSRIKHHTYLSSKS 851
+ G++Y+H I+H D+K N+L++ +K+ D G + Y +
Sbjct: 133 QLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TN 188
Query: 852 TAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKG----------------- 894
+ T E+ +PEVL P D++S +++EL T ++
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 895 -----------------------------LNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925
++ ++ + + D ++ +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 926 RDCWQTEPHLRPSFAQLM 943
Q +P R L+
Sbjct: 309 SPMLQLDPRKRADAGGLV 326
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.8 bits (222), Expect = 4e-21
Identities = 28/166 (16%), Positives = 52/166 (31%), Gaps = 32/166 (19%)
Query: 696 IGERIGIGSYGEVYRA-DWHGTEVAVKKF----------------LDQDFSGDSLSQFKC 738
IG+ +G G V+ E VK D FS ++ +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 739 EAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALD 798
E + +L+ V ++L E + + +++ +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEG----NAVLMELID--------AKELYRVRVENPDEVLDM 111
Query: 799 VAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844
+ + + + H IVH DL N+LV + + DF S
Sbjct: 112 ILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 967 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.18 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.61 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 96.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.86 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.55 | |
| d2q3za4 | 316 | Transglutaminase catalytic domain {Human (Homo sap | 92.69 | |
| d1x3za1 | 320 | Peptide:N-glycanase 1, PNG1 {Baker's yeast(Sacchar | 84.86 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=442.75 Aligned_cols=264 Identities=34% Similarity=0.631 Sum_probs=224.3
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
+|++..++|++.+.||+|+||+||+|++++ .||||++.....+....+.+.+|+.++++++|||||++++++.. +.++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 578888999999999999999999998765 69999987766667778899999999999999999999998754 5689
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
|||||+++|+|.+++...+..+++..++.|+.||+.||+|||++ +||||||||+||||+.++++||+|||+|+.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC--CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999999987677899999999999999999999998 7999999999999999999999999999875432
Q ss_pred --ccCCCCCCCCCCccChhccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc----ccCCCCC
Q 037068 846 --YLSSKSTAGTPEWMAPEVLRNE---PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR----RLEIPDD 916 (967)
Q Consensus 846 --~~~~~~~~GT~~YmAPE~l~g~---~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~----~~~ip~~ 916 (967)
........||+.|||||++.+. .|+.++|||||||+||||+||+.||.+............... ...++..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2233456799999999999653 589999999999999999999999998776544433322222 2245678
Q ss_pred CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 917 IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 917 ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
+++++.+||.+||+.||++|||+.+|+++|+.+.+.+
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999999999987643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=436.72 Aligned_cols=253 Identities=27% Similarity=0.470 Sum_probs=212.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--cCceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--SPHFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--~~~l~LV 767 (967)
++|++.+.||+|+||+||+|++ +|+.||||++.....+....+.+.+|++++++++|||||++++++.+ ++.++||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999976 47899999998776677777889999999999999999999998864 4568999
Q ss_pred EeecCCCchhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---CCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 768 TEFLPRGSLYRLLHR---PNHQLDERRRMRMALDVAKGMNYLHTSH---PTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 768 mEy~~gGsL~~lL~~---~~~~Lse~~i~~I~~QIa~aL~YLHs~n---~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
||||++|+|.+++.+ .+..+++..++.++.||+.||+|||+++ .+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 2467999999999999999999999863 1499999999999999999999999999987
Q ss_pred cccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHH
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAV 921 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL 921 (967)
............||+.|||||++.+..++.++|||||||++|||+||+.||...+..++...+. ......+|..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HTCCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHH
Confidence 7655444566789999999999999999999999999999999999999999998887776664 334456788999999
Q ss_pred HHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 922 AQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 922 ~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||.+||+.||++|||+.|+++|
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=427.83 Aligned_cols=255 Identities=32% Similarity=0.560 Sum_probs=216.5
Q ss_pred cCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.++|++.+.||+|+||+||+|.+. ++.||||++.... ...+++.+|++++++++||||+++++++..++.++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 468999999999999999999874 5679999986543 234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-cC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-LS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-~~ 848 (967)
|+++|+|.+++......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++++||+|||+++...... ..
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc--ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999999987777899999999999999999999998 69999999999999999999999999998765432 23
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.....||+.|+|||++.+..++.++|||||||++|||+| |++||......++...+. .+.+...|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHH
Confidence 344678999999999999999999999999999999999 567777777777766654 456677888999999999999
Q ss_pred hhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
||+.||++|||+.+|+++|+++.+
T Consensus 238 cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-50 Score=434.93 Aligned_cols=263 Identities=34% Similarity=0.627 Sum_probs=228.6
Q ss_pred ccchhhhhhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeee
Q 037068 681 LGEVAEWEILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAV 758 (967)
Q Consensus 681 l~~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~ 758 (967)
...+.+|++..++|++.++||+|+||+||+|++ .++.||||++.... ...+++.+|+.+|++++|||||++++++
T Consensus 6 ~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp STTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence 345567999999999999999999999999976 47789999986432 3456789999999999999999999999
Q ss_pred eccCceEEEEeecCCCchhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecc
Q 037068 759 TRSPHFSILTEFLPRGSLYRLLHR-PNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFG 837 (967)
Q Consensus 759 ~~~~~l~LVmEy~~gGsL~~lL~~-~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFG 837 (967)
.+++.++|||||+++|+|..++.. ....+++..++.|+.||+.||+|||++ ||+||||||+||||+.++++||+|||
T Consensus 83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC--CcccCccccCeEEECCCCcEEEcccc
Confidence 999999999999999999999864 356789999999999999999999998 79999999999999999999999999
Q ss_pred cccccccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChhHHHhhhhccccccCCCC
Q 037068 838 LSRIKHHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVP-WKGLNPMQVVGAVGFQNRRLEIPD 915 (967)
Q Consensus 838 LAr~~~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~P-F~~~~~~ei~~~i~~~~~~~~ip~ 915 (967)
+|+...... .......||+.|||||++.+..++.++|||||||++|||++|..| |...+..++...+ ....+++.|.
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~ 239 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPE 239 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCT
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCc
Confidence 998765432 223345588999999999999999999999999999999997655 5555555555444 3556778889
Q ss_pred CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 916 DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 916 ~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+++++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999999999988765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=431.87 Aligned_cols=249 Identities=26% Similarity=0.492 Sum_probs=222.4
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|++.+.||+|+||+||+|++ +++.||||++.+.... ......+.+|+.++++++||||+++++++.+++.++||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999976 4788999998654322 23456788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+++|+|.+++.. ...+++..++.|+.||+.||+|||++ |||||||||+||||+.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 999999999999875 45699999999999999999999998 79999999999999999999999999998655432
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+. ...+.+|..+++++.+||.+
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHH
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999988887777664 34567788999999999999
Q ss_pred hhhcCCCCCcCHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L 946 (967)
||+.||++|||+.|+++|-
T Consensus 238 ~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCH
T ss_pred HccCCHhHCcCHHHHHcCc
Confidence 9999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-49 Score=432.49 Aligned_cols=259 Identities=34% Similarity=0.572 Sum_probs=218.3
Q ss_pred hccCCeeEeEEeecCCceEEEEeecC--CC---eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 689 ILWEDLQIGERIGIGSYGEVYRADWH--GT---EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 689 i~~e~y~i~k~LGeG~FG~VYka~~~--g~---~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
+..++|++.+.||+|+||+||+|+++ ++ .||||++... ......+.+.+|+.+|++++|||||++++++...+.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45578999999999999999999763 32 4788876543 345566789999999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
+++|||||++|+|.+++......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++++||+|||+++...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC--CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988777899999999999999999999998 79999999999999999999999999998654
Q ss_pred cCcc-----CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 844 HTYL-----SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 844 ~~~~-----~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
.... ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.+....++...+. ...+++.|..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~ 258 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMDC 258 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccc
Confidence 3221 1223457899999999999999999999999999999998 899999998888777664 45667788899
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
++++.+||.+||+.||++|||+.||++.|+++.+
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 9999999999999999999999999999988765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=432.68 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=221.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.++||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+.+.++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5799999999999999999976 588999999875532 235678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+++|+|.+++.+ ..+++..++.|+.||+.||+|||++ |||||||||+|||++.++++||+|||+|+.........
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 9999999998875 4699999999999999999999998 79999999999999999999999999999776555556
Q ss_pred CCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc-cccccCCCCCCcHHHHHHHHHh
Q 037068 850 KSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-QNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~~C 928 (967)
....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+....+.. .......|..+++++.+||.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 677899999999999999999999999999999999999999998887666554432 2334566778999999999999
Q ss_pred hhcCCCCCcCHHHHHHH
Q 037068 929 WQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RPS~~ELLe~ 945 (967)
|+.||++|||+.|+++|
T Consensus 254 L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQH 270 (293)
T ss_dssp TCSSTTTSCCHHHHTTC
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=436.35 Aligned_cols=260 Identities=31% Similarity=0.497 Sum_probs=223.8
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecCC-------CeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMG 756 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g-------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig 756 (967)
..|++..++|++.+.||+|+||+||+|++.+ ..||+|++.... .......+.+|+.+++++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4688888999999999999999999997632 258999876543 333456788999999998 8999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeE
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPN----------------------HQLDERRRMRMALDVAKGMNYLHTSHPTIV 814 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~----------------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIV 814 (967)
++.+.+.++||||||++|+|.+++.... ..+++..++.|+.||+.||+|||++ +||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~--~Ii 186 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCV 186 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEE
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--Cee
Confidence 9999999999999999999999997543 2488999999999999999999998 799
Q ss_pred EeccCCCcEEEcCCCeEEEEecccccccccCcc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCC
Q 037068 815 HRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVP 891 (967)
Q Consensus 815 HRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~P 891 (967)
||||||+|||++.++++||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999999986544322 2234567999999999999999999999999999999998 8999
Q ss_pred CCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHH
Q 037068 892 WKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 892 F~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~ 947 (967)
|.+.+..+....+.....+++.|..+++++.+||.+||+.||++|||++||+++|.
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99877766655555566778889999999999999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=426.18 Aligned_cols=262 Identities=26% Similarity=0.463 Sum_probs=228.3
Q ss_pred hhccCCeeEeEE-eecCCceEEEEeecC----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC
Q 037068 688 EILWEDLQIGER-IGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP 762 (967)
Q Consensus 688 ei~~e~y~i~k~-LGeG~FG~VYka~~~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~ 762 (967)
.+..++|.+.+. ||+|+||+||+|.+. +..||||++... ......+.+.+|+++|++++|||||++++++.. +
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 345578888884 999999999999653 346999998654 345567789999999999999999999999865 4
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.++|||||+++|+|.+++...+..+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 68999999999999999877677899999999999999999999998 7999999999999999999999999999875
Q ss_pred ccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCc
Q 037068 843 HHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 843 ~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls 918 (967)
.... .......||+.|||||++.++.++.++|||||||++|||+| |+.||......++...+. .+.++++|..++
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 238 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 238 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCC
Confidence 4322 22334568999999999999999999999999999999998 899999988777766664 566788899999
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
+++.+||.+||+.||++|||+.+|++.|+.+...+.
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999988765544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-50 Score=432.65 Aligned_cols=250 Identities=29% Similarity=0.483 Sum_probs=220.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
+.|++.+.||+|+||+||+|++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++.++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 5799999999999999999976 47889999986543 3445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
||++|+|..++.+....+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+|+.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~--~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999999999876667799999999999999999999998 79999999999999999999999999998665443334
Q ss_pred CCCCCCCCccChhccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-ccccCCCCCCcHHHHH
Q 037068 850 KSTAGTPEWMAPEVLR-----NEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ-NRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~-----g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~-~~~~~ip~~ls~eL~d 923 (967)
....||+.|||||++. +..|+.++|||||||++|||+||+.||.+.+..+....+... ......|..+++++.+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5678999999999984 456899999999999999999999999998888776665432 2344556789999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~ 945 (967)
||.+||+.||++|||+.|+++|
T Consensus 248 li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=421.83 Aligned_cols=260 Identities=32% Similarity=0.584 Sum_probs=225.8
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
.+|++..++|++.+.||+|+||+||+|.++ ++.||||++.... ...+.+.+|+.++++++|||||++++++.+ +.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 468888999999999999999999999885 5679999986543 234678999999999999999999998754 56
Q ss_pred eEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
++|||||+++|+|.+++... ...+++..++.|+.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~--~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccchhheeeecccceeeccccceEEc
Confidence 79999999999999987653 23589999999999999999999998 7999999999999999999999999999876
Q ss_pred ccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 843 HHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 843 ~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.... .......||+.|||||++.+..++.++|||||||++|||+|| .+||......+....+. .+.++..|..++++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHH
Confidence 5432 234456799999999999999999999999999999999995 55666666666666554 55677788999999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999999999999999999988754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=421.33 Aligned_cols=263 Identities=29% Similarity=0.533 Sum_probs=220.4
Q ss_pred hhhhccCCeeEeEEeecCCceEEEEeecC-----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 037068 686 EWEILWEDLQIGERIGIGSYGEVYRADWH-----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR 760 (967)
Q Consensus 686 ~~ei~~e~y~i~k~LGeG~FG~VYka~~~-----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~ 760 (967)
+|++..++|++.+.||+|+||+||+|.+. +..||||++... ......+.+.+|+.++++++||||+++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 47888899999999999999999999763 235788876433 34555678999999999999999999999986
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
++.+++||||+++|+|..++......+++..++.++.||+.||.|||++ +||||||||+||+++.++.+||+|||+++
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc--CeeccccchhheeecCCCcEEEccchhhe
Confidence 4678999999999999998877777899999999999999999999998 79999999999999999999999999998
Q ss_pred ccccC-ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCc
Q 037068 841 IKHHT-YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDID 918 (967)
Q Consensus 841 ~~~~~-~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls 918 (967)
..... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||......++...+. .+.++++|..++
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 235 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 235 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 75433 223345668999999999999999999999999999999998 899999998888877764 556678899999
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
+++.+||.+||..||++|||+.||+++|+.+.+.-
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999886543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=425.57 Aligned_cols=251 Identities=27% Similarity=0.344 Sum_probs=211.4
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||+||+|++ +++.||||++..... ....+.+.+|+.++++++||||+++++++.+++.++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 47899999999999999999976 488999999875432 233456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC--c
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--Y 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~--~ 846 (967)
||+++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~--~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc--CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999975 55799999999999999999999998 7999999999999999999999999999875432 2
Q ss_pred cCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhH-HHhhhhccccccCCCCCCcHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQ-VVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~e-i~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
......+||+.|||||++.+..+ +.++|||||||++|||+||+.||....... ..............+..+++++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 23455789999999999998876 578999999999999999999998765432 2222222222333345789999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~ 945 (967)
|.+||+.||++|||+.|+++|
T Consensus 240 i~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999886
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=419.85 Aligned_cols=262 Identities=32% Similarity=0.536 Sum_probs=220.2
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecCC------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWHG------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS 761 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~g------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~ 761 (967)
++..++|++.+.||+|+||+||+|.+++ ..||||++... ........+.+|+.++++++|||||++++++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 3455789999999999999999997642 36999998543 3445566789999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
+.+++||||+.+++|.+++......+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc--ccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999998887777899999999999999999999998 699999999999999999999999999987
Q ss_pred cccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChhHHHhhhhccccccCCCCCC
Q 037068 842 KHHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVGFQNRRLEIPDDI 917 (967)
Q Consensus 842 ~~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~ei~~~i~~~~~~~~ip~~l 917 (967)
..... .......||+.|||||++.++.++.++|||||||++|||+++ .+||......++...+. .+.+++.|..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhh
Confidence 54332 123345689999999999999999999999999999999996 45566666666665553 56677888899
Q ss_pred cHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 918 DPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
++++.+||.+||+.||++|||+.+|++.|+.+.+..
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 999999999999999999999999999999887643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=421.16 Aligned_cols=248 Identities=31% Similarity=0.491 Sum_probs=212.5
Q ss_pred eeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec----cCceEEE
Q 037068 694 LQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR----SPHFSIL 767 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~----~~~l~LV 767 (967)
|++.++||+|+||+||+|++ +++.||+|++..........+.+.+|++++++++|||||++++++.. ...++||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 46778999999999999976 47789999998776667777889999999999999999999999865 3458999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc-CCCeEEEEecccccccccCc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD-KNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd-~~g~VKLsDFGLAr~~~~~~ 846 (967)
|||+++|+|.+++.+ ...+++..++.|+.||+.||+|||+++++|+||||||+||||+ .++.+||+|||+|+.....
T Consensus 91 mE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999999999999875 4579999999999999999999999854599999999999996 5789999999999865443
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChh-HHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPM-QVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~-ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
......||+.|||||++.+ .++.++|||||||++|||++|+.||...... ++...+........++..+++++.+||
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 2345689999999999876 5999999999999999999999999876544 344444333334455677899999999
Q ss_pred HHhhhcCCCCCcCHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||+.||++|||+.|+++|
T Consensus 247 ~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHTS
T ss_pred HHHccCCHhHCcCHHHHhCC
Confidence 99999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=417.94 Aligned_cols=252 Identities=31% Similarity=0.544 Sum_probs=226.7
Q ss_pred cCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
.++|++.++||+|+||+||+|+++ ++.||||++...... .+++.+|+.++++++||||+++++++.+++.+++|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 368899999999999999999985 558999998765433 4578999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc-cC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY-LS 848 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~-~~ 848 (967)
|+.+|+|..++......+++..+++|+.||++||.|||++ ||+||||||+||||+.++.+||+|||+++...... ..
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~--~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc--CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999999877777899999999999999999999998 79999999999999999999999999998655432 23
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..++...+. .+.++..|..+++++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHHHH
Confidence 344678999999999999999999999999999999998 899999999888877765 566778899999999999999
Q ss_pred hhhcCCCCCcCHHHHHHHHHH
Q 037068 928 CWQTEPHLRPSFAQLMSRLRC 948 (967)
Q Consensus 928 CLq~dPe~RPS~~ELLe~L~~ 948 (967)
||+.||++|||+++|+++|.+
T Consensus 237 cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCSSGGGSCCHHHHHHHHHC
T ss_pred HccCCHhHCcCHHHHHHHhhC
Confidence 999999999999999999854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=433.67 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=213.3
Q ss_pred hhccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
++..++|++.++||+|+||+||+|++ +++.||+|++... ........+.+|+.++++++|||||+++++|.+.+.++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC-CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh-hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34568999999999999999999986 4788999998654 34455678999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
|||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+.+ ||+||||||+||||+.++++||+|||+|+.....
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHH-CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC-CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999999976 456999999999999999999999743 7999999999999999999999999999866543
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhh--------------------
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVG-------------------- 905 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~-------------------- 905 (967)
. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+......
T Consensus 159 ~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 M--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp T--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred c--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2 345789999999999999999999999999999999999999998765432211100
Q ss_pred ---------------------ccccccCCC-CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 906 ---------------------FQNRRLEIP-DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 906 ---------------------~~~~~~~ip-~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
........+ ..+++++.+||.+||+.||++|||+.|+|+|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence 000111122 24688999999999999999999999999983
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=420.68 Aligned_cols=252 Identities=27% Similarity=0.490 Sum_probs=215.6
Q ss_pred EEeecCCceEEEEeecC----CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEeecCC
Q 037068 698 ERIGIGSYGEVYRADWH----GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEFLPR 773 (967)
Q Consensus 698 k~LGeG~FG~VYka~~~----g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy~~g 773 (967)
++||+|+||+||+|.+. ++.||||++.....+....+.+.+|+.+|++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999652 3579999987655555567789999999999999999999999865 467899999999
Q ss_pred CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCc---cCCC
Q 037068 774 GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY---LSSK 850 (967)
Q Consensus 774 GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~---~~~~ 850 (967)
|+|.+++.+ ...+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++...... ....
T Consensus 92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~--~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhC--CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999876 45699999999999999999999998 69999999999999999999999999998654322 2233
Q ss_pred CCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 037068 851 STAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCW 929 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 929 (967)
...||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+. .+.+++.|..+++++.+||.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHc
Confidence 4578999999999999999999999999999999998 899999998887776664 56678889999999999999999
Q ss_pred hcCCCCCcCHHHHHHHHHHHHHHhh
Q 037068 930 QTEPHLRPSFAQLMSRLRCLQRLLV 954 (967)
Q Consensus 930 q~dPe~RPS~~ELLe~L~~L~~l~~ 954 (967)
+.||++|||+.+|++.|+.+-....
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 9999999999999999887754443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=428.09 Aligned_cols=251 Identities=21% Similarity=0.386 Sum_probs=219.4
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||+||+|++ +++.||||++.+... .....+.+.+|++++++++||||+++++++.+++.++|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6899999999999999999976 488999999865322 2334577899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC--c
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT--Y 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~--~ 846 (967)
||+++|+|.+++.. .+.+++..++.++.||+.||+|||++ |||||||||+||||++++.+||+|||+|+..... .
T Consensus 88 Ey~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~--~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccc--cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999998875 45799999999999999999999998 7999999999999999999999999999876432 2
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIR 926 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 926 (967)
.......||+.|||||++.+..++.++|||||||++|||+||+.||...+..++...+. .....+|..+++++.+||+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVE 242 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHHHHHH
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHHHHHH
Confidence 22345679999999999999999999999999999999999999999988887777664 3346678899999999999
Q ss_pred HhhhcCCCCCcCHHHHHHHHH
Q 037068 927 DCWQTEPHLRPSFAQLMSRLR 947 (967)
Q Consensus 927 ~CLq~dPe~RPS~~ELLe~L~ 947 (967)
+||+.||++|||++|++++..
T Consensus 243 ~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp TTSCSSGGGSTTSGGGTCHHH
T ss_pred HHccCCHhHCcCHHHHcCCHH
Confidence 999999999999999876543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-48 Score=425.91 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=204.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
..++|++.+.||+|+||+||+|++ +++.||||++...... .....+.+|+.++++++||||+++++++.+++.++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 347899999999999999999976 4788999998765433 2345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc---CCCeEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD---KNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd---~~g~VKLsDFGLAr~~~~ 844 (967)
||||++|+|.+++.. ...+++..+..++.||+.||+|||++ |||||||||+|||+. .++.+||+|||+++....
T Consensus 86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~--~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhc--eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999999976 55799999999999999999999998 799999999999994 578999999999986654
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls~eL~ 922 (967)
.. ......||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+....... +.+..+|+++.
T Consensus 163 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 33 2445779999999999999999999999999999999999999999988877776665443333 34467999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+||.+||+.||++|||+.|+++|
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=429.39 Aligned_cols=250 Identities=23% Similarity=0.419 Sum_probs=225.1
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
.++|++.+.||+|+||+||+|++ +++.||||++.+... .......+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 47899999999999999999976 588999999875422 233467789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
||||++|+|..++.+ ...+++..++.++.||+.||+|||++ |||||||||+|||++.+|++||+|||+|+.......
T Consensus 84 ~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~--~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhc--CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999999876 45789999999999999999999999 799999999999999999999999999987655544
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+. ...+.+|..+++++.+||++
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHHh
Confidence 5566789999999999999999999999999999999999999999999888777664 34567889999999999999
Q ss_pred hhhcCCCCCcC-----HHHHHHH
Q 037068 928 CWQTEPHLRPS-----FAQLMSR 945 (967)
Q Consensus 928 CLq~dPe~RPS-----~~ELLe~ 945 (967)
||++||.+|++ ++|+++|
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hccCCchhhcccccccHHHHHcC
Confidence 99999999994 8999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-48 Score=423.55 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=215.9
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFS-GDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s-~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
+.|++.+.||+|+||+||+|++ +++.||||++...... ....+.+.+|+.++++++|||||++++++.+.+.++|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3599999999999999999976 5788999998765443 344567999999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
|||.+|+|..++.. ...+++..++.|+.||+.||.|||++ |||||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 99999999776654 46799999999999999999999998 799999999999999999999999999986543
Q ss_pred CCCCCCCCCccChhcccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHH
Q 037068 849 SKSTAGTPEWMAPEVLRN---EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQII 925 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g---~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 925 (967)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+.........+..+++++.+||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 235679999999999864 45899999999999999999999999988887776665544333444567899999999
Q ss_pred HHhhhcCCCCCcCHHHHHHH
Q 037068 926 RDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 926 ~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+||+.||++|||+.|+++|
T Consensus 248 ~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHTCSSGGGSCCHHHHTTC
T ss_pred HHHCcCChhHCcCHHHHHhC
Confidence 99999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.6e-48 Score=428.43 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=220.6
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++.++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 37899999999999999999976 48899999986542 344567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc--CCCeEEEEecccccccccCc
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD--KNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd--~~g~VKLsDFGLAr~~~~~~ 846 (967)
|||++|+|.+++.+....+++..++.|+.||+.||.|||++ |||||||||+||||+ .++.+||+|||+++......
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999999977667899999999999999999999998 799999999999996 46899999999998765432
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCcHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDIDPAVAQI 924 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls~eL~dL 924 (967)
......||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+....+....... ..+..+++++.+|
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2445789999999999999999999999999999999999999999998888777665433322 2235689999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~ 945 (967)
|.+||+.||++|||+.|+++|
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999997
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=415.31 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=220.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh----hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG----DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~----~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|++.+.||+|+||+||+|++ +|+.||||++.+..... ...+.+.+|+.++++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36899999999999999999976 48899999987654322 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC----eEEEEeccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW----VVKVCDFGLSR 840 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g----~VKLsDFGLAr 840 (967)
+||||||++|+|.+++.+ ...+++..++.++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+++
T Consensus 89 ~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~--~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhc--ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999876 35799999999999999999999998 799999999999998766 59999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCc
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDID 918 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls 918 (967)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+....+....... ..+..++
T Consensus 166 ~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 166 KIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp ECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 765443 2455679999999999999999999999999999999999999999988888776665333222 2346789
Q ss_pred HHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 919 PAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 919 ~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
+++.+||.+||+.||++|||+.|+++|
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=416.57 Aligned_cols=267 Identities=31% Similarity=0.557 Sum_probs=218.9
Q ss_pred cchhhhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeE
Q 037068 682 GEVAEWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVL 753 (967)
Q Consensus 682 ~~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVk 753 (967)
.+..+|++..++|++.++||+|+||+||+|.+. ++.||||++... ........+.+|..++.++ +|+||+.
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 356789999999999999999999999999752 357999997643 3344556778888888877 7899999
Q ss_pred Eeeeeec-cCceEEEEeecCCCchhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEec
Q 037068 754 FMGAVTR-SPHFSILTEFLPRGSLYRLLHRP---------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRD 817 (967)
Q Consensus 754 Lig~~~~-~~~l~LVmEy~~gGsL~~lL~~~---------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRD 817 (967)
+++++.. +..+++|||||++|+|.+++... ...+++..++.++.||+.||.|||++ +|||||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--~ivHrD 159 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRD 159 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT--TCCCSC
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC--CCcCCc
Confidence 9998765 45689999999999999998642 23589999999999999999999998 699999
Q ss_pred cCCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhC-CCCCCC
Q 037068 818 LKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKG 894 (967)
Q Consensus 818 LKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTG-k~PF~~ 894 (967)
|||+||||+.++++||+|||+|+...... .......||+.|||||++.+..++.++|||||||++|||+|| ..||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654332 223456799999999999999999999999999999999997 568887
Q ss_pred CChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 895 LNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 895 ~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
....+........+.++.+|..+++++.++|.+||+.||++|||+.||++||..+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 766555544444667788899999999999999999999999999999999998854
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-47 Score=417.04 Aligned_cols=263 Identities=31% Similarity=0.522 Sum_probs=229.3
Q ss_pred chhhhhhccCCeeEeEEeecCCceEEEEeecCC-------CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEe
Q 037068 683 EVAEWEILWEDLQIGERIGIGSYGEVYRADWHG-------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFM 755 (967)
Q Consensus 683 ~l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g-------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLi 755 (967)
.+.++++..++|++.+.||+|+||+||+|++++ +.||||++... ......+.+.+|+.++++++||||++++
T Consensus 4 ~~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred chhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 456788888999999999999999999997643 57999997643 3455567899999999999999999999
Q ss_pred eeeeccCceEEEEeecCCCchhhhhcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037068 756 GAVTRSPHFSILTEFLPRGSLYRLLHRP-----------------------NHQLDERRRMRMALDVAKGMNYLHTSHPT 812 (967)
Q Consensus 756 g~~~~~~~l~LVmEy~~gGsL~~lL~~~-----------------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~G 812 (967)
+++...+..+++|||+.+|+|.+++... ...+++..++.|+.||+.||+|||++ +
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--~ 160 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--K 160 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--T
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--C
Confidence 9999999999999999999999998542 13488999999999999999999998 6
Q ss_pred eEEeccCCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCC-
Q 037068 813 IVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS- 889 (967)
Q Consensus 813 IVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk- 889 (967)
||||||||+||||+.++++||+|||+|+...... .......||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 9999999999999999999999999998654332 2234567899999999999999999999999999999999985
Q ss_pred CCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 890 VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 890 ~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+||...+..+....+. .+..+++|..+++++.+||.+||+.+|++|||+.||++.|+++
T Consensus 241 ~p~~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp CTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 6899988888877765 4556778899999999999999999999999999999999876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=412.74 Aligned_cols=255 Identities=34% Similarity=0.652 Sum_probs=219.9
Q ss_pred hhhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-cCceE
Q 037068 687 WEILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-SPHFS 765 (967)
Q Consensus 687 ~ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-~~~l~ 765 (967)
|++..++|++.+.||+|+||.||+|+++++.||||++... ...+.+.+|++++++++||||+++++++.+ .+.++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 7778899999999999999999999999999999998543 234678999999999999999999998865 46689
Q ss_pred EEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 766 ILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+||||+++|+|.+++... ...+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC--ceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999998653 23589999999999999999999998 799999999999999999999999999986543
Q ss_pred CccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQ 923 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 923 (967)
. .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......++...+. .+.++++|..+++++.+
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHH
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHH
Confidence 3 334568899999999999999999999999999999998 789999888888777764 56778889999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
||.+||..||.+|||+.+|+++|+.++.
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-47 Score=425.81 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=220.9
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
.++|++.+.||+|+||+||+|++ +++.||||++.... ......+.+|+.++++++|||||+++++|.+++.++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 37899999999999999999976 58899999986542 334567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc--CCCeEEEEecccccccccCc
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD--KNWVVKVCDFGLSRIKHHTY 846 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd--~~g~VKLsDFGLAr~~~~~~ 846 (967)
|||++|+|.+++......+++..++.|+.||+.||.|||++ |||||||||+||||+ .++.+||+|||+|+......
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999999998877677899999999999999999999998 799999999999997 67899999999998765432
Q ss_pred cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccc--cCCCCCCcHHHHHH
Q 037068 847 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRR--LEIPDDIDPAVAQI 924 (967)
Q Consensus 847 ~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~--~~ip~~ls~eL~dL 924 (967)
......||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+....+...... ...+..+++++.+|
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 234567999999999999999999999999999999999999999999888777666533322 23446799999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHH
Q 037068 925 IRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~ 945 (967)
|.+||+.||.+|||+.|+|+|
T Consensus 263 i~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=416.07 Aligned_cols=256 Identities=28% Similarity=0.511 Sum_probs=219.2
Q ss_pred CCeeEeEEeecCCceEEEEeecC--CC----eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH--GT----EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFS 765 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~--g~----~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~ 765 (967)
++|++.+.||+|+||+||+|.+. |+ .||+|++... .+....+.+.+|+.++++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 57999999999999999999763 33 5888887543 3445567899999999999999999999999865 577
Q ss_pred EEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccC
Q 037068 766 ILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 766 LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~ 845 (967)
++|||+.+|+|.+++......+++..++.|+.||+.||.|||++ +||||||||+||||+.++++||+|||+++.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc--CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 88999999999998887778899999999999999999999998 7999999999999999999999999999876443
Q ss_pred cc--CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHHHH
Q 037068 846 YL--SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 846 ~~--~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 922 (967)
.. ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+....++...+. .+.+++.|..+++++.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~ 243 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVY 243 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHH
Confidence 22 2334568999999999999999999999999999999998 799999988777766554 5567788899999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
+||.+||+.||++|||+.||+++|..+.+.
T Consensus 244 ~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 244 MIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999888653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=410.99 Aligned_cols=266 Identities=32% Similarity=0.596 Sum_probs=229.4
Q ss_pred hhhhhhccCCeeEeEEeecCCceEEEEeecCC---------CeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeE
Q 037068 684 VAEWEILWEDLQIGERIGIGSYGEVYRADWHG---------TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVL 753 (967)
Q Consensus 684 l~~~ei~~e~y~i~k~LGeG~FG~VYka~~~g---------~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVk 753 (967)
..+|++..++|.+++.||+|+||.||+|+..+ ..||||++... .......++.+|...+.++ +|||||+
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 45688999999999999999999999997532 36999987643 4555667888999999888 8999999
Q ss_pred EeeeeeccCceEEEEeecCCCchhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEecc
Q 037068 754 FMGAVTRSPHFSILTEFLPRGSLYRLLHRPN---------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDL 818 (967)
Q Consensus 754 Lig~~~~~~~l~LVmEy~~gGsL~~lL~~~~---------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDL 818 (967)
+++++.+++.+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~--~ivHrDi 161 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDL 161 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCC
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC--CEEeeee
Confidence 9999999999999999999999999996532 4589999999999999999999999 6999999
Q ss_pred CCCcEEEcCCCeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 037068 819 KSPNLLVDKNWVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGL 895 (967)
Q Consensus 819 KPsNILLd~~g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~ 895 (967)
||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.++.|+.++|||||||++|||++ |..||...
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 9999999999999999999998765432 22345678999999999999999999999999999999998 78999998
Q ss_pred ChhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 896 NPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 896 ~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
+..++...+. .+.+++.|..+++++.+||.+||+.||.+|||+.||++.|.+|.++.
T Consensus 242 ~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 242 PVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp CHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 8887776664 56778889999999999999999999999999999999999987653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=413.77 Aligned_cols=262 Identities=33% Similarity=0.567 Sum_probs=218.0
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC-CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCc
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH-GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPH 763 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~ 763 (967)
.+|++..++|++.+.||+|+||+||+|+++ ++.||||++.... ...+.+.+|+.++++++|+|||++++++.+ +.
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 457788899999999999999999999875 4579999986443 234678999999999999999999999854 56
Q ss_pred eEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
+++||||+++|+|..++... ...+++..++.|+.||+.||.|||++ +|+||||||+||||+.++++||+|||+++..
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~--~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh--heecccccceEEEECCCCcEEEcccchhhhc
Confidence 89999999999999887643 35699999999999999999999998 7999999999999999999999999999876
Q ss_pred ccCc-cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 843 HHTY-LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 843 ~~~~-~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk-~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
.... .......||+.|+|||++.+..++.++|||||||++|||+||. +||......+....+. ...+.+++..++++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHH
Confidence 4332 2234467899999999999999999999999999999999964 5566666666666554 45567788999999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
+.++|.+||+.||++|||+.+|++.|..+....
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999999998887755433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=411.40 Aligned_cols=256 Identities=33% Similarity=0.557 Sum_probs=215.5
Q ss_pred cCCeeEeEEeecCCceEEEEeecC---C--CeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADWH---G--TEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~~---g--~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|++.+.||+|+||.||+|++. + ..||||++..... .....+.+.+|+.++++++||||+++++++.+ +.+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 478999999999999999999753 2 3689998865443 33456789999999999999999999999976 468
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
++||||+++|+|.+++......+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC--CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 899999999999988876666799999999999999999999998 699999999999999999999999999987544
Q ss_pred Ccc---CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChhHHHhhhhccccccCCCCCCcHH
Q 037068 845 TYL---SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPA 920 (967)
Q Consensus 845 ~~~---~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~e 920 (967)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+.....+++.+..++++
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence 321 2334557889999999999999999999999999999998 899999999998888877677788888999999
Q ss_pred HHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 921 VAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 921 L~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
+.+||.+||+.||++|||+.+|++.|++.
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999999988875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-47 Score=416.90 Aligned_cols=246 Identities=24% Similarity=0.431 Sum_probs=220.6
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||+||+|++ +|+.||||++.+... .....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 6899999999999999999976 488999999865422 2234677899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+|+|..++.. ...+++..++.++.||+.||+|||++ |||||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccC--cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999998876 55688999999999999999999998 7999999999999999999999999999876543
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+.. ....+|..+++++.++|.+|
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHH
Confidence 3456899999999999999999999999999999999999999999988887776642 34567889999999999999
Q ss_pred hhcCCCCCc-----CHHHHHHH
Q 037068 929 WQTEPHLRP-----SFAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RP-----S~~ELLe~ 945 (967)
|+.||.+|+ |++++++|
T Consensus 236 L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhhCHHhccccchhhHHHHHcC
Confidence 999999996 89999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-46 Score=403.33 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=215.3
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC----
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP---- 762 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~---- 762 (967)
+.++|++.+.||+|+||+||+|++ +++.||||++..... +......+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 347899999999999999999976 588999999876543 3445678999999999999999999999987654
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+||||||+++++|..++.. .+.+++..++.|+.||+.||+|||++ |||||||||+||||+.++.++|+|||.++..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~--~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC--CccCccccCcccccCccccceeehhhhhhhh
Confidence 38899999999999998865 45799999999999999999999998 7999999999999999999999999998754
Q ss_pred ccCc---cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCC
Q 037068 843 HHTY---LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDI 917 (967)
Q Consensus 843 ~~~~---~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~l 917 (967)
.... .......||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+....+....... .....+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 3322 23445679999999999999999999999999999999999999999988877665554333222 344678
Q ss_pred cHHHHHHHHHhhhcCCCCCc-CHHHHHHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRP-SFAQLMSRLRCLQ 950 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RP-S~~ELLe~L~~L~ 950 (967)
|+++.++|.+||+.||.+|| |++++++.|.+++
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 99999999999999999999 8999999988875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=409.93 Aligned_cols=259 Identities=33% Similarity=0.626 Sum_probs=221.9
Q ss_pred ccCCeeEeEEeecCCceEEEEeecC--CC--eEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeeccCce
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADWH--GT--EVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~~--g~--~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~~~~l 764 (967)
.+++|++.+.||+|+||+||+|+++ +. .||||++.... .....+.+.+|+++|+++ +|||||++++++.+.+.+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 4589999999999999999999774 33 47788765432 334456789999999999 799999999999999999
Q ss_pred EEEEeecCCCchhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC
Q 037068 765 SILTEFLPRGSLYRLLHRP---------------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW 829 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~---------------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g 829 (967)
++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~--~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC--CccccccccceEEEcCCC
Confidence 9999999999999998653 35799999999999999999999998 799999999999999999
Q ss_pred eEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChhHHHhhhhccc
Q 037068 830 VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLS-VPWKGLNPMQVVGAVGFQN 908 (967)
Q Consensus 830 ~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk-~PF~~~~~~ei~~~i~~~~ 908 (967)
.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||...+..++...+. .+
T Consensus 165 ~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~~ 242 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QG 242 (309)
T ss_dssp CEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GT
T ss_pred ceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-hc
Confidence 99999999998655433 234567899999999999999999999999999999999965 6898888888777664 55
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 909 RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 909 ~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.++++|..+++++.+||.+||+.||++|||+.||+++|.++.+..
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 678888999999999999999999999999999999999987644
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-47 Score=420.13 Aligned_cols=246 Identities=22% Similarity=0.400 Sum_probs=220.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILT 768 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVm 768 (967)
++|++.+.||+|+||+||+|++ +|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+...+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6899999999999999999976 488999999865322 2234567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccC
Q 037068 769 EFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLS 848 (967)
Q Consensus 769 Ey~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~ 848 (967)
||+.+|+|..++.+ ...+++..++.|+.||+.||.|||++ |||||||||+||||+.++++||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~--~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 99999999999876 45699999999999999999999998 7999999999999999999999999999876543
Q ss_pred CCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 037068 849 SKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDC 928 (967)
Q Consensus 849 ~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 928 (967)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.......+. .....+|..+++++.+||++|
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTCCHHHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHHHH
Confidence 335679999999999999999999999999999999999999999988877777664 334567889999999999999
Q ss_pred hhcCCCCCc-----CHHHHHHH
Q 037068 929 WQTEPHLRP-----SFAQLMSR 945 (967)
Q Consensus 929 Lq~dPe~RP-----S~~ELLe~ 945 (967)
|+.||.+|+ |++++++|
T Consensus 273 L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhhCHHhccccccccHHHHHcC
Confidence 999999994 89999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=406.85 Aligned_cols=265 Identities=29% Similarity=0.500 Sum_probs=230.4
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeec-------CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADW-------HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMG 756 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~-------~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig 756 (967)
.+|++..++|++.++||+|+||.||+|++ .++.||||++.... .......+.+|+.+++++ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 47899999999999999999999999964 24579999986543 345566789999999999 6999999999
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccC
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPN-----------------HQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLK 819 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------------~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLK 819 (967)
++.+...++||||||++|+|..++.... ..+++..++.|+.||+.||+|||++ +|||||||
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~--~ivHrDLK 172 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLA 172 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCS
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--Ceeecccc
Confidence 9999999999999999999999986422 3589999999999999999999999 69999999
Q ss_pred CCcEEEcCCCeEEEEecccccccccC--ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 037068 820 SPNLLVDKNWVVKVCDFGLSRIKHHT--YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELAT-LSVPWKGLN 896 (967)
Q Consensus 820 PsNILLd~~g~VKLsDFGLAr~~~~~--~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlT-Gk~PF~~~~ 896 (967)
|+|||++.++.+||+|||+++..... ........||+.|+|||.+.+..++.++|||||||++|||+| |.+||....
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543 223345678999999999999999999999999999999999 566777776
Q ss_pred hhHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH
Q 037068 897 PMQVVGAVGFQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRL 952 (967)
Q Consensus 897 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l 952 (967)
..+....+...+.++..|..+++++.+||.+||+.||++|||+.+|++.|+++.+.
T Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 65555555556677788889999999999999999999999999999999887654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=416.43 Aligned_cols=249 Identities=24% Similarity=0.433 Sum_probs=220.0
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCC-ChhhHHHHHHHHHHHH-HcCCCceeEEeeeeeccCceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDF-SGDSLSQFKCEAEIML-RLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~-s~~~~~~~~~Ei~ILk-~L~HpNIVkLig~~~~~~~l~LV 767 (967)
++|.+.+.||+|+||+||+|++ +++.||||++.+... .....+.+..|+.++. .++||||+++++++.+.+.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999977 588899999865321 1233456667777765 68999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL 847 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~ 847 (967)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++++||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~--~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999999999975 45689999999999999999999999 799999999999999999999999999987665555
Q ss_pred CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 037068 848 SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDPAVAQIIRD 927 (967)
Q Consensus 848 ~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 927 (967)
......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..++...+. ...+.+|..+++++.+||++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHH
Confidence 5566789999999999999999999999999999999999999999999888877764 33567788999999999999
Q ss_pred hhhcCCCCCcCHH-HHHHH
Q 037068 928 CWQTEPHLRPSFA-QLMSR 945 (967)
Q Consensus 928 CLq~dPe~RPS~~-ELLe~ 945 (967)
||+.||.+||++. ++++|
T Consensus 237 ~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HSCSSGGGSBTTBSCGGGS
T ss_pred hcccCCCCCcCHHHHHHhC
Confidence 9999999999995 78775
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=412.22 Aligned_cols=251 Identities=19% Similarity=0.303 Sum_probs=219.0
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSIL 767 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LV 767 (967)
+.++|++.+.||+|+||+||+|.+ +++.||||++.... .....+.+|+.+|+.++||||+++++++.+.+.+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999976 47789999986542 3345678999999999999999999999999999999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC--CCeEEEEecccccccccC
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK--NWVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~--~g~VKLsDFGLAr~~~~~ 845 (967)
||||++|+|.+++...+..+++..++.|+.||+.||+|||++ ||+||||||+|||++. .+.+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~--~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999999987666899999999999999999999998 7999999999999985 458999999999866443
Q ss_pred ccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccccc--CCCCCCcHHHHH
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRL--EIPDDIDPAVAQ 923 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~--~ip~~ls~eL~d 923 (967)
. ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+......+ ..+..+++++.+
T Consensus 158 ~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred C-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 2 2344678999999999999999999999999999999999999999998888777664332222 122478999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHH
Q 037068 924 IIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 924 LI~~CLq~dPe~RPS~~ELLe~L 946 (967)
||.+||+.||++|||+.|+++|-
T Consensus 237 li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHccCChhHCcCHHHHhcCH
Confidence 99999999999999999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.3e-46 Score=401.31 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=218.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh-------hhHHHHHHHHHHHHHcC-CCceeEEeeeeec
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-------DSLSQFKCEAEIMLRLR-HPNVVLFMGAVTR 760 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-------~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~ 760 (967)
.++|++.+.||+|+||+||+|++ +++.||||++....... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 58999999999999999999976 57899999987654332 12346889999999996 9999999999999
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
++.++|||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc--CCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999976 45799999999999999999999998 79999999999999999999999999998
Q ss_pred ccccCccCCCCCCCCCCccChhcccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccC--
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRN------EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLE-- 912 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g------~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~-- 912 (967)
...... ......||+.|+|||.+.+ ..++.++||||+||++|||+||+.||.+.+.......+......+.
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 765543 3455789999999999863 3468899999999999999999999999988777666554333333
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 913 IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 913 ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.+..+|+++.+||.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 234799999999999999999999999999887
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=403.16 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=210.3
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.+.||+|+||+||+|++ +++.||||++............+.+|++++++++|||||++++++.+.+.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999976 48899999986554444456788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
|+.++.+..+.......+++..++.++.||+.||+|||++ |||||||||+|||++.++.+||+|||+|+.........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~--~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC--CEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 9987655555555567799999999999999999999998 79999999999999999999999999998776655556
Q ss_pred CCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc----------------ccccC
Q 037068 850 KSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ----------------NRRLE 912 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~----------------~~~~~ 912 (967)
....||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+.......+... .....
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 6678999999999987765 578999999999999999999999988765544332100 00000
Q ss_pred C-----------CCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 913 I-----------PDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 913 i-----------p~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. ...+++++.+||++||+.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 12567899999999999999999999999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=406.37 Aligned_cols=261 Identities=33% Similarity=0.560 Sum_probs=229.4
Q ss_pred hhhhhccCCeeEeEEeecCCceEEEEeecC-------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeee
Q 037068 685 AEWEILWEDLQIGERIGIGSYGEVYRADWH-------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGA 757 (967)
Q Consensus 685 ~~~ei~~e~y~i~k~LGeG~FG~VYka~~~-------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~ 757 (967)
.+|++..++|++.+.||+|+||+||+|.++ ++.||||++... ........+.+|+.++++++||||++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 368999999999999999999999999764 467999998644 344555678999999999999999999999
Q ss_pred eeccCceEEEEeecCCCchhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC
Q 037068 758 VTRSPHFSILTEFLPRGSLYRLLHRP---------NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN 828 (967)
Q Consensus 758 ~~~~~~l~LVmEy~~gGsL~~lL~~~---------~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~ 828 (967)
+..++..++||||+.+|+|.+++... ...+++..+..++.||++||.|||++ +|+||||||+||||+.+
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~--~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAED 169 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECTT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC--CeeeceEcCCceeecCC
Confidence 99999999999999999999987531 23578999999999999999999998 69999999999999999
Q ss_pred CeEEEEecccccccccCc--cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChhHHHhhhh
Q 037068 829 WVVKVCDFGLSRIKHHTY--LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATL-SVPWKGLNPMQVVGAVG 905 (967)
Q Consensus 829 g~VKLsDFGLAr~~~~~~--~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTG-k~PF~~~~~~ei~~~i~ 905 (967)
+++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||+|| +.||.+.+..+....+.
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998654432 223445689999999999999999999999999999999998 58899988888877665
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHH
Q 037068 906 FQNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCL 949 (967)
Q Consensus 906 ~~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L 949 (967)
.+..++.|..+++.+.++|.+||+.+|++|||+.+|+++|++.
T Consensus 250 -~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5567788899999999999999999999999999999998765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.5e-46 Score=413.36 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=210.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh-hhHHHHH---HHHHHHHHcCCCceeEEeeeeeccCce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG-DSLSQFK---CEAEIMLRLRHPNVVLFMGAVTRSPHF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~-~~~~~~~---~Ei~ILk~L~HpNIVkLig~~~~~~~l 764 (967)
.++|++.+.||+|+||+||+|++ +|+.||||++.+..... .....+. .|+.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 37899999999999999999976 58899999986432211 1122233 446667777899999999999999999
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
||||||+.+|+|.+++.+ ...+++..++.|+.||+.||+|||++ |||||||||+||||+.++.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~--~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHC--CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999976 45689999999999999999999998 799999999999999999999999999986654
Q ss_pred CccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhh-hccccccCCCCCCcHHHH
Q 037068 845 TYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAV-GFQNRRLEIPDDIDPAVA 922 (967)
Q Consensus 845 ~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i-~~~~~~~~ip~~ls~eL~ 922 (967)
. ......||+.|||||++.+ ..|+.++|||||||++|||+||+.||............ ........+|..+++++.
T Consensus 160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 3 2445689999999999975 56899999999999999999999999876544332222 123445667889999999
Q ss_pred HHHHHhhhcCCCCCcC-----HHHHHHH
Q 037068 923 QIIRDCWQTEPHLRPS-----FAQLMSR 945 (967)
Q Consensus 923 dLI~~CLq~dPe~RPS-----~~ELLe~ 945 (967)
+||.+||+.||++||| ++|+++|
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 9999999999999999 7999988
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=400.53 Aligned_cols=247 Identities=23% Similarity=0.260 Sum_probs=204.7
Q ss_pred EeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh---hhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 696 IGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG---DSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~---~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
..++||+|+||+||+|++ +++.||||++....... .....+.+|+.++++++|||||++++++..++.++|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999976 47899999986543221 1234688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.++++..++. .+..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~--~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcc--ceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 99887766654 366799999999999999999999998 799999999999999999999999999987766655566
Q ss_pred CCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccc---------------------
Q 037068 851 STAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQN--------------------- 908 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~--------------------- 908 (967)
...||+.|+|||++.+. .++.++|||||||++|||+||..||.+.+..+....+....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 67899999999998755 57999999999999999999999999887766554432100
Q ss_pred cccC-----CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 909 RRLE-----IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 909 ~~~~-----ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.... +...+++++.+||.+||+.||++|||+.|+|+|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000 113568899999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=401.33 Aligned_cols=256 Identities=31% Similarity=0.535 Sum_probs=216.5
Q ss_pred EeEEeecCCceEEEEeecCC-----CeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-cCceEEEEe
Q 037068 696 IGERIGIGSYGEVYRADWHG-----TEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-SPHFSILTE 769 (967)
Q Consensus 696 i~k~LGeG~FG~VYka~~~g-----~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-~~~l~LVmE 769 (967)
+.++||+|+||+||+|++.. ..||||++... .+....+++.+|++++++++||||+++++++.. ++.+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 36789999999999997632 25899988543 355667889999999999999999999999765 567999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCcc--
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYL-- 847 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~-- 847 (967)
||++|+|.+++......+++..++.++.||+.||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~--~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc--CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999999988777889999999999999999999998 699999999999999999999999999986543321
Q ss_pred --CCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChhHHHhhhhccccccCCCCCCcHHHHHH
Q 037068 848 --SSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGL-NPMQVVGAVGFQNRRLEIPDDIDPAVAQI 924 (967)
Q Consensus 848 --~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~-~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 924 (967)
......||+.|+|||.+.+..++.++||||||+++|||+||..||... +..+....+ ..+.++..|..+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCcccCcHHHHHH
Confidence 223356899999999999999999999999999999999977766543 333333333 3566778889999999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHHHHHhhc
Q 037068 925 IRDCWQTEPHLRPSFAQLMSRLRCLQRLLVD 955 (967)
Q Consensus 925 I~~CLq~dPe~RPS~~ELLe~L~~L~~l~~~ 955 (967)
|.+||+.||++||++.||+++|+.+.+....
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999765443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=396.86 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=209.5
Q ss_pred CCeeEeEEeecCCceEEEEeecC---CCeEEEEEeecCCCChhhHHHHHHHHHHHHHc---CCCceeEEeeeeec-----
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH---GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL---RHPNVVLFMGAVTR----- 760 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~---g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L---~HpNIVkLig~~~~----- 760 (967)
++|++.++||+|+||+||+|++. ++.||||++............+.+|+.+++.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 78999999999999999999762 45699999876543333334456777777665 79999999998853
Q ss_pred cCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 761 SPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 761 ~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
...++++|||+.++.+..........+++..++.++.||+.||+|||++ +||||||||+|||++..+.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3468999999999888777666677899999999999999999999998 79999999999999999999999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc-------------
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ------------- 907 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~------------- 907 (967)
...... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..+....+...
T Consensus 165 ~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 654432 345678999999999999999999999999999999999999999988876654443210
Q ss_pred ------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 ------------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 ------------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.....++..+++.+.+||++||+.||++|||+.|+|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00112345688999999999999999999999999988
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-45 Score=395.27 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=209.5
Q ss_pred CCeeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEee
Q 037068 692 EDLQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTEF 770 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmEy 770 (967)
++|++.++||+|+||+||+|++ +++.||||++.....+......+.+|+.+|++++||||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 7999999999999999999987 478999999876554455567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCCC
Q 037068 771 LPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSSK 850 (967)
Q Consensus 771 ~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~~ 850 (967)
+.++.+..+... ...+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||++...........
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~--~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccC--cEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 988766666544 67799999999999999999999998 799999999999999999999999999987665544455
Q ss_pred CCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcc----------------------
Q 037068 851 STAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQ---------------------- 907 (967)
Q Consensus 851 ~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~---------------------- 907 (967)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+...
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 66799999999998765 5689999999999999999999999987765544332100
Q ss_pred -----ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 -----NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 -----~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
......+..+++++.+||++||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00012345678999999999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=402.38 Aligned_cols=246 Identities=26% Similarity=0.446 Sum_probs=203.7
Q ss_pred cCCeeEeE-EeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeeeec----cC
Q 037068 691 WEDLQIGE-RIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRL-RHPNVVLFMGAVTR----SP 762 (967)
Q Consensus 691 ~e~y~i~k-~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L-~HpNIVkLig~~~~----~~ 762 (967)
.++|.+.+ .||+|+||+||+|++ +++.||||++... ..+.+|+.++.++ +|||||+++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 36898875 599999999999976 5789999998542 4567899987655 89999999999875 45
Q ss_pred ceEEEEeecCCCchhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC---CCeEEEEeccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRP-NHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK---NWVVKVCDFGL 838 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~-~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~---~g~VKLsDFGL 838 (967)
.+|||||||++|+|.+++.+. ...+++..++.|+.||+.||+|||++ ||+||||||+|||++. .+.+||+|||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~--~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc--CCccccccccccccccccccccccccccce
Confidence 689999999999999999765 35699999999999999999999998 7999999999999975 56899999999
Q ss_pred ccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--cccccCCC--
Q 037068 839 SRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF--QNRRLEIP-- 914 (967)
Q Consensus 839 Ar~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~--~~~~~~ip-- 914 (967)
|+...... ......||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+.......+.. ......+|
T Consensus 161 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 161 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 98765443 34567899999999999999999999999999999999999999987665443332211 12222333
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 915 --DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 915 --~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..+++++.+||++||+.||++|||+.|+++|-
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 25789999999999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=395.18 Aligned_cols=242 Identities=21% Similarity=0.390 Sum_probs=205.9
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCCh----hhHHHHHHHHHHHHHcC--CCceeEEeeeeeccC
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSG----DSLSQFKCEAEIMLRLR--HPNVVLFMGAVTRSP 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~----~~~~~~~~Ei~ILk~L~--HpNIVkLig~~~~~~ 762 (967)
.++|++.+.||+|+||+||+|++ +++.||||++....... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 47899999999999999999976 48899999987643322 11234668999999996 899999999999999
Q ss_pred ceEEEEeecCC-CchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-CCeEEEEeccccc
Q 037068 763 HFSILTEFLPR-GSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-NWVVKVCDFGLSR 840 (967)
Q Consensus 763 ~l~LVmEy~~g-GsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-~g~VKLsDFGLAr 840 (967)
..++||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CCccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 577777765 45799999999999999999999998 7999999999999984 5899999999998
Q ss_pred ccccCccCCCCCCCCCCccChhccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhccccccCCCCCCcH
Q 037068 841 IKHHTYLSSKSTAGTPEWMAPEVLRNEPA-NEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNRRLEIPDDIDP 919 (967)
Q Consensus 841 ~~~~~~~~~~~~~GT~~YmAPE~l~g~~~-s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~~~~ip~~ls~ 919 (967)
...... .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||...+ ++. .....++..+|+
T Consensus 160 ~~~~~~--~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~------~~~~~~~~~~s~ 229 (273)
T d1xwsa_ 160 LLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII------RGQVFFRQRVSS 229 (273)
T ss_dssp ECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HCCCCCSSCCCH
T ss_pred eccccc--ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HHh------hcccCCCCCCCH
Confidence 665442 345789999999999988775 567899999999999999999997532 111 223456778999
Q ss_pred HHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 920 AVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 920 eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
++.+||++||+.||++|||++|+++|
T Consensus 230 ~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 230 ECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=390.75 Aligned_cols=257 Identities=30% Similarity=0.508 Sum_probs=203.0
Q ss_pred CCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC----ceEEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP----HFSIL 767 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~----~l~LV 767 (967)
++|.+.++||+|+||.||+|+++|+.||||++.... ........|+..+.+++||||+++++++.+.+ .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 578999999999999999999999999999975321 11122334555556789999999999997654 58999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS------HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~------n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
|||+++|+|..++++ ..+++..++.++.|++.||.|||+. .+|||||||||+||||+.++++||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999985 3589999999999999999999973 23899999999999999999999999999987
Q ss_pred cccCc----cCCCCCCCCCCccChhccccCC------CCchhHHHHHHHHHHHHHhCCCCCCCCC---------------
Q 037068 842 KHHTY----LSSKSTAGTPEWMAPEVLRNEP------ANEKCDVYSFGVILWELATLSVPWKGLN--------------- 896 (967)
Q Consensus 842 ~~~~~----~~~~~~~GT~~YmAPE~l~g~~------~s~ksDVWSLGvlL~ELlTGk~PF~~~~--------------- 896 (967)
..... .......||+.|||||++.+.. ++.++|||||||+||||+||..||....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 64432 1234567999999999987653 5678999999999999999988764322
Q ss_pred hhHHHhhhhccccccCCCCC-----CcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 897 PMQVVGAVGFQNRRLEIPDD-----IDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 897 ~~ei~~~i~~~~~~~~ip~~-----ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
.......+.....++.+|.. ....+.+|+.+||+.||++|||+.||+++|+++.+.-
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 12222233233334444433 2356899999999999999999999999999987653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=376.97 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=214.3
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccCceEEEEe
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSPHFSILTE 769 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~~l~LVmE 769 (967)
++|++.++||+|+||+||+|++ +++.||||++...........++.+|+.++++++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999976 47889999997665556667889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccccCccCC
Q 037068 770 FLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHHTYLSS 849 (967)
Q Consensus 770 y~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~~~~~~ 849 (967)
++.+++|..++.. .+.+++..++.++.|++.||+|||++ |||||||||+|||++.++.+||+|||.++.........
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~--~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcC--CEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 9999998887765 56789999999999999999999998 79999999999999999999999999998876655555
Q ss_pred CCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCC-CCChhHHHhhhhc---------------------
Q 037068 850 KSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWK-GLNPMQVVGAVGF--------------------- 906 (967)
Q Consensus 850 ~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~-~~~~~ei~~~i~~--------------------- 906 (967)
....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||. +.+..+....+..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 6667889999999988765 6899999999999999999998864 4444433332210
Q ss_pred ------cccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 907 ------QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 907 ------~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
.......+..+++.+.+||++||+.||++|||++|+|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011112334678999999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=387.37 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=206.5
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC------
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP------ 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~------ 762 (967)
.++|++.++||+|+||+||+|.+ +++.||||++.....+....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 58999999999999999999976 4889999998766556666778999999999999999999999997654
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+++||||+ +.+|..+++. ..+++..++.++.||+.||+|||++ |||||||||+|||++.++.+||+|||+|+..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhC--CCcccccCcchhhcccccccccccccceecc
Confidence 579999999 5678877764 4699999999999999999999998 7999999999999999999999999999876
Q ss_pred ccCccCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc---------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF--------------- 906 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~--------------- 906 (967)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred CCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 543 3456799999999998764 568999999999999999999999988776544322110
Q ss_pred --------------cccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH--HHHH
Q 037068 907 --------------QNRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR--LRCL 949 (967)
Q Consensus 907 --------------~~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~--L~~L 949 (967)
......+...+++++.+||.+||+.||.+|||+.|+|+| |+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000112345678999999999999999999999999998 4444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-43 Score=379.78 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=203.6
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec--------c
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR--------S 761 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~--------~ 761 (967)
++|++.++||+|+||+||+|++ +++.||||++............+.+|+.+|++++|+||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 7999999999999999999976 58899999987665555566778899999999999999999998754 3
Q ss_pred CceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 762 PHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
..+++||||+.++.+..+. .....+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~--~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccC--CEEecCcCchheeecCCCcEEeeecceeee
Confidence 4689999999877665444 4466799999999999999999999998 799999999999999999999999999976
Q ss_pred cccCc----cCCCCCCCCCCccChhccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc--ccCC-
Q 037068 842 KHHTY----LSSKSTAGTPEWMAPEVLRNE-PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR--RLEI- 913 (967)
Q Consensus 842 ~~~~~----~~~~~~~GT~~YmAPE~l~g~-~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~--~~~i- 913 (967)
..... .......||+.|+|||++.+. .+++++|||||||++|||++|+.||.+.+.......+..... ....
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 54321 223446799999999999765 589999999999999999999999998877665544321100 0000
Q ss_pred ------------------CC---------CCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 914 ------------------PD---------DIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 914 ------------------p~---------~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
+. ..++++.+||.+||+.||++|||+.|+|+|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 00 1366788999999999999999999999884
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-42 Score=371.72 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=203.6
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCcee-EEeeeeeccCceEEE
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVV-LFMGAVTRSPHFSIL 767 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIV-kLig~~~~~~~l~LV 767 (967)
.++|++.+.||+|+||+||+|++ +++.||||++...... .++..|+++++.++|+|++ .+.+++...+..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 36899999999999999999976 4789999987654322 3467899999999776654 555566777788999
Q ss_pred EeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEc---CCCeEEEEeccccccccc
Q 037068 768 TEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVD---KNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 768 mEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd---~~g~VKLsDFGLAr~~~~ 844 (967)
|||+ +++|...+......+++..+..++.||+.||+|||++ |||||||||+|||++ .+..+||+|||+|+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9998 4567666666677899999999999999999999998 799999999999986 355799999999987644
Q ss_pred Cc-------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc------ccccc
Q 037068 845 TY-------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF------QNRRL 911 (967)
Q Consensus 845 ~~-------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~------~~~~~ 911 (967)
.. .......||+.|||||.+.+..++.++|||||||++|||+||+.||...........+.. .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 32 123456799999999999999999999999999999999999999987665443222110 11112
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHH
Q 037068 912 EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQR 951 (967)
Q Consensus 912 ~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~ 951 (967)
..+..+|+++.++|.+||+.+|++||++.+|.+.|+.+..
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 2346789999999999999999999999999998887744
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=382.83 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=202.7
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeeccC----ce
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRSP----HF 764 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~~----~l 764 (967)
.++|++.++||+|+||+||+|.+ +++.||||++.... .....+.+.+|+.+|++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 36899999999999999999976 58899999986543 3445667899999999999999999999987543 34
Q ss_pred EEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccccc
Q 037068 765 SILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKHH 844 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~~ 844 (967)
+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ |||||||||+||||+.++.+||+|||+++....
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~--~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 556677889999999975 3699999999999999999999998 799999999999999999999999999986543
Q ss_pred Cc---cCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--------------
Q 037068 845 TY---LSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-------------- 906 (967)
Q Consensus 845 ~~---~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-------------- 906 (967)
.. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...+..........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 32 22345679999999999854 5678999999999999999999999988765433322210
Q ss_pred ----------ccccc-----CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 907 ----------QNRRL-----EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 907 ----------~~~~~-----~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..... .....+++++.+||.+||+.||++|||+.|+|+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 1224678899999999999999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.7e-42 Score=369.12 Aligned_cols=257 Identities=18% Similarity=0.255 Sum_probs=213.6
Q ss_pred ccCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCC-CceeEEeeeeeccCceEE
Q 037068 690 LWEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRH-PNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 690 ~~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~H-pNIVkLig~~~~~~~l~L 766 (967)
..++|++.++||+|+||+||+|++ +++.||||++..... ...+.+|+++++.|.| +||+.+++++......++
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 457999999999999999999976 478999998765432 2346678899999965 899999999999999999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcC-----CCeEEEEecccccc
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDK-----NWVVKVCDFGLSRI 841 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~-----~g~VKLsDFGLAr~ 841 (967)
||||+ +++|.+++...+..+++..+..++.|++.||+|||++ ||+||||||+||||+. .+.+||+|||+|+.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~--giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC--CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99998 6899999887777899999999999999999999998 7999999999999964 57899999999987
Q ss_pred cccCc-------cCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHH---Hhhhhc---cc
Q 037068 842 KHHTY-------LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV---VGAVGF---QN 908 (967)
Q Consensus 842 ~~~~~-------~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei---~~~i~~---~~ 908 (967)
..... .......||+.|||||++.+..++.++|||||||++|||+||+.||.+...... ...+.. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 54321 123446799999999999999999999999999999999999999986544322 222211 11
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHh
Q 037068 909 RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRLRCLQRLL 953 (967)
Q Consensus 909 ~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L~~L~~l~ 953 (967)
...+++..+|+++.+++..||..+|++||+++.+.+.|+++.+..
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 112344678999999999999999999999999999988876544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=379.83 Aligned_cols=244 Identities=24% Similarity=0.300 Sum_probs=198.5
Q ss_pred CeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeecc------Cce
Q 037068 693 DLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTRS------PHF 764 (967)
Q Consensus 693 ~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~~------~~l 764 (967)
+|+..++||+|+||+||+|++ +++.||||++...... ..+|+.+|++++|+||++++++|... ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999987 4889999998654321 23699999999999999999998542 347
Q ss_pred EEEEeecCCCchhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-eEEEEecccccc
Q 037068 765 SILTEFLPRGSLYRLLH--RPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW-VVKVCDFGLSRI 841 (967)
Q Consensus 765 ~LVmEy~~gGsL~~lL~--~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g-~VKLsDFGLAr~ 841 (967)
+||||||.++.+..+.. .....+++..++.|+.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc--CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 89999998764444332 3456799999999999999999999998 799999999999999765 899999999986
Q ss_pred cccCccCCCCCCCCCCccChhcccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--------------
Q 037068 842 KHHTYLSSKSTAGTPEWMAPEVLRN-EPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF-------------- 906 (967)
Q Consensus 842 ~~~~~~~~~~~~GT~~YmAPE~l~g-~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~-------------- 906 (967)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+..
T Consensus 173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 65433 2445689999999999875 4689999999999999999999999988776554433210
Q ss_pred -ccccc------------CCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 907 -QNRRL------------EIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 907 -~~~~~------------~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
..... .....+++++.+||.+||+.||++|||+.|+|+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 1123578999999999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-41 Score=370.95 Aligned_cols=242 Identities=20% Similarity=0.318 Sum_probs=199.2
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeec--cCceEE
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTR--SPHFSI 766 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~--~~~l~L 766 (967)
++|++.++||+|+||+||+|++ +++.||||++... ..+.+.+|+.+|++++ ||||++++++|.. ...+++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 6899999999999999999976 4889999997542 3467889999999995 9999999999874 456999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCC-CeEEEEecccccccccC
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKN-WVVKVCDFGLSRIKHHT 845 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~-g~VKLsDFGLAr~~~~~ 845 (967)
||||+.+++|..+.. .+++..+..++.||+.||.|||++ |||||||||+||||+.+ +.+||+|||+|+.....
T Consensus 110 v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~--gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhc--ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999999987743 599999999999999999999999 79999999999999864 57999999999876543
Q ss_pred ccCCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHH-Hhhhh----------------cc
Q 037068 846 YLSSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQV-VGAVG----------------FQ 907 (967)
Q Consensus 846 ~~~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei-~~~i~----------------~~ 907 (967)
. ......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||........ ...+. ..
T Consensus 184 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 Q-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp C-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred C-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 3 345667999999999987754 79999999999999999999999976543211 10000 00
Q ss_pred ---------c----------cccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 908 ---------N----------RRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 908 ---------~----------~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
. ........+++++.+||++||+.||++|||++|+|+|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0001113478999999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=382.83 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=211.3
Q ss_pred cCCeeEeEEeecCCceEEEEeec-----CCCeEEEEEeecCCC--ChhhHHHHHHHHHHHHHcCC-CceeEEeeeeeccC
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW-----HGTEVAVKKFLDQDF--SGDSLSQFKCEAEIMLRLRH-PNVVLFMGAVTRSP 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~-----~g~~VAVKkl~~~~~--s~~~~~~~~~Ei~ILk~L~H-pNIVkLig~~~~~~ 762 (967)
.++|++.++||+|+||+||+|++ +|+.||||++.+... +....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37899999999999999999964 478899999864322 12234567889999999966 89999999999999
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.++++|||+.+|+|..++.. ...+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcC--CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999876 44678999999999999999999998 6999999999999999999999999999865
Q ss_pred ccC-ccCCCCCCCCCCccChhccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc--cccccCCCCCC
Q 037068 843 HHT-YLSSKSTAGTPEWMAPEVLRNE--PANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF--QNRRLEIPDDI 917 (967)
Q Consensus 843 ~~~-~~~~~~~~GT~~YmAPE~l~g~--~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~--~~~~~~ip~~l 917 (967)
... ........|++.|++||.+.+. .++.++|||||||+||||+||+.||...........+.. ....+++|..+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 432 2234456799999999999765 467899999999999999999999987765444333321 23456677899
Q ss_pred cHHHHHHHHHhhhcCCCCCc-----CHHHHHHH
Q 037068 918 DPAVAQIIRDCWQTEPHLRP-----SFAQLMSR 945 (967)
Q Consensus 918 s~eL~dLI~~CLq~dPe~RP-----S~~ELLe~ 945 (967)
++++.+||.+||++||++|| |++|+++|
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 99999999999999999999 58999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=379.50 Aligned_cols=248 Identities=24% Similarity=0.308 Sum_probs=206.0
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec-----cCc
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR-----SPH 763 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~-----~~~ 763 (967)
.++|++.++||+|+||+||+|++ +++.||||++.....+......+.+|+.++++++||||+++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 48999999999999999999976 58899999987766666667789999999999999999999999864 334
Q ss_pred eEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEecccccccc
Q 037068 764 FSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIKH 843 (967)
Q Consensus 764 l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~~ 843 (967)
.+++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~--giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhC--CCcccccCCccccccccccccccccchhcccC
Confidence 5677888899999999864 4699999999999999999999998 79999999999999999999999999997654
Q ss_pred cCccCCCCCCCCCCccChhccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhcccc-------------
Q 037068 844 HTYLSSKSTAGTPEWMAPEVLRNEP-ANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGFQNR------------- 909 (967)
Q Consensus 844 ~~~~~~~~~~GT~~YmAPE~l~g~~-~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~~~~------------- 909 (967)
.. .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 173 ~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp GG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred cc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 33 34567899999999877654 68999999999999999999999998776554433321000
Q ss_pred --------ccC--------CCCCCcHHHHHHHHHhhhcCCCCCcCHHHHHHH
Q 037068 910 --------RLE--------IPDDIDPAVAQIIRDCWQTEPHLRPSFAQLMSR 945 (967)
Q Consensus 910 --------~~~--------ip~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~ 945 (967)
... ....+++++.+||++||+.||++|||+.|+|+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 001 113578999999999999999999999999998
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-42 Score=377.92 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=196.9
Q ss_pred cCCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCceeEEeeeeec------cC
Q 037068 691 WEDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNVVLFMGAVTR------SP 762 (967)
Q Consensus 691 ~e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNIVkLig~~~~------~~ 762 (967)
.++|++.++||+|+||+||+|.+ +|+.||||++.....+......+.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 37899999999999999999976 48899999998776666677789999999999999999999999864 36
Q ss_pred ceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEeccccccc
Q 037068 763 HFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSRIK 842 (967)
Q Consensus 763 ~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr~~ 842 (967)
.+|+||||+.++.+..+ . ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||+++..
T Consensus 96 ~~~iv~Ey~~~~l~~~~-~---~~~~~~~i~~~~~qil~gl~~LH~~--giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI-Q---MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHHH-T---SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHhh-h---cCCCHHHHHHHHHHHHHHHHHhhhc--ccccccCCccccccccccceeeechhhhhcc
Confidence 78999999977655444 2 3589999999999999999999999 7999999999999999999999999998865
Q ss_pred ccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHHHhhhhc----------------
Q 037068 843 HHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQVVGAVGF---------------- 906 (967)
Q Consensus 843 ~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei~~~i~~---------------- 906 (967)
.... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+..
T Consensus 170 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 170 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 5433 34456799999999999999999999999999999999999999987765443322210
Q ss_pred ------ccccc------------CCC------CCCcHHHHHHHHHhhhcCCCCCcCHHHHHHHH
Q 037068 907 ------QNRRL------------EIP------DDIDPAVAQIIRDCWQTEPHLRPSFAQLMSRL 946 (967)
Q Consensus 907 ------~~~~~------------~ip------~~ls~eL~dLI~~CLq~dPe~RPS~~ELLe~L 946 (967)
..... ..+ ...++++.+||++||+.||++|||++|+|+|-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 00000 000 12467889999999999999999999999983
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.6e-37 Score=336.17 Aligned_cols=247 Identities=17% Similarity=0.276 Sum_probs=188.5
Q ss_pred CCeeEeEEeecCCceEEEEeec--CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-----------CCceeEEeeee
Q 037068 692 EDLQIGERIGIGSYGEVYRADW--HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-----------HPNVVLFMGAV 758 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~--~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-----------HpNIVkLig~~ 758 (967)
++|+++++||+|+||+||+|++ +|+.||||++... ....+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999976 5889999998543 234467788999988875 57899999988
Q ss_pred ecc--CceEEEEeecCCCchh--hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCC-----
Q 037068 759 TRS--PHFSILTEFLPRGSLY--RLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNW----- 829 (967)
Q Consensus 759 ~~~--~~l~LVmEy~~gGsL~--~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g----- 829 (967)
... ...+++|+++..+... .........+++..+..++.||+.||+|||+.. ||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~-~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT-CEECSCCSGGGEEEEEEETTTTE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc-CcccccCChhHeeeeccCccccc
Confidence 653 4456666666544332 223344567899999999999999999999843 899999999999997654
Q ss_pred -eEEEEecccccccccCccCCCCCCCCCCccChhccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChhHH-------H
Q 037068 830 -VVKVCDFGLSRIKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATLSVPWKGLNPMQV-------V 901 (967)
Q Consensus 830 -~VKLsDFGLAr~~~~~~~~~~~~~GT~~YmAPE~l~g~~~s~ksDVWSLGvlL~ELlTGk~PF~~~~~~ei-------~ 901 (967)
.+|++|||.++..... .....||+.|+|||++.+..++.++||||+||++++|++|+.||...+.... .
T Consensus 169 ~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred ceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 5999999999865433 3456799999999999999999999999999999999999999975432110 0
Q ss_pred h---hhh----------------cc--------------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCcCHHHH
Q 037068 902 G---AVG----------------FQ--------------------NRRLEIPDDIDPAVAQIIRDCWQTEPHLRPSFAQL 942 (967)
Q Consensus 902 ~---~i~----------------~~--------------------~~~~~ip~~ls~eL~dLI~~CLq~dPe~RPS~~EL 942 (967)
. .+. +. ......+...++++.+||.+||..||.+|||+.|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0 000 00 00111223356789999999999999999999999
Q ss_pred HHH
Q 037068 943 MSR 945 (967)
Q Consensus 943 Le~ 945 (967)
|+|
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=9.1e-22 Score=198.06 Aligned_cols=166 Identities=19% Similarity=0.111 Sum_probs=119.7
Q ss_pred eeEeEEeecCCceEEEEeec-CCCeEEEEEeecCCCC----------------hhhHHHHHHHHHHHHHcCCCceeEEee
Q 037068 694 LQIGERIGIGSYGEVYRADW-HGTEVAVKKFLDQDFS----------------GDSLSQFKCEAEIMLRLRHPNVVLFMG 756 (967)
Q Consensus 694 y~i~k~LGeG~FG~VYka~~-~g~~VAVKkl~~~~~s----------------~~~~~~~~~Ei~ILk~L~HpNIVkLig 756 (967)
+.++++||+|+||+||+|++ +|+.||||++.....+ .........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999975 6889999986431100 011233566888899999999998876
Q ss_pred eeeccCceEEEEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCeEEeccCCCcEEEcCCCeEEEEec
Q 037068 757 AVTRSPHFSILTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTSHPTIVHRDLKSPNLLVDKNWVVKVCDF 836 (967)
Q Consensus 757 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~n~GIVHRDLKPsNILLd~~g~VKLsDF 836 (967)
+. ..+++|||+++..+..+ ++..+..++.||+.+|.|||++ ||+||||||+|||++++ .++|+||
T Consensus 82 ~~----~~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH~~--giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EE----TTEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEEETT-EEEECCC
T ss_pred ec----CCEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHhhC--CEEEccCChhheeeeCC-CEEEEEC
Confidence 53 24799999988765443 3344567899999999999998 79999999999999965 5899999
Q ss_pred ccccccccCccCCCCCCCCCCccCh--h---ccccCCCCchhHHHHHHHHH
Q 037068 837 GLSRIKHHTYLSSKSTAGTPEWMAP--E---VLRNEPANEKCDVYSFGVIL 882 (967)
Q Consensus 837 GLAr~~~~~~~~~~~~~GT~~YmAP--E---~l~g~~~s~ksDVWSLGvlL 882 (967)
|+|+....... ..|... + .+....|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99975443211 011111 0 01235578889999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.18 E-value=3.2e-06 Score=86.04 Aligned_cols=145 Identities=16% Similarity=0.072 Sum_probs=98.5
Q ss_pred hhccCCeeEeEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeeeeccCceEE
Q 037068 688 EILWEDLQIGERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLR-HPNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 688 ei~~e~y~i~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~-HpNIVkLig~~~~~~~l~L 766 (967)
....+.|++.+..+-++...||+....++.+++|+...... .....+.+|..+++.+. +--+.+++.+...++..++
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 33446777777655555678999988888899998654321 12234667888888774 3335677888888888999
Q ss_pred EEeecCCCchhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 037068 767 LTEFLPRGSLYRLLHRPNHQLDERRRMRMALDVAKGMNYLHTS------------------------------------- 809 (967)
Q Consensus 767 VmEy~~gGsL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLHs~------------------------------------- 809 (967)
||++++|.++....... .. ...++.++...|..||+.
T Consensus 88 v~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 99999998886554321 11 122344444445555531
Q ss_pred --------------------CCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 810 --------------------HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 810 --------------------n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
.+.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0138999999999999987777899998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.61 E-value=0.00021 Score=71.77 Aligned_cols=128 Identities=23% Similarity=0.241 Sum_probs=81.3
Q ss_pred EeecCCc-eEEEEeecCCC-eEEEEEeecCCCChhhHHHHHHHHHHHHHcCCC--ceeEEeeeeeccCceEEEEeecCCC
Q 037068 699 RIGIGSY-GEVYRADWHGT-EVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHP--NVVLFMGAVTRSPHFSILTEFLPRG 774 (967)
Q Consensus 699 ~LGeG~F-G~VYka~~~g~-~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~Hp--NIVkLig~~~~~~~l~LVmEy~~gG 774 (967)
.+..|.. ..||+....+. .+++|...... ...+..|...++.+... .+.+++.+..+++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4555554 67899977544 57777654322 22466788888877433 3567788878888899999999887
Q ss_pred chhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 037068 775 SLYRLLHRPNHQLDERRRMRMALDVAKGMNYLH----------------------------------------------- 807 (967)
Q Consensus 775 sL~~lL~~~~~~Lse~~i~~I~~QIa~aL~YLH----------------------------------------------- 807 (967)
++.... .... .++.++...|.-||
T Consensus 92 ~~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 92 DLLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp ETTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 654321 1111 11122222222222
Q ss_pred ----hc-----CCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 808 ----TS-----HPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 808 ----s~-----n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
+. .+.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 21 1148999999999999988778899998774
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.97 E-value=0.00029 Score=74.15 Aligned_cols=51 Identities=12% Similarity=-0.020 Sum_probs=46.1
Q ss_pred ecccccchhhHHHHHHHhhhcCCceeEeeccccccCCCCceEEEEcCCC-ceeeeec
Q 037068 272 CLDVGLSRHRALLFKVLADRINLPCMLVKGSYYTGTDDGAVNLIKLDNG-SEYIIDL 327 (967)
Q Consensus 272 ~l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~~~~a~~~v~~~~~-~~~~~dl 327 (967)
.-|+|.|.++|.+|-.+|-.+|||+|+|.| ..+|+|++|.+.+. +|.-||-
T Consensus 137 ~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~-----~~~H~W~Ev~~~~~~rWv~vDp 188 (287)
T d2f4ma1 137 ETRCGRCGEWANCFTLCCRALGFEARYVWD-----YTDHVWTEVYSPSQQRWLHCDA 188 (287)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEE-----TTTEEEEEEEETTTTEEEEEET
T ss_pred HhcCccHHHHHHHHHHHHHHcCCCeEEEec-----CCcceeEEEEecCCCcEEEecC
Confidence 568999999999999999999999999999 35899999999765 5999996
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.86 E-value=0.0015 Score=70.96 Aligned_cols=77 Identities=14% Similarity=0.111 Sum_probs=48.5
Q ss_pred eEEeecCCceEEEEeecC--CCeEEEEEeecC-CC----ChhhHHHHHHHHHHHHHcC-C--CceeEEeeeeeccCceEE
Q 037068 697 GERIGIGSYGEVYRADWH--GTEVAVKKFLDQ-DF----SGDSLSQFKCEAEIMLRLR-H--PNVVLFMGAVTRSPHFSI 766 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~--g~~VAVKkl~~~-~~----s~~~~~~~~~Ei~ILk~L~-H--pNIVkLig~~~~~~~l~L 766 (967)
.+.||.|....||++... ++.++||.-... .. ......+...|...|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457999999999999753 567888865321 00 1122344556888887662 2 345556554 3445689
Q ss_pred EEeecCCCc
Q 037068 767 LTEFLPRGS 775 (967)
Q Consensus 767 VmEy~~gGs 775 (967)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.29 E-value=0.028 Score=60.34 Aligned_cols=76 Identities=21% Similarity=0.359 Sum_probs=49.3
Q ss_pred CCeeEeEEeecCCceEEEEeecC---------CCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeeeecc
Q 037068 692 EDLQIGERIGIGSYGEVYRADWH---------GTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-VLFMGAVTRS 761 (967)
Q Consensus 692 e~y~i~k~LGeG~FG~VYka~~~---------g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-VkLig~~~~~ 761 (967)
+++++ +.|+-|-.=.+|++... ...|.+++.-. . ...-...+|..+++.+.-.++ .++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34544 67887888899998643 24466666532 1 122345679999998853344 477777653
Q ss_pred CceEEEEeecCCCch
Q 037068 762 PHFSILTEFLPRGSL 776 (967)
Q Consensus 762 ~~l~LVmEy~~gGsL 776 (967)
.+|+||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.14 E-value=0.025 Score=58.32 Aligned_cols=140 Identities=12% Similarity=0.014 Sum_probs=72.8
Q ss_pred eEEeecCCceEEEEeecCCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce-----eEEee---eeeccCceEEEE
Q 037068 697 GERIGIGSYGEVYRADWHGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV-----VLFMG---AVTRSPHFSILT 768 (967)
Q Consensus 697 ~k~LGeG~FG~VYka~~~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI-----VkLig---~~~~~~~l~LVm 768 (967)
.+.|..|---+.|+.+.++..+++|++... .+ ..++..|+.++..|...++ +...+ +.........++
T Consensus 23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~-~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~ 98 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTTKDPLILTLYEKR-VE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 98 (316)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eecCCCCcccCeEEEEECCCcEEEEEcCCC-CC---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceee
Confidence 344556666788999877778999987432 12 2345557777777743222 21111 112234455666
Q ss_pred eecCCCchhhhh--------------c----CC----CCCCCHH------------------HHHHHHHHHHHHHHHHHh
Q 037068 769 EFLPRGSLYRLL--------------H----RP----NHQLDER------------------RRMRMALDVAKGMNYLHT 808 (967)
Q Consensus 769 Ey~~gGsL~~lL--------------~----~~----~~~Lse~------------------~i~~I~~QIa~aL~YLHs 808 (967)
.++.+....... . .. ....... .....+..+...+...+.
T Consensus 99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (316)
T d2ppqa1 99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 178 (316)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence 666554331110 0 00 0000000 011222222222222221
Q ss_pred --cCCCeEEeccCCCcEEEcCCCeEEEEeccccc
Q 037068 809 --SHPTIVHRDLKSPNLLVDKNWVVKVCDFGLSR 840 (967)
Q Consensus 809 --~n~GIVHRDLKPsNILLd~~g~VKLsDFGLAr 840 (967)
...|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 179 ~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 179 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccccCCcchhhhhcccccceeEecccccc
Confidence 12379999999999999988878999999885
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.55 E-value=0.065 Score=55.90 Aligned_cols=131 Identities=12% Similarity=0.114 Sum_probs=73.8
Q ss_pred eEEEEeec-CCCeEEEEEeecCCCChhhHHHHHHHHHHHHHcCCCce--eEEee-----eeeccCceEEEEeecCCCchh
Q 037068 706 GEVYRADW-HGTEVAVKKFLDQDFSGDSLSQFKCEAEIMLRLRHPNV--VLFMG-----AVTRSPHFSILTEFLPRGSLY 777 (967)
Q Consensus 706 G~VYka~~-~g~~VAVKkl~~~~~s~~~~~~~~~Ei~ILk~L~HpNI--VkLig-----~~~~~~~l~LVmEy~~gGsL~ 777 (967)
-.||+++. +|+.+++|+...... ..+++..|...+..|...+| +..+. .+..++..+.+++++.|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 48999976 577899998654322 34567778888888743222 11111 223456678899998765432
Q ss_pred h-----h------h-------cCC----CCCCCHH-------------------HHHHHHHHHHHHHHHHHh-----cCC
Q 037068 778 R-----L------L-------HRP----NHQLDER-------------------RRMRMALDVAKGMNYLHT-----SHP 811 (967)
Q Consensus 778 ~-----l------L-------~~~----~~~Lse~-------------------~i~~I~~QIa~aL~YLHs-----~n~ 811 (967)
. + + ... ...++.. ....+...+-..++.+.. ...
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 1 0 000 0111111 111122222233333322 123
Q ss_pred CeEEeccCCCcEEEcCCCeEEEEecccccc
Q 037068 812 TIVHRDLKSPNLLVDKNWVVKVCDFGLSRI 841 (967)
Q Consensus 812 GIVHRDLKPsNILLd~~g~VKLsDFGLAr~ 841 (967)
++||+|+.+.|||++++ ..++||+.++.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 79999999999999754 34789998864
|
| >d2q3za4 d.3.1.4 (A:146-461) Transglutaminase catalytic domain {Human (Homo sapiens), tissue isozyme [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Transglutaminase catalytic domain species: Human (Homo sapiens), tissue isozyme [TaxId: 9606]
Probab=92.69 E-value=0.021 Score=59.68 Aligned_cols=48 Identities=17% Similarity=0.151 Sum_probs=36.8
Q ss_pred hHHHHHHHHHHhhcCceeeeeecccccchhhHHHHHHHhhhcCCceeEeec
Q 037068 251 RWTLRRTQLRNSLNTNILPLGCLDVGLSRHRALLFKVLADRINLPCMLVKG 301 (967)
Q Consensus 251 ~~~~~~~~l~~~~~~~v~plg~l~~g~~~~~a~lfk~~~d~~~~~~~lv~G 301 (967)
.|.-...-|++=+.+.+-| +|.|-|-|+|-.+-+++-.+|||||+|.|
T Consensus 108 ~W~GSv~IL~q~~~~~~~p---VkyGqCwvFA~v~~tvlR~lGIPaRvVT~ 155 (316)
T d2q3za4 108 SWIGSVDILRRWKNHGCQR---VKYGQCWVFAAVACTVLRCLGIPTRVVTN 155 (316)
T ss_dssp TCCBSHHHHHHHHHTTTCC---EEEECHHHHHHHHHHHHHHHTCCEEEEEE
T ss_pred CCCCcHHHHHHHHHcCCcc---cccchhHHHHHHHHHHHHhcCCCceEecc
Confidence 3444444444444444444 79999999999999999999999999999
|
| >d1x3za1 d.3.1.4 (A:8-327) Peptide:N-glycanase 1, PNG1 {Baker's yeast(Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Baker's yeast(Saccharomyces cerevisiae) [TaxId: 4932]
Probab=84.86 E-value=0.39 Score=50.20 Aligned_cols=58 Identities=14% Similarity=-0.013 Sum_probs=49.2
Q ss_pred ceeeeeecccccchhhHHHHHHHhhhcCCceeEeeccccccCCCCceEEEEcCCC-ceeeeecc
Q 037068 266 NILPLGCLDVGLSRHRALLFKVLADRINLPCMLVKGSYYTGTDDGAVNLIKLDNG-SEYIIDLM 328 (967)
Q Consensus 266 ~v~plg~l~~g~~~~~a~lfk~~~d~~~~~~~lv~G~~y~~~~~~a~~~v~~~~~-~~~~~dlm 328 (967)
++.-|=.-|.|=|-.+|.+|-.+|..+|+++|.|.- ..||.|++|..... +|-=||..
T Consensus 172 ~p~~LL~tR~GRcgEwan~F~~~~ra~g~~aR~V~~-----~~DhvW~EVys~~~kRWIhvDpc 230 (320)
T d1x3za1 172 DPIKLLETRKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFLNRWVHVDSC 230 (320)
T ss_dssp CHHHHHHHCEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTTTEEEEEETT
T ss_pred CHHHHHhhcCcchHHHHHHHHHHHHHcCCceEEEEE-----CCCceEEEEeecccCeEEEEcCC
Confidence 334455789999999999999999999999999987 66999999999765 47778863
|